The table below lists the options of the executed module.
Option | Value |
---|---|
analyze.sites | yes |
differential.report.sites | yes |
region.types | default |
differential.permutations | 0 |
differential.comparison.columns | 6, 7 |
differential.comparison.columns.all.pairwise | 6, 7 |
columns.pairing | default |
differential.site.test.method | limma |
differential.variability | no |
differential.variability.method | diffVar |
covariate.adjustment.columns | default |
differential.adjustment.sva | no |
differential.adjustment.celltype | no |
differential.enrichment.go | yes |
differential.enrichment.lola | no |
differential.enrichment.lola.dbs | ${LOLACore} |
Differential methylation analysis was conducted on site and region level according to the sample groups specified in the analysis.
The following comparisons were made:
In the following anlyses, p-values on the site level were computed using the limma
method. I.e. hierarchical linear models from the limma package were employed and fitted using an empirical Bayes approach on derived M-values.
Differential methylation on the site level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each site: a) the difference in mean methylation levels of the two groups being compared, b) the quotient in mean methylation and c) a statistical test (limma or t-test depending on the settings) assessing whether the methylation values in the two groups originate from distinct distributions. Additionally each site was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) rank among the three ranks. The smaller the combined rank for a site, the more evidence for differential methylation it exhibits. This section includes scatterplots of the site group means as well as volcano plots of each pairwise comparison colored according to the combined ranks or p-values of a given site.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated sites:
Rank Cutoff | |
BrM_ERP vs. BrM_HER2P (based on Tiss_Subprim) | 45 |
BrM_ERP vs. BrM_TNBC (based on Tiss_Subprim) | 73153 |
BrM_ERP vs. Bx_ERP (based on Tiss_Subprim) | 0 |
BrM_ERP vs. Bx_HER2P (based on Tiss_Subprim) | 201 |
BrM_ERP vs. Bx_TNBC (based on Tiss_Subprim) | 76661 |
BrM_HER2P vs. BrM_TNBC (based on Tiss_Subprim) | 81041 |
BrM_HER2P vs. Bx_ERP (based on Tiss_Subprim) | 95461 |
BrM_HER2P vs. Bx_HER2P (based on Tiss_Subprim) | 87803 |
BrM_HER2P vs. Bx_TNBC (based on Tiss_Subprim) | 79388 |
BrM_TNBC vs. Bx_ERP (based on Tiss_Subprim) | 71052 |
BrM_TNBC vs. Bx_HER2P (based on Tiss_Subprim) | 75153 |
BrM_TNBC vs. Bx_TNBC (based on Tiss_Subprim) | 56404 |
Bx_ERP vs. Bx_HER2P (based on Tiss_Subprim) | 4 |
Bx_ERP vs. Bx_TNBC (based on Tiss_Subprim) | 67795 |
Bx_HER2P vs. Bx_TNBC (based on Tiss_Subprim) | 61717 |
NT vs. YT (based on NT) | 97803 |
comparison | |
differential methylation measure |
Scatterplot for differential methylation (sites). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling.The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points).Additionally, the colored points represent differentially methylated sites (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the site level for the individual comparisons are provided in this section. Below, a brief explanation of the different columns can be found:
The tables for the individual comparisons can be found here:
Differential methylation on the region level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each region: the mean difference in means across all sites in a region of the two groups being compared and the mean of quotients in mean methylation as well as a combined p-value calculated from all site p-values in the region [1]. Additionally each region was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) value among the three ranks. The smaller the combined rank for a region, the more evidence for differential methylation it exhibits. Regions were defined based on the region types specified in the analysis. This section includes scatterplots of the region group means as well as volcano plots of each pairwise comparison colored according to the combined rank of a given region.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated regions:
tiling | genes | promoters | cpgislands | |
BrM_ERP vs. BrM_HER2P (based on Tiss_Subprim) | 0 | 10 | 40 | 0 |
BrM_ERP vs. BrM_TNBC (based on Tiss_Subprim) | 6873 | 19 | 305 | 355 |
BrM_ERP vs. Bx_ERP (based on Tiss_Subprim) | 46 | 11 | 0 | 12 |
BrM_ERP vs. Bx_HER2P (based on Tiss_Subprim) | 6 | 0 | 0 | 1 |
BrM_ERP vs. Bx_TNBC (based on Tiss_Subprim) | 77 | 0 | 60 | 177 |
BrM_HER2P vs. BrM_TNBC (based on Tiss_Subprim) | 10318 | 1021 | 1185 | 1329 |
BrM_HER2P vs. Bx_ERP (based on Tiss_Subprim) | 1958 | 45 | 13 | 0 |
BrM_HER2P vs. Bx_HER2P (based on Tiss_Subprim) | 155 | 0 | 0 | 0 |
BrM_HER2P vs. Bx_TNBC (based on Tiss_Subprim) | 5120 | 343 | 2972 | 1537 |
BrM_TNBC vs. Bx_ERP (based on Tiss_Subprim) | 8917 | 220 | 1549 | 1316 |
BrM_TNBC vs. Bx_HER2P (based on Tiss_Subprim) | 5505 | 1475 | 1249 | 2321 |
BrM_TNBC vs. Bx_TNBC (based on Tiss_Subprim) | 94 | 0 | 71 | 39 |
Bx_ERP vs. Bx_HER2P (based on Tiss_Subprim) | 93 | 0 | 25 | 2 |
Bx_ERP vs. Bx_TNBC (based on Tiss_Subprim) | 4104 | 9 | 3 | 70 |
Bx_HER2P vs. Bx_TNBC (based on Tiss_Subprim) | 3087 | 46 | 1351 | 872 |
NT vs. YT (based on NT) | 6882 | 1380 | 2098 | 2799 |
comparison | |
regions | |
differential methylation measure |
Scatterplot for differential methylation (regions). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly.
Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
regions | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the region level for the individual comparisons are provided in this section.
The tables for the individual comparisons can be found here:
tiling | genes | promoters | cpgislands | |
BrM_ERP vs. BrM_HER2P (based on Tiss_Subprim) | csv | csv | csv | csv |
BrM_ERP vs. BrM_TNBC (based on Tiss_Subprim) | csv | csv | csv | csv |
BrM_ERP vs. Bx_ERP (based on Tiss_Subprim) | csv | csv | csv | csv |
BrM_ERP vs. Bx_HER2P (based on Tiss_Subprim) | csv | csv | csv | csv |
BrM_ERP vs. Bx_TNBC (based on Tiss_Subprim) | csv | csv | csv | csv |
BrM_HER2P vs. BrM_TNBC (based on Tiss_Subprim) | csv | csv | csv | csv |
BrM_HER2P vs. Bx_ERP (based on Tiss_Subprim) | csv | csv | csv | csv |
BrM_HER2P vs. Bx_HER2P (based on Tiss_Subprim) | csv | csv | csv | csv |
BrM_HER2P vs. Bx_TNBC (based on Tiss_Subprim) | csv | csv | csv | csv |
BrM_TNBC vs. Bx_ERP (based on Tiss_Subprim) | csv | csv | csv | csv |
BrM_TNBC vs. Bx_HER2P (based on Tiss_Subprim) | csv | csv | csv | csv |
BrM_TNBC vs. Bx_TNBC (based on Tiss_Subprim) | csv | csv | csv | csv |
Bx_ERP vs. Bx_HER2P (based on Tiss_Subprim) | csv | csv | csv | csv |
Bx_ERP vs. Bx_TNBC (based on Tiss_Subprim) | csv | csv | csv | csv |
Bx_HER2P vs. Bx_TNBC (based on Tiss_Subprim) | csv | csv | csv | csv |
NT vs. YT (based on NT) | csv | csv | csv | csv |
GO Enrichment Analysis was conducted using a hypergeometric test that addresses the hierarchical structure of the ontology (see [2] for details). The wordclouds and tables below contain significant GO terms according to these tests.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
Wordclouds for GO enrichment terms.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 47.5422 | 0.2784 | 8 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 35.1144 | 0.3716 | 8 | 287 | detection of chemical stimulus |
GO:0007606 | 0 | 33.8781 | 0.3845 | 8 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 32.0686 | 0.4052 | 8 | 313 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 9.7041 | 1.261 | 8 | 974 | G protein-coupled receptor signaling pathway |
GO:0050877 | 1e-04 | 7.6163 | 1.5782 | 8 | 1219 | nervous system process |
GO:0044335 | 0.0026 | 809.9 | 0.0026 | 1 | 2 | canonical Wnt signaling pathway involved in neural crest cell differentiation |
GO:0009822 | 0.0039 | 404.925 | 0.0039 | 1 | 3 | alkaloid catabolic process |
GO:0036378 | 0.0052 | 269.9333 | 0.0052 | 1 | 4 | calcitriol biosynthetic process from calciol |
GO:0042369 | 0.0052 | 269.9333 | 0.0052 | 1 | 4 | vitamin D catabolic process |
GO:0044107 | 0.0052 | 269.9333 | 0.0052 | 1 | 4 | cellular alcohol metabolic process |
GO:0044278 | 0.0052 | 269.9333 | 0.0052 | 1 | 4 | cell wall disruption in another organism |
GO:0061317 | 0.0065 | 202.4375 | 0.0065 | 1 | 5 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment |
GO:0035195 | 0.0068 | 8.8029 | 0.3936 | 3 | 304 | miRNA-mediated gene silencing |
GO:0016441 | 0.0075 | 8.459 | 0.4091 | 3 | 316 | post-transcriptional gene silencing |
GO:0014034 | 0.0077 | 161.94 | 0.0078 | 1 | 6 | neural crest cell fate commitment |
GO:0016098 | 0.0077 | 161.94 | 0.0078 | 1 | 6 | monoterpenoid metabolic process |
GO:0002933 | 0.009 | 134.9417 | 0.0091 | 1 | 7 | lipid hydroxylation |
GO:0045617 | 0.009 | 134.9417 | 0.0091 | 1 | 7 | negative regulation of keratinocyte differentiation |
GO:0046222 | 0.009 | 134.9417 | 0.0091 | 1 | 7 | aflatoxin metabolic process |
GO:0031047 | 0.009 | 7.8925 | 0.4376 | 3 | 338 | gene silencing by RNA |
GO:0055007 | 0.0093 | 15.2565 | 0.1463 | 2 | 113 | cardiac muscle cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 2020.5 | 0.0947 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 243.8485 | 0.3078 | 26 | 104 | nucleosome assembly |
GO:0071824 | 0 | 102.6897 | 0.6215 | 26 | 210 | protein-DNA complex subunit organization |
GO:0032200 | 0 | 121.5152 | 0.4617 | 24 | 156 | telomere organization |
GO:0006338 | 0 | 89.3981 | 0.7014 | 26 | 237 | chromatin remodeling |
GO:0045653 | 0 | 1664.3529 | 0.0533 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006336 | 0 | 369.5359 | 0.0947 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0006352 | 0 | 60.1251 | 0.367 | 14 | 124 | DNA-templated transcription, initiation |
GO:0065003 | 0 | 13.7923 | 4.1608 | 27 | 1406 | protein-containing complex assembly |
GO:0045637 | 0 | 35.7788 | 0.5859 | 14 | 198 | regulation of myeloid cell differentiation |
GO:0040029 | 0 | 34.3368 | 0.3936 | 10 | 133 | regulation of gene expression, epigenetic |
GO:0045596 | 0 | 11.5176 | 1.8614 | 15 | 629 | negative regulation of cell differentiation |
GO:0044085 | 0 | 6.3643 | 8.7122 | 28 | 2944 | cellular component biogenesis |
GO:0006996 | 0 | 5.8918 | 10.6417 | 30 | 3596 | organelle organization |
GO:0002520 | 0 | 7.7222 | 2.7048 | 15 | 914 | immune system development |
GO:0030097 | 0 | 7.8913 | 2.4148 | 14 | 816 | hemopoiesis |
GO:2000026 | 0 | 5.2884 | 3.8323 | 15 | 1295 | regulation of multicellular organismal development |
GO:0097659 | 0 | 3.7794 | 9.4372 | 23 | 3189 | nucleic acid-templated transcription |
GO:0002682 | 0 | 4.9197 | 3.7376 | 14 | 1263 | regulation of immune system process |
GO:0034654 | 1e-04 | 3.2841 | 10.5411 | 23 | 3562 | nucleobase-containing compound biosynthetic process |
GO:0048513 | 5e-04 | 2.8477 | 9.6562 | 20 | 3263 | animal organ development |
GO:0065007 | 9e-04 | 3.7846 | 33.3603 | 43 | 11273 | biological regulation |
GO:0009059 | 0.0011 | 2.5824 | 12.6392 | 23 | 4271 | macromolecule biosynthetic process |
GO:0016070 | 0.0012 | 2.5603 | 12.7191 | 23 | 4298 | RNA metabolic process |
GO:0010467 | 0.0013 | 3.7979 | 4.9018 | 12 | 2555 | gene expression |
GO:0048485 | 0.0019 | 35.113 | 0.0651 | 2 | 22 | sympathetic nervous system development |
GO:0008152 | 0.0022 | 3.0211 | 31.6942 | 41 | 10710 | metabolic process |
GO:0046483 | 0.0023 | 2.3766 | 15.9714 | 26 | 5397 | heterocycle metabolic process |
GO:0044249 | 0.0027 | 2.3436 | 15.2375 | 25 | 5149 | cellular biosynthetic process |
GO:0097275 | 0.003 | Inf | 0.003 | 1 | 1 | cellular ammonium homeostasis |
GO:0097276 | 0.003 | Inf | 0.003 | 1 | 1 | cellular creatinine homeostasis |
GO:0097277 | 0.003 | Inf | 0.003 | 1 | 1 | cellular urea homeostasis |
GO:2000763 | 0.003 | Inf | 0.003 | 1 | 1 | positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process |
GO:2000764 | 0.003 | Inf | 0.003 | 1 | 1 | positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis |
GO:0007631 | 0.0032 | 11.0481 | 0.2959 | 3 | 100 | feeding behavior |
GO:1901360 | 0.005 | 2.1997 | 16.803 | 26 | 5678 | organic cyclic compound metabolic process |
GO:0002032 | 0.0059 | 344.0638 | 0.0059 | 1 | 2 | desensitization of G protein-coupled receptor signaling pathway by arrestin |
GO:0042412 | 0.0059 | 344.0638 | 0.0059 | 1 | 2 | taurine biosynthetic process |
GO:0061032 | 0.0059 | 344.0638 | 0.0059 | 1 | 2 | visceral serous pericardium development |
GO:0061885 | 0.0059 | 344.0638 | 0.0059 | 1 | 2 | positive regulation of mini excitatory postsynaptic potential |
GO:0090663 | 0.0059 | 344.0638 | 0.0059 | 1 | 2 | galanin-activated signaling pathway |
GO:1903929 | 0.0059 | 344.0638 | 0.0059 | 1 | 2 | primary palate development |
GO:0002025 | 0.0089 | 172.0213 | 0.0089 | 1 | 3 | norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure |
GO:0009822 | 0.0089 | 172.0213 | 0.0089 | 1 | 3 | alkaloid catabolic process |
GO:2001260 | 0.0089 | 172.0213 | 0.0089 | 1 | 3 | regulation of semaphorin-plexin signaling pathway |
GO:0021515 | 0.0096 | 14.6051 | 0.148 | 2 | 50 | cell differentiation in spinal cord |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048252 | 0 | 3601.7778 | 0.002 | 2 | 3 | lauric acid metabolic process |
GO:0043651 | 1e-04 | 224.9028 | 0.0122 | 2 | 18 | linoleic acid metabolic process |
GO:0046456 | 6e-04 | 70.4052 | 0.0359 | 2 | 53 | icosanoid biosynthetic process |
GO:1901625 | 7e-04 | Inf | 7e-04 | 1 | 1 | cellular response to ergosterol |
GO:1905608 | 7e-04 | Inf | 7e-04 | 1 | 1 | positive regulation of presynapse assembly |
GO:0003095 | 0.0014 | 1620.8 | 0.0014 | 1 | 2 | pressure natriuresis |
GO:0031408 | 0.0014 | 1620.8 | 0.0014 | 1 | 2 | oxylipin biosynthetic process |
GO:0015908 | 0.0018 | 38.93 | 0.0637 | 2 | 94 | fatty acid transport |
GO:0036101 | 0.0027 | 540.2 | 0.0027 | 1 | 4 | leukotriene B4 catabolic process |
GO:0002933 | 0.0047 | 270.05 | 0.0047 | 1 | 7 | lipid hydroxylation |
GO:0048680 | 0.0061 | 202.5125 | 0.0061 | 1 | 9 | positive regulation of axon regeneration |
GO:0097267 | 0.0061 | 202.5125 | 0.0061 | 1 | 9 | omega-hydroxylase P450 pathway |
GO:0050911 | 0.0089 | 16.6886 | 0.1458 | 2 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0010536 | 0 | 426.1842 | 0.0078 | 2 | 6 | positive regulation of activation of Janus kinase activity |
GO:0046427 | 0.0012 | 44.7673 | 0.0518 | 2 | 40 | positive regulation of receptor signaling pathway via JAK-STAT |
GO:0071622 | 0.0016 | 38.6483 | 0.0596 | 2 | 46 | regulation of granulocyte chemotaxis |
GO:0002573 | 0.0021 | 13.608 | 0.2576 | 3 | 199 | myeloid leukocyte differentiation |
GO:0050918 | 0.0024 | 31.4717 | 0.0725 | 2 | 56 | positive chemotaxis |
GO:0050920 | 0.0024 | 12.876 | 0.2719 | 3 | 210 | regulation of chemotaxis |
GO:0042531 | 0.0027 | 29.294 | 0.0777 | 2 | 60 | positive regulation of tyrosine phosphorylation of STAT protein |
GO:0072503 | 0.0027 | 8.0327 | 0.602 | 4 | 465 | cellular divalent inorganic cation homeostasis |
GO:0045670 | 0.003 | 27.8481 | 0.0816 | 2 | 63 | regulation of osteoclast differentiation |
GO:0035924 | 0.0033 | 26.5378 | 0.0855 | 2 | 66 | cellular response to vascular endothelial growth factor stimulus |
GO:0009822 | 0.0039 | 404.925 | 0.0039 | 1 | 3 | alkaloid catabolic process |
GO:2000503 | 0.0039 | 404.925 | 0.0039 | 1 | 3 | positive regulation of natural killer cell chemotaxis |
GO:0014068 | 0.0045 | 22.331 | 0.101 | 2 | 78 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0006875 | 0.005 | 6.7201 | 0.7147 | 4 | 552 | cellular metal ion homeostasis |
GO:0040017 | 0.0051 | 6.6948 | 0.7173 | 4 | 554 | positive regulation of locomotion |
GO:0036378 | 0.0052 | 269.9333 | 0.0052 | 1 | 4 | calcitriol biosynthetic process from calciol |
GO:0042369 | 0.0052 | 269.9333 | 0.0052 | 1 | 4 | vitamin D catabolic process |
GO:0044107 | 0.0052 | 269.9333 | 0.0052 | 1 | 4 | cellular alcohol metabolic process |
GO:2000330 | 0.0052 | 269.9333 | 0.0052 | 1 | 4 | positive regulation of T-helper 17 cell lineage commitment |
GO:0002690 | 0.0056 | 19.9554 | 0.1126 | 2 | 87 | positive regulation of leukocyte chemotaxis |
GO:0060326 | 0.0058 | 9.3064 | 0.3729 | 3 | 288 | cell chemotaxis |
GO:1990869 | 0.0058 | 19.4943 | 0.1152 | 2 | 89 | cellular response to chemokine |
GO:0042102 | 0.0064 | 18.6327 | 0.1204 | 2 | 93 | positive regulation of T cell proliferation |
GO:0009617 | 0.0064 | 6.2359 | 0.7678 | 4 | 593 | response to bacterium |
GO:1904892 | 0.0065 | 18.4291 | 0.1217 | 2 | 94 | regulation of receptor signaling pathway via STAT |
GO:0030593 | 0.0068 | 18.0347 | 0.1243 | 2 | 96 | neutrophil chemotaxis |
GO:0006805 | 0.0069 | 17.8438 | 0.1256 | 2 | 97 | xenobiotic metabolic process |
GO:0001676 | 0.0073 | 17.2943 | 0.1295 | 2 | 100 | long-chain fatty acid metabolic process |
GO:0016098 | 0.0077 | 161.94 | 0.0078 | 1 | 6 | monoterpenoid metabolic process |
GO:0031584 | 0.0077 | 161.94 | 0.0078 | 1 | 6 | activation of phospholipase D activity |
GO:0033634 | 0.0077 | 161.94 | 0.0078 | 1 | 6 | positive regulation of cell-cell adhesion mediated by integrin |
GO:0051142 | 0.0077 | 161.94 | 0.0078 | 1 | 6 | positive regulation of NK T cell proliferation |
GO:0070100 | 0.0077 | 161.94 | 0.0078 | 1 | 6 | negative regulation of chemokine-mediated signaling pathway |
GO:0006873 | 0.0081 | 5.834 | 0.8182 | 4 | 632 | cellular ion homeostasis |
GO:0006955 | 0.0085 | 4.0811 | 1.8799 | 6 | 1452 | immune response |
GO:0050867 | 0.0089 | 7.9409 | 0.435 | 3 | 336 | positive regulation of cell activation |
GO:0002933 | 0.009 | 134.9417 | 0.0091 | 1 | 7 | lipid hydroxylation |
GO:0007597 | 0.009 | 134.9417 | 0.0091 | 1 | 7 | blood coagulation, intrinsic pathway |
GO:0019367 | 0.009 | 134.9417 | 0.0091 | 1 | 7 | fatty acid elongation, saturated fatty acid |
GO:0034625 | 0.009 | 134.9417 | 0.0091 | 1 | 7 | fatty acid elongation, monounsaturated fatty acid |
GO:0034626 | 0.009 | 134.9417 | 0.0091 | 1 | 7 | fatty acid elongation, polyunsaturated fatty acid |
GO:0046222 | 0.009 | 134.9417 | 0.0091 | 1 | 7 | aflatoxin metabolic process |
GO:0006952 | 0.0099 | 3.94 | 1.9408 | 6 | 1499 | defense response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003002 | 2e-04 | 11.2372 | 0.5466 | 5 | 341 | regionalization |
GO:0048598 | 3e-04 | 8.0046 | 0.9473 | 6 | 591 | embryonic morphogenesis |
GO:0048704 | 4e-04 | 23.3391 | 0.1491 | 3 | 93 | embryonic skeletal system morphogenesis |
GO:0006357 | 5e-04 | 4.3788 | 3.7413 | 11 | 2334 | regulation of transcription by RNA polymerase II |
GO:0048568 | 6e-04 | 8.646 | 0.7037 | 5 | 439 | embryonic organ development |
GO:0021767 | 0.0016 | Inf | 0.0016 | 1 | 1 | mammillary body development |
GO:0042668 | 0.0016 | Inf | 0.0016 | 1 | 1 | auditory receptor cell fate determination |
GO:0045609 | 0.0016 | Inf | 0.0016 | 1 | 1 | positive regulation of inner ear auditory receptor cell differentiation |
GO:0045633 | 0.0016 | Inf | 0.0016 | 1 | 1 | positive regulation of mechanoreceptor differentiation |
GO:0061374 | 0.0016 | Inf | 0.0016 | 1 | 1 | mammillothalamic axonal tract development |
GO:0061381 | 0.0016 | Inf | 0.0016 | 1 | 1 | cell migration in diencephalon |
GO:1901625 | 0.0016 | Inf | 0.0016 | 1 | 1 | cellular response to ergosterol |
GO:0014014 | 0.0019 | 34.5192 | 0.0657 | 2 | 41 | negative regulation of gliogenesis |
GO:0021543 | 0.0021 | 13.1542 | 0.2597 | 3 | 162 | pallium development |
GO:0030900 | 0.0024 | 8.0657 | 0.5787 | 4 | 361 | forebrain development |
GO:0043009 | 0.0027 | 6.0416 | 0.9922 | 5 | 619 | chordate embryonic development |
GO:0021893 | 0.0032 | 647.72 | 0.0032 | 1 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:0042667 | 0.0032 | 647.72 | 0.0032 | 1 | 2 | auditory receptor cell fate specification |
GO:0061379 | 0.0032 | 647.72 | 0.0032 | 1 | 2 | inferior colliculus development |
GO:1902871 | 0.0032 | 647.72 | 0.0032 | 1 | 2 | positive regulation of amacrine cell differentiation |
GO:1905590 | 0.0032 | 647.72 | 0.0032 | 1 | 2 | fibronectin fibril organization |
GO:0007417 | 0.0037 | 4.7396 | 1.5549 | 6 | 970 | central nervous system development |
GO:0032501 | 0.0038 | 3.1883 | 10.7687 | 18 | 6718 | multicellular organismal process |
GO:0007412 | 0.0048 | 323.84 | 0.0048 | 1 | 3 | axon target recognition |
GO:0046952 | 0.0048 | 323.84 | 0.0048 | 1 | 3 | ketone body catabolic process |
GO:1903506 | 0.0052 | 3.1425 | 4.9291 | 11 | 3075 | regulation of nucleic acid-templated transcription |
GO:0009888 | 0.0059 | 3.5474 | 2.903 | 8 | 1811 | tissue development |
GO:0060322 | 0.006 | 4.9513 | 1.199 | 5 | 748 | head development |
GO:0019219 | 0.0062 | 2.9752 | 5.8252 | 12 | 3634 | regulation of nucleobase-containing compound metabolic process |
GO:0001550 | 0.0064 | 215.88 | 0.0064 | 1 | 4 | ovarian cumulus expansion |
GO:0061030 | 0.0064 | 215.88 | 0.0064 | 1 | 4 | epithelial cell differentiation involved in mammary gland alveolus development |
GO:0061737 | 0.0064 | 215.88 | 0.0064 | 1 | 4 | leukotriene signaling pathway |
GO:0090024 | 0.0064 | 215.88 | 0.0064 | 1 | 4 | negative regulation of neutrophil chemotaxis |
GO:0006351 | 0.0068 | 3.0058 | 5.1086 | 11 | 3187 | transcription, DNA-templated |
GO:0032774 | 0.0072 | 2.9848 | 5.1375 | 11 | 3205 | RNA biosynthetic process |
GO:0021855 | 0.008 | 161.9 | 0.008 | 1 | 5 | hypothalamus cell migration |
GO:0060120 | 0.008 | 161.9 | 0.008 | 1 | 5 | inner ear receptor cell fate commitment |
GO:0097211 | 0.008 | 161.9 | 0.008 | 1 | 5 | cellular response to gonadotropin-releasing hormone |
GO:0046533 | 0.0096 | 129.512 | 0.0096 | 1 | 6 | negative regulation of photoreceptor cell differentiation |
GO:1903911 | 0.0096 | 129.512 | 0.0096 | 1 | 6 | positive regulation of receptor clustering |
GO:0001708 | 0.0099 | 14.5851 | 0.1507 | 2 | 94 | cell fate specification |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006334 | 0 | 402.1507 | 0.3078 | 31 | 104 | nucleosome assembly |
GO:0006335 | 0 | 2020.5 | 0.0947 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0071824 | 0 | 162.9257 | 0.6215 | 31 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 141.3324 | 0.7014 | 31 | 237 | chromatin remodeling |
GO:0032200 | 0 | 121.5152 | 0.4617 | 24 | 156 | telomere organization |
GO:0045653 | 0 | 1664.3529 | 0.0533 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006336 | 0 | 369.5359 | 0.0947 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0065003 | 0 | 19.6238 | 4.1608 | 31 | 1406 | protein-containing complex assembly |
GO:0006352 | 0 | 60.1251 | 0.367 | 14 | 124 | DNA-templated transcription, initiation |
GO:0045637 | 0 | 35.7788 | 0.5859 | 14 | 198 | regulation of myeloid cell differentiation |
GO:0040029 | 0 | 39.1117 | 0.3936 | 11 | 133 | regulation of gene expression, epigenetic |
GO:0044085 | 0 | 9.1071 | 8.7122 | 32 | 2944 | cellular component biogenesis |
GO:0045596 | 0 | 10.416 | 1.8614 | 14 | 629 | negative regulation of cell differentiation |
GO:0002227 | 0 | 110.4993 | 0.0651 | 5 | 22 | innate immune response in mucosa |
GO:0002251 | 0 | 67.0432 | 0.0977 | 5 | 33 | organ or tissue specific immune response |
GO:0030097 | 0 | 7.8913 | 2.4148 | 14 | 816 | hemopoiesis |
GO:0002520 | 0 | 6.9872 | 2.7048 | 14 | 914 | immune system development |
GO:0019731 | 0 | 41.6718 | 0.148 | 5 | 50 | antibacterial humoral response |
GO:0051276 | 0 | 11.5977 | 1.1922 | 9 | 798 | chromosome organization |
GO:0061844 | 0 | 28.3756 | 0.2101 | 5 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0016043 | 0 | 4.0782 | 16.8681 | 33 | 5700 | cellular component organization |
GO:0050830 | 0 | 22.5399 | 0.2604 | 5 | 88 | defense response to Gram-positive bacterium |
GO:0002682 | 0 | 4.9197 | 3.7376 | 14 | 1263 | regulation of immune system process |
GO:2000026 | 0 | 4.7866 | 3.8323 | 14 | 1295 | regulation of multicellular organismal development |
GO:0097659 | 0 | 3.4747 | 9.4372 | 22 | 3189 | nucleic acid-templated transcription |
GO:0034654 | 2e-04 | 3.0194 | 10.5411 | 22 | 3562 | nucleobase-containing compound biosynthetic process |
GO:0006959 | 4e-04 | 8.9244 | 0.6303 | 5 | 213 | humoral immune response |
GO:0007194 | 0.0017 | 36.9634 | 0.0621 | 2 | 21 | negative regulation of adenylate cyclase activity |
GO:0010467 | 0.0019 | 3.5263 | 5.0978 | 12 | 2555 | gene expression |
GO:0009059 | 0.0028 | 2.3744 | 12.6392 | 22 | 4271 | macromolecule biosynthetic process |
GO:0097275 | 0.003 | Inf | 0.003 | 1 | 1 | cellular ammonium homeostasis |
GO:0097276 | 0.003 | Inf | 0.003 | 1 | 1 | cellular creatinine homeostasis |
GO:0097277 | 0.003 | Inf | 0.003 | 1 | 1 | cellular urea homeostasis |
GO:0016070 | 0.003 | 2.354 | 12.7191 | 22 | 4298 | RNA metabolic process |
GO:0048513 | 0.004 | 2.3902 | 9.6562 | 18 | 3263 | animal organ development |
GO:0090663 | 0.0059 | 344.0638 | 0.0059 | 1 | 2 | galanin-activated signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 1951.9138 | 0.0477 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 433.3831 | 0.0848 | 14 | 32 | DNA replication-dependent chromatin assembly |
GO:0006336 | 0 | 433.3831 | 0.0848 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0006334 | 0 | 96.8379 | 0.2757 | 15 | 104 | nucleosome assembly |
GO:0006352 | 0 | 70.5135 | 0.3287 | 14 | 124 | DNA-templated transcription, initiation |
GO:0032200 | 0 | 54.5143 | 0.4136 | 14 | 156 | telomere organization |
GO:0071824 | 0 | 43.9066 | 0.5567 | 15 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 38.5014 | 0.6283 | 15 | 237 | chromatin remodeling |
GO:0045637 | 0 | 41.9606 | 0.5249 | 14 | 198 | regulation of myeloid cell differentiation |
GO:0045596 | 0 | 15.0459 | 1.6675 | 16 | 629 | negative regulation of cell differentiation |
GO:0030097 | 0 | 9.2549 | 2.1633 | 14 | 816 | hemopoiesis |
GO:0002520 | 0 | 8.1946 | 2.4231 | 14 | 914 | immune system development |
GO:0002682 | 0 | 7.095 | 3.3483 | 16 | 1263 | regulation of immune system process |
GO:2000026 | 0 | 6.9026 | 3.4331 | 16 | 1295 | regulation of multicellular organismal development |
GO:0032501 | 0 | 5.3654 | 17.8097 | 34 | 6718 | multicellular organismal process |
GO:0097659 | 0 | 4.726 | 8.4542 | 23 | 3189 | nucleic acid-templated transcription |
GO:0065003 | 0 | 5.6945 | 3.7274 | 15 | 1406 | protein-containing complex assembly |
GO:0048513 | 0 | 4.1814 | 8.6504 | 22 | 3263 | animal organ development |
GO:0034654 | 0 | 4.1067 | 9.443 | 23 | 3562 | nucleobase-containing compound biosynthetic process |
GO:0048519 | 0 | 3.7 | 13.5044 | 27 | 5094 | negative regulation of biological process |
GO:0048869 | 0 | 3.6238 | 10.3921 | 23 | 3920 | cellular developmental process |
GO:0009059 | 0 | 3.5483 | 11.3226 | 24 | 4271 | macromolecule biosynthetic process |
GO:0016070 | 0 | 3.5179 | 11.3942 | 24 | 4298 | RNA metabolic process |
GO:0065007 | 2e-04 | 5.8684 | 29.8853 | 40 | 11273 | biological regulation |
GO:0046483 | 2e-04 | 3.077 | 14.3077 | 26 | 5397 | heterocycle metabolic process |
GO:0050794 | 5e-04 | 3.8022 | 26.6271 | 37 | 10044 | regulation of cellular process |
GO:0006725 | 5e-04 | 2.913 | 14.1183 | 25 | 5452 | cellular aromatic compound metabolic process |
GO:0034641 | 5e-04 | 2.8813 | 15.9116 | 27 | 6002 | cellular nitrogen compound metabolic process |
GO:1901360 | 6e-04 | 2.848 | 15.0527 | 26 | 5678 | organic cyclic compound metabolic process |
GO:0044249 | 9e-04 | 2.724 | 13.6502 | 24 | 5149 | cellular biosynthetic process |
GO:0044085 | 0.0025 | 2.6814 | 7.8047 | 16 | 2944 | cellular component biogenesis |
GO:0021767 | 0.0027 | Inf | 0.0027 | 1 | 1 | mammillary body development |
GO:0042668 | 0.0027 | Inf | 0.0027 | 1 | 1 | auditory receptor cell fate determination |
GO:0045609 | 0.0027 | Inf | 0.0027 | 1 | 1 | positive regulation of inner ear auditory receptor cell differentiation |
GO:0045633 | 0.0027 | Inf | 0.0027 | 1 | 1 | positive regulation of mechanoreceptor differentiation |
GO:0050783 | 0.0027 | Inf | 0.0027 | 1 | 1 | cocaine metabolic process |
GO:0061374 | 0.0027 | Inf | 0.0027 | 1 | 1 | mammillothalamic axonal tract development |
GO:0061381 | 0.0027 | Inf | 0.0027 | 1 | 1 | cell migration in diencephalon |
GO:0006996 | 0.003 | 2.5353 | 9.5332 | 18 | 3596 | organelle organization |
GO:0042667 | 0.0053 | 385.1429 | 0.0053 | 1 | 2 | auditory receptor cell fate specification |
GO:0061379 | 0.0053 | 385.1429 | 0.0053 | 1 | 2 | inferior colliculus development |
GO:1905652 | 0.0053 | 385.1429 | 0.0053 | 1 | 2 | negative regulation of artery morphogenesis |
GO:0007612 | 0.0058 | 8.9122 | 0.3658 | 3 | 138 | learning |
GO:0001661 | 0.0079 | 192.5595 | 0.008 | 1 | 3 | conditioned taste aversion |
GO:0006581 | 0.0079 | 192.5595 | 0.008 | 1 | 3 | acetylcholine catabolic process |
GO:0007412 | 0.0079 | 192.5595 | 0.008 | 1 | 3 | axon target recognition |
GO:0046952 | 0.0079 | 192.5595 | 0.008 | 1 | 3 | ketone body catabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0014016 | 0 | 635.2157 | 0.0059 | 2 | 5 | neuroblast differentiation |
GO:0042668 | 0.0012 | Inf | 0.0012 | 1 | 1 | auditory receptor cell fate determination |
GO:0045609 | 0.0012 | Inf | 0.0012 | 1 | 1 | positive regulation of inner ear auditory receptor cell differentiation |
GO:0045633 | 0.0012 | Inf | 0.0012 | 1 | 1 | positive regulation of mechanoreceptor differentiation |
GO:0050783 | 0.0012 | Inf | 0.0012 | 1 | 1 | cocaine metabolic process |
GO:1901625 | 0.0012 | Inf | 0.0012 | 1 | 1 | cellular response to ergosterol |
GO:0022617 | 0.0021 | 33.9181 | 0.0679 | 2 | 58 | extracellular matrix disassembly |
GO:0042667 | 0.0023 | 900 | 0.0023 | 1 | 2 | auditory receptor cell fate specification |
GO:0006581 | 0.0035 | 449.9722 | 0.0035 | 1 | 3 | acetylcholine catabolic process |
GO:0060120 | 0.0058 | 224.9583 | 0.0059 | 1 | 5 | inner ear receptor cell fate commitment |
GO:0019730 | 0.0069 | 18.0347 | 0.1253 | 2 | 107 | antimicrobial humoral response |
GO:0009804 | 0.007 | 179.9556 | 0.007 | 1 | 6 | coumarin metabolic process |
GO:0019695 | 0.007 | 179.9556 | 0.007 | 1 | 6 | choline metabolic process |
GO:0036112 | 0.007 | 179.9556 | 0.007 | 1 | 6 | medium-chain fatty-acyl-CoA metabolic process |
GO:1900619 | 0.007 | 179.9556 | 0.007 | 1 | 6 | acetate ester metabolic process |
GO:0046222 | 0.0082 | 149.9537 | 0.0082 | 1 | 7 | aflatoxin metabolic process |
GO:0009820 | 0.0093 | 128.5238 | 0.0094 | 1 | 8 | alkaloid metabolic process |
GO:1903979 | 0.0093 | 128.5238 | 0.0094 | 1 | 8 | negative regulation of microglial cell activation |
GO:2000980 | 0.0093 | 128.5238 | 0.0094 | 1 | 8 | regulation of inner ear receptor cell differentiation |
GO:0007586 | 0.0097 | 15.0093 | 0.1499 | 2 | 128 | digestion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006952 | 2e-04 | 11.828 | 1.0166 | 6 | 1499 | defense response |
GO:0031640 | 3e-04 | 105.719 | 0.0244 | 2 | 36 | killing of cells of another organism |
GO:0009617 | 5e-04 | 15.154 | 0.4022 | 4 | 593 | response to bacterium |
GO:0019244 | 7e-04 | Inf | 7e-04 | 1 | 1 | lactate biosynthetic process from pyruvate |
GO:0019516 | 7e-04 | Inf | 7e-04 | 1 | 1 | lactate oxidation |
GO:0035732 | 7e-04 | Inf | 7e-04 | 1 | 1 | nitric oxide storage |
GO:0043207 | 8e-04 | 9.99 | 0.8498 | 5 | 1253 | response to external biotic stimulus |
GO:1901687 | 0.002 | 810.35 | 0.002 | 1 | 3 | glutathione derivative biosynthetic process |
GO:0051771 | 0.0027 | 540.2 | 0.0027 | 1 | 4 | negative regulation of nitric-oxide synthase biosynthetic process |
GO:0061737 | 0.0027 | 540.2 | 0.0027 | 1 | 4 | leukotriene signaling pathway |
GO:1905700 | 0.0034 | 405.125 | 0.0034 | 1 | 5 | negative regulation of xenobiotic detoxification by transmembrane export across the plasma membrane |
GO:0098754 | 0.0037 | 26.6584 | 0.0922 | 2 | 136 | detoxification |
GO:0071638 | 0.0041 | 324.08 | 0.0041 | 1 | 6 | negative regulation of monocyte chemotactic protein-1 production |
GO:2001023 | 0.0041 | 324.08 | 0.0041 | 1 | 6 | regulation of response to drug |
GO:0001936 | 0.0047 | 23.3203 | 0.1051 | 2 | 155 | regulation of endothelial cell proliferation |
GO:0035726 | 0.0047 | 270.05 | 0.0047 | 1 | 7 | common myeloid progenitor cell proliferation |
GO:0033483 | 0.0061 | 202.5125 | 0.0061 | 1 | 9 | gas homeostasis |
GO:0051122 | 0.0061 | 202.5125 | 0.0061 | 1 | 9 | hepoxilin biosynthetic process |
GO:0072330 | 0.0079 | 17.7878 | 0.137 | 2 | 202 | monocarboxylic acid biosynthetic process |
GO:0002674 | 0.0081 | 147.2545 | 0.0081 | 1 | 12 | negative regulation of acute inflammatory response |
GO:0071356 | 0.0084 | 17.1787 | 0.1417 | 2 | 209 | cellular response to tumor necrosis factor |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 3e-04 | 32.341 | 0.1326 | 3 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 6e-04 | 24.0332 | 0.1769 | 3 | 287 | detection of chemical stimulus |
GO:1905183 | 6e-04 | Inf | 6e-04 | 1 | 1 | negative regulation of protein serine/threonine phosphatase activity |
GO:0007606 | 7e-04 | 23.2012 | 0.1831 | 3 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 8e-04 | 21.9816 | 0.193 | 3 | 313 | detection of stimulus involved in sensory perception |
GO:0032461 | 0.0012 | 1801 | 0.0012 | 1 | 2 | positive regulation of protein oligomerization |
GO:1905184 | 0.0012 | 1801 | 0.0012 | 1 | 2 | positive regulation of protein serine/threonine phosphatase activity |
GO:0061737 | 0.0025 | 600.2593 | 0.0025 | 1 | 4 | leukotriene signaling pathway |
GO:0032020 | 0.0037 | 360.1111 | 0.0037 | 1 | 6 | ISG15-protein conjugation |
GO:0045198 | 0.0092 | 128.5397 | 0.0092 | 1 | 15 | establishment of epithelial cell apical/basal polarity |
GO:0042742 | 0.0099 | 16.0251 | 0.1547 | 2 | 251 | defense response to bacterium |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006334 | 0 | 180.9101 | 0.1924 | 15 | 104 | nucleosome assembly |
GO:0071824 | 0 | 94.2327 | 0.3884 | 16 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 82.5805 | 0.4383 | 16 | 237 | chromatin remodeling |
GO:0006335 | 0 | 367.4545 | 0.0592 | 10 | 32 | DNA replication-dependent chromatin assembly |
GO:0040029 | 0 | 65.313 | 0.246 | 10 | 133 | regulation of gene expression, epigenetic |
GO:0032200 | 0 | 54.9452 | 0.2885 | 10 | 156 | telomere organization |
GO:0002227 | 0 | 190.2706 | 0.0407 | 5 | 22 | innate immune response in mucosa |
GO:0065003 | 0 | 12.1686 | 2.6005 | 16 | 1406 | protein-containing complex assembly |
GO:0002251 | 0 | 115.4429 | 0.061 | 5 | 33 | organ or tissue specific immune response |
GO:0019731 | 0 | 71.7556 | 0.0925 | 5 | 50 | antibacterial humoral response |
GO:0061844 | 0 | 48.8606 | 0.1313 | 5 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0050830 | 0 | 38.812 | 0.1628 | 5 | 88 | defense response to Gram-positive bacterium |
GO:0044085 | 0 | 5.1764 | 5.4451 | 16 | 2944 | cellular component biogenesis |
GO:0006959 | 0 | 15.3673 | 0.394 | 5 | 213 | humoral immune response |
GO:0051276 | 3e-04 | 8.2532 | 0.9935 | 6 | 798 | chromosome organization |
GO:0009617 | 0.0043 | 5.3068 | 1.0968 | 5 | 593 | response to bacterium |
GO:0016043 | 0.0047 | 2.774 | 10.5425 | 18 | 5700 | cellular component organization |
GO:0044245 | 0.0055 | 279.1034 | 0.0055 | 1 | 3 | polysaccharide digestion |
GO:0014054 | 0.0074 | 186.0575 | 0.0074 | 1 | 4 | positive regulation of gamma-aminobutyric acid secretion |
GO:0051919 | 0.0074 | 186.0575 | 0.0074 | 1 | 4 | positive regulation of fibrinolysis |
GO:0014050 | 0.0092 | 139.5345 | 0.0092 | 1 | 5 | negative regulation of glutamate secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009593 | 0 | 49.7656 | 0.2654 | 7 | 287 | detection of chemical stimulus |
GO:0007606 | 0 | 48.0194 | 0.2747 | 7 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 45.4628 | 0.2895 | 7 | 313 | detection of stimulus involved in sensory perception |
GO:0050911 | 0 | 51.0239 | 0.1988 | 6 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050877 | 0 | 14.1503 | 1.1273 | 8 | 1219 | nervous system process |
GO:0007186 | 1e-04 | 10.4938 | 0.9007 | 6 | 974 | G protein-coupled receptor signaling pathway |
GO:0010837 | 4e-04 | 80.268 | 0.0305 | 2 | 33 | regulation of keratinocyte proliferation |
GO:0045604 | 0.0012 | 45.1748 | 0.0527 | 2 | 57 | regulation of epidermal cell differentiation |
GO:0000117 | 0.0018 | 1157.4286 | 0.0018 | 1 | 2 | regulation of transcription involved in G2/M transition of mitotic cell cycle |
GO:0030573 | 0.0018 | 1157.4286 | 0.0018 | 1 | 2 | bile acid catabolic process |
GO:0030855 | 0.0024 | 8.8294 | 0.5965 | 4 | 645 | epithelial cell differentiation |
GO:0010482 | 0.0028 | 578.6786 | 0.0028 | 1 | 3 | regulation of epidermal cell division |
GO:0044278 | 0.0037 | 385.7619 | 0.0037 | 1 | 4 | cell wall disruption in another organism |
GO:0070309 | 0.0055 | 231.4286 | 0.0055 | 1 | 6 | lens fiber cell morphogenesis |
GO:0045617 | 0.0065 | 192.8452 | 0.0065 | 1 | 7 | negative regulation of keratinocyte differentiation |
GO:0051838 | 0.0074 | 165.2857 | 0.0074 | 1 | 8 | cytolysis by host of symbiont cells |
GO:0006068 | 0.0092 | 128.5397 | 0.0092 | 1 | 10 | ethanol catabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 53.7446 | 0.2916 | 9 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 39.6458 | 0.3893 | 9 | 287 | detection of chemical stimulus |
GO:0007606 | 0 | 38.2452 | 0.4028 | 9 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 36.1959 | 0.4245 | 9 | 313 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 10.9284 | 1.3211 | 9 | 974 | G protein-coupled receptor signaling pathway |
GO:0048252 | 0 | 1619.7 | 0.0041 | 2 | 3 | lauric acid metabolic process |
GO:0050877 | 0 | 8.5755 | 1.6534 | 9 | 1219 | nervous system process |
GO:0032501 | 1e-04 | 6.3793 | 9.112 | 18 | 6718 | multicellular organismal process |
GO:0043651 | 3e-04 | 101.1375 | 0.0244 | 2 | 18 | linoleic acid metabolic process |
GO:1901625 | 0.0014 | Inf | 0.0014 | 1 | 1 | cellular response to ergosterol |
GO:1905608 | 0.0014 | Inf | 0.0014 | 1 | 1 | positive regulation of presynapse assembly |
GO:0019369 | 0.0022 | 32.9571 | 0.0692 | 2 | 51 | arachidonic acid metabolic process |
GO:0046456 | 0.0023 | 31.6608 | 0.0719 | 2 | 53 | icosanoid biosynthetic process |
GO:0003095 | 0.0027 | 771.2857 | 0.0027 | 1 | 2 | pressure natriuresis |
GO:0031408 | 0.0027 | 771.2857 | 0.0027 | 1 | 2 | oxylipin biosynthetic process |
GO:1905652 | 0.0027 | 771.2857 | 0.0027 | 1 | 2 | negative regulation of artery morphogenesis |
GO:0036101 | 0.0054 | 257.0635 | 0.0054 | 1 | 4 | leukotriene B4 catabolic process |
GO:0051919 | 0.0054 | 257.0635 | 0.0054 | 1 | 4 | positive regulation of fibrinolysis |
GO:0050789 | 0.0067 | 5.2985 | 14.3882 | 20 | 10608 | regulation of biological process |
GO:1905700 | 0.0068 | 192.7857 | 0.0068 | 1 | 5 | negative regulation of xenobiotic detoxification by transmembrane export across the plasma membrane |
GO:0015908 | 0.0071 | 17.5065 | 0.1275 | 2 | 94 | fatty acid transport |
GO:2001023 | 0.0081 | 154.219 | 0.0081 | 1 | 6 | regulation of response to drug |
GO:0002933 | 0.0095 | 128.5079 | 0.0095 | 1 | 7 | lipid hydroxylation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 56.1932 | 0.2518 | 8 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 41.5041 | 0.3362 | 8 | 287 | detection of chemical stimulus |
GO:0007606 | 0 | 40.0428 | 0.3479 | 8 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 37.904 | 0.3666 | 8 | 313 | detection of stimulus involved in sensory perception |
GO:0048252 | 0 | 1905.8824 | 0.0035 | 2 | 3 | lauric acid metabolic process |
GO:0007186 | 0 | 11.47 | 1.1409 | 8 | 974 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 9.0023 | 1.4279 | 8 | 1219 | nervous system process |
GO:0043651 | 2e-04 | 119.0074 | 0.0211 | 2 | 18 | linoleic acid metabolic process |
GO:1901625 | 0.0012 | Inf | 0.0012 | 1 | 1 | cellular response to ergosterol |
GO:1905608 | 0.0012 | Inf | 0.0012 | 1 | 1 | positive regulation of presynapse assembly |
GO:0019369 | 0.0016 | 38.7803 | 0.0597 | 2 | 51 | arachidonic acid metabolic process |
GO:0046456 | 0.0017 | 37.2549 | 0.0621 | 2 | 53 | icosanoid biosynthetic process |
GO:0022617 | 0.0021 | 33.9181 | 0.0679 | 2 | 58 | extracellular matrix disassembly |
GO:0003095 | 0.0023 | 900 | 0.0023 | 1 | 2 | pressure natriuresis |
GO:0031408 | 0.0023 | 900 | 0.0023 | 1 | 2 | oxylipin biosynthetic process |
GO:1901568 | 0.0027 | 29.6636 | 0.0773 | 2 | 66 | fatty acid derivative metabolic process |
GO:0036101 | 0.0047 | 299.963 | 0.0047 | 1 | 4 | leukotriene B4 catabolic process |
GO:0016053 | 0.0048 | 10.1097 | 0.3491 | 3 | 298 | organic acid biosynthetic process |
GO:0015908 | 0.0053 | 20.5997 | 0.1101 | 2 | 94 | fatty acid transport |
GO:0036112 | 0.007 | 179.9556 | 0.007 | 1 | 6 | medium-chain fatty-acyl-CoA metabolic process |
GO:0002933 | 0.0082 | 149.9537 | 0.0082 | 1 | 7 | lipid hydroxylation |
GO:0006631 | 0.0088 | 8.0671 | 0.4346 | 3 | 371 | fatty acid metabolic process |
GO:0007586 | 0.0097 | 15.0093 | 0.1499 | 2 | 128 | digestion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009593 | 0 | 54.4205 | 0.5131 | 14 | 287 | detection of chemical stimulus |
GO:0050911 | 0 | 64.3122 | 0.3844 | 13 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 52.4645 | 0.531 | 14 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 49.6071 | 0.5596 | 14 | 313 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 14.8079 | 1.7414 | 14 | 974 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 11.6074 | 2.1795 | 14 | 1219 | nervous system process |
GO:0048252 | 0 | 1199.2593 | 0.0054 | 2 | 3 | lauric acid metabolic process |
GO:0043651 | 5e-04 | 74.8843 | 0.0322 | 2 | 18 | linoleic acid metabolic process |
GO:0032078 | 0.0018 | Inf | 0.0018 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
GO:1902483 | 0.0018 | Inf | 0.0018 | 1 | 1 | cytotoxic T cell pyroptotic process |
GO:1905608 | 0.0018 | Inf | 0.0018 | 1 | 1 | positive regulation of presynapse assembly |
GO:0019884 | 0.0023 | 31.4873 | 0.0715 | 2 | 40 | antigen processing and presentation of exogenous antigen |
GO:0023052 | 0.0031 | 2.9858 | 10.2805 | 18 | 5750 | signaling |
GO:0007154 | 0.0035 | 2.9459 | 10.3699 | 18 | 5800 | cell communication |
GO:0003095 | 0.0036 | 578.2143 | 0.0036 | 1 | 2 | pressure natriuresis |
GO:0031408 | 0.0036 | 578.2143 | 0.0036 | 1 | 2 | oxylipin biosynthetic process |
GO:0019369 | 0.0037 | 24.4021 | 0.0912 | 2 | 51 | arachidonic acid metabolic process |
GO:0046456 | 0.004 | 23.4423 | 0.0948 | 2 | 53 | icosanoid biosynthetic process |
GO:0051716 | 0.0065 | 2.7491 | 11.8646 | 19 | 6636 | cellular response to stimulus |
GO:0036101 | 0.0071 | 192.7143 | 0.0072 | 1 | 4 | leukotriene B4 catabolic process |
GO:0032501 | 0.0076 | 2.6922 | 12.0112 | 19 | 6718 | multicellular organismal process |
GO:0048006 | 0.0089 | 144.5268 | 0.0089 | 1 | 5 | antigen processing and presentation, endogenous lipid antigen via MHC class Ib |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009593 | 0 | 26.8455 | 0.4424 | 8 | 287 | detection of chemical stimulus |
GO:0007606 | 0 | 25.9003 | 0.4578 | 8 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 24.5169 | 0.4824 | 8 | 313 | detection of stimulus involved in sensory perception |
GO:0050911 | 0 | 29.8902 | 0.3314 | 7 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0035195 | 1e-04 | 13.291 | 0.4686 | 5 | 304 | miRNA-mediated gene silencing |
GO:0016441 | 1e-04 | 12.7685 | 0.4871 | 5 | 316 | post-transcriptional gene silencing |
GO:0007186 | 1e-04 | 8.1982 | 1.1928 | 7 | 874 | G protein-coupled receptor signaling pathway |
GO:0031047 | 1e-04 | 11.9084 | 0.521 | 5 | 338 | gene silencing by RNA |
GO:0050877 | 3e-04 | 5.8227 | 1.8789 | 8 | 1219 | nervous system process |
GO:0007218 | 5e-04 | 22.8679 | 0.1526 | 3 | 99 | neuropeptide signaling pathway |
GO:0031640 | 0.0014 | 41.3325 | 0.0555 | 2 | 36 | killing of cells of another organism |
GO:0061737 | 0.0062 | 224.8889 | 0.0062 | 1 | 4 | leukotriene signaling pathway |
GO:1903847 | 0.0062 | 224.8889 | 0.0062 | 1 | 4 | regulation of aorta morphogenesis |
GO:0090272 | 0.0077 | 168.6562 | 0.0077 | 1 | 5 | negative regulation of fibroblast growth factor production |
GO:1905700 | 0.0077 | 168.6562 | 0.0077 | 1 | 5 | negative regulation of xenobiotic detoxification by transmembrane export across the plasma membrane |
GO:0009804 | 0.0092 | 134.9167 | 0.0092 | 1 | 6 | coumarin metabolic process |
GO:2001023 | 0.0092 | 134.9167 | 0.0092 | 1 | 6 | regulation of response to drug |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 4358.5769 | 0.03 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 967.735 | 0.0533 | 14 | 32 | DNA replication-dependent chromatin assembly |
GO:0006336 | 0 | 967.735 | 0.0533 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0006334 | 0 | 192.6855 | 0.1731 | 14 | 104 | nucleosome assembly |
GO:0006352 | 0 | 157.4559 | 0.2064 | 14 | 124 | DNA-templated transcription, initiation |
GO:0032200 | 0 | 121.7302 | 0.2597 | 14 | 156 | telomere organization |
GO:0045637 | 0 | 93.6982 | 0.3296 | 14 | 198 | regulation of myeloid cell differentiation |
GO:0071824 | 0 | 87.8956 | 0.3496 | 14 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 77.1231 | 0.3945 | 14 | 237 | chromatin remodeling |
GO:0002520 | 0 | 28.9891 | 1.5215 | 17 | 914 | immune system development |
GO:0045596 | 0 | 31.7162 | 1.047 | 15 | 629 | negative regulation of cell differentiation |
GO:0030097 | 0 | 27.9873 | 1.3583 | 16 | 816 | hemopoiesis |
GO:0002682 | 0 | 14.969 | 2.1024 | 15 | 1263 | regulation of immune system process |
GO:2000026 | 0 | 14.5635 | 2.1557 | 15 | 1295 | regulation of multicellular organismal development |
GO:0065003 | 0 | 11.4508 | 2.3404 | 14 | 1406 | protein-containing complex assembly |
GO:0097659 | 0 | 6.9785 | 5.3084 | 17 | 3189 | nucleic acid-templated transcription |
GO:0048513 | 0 | 6.7806 | 5.4316 | 17 | 3263 | animal organ development |
GO:0048869 | 0 | 6.2998 | 6.5253 | 18 | 3920 | cellular developmental process |
GO:0034654 | 0 | 6.0653 | 5.9293 | 17 | 3562 | nucleobase-containing compound biosynthetic process |
GO:0044085 | 0 | 5.6606 | 4.9006 | 15 | 2944 | cellular component biogenesis |
GO:0009059 | 1e-04 | 4.7711 | 7.1096 | 17 | 4271 | macromolecule biosynthetic process |
GO:0016070 | 1e-04 | 4.7303 | 7.1545 | 17 | 4298 | RNA metabolic process |
GO:0032501 | 1e-04 | 4.9628 | 11.1829 | 21 | 6718 | multicellular organismal process |
GO:0006996 | 2e-04 | 4.4024 | 5.9859 | 15 | 3596 | organelle organization |
GO:0048519 | 2e-04 | 4.3802 | 8.4795 | 18 | 5094 | negative regulation of biological process |
GO:0044249 | 8e-04 | 3.664 | 8.5711 | 17 | 5149 | cellular biosynthetic process |
GO:0046483 | 0.0015 | 3.4167 | 8.9839 | 17 | 5397 | heterocycle metabolic process |
GO:0006725 | 0.0017 | 3.364 | 9.0771 | 17 | 5453 | cellular aromatic compound metabolic process |
GO:0051452 | 0.0022 | 32.306 | 0.0699 | 2 | 42 | intracellular pH reduction |
GO:1901360 | 0.0028 | 3.1628 | 9.4517 | 17 | 5678 | organic cyclic compound metabolic process |
GO:0097323 | 0.0033 | 622.7692 | 0.0033 | 1 | 2 | B cell adhesion |
GO:0065007 | 0.0043 | 5.4954 | 18.7652 | 25 | 11273 | biological regulation |
GO:0034641 | 0.0054 | 2.8995 | 9.991 | 17 | 6002 | cellular nitrogen compound metabolic process |
GO:0060465 | 0.0066 | 207.5641 | 0.0067 | 1 | 4 | pharynx development |
GO:0030641 | 0.0072 | 17.1925 | 0.1282 | 2 | 77 | regulation of cellular pH |
GO:0050794 | 0.008 | 3.5415 | 16.7194 | 23 | 10044 | regulation of cellular process |
GO:0060023 | 0.0083 | 155.6635 | 0.0083 | 1 | 5 | soft palate development |
GO:0044854 | 0.0099 | 124.5231 | 0.01 | 1 | 6 | plasma membrane raft assembly |
GO:1905460 | 0.0099 | 124.5231 | 0.01 | 1 | 6 | negative regulation of vascular associated smooth muscle cell apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 26.6221 | 0.6216 | 11 | 300 | protein heterodimerization activity |
GO:0045296 | 0 | 21.108 | 0.6775 | 10 | 327 | cadherin binding |
GO:0004984 | 0 | 20.3506 | 0.4413 | 7 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 11.1483 | 1.2431 | 10 | 600 | G protein-coupled receptor activity |
GO:0005549 | 0 | 38.1731 | 0.1264 | 4 | 61 | odorant binding |
GO:0038023 | 0 | 6.1088 | 2.4863 | 11 | 1200 | signaling receptor activity |
GO:0003677 | 4e-04 | 3.8001 | 4.7799 | 13 | 2307 | DNA binding |
GO:0004941 | 0.0021 | Inf | 0.0021 | 1 | 1 | beta2-adrenergic receptor activity |
GO:0008437 | 0.0021 | Inf | 0.0021 | 1 | 1 | thyrotropin-releasing hormone activity |
GO:0070009 | 0.0021 | Inf | 0.0021 | 1 | 1 | serine-type aminopeptidase activity |
GO:0004556 | 0.0041 | 496.2121 | 0.0041 | 1 | 2 | alpha-amylase activity |
GO:0051380 | 0.0083 | 165.3838 | 0.0083 | 1 | 4 | norepinephrine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 41.9445 | 0.3764 | 10 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 16.3848 | 1.0603 | 11 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 9.0273 | 2.1207 | 12 | 1200 | signaling receptor activity |
GO:0018685 | 0 | 1213.3333 | 0.0053 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0102033 | 0 | 303.2778 | 0.0106 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0008391 | 4e-04 | 80.8198 | 0.03 | 2 | 17 | arachidonic acid monooxygenase activity |
GO:0070009 | 0.0018 | Inf | 0.0018 | 1 | 1 | serine-type aminopeptidase activity |
GO:0102116 | 0.0018 | Inf | 0.0018 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0018 | Inf | 0.0018 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0140625 | 0.0035 | 585 | 0.0035 | 1 | 2 | opioid growth factor receptor activity |
GO:0005549 | 0.0052 | 20.4922 | 0.1078 | 2 | 61 | odorant binding |
GO:0018858 | 0.0053 | 292.4821 | 0.0053 | 1 | 3 | benzoate-CoA ligase activity |
GO:0050051 | 0.0071 | 194.9762 | 0.0071 | 1 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0102391 | 0.0071 | 194.9762 | 0.0071 | 1 | 4 | decanoate-CoA ligase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 90.2578 | 0.1947 | 8 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 30.5077 | 0.5484 | 8 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 19.1486 | 1.0969 | 9 | 1200 | signaling receptor activity |
GO:0005549 | 0 | 104.2297 | 0.0558 | 4 | 61 | odorant binding |
GO:0050591 | 9e-04 | Inf | 9e-04 | 1 | 1 | quinine 3-monooxygenase activity |
GO:0102320 | 9e-04 | Inf | 9e-04 | 1 | 1 | 1,8-cineole 2-exo-monooxygenase activity |
GO:0062181 | 0.0018 | 1171 | 0.0018 | 1 | 2 | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity |
GO:0030343 | 0.0027 | 585.4643 | 0.0027 | 1 | 3 | vitamin D3 25-hydroxylase activity |
GO:0062187 | 0.0027 | 585.4643 | 0.0027 | 1 | 3 | anandamide 8,9 epoxidase activity |
GO:0062188 | 0.0027 | 585.4643 | 0.0027 | 1 | 3 | anandamide 11,12 epoxidase activity |
GO:0070576 | 0.0027 | 585.4643 | 0.0027 | 1 | 3 | vitamin D 24-hydroxylase activity |
GO:0034875 | 0.0037 | 390.2857 | 0.0037 | 1 | 4 | caffeine oxidase activity |
GO:0050649 | 0.0037 | 390.2857 | 0.0037 | 1 | 4 | testosterone 6-beta-hydroxylase activity |
GO:0062189 | 0.0037 | 390.2857 | 0.0037 | 1 | 4 | anandamide 14,15 epoxidase activity |
GO:0101021 | 0.0046 | 292.6964 | 0.0046 | 1 | 5 | estrogen 2-hydroxylase activity |
GO:0101020 | 0.0073 | 167.2245 | 0.0073 | 1 | 8 | estrogen 16-alpha-hydroxylase activity |
GO:0016725 | 0.0082 | 146.3125 | 0.0082 | 1 | 9 | oxidoreductase activity, acting on CH or CH2 groups |
GO:0008401 | 0.0091 | 130.0476 | 0.0091 | 1 | 10 | retinoic acid 4-hydroxylase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 75.7724 | 0.8775 | 27 | 300 | protein heterodimerization activity |
GO:0003677 | 0 | 13.6296 | 6.7481 | 33 | 2307 | DNA binding |
GO:0019904 | 0 | 10.2485 | 1.8896 | 14 | 646 | protein domain specific binding |
GO:0097159 | 0 | 5.6282 | 16.7459 | 36 | 5725 | organic cyclic compound binding |
GO:0045296 | 0 | 13.3198 | 0.9565 | 10 | 327 | cadherin binding |
GO:1901363 | 0 | 5.1488 | 16.5353 | 35 | 5653 | heterocyclic compound binding |
GO:0003723 | 2e-04 | 3.664 | 4.8761 | 14 | 1667 | RNA binding |
GO:0004941 | 0.0029 | Inf | 0.0029 | 1 | 1 | beta2-adrenergic receptor activity |
GO:0008437 | 0.0029 | Inf | 0.0029 | 1 | 1 | thyrotropin-releasing hormone activity |
GO:0017172 | 0.0029 | Inf | 0.0029 | 1 | 1 | cysteine dioxygenase activity |
GO:0050591 | 0.0029 | Inf | 0.0029 | 1 | 1 | quinine 3-monooxygenase activity |
GO:0070009 | 0.0029 | Inf | 0.0029 | 1 | 1 | serine-type aminopeptidase activity |
GO:0102320 | 0.0029 | Inf | 0.0029 | 1 | 1 | 1,8-cineole 2-exo-monooxygenase activity |
GO:0062181 | 0.0058 | 348.1064 | 0.0059 | 1 | 2 | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity |
GO:0030343 | 0.0088 | 174.0426 | 0.0088 | 1 | 3 | vitamin D3 25-hydroxylase activity |
GO:0062187 | 0.0088 | 174.0426 | 0.0088 | 1 | 3 | anandamide 8,9 epoxidase activity |
GO:0062188 | 0.0088 | 174.0426 | 0.0088 | 1 | 3 | anandamide 11,12 epoxidase activity |
GO:0070576 | 0.0088 | 174.0426 | 0.0088 | 1 | 3 | vitamin D 24-hydroxylase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003690 | 4e-04 | 4.5851 | 2.93 | 10 | 1551 | double-stranded DNA binding |
GO:0000981 | 4e-04 | 4.8961 | 2.4029 | 9 | 1272 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0000976 | 9e-04 | 4.3873 | 2.6561 | 9 | 1406 | transcription cis-regulatory region binding |
GO:0043565 | 0.0018 | 3.9222 | 2.9394 | 9 | 1556 | sequence-specific DNA binding |
GO:0070009 | 0.0019 | Inf | 0.0019 | 1 | 1 | serine-type aminopeptidase activity |
GO:0008188 | 0.0028 | 28.1707 | 0.0793 | 2 | 42 | neuropeptide receptor activity |
GO:0008260 | 0.0038 | 545.9333 | 0.0038 | 1 | 2 | 3-oxoacid CoA-transferase activity |
GO:0016499 | 0.0038 | 545.9333 | 0.0038 | 1 | 2 | orexin receptor activity |
GO:0000978 | 0.0041 | 4.0238 | 2.1044 | 7 | 1114 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0140110 | 0.0044 | 3.3829 | 3.355 | 9 | 1776 | transcription regulator activity |
GO:0004930 | 0.005 | 5.1015 | 1.1335 | 5 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0.0061 | 3.7127 | 2.2669 | 7 | 1200 | signaling receptor activity |
GO:0046870 | 0.0094 | 136.4583 | 0.0094 | 1 | 5 | cadmium ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0018685 | 0 | 2981.0909 | 0.0024 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0102033 | 0 | 745.1364 | 0.0048 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0008391 | 1e-04 | 198.5697 | 0.0135 | 2 | 17 | arachidonic acid monooxygenase activity |
GO:0102116 | 8e-04 | Inf | 8e-04 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 8e-04 | Inf | 8e-04 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0140625 | 0.0016 | 1366.3333 | 0.0016 | 1 | 2 | opioid growth factor receptor activity |
GO:0050051 | 0.0032 | 455.3889 | 0.0032 | 1 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0020037 | 0.0042 | 24.0562 | 0.099 | 2 | 125 | heme binding |
GO:0005506 | 0.0051 | 21.9017 | 0.1085 | 2 | 137 | iron ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 4e-04 | 25.214 | 0.1448 | 3 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0004984 | 0.0015 | 15.4114 | 0.2336 | 3 | 213 | olfactory receptor activity |
GO:0001632 | 0.0022 | 964.1765 | 0.0022 | 1 | 2 | leukotriene B4 receptor activity |
GO:0045182 | 0.0025 | 12.9136 | 0.2775 | 3 | 253 | translation regulator activity |
GO:0004930 | 0.0036 | 7.5724 | 0.6581 | 4 | 600 | G protein-coupled receptor activity |
GO:0031730 | 0.0066 | 192.7882 | 0.0066 | 1 | 6 | CCR5 chemokine receptor binding |
GO:0038023 | 0.008 | 4.8912 | 1.3163 | 5 | 1200 | signaling receptor activity |
GO:0016175 | 0.0087 | 137.6891 | 0.0088 | 1 | 8 | superoxide-generating NAD(P)H oxidase activity |
GO:0019864 | 0.0098 | 120.4706 | 0.0099 | 1 | 9 | IgG binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060089 | 5e-04 | 6.3688 | 1.5356 | 7 | 1200 | molecular transducer activity |
GO:0004888 | 0.0012 | 6.2352 | 1.272 | 6 | 994 | transmembrane signaling receptor activity |
GO:0046817 | 0.0013 | Inf | 0.0013 | 1 | 1 | chemokine receptor antagonist activity |
GO:0050591 | 0.0013 | Inf | 0.0013 | 1 | 1 | quinine 3-monooxygenase activity |
GO:0102320 | 0.0013 | Inf | 0.0013 | 1 | 1 | 1,8-cineole 2-exo-monooxygenase activity |
GO:0031729 | 0.0026 | 819.4 | 0.0026 | 1 | 2 | CCR4 chemokine receptor binding |
GO:0045519 | 0.0026 | 819.4 | 0.0026 | 1 | 2 | interleukin-23 receptor binding |
GO:0062181 | 0.0026 | 819.4 | 0.0026 | 1 | 2 | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity |
GO:0102338 | 0.0026 | 819.4 | 0.0026 | 1 | 2 | 3-oxo-lignoceronyl-CoA synthase activity |
GO:0030298 | 0.0038 | 409.675 | 0.0038 | 1 | 3 | receptor signaling protein tyrosine kinase activator activity |
GO:0030343 | 0.0038 | 409.675 | 0.0038 | 1 | 3 | vitamin D3 25-hydroxylase activity |
GO:0062187 | 0.0038 | 409.675 | 0.0038 | 1 | 3 | anandamide 8,9 epoxidase activity |
GO:0062188 | 0.0038 | 409.675 | 0.0038 | 1 | 3 | anandamide 11,12 epoxidase activity |
GO:0070576 | 0.0038 | 409.675 | 0.0038 | 1 | 3 | vitamin D 24-hydroxylase activity |
GO:0102336 | 0.0038 | 409.675 | 0.0038 | 1 | 3 | 3-oxo-arachidoyl-CoA synthase activity |
GO:0031726 | 0.0051 | 273.1 | 0.0051 | 1 | 4 | CCR1 chemokine receptor binding |
GO:0034875 | 0.0051 | 273.1 | 0.0051 | 1 | 4 | caffeine oxidase activity |
GO:0050649 | 0.0051 | 273.1 | 0.0051 | 1 | 4 | testosterone 6-beta-hydroxylase activity |
GO:0062189 | 0.0051 | 273.1 | 0.0051 | 1 | 4 | anandamide 14,15 epoxidase activity |
GO:0101021 | 0.0064 | 204.8125 | 0.0064 | 1 | 5 | estrogen 2-hydroxylase activity |
GO:0031730 | 0.0077 | 163.84 | 0.0077 | 1 | 6 | CCR5 chemokine receptor binding |
GO:0009922 | 0.0089 | 136.525 | 0.009 | 1 | 7 | fatty acid elongase activity |
GO:0102756 | 0.0089 | 136.525 | 0.009 | 1 | 7 | very-long-chain 3-ketoacyl-CoA synthase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003690 | 0 | 7.2334 | 2.6464 | 12 | 1551 | double-stranded DNA binding |
GO:0000978 | 0 | 7.6882 | 1.9008 | 10 | 1114 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0000976 | 0 | 6.9516 | 2.399 | 11 | 1406 | transcription cis-regulatory region binding |
GO:0043565 | 0 | 6.2139 | 2.655 | 11 | 1556 | sequence-specific DNA binding |
GO:0140110 | 1e-04 | 5.3587 | 3.0303 | 11 | 1776 | transcription regulator activity |
GO:0000981 | 2e-04 | 7.5288 | 1.2532 | 7 | 834 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0031490 | 6e-04 | 20.7932 | 0.1655 | 3 | 97 | chromatin DNA binding |
GO:0001632 | 0.0034 | 606.7037 | 0.0034 | 1 | 2 | leukotriene B4 receptor activity |
GO:0008260 | 0.0034 | 606.7037 | 0.0034 | 1 | 2 | 3-oxoacid CoA-transferase activity |
GO:0003676 | 0.0059 | 2.8637 | 6.5163 | 13 | 3819 | nucleic acid binding |
GO:0001228 | 0.0062 | 6.1244 | 0.7473 | 4 | 438 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050591 | 9e-04 | Inf | 9e-04 | 1 | 1 | quinine 3-monooxygenase activity |
GO:0102320 | 9e-04 | Inf | 9e-04 | 1 | 1 | 1,8-cineole 2-exo-monooxygenase activity |
GO:0062181 | 0.0017 | 1261.1538 | 0.0017 | 1 | 2 | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity |
GO:0106386 | 0.0017 | 1261.1538 | 0.0017 | 1 | 2 | (3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity |
GO:0030343 | 0.0026 | 630.5385 | 0.0026 | 1 | 3 | vitamin D3 25-hydroxylase activity |
GO:0062187 | 0.0026 | 630.5385 | 0.0026 | 1 | 3 | anandamide 8,9 epoxidase activity |
GO:0062188 | 0.0026 | 630.5385 | 0.0026 | 1 | 3 | anandamide 11,12 epoxidase activity |
GO:0070404 | 0.0026 | 630.5385 | 0.0026 | 1 | 3 | NADH binding |
GO:0070576 | 0.0026 | 630.5385 | 0.0026 | 1 | 3 | vitamin D 24-hydroxylase activity |
GO:0034875 | 0.0034 | 420.3333 | 0.0034 | 1 | 4 | caffeine oxidase activity |
GO:0050649 | 0.0034 | 420.3333 | 0.0034 | 1 | 4 | testosterone 6-beta-hydroxylase activity |
GO:0062189 | 0.0034 | 420.3333 | 0.0034 | 1 | 4 | anandamide 14,15 epoxidase activity |
GO:0101021 | 0.0043 | 315.2308 | 0.0043 | 1 | 5 | estrogen 2-hydroxylase activity |
GO:0047035 | 0.006 | 210.1282 | 0.006 | 1 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:0035197 | 0.0068 | 180.0989 | 0.0068 | 1 | 8 | siRNA binding |
GO:0101020 | 0.0068 | 180.0989 | 0.0068 | 1 | 8 | estrogen 16-alpha-hydroxylase activity |
GO:0016725 | 0.0077 | 157.5769 | 0.0077 | 1 | 9 | oxidoreductase activity, acting on CH or CH2 groups |
GO:0008401 | 0.0085 | 140.0598 | 0.0085 | 1 | 10 | retinoic acid 4-hydroxylase activity |
GO:0097677 | 0.0093 | 126.0462 | 0.0094 | 1 | 11 | STAT family protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 82.4533 | 0.4936 | 16 | 300 | protein heterodimerization activity |
GO:0019904 | 0 | 26.8396 | 1.0629 | 14 | 646 | protein domain specific binding |
GO:0003723 | 0 | 11.1463 | 2.7428 | 15 | 1667 | RNA binding |
GO:0003677 | 0 | 10.4621 | 3.7958 | 17 | 2307 | DNA binding |
GO:1901363 | 6e-04 | 3.8147 | 9.3011 | 18 | 5653 | heterocyclic compound binding |
GO:0097159 | 8e-04 | 3.7414 | 9.4196 | 18 | 5725 | organic cyclic compound binding |
GO:0019834 | 0.0082 | 157.4904 | 0.0082 | 1 | 5 | phospholipase A2 inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008260 | 0.0026 | 819.4 | 0.0026 | 1 | 2 | 3-oxoacid CoA-transferase activity |
GO:0016262 | 0.0026 | 819.4 | 0.0026 | 1 | 2 | protein N-acetylglucosaminyltransferase activity |
GO:0045519 | 0.0026 | 819.4 | 0.0026 | 1 | 2 | interleukin-23 receptor binding |
GO:0050613 | 0.0026 | 819.4 | 0.0026 | 1 | 2 | delta14-sterol reductase activity |
GO:0016503 | 0.0038 | 409.675 | 0.0038 | 1 | 3 | pheromone receptor activity |
GO:0019834 | 0.0064 | 204.8125 | 0.0064 | 1 | 5 | phospholipase A2 inhibitor activity |
GO:0045569 | 0.0064 | 204.8125 | 0.0064 | 1 | 5 | TRAIL binding |
GO:0030881 | 0.0077 | 163.84 | 0.0077 | 1 | 6 | beta-2-microglobulin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 106.7463 | 0.9141 | 32 | 300 | protein heterodimerization activity |
GO:0003677 | 0 | 19.6657 | 7.0293 | 38 | 2307 | DNA binding |
GO:1901363 | 0 | 8.7247 | 17.2243 | 41 | 5653 | heterocyclic compound binding |
GO:0097159 | 0 | 8.5565 | 17.4436 | 41 | 5725 | organic cyclic compound binding |
GO:0019904 | 0 | 9.6779 | 1.9683 | 14 | 646 | protein domain specific binding |
GO:0045296 | 0 | 12.6522 | 0.9963 | 10 | 327 | cadherin binding |
GO:0003723 | 1e-04 | 3.8156 | 5.0792 | 15 | 1667 | RNA binding |
GO:0008437 | 0.003 | Inf | 0.003 | 1 | 1 | thyrotropin-releasing hormone activity |
GO:0070009 | 0.003 | Inf | 0.003 | 1 | 1 | serine-type aminopeptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 26.2378 | 0.8044 | 14 | 300 | protein heterodimerization activity |
GO:0003677 | 0 | 14.7201 | 1.6008 | 14 | 719 | DNA binding |
GO:0019904 | 0 | 11.6179 | 1.7321 | 14 | 646 | protein domain specific binding |
GO:0003723 | 0 | 4.607 | 4.4697 | 15 | 1667 | RNA binding |
GO:1901363 | 2e-04 | 3.0319 | 15.1573 | 27 | 5653 | heterocyclic compound binding |
GO:0097159 | 3e-04 | 2.9736 | 15.3504 | 27 | 5725 | organic cyclic compound binding |
GO:0003690 | 0.0021 | 3.2091 | 4.1587 | 11 | 1551 | double-stranded DNA binding |
GO:0031490 | 0.0022 | 12.6663 | 0.2601 | 3 | 97 | chromatin DNA binding |
GO:0070009 | 0.0027 | Inf | 0.0027 | 1 | 1 | serine-type aminopeptidase activity |
GO:0003990 | 0.0054 | 380.5814 | 0.0054 | 1 | 2 | acetylcholinesterase activity |
GO:0008260 | 0.0054 | 380.5814 | 0.0054 | 1 | 2 | 3-oxoacid CoA-transferase activity |
GO:0000981 | 0.0059 | 3.0749 | 3.4106 | 9 | 1272 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0033265 | 0.008 | 190.2791 | 0.008 | 1 | 3 | choline binding |
GO:0000978 | 0.0087 | 3.0661 | 2.987 | 8 | 1114 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008389 | 0.0014 | Inf | 0.0014 | 1 | 1 | coumarin 7-hydroxylase activity |
GO:0003990 | 0.0028 | 744.8182 | 0.0028 | 1 | 2 | acetylcholinesterase activity |
GO:0018858 | 0.0042 | 372.3864 | 0.0042 | 1 | 3 | benzoate-CoA ligase activity |
GO:0033265 | 0.0042 | 372.3864 | 0.0042 | 1 | 3 | choline binding |
GO:0102391 | 0.0056 | 248.2424 | 0.0056 | 1 | 4 | decanoate-CoA ligase activity |
GO:0031490 | 0.0081 | 16.3328 | 0.136 | 2 | 97 | chromatin DNA binding |
GO:0004321 | 0.0098 | 124.0985 | 0.0098 | 1 | 7 | fatty-acyl-CoA synthase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0018685 | 0 | 1489.5455 | 0.0044 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0004984 | 0 | 20.4681 | 0.3115 | 5 | 213 | olfactory receptor activity |
GO:0102033 | 0 | 372.3182 | 0.0088 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0004930 | 2e-04 | 8.862 | 0.8775 | 6 | 600 | G protein-coupled receptor activity |
GO:0008391 | 3e-04 | 99.2182 | 0.0249 | 2 | 17 | arachidonic acid monooxygenase activity |
GO:0102116 | 0.0015 | Inf | 0.0015 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0015 | Inf | 0.0015 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0004252 | 0.0017 | 14.3966 | 0.2399 | 3 | 164 | serine-type endopeptidase activity |
GO:0017171 | 0.0024 | 12.719 | 0.2706 | 3 | 185 | serine hydrolase activity |
GO:0018858 | 0.0044 | 356.1739 | 0.0044 | 1 | 3 | benzoate-CoA ligase activity |
GO:0050051 | 0.0058 | 237.4348 | 0.0059 | 1 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0102391 | 0.0058 | 237.4348 | 0.0059 | 1 | 4 | decanoate-CoA ligase activity |
GO:0038023 | 0.0065 | 4.2412 | 1.755 | 6 | 1200 | signaling receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004190 | 1e-04 | 148.8727 | 0.0176 | 2 | 24 | aspartic-type endopeptidase activity |
GO:0035730 | 7e-04 | Inf | 7e-04 | 1 | 1 | S-nitrosoglutathione binding |
GO:0035731 | 7e-04 | Inf | 7e-04 | 1 | 1 | dinitrosyl-iron complex binding |
GO:0001632 | 0.0015 | 1490.6364 | 0.0015 | 1 | 2 | leukotriene B4 receptor activity |
GO:0070026 | 0.0022 | 745.2727 | 0.0022 | 1 | 3 | nitric oxide binding |
GO:0004459 | 0.0037 | 372.5909 | 0.0037 | 1 | 5 | L-lactate dehydrogenase activity |
GO:0008432 | 0.0066 | 186.25 | 0.0066 | 1 | 9 | JUN kinase binding |
GO:0019864 | 0.0066 | 186.25 | 0.0066 | 1 | 9 | IgG binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001874 | 0.0014 | Inf | 0.0014 | 1 | 1 | (1->3)-beta-D-glucan immune receptor activity |
GO:0031707 | 0.0014 | Inf | 0.0014 | 1 | 1 | endothelin A receptor binding |
GO:0001872 | 0.0028 | 744.8182 | 0.0028 | 1 | 2 | (1->3)-beta-D-glucan binding |
GO:0032558 | 0.0028 | 744.8182 | 0.0028 | 1 | 2 | adenyl deoxyribonucleotide binding |
GO:0008426 | 0.0042 | 372.3864 | 0.0042 | 1 | 3 | protein kinase C inhibitor activity |
GO:0008853 | 0.0042 | 372.3864 | 0.0042 | 1 | 3 | exodeoxyribonuclease III activity |
GO:0031708 | 0.0042 | 372.3864 | 0.0042 | 1 | 3 | endothelin B receptor binding |
GO:0032552 | 0.0056 | 248.2424 | 0.0056 | 1 | 4 | deoxyribonucleotide binding |
GO:1905172 | 0.0056 | 248.2424 | 0.0056 | 1 | 4 | RISC complex binding |
GO:0019834 | 0.007 | 186.1705 | 0.007 | 1 | 5 | phospholipase A2 inhibitor activity |
GO:0015349 | 0.0084 | 148.9273 | 0.0084 | 1 | 6 | thyroid hormone transmembrane transporter activity |
GO:0032405 | 0.0084 | 148.9273 | 0.0084 | 1 | 6 | MutLalpha complex binding |
GO:0032407 | 0.0098 | 124.0985 | 0.0098 | 1 | 7 | MutSalpha complex binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008009 | 2e-04 | 114.007 | 0.0236 | 2 | 43 | chemokine activity |
GO:0001874 | 5e-04 | Inf | 5e-04 | 1 | 1 | (1->3)-beta-D-glucan immune receptor activity |
GO:0001872 | 0.0011 | 2050 | 0.0011 | 1 | 2 | (1->3)-beta-D-glucan binding |
GO:0031726 | 0.0022 | 683.25 | 0.0022 | 1 | 4 | CCR1 chemokine receptor binding |
GO:0031728 | 0.0027 | 512.4062 | 0.0027 | 1 | 5 | CCR3 chemokine receptor binding |
GO:0031730 | 0.0033 | 409.9 | 0.0033 | 1 | 6 | CCR5 chemokine receptor binding |
GO:0004865 | 0.006 | 204.8875 | 0.006 | 1 | 11 | protein serine/threonine phosphatase inhibitor activity |
GO:0031386 | 0.006 | 204.8875 | 0.006 | 1 | 11 | protein tag |
GO:0016004 | 0.0066 | 186.25 | 0.0066 | 1 | 12 | phospholipase activator activity |
GO:0005126 | 0.0069 | 19.8259 | 0.1289 | 2 | 235 | cytokine receptor binding |
GO:0030246 | 0.0077 | 18.6859 | 0.1366 | 2 | 249 | carbohydrate binding |
GO:0001846 | 0.0082 | 146.3125 | 0.0082 | 1 | 15 | opsonin binding |
GO:0001664 | 0.0086 | 17.6683 | 0.1442 | 2 | 263 | G protein-coupled receptor binding |
GO:0004698 | 0.0087 | 136.55 | 0.0088 | 1 | 16 | calcium-dependent protein kinase C activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 2e-04 | 33.0408 | 0.1298 | 3 | 213 | olfactory receptor activity |
GO:0001632 | 0.0012 | 1822.1111 | 0.0012 | 1 | 2 | leukotriene B4 receptor activity |
GO:0017060 | 0.0012 | 1822.1111 | 0.0012 | 1 | 2 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity |
GO:0004930 | 0.0032 | 13.554 | 0.3217 | 3 | 586 | G protein-coupled receptor activity |
GO:0017083 | 0.0037 | 364.3333 | 0.0037 | 1 | 6 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO:0038023 | 0.0042 | 8.4749 | 0.7313 | 4 | 1200 | signaling receptor activity |
GO:0004865 | 0.0067 | 182.1111 | 0.0067 | 1 | 11 | protein serine/threonine phosphatase inhibitor activity |
GO:0031386 | 0.0067 | 182.1111 | 0.0067 | 1 | 11 | protein tag |
GO:0004953 | 0.0085 | 140.0598 | 0.0085 | 1 | 14 | icosanoid receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 1e-04 | 23.8263 | 0.2207 | 4 | 213 | olfactory receptor activity |
GO:0004930 | 3e-04 | 11.063 | 0.6216 | 5 | 600 | G protein-coupled receptor activity |
GO:0038023 | 9e-04 | 6.9434 | 1.2431 | 6 | 1200 | signaling receptor activity |
GO:0001874 | 0.001 | Inf | 0.001 | 1 | 1 | (1->3)-beta-D-glucan immune receptor activity |
GO:0031707 | 0.001 | Inf | 0.001 | 1 | 1 | endothelin A receptor binding |
GO:0001872 | 0.0021 | 1024.5 | 0.0021 | 1 | 2 | (1->3)-beta-D-glucan binding |
GO:0008426 | 0.0031 | 512.2188 | 0.0031 | 1 | 3 | protein kinase C inhibitor activity |
GO:0031708 | 0.0031 | 512.2188 | 0.0031 | 1 | 3 | endothelin B receptor binding |
GO:1905172 | 0.0041 | 341.4583 | 0.0041 | 1 | 4 | RISC complex binding |
GO:0008508 | 0.0052 | 256.0781 | 0.0052 | 1 | 5 | bile acid:sodium symporter activity |
GO:1903231 | 0.0081 | 16.68 | 0.1367 | 2 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031707 | 7e-04 | Inf | 7e-04 | 1 | 1 | endothelin A receptor binding |
GO:0031708 | 0.002 | 819.85 | 0.002 | 1 | 3 | endothelin B receptor binding |
GO:0033038 | 0.0093 | 126.0462 | 0.0094 | 1 | 14 | bitter taste receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 60.4507 | 0.5667 | 16 | 300 | protein heterodimerization activity |
GO:0045296 | 0 | 24.128 | 0.6177 | 10 | 327 | cadherin binding |
GO:0003677 | 0 | 7.4708 | 4.3581 | 17 | 2307 | DNA binding |
GO:0008437 | 0.0019 | Inf | 0.0019 | 1 | 1 | thyrotropin-releasing hormone activity |
GO:0070009 | 0.0019 | Inf | 0.0019 | 1 | 1 | serine-type aminopeptidase activity |
GO:0004556 | 0.0038 | 545.9333 | 0.0038 | 1 | 2 | alpha-amylase activity |
GO:1901363 | 0.006 | 2.64 | 10.679 | 18 | 5653 | heterocyclic compound binding |
GO:0097159 | 0.0069 | 2.5892 | 10.8151 | 18 | 5725 | organic cyclic compound binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 52.1353 | 0.1947 | 6 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 17.734 | 0.5484 | 6 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 11.1498 | 1.0969 | 7 | 1200 | signaling receptor activity |
GO:0047704 | 9e-04 | Inf | 9e-04 | 1 | 1 | bile-salt sulfotransferase activity |
GO:0005549 | 0.0014 | 42.5971 | 0.0558 | 2 | 61 | odorant binding |
GO:0004027 | 0.0018 | 1171 | 0.0018 | 1 | 2 | alcohol sulfotransferase activity |
GO:0008426 | 0.0027 | 585.4643 | 0.0027 | 1 | 3 | protein kinase C inhibitor activity |
GO:0003696 | 0.0037 | 390.2857 | 0.0037 | 1 | 4 | satellite DNA binding |
GO:0050294 | 0.0037 | 390.2857 | 0.0037 | 1 | 4 | steroid sulfotransferase activity |
GO:0019237 | 0.0055 | 234.1429 | 0.0055 | 1 | 6 | centromeric DNA binding |
GO:0031849 | 0.0055 | 234.1429 | 0.0055 | 1 | 6 | olfactory receptor binding |
GO:0050656 | 0.0073 | 167.2245 | 0.0073 | 1 | 8 | 3'-phosphoadenosine 5'-phosphosulfate binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 12.2743 | 0.6947 | 6 | 600 | G protein-coupled receptor activity |
GO:0004984 | 1e-04 | 20.6469 | 0.2466 | 4 | 213 | olfactory receptor activity |
GO:0038023 | 0.0018 | 5.8744 | 1.3894 | 6 | 1200 | signaling receptor activity |
GO:0003696 | 0.0046 | 303.4815 | 0.0046 | 1 | 4 | satellite DNA binding |
GO:0019237 | 0.0069 | 182.0667 | 0.0069 | 1 | 6 | centromeric DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 59.5037 | 0.2726 | 9 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 20.0482 | 0.7678 | 9 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 11.6112 | 1.5356 | 10 | 1200 | signaling receptor activity |
GO:0018685 | 0 | 1725.0526 | 0.0038 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0102033 | 0 | 431.1842 | 0.0077 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0008391 | 2e-04 | 114.9053 | 0.0218 | 2 | 17 | arachidonic acid monooxygenase activity |
GO:0070009 | 0.0013 | Inf | 0.0013 | 1 | 1 | serine-type aminopeptidase activity |
GO:0102116 | 0.0013 | Inf | 0.0013 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0013 | Inf | 0.0013 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0050051 | 0.0051 | 273.1 | 0.0051 | 1 | 4 | leukotriene-B4 20-monooxygenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 57.4226 | 0.2466 | 8 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 19.4091 | 0.6947 | 8 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 11.4861 | 1.3894 | 9 | 1200 | signaling receptor activity |
GO:0018685 | 0 | 1928.2353 | 0.0035 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0102033 | 0 | 481.9706 | 0.0069 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0008391 | 2e-04 | 128.4392 | 0.0197 | 2 | 17 | arachidonic acid monooxygenase activity |
GO:0004252 | 8e-04 | 18.9014 | 0.1899 | 3 | 164 | serine-type endopeptidase activity |
GO:0102116 | 0.0012 | Inf | 0.0012 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0012 | Inf | 0.0012 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0017171 | 0.0012 | 16.6988 | 0.2142 | 3 | 185 | serine hydrolase activity |
GO:0005549 | 0.0022 | 32.5663 | 0.0706 | 2 | 61 | odorant binding |
GO:0140625 | 0.0023 | 910.5556 | 0.0023 | 1 | 2 | opioid growth factor receptor activity |
GO:0018858 | 0.0035 | 455.25 | 0.0035 | 1 | 3 | benzoate-CoA ligase activity |
GO:0050051 | 0.0046 | 303.4815 | 0.0046 | 1 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0102391 | 0.0046 | 303.4815 | 0.0046 | 1 | 4 | decanoate-CoA ligase activity |
GO:0004321 | 0.0081 | 151.713 | 0.0081 | 1 | 7 | fatty-acyl-CoA synthase activity |
GO:0020037 | 0.009 | 15.56 | 0.1447 | 2 | 125 | heme binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 80.92 | 0.3375 | 13 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 31.4522 | 0.9506 | 14 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 20.5405 | 1.9013 | 16 | 1200 | signaling receptor activity |
GO:0005549 | 0 | 69.4218 | 0.0966 | 5 | 61 | odorant binding |
GO:0018685 | 0 | 1365.25 | 0.0048 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0102033 | 0 | 341.25 | 0.0095 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0008391 | 3e-04 | 90.9389 | 0.0269 | 2 | 17 | arachidonic acid monooxygenase activity |
GO:0102116 | 0.0016 | Inf | 0.0016 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0016 | Inf | 0.0016 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0004252 | 0.0022 | 13.1431 | 0.2598 | 3 | 164 | serine-type endopeptidase activity |
GO:0017171 | 0.003 | 11.6116 | 0.2931 | 3 | 185 | serine hydrolase activity |
GO:0050051 | 0.0063 | 218.4133 | 0.0063 | 1 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0030883 | 0.0079 | 163.8 | 0.0079 | 1 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0079 | 163.8 | 0.0079 | 1 | 5 | exogenous lipid antigen binding |
GO:0005132 | 0.0095 | 131.032 | 0.0095 | 1 | 6 | type I interferon receptor binding |
GO:0032395 | 0.0095 | 131.032 | 0.0095 | 1 | 6 | MHC class II receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 36.6583 | 0.2856 | 7 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 15.2471 | 0.8044 | 8 | 600 | G protein-coupled receptor activity |
GO:0005549 | 0 | 63.6686 | 0.0818 | 4 | 61 | odorant binding |
GO:0038023 | 1e-04 | 7.2848 | 1.6088 | 8 | 1200 | signaling receptor activity |
GO:0008389 | 0.0013 | Inf | 0.0013 | 1 | 1 | coumarin 7-hydroxylase activity |
GO:0001632 | 0.0027 | 780.3333 | 0.0027 | 1 | 2 | leukotriene B4 receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 39.3811 | 0.6216 | 14 | 300 | protein heterodimerization activity |
GO:0019904 | 0 | 17.438 | 1.3385 | 14 | 646 | protein domain specific binding |
GO:0003723 | 0 | 10.0472 | 3.4539 | 18 | 1667 | RNA binding |
GO:0003677 | 0 | 5.4649 | 4.7799 | 16 | 2307 | DNA binding |
GO:0004984 | 0 | 16.7381 | 0.4413 | 6 | 213 | olfactory receptor activity |
GO:0005549 | 3e-04 | 27.2269 | 0.1264 | 3 | 61 | odorant binding |
GO:1901363 | 0.001 | 3.0816 | 11.7125 | 21 | 5653 | heterocyclic compound binding |
GO:0097159 | 0.0012 | 3.0223 | 11.8617 | 21 | 5725 | organic cyclic compound binding |
GO:0004930 | 0.0013 | 5.6934 | 1.2431 | 6 | 600 | G protein-coupled receptor activity |
GO:1903231 | 0.0025 | 12.1883 | 0.2735 | 3 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0106386 | 0.0041 | 496.2121 | 0.0041 | 1 | 2 | (3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity |
GO:0008426 | 0.0062 | 248.0909 | 0.0062 | 1 | 3 | protein kinase C inhibitor activity |
GO:0070404 | 0.0062 | 248.0909 | 0.0062 | 1 | 3 | NADH binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 71.6421 | 0.457 | 14 | 300 | protein heterodimerization activity |
GO:0019904 | 0 | 31.7235 | 0.9842 | 14 | 646 | protein domain specific binding |
GO:0003723 | 0 | 13.3774 | 2.5396 | 15 | 1667 | RNA binding |
GO:0003677 | 0 | 10.9367 | 3.5146 | 16 | 2307 | DNA binding |
GO:0008308 | 2e-04 | 109.5117 | 0.0229 | 2 | 15 | voltage-gated anion channel activity |
GO:1901363 | 6e-04 | 4.0528 | 8.6121 | 17 | 5653 | heterocyclic compound binding |
GO:0097159 | 8e-04 | 3.9749 | 8.7218 | 17 | 5725 | organic cyclic compound binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 56.4737 | 0.5484 | 15 | 300 | protein heterodimerization activity |
GO:0019904 | 0 | 21.803 | 1.181 | 14 | 646 | protein domain specific binding |
GO:0003723 | 0 | 10.1957 | 3.0475 | 16 | 1667 | RNA binding |
GO:0003677 | 0 | 9.2339 | 4.2176 | 18 | 2307 | DNA binding |
GO:1901363 | 3e-04 | 3.8157 | 10.3346 | 20 | 5653 | heterocyclic compound binding |
GO:0097159 | 4e-04 | 3.7423 | 10.4662 | 20 | 5725 | organic cyclic compound binding |
GO:0031707 | 0.0018 | Inf | 0.0018 | 1 | 1 | endothelin A receptor binding |
GO:0008426 | 0.0055 | 282.3793 | 0.0055 | 1 | 3 | protein kinase C inhibitor activity |
GO:0031708 | 0.0055 | 282.3793 | 0.0055 | 1 | 3 | endothelin B receptor binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 288.5185 | 0.0699 | 10 | 31 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 63.4893 | 0.2366 | 10 | 105 | nucleosome assembly |
GO:0040029 | 0 | 49.3564 | 0.2975 | 10 | 132 | regulation of gene expression, epigenetic |
GO:0032200 | 0 | 42.0539 | 0.3448 | 10 | 153 | telomere organization |
GO:0071824 | 0 | 29.963 | 0.4733 | 10 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 26.4733 | 0.5319 | 10 | 236 | chromatin remodeling |
GO:0050911 | 0 | 11.0887 | 0.6468 | 6 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 1e-04 | 8.7622 | 0.8114 | 6 | 360 | detection of chemical stimulus |
GO:0065003 | 1e-04 | 4.7224 | 3.0857 | 11 | 1407 | protein-containing complex assembly |
GO:0007606 | 2e-04 | 8.4685 | 0.8384 | 6 | 372 | sensory perception of chemical stimulus |
GO:1903244 | 2e-04 | 133.6571 | 0.0203 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0050906 | 2e-04 | 8.1935 | 0.8654 | 6 | 384 | detection of stimulus involved in sensory perception |
GO:1905205 | 2e-04 | 116.9429 | 0.0225 | 2 | 10 | positive regulation of connective tissue replacement |
GO:0014744 | 4e-04 | 77.9429 | 0.0316 | 2 | 14 | positive regulation of muscle adaptation |
GO:0010612 | 7e-04 | 58.4429 | 0.0406 | 2 | 18 | regulation of cardiac muscle adaptation |
GO:0050789 | 9e-04 | 4.3924 | 24.1648 | 33 | 10722 | regulation of biological process |
GO:1903671 | 0.0016 | 38.9429 | 0.0586 | 2 | 26 | negative regulation of sprouting angiogenesis |
GO:0050877 | 0.0017 | 3.8308 | 2.8781 | 9 | 1277 | nervous system process |
GO:0003299 | 0.0022 | 32.2187 | 0.0699 | 2 | 31 | muscle hypertrophy in response to stress |
GO:0097275 | 0.0023 | Inf | 0.0023 | 1 | 1 | cellular ammonium homeostasis |
GO:0097276 | 0.0023 | Inf | 0.0023 | 1 | 1 | cellular creatinine homeostasis |
GO:0097277 | 0.0023 | Inf | 0.0023 | 1 | 1 | cellular urea homeostasis |
GO:0014742 | 0.003 | 27.4723 | 0.0811 | 2 | 36 | positive regulation of muscle hypertrophy |
GO:0010467 | 0.0042 | 2.5227 | 13.6217 | 22 | 6044 | gene expression |
GO:1904270 | 0.0045 | 454.9722 | 0.0045 | 1 | 2 | pyroptosome complex assembly |
GO:0051898 | 0.0063 | 18.2958 | 0.1194 | 2 | 53 | negative regulation of protein kinase B signaling |
GO:0014888 | 0.0066 | 17.9429 | 0.1217 | 2 | 54 | striated muscle adaptation |
GO:1904059 | 0.0067 | 227.4722 | 0.0068 | 1 | 3 | regulation of locomotor rhythm |
GO:0060255 | 0.008 | 2.3369 | 13.3242 | 21 | 5912 | regulation of macromolecule metabolic process |
GO:0007186 | 0.0081 | 3.4311 | 2.3664 | 7 | 1050 | G protein-coupled receptor signaling pathway |
GO:0044085 | 0.0089 | 2.5073 | 6.5877 | 13 | 2923 | cellular component biogenesis |
GO:0010611 | 0.0097 | 14.5679 | 0.1487 | 2 | 66 | regulation of cardiac muscle hypertrophy |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048252 | 0 | Inf | 0.0026 | 2 | 2 | lauric acid metabolic process |
GO:0019373 | 2e-04 | 107.7632 | 0.023 | 2 | 18 | epoxygenase P450 pathway |
GO:0043651 | 2e-04 | 107.7632 | 0.023 | 2 | 18 | linoleic acid metabolic process |
GO:0050911 | 4e-04 | 13.3968 | 0.3671 | 4 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0.001 | 10.6015 | 0.4605 | 4 | 360 | detection of chemical stimulus |
GO:0007606 | 0.0011 | 10.2481 | 0.4758 | 4 | 372 | sensory perception of chemical stimulus |
GO:0050906 | 0.0013 | 9.917 | 0.4912 | 4 | 384 | detection of stimulus involved in sensory perception |
GO:0046456 | 0.002 | 34.4126 | 0.0665 | 2 | 52 | icosanoid biosynthetic process |
GO:0001519 | 0.0026 | 819.75 | 0.0026 | 1 | 2 | peptide amidation |
GO:0031408 | 0.0026 | 819.75 | 0.0026 | 1 | 2 | oxylipin biosynthetic process |
GO:0032827 | 0.0026 | 819.75 | 0.0026 | 1 | 2 | negative regulation of natural killer cell differentiation involved in immune response |
GO:0097214 | 0.0026 | 819.75 | 0.0026 | 1 | 2 | positive regulation of lysosomal membrane permeability |
GO:2000296 | 0.0026 | 819.75 | 0.0026 | 1 | 2 | negative regulation of hydrogen peroxide catabolic process |
GO:2000376 | 0.0026 | 819.75 | 0.0026 | 1 | 2 | positive regulation of oxygen metabolic process |
GO:0003095 | 0.0038 | 409.85 | 0.0038 | 1 | 3 | pressure natriuresis |
GO:0031914 | 0.0038 | 409.85 | 0.0038 | 1 | 3 | negative regulation of synaptic plasticity |
GO:0055073 | 0.0038 | 409.85 | 0.0038 | 1 | 3 | cadmium ion homeostasis |
GO:0061789 | 0.0038 | 409.85 | 0.0038 | 1 | 3 | dense core granule priming |
GO:0033559 | 0.0044 | 22.8235 | 0.0996 | 2 | 86 | unsaturated fatty acid metabolic process |
GO:0032787 | 0.0048 | 6.7918 | 0.7074 | 4 | 553 | monocarboxylic acid metabolic process |
GO:0003073 | 0.0051 | 20.9422 | 0.1074 | 2 | 84 | regulation of systemic arterial blood pressure |
GO:0001822 | 0.0054 | 9.5581 | 0.3633 | 3 | 284 | kidney development |
GO:0016053 | 0.0057 | 9.3548 | 0.371 | 3 | 290 | organic acid biosynthetic process |
GO:0044255 | 0.0058 | 5.1616 | 1.2037 | 5 | 941 | cellular lipid metabolic process |
GO:0036091 | 0.0064 | 204.9 | 0.0064 | 1 | 5 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress |
GO:0036101 | 0.0064 | 204.9 | 0.0064 | 1 | 5 | leukotriene B4 catabolic process |
GO:0097212 | 0.0064 | 204.9 | 0.0064 | 1 | 5 | lysosomal membrane organization |
GO:0099525 | 0.0064 | 204.9 | 0.0064 | 1 | 5 | presynaptic dense core vesicle exocytosis |
GO:0002249 | 0.0077 | 163.91 | 0.0077 | 1 | 6 | lymphocyte anergy |
GO:0002667 | 0.0077 | 163.91 | 0.0077 | 1 | 6 | regulation of T cell anergy |
GO:0009253 | 0.0077 | 163.91 | 0.0077 | 1 | 6 | peptidoglycan catabolic process |
GO:0001655 | 0.0083 | 8.1646 | 0.4234 | 3 | 331 | urogenital system development |
GO:0002933 | 0.0089 | 136.5833 | 0.009 | 1 | 7 | lipid hydroxylation |
GO:0009804 | 0.0089 | 136.5833 | 0.009 | 1 | 7 | coumarin metabolic process |
GO:0046222 | 0.0089 | 136.5833 | 0.009 | 1 | 7 | aflatoxin metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0040011 | 0 | 5.3538 | 4.9679 | 18 | 1773 | locomotion |
GO:0051674 | 0 | 5.1183 | 4.4106 | 16 | 1609 | localization of cell |
GO:0006928 | 0 | 4.6298 | 5.6432 | 18 | 2014 | movement of cell or subcellular component |
GO:0022008 | 1e-04 | 4.2499 | 4.3206 | 14 | 1542 | neurogenesis |
GO:0048665 | 1e-04 | 42.2326 | 0.0841 | 3 | 30 | neuron fate specification |
GO:0072009 | 2e-04 | 16.1458 | 0.2802 | 4 | 100 | nephron epithelium development |
GO:0048513 | 2e-04 | 3.1575 | 9.042 | 20 | 3227 | animal organ development |
GO:1903244 | 3e-04 | 106.2597 | 0.0252 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:1905205 | 3e-04 | 92.9716 | 0.028 | 2 | 10 | positive regulation of connective tissue replacement |
GO:0031589 | 4e-04 | 7.1803 | 0.9555 | 6 | 341 | cell-substrate adhesion |
GO:2000179 | 4e-04 | 24.2316 | 0.1401 | 3 | 50 | positive regulation of neural precursor cell proliferation |
GO:0051898 | 4e-04 | 22.7735 | 0.1485 | 3 | 53 | negative regulation of protein kinase B signaling |
GO:0048731 | 5e-04 | 3.7203 | 5.6356 | 14 | 2752 | system development |
GO:0010273 | 6e-04 | 67.6033 | 0.0364 | 2 | 13 | detoxification of copper ion |
GO:0014744 | 7e-04 | 61.9659 | 0.0392 | 2 | 14 | positive regulation of muscle adaptation |
GO:0001568 | 8e-04 | 4.6098 | 2.0258 | 8 | 723 | blood vessel development |
GO:0050789 | 9e-04 | 3.5505 | 30.0428 | 40 | 10722 | regulation of biological process |
GO:0072078 | 9e-04 | 17.7765 | 0.1877 | 3 | 67 | nephron tubule morphogenesis |
GO:0072359 | 9e-04 | 3.8228 | 3.1354 | 10 | 1119 | circulatory system development |
GO:0007379 | 9e-04 | 53.1071 | 0.0448 | 2 | 16 | segment specification |
GO:0032095 | 9e-04 | 53.1071 | 0.0448 | 2 | 16 | regulation of response to food |
GO:0097501 | 0.001 | 49.5636 | 0.0476 | 2 | 17 | stress response to metal ion |
GO:0048523 | 0.001 | 2.6299 | 12.7013 | 23 | 4533 | negative regulation of cellular process |
GO:0021953 | 0.0011 | 9.8356 | 0.4511 | 4 | 161 | central nervous system neuron differentiation |
GO:0072028 | 0.0011 | 16.4833 | 0.2017 | 3 | 72 | nephron morphogenesis |
GO:0003159 | 0.0011 | 46.4631 | 0.0504 | 2 | 18 | morphogenesis of an endothelium |
GO:0010612 | 0.0011 | 46.4631 | 0.0504 | 2 | 18 | regulation of cardiac muscle adaptation |
GO:0048729 | 0.0012 | 4.852 | 1.656 | 7 | 591 | tissue morphogenesis |
GO:0071294 | 0.0014 | 41.2955 | 0.056 | 2 | 20 | cellular response to zinc ion |
GO:0001667 | 0.0014 | 5.4565 | 1.2441 | 6 | 444 | ameboidal-type cell migration |
GO:0001656 | 0.0016 | 14.2073 | 0.2326 | 3 | 83 | metanephros development |
GO:0060562 | 0.0017 | 6.4238 | 0.8686 | 5 | 310 | epithelial tube morphogenesis |
GO:0061326 | 0.0017 | 13.859 | 0.2382 | 3 | 85 | renal tubule development |
GO:0021871 | 0.0019 | 35.3896 | 0.0644 | 2 | 23 | forebrain regionalization |
GO:0071363 | 0.0019 | 4.4479 | 1.7989 | 7 | 642 | cellular response to growth factor stimulus |
GO:0071495 | 0.0021 | 3.3837 | 3.5081 | 10 | 1252 | cellular response to endogenous stimulus |
GO:0032104 | 0.0022 | 32.3083 | 0.07 | 2 | 25 | regulation of response to extracellular stimulus |
GO:0071280 | 0.0022 | 32.3083 | 0.07 | 2 | 25 | cellular response to copper ion |
GO:0001655 | 0.0023 | 6.0022 | 0.9275 | 5 | 331 | urogenital system development |
GO:0090132 | 0.0023 | 5.9463 | 0.9359 | 5 | 334 | epithelium migration |
GO:1903671 | 0.0024 | 30.9602 | 0.0729 | 2 | 26 | negative regulation of sprouting angiogenesis |
GO:0048869 | 0.0024 | 2.6091 | 9.4 | 18 | 3617 | cellular developmental process |
GO:0003008 | 0.0027 | 2.8404 | 5.6236 | 13 | 2007 | system process |
GO:0097476 | 0.0027 | Inf | 0.0027 | 1 | 1 | spinal cord motor neuron migration |
GO:0032903 | 0.0028 | Inf | 0.0028 | 1 | 1 | regulation of nerve growth factor production |
GO:0035847 | 0.0028 | Inf | 0.0028 | 1 | 1 | uterine epithelium development |
GO:0035849 | 0.0028 | Inf | 0.0028 | 1 | 1 | nephric duct elongation |
GO:0035852 | 0.0028 | Inf | 0.0028 | 1 | 1 | horizontal cell localization |
GO:0045720 | 0.0028 | Inf | 0.0028 | 1 | 1 | negative regulation of integrin biosynthetic process |
GO:0048572 | 0.0028 | Inf | 0.0028 | 1 | 1 | short-day photoperiodism |
GO:0060945 | 0.0028 | Inf | 0.0028 | 1 | 1 | cardiac neuron differentiation |
GO:0070208 | 0.0028 | Inf | 0.0028 | 1 | 1 | protein heterotrimerization |
GO:0090138 | 0.0028 | Inf | 0.0028 | 1 | 1 | regulation of actin cytoskeleton organization by cell-cell adhesion |
GO:0097379 | 0.0028 | Inf | 0.0028 | 1 | 1 | dorsal spinal cord interneuron posterior axon guidance |
GO:1902203 | 0.0028 | Inf | 0.0028 | 1 | 1 | negative regulation of hepatocyte growth factor receptor signaling pathway |
GO:1902870 | 0.0028 | Inf | 0.0028 | 1 | 1 | negative regulation of amacrine cell differentiation |
GO:1903056 | 0.0028 | Inf | 0.0028 | 1 | 1 | regulation of melanosome organization |
GO:2000744 | 0.0028 | Inf | 0.0028 | 1 | 1 | positive regulation of anterior head development |
GO:2001113 | 0.0028 | Inf | 0.0028 | 1 | 1 | negative regulation of cellular response to hepatocyte growth factor stimulus |
GO:0035239 | 0.0028 | 4.7644 | 1.4356 | 6 | 564 | tube morphogenesis |
GO:0032501 | 0.003 | 2.9881 | 8.4761 | 16 | 4006 | multicellular organismal process |
GO:0016477 | 0.0032 | 4.1193 | 1.9952 | 7 | 854 | cell migration |
GO:0021987 | 0.0032 | 11.0192 | 0.297 | 3 | 106 | cerebral cortex development |
GO:0003299 | 0.0034 | 25.6144 | 0.0869 | 2 | 31 | muscle hypertrophy in response to stress |
GO:1903507 | 0.0037 | 3.2964 | 3.1774 | 9 | 1134 | negative regulation of nucleic acid-templated transcription |
GO:0048646 | 0.0038 | 3.2933 | 3.1802 | 9 | 1135 | anatomical structure formation involved in morphogenesis |
GO:0071276 | 0.0038 | 23.9589 | 0.0925 | 2 | 33 | cellular response to cadmium ion |
GO:0021537 | 0.0042 | 6.6543 | 0.6585 | 4 | 235 | telencephalon development |
GO:0014742 | 0.0046 | 21.8409 | 0.1009 | 2 | 36 | positive regulation of muscle hypertrophy |
GO:0090051 | 0.0046 | 21.8409 | 0.1009 | 2 | 36 | negative regulation of cell migration involved in sprouting angiogenesis |
GO:0006882 | 0.0048 | 21.2156 | 0.1037 | 2 | 37 | cellular zinc ion homeostasis |
GO:2000145 | 0.0049 | 3.3984 | 2.6983 | 8 | 963 | regulation of cell motility |
GO:0120035 | 0.0054 | 4.1133 | 1.6307 | 6 | 582 | regulation of plasma membrane bounded cell projection organization |
GO:0046370 | 0.0056 | 363.7778 | 0.0056 | 1 | 2 | fructose biosynthetic process |
GO:0060067 | 0.0056 | 363.7778 | 0.0056 | 1 | 2 | cervix development |
GO:0072272 | 0.0056 | 363.7778 | 0.0056 | 1 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
GO:0097214 | 0.0056 | 363.7778 | 0.0056 | 1 | 2 | positive regulation of lysosomal membrane permeability |
GO:0097324 | 0.0056 | 363.7778 | 0.0056 | 1 | 2 | melanocyte migration |
GO:0097498 | 0.0056 | 363.7778 | 0.0056 | 1 | 2 | endothelial tube lumen extension |
GO:0140039 | 0.0056 | 363.7778 | 0.0056 | 1 | 2 | cell-cell adhesion in response to extracellular stimulus |
GO:2000296 | 0.0056 | 363.7778 | 0.0056 | 1 | 2 | negative regulation of hydrogen peroxide catabolic process |
GO:2000376 | 0.0056 | 363.7778 | 0.0056 | 1 | 2 | positive regulation of oxygen metabolic process |
GO:2000768 | 0.0056 | 363.7778 | 0.0056 | 1 | 2 | positive regulation of nephron tubule epithelial cell differentiation |
GO:0045165 | 0.0056 | 6.0918 | 0.7173 | 4 | 256 | cell fate commitment |
GO:0043542 | 0.0058 | 6.0431 | 0.7229 | 4 | 258 | endothelial cell migration |
GO:2000181 | 0.0059 | 8.8534 | 0.3671 | 3 | 131 | negative regulation of blood vessel morphogenesis |
GO:0030182 | 0.006 | 3.3115 | 2.8098 | 8 | 1114 | neuron differentiation |
GO:0098754 | 0.006 | 8.7842 | 0.3699 | 3 | 132 | detoxification |
GO:0035850 | 0.0062 | 18.558 | 0.1177 | 2 | 42 | epithelial cell differentiation involved in kidney development |
GO:0051241 | 0.0062 | 3.257 | 2.8156 | 8 | 1027 | negative regulation of multicellular organismal process |
GO:0043535 | 0.0064 | 8.583 | 0.3783 | 3 | 135 | regulation of blood vessel endothelial cell migration |
GO:0051253 | 0.0065 | 3.0075 | 3.4576 | 9 | 1234 | negative regulation of RNA metabolic process |
GO:0010632 | 0.0067 | 5.7883 | 0.7537 | 4 | 269 | regulation of epithelial cell migration |
GO:0002040 | 0.0069 | 8.3502 | 0.3892 | 3 | 145 | sprouting angiogenesis |
GO:0021517 | 0.007 | 17.26 | 0.1261 | 2 | 45 | ventral spinal cord development |
GO:0050770 | 0.007 | 8.2672 | 0.3923 | 3 | 140 | regulation of axonogenesis |
GO:0009890 | 0.0072 | 2.7969 | 4.1721 | 10 | 1489 | negative regulation of biosynthetic process |
GO:0070887 | 0.0075 | 2.3584 | 7.8511 | 15 | 2802 | cellular response to chemical stimulus |
GO:0061564 | 0.0075 | 4.4676 | 1.2329 | 5 | 440 | axon development |
GO:0060041 | 0.0078 | 7.9736 | 0.4063 | 3 | 145 | retina development in camera-type eye |
GO:0000122 | 0.008 | 3.3822 | 2.3312 | 7 | 832 | negative regulation of transcription by RNA polymerase II |
GO:0032502 | 0.0081 | 3.856 | 2.5036 | 7 | 1608 | developmental process |
GO:0001705 | 0.0084 | 181.8778 | 0.0084 | 1 | 3 | ectoderm formation |
GO:0033624 | 0.0084 | 181.8778 | 0.0084 | 1 | 3 | negative regulation of integrin activation |
GO:0055073 | 0.0084 | 181.8778 | 0.0084 | 1 | 3 | cadmium ion homeostasis |
GO:0060164 | 0.0084 | 181.8778 | 0.0084 | 1 | 3 | regulation of timing of neuron differentiation |
GO:0097377 | 0.0084 | 181.8778 | 0.0084 | 1 | 3 | spinal cord interneuron axon guidance |
GO:0097477 | 0.0084 | 181.8778 | 0.0084 | 1 | 3 | lateral motor column neuron migration |
GO:1904178 | 0.0084 | 181.8778 | 0.0084 | 1 | 3 | negative regulation of adipose tissue development |
GO:0030198 | 0.0084 | 5.4141 | 0.8042 | 4 | 287 | extracellular matrix organization |
GO:2000026 | 0.0084 | 2.8776 | 3.6005 | 9 | 1285 | regulation of multicellular organismal development |
GO:0051093 | 0.0085 | 3.3466 | 2.3605 | 7 | 861 | negative regulation of developmental process |
GO:0021515 | 0.0086 | 15.4574 | 0.1401 | 2 | 50 | cell differentiation in spinal cord |
GO:0001764 | 0.0091 | 7.4942 | 0.4315 | 3 | 154 | neuron migration |
GO:0001658 | 0.0093 | 14.8373 | 0.1457 | 2 | 52 | branching involved in ureteric bud morphogenesis |
GO:0008015 | 0.0099 | 4.1623 | 1.3197 | 5 | 471 | blood circulation |
GO:0000904 | 0.01 | 3.5934 | 1.8549 | 6 | 662 | cell morphogenesis involved in differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051674 | 0 | 5.7315 | 3.3343 | 13 | 1610 | localization of cell |
GO:0045165 | 0 | 13.8283 | 0.5302 | 6 | 256 | cell fate commitment |
GO:0040011 | 0 | 5.1434 | 3.6719 | 13 | 1773 | locomotion |
GO:0006928 | 1e-04 | 4.4493 | 4.171 | 13 | 2014 | movement of cell or subcellular component |
GO:2000179 | 1e-04 | 33.6362 | 0.1036 | 3 | 50 | positive regulation of neural precursor cell proliferation |
GO:0061180 | 3e-04 | 25.475 | 0.1346 | 3 | 65 | mammary gland epithelium development |
GO:0048468 | 4e-04 | 4.0231 | 4.0758 | 12 | 1968 | cell development |
GO:0032989 | 5e-04 | 5.8172 | 1.4621 | 7 | 706 | cellular component morphogenesis |
GO:0032501 | 5e-04 | 3.64 | 12.4726 | 22 | 6530 | multicellular organismal process |
GO:0090132 | 6e-04 | 8.4132 | 0.6917 | 5 | 334 | epithelium migration |
GO:0022008 | 8e-04 | 4.0391 | 3.1935 | 10 | 1542 | neurogenesis |
GO:0052652 | 9e-04 | 53.8289 | 0.0435 | 2 | 21 | cyclic purine nucleotide metabolic process |
GO:0061042 | 9e-04 | 53.8289 | 0.0435 | 2 | 21 | vascular wound healing |
GO:0001759 | 0.001 | 48.6964 | 0.0476 | 2 | 23 | organ induction |
GO:0035295 | 0.0011 | 4.5069 | 2.1849 | 8 | 1055 | tube development |
GO:0016477 | 0.0012 | 5.0912 | 1.7154 | 7 | 942 | cell migration |
GO:0042060 | 0.0013 | 7.015 | 0.8243 | 5 | 398 | wound healing |
GO:0003018 | 0.0016 | 8.9306 | 0.5074 | 4 | 245 | vascular process in circulatory system |
GO:0048665 | 0.0017 | 36.5067 | 0.0621 | 2 | 30 | neuron fate specification |
GO:0021988 | 0.0019 | 35.2457 | 0.0642 | 2 | 31 | olfactory lobe development |
GO:0043542 | 0.0019 | 8.4667 | 0.5343 | 4 | 258 | endothelial cell migration |
GO:0048514 | 0.002 | 5.2286 | 1.3482 | 6 | 651 | blood vessel morphogenesis |
GO:0001667 | 0.0021 | 6.2619 | 0.9195 | 5 | 444 | ameboidal-type cell migration |
GO:0014843 | 0.0021 | Inf | 0.0021 | 1 | 1 | growth factor dependent regulation of skeletal muscle satellite cell proliferation |
GO:0060945 | 0.0021 | Inf | 0.0021 | 1 | 1 | cardiac neuron differentiation |
GO:1902748 | 0.0021 | Inf | 0.0021 | 1 | 1 | positive regulation of lens fiber cell differentiation |
GO:0090050 | 0.0021 | 32.9677 | 0.0683 | 2 | 33 | positive regulation of cell migration involved in sprouting angiogenesis |
GO:0071312 | 0.0024 | 30.9659 | 0.0725 | 2 | 35 | cellular response to alkaloid |
GO:0072001 | 0.0026 | 7.7895 | 0.5811 | 4 | 289 | renal system development |
GO:0019932 | 0.0027 | 7.6961 | 0.5861 | 4 | 283 | second-messenger-mediated signaling |
GO:0070887 | 0.0027 | 3.0173 | 5.803 | 13 | 2802 | cellular response to chemical stimulus |
GO:0043535 | 0.0027 | 11.9142 | 0.2796 | 3 | 135 | regulation of blood vessel endothelial cell migration |
GO:0007420 | 0.0028 | 4.8662 | 1.4435 | 6 | 697 | brain development |
GO:0009187 | 0.0028 | 28.3802 | 0.0787 | 2 | 38 | cyclic nucleotide metabolic process |
GO:0048754 | 0.0031 | 11.3094 | 0.2941 | 3 | 142 | branching morphogenesis of an epithelial tube |
GO:2000145 | 0.0031 | 4.1837 | 1.9944 | 7 | 963 | regulation of cell motility |
GO:0021795 | 0.0034 | 25.5359 | 0.087 | 2 | 42 | cerebral cortex cell migration |
GO:1904707 | 0.0036 | 24.9116 | 0.0891 | 2 | 43 | positive regulation of vascular associated smooth muscle cell proliferation |
GO:0007568 | 0.0036 | 10.6886 | 0.3107 | 3 | 150 | aging |
GO:0048646 | 0.004 | 4.0112 | 2.0976 | 7 | 1072 | anatomical structure formation involved in morphogenesis |
GO:0014809 | 0.0041 | 496.4242 | 0.0041 | 1 | 2 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion |
GO:0021823 | 0.0041 | 496.4242 | 0.0041 | 1 | 2 | cerebral cortex tangential migration using cell-cell interactions |
GO:0021836 | 0.0041 | 496.4242 | 0.0041 | 1 | 2 | chemorepulsion involved in postnatal olfactory bulb interneuron migration |
GO:0042660 | 0.0041 | 496.4242 | 0.0041 | 1 | 2 | positive regulation of cell fate specification |
GO:0046370 | 0.0041 | 496.4242 | 0.0041 | 1 | 2 | fructose biosynthetic process |
GO:0048343 | 0.0041 | 496.4242 | 0.0041 | 1 | 2 | paraxial mesodermal cell fate commitment |
GO:0050925 | 0.0041 | 496.4242 | 0.0041 | 1 | 2 | negative regulation of negative chemotaxis |
GO:0140039 | 0.0041 | 496.4242 | 0.0041 | 1 | 2 | cell-cell adhesion in response to extracellular stimulus |
GO:1902257 | 0.0041 | 496.4242 | 0.0041 | 1 | 2 | negative regulation of apoptotic process involved in outflow tract morphogenesis |
GO:0001944 | 0.0042 | 4.4603 | 1.5678 | 6 | 757 | vasculature development |
GO:0021872 | 0.0042 | 22.6917 | 0.0973 | 2 | 47 | forebrain generation of neurons |
GO:0006950 | 0.0043 | 3.5168 | 3.4116 | 9 | 1958 | response to stress |
GO:0021543 | 0.0044 | 9.9377 | 0.3334 | 3 | 161 | pallium development |
GO:0021953 | 0.0044 | 9.9377 | 0.3334 | 3 | 161 | central nervous system neuron differentiation |
GO:0010634 | 0.0047 | 9.7508 | 0.3396 | 3 | 164 | positive regulation of epithelial cell migration |
GO:0002042 | 0.0048 | 21.3085 | 0.1035 | 2 | 53 | cell migration involved in sprouting angiogenesis |
GO:0007566 | 0.0048 | 21.2695 | 0.1036 | 2 | 50 | embryo implantation |
GO:2001258 | 0.0048 | 21.2695 | 0.1036 | 2 | 50 | negative regulation of cation channel activity |
GO:0003002 | 0.005 | 6.4264 | 0.6979 | 4 | 337 | regionalization |
GO:0061005 | 0.005 | 20.8342 | 0.1056 | 2 | 51 | cell differentiation involved in kidney development |
GO:0006749 | 0.0052 | 20.4163 | 0.1077 | 2 | 52 | glutathione metabolic process |
GO:0072132 | 0.0054 | 20.0147 | 0.1098 | 2 | 53 | mesenchyme morphogenesis |
GO:1904645 | 0.0054 | 20.0147 | 0.1098 | 2 | 53 | response to amyloid-beta |
GO:0045766 | 0.0055 | 9.1749 | 0.3604 | 3 | 174 | positive regulation of angiogenesis |
GO:0060038 | 0.0056 | 19.6286 | 0.1118 | 2 | 54 | cardiac muscle cell proliferation |
GO:0007507 | 0.0057 | 4.8897 | 1.166 | 5 | 563 | heart development |
GO:0046668 | 0.0062 | 248.197 | 0.0062 | 1 | 3 | regulation of retinal cell programmed cell death |
GO:0048769 | 0.0062 | 248.197 | 0.0062 | 1 | 3 | sarcomerogenesis |
GO:0060128 | 0.0062 | 248.197 | 0.0062 | 1 | 3 | corticotropin hormone secreting cell differentiation |
GO:0060164 | 0.0062 | 248.197 | 0.0062 | 1 | 3 | regulation of timing of neuron differentiation |
GO:0072011 | 0.0062 | 248.197 | 0.0062 | 1 | 3 | glomerular endothelium development |
GO:1903712 | 0.0062 | 248.197 | 0.0062 | 1 | 3 | cysteine transmembrane transport |
GO:2000546 | 0.0062 | 248.197 | 0.0062 | 1 | 3 | positive regulation of endothelial cell chemotaxis to fibroblast growth factor |
GO:0048812 | 0.0064 | 4.7572 | 1.1971 | 5 | 578 | neuron projection morphogenesis |
GO:0021885 | 0.0064 | 18.2221 | 0.1201 | 2 | 58 | forebrain cell migration |
GO:0022617 | 0.0064 | 18.2221 | 0.1201 | 2 | 58 | extracellular matrix disassembly |
GO:0001763 | 0.0067 | 8.5198 | 0.3873 | 3 | 187 | morphogenesis of a branching structure |
GO:0048858 | 0.0073 | 4.599 | 1.2364 | 5 | 597 | cell projection morphogenesis |
GO:0048589 | 0.0075 | 4.5669 | 1.2447 | 5 | 601 | developmental growth |
GO:0048645 | 0.0075 | 16.7234 | 0.1305 | 2 | 63 | animal organ formation |
GO:0007169 | 0.0075 | 4.559 | 1.2468 | 5 | 602 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0060537 | 0.0079 | 5.6 | 0.7973 | 4 | 385 | muscle tissue development |
GO:0055065 | 0.0081 | 4.4734 | 1.2695 | 5 | 613 | metal ion homeostasis |
GO:0002528 | 0.0083 | 165.4545 | 0.0083 | 1 | 4 | regulation of vascular permeability involved in acute inflammatory response |
GO:0018916 | 0.0083 | 165.4545 | 0.0083 | 1 | 4 | nitrobenzene metabolic process |
GO:0021828 | 0.0083 | 165.4545 | 0.0083 | 1 | 4 | gonadotrophin-releasing hormone neuronal migration to the hypothalamus |
GO:0022028 | 0.0083 | 165.4545 | 0.0083 | 1 | 4 | tangential migration from the subventricular zone to the olfactory bulb |
GO:0022614 | 0.0083 | 165.4545 | 0.0083 | 1 | 4 | membrane to membrane docking |
GO:0033600 | 0.0083 | 165.4545 | 0.0083 | 1 | 4 | negative regulation of mammary gland epithelial cell proliferation |
GO:0035481 | 0.0083 | 165.4545 | 0.0083 | 1 | 4 | positive regulation of Notch signaling pathway involved in heart induction |
GO:0060129 | 0.0083 | 165.4545 | 0.0083 | 1 | 4 | thyroid-stimulating hormone-secreting cell differentiation |
GO:0060157 | 0.0083 | 165.4545 | 0.0083 | 1 | 4 | urinary bladder development |
GO:0061737 | 0.0083 | 165.4545 | 0.0083 | 1 | 4 | leukotriene signaling pathway |
GO:0097476 | 0.0083 | 165.4545 | 0.0083 | 1 | 4 | spinal cord motor neuron migration |
GO:2000697 | 0.0083 | 165.4545 | 0.0083 | 1 | 4 | negative regulation of epithelial cell differentiation involved in kidney development |
GO:0050789 | 0.0084 | 3.0863 | 22.2055 | 29 | 10722 | regulation of biological process |
GO:0035924 | 0.0087 | 15.4517 | 0.1408 | 2 | 68 | cellular response to vascular endothelial growth factor stimulus |
GO:0021536 | 0.009 | 15.2201 | 0.1429 | 2 | 69 | diencephalon development |
GO:0072089 | 0.009 | 15.2201 | 0.1429 | 2 | 69 | stem cell proliferation |
GO:0030855 | 0.0091 | 4.3398 | 1.3068 | 5 | 631 | epithelial cell differentiation |
GO:0010975 | 0.0093 | 5.3414 | 0.8346 | 4 | 403 | regulation of neuron projection development |
GO:0009314 | 0.0098 | 5.2602 | 0.847 | 4 | 409 | response to radiation |
GO:0033002 | 0.0098 | 7.3818 | 0.4453 | 3 | 215 | muscle cell proliferation |
GO:0006952 | 0.0098 | 3.0823 | 3.0962 | 8 | 1495 | defense response |
GO:0030198 | 0.01 | 7.37 | 0.4479 | 3 | 229 | extracellular matrix organization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048731 | 0 | 6.4136 | 5.7106 | 18 | 2912 | system development |
GO:0022008 | 0 | 6.2303 | 2.4692 | 11 | 1203 | neurogenesis |
GO:1903244 | 2e-04 | 129.9365 | 0.0208 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:1905205 | 2e-04 | 113.6875 | 0.0231 | 2 | 10 | positive regulation of connective tissue replacement |
GO:0030182 | 2e-04 | 5.2344 | 2.2199 | 9 | 1092 | neuron differentiation |
GO:0051898 | 2e-04 | 27.9926 | 0.1227 | 3 | 53 | negative regulation of protein kinase B signaling |
GO:0048468 | 3e-04 | 3.8366 | 4.5553 | 13 | 1968 | cell development |
GO:0040011 | 4e-04 | 3.8312 | 4.1039 | 12 | 1773 | locomotion |
GO:0014744 | 5e-04 | 75.7731 | 0.0324 | 2 | 14 | positive regulation of muscle adaptation |
GO:2000026 | 5e-04 | 4.2308 | 2.9744 | 10 | 1285 | regulation of multicellular organismal development |
GO:0045765 | 8e-04 | 7.8539 | 0.7291 | 5 | 315 | regulation of angiogenesis |
GO:0051674 | 8e-04 | 3.7658 | 3.7266 | 11 | 1610 | localization of cell |
GO:0010612 | 8e-04 | 56.816 | 0.0417 | 2 | 18 | regulation of cardiac muscle adaptation |
GO:0034103 | 9e-04 | 17.6854 | 0.1898 | 3 | 82 | regulation of tissue remodeling |
GO:0050767 | 0.001 | 7.2786 | 0.7847 | 5 | 339 | regulation of neurogenesis |
GO:0051093 | 0.0011 | 9.9903 | 0.4583 | 4 | 226 | negative regulation of developmental process |
GO:0008285 | 0.0012 | 4.9687 | 1.6643 | 7 | 719 | negative regulation of cell population proliferation |
GO:0048513 | 0.0013 | 2.9825 | 7.4695 | 16 | 3227 | animal organ development |
GO:0006928 | 0.0014 | 3.3145 | 4.6618 | 12 | 2014 | movement of cell or subcellular component |
GO:0060384 | 0.0015 | 39.5072 | 0.0579 | 2 | 25 | innervation |
GO:1903671 | 0.0016 | 37.8588 | 0.0602 | 2 | 26 | negative regulation of sprouting angiogenesis |
GO:1902547 | 0.0018 | 36.3422 | 0.0625 | 2 | 27 | regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0002526 | 0.0018 | 13.6782 | 0.243 | 3 | 105 | acute inflammatory response |
GO:0009308 | 0.0019 | 13.4135 | 0.2477 | 3 | 107 | amine metabolic process |
GO:0007600 | 0.002 | 4.4796 | 1.8355 | 7 | 793 | sensory perception |
GO:0001662 | 0.0022 | 32.4425 | 0.0694 | 2 | 30 | behavioral fear response |
GO:0048665 | 0.0022 | 32.4425 | 0.0694 | 2 | 30 | neuron fate specification |
GO:0032903 | 0.0023 | Inf | 0.0023 | 1 | 1 | regulation of nerve growth factor production |
GO:0048572 | 0.0023 | Inf | 0.0023 | 1 | 1 | short-day photoperiodism |
GO:0050783 | 0.0023 | Inf | 0.0023 | 1 | 1 | cocaine metabolic process |
GO:0060945 | 0.0023 | Inf | 0.0023 | 1 | 1 | cardiac neuron differentiation |
GO:1902203 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of hepatocyte growth factor receptor signaling pathway |
GO:1902870 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of amacrine cell differentiation |
GO:1904445 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of establishment of Sertoli cell barrier |
GO:2001113 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of cellular response to hepatocyte growth factor stimulus |
GO:0003299 | 0.0023 | 31.3218 | 0.0718 | 2 | 31 | muscle hypertrophy in response to stress |
GO:0021988 | 0.0023 | 31.3218 | 0.0718 | 2 | 31 | olfactory lobe development |
GO:0003008 | 0.0023 | 3.7103 | 3.0416 | 9 | 1463 | system process |
GO:0010975 | 0.0024 | 7.9626 | 0.5655 | 4 | 263 | regulation of neuron projection development |
GO:0014070 | 0.0026 | 4.279 | 1.9165 | 7 | 828 | response to organic cyclic compound |
GO:0048518 | 0.0026 | 2.6167 | 13.1103 | 22 | 5664 | positive regulation of biological process |
GO:0046326 | 0.0028 | 28.3802 | 0.0787 | 2 | 34 | positive regulation of glucose import |
GO:0014742 | 0.0031 | 26.7075 | 0.0833 | 2 | 36 | positive regulation of muscle hypertrophy |
GO:0045596 | 0.0032 | 4.6872 | 1.4721 | 6 | 636 | negative regulation of cell differentiation |
GO:0065007 | 0.0032 | 3.79 | 26.2993 | 34 | 11362 | biological regulation |
GO:0009991 | 0.0033 | 5.5274 | 1.0231 | 5 | 442 | response to extracellular stimulus |
GO:2000181 | 0.0034 | 10.8824 | 0.3032 | 3 | 131 | negative regulation of blood vessel morphogenesis |
GO:0035239 | 0.0035 | 4.04 | 2.023 | 7 | 874 | tube morphogenesis |
GO:0072359 | 0.0035 | 3.6647 | 2.5901 | 8 | 1119 | circulatory system development |
GO:0007268 | 0.0037 | 4.5227 | 1.5231 | 6 | 658 | chemical synaptic transmission |
GO:0099537 | 0.0039 | 4.4727 | 1.5393 | 6 | 665 | trans-synaptic signaling |
GO:0007584 | 0.004 | 10.2372 | 0.3217 | 3 | 139 | response to nutrient |
GO:0050770 | 0.0041 | 10.1618 | 0.3241 | 3 | 140 | regulation of axonogenesis |
GO:0021795 | 0.0042 | 22.6931 | 0.0972 | 2 | 42 | cerebral cortex cell migration |
GO:0021823 | 0.0046 | 442.6486 | 0.0046 | 1 | 2 | cerebral cortex tangential migration using cell-cell interactions |
GO:0021836 | 0.0046 | 442.6486 | 0.0046 | 1 | 2 | chemorepulsion involved in postnatal olfactory bulb interneuron migration |
GO:0050925 | 0.0046 | 442.6486 | 0.0046 | 1 | 2 | negative regulation of negative chemotaxis |
GO:0071642 | 0.0046 | 442.6486 | 0.0046 | 1 | 2 | positive regulation of macrophage inflammatory protein 1 alpha production |
GO:0140039 | 0.0046 | 442.6486 | 0.0046 | 1 | 2 | cell-cell adhesion in response to extracellular stimulus |
GO:0007605 | 0.0047 | 9.6637 | 0.3403 | 3 | 147 | sensory perception of sound |
GO:0035176 | 0.0049 | 21.1059 | 0.1042 | 2 | 45 | social behavior |
GO:0007568 | 0.005 | 9.4647 | 0.3472 | 3 | 150 | aging |
GO:0031346 | 0.005 | 6.366 | 0.6988 | 4 | 310 | positive regulation of cell projection organization |
GO:0010043 | 0.0053 | 20.1654 | 0.1088 | 2 | 47 | response to zinc ion |
GO:0048260 | 0.0053 | 20.1654 | 0.1088 | 2 | 47 | positive regulation of receptor-mediated endocytosis |
GO:0050794 | 0.0055 | 2.8446 | 23.156 | 31 | 10004 | regulation of cellular process |
GO:0010243 | 0.0055 | 3.7004 | 2.1966 | 7 | 949 | response to organonitrogen compound |
GO:0001568 | 0.0059 | 4.0957 | 1.6735 | 6 | 723 | blood vessel development |
GO:2000179 | 0.006 | 18.9016 | 0.1157 | 2 | 50 | positive regulation of neural precursor cell proliferation |
GO:2000145 | 0.006 | 3.6429 | 2.229 | 7 | 963 | regulation of cell motility |
GO:0006952 | 0.006 | 3.1103 | 3.4604 | 9 | 1495 | defense response |
GO:0007416 | 0.0061 | 8.7998 | 0.3727 | 3 | 161 | synapse assembly |
GO:0048667 | 0.0063 | 4.7241 | 1.1897 | 5 | 514 | cell morphogenesis involved in neuron differentiation |
GO:0014888 | 0.0069 | 17.4434 | 0.125 | 2 | 54 | striated muscle adaptation |
GO:0006581 | 0.0069 | 221.3108 | 0.0069 | 1 | 3 | acetylcholine catabolic process |
GO:0033092 | 0.0069 | 221.3108 | 0.0069 | 1 | 3 | positive regulation of immature T cell proliferation in thymus |
GO:0043420 | 0.0069 | 221.3108 | 0.0069 | 1 | 3 | anthranilate metabolic process |
GO:0060164 | 0.0069 | 221.3108 | 0.0069 | 1 | 3 | regulation of timing of neuron differentiation |
GO:1902952 | 0.0069 | 221.3108 | 0.0069 | 1 | 3 | positive regulation of dendritic spine maintenance |
GO:1903712 | 0.0069 | 221.3108 | 0.0069 | 1 | 3 | cysteine transmembrane transport |
GO:1904178 | 0.0069 | 221.3108 | 0.0069 | 1 | 3 | negative regulation of adipose tissue development |
GO:0071345 | 0.0074 | 3.9018 | 1.7522 | 6 | 757 | cellular response to cytokine stimulus |
GO:0045664 | 0.0077 | 8.0758 | 0.4058 | 3 | 180 | regulation of neuron differentiation |
GO:0031589 | 0.0077 | 5.6003 | 0.7893 | 4 | 341 | cell-substrate adhesion |
GO:0021885 | 0.0079 | 16.1935 | 0.1343 | 2 | 58 | forebrain cell migration |
GO:0044057 | 0.008 | 4.4527 | 1.2592 | 5 | 544 | regulation of system process |
GO:0021987 | 0.0087 | 15.4431 | 0.1407 | 2 | 64 | cerebral cortex development |
GO:0032502 | 0.009 | 2.797 | 7.8282 | 14 | 4830 | developmental process |
GO:0002865 | 0.0092 | 147.5315 | 0.0093 | 1 | 4 | negative regulation of acute inflammatory response to antigenic stimulus |
GO:0019805 | 0.0092 | 147.5315 | 0.0093 | 1 | 4 | quinolinate biosynthetic process |
GO:0022028 | 0.0092 | 147.5315 | 0.0093 | 1 | 4 | tangential migration from the subventricular zone to the olfactory bulb |
GO:0022614 | 0.0092 | 147.5315 | 0.0093 | 1 | 4 | membrane to membrane docking |
GO:0030167 | 0.0092 | 147.5315 | 0.0093 | 1 | 4 | proteoglycan catabolic process |
GO:0032100 | 0.0092 | 147.5315 | 0.0093 | 1 | 4 | positive regulation of appetite |
GO:0032109 | 0.0092 | 147.5315 | 0.0093 | 1 | 4 | positive regulation of response to nutrient levels |
GO:0033600 | 0.0092 | 147.5315 | 0.0093 | 1 | 4 | negative regulation of mammary gland epithelial cell proliferation |
GO:0034398 | 0.0092 | 147.5315 | 0.0093 | 1 | 4 | telomere tethering at nuclear periphery |
GO:0035481 | 0.0092 | 147.5315 | 0.0093 | 1 | 4 | positive regulation of Notch signaling pathway involved in heart induction |
GO:0070197 | 0.0092 | 147.5315 | 0.0093 | 1 | 4 | meiotic attachment of telomere to nuclear envelope |
GO:1904000 | 0.0092 | 147.5315 | 0.0093 | 1 | 4 | positive regulation of eating behavior |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008285 | 0 | 15.4236 | 0.7445 | 7 | 719 | negative regulation of cell population proliferation |
GO:0051674 | 1e-04 | 8.2108 | 1.6672 | 8 | 1610 | localization of cell |
GO:0043062 | 2e-04 | 17.4605 | 0.2982 | 4 | 288 | extracellular structure organization |
GO:0045229 | 2e-04 | 17.3362 | 0.3003 | 4 | 290 | external encapsulating structure organization |
GO:1902547 | 3e-04 | 87.3333 | 0.028 | 2 | 27 | regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0021988 | 5e-04 | 75.269 | 0.0321 | 2 | 31 | olfactory lobe development |
GO:0043534 | 5e-04 | 22.3132 | 0.1646 | 3 | 159 | blood vessel endothelial cell migration |
GO:0002040 | 7e-04 | 20.7041 | 0.1771 | 3 | 171 | sprouting angiogenesis |
GO:1904018 | 7e-04 | 20.3371 | 0.1802 | 3 | 174 | positive regulation of vasculature development |
GO:1902203 | 0.001 | Inf | 0.001 | 1 | 1 | negative regulation of hepatocyte growth factor receptor signaling pathway |
GO:1904445 | 0.001 | Inf | 0.001 | 1 | 1 | negative regulation of establishment of Sertoli cell barrier |
GO:2001113 | 0.001 | Inf | 0.001 | 1 | 1 | negative regulation of cellular response to hepatocyte growth factor stimulus |
GO:0051093 | 0.001 | 8.282 | 0.8365 | 5 | 858 | negative regulation of developmental process |
GO:2000179 | 0.0012 | 45.4222 | 0.0518 | 2 | 50 | positive regulation of neural precursor cell proliferation |
GO:0002009 | 0.0013 | 10.2271 | 0.5002 | 4 | 483 | morphogenesis of an epithelium |
GO:0009888 | 0.0013 | 5.7458 | 1.8515 | 7 | 1788 | tissue development |
GO:2000026 | 0.0013 | 6.4486 | 1.3306 | 6 | 1285 | regulation of multicellular organismal development |
GO:0072132 | 0.0013 | 42.7425 | 0.0549 | 2 | 53 | mesenchyme morphogenesis |
GO:0048488 | 0.0014 | 41.9179 | 0.0559 | 2 | 54 | synaptic vesicle endocytosis |
GO:0021885 | 0.0016 | 38.9143 | 0.0601 | 2 | 58 | forebrain cell migration |
GO:0030199 | 0.0016 | 38.9143 | 0.0601 | 2 | 58 | collagen fibril organization |
GO:0030334 | 0.0018 | 7.134 | 0.9423 | 5 | 910 | regulation of cell migration |
GO:0061180 | 0.002 | 34.5757 | 0.0673 | 2 | 65 | mammary gland epithelium development |
GO:0007155 | 0.0021 | 5.8809 | 1.4476 | 6 | 1398 | cell adhesion |
GO:0021823 | 0.0021 | 1024.9375 | 0.0021 | 1 | 2 | cerebral cortex tangential migration using cell-cell interactions |
GO:0021836 | 0.0021 | 1024.9375 | 0.0021 | 1 | 2 | chemorepulsion involved in postnatal olfactory bulb interneuron migration |
GO:0048343 | 0.0021 | 1024.9375 | 0.0021 | 1 | 2 | paraxial mesodermal cell fate commitment |
GO:0050925 | 0.0021 | 1024.9375 | 0.0021 | 1 | 2 | negative regulation of negative chemotaxis |
GO:1902257 | 0.0021 | 1024.9375 | 0.0021 | 1 | 2 | negative regulation of apoptotic process involved in outflow tract morphogenesis |
GO:0045165 | 0.0022 | 13.6762 | 0.2651 | 3 | 256 | cell fate commitment |
GO:0007507 | 0.0023 | 8.7194 | 0.583 | 4 | 563 | heart development |
GO:0048468 | 0.0023 | 5.1542 | 2.0379 | 7 | 1968 | cell development |
GO:0090049 | 0.0023 | 32.0235 | 0.0725 | 2 | 70 | regulation of cell migration involved in sprouting angiogenesis |
GO:0120039 | 0.0028 | 8.2596 | 0.6141 | 4 | 593 | plasma membrane bounded cell projection morphogenesis |
GO:0040012 | 0.0028 | 6.4372 | 1.0376 | 5 | 1002 | regulation of locomotion |
GO:0003151 | 0.003 | 28.2649 | 0.0818 | 2 | 79 | outflow tract morphogenesis |
GO:0033092 | 0.0031 | 512.4375 | 0.0031 | 1 | 3 | positive regulation of immature T cell proliferation in thymus |
GO:0060164 | 0.0031 | 512.4375 | 0.0031 | 1 | 3 | regulation of timing of neuron differentiation |
GO:0072011 | 0.0031 | 512.4375 | 0.0031 | 1 | 3 | glomerular endothelium development |
GO:0032990 | 0.0031 | 7.9647 | 0.6358 | 4 | 614 | cell part morphogenesis |
GO:0051270 | 0.0032 | 6.2305 | 1.0697 | 5 | 1033 | regulation of cellular component movement |
GO:0046330 | 0.0037 | 25.0008 | 0.0922 | 2 | 89 | positive regulation of JNK cascade |
GO:0048514 | 0.0039 | 7.4916 | 0.6741 | 4 | 651 | blood vessel morphogenesis |
GO:0045765 | 0.0039 | 11.0495 | 0.3262 | 3 | 315 | regulation of angiogenesis |
GO:0046620 | 0.0039 | 24.436 | 0.0942 | 2 | 91 | regulation of organ growth |
GO:0050789 | 0.0039 | Inf | 7.5667 | 12 | 9720 | regulation of biological process |
GO:0021987 | 0.0041 | 24.0015 | 0.0965 | 2 | 99 | cerebral cortex development |
GO:0022028 | 0.0041 | 341.6042 | 0.0041 | 1 | 4 | tangential migration from the subventricular zone to the olfactory bulb |
GO:0030167 | 0.0041 | 341.6042 | 0.0041 | 1 | 4 | proteoglycan catabolic process |
GO:0033600 | 0.0041 | 341.6042 | 0.0041 | 1 | 4 | negative regulation of mammary gland epithelial cell proliferation |
GO:0035481 | 0.0041 | 341.6042 | 0.0041 | 1 | 4 | positive regulation of Notch signaling pathway involved in heart induction |
GO:0060800 | 0.0041 | 341.6042 | 0.0041 | 1 | 4 | regulation of cell differentiation involved in embryonic placenta development |
GO:0010631 | 0.0045 | 10.4674 | 0.3438 | 3 | 332 | epithelial cell migration |
GO:0050767 | 0.0048 | 10.2449 | 0.351 | 3 | 339 | regulation of neurogenesis |
GO:0090130 | 0.0048 | 10.2449 | 0.351 | 3 | 339 | tissue migration |
GO:0048646 | 0.0048 | 5.6305 | 1.1753 | 5 | 1135 | anatomical structure formation involved in morphogenesis |
GO:0016199 | 0.0052 | 256.1875 | 0.0052 | 1 | 5 | axon midline choice point recognition |
GO:0021764 | 0.0052 | 256.1875 | 0.0052 | 1 | 5 | amygdala development |
GO:0021800 | 0.0052 | 256.1875 | 0.0052 | 1 | 5 | cerebral cortex tangential migration |
GO:0021891 | 0.0052 | 256.1875 | 0.0052 | 1 | 5 | olfactory bulb interneuron development |
GO:0033591 | 0.0052 | 256.1875 | 0.0052 | 1 | 5 | response to L-ascorbic acid |
GO:0035385 | 0.0052 | 256.1875 | 0.0052 | 1 | 5 | Roundabout signaling pathway |
GO:0035470 | 0.0052 | 256.1875 | 0.0052 | 1 | 5 | positive regulation of vascular wound healing |
GO:0061302 | 0.0052 | 256.1875 | 0.0052 | 1 | 5 | smooth muscle cell-matrix adhesion |
GO:0072144 | 0.0052 | 256.1875 | 0.0052 | 1 | 5 | glomerular mesangial cell development |
GO:0060840 | 0.0053 | 20.8923 | 0.1098 | 2 | 106 | artery development |
GO:0006928 | 0.0054 | 7.3669 | 0.7652 | 4 | 981 | movement of cell or subcellular component |
GO:0016477 | 0.0056 | 10.2702 | 0.3793 | 3 | 489 | cell migration |
GO:0035239 | 0.0057 | 20.8497 | 0.1155 | 2 | 151 | tube morphogenesis |
GO:0001654 | 0.0057 | 9.5748 | 0.3749 | 3 | 362 | eye development |
GO:1990266 | 0.006 | 19.5664 | 0.117 | 2 | 113 | neutrophil migration |
GO:0048880 | 0.0062 | 9.3095 | 0.3852 | 3 | 372 | sensory system development |
GO:0002248 | 0.0062 | 204.9375 | 0.0062 | 1 | 6 | connective tissue replacement involved in inflammatory response wound healing |
GO:0003278 | 0.0062 | 204.9375 | 0.0062 | 1 | 6 | apoptotic process involved in heart morphogenesis |
GO:0010193 | 0.0062 | 204.9375 | 0.0062 | 1 | 6 | response to ozone |
GO:0021960 | 0.0062 | 204.9375 | 0.0062 | 1 | 6 | anterior commissure morphogenesis |
GO:0070100 | 0.0062 | 204.9375 | 0.0062 | 1 | 6 | negative regulation of chemokine-mediated signaling pathway |
GO:1901509 | 0.0062 | 204.9375 | 0.0062 | 1 | 6 | regulation of endothelial tube morphogenesis |
GO:1903423 | 0.0062 | 204.9375 | 0.0062 | 1 | 6 | positive regulation of synaptic vesicle recycling |
GO:1904746 | 0.0062 | 204.9375 | 0.0062 | 1 | 6 | negative regulation of apoptotic process involved in development |
GO:0003206 | 0.007 | 17.9383 | 0.1274 | 2 | 123 | cardiac chamber morphogenesis |
GO:0003231 | 0.0071 | 17.7902 | 0.1284 | 2 | 124 | cardiac ventricle development |
GO:0021796 | 0.0072 | 170.7708 | 0.0072 | 1 | 7 | cerebral cortex regionalization |
GO:0035234 | 0.0072 | 170.7708 | 0.0072 | 1 | 7 | ectopic germ cell programmed cell death |
GO:0040034 | 0.0072 | 170.7708 | 0.0072 | 1 | 7 | regulation of development, heterochronic |
GO:0048341 | 0.0072 | 170.7708 | 0.0072 | 1 | 7 | paraxial mesoderm formation |
GO:0060215 | 0.0072 | 170.7708 | 0.0072 | 1 | 7 | primitive hemopoiesis |
GO:0061002 | 0.0072 | 170.7708 | 0.0072 | 1 | 7 | negative regulation of dendritic spine morphogenesis |
GO:0072007 | 0.0072 | 170.7708 | 0.0072 | 1 | 7 | mesangial cell differentiation |
GO:1900748 | 0.0072 | 170.7708 | 0.0072 | 1 | 7 | positive regulation of vascular endothelial growth factor signaling pathway |
GO:0070304 | 0.0074 | 17.5011 | 0.1305 | 2 | 126 | positive regulation of stress-activated protein kinase signaling cascade |
GO:0042060 | 0.0075 | 8.6826 | 0.4121 | 3 | 398 | wound healing |
GO:0048813 | 0.0075 | 17.36 | 0.1315 | 2 | 127 | dendrite morphogenesis |
GO:0010975 | 0.0077 | 8.5714 | 0.4173 | 3 | 403 | regulation of neuron projection development |
GO:0030182 | 0.0079 | 4.9597 | 1.3213 | 5 | 1276 | neuron differentiation |
GO:0002118 | 0.0083 | 146.3661 | 0.0083 | 1 | 8 | aggressive behavior |
GO:0033083 | 0.0083 | 146.3661 | 0.0083 | 1 | 8 | regulation of immature T cell proliferation |
GO:0099641 | 0.0083 | 146.3661 | 0.0083 | 1 | 8 | anterograde axonal protein transport |
GO:0048754 | 0.0093 | 15.4857 | 0.147 | 2 | 142 | branching morphogenesis of an epithelial tube |
GO:0038063 | 0.0093 | 128.0625 | 0.0093 | 1 | 9 | collagen-activated tyrosine kinase receptor signaling pathway |
GO:2001236 | 0.0097 | 15.158 | 0.1501 | 2 | 145 | regulation of extrinsic apoptotic signaling pathway |
GO:0061564 | 0.0098 | 7.8276 | 0.4556 | 3 | 440 | axon development |
GO:0007389 | 0.0099 | 7.8092 | 0.4567 | 3 | 441 | pattern specification process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0018230 | 6e-04 | 65.48 | 0.0362 | 2 | 22 | peptidyl-L-cysteine S-palmitoylation |
GO:0018198 | 0.0026 | 29.72 | 0.0757 | 2 | 46 | peptidyl-cysteine modification |
GO:0038043 | 0.0033 | 630.3462 | 0.0033 | 1 | 2 | interleukin-5-mediated signaling pathway |
GO:0038156 | 0.0049 | 315.1538 | 0.0049 | 1 | 3 | interleukin-3-mediated signaling pathway |
GO:0038157 | 0.0049 | 315.1538 | 0.0049 | 1 | 3 | granulocyte-macrophage colony-stimulating factor signaling pathway |
GO:0097194 | 0.0065 | 18.1311 | 0.1217 | 2 | 74 | execution phase of apoptosis |
GO:0036414 | 0.0066 | 210.0897 | 0.0066 | 1 | 4 | histone citrullination |
GO:0060157 | 0.0066 | 210.0897 | 0.0066 | 1 | 4 | urinary bladder development |
GO:0061737 | 0.0066 | 210.0897 | 0.0066 | 1 | 4 | leukotriene signaling pathway |
GO:1990743 | 0.0082 | 157.5577 | 0.0082 | 1 | 5 | protein sialylation |
GO:0006497 | 0.0095 | 14.82 | 0.148 | 2 | 90 | protein lipidation |
GO:0006572 | 0.0098 | 126.0385 | 0.0099 | 1 | 6 | tyrosine catabolic process |
GO:0036016 | 0.0098 | 126.0385 | 0.0099 | 1 | 6 | cellular response to interleukin-3 |
GO:0061370 | 0.0098 | 126.0385 | 0.0099 | 1 | 6 | testosterone biosynthetic process |
GO:2000110 | 0.0098 | 126.0385 | 0.0099 | 1 | 6 | negative regulation of macrophage apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031508 | 0 | 780.5714 | 0.0056 | 2 | 4 | pericentric heterochromatin assembly |
GO:1902340 | 0 | 780.5714 | 0.0056 | 2 | 4 | negative regulation of chromosome condensation |
GO:0090230 | 0 | 390.2381 | 0.0084 | 2 | 6 | regulation of centromere complex assembly |
GO:0031509 | 0 | 312.1714 | 0.0098 | 2 | 7 | subtelomeric heterochromatin assembly |
GO:0006336 | 9e-04 | 53.7438 | 0.0434 | 2 | 31 | DNA replication-independent chromatin assembly |
GO:0007338 | 9e-04 | 17.7996 | 0.1961 | 3 | 140 | single fertilization |
GO:0007286 | 0.0014 | 15.4139 | 0.2256 | 3 | 161 | spermatid development |
GO:0007566 | 0.0022 | 32.4325 | 0.07 | 2 | 50 | embryo implantation |
GO:0031507 | 0.0038 | 24.3006 | 0.0925 | 2 | 66 | heterochromatin assembly |
GO:0007283 | 0.0047 | 6.7902 | 0.6963 | 4 | 497 | spermatogenesis |
GO:0060318 | 0.0056 | 248.3485 | 0.0056 | 1 | 4 | definitive erythrocyte differentiation |
GO:0002309 | 0.007 | 186.25 | 0.007 | 1 | 5 | T cell proliferation involved in immune response |
GO:0009609 | 0.007 | 186.25 | 0.007 | 1 | 5 | response to symbiotic bacterium |
GO:0048477 | 0.0076 | 16.8758 | 0.1317 | 2 | 94 | oogenesis |
GO:0006572 | 0.0084 | 148.9909 | 0.0084 | 1 | 6 | tyrosine catabolic process |
GO:0071569 | 0.0084 | 148.9909 | 0.0084 | 1 | 6 | protein ufmylation |
GO:0006334 | 0.0094 | 15.0633 | 0.1471 | 2 | 105 | nucleosome assembly |
GO:0044387 | 0.0098 | 124.1515 | 0.0098 | 1 | 7 | negative regulation of protein kinase activity by regulation of protein phosphorylation |
GO:0051901 | 0.0098 | 124.1515 | 0.0098 | 1 | 7 | positive regulation of mitochondrial depolarization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 410.2005 | 0.0548 | 10 | 31 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 90.2659 | 0.1855 | 10 | 105 | nucleosome assembly |
GO:0040029 | 0 | 70.1726 | 0.2332 | 10 | 132 | regulation of gene expression, epigenetic |
GO:0032200 | 0 | 59.7902 | 0.2703 | 10 | 153 | telomere organization |
GO:0071824 | 0 | 42.6 | 0.371 | 10 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 37.6386 | 0.4169 | 10 | 236 | chromatin remodeling |
GO:0065003 | 0 | 6.5526 | 2.4889 | 11 | 1409 | protein-containing complex assembly |
GO:0038098 | 0 | 606.8889 | 0.0071 | 2 | 4 | sequestering of BMP from receptor via BMP binding |
GO:0035582 | 0 | 404.5679 | 0.0088 | 2 | 5 | sequestering of BMP in extracellular matrix |
GO:0090027 | 1e-04 | 242.7111 | 0.0124 | 2 | 7 | negative regulation of monocyte chemotaxis |
GO:0048263 | 1e-04 | 151.6667 | 0.0177 | 2 | 10 | determination of dorsal identity |
GO:1900116 | 2e-04 | 121.3185 | 0.0212 | 2 | 12 | extracellular negative regulation of signal transduction |
GO:0002688 | 0.001 | 16.92 | 0.2014 | 3 | 114 | regulation of leukocyte chemotaxis |
GO:0044085 | 0.0026 | 3.268 | 5.1634 | 12 | 2923 | cellular component biogenesis |
GO:0002686 | 0.0036 | 24.6999 | 0.0901 | 2 | 51 | negative regulation of leukocyte migration |
GO:1901492 | 0.0053 | 292.6071 | 0.0053 | 1 | 3 | positive regulation of lymphangiogenesis |
GO:1904059 | 0.0053 | 292.6071 | 0.0053 | 1 | 3 | regulation of locomotor rhythm |
GO:0006643 | 0.0054 | 9.3392 | 0.3586 | 3 | 203 | membrane lipid metabolic process |
GO:0050922 | 0.0057 | 19.5054 | 0.1131 | 2 | 64 | negative regulation of chemotaxis |
GO:0097529 | 0.006 | 8.9756 | 0.3727 | 3 | 211 | myeloid leukocyte migration |
GO:0016043 | 0.0062 | 2.721 | 9.9416 | 17 | 5628 | cellular component organization |
GO:1902462 | 0.007 | 195.0595 | 0.0071 | 1 | 4 | positive regulation of mesenchymal stem cell proliferation |
GO:0060754 | 0.0088 | 146.2857 | 0.0088 | 1 | 5 | positive regulation of mast cell chemotaxis |
GO:0045185 | 0.0094 | 14.9127 | 0.1466 | 2 | 83 | maintenance of protein location |
GO:0045666 | 0.0098 | 14.5515 | 0.1501 | 2 | 85 | positive regulation of neuron differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903017 | 6e-04 | Inf | 6e-04 | 1 | 1 | positive regulation of exo-alpha-sialidase activity |
GO:0006683 | 0.0012 | 1822.8889 | 0.0012 | 1 | 2 | galactosylceramide catabolic process |
GO:0051692 | 0.0012 | 1822.8889 | 0.0012 | 1 | 2 | cellular oligosaccharide catabolic process |
GO:1901805 | 0.0012 | 1822.8889 | 0.0012 | 1 | 2 | beta-glucoside catabolic process |
GO:1901492 | 0.0018 | 911.3889 | 0.0018 | 1 | 3 | positive regulation of lymphangiogenesis |
GO:0006680 | 0.0024 | 607.5556 | 0.0024 | 1 | 4 | glucosylceramide catabolic process |
GO:1902462 | 0.0024 | 607.5556 | 0.0024 | 1 | 4 | positive regulation of mesenchymal stem cell proliferation |
GO:0002687 | 0.0026 | 32.0472 | 0.0786 | 2 | 129 | positive regulation of leukocyte migration |
GO:0002309 | 0.003 | 455.6389 | 0.003 | 1 | 5 | T cell proliferation involved in immune response |
GO:0060754 | 0.003 | 455.6389 | 0.003 | 1 | 5 | positive regulation of mast cell chemotaxis |
GO:2000147 | 0.0036 | 12.617 | 0.3301 | 3 | 542 | positive regulation of cell motility |
GO:0006665 | 0.0039 | 26.0433 | 0.0962 | 2 | 158 | sphingolipid metabolic process |
GO:0051901 | 0.0043 | 303.7222 | 0.0043 | 1 | 7 | positive regulation of mitochondrial depolarization |
GO:0019374 | 0.0055 | 227.7639 | 0.0055 | 1 | 9 | galactolipid metabolic process |
GO:0050920 | 0.0067 | 19.7585 | 0.1261 | 2 | 207 | regulation of chemotaxis |
GO:0097531 | 0.0067 | 182.1889 | 0.0067 | 1 | 11 | mast cell migration |
GO:0032944 | 0.007 | 19.1896 | 0.1297 | 2 | 213 | regulation of mononuclear cell proliferation |
GO:0044793 | 0.0073 | 165.6162 | 0.0073 | 1 | 12 | negative regulation by host of viral process |
GO:0050930 | 0.0073 | 165.6162 | 0.0073 | 1 | 12 | induction of positive chemotaxis |
GO:0010745 | 0.0079 | 151.8056 | 0.0079 | 1 | 13 | negative regulation of macrophage derived foam cell differentiation |
GO:0046479 | 0.0079 | 151.8056 | 0.0079 | 1 | 13 | glycosphingolipid catabolic process |
GO:0008228 | 0.0085 | 140.1197 | 0.0085 | 1 | 14 | opsonization |
GO:0006677 | 0.0097 | 121.4222 | 0.0097 | 1 | 16 | glycosylceramide metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048252 | 0 | Inf | 0.0019 | 2 | 2 | lauric acid metabolic process |
GO:0043651 | 1e-04 | 146.2946 | 0.0175 | 2 | 18 | linoleic acid metabolic process |
GO:0032309 | 8e-04 | 57.0035 | 0.0419 | 2 | 43 | icosanoid secretion |
GO:0046521 | 0.001 | Inf | 0.001 | 1 | 1 | sphingoid catabolic process |
GO:0050783 | 0.001 | Inf | 0.001 | 1 | 1 | cocaine metabolic process |
GO:1905364 | 0.001 | Inf | 0.001 | 1 | 1 | regulation of endosomal vesicle fusion |
GO:0046456 | 0.0011 | 46.7171 | 0.0507 | 2 | 52 | icosanoid biosynthetic process |
GO:0001519 | 0.0019 | 1093.3333 | 0.0019 | 1 | 2 | peptide amidation |
GO:0031408 | 0.0019 | 1093.3333 | 0.0019 | 1 | 2 | oxylipin biosynthetic process |
GO:0032827 | 0.0019 | 1093.3333 | 0.0019 | 1 | 2 | negative regulation of natural killer cell differentiation involved in immune response |
GO:0050911 | 0.0025 | 13.0962 | 0.2797 | 3 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0003095 | 0.0029 | 546.6333 | 0.0029 | 1 | 3 | pressure natriuresis |
GO:0006581 | 0.0029 | 546.6333 | 0.0029 | 1 | 3 | acetylcholine catabolic process |
GO:0031914 | 0.0029 | 546.6333 | 0.0029 | 1 | 3 | negative regulation of synaptic plasticity |
GO:0061789 | 0.0029 | 546.6333 | 0.0029 | 1 | 3 | dense core granule priming |
GO:0015908 | 0.0038 | 25.0507 | 0.0926 | 2 | 95 | fatty acid transport |
GO:0050727 | 0.0046 | 10.4912 | 0.347 | 3 | 356 | regulation of inflammatory response |
GO:0009593 | 0.0047 | 10.371 | 0.3509 | 3 | 360 | detection of chemical stimulus |
GO:0014016 | 0.0049 | 273.2833 | 0.0049 | 1 | 5 | neuroblast differentiation |
GO:0036101 | 0.0049 | 273.2833 | 0.0049 | 1 | 5 | leukotriene B4 catabolic process |
GO:0099525 | 0.0049 | 273.2833 | 0.0049 | 1 | 5 | presynaptic dense core vesicle exocytosis |
GO:1900060 | 0.0049 | 273.2833 | 0.0049 | 1 | 5 | negative regulation of ceramide biosynthetic process |
GO:0007606 | 0.0052 | 10.0263 | 0.3626 | 3 | 372 | sensory perception of chemical stimulus |
GO:0050906 | 0.0057 | 9.7032 | 0.3742 | 3 | 384 | detection of stimulus involved in sensory perception |
GO:0002361 | 0.0058 | 218.6133 | 0.0058 | 1 | 6 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0009253 | 0.0058 | 218.6133 | 0.0058 | 1 | 6 | peptidoglycan catabolic process |
GO:0019695 | 0.0058 | 218.6133 | 0.0058 | 1 | 6 | choline metabolic process |
GO:1900619 | 0.0058 | 218.6133 | 0.0058 | 1 | 6 | acetate ester metabolic process |
GO:0002933 | 0.0068 | 182.1667 | 0.0068 | 1 | 7 | lipid hydroxylation |
GO:0009820 | 0.0078 | 156.1333 | 0.0078 | 1 | 8 | alkaloid metabolic process |
GO:0032815 | 0.0087 | 136.6083 | 0.0088 | 1 | 9 | negative regulation of natural killer cell activation |
GO:0051593 | 0.0087 | 136.6083 | 0.0088 | 1 | 9 | response to folic acid |
GO:0003008 | 0.0089 | 4.3178 | 1.956 | 6 | 2007 | system process |
GO:0016081 | 0.0097 | 121.4222 | 0.0097 | 1 | 10 | synaptic vesicle docking |
GO:0016188 | 0.0097 | 121.4222 | 0.0097 | 1 | 10 | synaptic vesicle maturation |
GO:0032823 | 0.0097 | 121.4222 | 0.0097 | 1 | 10 | regulation of natural killer cell differentiation |
GO:0097267 | 0.0097 | 121.4222 | 0.0097 | 1 | 10 | omega-hydroxylase P450 pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048252 | 0 | Inf | 0.0016 | 2 | 2 | lauric acid metabolic process |
GO:0019373 | 1e-04 | 186.2273 | 0.0143 | 2 | 18 | epoxygenase P450 pathway |
GO:0043651 | 1e-04 | 186.2273 | 0.0143 | 2 | 18 | linoleic acid metabolic process |
GO:0046456 | 8e-04 | 59.4691 | 0.0412 | 2 | 52 | icosanoid biosynthetic process |
GO:0046521 | 8e-04 | Inf | 8e-04 | 1 | 1 | sphingoid catabolic process |
GO:1901170 | 8e-04 | Inf | 8e-04 | 1 | 1 | naphthalene catabolic process |
GO:1905364 | 8e-04 | Inf | 8e-04 | 1 | 1 | regulation of endosomal vesicle fusion |
GO:0001519 | 0.0016 | 1366.9167 | 0.0016 | 1 | 2 | peptide amidation |
GO:0031408 | 0.0016 | 1366.9167 | 0.0016 | 1 | 2 | oxylipin biosynthetic process |
GO:0032827 | 0.0016 | 1366.9167 | 0.0016 | 1 | 2 | negative regulation of natural killer cell differentiation involved in immune response |
GO:1905954 | 0.0022 | 33.7107 | 0.0713 | 2 | 90 | positive regulation of lipid localization |
GO:0003095 | 0.0024 | 683.4167 | 0.0024 | 1 | 3 | pressure natriuresis |
GO:0099576 | 0.0024 | 683.4167 | 0.0024 | 1 | 3 | regulation of protein catabolic process at postsynapse, modulating synaptic transmission |
GO:0006631 | 0.0025 | 13.4849 | 0.2851 | 3 | 360 | fatty acid metabolic process |
GO:0036101 | 0.004 | 341.6667 | 0.004 | 1 | 5 | leukotriene B4 catabolic process |
GO:0061302 | 0.004 | 341.6667 | 0.004 | 1 | 5 | smooth muscle cell-matrix adhesion |
GO:1900060 | 0.004 | 341.6667 | 0.004 | 1 | 5 | negative regulation of ceramide biosynthetic process |
GO:0009253 | 0.0047 | 273.3167 | 0.0048 | 1 | 6 | peptidoglycan catabolic process |
GO:0002933 | 0.0055 | 227.75 | 0.0055 | 1 | 7 | lipid hydroxylation |
GO:0010886 | 0.0055 | 227.75 | 0.0055 | 1 | 7 | positive regulation of cholesterol storage |
GO:0120252 | 0.0055 | 227.75 | 0.0055 | 1 | 7 | hydrocarbon metabolic process |
GO:0051606 | 0.0062 | 9.7024 | 0.392 | 3 | 495 | detection of stimulus |
GO:0032815 | 0.0071 | 170.7917 | 0.0071 | 1 | 9 | negative regulation of natural killer cell activation |
GO:0038063 | 0.0071 | 170.7917 | 0.0071 | 1 | 9 | collagen-activated tyrosine kinase receptor signaling pathway |
GO:0044283 | 0.0072 | 9.1821 | 0.4134 | 3 | 522 | small molecule biosynthetic process |
GO:0032823 | 0.0079 | 151.8056 | 0.0079 | 1 | 10 | regulation of natural killer cell differentiation |
GO:0097267 | 0.0079 | 151.8056 | 0.0079 | 1 | 10 | omega-hydroxylase P450 pathway |
GO:0016045 | 0.0095 | 124.1894 | 0.0095 | 1 | 12 | detection of bacterium |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 3583.7812 | 0.0329 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 842.5735 | 0.0566 | 14 | 31 | DNA replication-dependent chromatin assembly |
GO:0006336 | 0 | 842.5735 | 0.0566 | 14 | 31 | DNA replication-independent chromatin assembly |
GO:0006334 | 0 | 156.6923 | 0.1919 | 14 | 105 | nucleosome assembly |
GO:0006352 | 0 | 131.89 | 0.2229 | 14 | 122 | DNA-templated transcription, initiation |
GO:0032200 | 0 | 102.2806 | 0.2796 | 14 | 153 | telomere organization |
GO:0045637 | 0 | 78.784 | 0.3545 | 14 | 194 | regulation of myeloid cell differentiation |
GO:0071824 | 0 | 72.2812 | 0.3837 | 14 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 63.7134 | 0.4313 | 14 | 236 | chromatin remodeling |
GO:0045596 | 0 | 25.3881 | 1.1622 | 15 | 636 | negative regulation of cell differentiation |
GO:0002682 | 0 | 16.072 | 2.2842 | 17 | 1250 | regulation of immune system process |
GO:0030097 | 0 | 17.2293 | 1.4729 | 14 | 806 | hemopoiesis |
GO:0002520 | 0 | 15.2903 | 1.6465 | 14 | 901 | immune system development |
GO:2000026 | 0 | 11.9031 | 2.3482 | 15 | 1285 | regulation of multicellular organismal development |
GO:0065003 | 0 | 9.4036 | 2.5748 | 14 | 1409 | protein-containing complex assembly |
GO:0097659 | 0 | 5.5453 | 5.7453 | 17 | 3144 | nucleic acid-templated transcription |
GO:0044085 | 0 | 5.2995 | 5.3414 | 16 | 2923 | cellular component biogenesis |
GO:0034654 | 0 | 4.8202 | 6.4214 | 17 | 3514 | nucleobase-containing compound biosynthetic process |
GO:0048513 | 0 | 4.6896 | 5.8969 | 16 | 3227 | animal organ development |
GO:0016339 | 1e-04 | 46.5755 | 0.0767 | 3 | 42 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0048869 | 1e-04 | 4.2497 | 7.0774 | 17 | 3873 | cellular developmental process |
GO:0007156 | 2e-04 | 16.4322 | 0.2851 | 4 | 156 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0009059 | 3e-04 | 3.7715 | 7.7408 | 17 | 4236 | macromolecule biosynthetic process |
GO:0048519 | 4e-04 | 3.7013 | 9.5626 | 19 | 5233 | negative regulation of biological process |
GO:0006996 | 5e-04 | 3.6567 | 6.4579 | 15 | 3534 | organelle organization |
GO:0016070 | 5e-04 | 3.5681 | 8.0624 | 17 | 4412 | RNA metabolic process |
GO:0044249 | 0.001 | 3.3358 | 9.3214 | 18 | 5101 | cellular biosynthetic process |
GO:0032501 | 0.0012 | 3.377 | 12.2745 | 21 | 6717 | multicellular organismal process |
GO:0086024 | 0.0018 | Inf | 0.0018 | 1 | 1 | adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate |
GO:0097275 | 0.0018 | Inf | 0.0018 | 1 | 1 | cellular ammonium homeostasis |
GO:0097276 | 0.0018 | Inf | 0.0018 | 1 | 1 | cellular creatinine homeostasis |
GO:0097277 | 0.0018 | Inf | 0.0018 | 1 | 1 | cellular urea homeostasis |
GO:0046483 | 0.0025 | 2.9929 | 10.0305 | 18 | 5489 | heterocycle metabolic process |
GO:0006725 | 0.0029 | 2.949 | 10.1291 | 18 | 5543 | cellular aromatic compound metabolic process |
GO:0034641 | 0.0032 | 2.9281 | 11.1452 | 19 | 6099 | cellular nitrogen compound metabolic process |
GO:1901898 | 0.0037 | 565.0345 | 0.0037 | 1 | 2 | negative regulation of relaxation of cardiac muscle |
GO:1901360 | 0.0046 | 2.7786 | 10.5312 | 18 | 5763 | organic cyclic compound metabolic process |
GO:0042270 | 0.0055 | 282.5 | 0.0055 | 1 | 3 | protection from natural killer cell mediated cytotoxicity |
GO:1901492 | 0.0055 | 282.5 | 0.0055 | 1 | 3 | positive regulation of lymphangiogenesis |
GO:1902462 | 0.0073 | 188.3218 | 0.0073 | 1 | 4 | positive regulation of mesenchymal stem cell proliferation |
GO:0006032 | 0.0091 | 141.2328 | 0.0091 | 1 | 5 | chitin catabolic process |
GO:0015739 | 0.0091 | 141.2328 | 0.0091 | 1 | 5 | sialic acid transport |
GO:0060754 | 0.0091 | 141.2328 | 0.0091 | 1 | 5 | positive regulation of mast cell chemotaxis |
GO:0097070 | 0.0091 | 141.2328 | 0.0091 | 1 | 5 | ductus arteriosus closure |
GO:1904717 | 0.0091 | 141.2328 | 0.0091 | 1 | 5 | regulation of AMPA glutamate receptor clustering |
GO:0051781 | 0.0098 | 14.5598 | 0.1498 | 2 | 82 | positive regulation of cell division |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 22.3251 | 0.705 | 11 | 303 | protein heterodimerization activity |
GO:0045296 | 0 | 18.5355 | 0.7399 | 10 | 318 | cadherin binding |
GO:0003677 | 0 | 4.5135 | 5.2983 | 16 | 2277 | DNA binding |
GO:0004984 | 0 | 10.7621 | 0.6632 | 6 | 285 | olfactory receptor activity |
GO:0004930 | 8e-04 | 5.2983 | 1.566 | 7 | 673 | G protein-coupled receptor activity |
GO:0005549 | 9e-04 | 17.3711 | 0.1931 | 3 | 83 | odorant binding |
GO:0038023 | 0.002 | 3.7348 | 2.9295 | 9 | 1259 | signaling receptor activity |
GO:1904315 | 0.0037 | 24.4084 | 0.0907 | 2 | 39 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential |
GO:0047376 | 0.0046 | 440.3243 | 0.0047 | 1 | 2 | all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity |
GO:0022835 | 0.0067 | 17.6928 | 0.1233 | 2 | 53 | transmitter-gated channel activity |
GO:0001601 | 0.007 | 220.1486 | 0.007 | 1 | 3 | peptide YY receptor activity |
GO:1901363 | 0.0074 | 2.3282 | 13.191 | 21 | 5669 | heterocyclic compound binding |
GO:0098960 | 0.0075 | 16.7068 | 0.1303 | 2 | 56 | postsynaptic neurotransmitter receptor activity |
GO:0097159 | 0.0087 | 2.284 | 13.3562 | 21 | 5740 | organic cyclic compound binding |
GO:0005230 | 0.0097 | 14.5439 | 0.1489 | 2 | 64 | extracellular ligand-gated ion channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0018685 | 0 | 1019.4375 | 0.0044 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0102033 | 0 | 407.7 | 0.0077 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0008392 | 1e-04 | 156.7308 | 0.0165 | 2 | 15 | arachidonic acid epoxygenase activity |
GO:0004984 | 2e-04 | 16.301 | 0.3141 | 4 | 285 | olfactory receptor activity |
GO:0070330 | 2e-04 | 107.1974 | 0.0231 | 2 | 21 | aromatase activity |
GO:0020037 | 3e-04 | 26.7636 | 0.1367 | 3 | 124 | heme binding |
GO:0005506 | 4e-04 | 24.3308 | 0.1499 | 3 | 136 | iron ion binding |
GO:0102116 | 0.0011 | Inf | 0.0011 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0011 | Inf | 0.0011 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0008389 | 0.0022 | 959.5294 | 0.0022 | 1 | 2 | coumarin 7-hydroxylase activity |
GO:0042284 | 0.0022 | 959.5294 | 0.0022 | 1 | 2 | sphingolipid delta-4 desaturase activity |
GO:0050251 | 0.0022 | 959.5294 | 0.0022 | 1 | 2 | retinol isomerase activity |
GO:0008391 | 0.0039 | 362.1556 | 0.0039 | 1 | 4 | arachidonic acid monooxygenase activity |
GO:0008745 | 0.0044 | 319.8039 | 0.0044 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0016491 | 0.0051 | 6.8301 | 0.7263 | 4 | 659 | oxidoreductase activity |
GO:0016019 | 0.0055 | 239.8382 | 0.0055 | 1 | 5 | peptidoglycan immune receptor activity |
GO:0046870 | 0.0055 | 239.8382 | 0.0055 | 1 | 5 | cadmium ion binding |
GO:0050051 | 0.0055 | 239.8382 | 0.0055 | 1 | 5 | leukotriene-B4 20-monooxygenase activity |
GO:0004930 | 0.0055 | 6.6812 | 0.7418 | 4 | 673 | G protein-coupled receptor activity |
GO:0038023 | 0.0099 | 4.6188 | 1.3877 | 5 | 1259 | signaling receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0018685 | 0 | 906.0556 | 0.0049 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0102033 | 0 | 362.3556 | 0.0086 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0008391 | 2e-04 | 106.4967 | 0.0233 | 2 | 19 | arachidonic acid monooxygenase activity |
GO:0102116 | 0.0012 | Inf | 0.0012 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0012 | Inf | 0.0012 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0005539 | 0.0022 | 13.4009 | 0.2633 | 3 | 215 | glycosaminoglycan binding |
GO:0005518 | 0.0031 | 27.3485 | 0.0833 | 2 | 68 | collagen binding |
GO:1901681 | 0.0033 | 11.5244 | 0.3049 | 3 | 249 | sulfur compound binding |
GO:0038062 | 0.0037 | 429.1842 | 0.0037 | 1 | 3 | protein tyrosine kinase collagen receptor activity |
GO:0008745 | 0.0049 | 286.1053 | 0.0049 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0016019 | 0.0061 | 214.5658 | 0.0061 | 1 | 5 | peptidoglycan immune receptor activity |
GO:0050051 | 0.0061 | 214.5658 | 0.0061 | 1 | 5 | leukotriene-B4 20-monooxygenase activity |
GO:0008046 | 0.0085 | 143.0263 | 0.0086 | 1 | 7 | axon guidance receptor activity |
GO:0020037 | 0.0099 | 14.7441 | 0.1519 | 2 | 124 | heme binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001632 | 0.0027 | 776.5714 | 0.0027 | 1 | 2 | leukotriene B4 receptor activity |
GO:0004794 | 0.0027 | 776.5714 | 0.0027 | 1 | 2 | L-threonine ammonia-lyase activity |
GO:0003941 | 0.004 | 388.2619 | 0.004 | 1 | 3 | L-serine ammonia-lyase activity |
GO:0016175 | 0.0094 | 129.3889 | 0.0094 | 1 | 7 | superoxide-generating NAD(P)H oxidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0017020 | 0.0031 | 509.75 | 0.0031 | 1 | 3 | myosin phosphatase regulator activity |
GO:0004383 | 0.0073 | 169.875 | 0.0073 | 1 | 7 | guanylate cyclase activity |
GO:0001653 | 0.0089 | 15.8608 | 0.1437 | 2 | 138 | peptide receptor activity |
GO:0004726 | 0.0093 | 127.3906 | 0.0094 | 1 | 9 | non-membrane spanning protein tyrosine phosphatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005518 | 3e-04 | 24.9738 | 0.1374 | 3 | 68 | collagen binding |
GO:0009975 | 8e-04 | 55.2767 | 0.0424 | 2 | 21 | cyclase activity |
GO:0016849 | 9e-04 | 52.5097 | 0.0445 | 2 | 22 | phosphorus-oxygen lyase activity |
GO:0031798 | 0.002 | Inf | 0.002 | 1 | 1 | type 1 metabotropic glutamate receptor binding |
GO:0043795 | 0.002 | Inf | 0.002 | 1 | 1 | glyceraldehyde oxidoreductase activity |
GO:0005178 | 0.0033 | 11.063 | 0.3011 | 3 | 149 | integrin binding |
GO:0008201 | 0.0038 | 10.5523 | 0.3152 | 3 | 156 | heparin binding |
GO:0001632 | 0.004 | 509.2812 | 0.004 | 1 | 2 | leukotriene B4 receptor activity |
GO:0008281 | 0.004 | 509.2812 | 0.004 | 1 | 2 | sulfonylurea receptor activity |
GO:0034986 | 0.004 | 509.2812 | 0.004 | 1 | 2 | iron chaperone activity |
GO:0036130 | 0.004 | 509.2812 | 0.004 | 1 | 2 | prostaglandin H2 endoperoxidase reductase activity |
GO:0047956 | 0.004 | 509.2812 | 0.004 | 1 | 2 | glycerol dehydrogenase [NADP+] activity |
GO:0033229 | 0.0061 | 254.625 | 0.0061 | 1 | 3 | cysteine transmembrane transporter activity |
GO:0038062 | 0.0061 | 254.625 | 0.0061 | 1 | 3 | protein tyrosine kinase collagen receptor activity |
GO:0004687 | 0.0081 | 169.7396 | 0.0081 | 1 | 4 | myosin light chain kinase activity |
GO:0008131 | 0.0081 | 169.7396 | 0.0081 | 1 | 4 | primary amine oxidase activity |
GO:0047655 | 0.0081 | 169.7396 | 0.0081 | 1 | 4 | allyl-alcohol dehydrogenase activity |
GO:0090722 | 0.0081 | 169.7396 | 0.0081 | 1 | 4 | receptor-receptor interaction |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 31.8566 | 0.8164 | 16 | 303 | protein heterodimerization activity |
GO:0019904 | 0 | 13.1586 | 1.7001 | 15 | 631 | protein domain specific binding |
GO:0003723 | 0 | 5.8216 | 4.7123 | 18 | 1749 | RNA binding |
GO:0003677 | 0 | 4.2991 | 6.1348 | 18 | 2277 | DNA binding |
GO:0005509 | 3e-04 | 5.346 | 1.7728 | 8 | 658 | calcium ion binding |
GO:0000979 | 0.0012 | 45.5742 | 0.0512 | 2 | 19 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:1901363 | 0.0022 | 2.4812 | 15.2738 | 25 | 5669 | heterocyclic compound binding |
GO:0097159 | 0.0026 | 2.434 | 15.4651 | 25 | 5740 | organic cyclic compound binding |
GO:0052665 | 0.0027 | Inf | 0.0027 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GO:0031492 | 0.0045 | 22.1116 | 0.0997 | 2 | 37 | nucleosomal DNA binding |
GO:0106386 | 0.0054 | 378.7442 | 0.0054 | 1 | 2 | (3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity |
GO:0001730 | 0.0081 | 189.3605 | 0.0081 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
GO:0070404 | 0.0081 | 189.3605 | 0.0081 | 1 | 3 | NADH binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 26.7255 | 0.7978 | 14 | 303 | protein heterodimerization activity |
GO:0019904 | 0 | 13.6294 | 1.6614 | 15 | 631 | protein domain specific binding |
GO:0003723 | 0 | 6.0549 | 4.6052 | 18 | 1749 | RNA binding |
GO:0003677 | 0 | 4.0585 | 5.9954 | 17 | 2277 | DNA binding |
GO:0005509 | 0 | 6.3786 | 1.7325 | 9 | 658 | calcium ion binding |
GO:0052665 | 0.0026 | Inf | 0.0026 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GO:0097158 | 0.0053 | 387.7857 | 0.0053 | 1 | 2 | pre-mRNA intronic pyrimidine-rich binding |
GO:0001730 | 0.0079 | 193.881 | 0.0079 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
GO:0005094 | 0.0079 | 193.881 | 0.0079 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0017124 | 0.0014 | 15.348 | 0.2202 | 3 | 116 | SH3 domain binding |
GO:0052665 | 0.0019 | Inf | 0.0019 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GO:0015647 | 0.0038 | 543.3 | 0.0038 | 1 | 2 | peptidoglycan transmembrane transporter activity |
GO:0008237 | 0.0042 | 10.2268 | 0.3265 | 3 | 172 | metallopeptidase activity |
GO:0001730 | 0.0057 | 271.6333 | 0.0057 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
GO:0015333 | 0.0076 | 181.0778 | 0.0076 | 1 | 4 | peptide:proton symporter activity |
GO:0071916 | 0.0076 | 181.0778 | 0.0076 | 1 | 4 | dipeptide transmembrane transporter activity |
GO:0015057 | 0.0095 | 135.8 | 0.0095 | 1 | 5 | thrombin-activated receptor activity |
GO:0045569 | 0.0095 | 135.8 | 0.0095 | 1 | 5 | TRAIL binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 25.2446 | 0.8906 | 15 | 303 | protein heterodimerization activity |
GO:0045296 | 0 | 13.6492 | 0.9347 | 10 | 318 | cadherin binding |
GO:0003677 | 0 | 4.8359 | 6.6925 | 21 | 2277 | DNA binding |
GO:0004941 | 0.0029 | Inf | 0.0029 | 1 | 1 | beta2-adrenergic receptor activity |
GO:0017172 | 0.0029 | Inf | 0.0029 | 1 | 1 | cysteine dioxygenase activity |
GO:0001785 | 0.0059 | 346.4255 | 0.0059 | 1 | 2 | prostaglandin J receptor activity |
GO:0004956 | 0.0059 | 346.4255 | 0.0059 | 1 | 2 | prostaglandin D receptor activity |
GO:0005019 | 0.0059 | 346.4255 | 0.0059 | 1 | 2 | platelet-derived growth factor beta-receptor activity |
GO:0005139 | 0.0059 | 346.4255 | 0.0059 | 1 | 2 | interleukin-7 receptor binding |
GO:0015275 | 0.0059 | 346.4255 | 0.0059 | 1 | 2 | stretch-activated, cation-selective, calcium channel activity |
GO:0004992 | 0.0088 | 173.2021 | 0.0088 | 1 | 3 | platelet activating factor receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008198 | 0.0012 | 45.5854 | 0.0507 | 2 | 23 | ferrous iron binding |
GO:0000334 | 0.0022 | Inf | 0.0022 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
GO:0031798 | 0.0022 | Inf | 0.0022 | 1 | 1 | type 1 metabotropic glutamate receptor binding |
GO:0015276 | 0.003 | 11.3925 | 0.291 | 3 | 132 | ligand-gated ion channel activity |
GO:0003990 | 0.0044 | 465.5429 | 0.0044 | 1 | 2 | acetylcholinesterase activity |
GO:0008281 | 0.0044 | 465.5429 | 0.0044 | 1 | 2 | sulfonylurea receptor activity |
GO:0034986 | 0.0044 | 465.5429 | 0.0044 | 1 | 2 | iron chaperone activity |
GO:0003690 | 0.0049 | 3.2496 | 3.3617 | 9 | 1525 | double-stranded DNA binding |
GO:0000981 | 0.005 | 3.4689 | 2.7511 | 8 | 1248 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0043565 | 0.005 | 3.2331 | 3.3771 | 9 | 1532 | sequence-specific DNA binding |
GO:0050840 | 0.0063 | 18.3744 | 0.119 | 2 | 54 | extracellular matrix binding |
GO:0031841 | 0.0066 | 232.7571 | 0.0066 | 1 | 3 | neuropeptide Y receptor binding |
GO:0033229 | 0.0066 | 232.7571 | 0.0066 | 1 | 3 | cysteine transmembrane transporter activity |
GO:0033265 | 0.0066 | 232.7571 | 0.0066 | 1 | 3 | choline binding |
GO:0070699 | 0.0066 | 232.7571 | 0.0066 | 1 | 3 | type II activin receptor binding |
GO:0008131 | 0.0088 | 155.1619 | 0.0088 | 1 | 4 | primary amine oxidase activity |
GO:0031697 | 0.0088 | 155.1619 | 0.0088 | 1 | 4 | beta-1 adrenergic receptor binding |
GO:0000978 | 0.0089 | 3.3771 | 2.4116 | 7 | 1094 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0000976 | 0.0091 | 3.1027 | 3.0465 | 8 | 1382 | transcription cis-regulatory region binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031798 | 0.0015 | Inf | 0.0015 | 1 | 1 | type 1 metabotropic glutamate receptor binding |
GO:0015459 | 0.0024 | 30.7936 | 0.0735 | 2 | 50 | potassium channel regulator activity |
GO:0003990 | 0.0029 | 708.9565 | 0.0029 | 1 | 2 | acetylcholinesterase activity |
GO:0008281 | 0.0029 | 708.9565 | 0.0029 | 1 | 2 | sulfonylurea receptor activity |
GO:0033229 | 0.0044 | 354.4565 | 0.0044 | 1 | 3 | cysteine transmembrane transporter activity |
GO:0033265 | 0.0044 | 354.4565 | 0.0044 | 1 | 3 | choline binding |
GO:0004867 | 0.0064 | 18.4398 | 0.1205 | 2 | 82 | serine-type endopeptidase inhibitor activity |
GO:0005314 | 0.0073 | 177.2065 | 0.0073 | 1 | 5 | high-affinity glutamate transmembrane transporter activity |
GO:0016312 | 0.0073 | 177.2065 | 0.0073 | 1 | 5 | inositol bisphosphate phosphatase activity |
GO:0005249 | 0.0073 | 17.1469 | 0.1293 | 2 | 88 | voltage-gated potassium channel activity |
GO:0015272 | 0.0088 | 141.7565 | 0.0088 | 1 | 6 | ATP-activated inward rectifier potassium channel activity |
GO:0031802 | 0.0088 | 141.7565 | 0.0088 | 1 | 6 | type 5 metabotropic glutamate receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031798 | 0.001 | Inf | 0.001 | 1 | 1 | type 1 metabotropic glutamate receptor binding |
GO:0008281 | 0.0021 | 1019.5625 | 0.0021 | 1 | 2 | sulfonylurea receptor activity |
GO:0005518 | 0.0022 | 32.8242 | 0.0708 | 2 | 68 | collagen binding |
GO:0038062 | 0.0031 | 509.75 | 0.0031 | 1 | 3 | protein tyrosine kinase collagen receptor activity |
GO:0015272 | 0.0062 | 203.8625 | 0.0062 | 1 | 6 | ATP-activated inward rectifier potassium channel activity |
GO:0031802 | 0.0062 | 203.8625 | 0.0062 | 1 | 6 | type 5 metabotropic glutamate receptor binding |
GO:0008046 | 0.0073 | 169.875 | 0.0073 | 1 | 7 | axon guidance receptor activity |
GO:0038023 | 0.0076 | 5.004 | 1.3106 | 5 | 1259 | signaling receptor activity |
GO:0003700 | 0.0085 | 4.865 | 1.3449 | 5 | 1292 | DNA-binding transcription factor activity |
GO:0000977 | 0.0085 | 4.8609 | 1.346 | 5 | 1293 | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO:0043167 | 0.0087 | 3.6146 | 5.7263 | 11 | 5501 | ion binding |
GO:0001228 | 0.0093 | 7.992 | 0.4466 | 3 | 429 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0019864 | 0.0093 | 127.3906 | 0.0094 | 1 | 9 | IgG binding |
GO:0043225 | 0.0093 | 127.3906 | 0.0094 | 1 | 9 | ATPase-coupled inorganic anion transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019706 | 8e-04 | 54.8148 | 0.0426 | 2 | 24 | protein-cysteine S-palmitoyltransferase activity |
GO:0016417 | 0.0011 | 46.3704 | 0.0497 | 2 | 28 | S-acyltransferase activity |
GO:0004411 | 0.0018 | Inf | 0.0018 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
GO:0004912 | 0.0018 | Inf | 0.0018 | 1 | 1 | interleukin-3 receptor activity |
GO:0046538 | 0.0018 | Inf | 0.0018 | 1 | 1 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
GO:1903924 | 0.0018 | Inf | 0.0018 | 1 | 1 | estradiol binding |
GO:0001632 | 0.0035 | 582.1786 | 0.0036 | 1 | 2 | leukotriene B4 receptor activity |
GO:0003835 | 0.0035 | 582.1786 | 0.0036 | 1 | 2 | beta-galactoside alpha-2,6-sialyltransferase activity |
GO:0004914 | 0.0035 | 582.1786 | 0.0036 | 1 | 2 | interleukin-5 receptor activity |
GO:0004082 | 0.0053 | 291.0714 | 0.0053 | 1 | 3 | bisphosphoglycerate mutase activity |
GO:0070401 | 0.0053 | 291.0714 | 0.0053 | 1 | 3 | NADP+ binding |
GO:0004668 | 0.0071 | 194.0357 | 0.0071 | 1 | 4 | protein-arginine deiminase activity |
GO:0035410 | 0.0071 | 194.0357 | 0.0071 | 1 | 4 | dihydrotestosterone 17-beta-dehydrogenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000979 | 6e-04 | 63.851 | 0.0372 | 2 | 19 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0005509 | 0.0015 | 5.5381 | 1.2893 | 6 | 658 | calcium ion binding |
GO:0046539 | 0.002 | Inf | 0.002 | 1 | 1 | histamine N-methyltransferase activity |
GO:0052665 | 0.002 | Inf | 0.002 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GO:0031492 | 0.0024 | 30.979 | 0.0725 | 2 | 37 | nucleosomal DNA binding |
GO:0001730 | 0.0059 | 262.8548 | 0.0059 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
GO:0019834 | 0.0098 | 131.4113 | 0.0098 | 1 | 5 | phospholipase A2 inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016015 | 1e-04 | 260.784 | 0.0116 | 2 | 7 | morphogen activity |
GO:0036122 | 4e-04 | 86.8747 | 0.0281 | 2 | 17 | BMP binding |
GO:0004912 | 0.0017 | Inf | 0.0017 | 1 | 1 | interleukin-3 receptor activity |
GO:0050479 | 0.0017 | Inf | 0.0017 | 1 | 1 | glyceryl-ether monooxygenase activity |
GO:0102758 | 0.0017 | Inf | 0.0017 | 1 | 1 | very-long-chain enoyl-CoA reductase activity |
GO:0140616 | 0.0017 | Inf | 0.0017 | 1 | 1 | iodotyrosine deiodinase activity |
GO:0004914 | 0.0033 | 627.0385 | 0.0033 | 1 | 2 | interleukin-5 receptor activity |
GO:0005139 | 0.0033 | 627.0385 | 0.0033 | 1 | 2 | interleukin-7 receptor binding |
GO:0030546 | 0.0059 | 6.2123 | 0.7407 | 4 | 448 | signaling receptor activator activity |
GO:0017099 | 0.0066 | 208.9872 | 0.0066 | 1 | 4 | very-long-chain-acyl-CoA dehydrogenase activity |
GO:0030550 | 0.0099 | 125.3769 | 0.0099 | 1 | 6 | acetylcholine receptor inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0061657 | 0.0015 | Inf | 0.0015 | 1 | 1 | UFM1 conjugating enzyme activity |
GO:0001632 | 0.0029 | 708.9565 | 0.0029 | 1 | 2 | leukotriene B4 receptor activity |
GO:0015056 | 0.0029 | 708.9565 | 0.0029 | 1 | 2 | corticotrophin-releasing factor receptor activity |
GO:0043404 | 0.0029 | 708.9565 | 0.0029 | 1 | 2 | corticotropin-releasing hormone receptor activity |
GO:0051424 | 0.0029 | 708.9565 | 0.0029 | 1 | 2 | corticotropin-releasing hormone binding |
GO:0048306 | 0.0057 | 19.6752 | 0.1132 | 2 | 77 | calcium-dependent protein binding |
GO:0004668 | 0.0059 | 236.2899 | 0.0059 | 1 | 4 | protein-arginine deiminase activity |
GO:0022850 | 0.0073 | 177.2065 | 0.0073 | 1 | 5 | serotonin-gated cation-selective channel activity |
GO:0071253 | 0.0073 | 177.2065 | 0.0073 | 1 | 5 | connexin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000979 | 3e-04 | 87.1123 | 0.0279 | 2 | 19 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0046982 | 9e-04 | 10.7077 | 0.4453 | 4 | 303 | protein heterodimerization activity |
GO:0031492 | 0.0013 | 42.2649 | 0.0544 | 2 | 37 | nucleosomal DNA binding |
GO:0004411 | 0.0015 | Inf | 0.0015 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
GO:0047179 | 0.0059 | 236.2899 | 0.0059 | 1 | 4 | platelet-activating factor acetyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0052665 | 8e-04 | Inf | 8e-04 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GO:0102483 | 8e-04 | Inf | 8e-04 | 1 | 1 | scopolin beta-glucosidase activity |
GO:0004336 | 0.0016 | 1359.75 | 0.0016 | 1 | 2 | galactosylceramidase activity |
GO:0017042 | 0.0016 | 1359.75 | 0.0016 | 1 | 2 | glycosylceramidase activity |
GO:0097158 | 0.0016 | 1359.75 | 0.0016 | 1 | 2 | pre-mRNA intronic pyrimidine-rich binding |
GO:0004348 | 0.0024 | 679.8333 | 0.0024 | 1 | 3 | glucosylceramidase activity |
GO:0004565 | 0.0032 | 453.1944 | 0.0032 | 1 | 4 | beta-galactosidase activity |
GO:0008422 | 0.0032 | 453.1944 | 0.0032 | 1 | 4 | beta-glucosidase activity |
GO:0008061 | 0.0056 | 226.5556 | 0.0056 | 1 | 7 | chitin binding |
GO:0062105 | 0.0056 | 226.5556 | 0.0056 | 1 | 7 | RNA 2'-O-methyltransferase activity |
GO:0097493 | 0.0079 | 151.0093 | 0.008 | 1 | 10 | structural molecule activity conferring elasticity |
GO:0003730 | 0.0097 | 15.5996 | 0.1512 | 2 | 190 | mRNA 3'-UTR binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 28.757 | 0.5381 | 10 | 303 | protein heterodimerization activity |
GO:0045296 | 0 | 27.3308 | 0.5647 | 10 | 318 | cadherin binding |
GO:0016015 | 1e-04 | 241.437 | 0.0124 | 2 | 7 | morphogen activity |
GO:0003677 | 3e-04 | 4.3746 | 4.0434 | 12 | 2277 | DNA binding |
GO:0036122 | 4e-04 | 80.4296 | 0.0302 | 2 | 17 | BMP binding |
GO:0043185 | 0.0018 | Inf | 0.0018 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0050479 | 0.0018 | Inf | 0.0018 | 1 | 1 | glyceryl-ether monooxygenase activity |
GO:0102758 | 0.0018 | Inf | 0.0018 | 1 | 1 | very-long-chain enoyl-CoA reductase activity |
GO:0016300 | 0.0053 | 291.0714 | 0.0053 | 1 | 3 | tRNA (uracil) methyltransferase activity |
GO:0033265 | 0.0053 | 291.0714 | 0.0053 | 1 | 3 | choline binding |
GO:0017099 | 0.0071 | 194.0357 | 0.0071 | 1 | 4 | very-long-chain-acyl-CoA dehydrogenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016015 | 0 | 466 | 0.0069 | 2 | 7 | morphogen activity |
GO:0036122 | 1e-04 | 155.2381 | 0.0167 | 2 | 17 | BMP binding |
GO:0004866 | 4e-04 | 25.0377 | 0.1489 | 3 | 152 | endopeptidase inhibitor activity |
GO:0061134 | 8e-04 | 19.3786 | 0.191 | 3 | 195 | peptidase regulator activity |
GO:0004699 | 0.002 | 1087.6 | 0.002 | 1 | 2 | calcium-independent protein kinase C activity |
GO:0008520 | 0.002 | 1087.6 | 0.002 | 1 | 2 | L-ascorbate:sodium symporter activity |
GO:0015229 | 0.002 | 1087.6 | 0.002 | 1 | 2 | L-ascorbic acid transmembrane transporter activity |
GO:0005549 | 0.0029 | 28.6314 | 0.0813 | 2 | 83 | odorant binding |
GO:0004857 | 0.0044 | 10.6823 | 0.3409 | 3 | 348 | enzyme inhibitor activity |
GO:0098772 | 0.0048 | 4.9778 | 1.7253 | 6 | 1761 | molecular function regulator activity |
GO:0015205 | 0.0068 | 181.2111 | 0.0069 | 1 | 7 | nucleobase transmembrane transporter activity |
GO:0033300 | 0.0078 | 155.3143 | 0.0078 | 1 | 8 | dehydroascorbic acid transmembrane transporter activity |
GO:0043560 | 0.0098 | 120.7852 | 0.0098 | 1 | 10 | insulin receptor substrate binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043185 | 6e-04 | Inf | 6e-04 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0102483 | 6e-04 | Inf | 6e-04 | 1 | 1 | scopolin beta-glucosidase activity |
GO:0004336 | 0.0011 | 2040.125 | 0.0011 | 1 | 2 | galactosylceramidase activity |
GO:0017042 | 0.0011 | 2040.125 | 0.0011 | 1 | 2 | glycosylceramidase activity |
GO:0048018 | 0.0015 | 18.1324 | 0.243 | 3 | 441 | receptor ligand activity |
GO:0004348 | 0.0017 | 1020 | 0.0017 | 1 | 3 | glucosylceramidase activity |
GO:0033265 | 0.0017 | 1020 | 0.0017 | 1 | 3 | choline binding |
GO:0030545 | 0.0019 | 16.5021 | 0.2662 | 3 | 483 | signaling receptor regulator activity |
GO:0004565 | 0.0022 | 679.9583 | 0.0022 | 1 | 4 | beta-galactosidase activity |
GO:0008422 | 0.0022 | 679.9583 | 0.0022 | 1 | 4 | beta-glucosidase activity |
GO:0001849 | 0.0039 | 339.9167 | 0.0039 | 1 | 7 | complement component C1q complex binding |
GO:0050291 | 0.0039 | 339.9167 | 0.0039 | 1 | 7 | sphingosine N-acyltransferase activity |
GO:0005126 | 0.0072 | 19.3912 | 0.1317 | 2 | 239 | cytokine receptor binding |
GO:0030169 | 0.0093 | 127.3906 | 0.0094 | 1 | 17 | low-density lipoprotein particle binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0018685 | 0 | 1254.9231 | 0.0037 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0102033 | 0 | 501.8769 | 0.0064 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0008391 | 1e-04 | 147.5023 | 0.0175 | 2 | 19 | arachidonic acid monooxygenase activity |
GO:0102116 | 9e-04 | Inf | 9e-04 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 9e-04 | Inf | 9e-04 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0003990 | 0.0018 | 1165.3571 | 0.0018 | 1 | 2 | acetylcholinesterase activity |
GO:0008481 | 0.0018 | 1165.3571 | 0.0018 | 1 | 2 | sphinganine kinase activity |
GO:0017050 | 0.0018 | 1165.3571 | 0.0018 | 1 | 2 | D-erythro-sphingosine kinase activity |
GO:0004984 | 0.002 | 14.2145 | 0.2618 | 3 | 285 | olfactory receptor activity |
GO:0004930 | 0.0027 | 8.505 | 0.6181 | 4 | 673 | G protein-coupled receptor activity |
GO:0016300 | 0.0028 | 582.6429 | 0.0028 | 1 | 3 | tRNA (uracil) methyltransferase activity |
GO:0033265 | 0.0028 | 582.6429 | 0.0028 | 1 | 3 | choline binding |
GO:0008745 | 0.0037 | 388.4048 | 0.0037 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0038023 | 0.0042 | 6.0056 | 1.1564 | 5 | 1259 | signaling receptor activity |
GO:0016019 | 0.0046 | 291.2857 | 0.0046 | 1 | 5 | peptidoglycan immune receptor activity |
GO:0050051 | 0.0046 | 291.2857 | 0.0046 | 1 | 5 | leukotriene-B4 20-monooxygenase activity |
GO:0020037 | 0.0056 | 20.4212 | 0.1139 | 2 | 124 | heme binding |
GO:0038036 | 0.0064 | 194.1667 | 0.0064 | 1 | 7 | sphingosine-1-phosphate receptor activity |
GO:0005506 | 0.0067 | 18.5786 | 0.1249 | 2 | 136 | iron ion binding |
GO:0052689 | 0.007 | 18.1684 | 0.1277 | 2 | 139 | carboxylic ester hydrolase activity |
GO:0043169 | 0.0083 | 4.1847 | 3.3868 | 8 | 3950 | cation binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0018685 | 0 | 1631.7 | 0.0029 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0102033 | 0 | 652.56 | 0.0051 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0008392 | 1e-04 | 250.8615 | 0.011 | 2 | 15 | arachidonic acid epoxygenase activity |
GO:0020037 | 1e-04 | 44.6226 | 0.0911 | 3 | 124 | heme binding |
GO:0070330 | 1e-04 | 171.5789 | 0.0154 | 2 | 21 | aromatase activity |
GO:0005506 | 1e-04 | 40.5664 | 0.0999 | 3 | 136 | iron ion binding |
GO:0102116 | 7e-04 | Inf | 7e-04 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 7e-04 | Inf | 7e-04 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0060089 | 0.0014 | 8.5811 | 0.9251 | 5 | 1259 | molecular transducer activity |
GO:0008481 | 0.0015 | 1483.4545 | 0.0015 | 1 | 2 | sphinganine kinase activity |
GO:0017050 | 0.0015 | 1483.4545 | 0.0015 | 1 | 2 | D-erythro-sphingosine kinase activity |
GO:0038062 | 0.0022 | 741.6818 | 0.0022 | 1 | 3 | protein tyrosine kinase collagen receptor activity |
GO:0008391 | 0.0024 | 603.8148 | 0.0025 | 1 | 4 | arachidonic acid monooxygenase activity |
GO:0008745 | 0.0029 | 494.4242 | 0.0029 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0016019 | 0.0037 | 370.7955 | 0.0037 | 1 | 5 | peptidoglycan immune receptor activity |
GO:0050051 | 0.0037 | 370.7955 | 0.0037 | 1 | 5 | leukotriene-B4 20-monooxygenase activity |
GO:0038036 | 0.0051 | 247.1667 | 0.0051 | 1 | 7 | sphingosine-1-phosphate receptor activity |
GO:0004888 | 0.0057 | 7.2341 | 0.7782 | 4 | 1059 | transmembrane signaling receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 28.6357 | 0.2618 | 5 | 285 | olfactory receptor activity |
GO:0038023 | 1e-04 | 10.528 | 1.1564 | 7 | 1259 | signaling receptor activity |
GO:0004930 | 2e-04 | 11.7126 | 0.6181 | 5 | 673 | G protein-coupled receptor activity |
GO:0004825 | 0.0018 | 1165.3571 | 0.0018 | 1 | 2 | methionine-tRNA ligase activity |
GO:0047376 | 0.0018 | 1165.3571 | 0.0018 | 1 | 2 | all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity |
GO:0008745 | 0.0037 | 388.4048 | 0.0037 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0016019 | 0.0046 | 291.2857 | 0.0046 | 1 | 5 | peptidoglycan immune receptor activity |
GO:0030883 | 0.0046 | 291.2857 | 0.0046 | 1 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0046 | 291.2857 | 0.0046 | 1 | 5 | exogenous lipid antigen binding |
GO:0005132 | 0.0082 | 145.6071 | 0.0083 | 1 | 9 | type I interferon receptor binding |
GO:0071723 | 0.0082 | 145.6071 | 0.0083 | 1 | 9 | lipopeptide binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000979 | 2e-04 | 119.8235 | 0.0209 | 2 | 19 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0004984 | 2e-04 | 16.301 | 0.3141 | 4 | 285 | olfactory receptor activity |
GO:0004930 | 6e-04 | 9.0079 | 0.7418 | 5 | 673 | G protein-coupled receptor activity |
GO:0031492 | 7e-04 | 58.1357 | 0.0408 | 2 | 37 | nucleosomal DNA binding |
GO:0001632 | 0.0022 | 959.5294 | 0.0022 | 1 | 2 | leukotriene B4 receptor activity |
GO:0046982 | 0.0042 | 10.6753 | 0.334 | 3 | 303 | protein heterodimerization activity |
GO:0017124 | 0.0071 | 17.7621 | 0.1279 | 2 | 116 | SH3 domain binding |
GO:0016175 | 0.0077 | 159.8725 | 0.0077 | 1 | 7 | superoxide-generating NAD(P)H oxidase activity |
GO:0043295 | 0.0099 | 119.8897 | 0.0099 | 1 | 9 | glutathione binding |
GO:0038023 | 0.0099 | 4.6188 | 1.3877 | 5 | 1259 | signaling receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000979 | 1e-04 | 191.7882 | 0.014 | 2 | 19 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0031492 | 3e-04 | 93.0514 | 0.0272 | 2 | 37 | nucleosomal DNA binding |
GO:0106386 | 0.0015 | 1483.4545 | 0.0015 | 1 | 2 | (3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity |
GO:0070404 | 0.0022 | 741.6818 | 0.0022 | 1 | 3 | NADH binding |
GO:0031698 | 0.0044 | 296.6182 | 0.0044 | 1 | 6 | beta-2 adrenergic receptor binding |
GO:0047035 | 0.0051 | 247.1667 | 0.0051 | 1 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:0044594 | 0.0095 | 123.5379 | 0.0096 | 1 | 13 | 17-beta-hydroxysteroid dehydrogenase (NAD+) activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 55.6007 | 0.5566 | 15 | 303 | protein heterodimerization activity |
GO:0019904 | 0 | 25.4627 | 1.1591 | 15 | 631 | protein domain specific binding |
GO:0003677 | 0 | 8.1245 | 4.1828 | 17 | 2277 | DNA binding |
GO:0003723 | 0 | 7.346 | 3.2129 | 14 | 1749 | RNA binding |
GO:0043185 | 0.0018 | Inf | 0.0018 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:1901363 | 0.004 | 2.8269 | 10.4139 | 18 | 5669 | heterocyclic compound binding |
GO:0097159 | 0.0047 | 2.7732 | 10.5444 | 18 | 5740 | organic cyclic compound binding |
GO:0015136 | 0.0092 | 140.4914 | 0.0092 | 1 | 5 | sialic acid transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 45.6247 | 0.5752 | 14 | 303 | protein heterodimerization activity |
GO:0019904 | 0 | 23.8697 | 1.1978 | 15 | 631 | protein domain specific binding |
GO:0003723 | 0 | 8.966 | 3.32 | 16 | 1749 | RNA binding |
GO:0003677 | 0 | 5.8181 | 4.3223 | 15 | 2277 | DNA binding |
GO:0052665 | 0.0019 | Inf | 0.0019 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GO:0102483 | 0.0019 | Inf | 0.0019 | 1 | 1 | scopolin beta-glucosidase activity |
GO:1901363 | 0.0022 | 2.9845 | 10.7611 | 19 | 5669 | heterocyclic compound binding |
GO:0097159 | 0.0026 | 2.9278 | 10.8958 | 19 | 5740 | organic cyclic compound binding |
GO:0004336 | 0.0038 | 543.3 | 0.0038 | 1 | 2 | galactosylceramidase activity |
GO:0017042 | 0.0038 | 543.3 | 0.0038 | 1 | 2 | glycosylceramidase activity |
GO:0097158 | 0.0038 | 543.3 | 0.0038 | 1 | 2 | pre-mRNA intronic pyrimidine-rich binding |
GO:0004348 | 0.0057 | 271.6333 | 0.0057 | 1 | 3 | glucosylceramidase activity |
GO:0004565 | 0.0076 | 181.0778 | 0.0076 | 1 | 4 | beta-galactosidase activity |
GO:0008422 | 0.0076 | 181.0778 | 0.0076 | 1 | 4 | beta-glucosidase activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 312.3506 | 0.3512 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 35.0088 | 1.1413 | 26 | 104 | nucleosome assembly |
GO:0045653 | 0 | 342.2744 | 0.1975 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0071824 | 0 | 15.4957 | 2.3046 | 27 | 210 | protein-DNA complex subunit organization |
GO:0032200 | 0 | 18.7839 | 1.712 | 24 | 156 | telomere organization |
GO:0006338 | 0 | 13.4804 | 2.6009 | 27 | 237 | chromatin remodeling |
GO:0050911 | 0 | 14.3476 | 2.3594 | 26 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0006336 | 0 | 75.9946 | 0.3512 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0051606 | 0 | 8.9456 | 4.7298 | 33 | 431 | detection of stimulus |
GO:0007600 | 0 | 5.5855 | 6.7702 | 31 | 631 | sensory perception |
GO:0007186 | 0 | 4.5333 | 10.6888 | 39 | 974 | G protein-coupled receptor signaling pathway |
GO:0003008 | 0 | 3.2356 | 21.4763 | 54 | 1957 | system process |
GO:0045637 | 0 | 9.2528 | 2.1729 | 17 | 198 | regulation of myeloid cell differentiation |
GO:0006352 | 0 | 12.3641 | 1.3608 | 14 | 124 | DNA-templated transcription, initiation |
GO:0040029 | 0 | 8.5953 | 1.4596 | 11 | 133 | regulation of gene expression, epigenetic |
GO:0002520 | 0 | 2.9191 | 10.0303 | 26 | 914 | immune system development |
GO:0030097 | 0 | 3.0008 | 8.9549 | 24 | 816 | hemopoiesis |
GO:0045596 | 0 | 3.2078 | 6.9027 | 20 | 629 | negative regulation of cell differentiation |
GO:0035195 | 0 | 4.2646 | 3.3361 | 13 | 304 | miRNA-mediated gene silencing |
GO:0016441 | 0 | 4.0925 | 3.4678 | 13 | 316 | post-transcriptional gene silencing |
GO:0065003 | 1e-04 | 2.3398 | 15.4296 | 32 | 1406 | protein-containing complex assembly |
GO:0031047 | 1e-04 | 3.8102 | 3.7092 | 13 | 338 | gene silencing by RNA |
GO:0001580 | 3e-04 | 14.7283 | 0.3182 | 4 | 29 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0002682 | 3e-04 | 2.238 | 13.8603 | 28 | 1263 | regulation of immune system process |
GO:0050907 | 4e-04 | 12.9566 | 0.3514 | 4 | 37 | detection of chemical stimulus involved in sensory perception |
GO:0060078 | 4e-04 | 5.6202 | 1.3498 | 7 | 123 | regulation of postsynaptic membrane potential |
GO:1904862 | 5e-04 | 22.9 | 0.1646 | 3 | 15 | inhibitory synapse assembly |
GO:0050789 | 0.001 | 1.7793 | 93.7187 | 112 | 9345 | regulation of biological process |
GO:0014050 | 0.0012 | 60.7538 | 0.0549 | 2 | 5 | negative regulation of glutamate secretion |
GO:0051932 | 0.0019 | 8.3584 | 0.5268 | 4 | 48 | synaptic transmission, GABAergic |
GO:0086043 | 0.0024 | 36.4477 | 0.0768 | 2 | 7 | bundle of His cell action potential |
GO:0007214 | 0.0025 | 12.4831 | 0.2744 | 3 | 25 | gamma-aminobutyric acid signaling pathway |
GO:0050909 | 0.0025 | 7.66 | 0.5707 | 4 | 52 | sensory perception of taste |
GO:0051838 | 0.0032 | 30.3712 | 0.0878 | 2 | 8 | cytolysis by host of symbiont cells |
GO:0097267 | 0.0041 | 26.0308 | 0.0988 | 2 | 9 | omega-hydroxylase P450 pathway |
GO:1903244 | 0.0041 | 26.0308 | 0.0988 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0019233 | 0.0041 | 5.0661 | 1.0535 | 5 | 96 | sensory perception of pain |
GO:1902476 | 0.0045 | 6.4469 | 0.6694 | 4 | 61 | chloride transmembrane transport |
GO:0060371 | 0.0051 | 22.7756 | 0.1097 | 2 | 10 | regulation of atrial cardiac muscle cell membrane depolarization |
GO:1905205 | 0.0051 | 22.7756 | 0.1097 | 2 | 10 | positive regulation of connective tissue replacement |
GO:0019228 | 0.0061 | 8.854 | 0.3731 | 3 | 34 | neuronal action potential |
GO:0086016 | 0.0062 | 20.2437 | 0.1207 | 2 | 11 | AV node cell action potential |
GO:0042221 | 0.0063 | 1.5285 | 42.9307 | 58 | 3912 | response to chemical |
GO:0002674 | 0.0074 | 18.2182 | 0.1317 | 2 | 12 | negative regulation of acute inflammatory response |
GO:0044793 | 0.0074 | 18.2182 | 0.1317 | 2 | 12 | negative regulation by host of viral process |
GO:0086067 | 0.0074 | 18.2182 | 0.1317 | 2 | 12 | AV node cell to bundle of His cell communication |
GO:0010838 | 0.0086 | 16.561 | 0.1427 | 2 | 13 | positive regulation of keratinocyte proliferation |
GO:0014744 | 0.01 | 15.1799 | 0.1536 | 2 | 14 | positive regulation of muscle adaptation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 24.7991 | 1.8425 | 31 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 19.3987 | 2.4595 | 33 | 287 | detection of chemical stimulus |
GO:0007606 | 0 | 18.6521 | 2.5452 | 33 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 17.5685 | 2.6823 | 33 | 313 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 6.5525 | 8.3469 | 40 | 974 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 4.7468 | 10.4464 | 38 | 1219 | nervous system process |
GO:0019373 | 0 | 43.2862 | 0.1285 | 4 | 15 | epoxygenase P450 pathway |
GO:0032501 | 0 | 1.9872 | 57.571 | 81 | 6718 | multicellular organismal process |
GO:0048252 | 2e-04 | 234.7445 | 0.0257 | 2 | 3 | lauric acid metabolic process |
GO:0001676 | 2e-04 | 7.6725 | 0.857 | 6 | 100 | long-chain fatty acid metabolic process |
GO:0033559 | 2e-04 | 7.5117 | 0.8741 | 6 | 102 | unsaturated fatty acid metabolic process |
GO:0006690 | 3e-04 | 7.0672 | 0.9255 | 6 | 108 | icosanoid metabolic process |
GO:0036101 | 4e-04 | 117.365 | 0.0343 | 2 | 4 | leukotriene B4 catabolic process |
GO:0010668 | 0.0011 | 58.6752 | 0.0514 | 2 | 6 | ectodermal cell differentiation |
GO:1903671 | 0.0012 | 16.1019 | 0.2142 | 3 | 25 | negative regulation of sprouting angiogenesis |
GO:0120254 | 0.0014 | 5.2891 | 1.2169 | 6 | 142 | olefinic compound metabolic process |
GO:0002933 | 0.0015 | 46.9372 | 0.06 | 2 | 7 | lipid hydroxylation |
GO:0051716 | 0.0021 | 1.6515 | 56.8683 | 74 | 6636 | cellular response to stimulus |
GO:0023052 | 0.0022 | 1.6538 | 49.2756 | 66 | 5750 | signaling |
GO:0097267 | 0.0025 | 33.5224 | 0.0771 | 2 | 9 | omega-hydroxylase P450 pathway |
GO:0007154 | 0.0029 | 1.6315 | 49.7041 | 66 | 5800 | cell communication |
GO:0010273 | 0.0045 | 23.4613 | 0.1028 | 2 | 12 | detoxification of copper ion |
GO:0050789 | 0.0064 | 1.6401 | 90.907 | 105 | 10608 | regulation of biological process |
GO:0032309 | 0.0067 | 8.4238 | 0.3856 | 3 | 45 | icosanoid secretion |
GO:0097501 | 0.0071 | 18.0438 | 0.1285 | 2 | 15 | stress response to metal ion |
GO:1901569 | 0.0071 | 18.0438 | 0.1285 | 2 | 15 | fatty acid derivative catabolic process |
GO:0070231 | 0.008 | 7.8608 | 0.4113 | 3 | 48 | T cell apoptotic process |
GO:1903588 | 0.0081 | 16.7539 | 0.1371 | 2 | 16 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO:0042666 | 0.0086 | Inf | 0.0086 | 1 | 1 | negative regulation of ectodermal cell fate specification |
GO:0045221 | 0.0086 | Inf | 0.0086 | 1 | 1 | negative regulation of FasL production |
GO:0051878 | 0.0086 | Inf | 0.0086 | 1 | 1 | lateral element assembly |
GO:0071104 | 0.0086 | Inf | 0.0086 | 1 | 1 | response to interleukin-9 |
GO:0110119 | 0.0086 | Inf | 0.0086 | 1 | 1 | positive regulation of very-low-density lipoprotein particle clearance |
GO:1901170 | 0.0086 | Inf | 0.0086 | 1 | 1 | naphthalene catabolic process |
GO:1901625 | 0.0086 | Inf | 0.0086 | 1 | 1 | cellular response to ergosterol |
GO:1902203 | 0.0086 | Inf | 0.0086 | 1 | 1 | negative regulation of hepatocyte growth factor receptor signaling pathway |
GO:1905608 | 0.0086 | Inf | 0.0086 | 1 | 1 | positive regulation of presynapse assembly |
GO:1990256 | 0.0086 | Inf | 0.0086 | 1 | 1 | signal clustering |
GO:2001113 | 0.0086 | Inf | 0.0086 | 1 | 1 | negative regulation of cellular response to hepatocyte growth factor stimulus |
GO:0015908 | 0.0087 | 5.2645 | 0.8055 | 4 | 94 | fatty acid transport |
GO:0006805 | 0.0097 | 5.0937 | 0.8313 | 4 | 97 | xenobiotic metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 312.3506 | 0.3512 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 46.1317 | 1.1413 | 31 | 104 | nucleosome assembly |
GO:0071824 | 0 | 18.6886 | 2.3046 | 31 | 210 | protein-DNA complex subunit organization |
GO:0045653 | 0 | 342.2744 | 0.1975 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006338 | 0 | 16.2115 | 2.6009 | 31 | 237 | chromatin remodeling |
GO:0032200 | 0 | 18.7839 | 1.712 | 24 | 156 | telomere organization |
GO:0006336 | 0 | 75.9946 | 0.3512 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0006352 | 0 | 12.3641 | 1.3608 | 14 | 124 | DNA-templated transcription, initiation |
GO:0045637 | 0 | 7.975 | 2.1729 | 15 | 198 | regulation of myeloid cell differentiation |
GO:0065003 | 0 | 3.1141 | 15.4296 | 40 | 1406 | protein-containing complex assembly |
GO:0040029 | 0 | 8.5953 | 1.4596 | 11 | 133 | regulation of gene expression, epigenetic |
GO:0034654 | 0 | 2.2201 | 39.0898 | 68 | 3562 | nucleobase-containing compound biosynthetic process |
GO:0045596 | 0 | 3.8402 | 5.8506 | 20 | 549 | negative regulation of cell differentiation |
GO:0002227 | 0 | 27.2441 | 0.2414 | 5 | 22 | innate immune response in mucosa |
GO:2000026 | 0 | 2.5647 | 14.2115 | 32 | 1295 | regulation of multicellular organismal development |
GO:0006351 | 0 | 2.1083 | 31.2085 | 54 | 3063 | transcription, DNA-templated |
GO:0002520 | 0 | 2.7851 | 10.0303 | 25 | 914 | immune system development |
GO:0002251 | 0 | 16.5297 | 0.3621 | 5 | 33 | organ or tissue specific immune response |
GO:0048513 | 0 | 1.9866 | 35.8085 | 59 | 3263 | animal organ development |
GO:0016070 | 0 | 1.8992 | 47.1667 | 72 | 4298 | RNA metabolic process |
GO:0001714 | 1e-04 | 54.984 | 0.0878 | 3 | 8 | endodermal cell fate specification |
GO:0002118 | 1e-04 | 54.984 | 0.0878 | 3 | 8 | aggressive behavior |
GO:0048869 | 1e-04 | 1.8636 | 43.0185 | 66 | 3920 | cellular developmental process |
GO:0030097 | 1e-04 | 2.7083 | 8.9549 | 22 | 816 | hemopoiesis |
GO:0007389 | 1e-04 | 3.3411 | 4.8835 | 15 | 445 | pattern specification process |
GO:0061032 | 1e-04 | Inf | 0.0219 | 2 | 2 | visceral serous pericardium development |
GO:0009059 | 2e-04 | 1.7837 | 46.8704 | 69 | 4271 | macromolecule biosynthetic process |
GO:0010467 | 2e-04 | 2.6095 | 10.3496 | 23 | 1183 | gene expression |
GO:0019731 | 2e-04 | 10.2742 | 0.5487 | 5 | 50 | antibacterial humoral response |
GO:0001656 | 4e-04 | 6.9602 | 0.9438 | 6 | 86 | metanephros development |
GO:0044085 | 4e-04 | 1.8252 | 32.3078 | 51 | 2944 | cellular component biogenesis |
GO:0009952 | 4e-04 | 4.3732 | 2.2168 | 9 | 202 | anterior/posterior pattern specification |
GO:1904862 | 5e-04 | 22.9 | 0.1646 | 3 | 15 | inhibitory synapse assembly |
GO:2001141 | 6e-04 | 1.7716 | 33.8332 | 52 | 3083 | regulation of RNA biosynthetic process |
GO:0007631 | 8e-04 | 5.9184 | 1.0974 | 6 | 100 | feeding behavior |
GO:0010468 | 9e-04 | 1.688 | 45.9673 | 65 | 4428 | regulation of gene expression |
GO:0050789 | 9e-04 | 1.7223 | 116.4133 | 136 | 10608 | regulation of biological process |
GO:0061844 | 0.0011 | 6.996 | 0.7792 | 5 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0048562 | 0.0014 | 3.3508 | 3.1825 | 10 | 290 | embryonic organ morphogenesis |
GO:0035987 | 0.0016 | 8.7575 | 0.5048 | 4 | 46 | endodermal cell differentiation |
GO:0045944 | 0.0016 | 2.0763 | 12.5544 | 24 | 1144 | positive regulation of transcription by RNA polymerase II |
GO:0007406 | 0.0017 | 45.5625 | 0.0658 | 2 | 6 | negative regulation of neuroblast proliferation |
GO:0021895 | 0.002 | 13.7331 | 0.2524 | 3 | 23 | cerebral cortex neuron differentiation |
GO:0003308 | 0.0024 | 36.4477 | 0.0768 | 2 | 7 | negative regulation of Wnt signaling pathway involved in heart development |
GO:1904936 | 0.0024 | 36.4477 | 0.0768 | 2 | 7 | interneuron migration |
GO:0050830 | 0.0028 | 5.5571 | 0.9657 | 5 | 88 | defense response to Gram-positive bacterium |
GO:0070474 | 0.0032 | 30.3712 | 0.0878 | 2 | 8 | positive regulation of uterine smooth muscle contraction |
GO:0046483 | 0.0033 | 1.5365 | 59.2273 | 77 | 5397 | heterocycle metabolic process |
GO:0050877 | 0.0037 | 1.9362 | 13.3774 | 24 | 1219 | nervous system process |
GO:0032501 | 0.0039 | 1.5405 | 64.8177 | 82 | 6273 | multicellular organismal process |
GO:0051961 | 0.0043 | 4.1727 | 1.5254 | 6 | 139 | negative regulation of nervous system development |
GO:0061351 | 0.0043 | 4.1727 | 1.5254 | 6 | 139 | neural precursor cell proliferation |
GO:0061311 | 0.0047 | 9.8045 | 0.3402 | 3 | 31 | cell surface receptor signaling pathway involved in heart development |
GO:0007218 | 0.0047 | 4.9035 | 1.0864 | 5 | 99 | neuropeptide signaling pathway |
GO:0006357 | 0.0047 | 1.9626 | 12.1557 | 22 | 1190 | regulation of transcription by RNA polymerase II |
GO:1903508 | 0.0049 | 1.8057 | 16.8014 | 28 | 1531 | positive regulation of nucleic acid-templated transcription |
GO:0048663 | 0.005 | 6.2275 | 0.6914 | 4 | 63 | neuron fate commitment |
GO:0072124 | 0.0051 | 22.7756 | 0.1097 | 2 | 10 | regulation of glomerular mesangial cell proliferation |
GO:0060795 | 0.0051 | 9.4658 | 0.3512 | 3 | 32 | cell fate commitment involved in formation of primary germ layer |
GO:0060914 | 0.0051 | 9.4658 | 0.3512 | 3 | 32 | heart formation |
GO:0035051 | 0.0051 | 4.0202 | 1.5803 | 6 | 144 | cardiocyte differentiation |
GO:0010454 | 0.0062 | 20.2437 | 0.1207 | 2 | 11 | negative regulation of cell fate commitment |
GO:0060923 | 0.0062 | 20.2437 | 0.1207 | 2 | 11 | cardiac muscle cell fate commitment |
GO:0072017 | 0.0062 | 20.2437 | 0.1207 | 2 | 11 | distal tubule development |
GO:0035195 | 0.0065 | 2.8427 | 3.3361 | 9 | 304 | miRNA-mediated gene silencing |
GO:0007399 | 0.0066 | 1.6708 | 22.9426 | 35 | 2145 | nervous system development |
GO:0006725 | 0.0069 | 1.4779 | 59.8418 | 76 | 5453 | cellular aromatic compound metabolic process |
GO:0002024 | 0.0074 | 18.2182 | 0.1317 | 2 | 12 | diet induced thermogenesis |
GO:0010273 | 0.0074 | 18.2182 | 0.1317 | 2 | 12 | detoxification of copper ion |
GO:0010960 | 0.0074 | 18.2182 | 0.1317 | 2 | 12 | magnesium ion homeostasis |
GO:0042659 | 0.0074 | 18.2182 | 0.1317 | 2 | 12 | regulation of cell fate specification |
GO:0048699 | 0.0074 | 1.8001 | 14.9248 | 25 | 1360 | generation of neurons |
GO:0045665 | 0.0077 | 5.4812 | 0.7792 | 4 | 71 | negative regulation of neuron differentiation |
GO:0050906 | 0.0078 | 2.757 | 3.4349 | 9 | 313 | detection of stimulus involved in sensory perception |
GO:0090596 | 0.0083 | 2.9368 | 2.8642 | 8 | 261 | sensory organ morphogenesis |
GO:0016441 | 0.0083 | 2.7295 | 3.4678 | 9 | 316 | post-transcriptional gene silencing |
GO:0044249 | 0.0085 | 1.467 | 56.5057 | 72 | 5149 | cellular biosynthetic process |
GO:0021978 | 0.0086 | 16.561 | 0.1427 | 2 | 13 | telencephalon regionalization |
GO:0042538 | 0.0086 | 16.561 | 0.1427 | 2 | 13 | hyperosmotic salinity response |
GO:1901360 | 0.0089 | 1.4544 | 62.311 | 78 | 5678 | organic cyclic compound metabolic process |
GO:0021543 | 0.009 | 3.5523 | 1.7778 | 6 | 162 | pallium development |
GO:0045685 | 0.0093 | 5.1711 | 0.8231 | 4 | 75 | regulation of glial cell differentiation |
GO:0007492 | 0.0097 | 5.099 | 0.834 | 4 | 76 | endoderm development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 255.3191 | 0.4182 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 30.1956 | 1.3593 | 27 | 104 | nucleosome assembly |
GO:0045653 | 0 | 282.899 | 0.2353 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0071824 | 0 | 12.6207 | 2.7448 | 27 | 210 | protein-DNA complex subunit organization |
GO:0032200 | 0 | 15.354 | 2.039 | 24 | 156 | telomere organization |
GO:0006338 | 0 | 11.5033 | 3.0977 | 28 | 237 | chromatin remodeling |
GO:0006336 | 0 | 62.8114 | 0.4182 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0045637 | 0 | 9.2638 | 2.5879 | 20 | 198 | regulation of myeloid cell differentiation |
GO:0045596 | 0 | 4.4135 | 8.2212 | 31 | 629 | negative regulation of cell differentiation |
GO:0006352 | 0 | 10.2191 | 1.6207 | 14 | 124 | DNA-templated transcription, initiation |
GO:0007389 | 0 | 4.4058 | 5.648 | 22 | 436 | pattern specification process |
GO:2000026 | 0 | 2.821 | 16.926 | 41 | 1295 | regulation of multicellular organismal development |
GO:0048731 | 0 | 2.2807 | 37.9877 | 68 | 3160 | system development |
GO:0065007 | 0 | 2.2387 | 147.3413 | 177 | 11273 | biological regulation |
GO:0018130 | 0 | 2.0002 | 47.4321 | 77 | 3629 | heterocycle biosynthetic process |
GO:0019438 | 0 | 1.9922 | 47.5758 | 77 | 3640 | aromatic compound biosynthetic process |
GO:0032501 | 0 | 1.9801 | 72.3189 | 103 | 6153 | multicellular organismal process |
GO:0006357 | 0 | 2.6399 | 14.7605 | 34 | 1190 | regulation of transcription by RNA polymerase II |
GO:0048869 | 0 | 1.9901 | 47.4513 | 76 | 3826 | cellular developmental process |
GO:0048568 | 0 | 3.6537 | 5.7379 | 19 | 439 | embryonic organ development |
GO:0048665 | 0 | 24.3674 | 0.272 | 5 | 21 | neuron fate specification |
GO:1901362 | 0 | 1.935 | 49.4057 | 78 | 3780 | organic cyclic compound biosynthetic process |
GO:0040029 | 0 | 6.3934 | 1.7383 | 10 | 133 | regulation of gene expression, epigenetic |
GO:0021871 | 0 | 21.4573 | 0.3006 | 5 | 23 | forebrain regionalization |
GO:0048598 | 0 | 3.4559 | 6.0513 | 19 | 473 | embryonic morphogenesis |
GO:0022008 | 0 | 2.282 | 20.4289 | 41 | 1563 | neurogenesis |
GO:0007631 | 0 | 7.688 | 1.1659 | 8 | 90 | feeding behavior |
GO:0006351 | 0 | 1.9592 | 37.6786 | 62 | 3063 | transcription, DNA-templated |
GO:0002520 | 0 | 2.5973 | 11.9462 | 28 | 914 | immune system development |
GO:0030097 | 0 | 2.6927 | 10.6654 | 26 | 816 | hemopoiesis |
GO:0032774 | 0 | 1.9448 | 37.9 | 62 | 3081 | RNA biosynthetic process |
GO:0072088 | 0 | 8.6423 | 0.9149 | 7 | 70 | nephron epithelium morphogenesis |
GO:0061333 | 0 | 8.3753 | 0.9411 | 7 | 72 | renal tubule morphogenesis |
GO:0010467 | 0 | 2.5939 | 12.6833 | 28 | 1183 | gene expression |
GO:0009952 | 1e-04 | 4.532 | 2.6402 | 11 | 202 | anterior/posterior pattern specification |
GO:0021796 | 1e-04 | 57.4306 | 0.0915 | 3 | 7 | cerebral cortex regionalization |
GO:0044271 | 1e-04 | 1.744 | 55.8232 | 81 | 4271 | cellular nitrogen compound biosynthetic process |
GO:0050911 | 1e-04 | 4.2397 | 2.8101 | 11 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0072171 | 1e-04 | 8.6052 | 0.7842 | 6 | 60 | mesonephric tubule morphogenesis |
GO:0072080 | 1e-04 | 6.885 | 1.124 | 7 | 86 | nephron tubule development |
GO:0060993 | 2e-04 | 6.7142 | 1.1502 | 7 | 88 | kidney morphogenesis |
GO:0090304 | 2e-04 | 1.6906 | 63.0118 | 88 | 4821 | nucleic acid metabolic process |
GO:0048513 | 2e-04 | 2.0693 | 20.9751 | 38 | 1836 | animal organ development |
GO:0060536 | 2e-04 | 32.8113 | 0.1307 | 3 | 10 | cartilage morphogenesis |
GO:0120162 | 3e-04 | 6.1076 | 1.2547 | 7 | 96 | positive regulation of cold-induced thermogenesis |
GO:0050877 | 3e-04 | 2.1366 | 15.9327 | 31 | 1219 | nervous system process |
GO:0021953 | 3e-04 | 4.5642 | 2.1305 | 9 | 163 | central nervous system neuron differentiation |
GO:0048332 | 3e-04 | 7.2561 | 0.9149 | 6 | 70 | mesoderm morphogenesis |
GO:0010556 | 4e-04 | 1.6969 | 46.4387 | 68 | 3553 | regulation of macromolecule biosynthetic process |
GO:0031326 | 4e-04 | 1.6803 | 48.3731 | 70 | 3701 | regulation of cellular biosynthetic process |
GO:0010273 | 4e-04 | 25.5167 | 0.1568 | 3 | 12 | detoxification of copper ion |
GO:0021515 | 5e-04 | 8.5684 | 0.6535 | 5 | 50 | cell differentiation in spinal cord |
GO:0002682 | 5e-04 | 2.0541 | 16.5078 | 31 | 1263 | regulation of immune system process |
GO:0007412 | 5e-04 | 152.4476 | 0.0392 | 2 | 3 | axon target recognition |
GO:0048935 | 6e-04 | 22.9636 | 0.1699 | 3 | 13 | peripheral nervous system neuron development |
GO:0050794 | 6e-04 | 1.6425 | 131.2779 | 154 | 10044 | regulation of cellular process |
GO:0001658 | 6e-04 | 8.0314 | 0.6927 | 5 | 53 | branching involved in ureteric bud morphogenesis |
GO:0010468 | 6e-04 | 1.6329 | 55.6012 | 77 | 4428 | regulation of gene expression |
GO:0035115 | 7e-04 | 11.3825 | 0.4052 | 4 | 31 | embryonic forelimb morphogenesis |
GO:0048704 | 7e-04 | 6.1622 | 1.0624 | 6 | 82 | embryonic skeletal system morphogenesis |
GO:0021510 | 7e-04 | 11.2603 | 0.408 | 4 | 32 | spinal cord development |
GO:0003207 | 7e-04 | 20.8747 | 0.183 | 3 | 14 | cardiac chamber formation |
GO:0045664 | 8e-04 | 3.9428 | 2.4441 | 9 | 187 | regulation of neuron differentiation |
GO:0097501 | 9e-04 | 19.134 | 0.1961 | 3 | 15 | stress response to metal ion |
GO:0007420 | 0.001 | 2.3301 | 9.2145 | 20 | 705 | brain development |
GO:0009954 | 0.001 | 10.2423 | 0.4444 | 4 | 34 | proximal/distal pattern formation |
GO:0009058 | 0.001 | 1.5636 | 69.1418 | 91 | 5290 | biosynthetic process |
GO:0003219 | 0.001 | 76.219 | 0.0523 | 2 | 4 | cardiac right ventricle formation |
GO:0072268 | 0.001 | 76.219 | 0.0523 | 2 | 4 | pattern specification involved in metanephros development |
GO:0097476 | 0.001 | 76.219 | 0.0523 | 2 | 4 | spinal cord motor neuron migration |
GO:0009888 | 0.0011 | 2.3592 | 8.6877 | 19 | 710 | tissue development |
GO:0001657 | 0.0012 | 5.5215 | 1.1763 | 6 | 90 | ureteric bud development |
GO:0060429 | 0.0012 | 2.0294 | 14.3904 | 27 | 1101 | epithelium development |
GO:0072163 | 0.0012 | 5.4562 | 1.1894 | 6 | 91 | mesonephric epithelium development |
GO:0001708 | 0.0013 | 6.7483 | 0.8104 | 5 | 64 | cell fate specification |
GO:0065003 | 0.0014 | 1.8934 | 18.3768 | 32 | 1406 | protein-containing complex assembly |
GO:0009593 | 0.0014 | 3.1194 | 3.7512 | 11 | 287 | detection of chemical stimulus |
GO:0048645 | 0.0015 | 6.5295 | 0.8365 | 5 | 64 | animal organ formation |
GO:0072081 | 0.0017 | 50.8095 | 0.0654 | 2 | 5 | specification of nephron tubule identity |
GO:1905700 | 0.0017 | 50.8095 | 0.0654 | 2 | 5 | negative regulation of xenobiotic detoxification by transmembrane export across the plasma membrane |
GO:0051252 | 0.0018 | 1.5984 | 43.7985 | 62 | 3351 | regulation of RNA metabolic process |
GO:0007606 | 0.0019 | 3.0084 | 3.8819 | 11 | 297 | sensory perception of chemical stimulus |
GO:0098754 | 0.0021 | 4.2032 | 1.7776 | 7 | 136 | detoxification |
GO:0019222 | 0.0021 | 1.5028 | 82.1206 | 103 | 6283 | regulation of metabolic process |
GO:0021516 | 0.0021 | 13.5021 | 0.2614 | 3 | 20 | dorsal spinal cord development |
GO:0072006 | 0.0024 | 4.1069 | 1.8168 | 7 | 139 | nephron development |
GO:0120039 | 0.0025 | 2.2943 | 7.8814 | 17 | 603 | plasma membrane bounded cell projection morphogenesis |
GO:0031290 | 0.0025 | 12.7512 | 0.2745 | 3 | 21 | retinal ganglion cell axon guidance |
GO:0060065 | 0.0025 | 12.7512 | 0.2745 | 3 | 21 | uterus development |
GO:0071294 | 0.0025 | 12.7512 | 0.2745 | 3 | 21 | cellular response to zinc ion |
GO:2000543 | 0.0025 | 38.1048 | 0.0784 | 2 | 6 | positive regulation of gastrulation |
GO:2001023 | 0.0025 | 38.1048 | 0.0784 | 2 | 6 | regulation of response to drug |
GO:0021517 | 0.0028 | 7.4892 | 0.5882 | 4 | 45 | ventral spinal cord development |
GO:0050906 | 0.0028 | 2.8461 | 4.091 | 11 | 313 | detection of stimulus involved in sensory perception |
GO:0043009 | 0.0032 | 2.231 | 8.0905 | 17 | 619 | chordate embryonic development |
GO:0050885 | 0.0033 | 7.14 | 0.6143 | 4 | 47 | neuromuscular process controlling balance |
GO:0000904 | 0.0034 | 2.1645 | 8.8355 | 18 | 676 | cell morphogenesis involved in differentiation |
GO:0051971 | 0.0034 | 30.4819 | 0.0915 | 2 | 7 | positive regulation of transmission of nerve impulse |
GO:0032990 | 0.0035 | 2.2082 | 8.1689 | 17 | 625 | cell part morphogenesis |
GO:0071280 | 0.0036 | 10.9275 | 0.3137 | 3 | 24 | cellular response to copper ion |
GO:2000679 | 0.0036 | 10.9275 | 0.3137 | 3 | 24 | positive regulation of transcription regulatory region DNA binding |
GO:0045778 | 0.0041 | 6.6731 | 0.6535 | 4 | 50 | positive regulation of ossification |
GO:0007214 | 0.0041 | 10.4302 | 0.3268 | 3 | 25 | gamma-aminobutyric acid signaling pathway |
GO:1903506 | 0.0043 | 1.775 | 19.0254 | 31 | 1544 | regulation of nucleic acid-templated transcription |
GO:1990845 | 0.0043 | 3.6592 | 2.0259 | 7 | 155 | adaptive thermogenesis |
GO:0048382 | 0.0045 | 25.4 | 0.1046 | 2 | 8 | mesendoderm development |
GO:0048793 | 0.0045 | 25.4 | 0.1046 | 2 | 8 | pronephros development |
GO:0070474 | 0.0045 | 25.4 | 0.1046 | 2 | 8 | positive regulation of uterine smooth muscle contraction |
GO:0072177 | 0.0045 | 25.4 | 0.1046 | 2 | 8 | mesonephric duct development |
GO:0035113 | 0.0046 | 4.1338 | 1.5423 | 6 | 118 | embryonic appendage morphogenesis |
GO:0042744 | 0.0051 | 9.5598 | 0.3529 | 3 | 27 | hydrogen peroxide catabolic process |
GO:0001704 | 0.0051 | 4.8106 | 1.1103 | 5 | 86 | formation of primary germ layer |
GO:0042471 | 0.0051 | 4.0252 | 1.5815 | 6 | 121 | ear morphogenesis |
GO:0021543 | 0.0055 | 3.4924 | 2.1174 | 7 | 162 | pallium development |
GO:0003266 | 0.0058 | 21.7701 | 0.1176 | 2 | 9 | regulation of secondary heart field cardioblast proliferation |
GO:0021520 | 0.0058 | 21.7701 | 0.1176 | 2 | 9 | spinal cord motor neuron cell fate specification |
GO:0032353 | 0.0058 | 21.7701 | 0.1176 | 2 | 9 | negative regulation of hormone biosynthetic process |
GO:0035360 | 0.0058 | 21.7701 | 0.1176 | 2 | 9 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
GO:0072048 | 0.0058 | 21.7701 | 0.1176 | 2 | 9 | renal system pattern specification |
GO:0007423 | 0.0058 | 2.2064 | 7.1756 | 15 | 549 | sensory organ development |
GO:0032410 | 0.0059 | 4.6345 | 1.1502 | 5 | 88 | negative regulation of transporter activity |
GO:0032502 | 0.0063 | 1.762 | 19.84 | 31 | 1968 | developmental process |
GO:0007409 | 0.0065 | 2.4142 | 5.2315 | 12 | 404 | axonogenesis |
GO:0007628 | 0.0069 | 8.496 | 0.3921 | 3 | 30 | adult walking behavior |
GO:0001935 | 0.0071 | 3.3193 | 2.2219 | 7 | 170 | endothelial cell proliferation |
GO:0009953 | 0.0071 | 4.4203 | 1.2025 | 5 | 92 | dorsal/ventral pattern formation |
GO:0042756 | 0.0071 | 19.0476 | 0.1307 | 2 | 10 | drinking behavior |
GO:0048588 | 0.0072 | 3.0082 | 2.797 | 8 | 214 | developmental cell growth |
GO:0030534 | 0.0078 | 3.6713 | 1.7253 | 6 | 132 | adult behavior |
GO:0045944 | 0.0079 | 1.7788 | 14.9524 | 25 | 1144 | positive regulation of transcription by RNA polymerase II |
GO:0001659 | 0.008 | 3.239 | 2.2742 | 7 | 174 | temperature homeostasis |
GO:0048333 | 0.0083 | 7.9091 | 0.4182 | 3 | 32 | mesodermal cell differentiation |
GO:0060795 | 0.0083 | 7.9091 | 0.4182 | 3 | 32 | cell fate commitment involved in formation of primary germ layer |
GO:0051216 | 0.0086 | 3.1891 | 2.3079 | 7 | 179 | cartilage development |
GO:0003263 | 0.0087 | 16.9302 | 0.1438 | 2 | 11 | cardioblast proliferation |
GO:0021794 | 0.0087 | 16.9302 | 0.1438 | 2 | 11 | thalamus development |
GO:0060272 | 0.0087 | 16.9302 | 0.1438 | 2 | 11 | embryonic skeletal joint morphogenesis |
GO:0072178 | 0.0087 | 16.9302 | 0.1438 | 2 | 11 | nephric duct morphogenesis |
GO:0072182 | 0.0087 | 16.9302 | 0.1438 | 2 | 11 | regulation of nephron tubule epithelial cell differentiation |
GO:1902667 | 0.0087 | 16.9302 | 0.1438 | 2 | 11 | regulation of axon guidance |
GO:1903238 | 0.0087 | 16.9302 | 0.1438 | 2 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0030182 | 0.0089 | 1.8594 | 11.995 | 21 | 973 | neuron differentiation |
GO:0071276 | 0.009 | 7.645 | 0.4313 | 3 | 33 | cellular response to cadmium ion |
GO:0035282 | 0.0093 | 4.1336 | 1.2809 | 5 | 98 | segmentation |
GO:0045453 | 0.0093 | 5.1985 | 0.8234 | 4 | 63 | bone resorption |
GO:0045670 | 0.0093 | 5.1985 | 0.8234 | 4 | 63 | regulation of osteoclast differentiation |
GO:0043524 | 0.0093 | 3.5301 | 1.7906 | 6 | 137 | negative regulation of neuron apoptotic process |
GO:1903508 | 0.0094 | 1.6565 | 20.0106 | 31 | 1531 | positive regulation of nucleic acid-templated transcription |
GO:0007218 | 0.0097 | 4.0893 | 1.294 | 5 | 99 | neuropeptide signaling pathway |
GO:0048519 | 0.0098 | 1.412 | 66.58 | 83 | 5094 | negative regulation of biological process |
GO:0045777 | 0.0098 | 7.3979 | 0.4444 | 3 | 34 | positive regulation of blood pressure |
GO:1902692 | 0.0098 | 7.3979 | 0.4444 | 3 | 34 | regulation of neuroblast proliferation |
GO:0006940 | 0.0098 | 5.1115 | 0.8365 | 4 | 64 | regulation of smooth muscle contraction |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 11.013 | 1.7497 | 16 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051606 | 0 | 6.3975 | 3.5075 | 19 | 431 | detection of stimulus |
GO:0007186 | 0 | 4.1113 | 7.9265 | 27 | 974 | G protein-coupled receptor signaling pathway |
GO:0007600 | 0 | 4.611 | 5.9164 | 23 | 727 | sensory perception |
GO:0048252 | 0 | Inf | 0.0244 | 3 | 3 | lauric acid metabolic process |
GO:0003008 | 0 | 2.5556 | 15.9263 | 34 | 1957 | system process |
GO:0046968 | 2e-04 | 247.4923 | 0.0244 | 2 | 3 | peptide antigen transport |
GO:0031424 | 3e-04 | 9.2751 | 0.5941 | 5 | 73 | keratinization |
GO:0097022 | 4e-04 | 123.7385 | 0.0326 | 2 | 4 | lymphocyte migration into lymph node |
GO:0002361 | 0.001 | 61.8615 | 0.0488 | 2 | 6 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:2000252 | 0.001 | 61.8615 | 0.0488 | 2 | 6 | negative regulation of feeding behavior |
GO:0015840 | 0.0013 | 49.4862 | 0.057 | 2 | 7 | urea transport |
GO:0032808 | 0.0013 | 49.4862 | 0.057 | 2 | 7 | lacrimal gland development |
GO:0048752 | 0.0013 | 49.4862 | 0.057 | 2 | 7 | semicircular canal morphogenesis |
GO:0001580 | 0.0016 | 14.3667 | 0.236 | 3 | 29 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0009820 | 0.0018 | 41.2359 | 0.0651 | 2 | 8 | alkaloid metabolic process |
GO:0019062 | 0.0018 | 41.2359 | 0.0651 | 2 | 8 | virion attachment to host cell |
GO:0042221 | 0.002 | 1.7487 | 31.8363 | 47 | 3912 | response to chemical |
GO:0042355 | 0.0023 | 35.3429 | 0.0732 | 2 | 9 | L-fucose catabolic process |
GO:0060054 | 0.0023 | 35.3429 | 0.0732 | 2 | 9 | positive regulation of epithelial cell proliferation involved in wound healing |
GO:0050907 | 0.0024 | 12.3803 | 0.2682 | 3 | 37 | detection of chemical stimulus involved in sensory perception |
GO:0042756 | 0.0028 | 30.9231 | 0.0814 | 2 | 10 | drinking behavior |
GO:0071600 | 0.0028 | 30.9231 | 0.0814 | 2 | 10 | otic vesicle morphogenesis |
GO:0075733 | 0.0028 | 30.9231 | 0.0814 | 2 | 10 | intracellular transport of virus |
GO:1902622 | 0.0033 | 10.9808 | 0.3011 | 3 | 37 | regulation of neutrophil migration |
GO:0035195 | 0.0034 | 3.442 | 2.474 | 8 | 304 | miRNA-mediated gene silencing |
GO:1903238 | 0.0034 | 27.4855 | 0.0895 | 2 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0060429 | 0.0035 | 2.1876 | 8.96 | 18 | 1101 | epithelium development |
GO:0016441 | 0.0043 | 3.3054 | 2.5716 | 8 | 316 | post-transcriptional gene silencing |
GO:0048512 | 0.0048 | 9.5701 | 0.3418 | 3 | 42 | circadian behavior |
GO:0002864 | 0.0048 | 22.4853 | 0.1058 | 2 | 13 | regulation of acute inflammatory response to antigenic stimulus |
GO:0044406 | 0.0048 | 22.4853 | 0.1058 | 2 | 13 | adhesion of symbiont to host |
GO:0048484 | 0.0048 | 22.4853 | 0.1058 | 2 | 13 | enteric nervous system development |
GO:0050930 | 0.0048 | 22.4853 | 0.1058 | 2 | 13 | induction of positive chemotaxis |
GO:0097530 | 0.0057 | 4.6524 | 1.1393 | 5 | 140 | granulocyte migration |
GO:0032309 | 0.0058 | 8.8848 | 0.3662 | 3 | 45 | icosanoid secretion |
GO:0035176 | 0.0062 | 8.6777 | 0.3744 | 3 | 46 | social behavior |
GO:0019373 | 0.0064 | 19.0237 | 0.1221 | 2 | 15 | epoxygenase P450 pathway |
GO:0031047 | 0.0065 | 3.0807 | 2.7507 | 8 | 338 | gene silencing by RNA |
GO:0050789 | 0.0066 | 1.6594 | 86.329 | 100 | 10608 | regulation of biological process |
GO:0015908 | 0.0073 | 5.5549 | 0.765 | 4 | 94 | fatty acid transport |
GO:0006004 | 0.0073 | 17.6637 | 0.1302 | 2 | 16 | fucose metabolic process |
GO:1903588 | 0.0073 | 17.6637 | 0.1302 | 2 | 16 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO:0002686 | 0.0074 | 8.1102 | 0.3988 | 3 | 49 | negative regulation of leukocyte migration |
GO:0043588 | 0.0079 | 3.2562 | 2.2705 | 7 | 279 | skin development |
GO:0003144 | 0.0081 | Inf | 0.0081 | 1 | 1 | embryonic heart tube formation |
GO:0006585 | 0.0081 | Inf | 0.0081 | 1 | 1 | dopamine biosynthetic process from tyrosine |
GO:0018963 | 0.0081 | Inf | 0.0081 | 1 | 1 | phthalate metabolic process |
GO:0042666 | 0.0081 | Inf | 0.0081 | 1 | 1 | negative regulation of ectodermal cell fate specification |
GO:0045818 | 0.0081 | Inf | 0.0081 | 1 | 1 | negative regulation of glycogen catabolic process |
GO:0050677 | 0.0081 | Inf | 0.0081 | 1 | 1 | positive regulation of urothelial cell proliferation |
GO:0050783 | 0.0081 | Inf | 0.0081 | 1 | 1 | cocaine metabolic process |
GO:0060101 | 0.0081 | Inf | 0.0081 | 1 | 1 | negative regulation of phagocytosis, engulfment |
GO:0060436 | 0.0081 | Inf | 0.0081 | 1 | 1 | bronchiole morphogenesis |
GO:0060496 | 0.0081 | Inf | 0.0081 | 1 | 1 | mesenchymal-epithelial cell signaling involved in lung development |
GO:0060879 | 0.0081 | Inf | 0.0081 | 1 | 1 | semicircular canal fusion |
GO:0061115 | 0.0081 | Inf | 0.0081 | 1 | 1 | lung proximal/distal axis specification |
GO:0071338 | 0.0081 | Inf | 0.0081 | 1 | 1 | positive regulation of hair follicle cell proliferation |
GO:0090321 | 0.0081 | Inf | 0.0081 | 1 | 1 | positive regulation of chylomicron remnant clearance |
GO:0110119 | 0.0081 | Inf | 0.0081 | 1 | 1 | positive regulation of very-low-density lipoprotein particle clearance |
GO:1901625 | 0.0081 | Inf | 0.0081 | 1 | 1 | cellular response to ergosterol |
GO:1902203 | 0.0081 | Inf | 0.0081 | 1 | 1 | negative regulation of hepatocyte growth factor receptor signaling pathway |
GO:1902569 | 0.0081 | Inf | 0.0081 | 1 | 1 | negative regulation of activation of Janus kinase activity |
GO:1905608 | 0.0081 | Inf | 0.0081 | 1 | 1 | positive regulation of presynapse assembly |
GO:1905716 | 0.0081 | Inf | 0.0081 | 1 | 1 | negative regulation of cornification |
GO:2001113 | 0.0081 | Inf | 0.0081 | 1 | 1 | negative regulation of cellular response to hepatocyte growth factor stimulus |
GO:0009404 | 0.0083 | 16.4851 | 0.1383 | 2 | 17 | toxin metabolic process |
GO:0036065 | 0.0083 | 16.4851 | 0.1383 | 2 | 17 | fucosylation |
GO:0009913 | 0.0085 | 3.6005 | 1.7578 | 6 | 216 | epidermal cell differentiation |
GO:0050909 | 0.0087 | 7.6122 | 0.4232 | 3 | 52 | sensory perception of taste |
GO:0042749 | 0.0092 | 15.4538 | 0.1465 | 2 | 18 | regulation of circadian sleep/wake cycle |
GO:0043651 | 0.0092 | 15.4538 | 0.1465 | 2 | 18 | linoleic acid metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007389 | 0 | 6.1168 | 4.2525 | 22 | 445 | pattern specification process |
GO:0045165 | 0 | 7.8118 | 2.0622 | 14 | 221 | cell fate commitment |
GO:0048704 | 0 | 11.7277 | 0.8887 | 9 | 93 | embryonic skeletal system morphogenesis |
GO:0048699 | 0 | 3.0662 | 12.7854 | 33 | 1355 | generation of neurons |
GO:0010468 | 0 | 2.2964 | 43.5854 | 73 | 4561 | regulation of gene expression |
GO:0006351 | 0 | 2.4036 | 30.4553 | 57 | 3187 | transcription, DNA-templated |
GO:0032774 | 0 | 2.3866 | 30.6273 | 57 | 3205 | RNA biosynthetic process |
GO:0048665 | 0 | 33.8725 | 0.1982 | 5 | 21 | neuron fate specification |
GO:0043066 | 0 | 3.3646 | 7.7787 | 23 | 814 | negative regulation of apoptotic process |
GO:0060485 | 0 | 5.3963 | 2.6853 | 13 | 281 | mesenchyme development |
GO:0045944 | 0 | 2.9533 | 10.9322 | 28 | 1144 | positive regulation of transcription by RNA polymerase II |
GO:0010557 | 0 | 2.5647 | 16.5416 | 36 | 1731 | positive regulation of macromolecule biosynthetic process |
GO:0043009 | 0 | 3.6009 | 5.9152 | 19 | 619 | chordate embryonic development |
GO:0010558 | 0 | 2.6837 | 13.3785 | 31 | 1400 | negative regulation of macromolecule biosynthetic process |
GO:0018130 | 0 | 2.1146 | 34.448 | 58 | 3628 | heterocycle biosynthetic process |
GO:1903507 | 0 | 2.8039 | 10.9991 | 27 | 1151 | negative regulation of nucleic acid-templated transcription |
GO:0019219 | 0 | 2.0883 | 34.7269 | 58 | 3634 | regulation of nucleobase-containing compound metabolic process |
GO:0019438 | 0 | 2.0838 | 34.7842 | 58 | 3640 | aromatic compound biosynthetic process |
GO:0019222 | 0 | 1.9847 | 60.041 | 86 | 6283 | regulation of metabolic process |
GO:0044271 | 0 | 2.0363 | 40.8141 | 65 | 4271 | cellular nitrogen compound biosynthetic process |
GO:1903508 | 0 | 2.528 | 14.6304 | 32 | 1531 | positive regulation of nucleic acid-templated transcription |
GO:0031328 | 0 | 2.405 | 17.4972 | 36 | 1831 | positive regulation of cellular biosynthetic process |
GO:1901362 | 0 | 2.061 | 35.8817 | 59 | 3779 | organic cyclic compound biosynthetic process |
GO:0000122 | 0 | 3.0362 | 8.1418 | 22 | 852 | negative regulation of transcription by RNA polymerase II |
GO:0009952 | 0 | 5.7015 | 1.9303 | 10 | 202 | anterior/posterior pattern specification |
GO:0060548 | 0 | 2.912 | 8.8872 | 23 | 930 | negative regulation of cell death |
GO:0006357 | 0 | 3.5262 | 5.4701 | 17 | 675 | regulation of transcription by RNA polymerase II |
GO:0014033 | 0 | 8.7879 | 0.8887 | 7 | 93 | neural crest cell differentiation |
GO:0007218 | 0 | 8.2117 | 0.9461 | 7 | 99 | neuropeptide signaling pathway |
GO:0051253 | 1e-04 | 2.5554 | 11.9642 | 27 | 1252 | negative regulation of RNA metabolic process |
GO:0048332 | 1e-04 | 10.0677 | 0.6689 | 6 | 70 | mesoderm morphogenesis |
GO:0007369 | 1e-04 | 5.7637 | 1.7105 | 9 | 179 | gastrulation |
GO:0045664 | 1e-04 | 5.5019 | 1.787 | 9 | 187 | regulation of neuron differentiation |
GO:0031327 | 1e-04 | 2.4108 | 13.6757 | 29 | 1449 | negative regulation of cellular biosynthetic process |
GO:0045859 | 1e-04 | 3.1697 | 5.9057 | 17 | 618 | regulation of protein kinase activity |
GO:0051254 | 1e-04 | 2.2992 | 15.9109 | 32 | 1665 | positive regulation of RNA metabolic process |
GO:0042756 | 1e-04 | 45.2763 | 0.0956 | 3 | 10 | drinking behavior |
GO:0002761 | 1e-04 | 7.1892 | 1.0703 | 7 | 112 | regulation of myeloid leukocyte differentiation |
GO:0009887 | 1e-04 | 2.7507 | 8.4986 | 21 | 914 | animal organ morphogenesis |
GO:0009058 | 1e-04 | 1.8511 | 50.5518 | 73 | 5290 | biosynthetic process |
GO:0033674 | 1e-04 | 3.526 | 4.3385 | 14 | 454 | positive regulation of kinase activity |
GO:0051674 | 1e-04 | 2.2839 | 15.4427 | 31 | 1616 | localization of cell |
GO:0050678 | 1e-04 | 3.9164 | 3.3351 | 12 | 349 | regulation of epithelial cell proliferation |
GO:0048568 | 1e-04 | 3.9142 | 3.3404 | 12 | 357 | embryonic organ development |
GO:0014031 | 2e-04 | 7.9463 | 0.8314 | 6 | 87 | mesenchymal cell development |
GO:0048864 | 2e-04 | 7.9463 | 0.8314 | 6 | 87 | stem cell development |
GO:0043067 | 2e-04 | 2.3389 | 12.9581 | 27 | 1356 | regulation of programmed cell death |
GO:0001755 | 2e-04 | 10.0704 | 0.5543 | 5 | 58 | neural crest cell migration |
GO:0048484 | 2e-04 | 31.6875 | 0.1242 | 3 | 13 | enteric nervous system development |
GO:0060795 | 2e-04 | 15.1722 | 0.3058 | 4 | 32 | cell fate commitment involved in formation of primary germ layer |
GO:0001934 | 2e-04 | 2.8982 | 6.4217 | 17 | 672 | positive regulation of protein phosphorylation |
GO:0007412 | 3e-04 | 209.9869 | 0.0287 | 2 | 3 | axon target recognition |
GO:0009954 | 3e-04 | 14.1589 | 0.3249 | 4 | 34 | proximal/distal pattern formation |
GO:0045937 | 3e-04 | 2.6553 | 7.8551 | 19 | 822 | positive regulation of phosphate metabolic process |
GO:0009888 | 4e-04 | 2.4168 | 10.6723 | 23 | 1227 | tissue development |
GO:0032147 | 4e-04 | 5.7529 | 1.3187 | 7 | 138 | activation of protein kinase activity |
GO:0097530 | 4e-04 | 5.6657 | 1.3379 | 7 | 140 | granulocyte migration |
GO:0051172 | 4e-04 | 1.9929 | 21.2241 | 37 | 2221 | negative regulation of nitrogen compound metabolic process |
GO:0051241 | 4e-04 | 2.5933 | 8.0518 | 19 | 869 | negative regulation of multicellular organismal process |
GO:0051338 | 4e-04 | 2.5874 | 8.0462 | 19 | 842 | regulation of transferase activity |
GO:0032095 | 4e-04 | 24.3704 | 0.1529 | 3 | 16 | regulation of response to food |
GO:0042330 | 4e-04 | 2.9393 | 5.5425 | 15 | 580 | taxis |
GO:0001763 | 5e-04 | 4.7231 | 1.8252 | 8 | 191 | morphogenesis of a branching structure |
GO:0097022 | 5e-04 | 104.9869 | 0.0382 | 2 | 4 | lymphocyte migration into lymph node |
GO:2000026 | 6e-04 | 2.2403 | 12.3752 | 25 | 1295 | regulation of multicellular organismal development |
GO:0008284 | 6e-04 | 2.5099 | 8.2797 | 19 | 872 | positive regulation of cell population proliferation |
GO:0002009 | 6e-04 | 3.2825 | 3.9456 | 12 | 422 | morphogenesis of an epithelium |
GO:0051173 | 7e-04 | 1.8554 | 27.4451 | 44 | 2872 | positive regulation of nitrogen compound metabolic process |
GO:0060415 | 7e-04 | 7.8417 | 0.6976 | 5 | 73 | muscle tissue morphogenesis |
GO:0002685 | 7e-04 | 4.4522 | 1.9303 | 8 | 202 | regulation of leukocyte migration |
GO:0006607 | 7e-04 | 19.7973 | 0.1816 | 3 | 19 | NLS-bearing protein import into nucleus |
GO:0072507 | 8e-04 | 3.0244 | 4.6347 | 13 | 485 | divalent inorganic cation homeostasis |
GO:0050794 | 8e-04 | 1.7767 | 95.9815 | 115 | 10044 | regulation of cellular process |
GO:0060322 | 8e-04 | 2.5841 | 7.148 | 17 | 748 | head development |
GO:0048869 | 8e-04 | 1.8228 | 31.4239 | 48 | 3661 | cellular developmental process |
GO:0021516 | 9e-04 | 18.6316 | 0.1911 | 3 | 20 | dorsal spinal cord development |
GO:0033630 | 9e-04 | 18.6316 | 0.1911 | 3 | 20 | positive regulation of cell adhesion mediated by integrin |
GO:0042474 | 9e-04 | 18.6316 | 0.1911 | 3 | 20 | middle ear morphogenesis |
GO:0048598 | 9e-04 | 3.3385 | 3.5478 | 11 | 392 | embryonic morphogenesis |
GO:0014016 | 9e-04 | 69.9869 | 0.0478 | 2 | 5 | neuroblast differentiation |
GO:0060406 | 9e-04 | 69.9869 | 0.0478 | 2 | 5 | positive regulation of penile erection |
GO:0021953 | 0.001 | 4.8234 | 1.5576 | 7 | 163 | central nervous system neuron differentiation |
GO:0010894 | 0.001 | 17.5954 | 0.2007 | 3 | 21 | negative regulation of steroid biosynthetic process |
GO:0055010 | 0.001 | 9.8703 | 0.4491 | 4 | 47 | ventricular cardiac muscle tissue morphogenesis |
GO:0007517 | 0.001 | 3.4935 | 3.0675 | 10 | 321 | muscle organ development |
GO:0007589 | 0.0012 | 6.8321 | 0.7932 | 5 | 83 | body fluid secretion |
GO:2000177 | 0.0012 | 6.8321 | 0.7932 | 5 | 83 | regulation of neural precursor cell proliferation |
GO:0060537 | 0.0012 | 3.1961 | 3.6887 | 11 | 386 | muscle tissue development |
GO:0003206 | 0.0013 | 5.396 | 1.1945 | 6 | 125 | cardiac chamber morphogenesis |
GO:0048738 | 0.0013 | 4.0502 | 2.1119 | 8 | 221 | cardiac muscle tissue development |
GO:0021871 | 0.0013 | 15.8339 | 0.2198 | 3 | 23 | forebrain regionalization |
GO:0002361 | 0.0013 | 52.4869 | 0.0573 | 2 | 6 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0003278 | 0.0013 | 52.4869 | 0.0573 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0010536 | 0.0013 | 52.4869 | 0.0573 | 2 | 6 | positive regulation of activation of Janus kinase activity |
GO:0060455 | 0.0013 | 52.4869 | 0.0573 | 2 | 6 | negative regulation of gastric acid secretion |
GO:0072143 | 0.0013 | 52.4869 | 0.0573 | 2 | 6 | mesangial cell development |
GO:0009410 | 0.0014 | 4.0112 | 2.1331 | 8 | 230 | response to xenobiotic stimulus |
GO:0010721 | 0.0015 | 4.4755 | 1.6723 | 7 | 175 | negative regulation of cell development |
GO:0002052 | 0.0015 | 15.0789 | 0.2293 | 3 | 24 | positive regulation of neuroblast proliferation |
GO:0060993 | 0.0015 | 6.4185 | 0.8409 | 5 | 88 | kidney morphogenesis |
GO:0007631 | 0.0016 | 6.3918 | 0.8439 | 5 | 90 | feeding behavior |
GO:0045638 | 0.0016 | 6.3417 | 0.8505 | 5 | 89 | negative regulation of myeloid cell differentiation |
GO:0016477 | 0.0017 | 2.3511 | 8.3416 | 18 | 916 | cell migration |
GO:0032104 | 0.0017 | 14.3926 | 0.2389 | 3 | 25 | regulation of response to extracellular stimulus |
GO:0001657 | 0.0017 | 6.2667 | 0.86 | 5 | 90 | ureteric bud development |
GO:0050767 | 0.0017 | 3.2582 | 3.2777 | 10 | 343 | regulation of neurogenesis |
GO:0042325 | 0.0018 | 2.1453 | 11.1998 | 22 | 1172 | regulation of phosphorylation |
GO:0072163 | 0.0018 | 6.1934 | 0.8696 | 5 | 91 | mesonephric epithelium development |
GO:0021796 | 0.0018 | 41.9869 | 0.0669 | 2 | 7 | cerebral cortex regionalization |
GO:0032808 | 0.0018 | 41.9869 | 0.0669 | 2 | 7 | lacrimal gland development |
GO:0035726 | 0.0018 | 41.9869 | 0.0669 | 2 | 7 | common myeloid progenitor cell proliferation |
GO:0048752 | 0.0018 | 41.9869 | 0.0669 | 2 | 7 | semicircular canal morphogenesis |
GO:2000726 | 0.0018 | 41.9869 | 0.0669 | 2 | 7 | negative regulation of cardiac muscle cell differentiation |
GO:1902624 | 0.0019 | 13.766 | 0.2485 | 3 | 26 | positive regulation of neutrophil migration |
GO:0098754 | 0.002 | 4.936 | 1.2996 | 6 | 136 | detoxification |
GO:0042744 | 0.0021 | 13.1916 | 0.258 | 3 | 27 | hydrogen peroxide catabolic process |
GO:0072359 | 0.0021 | 2.1467 | 10.6455 | 21 | 1114 | circulatory system development |
GO:0008015 | 0.0022 | 2.809 | 4.5678 | 12 | 478 | blood circulation |
GO:0003015 | 0.0022 | 3.7141 | 2.2935 | 8 | 240 | heart process |
GO:0051961 | 0.0022 | 4.8237 | 1.3283 | 6 | 139 | negative regulation of nervous system development |
GO:0072006 | 0.0022 | 4.8237 | 1.3283 | 6 | 139 | nephron development |
GO:0019233 | 0.0023 | 5.8513 | 0.9174 | 5 | 96 | sensory perception of pain |
GO:0051216 | 0.0023 | 4.1276 | 1.8061 | 7 | 189 | cartilage development |
GO:0048147 | 0.0024 | 12.6632 | 0.2676 | 3 | 28 | negative regulation of fibroblast proliferation |
GO:0006954 | 0.0024 | 2.3805 | 7.234 | 16 | 757 | inflammatory response |
GO:0048519 | 0.0025 | 1.7105 | 34.9185 | 50 | 4086 | negative regulation of biological process |
GO:0065007 | 0.0025 | 1.8368 | 72.4013 | 87 | 8408 | biological regulation |
GO:0040017 | 0.0026 | 2.627 | 5.2941 | 13 | 554 | positive regulation of locomotion |
GO:0072171 | 0.0026 | 7.5728 | 0.5734 | 4 | 60 | mesonephric tubule morphogenesis |
GO:0031069 | 0.0026 | 12.1754 | 0.2771 | 3 | 29 | hair follicle morphogenesis |
GO:1905207 | 0.0026 | 12.1754 | 0.2771 | 3 | 29 | regulation of cardiocyte differentiation |
GO:0055065 | 0.0027 | 2.5156 | 5.963 | 14 | 624 | metal ion homeostasis |
GO:0048754 | 0.0027 | 4.6138 | 1.3856 | 6 | 145 | branching morphogenesis of an epithelial tube |
GO:0008016 | 0.0027 | 3.9944 | 1.8634 | 7 | 195 | regulation of heart contraction |
GO:0055082 | 0.0027 | 2.3505 | 7.32 | 16 | 766 | cellular chemical homeostasis |
GO:0006874 | 0.0028 | 2.8595 | 4.0996 | 11 | 429 | cellular calcium ion homeostasis |
GO:0001501 | 0.0029 | 3.2527 | 2.945 | 9 | 319 | skeletal system development |
GO:0045671 | 0.0029 | 11.7237 | 0.2867 | 3 | 30 | negative regulation of osteoclast differentiation |
GO:0001938 | 0.003 | 5.4873 | 0.9747 | 5 | 102 | positive regulation of endothelial cell proliferation |
GO:0003008 | 0.003 | 1.8353 | 18.7013 | 31 | 1957 | system process |
GO:0048333 | 0.0031 | 11.3791 | 0.2943 | 3 | 31 | mesodermal cell differentiation |
GO:0021520 | 0.0031 | 29.9869 | 0.086 | 2 | 9 | spinal cord motor neuron cell fate specification |
GO:0032353 | 0.0031 | 29.9869 | 0.086 | 2 | 9 | negative regulation of hormone biosynthetic process |
GO:0042355 | 0.0031 | 29.9869 | 0.086 | 2 | 9 | L-fucose catabolic process |
GO:0060054 | 0.0031 | 29.9869 | 0.086 | 2 | 9 | positive regulation of epithelial cell proliferation involved in wound healing |
GO:0060926 | 0.0031 | 29.9869 | 0.086 | 2 | 9 | cardiac pacemaker cell development |
GO:1904238 | 0.0031 | 29.9869 | 0.086 | 2 | 9 | pericyte cell differentiation |
GO:0098801 | 0.0032 | 11.3043 | 0.2962 | 3 | 31 | regulation of renal system process |
GO:1901700 | 0.0032 | 1.9766 | 13.2849 | 24 | 1426 | response to oxygen-containing compound |
GO:0070374 | 0.0036 | 3.7902 | 1.959 | 7 | 205 | positive regulation of ERK1 and ERK2 cascade |
GO:0071466 | 0.0036 | 4.3308 | 1.4716 | 6 | 154 | cellular response to xenobiotic stimulus |
GO:0043408 | 0.0037 | 2.4206 | 6.1828 | 14 | 647 | regulation of MAPK cascade |
GO:0007417 | 0.0037 | 2.3475 | 6.87 | 15 | 764 | central nervous system development |
GO:0050801 | 0.0037 | 2.3413 | 6.8613 | 15 | 718 | ion homeostasis |
GO:0006928 | 0.0038 | 1.9519 | 13.4887 | 24 | 1478 | movement of cell or subcellular component |
GO:0003211 | 0.0039 | 26.2369 | 0.0956 | 2 | 10 | cardiac ventricle formation |
GO:0071600 | 0.0039 | 26.2369 | 0.0956 | 2 | 10 | otic vesicle morphogenesis |
GO:0072593 | 0.004 | 3.7142 | 1.9972 | 7 | 209 | reactive oxygen species metabolic process |
GO:0030335 | 0.0041 | 2.5856 | 4.9405 | 12 | 517 | positive regulation of cell migration |
GO:0050920 | 0.0041 | 3.6957 | 2.0068 | 7 | 210 | regulation of chemotaxis |
GO:0045777 | 0.0041 | 10.2084 | 0.3249 | 3 | 34 | positive regulation of blood pressure |
GO:0035295 | 0.0043 | 2.1326 | 9.0948 | 18 | 972 | tube development |
GO:0030855 | 0.0043 | 2.4636 | 5.6293 | 13 | 599 | epithelial cell differentiation |
GO:0072088 | 0.0045 | 6.4214 | 0.6689 | 4 | 70 | nephron epithelium morphogenesis |
GO:0009617 | 0.0046 | 2.4442 | 5.6668 | 13 | 593 | response to bacterium |
GO:0021543 | 0.0047 | 4.1066 | 1.5481 | 6 | 162 | pallium development |
GO:0030900 | 0.0047 | 3.0064 | 3.1719 | 9 | 338 | forebrain development |
GO:0010454 | 0.0047 | 23.3203 | 0.1051 | 2 | 11 | negative regulation of cell fate commitment |
GO:0032099 | 0.0047 | 23.3203 | 0.1051 | 2 | 11 | negative regulation of appetite |
GO:0032108 | 0.0047 | 23.3203 | 0.1051 | 2 | 11 | negative regulation of response to nutrient levels |
GO:0051133 | 0.0047 | 23.3203 | 0.1051 | 2 | 11 | regulation of NK T cell activation |
GO:1903238 | 0.0047 | 23.3203 | 0.1051 | 2 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0032944 | 0.0048 | 3.5883 | 2.0641 | 7 | 216 | regulation of mononuclear cell proliferation |
GO:0010092 | 0.0049 | 9.5885 | 0.344 | 3 | 36 | specification of animal organ identity |
GO:0071542 | 0.0049 | 9.5885 | 0.344 | 3 | 36 | dopaminergic neuron differentiation |
GO:0061333 | 0.005 | 6.2318 | 0.688 | 4 | 72 | renal tubule morphogenesis |
GO:0045596 | 0.0051 | 2.9691 | 3.2168 | 9 | 364 | negative regulation of cell differentiation |
GO:0042886 | 0.0051 | 3.2078 | 2.6375 | 8 | 276 | amide transport |
GO:0040007 | 0.0051 | 2.1386 | 8.524 | 17 | 892 | growth |
GO:0048771 | 0.0052 | 4.0029 | 1.5863 | 6 | 166 | tissue remodeling |
GO:0007501 | 0.0056 | 20.9869 | 0.1147 | 2 | 12 | mesodermal cell fate specification |
GO:0010273 | 0.0056 | 20.9869 | 0.1147 | 2 | 12 | detoxification of copper ion |
GO:0042659 | 0.0056 | 20.9869 | 0.1147 | 2 | 12 | regulation of cell fate specification |
GO:0060019 | 0.0056 | 20.9869 | 0.1147 | 2 | 12 | radial glial cell differentiation |
GO:0032941 | 0.0057 | 9.0395 | 0.3631 | 3 | 38 | secretion by tissue |
GO:0021510 | 0.0057 | 5.997 | 0.7131 | 4 | 76 | spinal cord development |
GO:0032355 | 0.0057 | 4.664 | 1.1372 | 5 | 119 | response to estradiol |
GO:0031175 | 0.0058 | 2.1105 | 8.6292 | 17 | 903 | neuron projection development |
GO:1903506 | 0.006 | 2.2386 | 7.2899 | 15 | 898 | regulation of nucleic acid-templated transcription |
GO:0032570 | 0.0061 | 8.7878 | 0.3727 | 3 | 39 | response to progesterone |
GO:0042554 | 0.0061 | 8.7878 | 0.3727 | 3 | 39 | superoxide anion generation |
GO:0090304 | 0.0063 | 1.5412 | 46.07 | 61 | 4821 | nucleic acid metabolic process |
GO:0030003 | 0.0063 | 2.3434 | 5.8961 | 13 | 617 | cellular cation homeostasis |
GO:0007422 | 0.0063 | 5.8031 | 0.7358 | 4 | 77 | peripheral nervous system development |
GO:0008306 | 0.0063 | 5.8031 | 0.7358 | 4 | 77 | associative learning |
GO:0051174 | 0.0064 | 1.9058 | 12.4707 | 22 | 1305 | regulation of phosphorus metabolic process |
GO:0046427 | 0.0065 | 8.5498 | 0.3822 | 3 | 40 | positive regulation of receptor signaling pathway via JAK-STAT |
GO:0002864 | 0.0066 | 19.0778 | 0.1242 | 2 | 13 | regulation of acute inflammatory response to antigenic stimulus |
GO:0015671 | 0.0066 | 19.0778 | 0.1242 | 2 | 13 | oxygen transport |
GO:0032341 | 0.0066 | 19.0778 | 0.1242 | 2 | 13 | aldosterone metabolic process |
GO:0033605 | 0.0066 | 19.0778 | 0.1242 | 2 | 13 | positive regulation of catecholamine secretion |
GO:0035815 | 0.0066 | 19.0778 | 0.1242 | 2 | 13 | positive regulation of renal sodium excretion |
GO:0048935 | 0.0066 | 19.0778 | 0.1242 | 2 | 13 | peripheral nervous system neuron development |
GO:0050930 | 0.0066 | 19.0778 | 0.1242 | 2 | 13 | induction of positive chemotaxis |
GO:1902931 | 0.0066 | 19.0778 | 0.1242 | 2 | 13 | negative regulation of alcohol biosynthetic process |
GO:0051272 | 0.0067 | 2.4172 | 5.2654 | 12 | 551 | positive regulation of cellular component movement |
GO:0071396 | 0.0067 | 2.4172 | 5.2654 | 12 | 551 | cellular response to lipid |
GO:0007166 | 0.0067 | 1.6675 | 23.9189 | 36 | 2503 | cell surface receptor signaling pathway |
GO:0065009 | 0.0069 | 1.6302 | 27.3782 | 40 | 2865 | regulation of molecular function |
GO:0003231 | 0.007 | 4.4292 | 1.1945 | 5 | 125 | cardiac ventricle development |
GO:0014014 | 0.007 | 8.3243 | 0.3918 | 3 | 41 | negative regulation of gliogenesis |
GO:0044058 | 0.007 | 8.3243 | 0.3918 | 3 | 41 | regulation of digestive system process |
GO:0003151 | 0.0072 | 5.573 | 0.7645 | 4 | 80 | outflow tract morphogenesis |
GO:0043407 | 0.0077 | 8.006 | 0.406 | 3 | 43 | negative regulation of MAP kinase activity |
GO:0048534 | 0.0079 | 2.0863 | 8.18 | 16 | 856 | hematopoietic or lymphoid organ development |
GO:0035050 | 0.0079 | 5.4294 | 0.7836 | 4 | 82 | embryonic heart tube development |
GO:0070661 | 0.008 | 2.9604 | 2.8477 | 8 | 298 | leukocyte proliferation |
GO:0045933 | 0.008 | 7.9071 | 0.4109 | 3 | 43 | positive regulation of muscle contraction |
GO:0050671 | 0.0085 | 4.2167 | 1.2518 | 5 | 131 | positive regulation of lymphocyte proliferation |
GO:0045776 | 0.0085 | 7.7137 | 0.4205 | 3 | 44 | negative regulation of blood pressure |
GO:0007204 | 0.0086 | 2.9193 | 2.8859 | 8 | 302 | positive regulation of cytosolic calcium ion concentration |
GO:0072001 | 0.0086 | 2.9193 | 2.8859 | 8 | 302 | renal system development |
GO:0031644 | 0.0087 | 4.1832 | 1.2614 | 5 | 132 | regulation of nervous system process |
GO:0003214 | 0.0088 | 16.1408 | 0.1433 | 2 | 15 | cardiac left ventricle morphogenesis |
GO:0019896 | 0.0088 | 16.1408 | 0.1433 | 2 | 15 | axonal transport of mitochondrion |
GO:0043508 | 0.0088 | 16.1408 | 0.1433 | 2 | 15 | negative regulation of JUN kinase activity |
GO:0097501 | 0.0088 | 16.1408 | 0.1433 | 2 | 15 | stress response to metal ion |
GO:0042592 | 0.0089 | 1.7608 | 16.016 | 26 | 1676 | homeostatic process |
GO:0001656 | 0.0093 | 5.1633 | 0.8218 | 4 | 86 | metanephros development |
GO:0042475 | 0.0093 | 5.1633 | 0.8218 | 4 | 86 | odontogenesis of dentin-containing tooth |
GO:0072080 | 0.0093 | 5.1633 | 0.8218 | 4 | 86 | nephron tubule development |
GO:0051239 | 0.0095 | 2.1653 | 6.948 | 14 | 818 | regulation of multicellular organismal process |
GO:0003106 | 0.0096 | Inf | 0.0096 | 1 | 1 | negative regulation of glomerular filtration by angiotensin |
GO:0003144 | 0.0096 | Inf | 0.0096 | 1 | 1 | embryonic heart tube formation |
GO:0003168 | 0.0096 | Inf | 0.0096 | 1 | 1 | Purkinje myocyte differentiation |
GO:0010189 | 0.0096 | Inf | 0.0096 | 1 | 1 | vitamin E biosynthetic process |
GO:0010509 | 0.0096 | Inf | 0.0096 | 1 | 1 | polyamine homeostasis |
GO:0018964 | 0.0096 | Inf | 0.0096 | 1 | 1 | propylene metabolic process |
GO:0021767 | 0.0096 | Inf | 0.0096 | 1 | 1 | mammillary body development |
GO:0030221 | 0.0096 | Inf | 0.0096 | 1 | 1 | basophil differentiation |
GO:0034231 | 0.0096 | Inf | 0.0096 | 1 | 1 | islet amyloid polypeptide processing |
GO:0035645 | 0.0096 | Inf | 0.0096 | 1 | 1 | enteric smooth muscle cell differentiation |
GO:0035732 | 0.0096 | Inf | 0.0096 | 1 | 1 | nitric oxide storage |
GO:0042666 | 0.0096 | Inf | 0.0096 | 1 | 1 | negative regulation of ectodermal cell fate specification |
GO:0042668 | 0.0096 | Inf | 0.0096 | 1 | 1 | auditory receptor cell fate determination |
GO:0045609 | 0.0096 | Inf | 0.0096 | 1 | 1 | positive regulation of inner ear auditory receptor cell differentiation |
GO:0045633 | 0.0096 | Inf | 0.0096 | 1 | 1 | positive regulation of mechanoreceptor differentiation |
GO:0050677 | 0.0096 | Inf | 0.0096 | 1 | 1 | positive regulation of urothelial cell proliferation |
GO:0050783 | 0.0096 | Inf | 0.0096 | 1 | 1 | cocaine metabolic process |
GO:0051042 | 0.0096 | Inf | 0.0096 | 1 | 1 | negative regulation of calcium-independent cell-cell adhesion |
GO:0051355 | 0.0096 | Inf | 0.0096 | 1 | 1 | proprioception involved in equilibrioception |
GO:0060101 | 0.0096 | Inf | 0.0096 | 1 | 1 | negative regulation of phagocytosis, engulfment |
GO:0060217 | 0.0096 | Inf | 0.0096 | 1 | 1 | hemangioblast cell differentiation |
GO:0060436 | 0.0096 | Inf | 0.0096 | 1 | 1 | bronchiole morphogenesis |
GO:0060450 | 0.0096 | Inf | 0.0096 | 1 | 1 | positive regulation of hindgut contraction |
GO:0060496 | 0.0096 | Inf | 0.0096 | 1 | 1 | mesenchymal-epithelial cell signaling involved in lung development |
GO:0060804 | 0.0096 | Inf | 0.0096 | 1 | 1 | positive regulation of Wnt signaling pathway by BMP signaling pathway |
GO:0060879 | 0.0096 | Inf | 0.0096 | 1 | 1 | semicircular canal fusion |
GO:0061115 | 0.0096 | Inf | 0.0096 | 1 | 1 | lung proximal/distal axis specification |
GO:0061185 | 0.0096 | Inf | 0.0096 | 1 | 1 | negative regulation of dermatome development |
GO:0061374 | 0.0096 | Inf | 0.0096 | 1 | 1 | mammillothalamic axonal tract development |
GO:0061381 | 0.0096 | Inf | 0.0096 | 1 | 1 | cell migration in diencephalon |
GO:0071338 | 0.0096 | Inf | 0.0096 | 1 | 1 | positive regulation of hair follicle cell proliferation |
GO:0072168 | 0.0096 | Inf | 0.0096 | 1 | 1 | specification of anterior mesonephric tubule identity |
GO:0072169 | 0.0096 | Inf | 0.0096 | 1 | 1 | specification of posterior mesonephric tubule identity |
GO:0072184 | 0.0096 | Inf | 0.0096 | 1 | 1 | renal vesicle progenitor cell differentiation |
GO:0072259 | 0.0096 | Inf | 0.0096 | 1 | 1 | metanephric interstitial fibroblast development |
GO:1901625 | 0.0096 | Inf | 0.0096 | 1 | 1 | cellular response to ergosterol |
GO:1902569 | 0.0096 | Inf | 0.0096 | 1 | 1 | negative regulation of activation of Janus kinase activity |
GO:1905025 | 0.0096 | Inf | 0.0096 | 1 | 1 | negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential |
GO:0035176 | 0.0096 | 7.354 | 0.4396 | 3 | 46 | social behavior |
GO:0035850 | 0.0096 | 7.354 | 0.4396 | 3 | 46 | epithelial cell differentiation involved in kidney development |
GO:0071622 | 0.0096 | 7.354 | 0.4396 | 3 | 46 | regulation of granulocyte chemotaxis |
GO:0010556 | 0.0096 | 2.1174 | 7.7128 | 15 | 994 | regulation of macromolecule biosynthetic process |
GO:2000145 | 0.0097 | 1.9912 | 9.107 | 17 | 953 | regulation of cell motility |
GO:0051046 | 0.0097 | 2.2937 | 5.533 | 12 | 579 | regulation of secretion |
GO:0006004 | 0.01 | 14.9869 | 0.1529 | 2 | 16 | fucose metabolic process |
GO:0030002 | 0.01 | 14.9869 | 0.1529 | 2 | 16 | cellular anion homeostasis |
GO:0030949 | 0.01 | 14.9869 | 0.1529 | 2 | 16 | positive regulation of vascular endothelial growth factor receptor signaling pathway |
GO:0045779 | 0.01 | 14.9869 | 0.1529 | 2 | 16 | negative regulation of bone resorption |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 322.9329 | 0.3413 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 50.3546 | 1.1092 | 32 | 104 | nucleosome assembly |
GO:0071824 | 0 | 21.1344 | 2.2398 | 33 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 18.306 | 2.5278 | 33 | 237 | chromatin remodeling |
GO:0045653 | 0 | 353.1478 | 0.192 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0032200 | 0 | 19.4204 | 1.6639 | 24 | 156 | telomere organization |
GO:0006336 | 0 | 78.4088 | 0.3413 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0006352 | 0 | 12.7569 | 1.3226 | 14 | 124 | DNA-templated transcription, initiation |
GO:0045637 | 0 | 8.2299 | 2.1118 | 15 | 198 | regulation of myeloid cell differentiation |
GO:0065003 | 0 | 3.2323 | 14.9962 | 40 | 1406 | protein-containing complex assembly |
GO:0040029 | 0 | 8.8633 | 1.4186 | 11 | 133 | regulation of gene expression, epigenetic |
GO:0002227 | 0 | 28.0637 | 0.2346 | 5 | 22 | innate immune response in mucosa |
GO:0045596 | 0 | 3.5083 | 6.7088 | 21 | 629 | negative regulation of cell differentiation |
GO:0019731 | 0 | 13.0672 | 0.5333 | 6 | 50 | antibacterial humoral response |
GO:0002251 | 0 | 17.027 | 0.352 | 5 | 33 | organ or tissue specific immune response |
GO:2000026 | 3e-04 | 2.2526 | 13.8123 | 28 | 1295 | regulation of multicellular organismal development |
GO:0002520 | 3e-04 | 2.4754 | 9.7486 | 22 | 914 | immune system development |
GO:0044085 | 6e-04 | 1.7952 | 31.4002 | 49 | 2944 | cellular component biogenesis |
GO:0072268 | 7e-04 | 93.8304 | 0.0427 | 2 | 4 | pattern specification involved in metanephros development |
GO:0007186 | 7e-04 | 2.3102 | 10.3885 | 22 | 974 | G protein-coupled receptor signaling pathway |
GO:0061844 | 0.001 | 7.2064 | 0.7573 | 5 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0021869 | 0.0011 | 62.5497 | 0.0533 | 2 | 5 | forebrain ventricular zone progenitor cell division |
GO:0072081 | 0.0011 | 62.5497 | 0.0533 | 2 | 5 | specification of nephron tubule identity |
GO:0048869 | 0.0011 | 1.6764 | 41.8101 | 60 | 3920 | cellular developmental process |
GO:0030097 | 0.0011 | 2.3607 | 8.7033 | 19 | 816 | hemopoiesis |
GO:0097659 | 0.0012 | 1.7197 | 34.0134 | 51 | 3189 | nucleic acid-templated transcription |
GO:0007406 | 0.0016 | 46.9094 | 0.064 | 2 | 6 | negative regulation of neuroblast proliferation |
GO:0048513 | 0.002 | 1.6704 | 34.8027 | 51 | 3263 | animal organ development |
GO:0050789 | 0.0021 | 1.6582 | 113.1433 | 131 | 10608 | regulation of biological process |
GO:0050911 | 0.0022 | 3.7101 | 2.2932 | 8 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050830 | 0.0025 | 5.7243 | 0.9386 | 5 | 88 | defense response to Gram-positive bacterium |
GO:0009593 | 0.0037 | 3.1128 | 3.0611 | 9 | 287 | detection of chemical stimulus |
GO:0072048 | 0.0039 | 26.8003 | 0.096 | 2 | 9 | renal system pattern specification |
GO:0007606 | 0.0047 | 3.0029 | 3.1678 | 9 | 297 | sensory perception of chemical stimulus |
GO:0032501 | 0.0047 | 1.5053 | 71.6531 | 89 | 6718 | multicellular organismal process |
GO:0072070 | 0.0048 | 23.4488 | 0.1067 | 2 | 10 | loop of Henle development |
GO:0009954 | 0.0056 | 9.1173 | 0.3626 | 3 | 34 | proximal/distal pattern formation |
GO:0010455 | 0.0058 | 20.8421 | 0.1173 | 2 | 11 | positive regulation of cell fate commitment |
GO:0072017 | 0.0058 | 20.8421 | 0.1173 | 2 | 11 | distal tubule development |
GO:0050906 | 0.0065 | 2.8419 | 3.3384 | 9 | 313 | detection of stimulus involved in sensory perception |
GO:0002024 | 0.007 | 18.7567 | 0.128 | 2 | 12 | diet induced thermogenesis |
GO:0006959 | 0.0079 | 3.2427 | 2.2718 | 7 | 213 | humoral immune response |
GO:0009071 | 0.0082 | 17.0505 | 0.1387 | 2 | 13 | serine family amino acid catabolic process |
GO:0072210 | 0.0082 | 7.8485 | 0.416 | 3 | 39 | metanephric nephron development |
GO:0014003 | 0.0088 | 7.6359 | 0.4266 | 3 | 40 | oligodendrocyte development |
GO:0001935 | 0.0098 | 3.4796 | 1.8132 | 6 | 170 | endothelial cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 298.6398 | 0.365 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 46.3704 | 1.1862 | 32 | 104 | nucleosome assembly |
GO:0071824 | 0 | 18.632 | 2.3952 | 32 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 16.1505 | 2.7031 | 32 | 237 | chromatin remodeling |
GO:0045653 | 0 | 328.1199 | 0.2053 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0032200 | 0 | 17.9593 | 1.7793 | 24 | 156 | telomere organization |
GO:0006336 | 0 | 72.8519 | 0.365 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0045596 | 0 | 5.1964 | 7.1742 | 31 | 629 | negative regulation of cell differentiation |
GO:0045637 | 0 | 9.494 | 2.2583 | 18 | 198 | regulation of myeloid cell differentiation |
GO:0006352 | 0 | 11.8527 | 1.4143 | 14 | 124 | DNA-templated transcription, initiation |
GO:0032501 | 0 | 2.4752 | 64.0651 | 100 | 6153 | multicellular organismal process |
GO:0065007 | 0 | 2.972 | 128.5761 | 161 | 11273 | biological regulation |
GO:1903238 | 0 | 74.2083 | 0.1255 | 5 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0019731 | 0 | 17.2107 | 0.5703 | 8 | 50 | antibacterial humoral response |
GO:0002682 | 0 | 2.8135 | 14.4054 | 35 | 1263 | regulation of immune system process |
GO:0048665 | 0 | 22.3617 | 0.3422 | 6 | 30 | neuron fate specification |
GO:2000026 | 0 | 2.7361 | 14.7703 | 35 | 1295 | regulation of multicellular organismal development |
GO:0061844 | 0 | 11.4587 | 0.8098 | 8 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0030097 | 0 | 3.1556 | 9.307 | 26 | 816 | hemopoiesis |
GO:0040029 | 0 | 7.3923 | 1.517 | 10 | 133 | regulation of gene expression, epigenetic |
GO:0002227 | 0 | 26.1732 | 0.2509 | 5 | 22 | innate immune response in mucosa |
GO:0002520 | 0 | 2.9184 | 10.4248 | 27 | 914 | immune system development |
GO:0018130 | 0 | 2.0359 | 41.3912 | 68 | 3629 | heterocycle biosynthetic process |
GO:0019438 | 0 | 2.0278 | 41.5166 | 68 | 3640 | aromatic compound biosynthetic process |
GO:0050911 | 0 | 5.4097 | 2.4522 | 12 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050877 | 0 | 2.6162 | 13.9035 | 32 | 1219 | nervous system process |
GO:0007389 | 0 | 3.6899 | 5.0755 | 17 | 445 | pattern specification process |
GO:0050794 | 0 | 2.13 | 87.8645 | 113 | 8461 | regulation of cellular process |
GO:0007218 | 0 | 7.919 | 1.1292 | 8 | 99 | neuropeptide signaling pathway |
GO:0048869 | 0 | 1.99 | 39.6813 | 64 | 3661 | cellular developmental process |
GO:0065003 | 0 | 2.4064 | 16.0364 | 34 | 1406 | protein-containing complex assembly |
GO:0006357 | 0 | 2.1072 | 26.6208 | 48 | 2334 | regulation of transcription by RNA polymerase II |
GO:1901362 | 0 | 1.9294 | 43.1134 | 68 | 3780 | organic cyclic compound biosynthetic process |
GO:0002251 | 0 | 15.88 | 0.3764 | 5 | 33 | organ or tissue specific immune response |
GO:1904994 | 0 | 15.88 | 0.3764 | 5 | 33 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0048704 | 0 | 8.4589 | 0.9258 | 7 | 82 | embryonic skeletal system morphogenesis |
GO:0002691 | 0 | 14.8194 | 0.3992 | 5 | 35 | regulation of cellular extravasation |
GO:0048598 | 0 | 3.0942 | 6.7408 | 19 | 591 | embryonic morphogenesis |
GO:0048513 | 1e-04 | 2.2475 | 17.4313 | 34 | 1666 | animal organ development |
GO:0006351 | 1e-04 | 1.9272 | 32.5406 | 53 | 3063 | transcription, DNA-templated |
GO:0009593 | 1e-04 | 3.9752 | 3.2734 | 12 | 287 | detection of chemical stimulus |
GO:1905652 | 1e-04 | Inf | 0.0228 | 2 | 2 | negative regulation of artery morphogenesis |
GO:0032774 | 1e-04 | 1.9131 | 32.7318 | 53 | 3081 | RNA biosynthetic process |
GO:0048568 | 2e-04 | 3.2487 | 5.0071 | 15 | 439 | embryonic organ development |
GO:0007606 | 2e-04 | 3.8333 | 3.3875 | 12 | 297 | sensory perception of chemical stimulus |
GO:0044271 | 2e-04 | 1.755 | 48.7136 | 71 | 4271 | cellular nitrogen compound biosynthetic process |
GO:0050906 | 3e-04 | 3.6258 | 3.57 | 12 | 313 | detection of stimulus involved in sensory perception |
GO:0007628 | 4e-04 | 13.6073 | 0.3422 | 4 | 30 | adult walking behavior |
GO:0007631 | 4e-04 | 8.9847 | 0.6197 | 5 | 56 | feeding behavior |
GO:0001661 | 4e-04 | 175.235 | 0.0342 | 2 | 3 | conditioned taste aversion |
GO:0007412 | 4e-04 | 175.235 | 0.0342 | 2 | 3 | axon target recognition |
GO:0072190 | 4e-04 | 175.235 | 0.0342 | 2 | 3 | ureter urothelium development |
GO:0007186 | 4e-04 | 2.529 | 8.6235 | 20 | 795 | G protein-coupled receptor signaling pathway |
GO:0072507 | 5e-04 | 2.9221 | 5.5318 | 15 | 485 | divalent inorganic cation homeostasis |
GO:0042127 | 5e-04 | 2.0289 | 18.0552 | 33 | 1583 | regulation of cell population proliferation |
GO:0042471 | 5e-04 | 5.4922 | 1.3801 | 7 | 121 | ear morphogenesis |
GO:0072171 | 6e-04 | 8.0707 | 0.6843 | 5 | 60 | mesonephric tubule morphogenesis |
GO:0032095 | 7e-04 | 20.3153 | 0.1825 | 3 | 16 | regulation of response to food |
GO:0097022 | 8e-04 | 87.612 | 0.0456 | 2 | 4 | lymphocyte migration into lymph node |
GO:1903506 | 9e-04 | 1.729 | 35.0724 | 53 | 3075 | regulation of nucleic acid-templated transcription |
GO:0045165 | 0.0011 | 3.7676 | 2.5521 | 9 | 227 | cell fate commitment |
GO:0001938 | 0.0011 | 5.5653 | 1.1634 | 6 | 102 | positive regulation of endothelial cell proliferation |
GO:0072088 | 0.0012 | 6.8248 | 0.7984 | 5 | 70 | nephron epithelium morphogenesis |
GO:0055082 | 0.0012 | 2.3425 | 8.7367 | 19 | 766 | cellular chemical homeostasis |
GO:0048519 | 0.0012 | 1.6014 | 58.1005 | 78 | 5094 | negative regulation of biological process |
GO:0014016 | 0.0013 | 58.4044 | 0.057 | 2 | 5 | neuroblast differentiation |
GO:1905700 | 0.0013 | 58.4044 | 0.057 | 2 | 5 | negative regulation of xenobiotic detoxification by transmembrane export across the plasma membrane |
GO:0006874 | 0.0013 | 2.8378 | 4.893 | 13 | 429 | cellular calcium ion homeostasis |
GO:0061333 | 0.0014 | 6.6202 | 0.8212 | 5 | 72 | renal tubule morphogenesis |
GO:0019222 | 0.0015 | 1.573 | 71.6618 | 92 | 6283 | regulation of metabolic process |
GO:0033993 | 0.0015 | 2.2462 | 9.5922 | 20 | 841 | response to lipid |
GO:0009058 | 0.0015 | 1.583 | 60.336 | 80 | 5290 | biosynthetic process |
GO:0022008 | 0.0016 | 2.022 | 14.0351 | 26 | 1278 | neurogenesis |
GO:0042063 | 0.0016 | 3.2748 | 3.2506 | 10 | 285 | gliogenesis |
GO:0031326 | 0.0016 | 1.6339 | 42.2124 | 60 | 3701 | regulation of cellular biosynthetic process |
GO:0030182 | 0.0017 | 2.0409 | 13.3201 | 25 | 1200 | neuron differentiation |
GO:0090304 | 0.0017 | 1.5853 | 54.9867 | 74 | 4821 | nucleic acid metabolic process |
GO:0002361 | 0.0019 | 43.8005 | 0.0684 | 2 | 6 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0060017 | 0.0019 | 43.8005 | 0.0684 | 2 | 6 | parathyroid gland development |
GO:2000252 | 0.0019 | 43.8005 | 0.0684 | 2 | 6 | negative regulation of feeding behavior |
GO:2001023 | 0.0019 | 43.8005 | 0.0684 | 2 | 6 | regulation of response to drug |
GO:0030003 | 0.0019 | 2.4313 | 7.0373 | 16 | 617 | cellular cation homeostasis |
GO:0048708 | 0.002 | 6.0738 | 0.8896 | 5 | 78 | astrocyte differentiation |
GO:0010468 | 0.002 | 1.6033 | 48.1693 | 66 | 4428 | regulation of gene expression |
GO:0001501 | 0.0021 | 2.5756 | 5.7941 | 14 | 508 | skeletal system development |
GO:0055065 | 0.0021 | 2.4022 | 7.1171 | 16 | 624 | metal ion homeostasis |
GO:0021871 | 0.0022 | 13.1992 | 0.2623 | 3 | 23 | forebrain regionalization |
GO:0009952 | 0.0023 | 3.6906 | 2.3039 | 8 | 202 | anterior/posterior pattern specification |
GO:0060563 | 0.0025 | 12.5699 | 0.2737 | 3 | 24 | neuroepithelial cell differentiation |
GO:0019933 | 0.0025 | 7.6815 | 0.5703 | 4 | 50 | cAMP-mediated signaling |
GO:0009887 | 0.0025 | 2.1438 | 10.0298 | 20 | 898 | animal organ morphogenesis |
GO:0061448 | 0.0025 | 3.3094 | 2.8856 | 9 | 253 | connective tissue development |
GO:0021543 | 0.0026 | 4.029 | 1.8477 | 7 | 162 | pallium development |
GO:0021796 | 0.0026 | 35.0383 | 0.0798 | 2 | 7 | cerebral cortex regionalization |
GO:0021902 | 0.0026 | 35.0383 | 0.0798 | 2 | 7 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0060534 | 0.0026 | 35.0383 | 0.0798 | 2 | 7 | trachea cartilage development |
GO:2000726 | 0.0026 | 35.0383 | 0.0798 | 2 | 7 | negative regulation of cardiac muscle cell differentiation |
GO:0032104 | 0.0028 | 11.9978 | 0.2851 | 3 | 25 | regulation of response to extracellular stimulus |
GO:1903671 | 0.0028 | 11.9978 | 0.2851 | 3 | 25 | negative regulation of sprouting angiogenesis |
GO:0010467 | 0.0028 | 2.1334 | 11.0599 | 21 | 1183 | gene expression |
GO:0007420 | 0.003 | 2.2572 | 8.041 | 17 | 705 | brain development |
GO:0072080 | 0.003 | 5.4712 | 0.9809 | 5 | 86 | nephron tubule development |
GO:0001658 | 0.0031 | 7.2098 | 0.6045 | 4 | 53 | branching involved in ureteric bud morphogenesis |
GO:0045666 | 0.0032 | 5.4041 | 0.9923 | 5 | 87 | positive regulation of neuron differentiation |
GO:0050830 | 0.0033 | 5.3387 | 1.0037 | 5 | 88 | defense response to Gram-positive bacterium |
GO:0060993 | 0.0033 | 5.3387 | 1.0037 | 5 | 88 | kidney morphogenesis |
GO:1903532 | 0.0034 | 3.1519 | 3.0225 | 9 | 265 | positive regulation of secretion by cell |
GO:0001657 | 0.0037 | 5.2124 | 1.0265 | 5 | 90 | ureteric bud development |
GO:0045761 | 0.0038 | 6.7926 | 0.6387 | 4 | 56 | regulation of adenylate cyclase activity |
GO:0001659 | 0.0039 | 3.7367 | 1.9846 | 7 | 174 | temperature homeostasis |
GO:0072163 | 0.0039 | 5.1515 | 1.0379 | 5 | 91 | mesonephric epithelium development |
GO:0030534 | 0.0041 | 4.2322 | 1.5055 | 6 | 132 | adult behavior |
GO:0032353 | 0.0044 | 25.0242 | 0.1027 | 2 | 9 | negative regulation of hormone biosynthetic process |
GO:0035360 | 0.0044 | 25.0242 | 0.1027 | 2 | 9 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
GO:0042355 | 0.0044 | 25.0242 | 0.1027 | 2 | 9 | L-fucose catabolic process |
GO:0060872 | 0.0044 | 25.0242 | 0.1027 | 2 | 9 | semicircular canal development |
GO:0050679 | 0.0045 | 4.9497 | 1.0772 | 5 | 97 | positive regulation of epithelial cell proliferation |
GO:0007200 | 0.0046 | 4.9213 | 1.0835 | 5 | 95 | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO:0061036 | 0.0047 | 9.7729 | 0.3422 | 3 | 30 | positive regulation of cartilage development |
GO:0021510 | 0.0048 | 4.8669 | 1.0949 | 5 | 96 | spinal cord development |
GO:0120162 | 0.0048 | 4.8669 | 1.0949 | 5 | 96 | positive regulation of cold-induced thermogenesis |
GO:0043009 | 0.0049 | 2.2542 | 7.0601 | 15 | 619 | chordate embryonic development |
GO:0035115 | 0.0052 | 9.4233 | 0.3536 | 3 | 31 | embryonic forelimb morphogenesis |
GO:0061351 | 0.0052 | 4.0077 | 1.5854 | 6 | 139 | neural precursor cell proliferation |
GO:0072006 | 0.0052 | 4.0077 | 1.5854 | 6 | 139 | nephron development |
GO:0035107 | 0.0054 | 3.9776 | 1.5968 | 6 | 140 | appendage morphogenesis |
GO:0071600 | 0.0055 | 21.8948 | 0.1141 | 2 | 10 | otic vesicle morphogenesis |
GO:0098917 | 0.0055 | 21.8948 | 0.1141 | 2 | 10 | retrograde trans-synaptic signaling |
GO:0060795 | 0.0057 | 9.0978 | 0.365 | 3 | 32 | cell fate commitment involved in formation of primary germ layer |
GO:0045453 | 0.0058 | 5.9841 | 0.7186 | 4 | 63 | bone resorption |
GO:0051252 | 0.0058 | 1.5507 | 38.2204 | 53 | 3351 | regulation of RNA metabolic process |
GO:0031128 | 0.0062 | 8.794 | 0.3764 | 3 | 33 | developmental induction |
GO:0110110 | 0.0062 | 8.794 | 0.3764 | 3 | 33 | positive regulation of animal organ morphogenesis |
GO:0021761 | 0.0062 | 4.5641 | 1.1634 | 5 | 102 | limbic system development |
GO:0032099 | 0.0067 | 19.4608 | 0.1255 | 2 | 11 | negative regulation of appetite |
GO:0032108 | 0.0067 | 19.4608 | 0.1255 | 2 | 11 | negative regulation of response to nutrient levels |
GO:0060174 | 0.0067 | 19.4608 | 0.1255 | 2 | 11 | limb bud formation |
GO:0060272 | 0.0067 | 19.4608 | 0.1255 | 2 | 11 | embryonic skeletal joint morphogenesis |
GO:0060433 | 0.0067 | 19.4608 | 0.1255 | 2 | 11 | bronchus development |
GO:1902692 | 0.0067 | 8.5097 | 0.3878 | 3 | 34 | regulation of neuroblast proliferation |
GO:1903587 | 0.0067 | 8.5097 | 0.3878 | 3 | 34 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO:0050805 | 0.0068 | 5.6935 | 0.7528 | 4 | 66 | negative regulation of synaptic transmission |
GO:0071300 | 0.0068 | 5.6935 | 0.7528 | 4 | 66 | cellular response to retinoic acid |
GO:0009605 | 0.0071 | 1.6011 | 28.0808 | 41 | 2462 | response to external stimulus |
GO:0045823 | 0.0073 | 8.2433 | 0.3992 | 3 | 35 | positive regulation of heart contraction |
GO:0010557 | 0.0074 | 1.6974 | 19.7432 | 31 | 1731 | positive regulation of macromolecule biosynthetic process |
GO:0050795 | 0.0076 | 5.5148 | 0.7756 | 4 | 68 | regulation of behavior |
GO:0002062 | 0.0076 | 4.3391 | 1.2204 | 5 | 107 | chondrocyte differentiation |
GO:0010092 | 0.0079 | 7.993 | 0.4106 | 3 | 36 | specification of animal organ identity |
GO:0060428 | 0.0079 | 7.993 | 0.4106 | 3 | 36 | lung epithelium development |
GO:0002024 | 0.0079 | 17.5137 | 0.1369 | 2 | 12 | diet induced thermogenesis |
GO:0007501 | 0.0079 | 17.5137 | 0.1369 | 2 | 12 | mesodermal cell fate specification |
GO:0010273 | 0.0079 | 17.5137 | 0.1369 | 2 | 12 | detoxification of copper ion |
GO:0046322 | 0.0079 | 17.5137 | 0.1369 | 2 | 12 | negative regulation of fatty acid oxidation |
GO:0097154 | 0.0079 | 17.5137 | 0.1369 | 2 | 12 | GABAergic neuron differentiation |
GO:0007204 | 0.0079 | 2.7474 | 3.4445 | 9 | 302 | positive regulation of cytosolic calcium ion concentration |
GO:0007611 | 0.0081 | 2.9496 | 2.8514 | 8 | 250 | learning or memory |
GO:0009617 | 0.0081 | 2.1855 | 6.7636 | 14 | 593 | response to bacterium |
GO:0050801 | 0.0082 | 2.0679 | 8.1893 | 16 | 718 | ion homeostasis |
GO:0051954 | 0.0085 | 7.7574 | 0.422 | 3 | 37 | positive regulation of amine transport |
GO:1905562 | 0.0085 | 7.7574 | 0.422 | 3 | 37 | regulation of vascular endothelial cell proliferation |
GO:0048729 | 0.0087 | 2.1661 | 6.8206 | 14 | 598 | tissue morphogenesis |
GO:0051937 | 0.0088 | 5.2669 | 0.8098 | 4 | 71 | catecholamine transport |
GO:0042755 | 0.0092 | 7.5353 | 0.4334 | 3 | 38 | eating behavior |
GO:0002864 | 0.0093 | 15.9205 | 0.1483 | 2 | 13 | regulation of acute inflammatory response to antigenic stimulus |
GO:0032341 | 0.0093 | 15.9205 | 0.1483 | 2 | 13 | aldosterone metabolic process |
GO:1902931 | 0.0093 | 15.9205 | 0.1483 | 2 | 13 | negative regulation of alcohol biosynthetic process |
GO:1901700 | 0.0094 | 1.7068 | 17.6218 | 28 | 1545 | response to oxygen-containing compound |
GO:0021782 | 0.0095 | 4.0965 | 1.2888 | 5 | 113 | glial cell development |
GO:0019730 | 0.0098 | 15.3565 | 0.1519 | 2 | 14 | antimicrobial humoral response |
GO:0021983 | 0.0099 | 7.3255 | 0.4448 | 3 | 39 | pituitary gland development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 373.4651 | 0.3018 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 58.7511 | 0.981 | 32 | 104 | nucleosome assembly |
GO:0071824 | 0 | 24.6879 | 1.9809 | 33 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 21.3839 | 2.2356 | 33 | 237 | chromatin remodeling |
GO:0045653 | 0 | 404.464 | 0.1698 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0032200 | 0 | 23.7595 | 1.4715 | 25 | 156 | telomere organization |
GO:0006336 | 0 | 89.8026 | 0.3018 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0006352 | 0 | 14.6107 | 1.1697 | 14 | 124 | DNA-templated transcription, initiation |
GO:0045637 | 0 | 9.4345 | 1.8677 | 15 | 198 | regulation of myeloid cell differentiation |
GO:0061844 | 0 | 18.3492 | 0.6697 | 10 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0065003 | 0 | 3.4245 | 13.2625 | 37 | 1406 | protein-containing complex assembly |
GO:0006959 | 0 | 8.0312 | 2.0092 | 14 | 213 | humoral immune response |
GO:0050911 | 0 | 7.9503 | 2.0281 | 14 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051606 | 0 | 5.3877 | 4.0655 | 19 | 431 | detection of stimulus |
GO:0040029 | 0 | 10.1244 | 1.2546 | 11 | 133 | regulation of gene expression, epigenetic |
GO:0007186 | 0 | 3.265 | 9.1875 | 26 | 974 | G protein-coupled receptor signaling pathway |
GO:0002227 | 0 | 31.8959 | 0.2075 | 5 | 22 | innate immune response in mucosa |
GO:0050830 | 0 | 11.0255 | 0.8301 | 8 | 88 | defense response to Gram-positive bacterium |
GO:0007600 | 0 | 3.4615 | 6.8576 | 21 | 727 | sensory perception |
GO:0045596 | 0 | 3.5929 | 5.9332 | 19 | 629 | negative regulation of cell differentiation |
GO:0002251 | 0 | 19.3521 | 0.3113 | 5 | 33 | organ or tissue specific immune response |
GO:0019731 | 1e-04 | 12.0285 | 0.4716 | 5 | 50 | antibacterial humoral response |
GO:0030097 | 2e-04 | 2.7166 | 7.6972 | 19 | 816 | hemopoiesis |
GO:0090370 | 3e-04 | 26.7583 | 0.1415 | 3 | 15 | negative regulation of cholesterol efflux |
GO:0002682 | 8e-04 | 2.2266 | 11.9136 | 24 | 1263 | regulation of immune system process |
GO:0014050 | 9e-04 | 70.9227 | 0.0472 | 2 | 5 | negative regulation of glutamate secretion |
GO:0002376 | 9e-04 | 2.8526 | 5.3676 | 14 | 625 | immune system process |
GO:0002520 | 0.001 | 2.4036 | 8.6216 | 19 | 914 | immune system development |
GO:0009617 | 0.0015 | 2.6942 | 5.5936 | 14 | 593 | response to bacterium |
GO:2000535 | 0.0018 | 42.5483 | 0.066 | 2 | 7 | regulation of entry of bacterium into host cell |
GO:0051838 | 0.0024 | 35.4547 | 0.0755 | 2 | 8 | cytolysis by host of symbiont cells |
GO:0003008 | 0.0025 | 1.8656 | 18.46 | 31 | 1957 | system process |
GO:0001580 | 0.0025 | 12.3392 | 0.2736 | 3 | 29 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0060354 | 0.003 | 30.3879 | 0.0849 | 2 | 9 | negative regulation of cell adhesion molecule production |
GO:0050907 | 0.004 | 10.2716 | 0.3213 | 3 | 37 | detection of chemical stimulus involved in sensory perception |
GO:0010455 | 0.0046 | 23.6321 | 0.1038 | 2 | 11 | positive regulation of cell fate commitment |
GO:0044085 | 0.0051 | 1.66 | 27.7702 | 41 | 2944 | cellular component biogenesis |
GO:0098542 | 0.0065 | 2.082 | 8.7442 | 17 | 927 | defense response to other organism |
GO:0035195 | 0.0083 | 2.9396 | 2.8676 | 8 | 304 | miRNA-mediated gene silencing |
GO:0001899 | 0.0094 | Inf | 0.0094 | 1 | 1 | negative regulation of cytolysis by symbiont of host cells |
GO:0001907 | 0.0094 | Inf | 0.0094 | 1 | 1 | killing by symbiont of host cells |
GO:0070159 | 0.0094 | Inf | 0.0094 | 1 | 1 | mitochondrial threonyl-tRNA aminoacylation |
GO:0097601 | 0.0094 | Inf | 0.0094 | 1 | 1 | retina blood vessel maintenance |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 30.4735 | 1.5774 | 31 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051606 | 0 | 15.8227 | 3.1621 | 34 | 431 | detection of stimulus |
GO:0007600 | 0 | 10.4939 | 5.3337 | 38 | 727 | sensory perception |
GO:0007186 | 0 | 6.8167 | 7.079 | 35 | 973 | G protein-coupled receptor signaling pathway |
GO:0003008 | 0 | 4.0406 | 14.3578 | 42 | 1957 | system process |
GO:0042221 | 0 | 2.7281 | 28.7009 | 55 | 3912 | response to chemical |
GO:0035195 | 1e-04 | 4.9326 | 2.2303 | 10 | 304 | miRNA-mediated gene silencing |
GO:0016441 | 1e-04 | 4.7356 | 2.3184 | 10 | 316 | post-transcriptional gene silencing |
GO:0006959 | 2e-04 | 5.5886 | 1.5627 | 8 | 213 | humoral immune response |
GO:0031047 | 2e-04 | 4.4118 | 2.4798 | 10 | 338 | gene silencing by RNA |
GO:0050830 | 5e-04 | 8.4644 | 0.6456 | 5 | 88 | defense response to Gram-positive bacterium |
GO:0007154 | 7e-04 | 1.8356 | 42.5524 | 60 | 5800 | cell communication |
GO:0051707 | 7e-04 | 2.4403 | 9.1781 | 20 | 1251 | response to other organism |
GO:0045087 | 8e-04 | 2.9204 | 5.2604 | 14 | 717 | innate immune response |
GO:0051716 | 9e-04 | 1.8065 | 48.6858 | 66 | 6636 | cellular response to stimulus |
GO:0023052 | 0.001 | 1.7987 | 42.1856 | 59 | 5750 | signaling |
GO:0009607 | 0.0011 | 2.3612 | 9.4569 | 20 | 1289 | response to biotic stimulus |
GO:0050907 | 0.0011 | 16.4875 | 0.2034 | 3 | 37 | detection of chemical stimulus involved in sensory perception |
GO:0001580 | 0.0012 | 15.9897 | 0.2128 | 3 | 29 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0051838 | 0.0015 | 45.8547 | 0.0587 | 2 | 8 | cytolysis by host of symbiont cells |
GO:0061844 | 0.0018 | 8.3239 | 0.5209 | 4 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0006952 | 0.0028 | 2.1201 | 10.9976 | 21 | 1499 | defense response |
GO:0048525 | 0.0037 | 6.7949 | 0.6309 | 4 | 86 | negative regulation of viral process |
GO:0006953 | 0.0041 | 10.1304 | 0.3228 | 3 | 44 | acute-phase response |
GO:0051702 | 0.0042 | 6.5539 | 0.653 | 4 | 89 | biological process involved in interaction with symbiont |
GO:0032308 | 0.0046 | 22.9188 | 0.1027 | 2 | 14 | positive regulation of prostaglandin secretion |
GO:0042742 | 0.006 | 4.6046 | 1.1519 | 5 | 163 | defense response to bacterium |
GO:0002218 | 0.0062 | 8.6492 | 0.3742 | 3 | 51 | activation of innate immune response |
GO:0050909 | 0.0066 | 8.4722 | 0.3815 | 3 | 52 | sensory perception of taste |
GO:0002827 | 0.0068 | 18.3316 | 0.1247 | 2 | 17 | positive regulation of T-helper 1 type immune response |
GO:0032645 | 0.0068 | 18.3316 | 0.1247 | 2 | 17 | regulation of granulocyte macrophage colony-stimulating factor production |
GO:0001899 | 0.0073 | Inf | 0.0073 | 1 | 1 | negative regulation of cytolysis by symbiont of host cells |
GO:0001907 | 0.0073 | Inf | 0.0073 | 1 | 1 | killing by symbiont of host cells |
GO:0019310 | 0.0073 | Inf | 0.0073 | 1 | 1 | inositol catabolic process |
GO:0031583 | 0.0073 | Inf | 0.0073 | 1 | 1 | phospholipase D-activating G protein-coupled receptor signaling pathway |
GO:0032078 | 0.0073 | Inf | 0.0073 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
GO:0032716 | 0.0073 | Inf | 0.0073 | 1 | 1 | negative regulation of interleukin-7 production |
GO:0042313 | 0.0073 | Inf | 0.0073 | 1 | 1 | protein kinase C deactivation |
GO:0043179 | 0.0073 | Inf | 0.0073 | 1 | 1 | rhythmic excitation |
GO:1901646 | 0.0073 | Inf | 0.0073 | 1 | 1 | negative regulation of synoviocyte proliferation |
GO:1902483 | 0.0073 | Inf | 0.0073 | 1 | 1 | cytotoxic T cell pyroptotic process |
GO:1905183 | 0.0073 | Inf | 0.0073 | 1 | 1 | negative regulation of protein serine/threonine phosphatase activity |
GO:0015732 | 0.0084 | 16.173 | 0.1394 | 2 | 19 | prostaglandin transport |
GO:0034105 | 0.0084 | 16.173 | 0.1394 | 2 | 19 | positive regulation of tissue remodeling |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 45.1069 | 1.8822 | 46 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 32.4614 | 2.6001 | 48 | 297 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 32.6485 | 2.5126 | 47 | 287 | detection of chemical stimulus |
GO:0050906 | 0 | 29.4089 | 2.7402 | 47 | 313 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 11.087 | 8.527 | 57 | 974 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 7.3824 | 10.6719 | 52 | 1219 | nervous system process |
GO:0023052 | 1e-04 | 1.9383 | 50.3391 | 73 | 5750 | signaling |
GO:0032501 | 1e-04 | 1.9591 | 56.3798 | 79 | 6645 | multicellular organismal process |
GO:0007154 | 1e-04 | 1.9122 | 50.7768 | 73 | 5800 | cell communication |
GO:0045087 | 1e-04 | 3.0897 | 6.0896 | 17 | 705 | innate immune response |
GO:0048252 | 2e-04 | 229.6714 | 0.0263 | 2 | 3 | lauric acid metabolic process |
GO:0035195 | 3e-04 | 4.0672 | 2.6614 | 10 | 304 | miRNA-mediated gene silencing |
GO:0048245 | 4e-04 | 24.7646 | 0.1488 | 3 | 17 | eosinophil chemotaxis |
GO:0031424 | 4e-04 | 8.5927 | 0.6391 | 5 | 73 | keratinization |
GO:0016441 | 5e-04 | 3.9047 | 2.7665 | 10 | 316 | post-transcriptional gene silencing |
GO:0051716 | 5e-04 | 1.7692 | 58.0957 | 78 | 6636 | cellular response to stimulus |
GO:0051707 | 5e-04 | 2.3373 | 10.952 | 23 | 1251 | response to other organism |
GO:0006959 | 6e-04 | 4.6226 | 1.8647 | 8 | 213 | humoral immune response |
GO:0031047 | 8e-04 | 3.6377 | 2.9591 | 10 | 338 | gene silencing by RNA |
GO:0009607 | 8e-04 | 2.2613 | 11.2847 | 23 | 1289 | response to biotic stimulus |
GO:0006952 | 0.0012 | 2.117 | 13.1232 | 25 | 1499 | defense response |
GO:0048247 | 0.0014 | 9.1088 | 0.4815 | 4 | 55 | lymphocyte chemotaxis |
GO:0042742 | 0.0017 | 3.8904 | 2.1974 | 8 | 251 | defense response to bacterium |
GO:0002548 | 0.0022 | 7.8698 | 0.5515 | 4 | 63 | monocyte chemotaxis |
GO:1990266 | 0.0033 | 5.3469 | 0.998 | 5 | 114 | neutrophil migration |
GO:0061844 | 0.0035 | 6.9267 | 0.6216 | 4 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0001867 | 0.0047 | 22.9543 | 0.1051 | 2 | 12 | complement activation, lectin pathway |
GO:0070098 | 0.0056 | 6.0233 | 0.7091 | 4 | 81 | chemokine-mediated signaling pathway |
GO:0019373 | 0.0074 | 17.6538 | 0.1313 | 2 | 15 | epoxygenase P450 pathway |
GO:1990868 | 0.0077 | 5.4537 | 0.7792 | 4 | 89 | response to chemokine |
GO:0002404 | 0.0088 | Inf | 0.0088 | 1 | 1 | antigen sampling in mucosal-associated lymphoid tissue |
GO:0002412 | 0.0088 | Inf | 0.0088 | 1 | 1 | antigen transcytosis by M cells in mucosal-associated lymphoid tissue |
GO:0007618 | 0.0088 | Inf | 0.0088 | 1 | 1 | mating |
GO:0032078 | 0.0088 | Inf | 0.0088 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
GO:0110119 | 0.0088 | Inf | 0.0088 | 1 | 1 | positive regulation of very-low-density lipoprotein particle clearance |
GO:1902483 | 0.0088 | Inf | 0.0088 | 1 | 1 | cytotoxic T cell pyroptotic process |
GO:1905608 | 0.0088 | Inf | 0.0088 | 1 | 1 | positive regulation of presynapse assembly |
GO:1990256 | 0.0088 | Inf | 0.0088 | 1 | 1 | signal clustering |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 25.7653 | 1.4713 | 26 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 20.6447 | 1.9641 | 28 | 287 | detection of chemical stimulus |
GO:0007606 | 0 | 19.8647 | 2.0325 | 28 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 18.7306 | 2.142 | 28 | 313 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 6.8196 | 6.6655 | 33 | 974 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 4.6475 | 8.3421 | 30 | 1219 | nervous system process |
GO:0035195 | 0 | 6.5658 | 2.0804 | 12 | 304 | miRNA-mediated gene silencing |
GO:0016441 | 0 | 6.3018 | 2.1625 | 12 | 316 | post-transcriptional gene silencing |
GO:0031047 | 0 | 5.8684 | 2.3131 | 12 | 338 | gene silencing by RNA |
GO:1901687 | 1e-04 | 295.5596 | 0.0205 | 2 | 3 | glutathione derivative biosynthetic process |
GO:0051122 | 0.0016 | 42.2071 | 0.0616 | 2 | 9 | hepoxilin biosynthetic process |
GO:0033860 | 0.0025 | 32.8236 | 0.0753 | 2 | 11 | regulation of NAD(P)H oxidase activity |
GO:0002674 | 0.0029 | 29.5394 | 0.0821 | 2 | 12 | negative regulation of acute inflammatory response |
GO:0006953 | 0.0034 | 10.8862 | 0.3011 | 3 | 44 | acute-phase response |
GO:0045840 | 0.0034 | 10.8862 | 0.3011 | 3 | 44 | positive regulation of mitotic nuclear division |
GO:0001676 | 0.0049 | 6.2356 | 0.6843 | 4 | 100 | long-chain fatty acid metabolic process |
GO:0006954 | 0.0056 | 2.4997 | 5.1805 | 12 | 757 | inflammatory response |
GO:0002644 | 0.0068 | Inf | 0.0068 | 1 | 1 | negative regulation of tolerance induction |
GO:0003106 | 0.0068 | Inf | 0.0068 | 1 | 1 | negative regulation of glomerular filtration by angiotensin |
GO:0035732 | 0.0068 | Inf | 0.0068 | 1 | 1 | nitric oxide storage |
GO:0045818 | 0.0068 | Inf | 0.0068 | 1 | 1 | negative regulation of glycogen catabolic process |
GO:0032930 | 0.0074 | 17.3686 | 0.13 | 2 | 19 | positive regulation of superoxide anion generation |
GO:0042742 | 0.0076 | 3.7001 | 1.7177 | 6 | 251 | defense response to bacterium |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 15.2855 | 2.2325 | 26 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 7.91 | 6.2888 | 38 | 600 | G protein-coupled receptor activity |
GO:0046982 | 0 | 11.4136 | 3.1444 | 28 | 300 | protein heterodimerization activity |
GO:0038023 | 0 | 4.772 | 12.5777 | 46 | 1200 | signaling receptor activity |
GO:0005549 | 0 | 19.5921 | 0.6394 | 10 | 61 | odorant binding |
GO:0003677 | 0 | 2.2568 | 24.1806 | 46 | 2307 | DNA binding |
GO:0008503 | 1e-04 | 48.0237 | 0.0943 | 3 | 9 | benzodiazepine receptor activity |
GO:0019904 | 2e-04 | 2.9053 | 6.771 | 18 | 646 | protein domain specific binding |
GO:0022851 | 2e-04 | 36.0133 | 0.1153 | 3 | 11 | GABA-gated chloride ion channel activity |
GO:0005253 | 2e-04 | 7.8951 | 0.8385 | 6 | 80 | anion channel activity |
GO:0005237 | 2e-04 | 32.0099 | 0.1258 | 3 | 12 | inhibitory extracellular ligand-gated ion channel activity |
GO:1903231 | 5e-04 | 5.4687 | 1.3835 | 7 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0004890 | 6e-04 | 22.1552 | 0.1677 | 3 | 16 | GABA-A receptor activity |
GO:0045296 | 7e-04 | 3.4425 | 3.4274 | 11 | 327 | cadherin binding |
GO:1904315 | 0.001 | 10.1504 | 0.4402 | 4 | 42 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential |
GO:0070330 | 0.0013 | 15.9961 | 0.2201 | 3 | 21 | aromatase activity |
GO:0031849 | 0.0016 | 47.7471 | 0.0629 | 2 | 6 | olfactory receptor binding |
GO:0022836 | 0.0022 | 3.1407 | 3.3855 | 10 | 323 | gated channel activity |
GO:0022835 | 0.0028 | 7.4112 | 0.587 | 4 | 56 | transmitter-gated channel activity |
GO:0001849 | 0.0029 | 31.8275 | 0.0839 | 2 | 8 | complement component C1q complex binding |
GO:0098960 | 0.0036 | 6.8801 | 0.6289 | 4 | 60 | postsynaptic neurotransmitter receptor activity |
GO:0008395 | 0.0053 | 9.2806 | 0.3564 | 3 | 34 | steroid hydroxylase activity |
GO:0008392 | 0.0079 | 17.3551 | 0.1363 | 2 | 13 | arachidonic acid epoxygenase activity |
GO:0033038 | 0.0091 | 15.9078 | 0.1467 | 2 | 14 | bitter taste receptor activity |
GO:0008188 | 0.0096 | 7.3732 | 0.4402 | 3 | 42 | neuropeptide receptor activity |
GO:0022803 | 0.0097 | 2.3862 | 4.8529 | 11 | 463 | passive transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 25.3744 | 1.8042 | 31 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 11.3355 | 5.0823 | 40 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 6.7997 | 8.7071 | 42 | 1057 | signaling receptor activity |
GO:0070330 | 0 | 37.9081 | 0.1779 | 5 | 21 | aromatase activity |
GO:0008392 | 0 | 53.5374 | 0.1101 | 4 | 13 | arachidonic acid epoxygenase activity |
GO:0020037 | 0 | 8.4317 | 1.0588 | 8 | 125 | heme binding |
GO:0004321 | 0 | 89.7077 | 0.0593 | 3 | 7 | fatty-acyl-CoA synthase activity |
GO:0047760 | 0 | 59.7978 | 0.0762 | 3 | 9 | butyrate-CoA ligase activity |
GO:0005549 | 2e-04 | 10.8042 | 0.5167 | 5 | 61 | odorant binding |
GO:0018685 | 2e-04 | 237.5182 | 0.0254 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0018858 | 2e-04 | 237.5182 | 0.0254 | 2 | 3 | benzoate-CoA ligase activity |
GO:0008391 | 4e-04 | 122.2556 | 0.0329 | 2 | 4 | arachidonic acid monooxygenase activity |
GO:0050051 | 4e-04 | 118.7518 | 0.0339 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0102391 | 4e-04 | 118.7518 | 0.0339 | 2 | 4 | decanoate-CoA ligase activity |
GO:0015645 | 7e-04 | 19.9179 | 0.1779 | 3 | 21 | fatty acid ligase activity |
GO:0102033 | 0.001 | 59.3686 | 0.0508 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0005506 | 0.0011 | 5.5582 | 1.1605 | 6 | 137 | iron ion binding |
GO:0004175 | 0.0017 | 3.2593 | 3.2865 | 10 | 388 | endopeptidase activity |
GO:0008395 | 0.0029 | 11.556 | 0.288 | 3 | 34 | steroid hydroxylase activity |
GO:0019825 | 0.0032 | 11.1942 | 0.2965 | 3 | 35 | oxygen binding |
GO:0016877 | 0.0043 | 9.9479 | 0.3303 | 3 | 39 | ligase activity, forming carbon-sulfur bonds |
GO:0008188 | 0.0054 | 9.181 | 0.3558 | 3 | 42 | neuropeptide receptor activity |
GO:0033038 | 0.0061 | 19.7798 | 0.1186 | 2 | 14 | bitter taste receptor activity |
GO:0097153 | 0.007 | 18.2572 | 0.1271 | 2 | 15 | cysteine-type endopeptidase activity involved in apoptotic process |
GO:0001653 | 0.0074 | 4.3622 | 1.2113 | 5 | 143 | peptide receptor activity |
GO:0008389 | 0.0085 | Inf | 0.0085 | 1 | 1 | coumarin 7-hydroxylase activity |
GO:0070009 | 0.0085 | Inf | 0.0085 | 1 | 1 | serine-type aminopeptidase activity |
GO:0097258 | 0.0085 | Inf | 0.0085 | 1 | 1 | 20-hydroxy-leukotriene B4 omega oxidase activity |
GO:0097259 | 0.0085 | Inf | 0.0085 | 1 | 1 | 20-aldehyde-leukotriene B4 20-monooxygenase activity |
GO:0102116 | 0.0085 | Inf | 0.0085 | 1 | 1 | laurate hydroxylase activity |
GO:0102207 | 0.0085 | Inf | 0.0085 | 1 | 1 | docosanoate omega-hydroxylase activity |
GO:0103002 | 0.0085 | Inf | 0.0085 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0043395 | 0.01 | 14.8312 | 0.1525 | 2 | 18 | heparan sulfate proteoglycan binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 19.3247 | 1.2331 | 18 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 9.7764 | 3.4735 | 25 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 5.9744 | 6.947 | 30 | 1200 | signaling receptor activity |
GO:0005549 | 0 | 32.7297 | 0.3531 | 9 | 61 | odorant binding |
GO:1903231 | 1e-04 | 8.6619 | 0.7642 | 6 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0070330 | 2e-04 | 29.5236 | 0.1216 | 3 | 21 | aromatase activity |
GO:0020037 | 8e-04 | 7.4977 | 0.7236 | 5 | 125 | heme binding |
GO:0046703 | 9e-04 | 58.4552 | 0.0463 | 2 | 8 | natural killer cell lectin-like receptor binding |
GO:0008503 | 0.0012 | 50.1014 | 0.0521 | 2 | 9 | benzodiazepine receptor activity |
GO:0022851 | 0.0018 | 38.963 | 0.0637 | 2 | 11 | GABA-gated chloride ion channel activity |
GO:0003730 | 0.0019 | 6.0687 | 0.8857 | 5 | 153 | mRNA 3'-UTR binding |
GO:0005237 | 0.0021 | 35.0645 | 0.0695 | 2 | 12 | inhibitory extracellular ligand-gated ion channel activity |
GO:0033038 | 0.0029 | 29.2168 | 0.081 | 2 | 14 | bitter taste receptor activity |
GO:0030246 | 0.0032 | 4.4589 | 1.4415 | 6 | 249 | carbohydrate binding |
GO:0045182 | 0.0035 | 4.3856 | 1.4647 | 6 | 253 | translation regulator activity |
GO:0004890 | 0.0038 | 25.0399 | 0.0926 | 2 | 16 | GABA-A receptor activity |
GO:0008391 | 0.0043 | 23.3692 | 0.0984 | 2 | 17 | arachidonic acid monooxygenase activity |
GO:0008123 | 0.0058 | Inf | 0.0058 | 1 | 1 | cholesterol 7-alpha-monooxygenase activity |
GO:0031855 | 0.0058 | Inf | 0.0058 | 1 | 1 | oxytocin receptor binding |
GO:0050591 | 0.0058 | Inf | 0.0058 | 1 | 1 | quinine 3-monooxygenase activity |
GO:0097163 | 0.0058 | Inf | 0.0058 | 1 | 1 | sulfur carrier activity |
GO:0102320 | 0.0058 | Inf | 0.0058 | 1 | 1 | 1,8-cineole 2-exo-monooxygenase activity |
GO:0005506 | 0.0082 | 5.3481 | 0.7931 | 4 | 137 | iron ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 15.0132 | 3.1079 | 34 | 300 | protein heterodimerization activity |
GO:0003677 | 0 | 4.6038 | 23.8995 | 72 | 2307 | DNA binding |
GO:0001067 | 0 | 3.458 | 14.5862 | 41 | 1408 | transcription regulatory region nucleic acid binding |
GO:1990837 | 0 | 3.3222 | 15.1146 | 41 | 1459 | sequence-specific double-stranded DNA binding |
GO:0000978 | 0 | 3.5093 | 11.5405 | 34 | 1114 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0140110 | 0 | 2.5707 | 18.3985 | 40 | 1776 | transcription regulator activity |
GO:0097159 | 0 | 2.0673 | 59.3083 | 89 | 5725 | organic cyclic compound binding |
GO:1901363 | 0 | 2.0586 | 58.5625 | 88 | 5653 | heterocyclic compound binding |
GO:0000981 | 0 | 3.2488 | 8.0413 | 23 | 834 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0001228 | 0 | 3.8944 | 4.5375 | 16 | 438 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0008188 | 1e-04 | 13.2703 | 0.4351 | 5 | 42 | neuropeptide receptor activity |
GO:0004930 | 2e-04 | 2.984 | 6.2157 | 17 | 600 | G protein-coupled receptor activity |
GO:0019904 | 3e-04 | 2.8581 | 6.4757 | 17 | 632 | protein domain specific binding |
GO:0001653 | 7e-04 | 5.0852 | 1.4814 | 7 | 143 | peptide receptor activity |
GO:0045296 | 0.0022 | 3.1394 | 3.3876 | 10 | 327 | cadherin binding |
GO:0060089 | 0.0031 | 2.0024 | 12.4314 | 23 | 1200 | molecular transducer activity |
GO:0008503 | 0.0037 | 27.6071 | 0.0932 | 2 | 9 | benzodiazepine receptor activity |
GO:0022851 | 0.0055 | 21.4696 | 0.114 | 2 | 11 | GABA-gated chloride ion channel activity |
GO:0005237 | 0.0066 | 19.3214 | 0.1243 | 2 | 12 | inhibitory extracellular ligand-gated ion channel activity |
GO:0071837 | 0.0089 | 16.0992 | 0.145 | 2 | 14 | HMG box domain binding |
GO:0000977 | 0.0094 | 3.5237 | 1.796 | 6 | 202 | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO:0005253 | 0.0096 | 5.1249 | 0.8288 | 4 | 80 | anion channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 10.8812 | 1.7653 | 16 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 5.84 | 4.9726 | 24 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.8149 | 9.9452 | 31 | 1200 | signaling receptor activity |
GO:0008392 | 1e-04 | 36.6857 | 0.1077 | 3 | 13 | arachidonic acid epoxygenase activity |
GO:0018685 | 2e-04 | 242.8806 | 0.0249 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0070330 | 7e-04 | 20.3709 | 0.174 | 3 | 21 | aromatase activity |
GO:0017083 | 0.001 | 60.709 | 0.0497 | 2 | 6 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO:0102033 | 0.001 | 60.709 | 0.0497 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0046790 | 0.0036 | 26.9735 | 0.0912 | 2 | 11 | virion binding |
GO:0020037 | 0.0039 | 5.138 | 1.036 | 5 | 125 | heme binding |
GO:0008417 | 0.005 | 22.0665 | 0.1077 | 2 | 13 | fucosyltransferase activity |
GO:0004175 | 0.0051 | 2.9721 | 3.2156 | 9 | 388 | endopeptidase activity |
GO:0005506 | 0.0057 | 4.6675 | 1.1354 | 5 | 137 | iron ion binding |
GO:0033038 | 0.0058 | 20.2264 | 0.116 | 2 | 14 | bitter taste receptor activity |
GO:0052689 | 0.0068 | 4.4629 | 1.1851 | 5 | 143 | carboxylic ester hydrolase activity |
GO:0004890 | 0.0076 | 17.3348 | 0.1326 | 2 | 16 | GABA-A receptor activity |
GO:0004511 | 0.0083 | Inf | 0.0083 | 1 | 1 | tyrosine 3-monooxygenase activity |
GO:0008389 | 0.0083 | Inf | 0.0083 | 1 | 1 | coumarin 7-hydroxylase activity |
GO:0035478 | 0.0083 | Inf | 0.0083 | 1 | 1 | chylomicron binding |
GO:0043185 | 0.0083 | Inf | 0.0083 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0052722 | 0.0083 | Inf | 0.0083 | 1 | 1 | fatty acid in-chain hydroxylase activity |
GO:0102116 | 0.0083 | Inf | 0.0083 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0083 | Inf | 0.0083 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0042605 | 0.0085 | 16.1781 | 0.1409 | 2 | 17 | peptide antigen binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038023 | 0 | 3.6613 | 5.9232 | 18 | 1200 | signaling receptor activity |
GO:1903231 | 0 | 10.2876 | 0.6516 | 6 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0004984 | 1e-04 | 7.4036 | 1.0514 | 7 | 213 | olfactory receptor activity |
GO:0005549 | 2e-04 | 14.8298 | 0.3011 | 4 | 61 | odorant binding |
GO:0001875 | 2e-04 | 137.7722 | 0.0247 | 2 | 5 | lipopolysaccharide immune receptor activity |
GO:0031730 | 4e-04 | 103.3228 | 0.0296 | 2 | 6 | CCR5 chemokine receptor binding |
GO:0046703 | 7e-04 | 68.8734 | 0.0395 | 2 | 8 | natural killer cell lectin-like receptor binding |
GO:0043295 | 0.0011 | 51.6487 | 0.0494 | 2 | 10 | glutathione binding |
GO:0045182 | 0.0016 | 5.2087 | 1.2488 | 6 | 253 | translation regulator activity |
GO:0004930 | 0.0028 | 3.3287 | 2.9616 | 9 | 600 | G protein-coupled receptor activity |
GO:0070330 | 0.0048 | 21.7322 | 0.1037 | 2 | 21 | aromatase activity |
GO:0008389 | 0.0049 | Inf | 0.0049 | 1 | 1 | coumarin 7-hydroxylase activity |
GO:0031703 | 0.0049 | Inf | 0.0049 | 1 | 1 | type 2 angiotensin receptor binding |
GO:0046817 | 0.0049 | Inf | 0.0049 | 1 | 1 | chemokine receptor antagonist activity |
GO:0050591 | 0.0049 | Inf | 0.0049 | 1 | 1 | quinine 3-monooxygenase activity |
GO:0102320 | 0.0049 | Inf | 0.0049 | 1 | 1 | 1,8-cineole 2-exo-monooxygenase activity |
GO:0004364 | 0.0057 | 19.66 | 0.1135 | 2 | 23 | glutathione transferase activity |
GO:0004190 | 0.0062 | 18.7652 | 0.1185 | 2 | 24 | aspartic-type endopeptidase activity |
GO:0003730 | 0.0069 | 5.6411 | 0.7552 | 4 | 153 | mRNA 3'-UTR binding |
GO:0001632 | 0.0098 | 204.1 | 0.0099 | 1 | 2 | leukotriene B4 receptor activity |
GO:0031729 | 0.0098 | 204.1 | 0.0099 | 1 | 2 | CCR4 chemokine receptor binding |
GO:0033041 | 0.0098 | 204.1 | 0.0099 | 1 | 2 | sweet taste receptor activity |
GO:0045519 | 0.0098 | 204.1 | 0.0099 | 1 | 2 | interleukin-23 receptor binding |
GO:0062181 | 0.0098 | 204.1 | 0.0099 | 1 | 2 | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 0 | 12.4378 | 0.74 | 8 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0003730 | 0 | 9.122 | 0.8578 | 7 | 153 | mRNA 3'-UTR binding |
GO:0045182 | 1e-04 | 6.248 | 1.4184 | 8 | 253 | translation regulator activity |
GO:0031730 | 5e-04 | 90.6333 | 0.0336 | 2 | 6 | CCR5 chemokine receptor binding |
GO:0046703 | 9e-04 | 60.4148 | 0.0449 | 2 | 8 | natural killer cell lectin-like receptor binding |
GO:0060089 | 0.0026 | 2.4878 | 6.7276 | 15 | 1200 | molecular transducer activity |
GO:0048018 | 0.0031 | 3.5358 | 2.4444 | 8 | 436 | receptor ligand activity |
GO:0030545 | 0.0052 | 3.2326 | 2.663 | 8 | 475 | signaling receptor regulator activity |
GO:0046817 | 0.0056 | Inf | 0.0056 | 1 | 1 | chemokine receptor antagonist activity |
GO:0050591 | 0.0056 | Inf | 0.0056 | 1 | 1 | quinine 3-monooxygenase activity |
GO:0102320 | 0.0056 | Inf | 0.0056 | 1 | 1 | 1,8-cineole 2-exo-monooxygenase activity |
GO:0005104 | 0.0079 | 16.4606 | 0.1346 | 2 | 24 | fibroblast growth factor receptor binding |
GO:0004888 | 0.0094 | 2.3426 | 5.5727 | 12 | 994 | transmembrane signaling receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 16.8905 | 2.1207 | 26 | 300 | protein heterodimerization activity |
GO:0003677 | 0 | 3.2566 | 16.3079 | 40 | 2307 | DNA binding |
GO:0045296 | 0 | 5.8531 | 2.3115 | 12 | 327 | cadherin binding |
GO:0019904 | 0 | 3.6865 | 4.5665 | 15 | 646 | protein domain specific binding |
GO:0032394 | 0.001 | 57.1544 | 0.0495 | 2 | 7 | MHC class Ib receptor activity |
GO:0003723 | 0.0015 | 2.2098 | 11.2185 | 22 | 1625 | RNA binding |
GO:1903231 | 0.0025 | 5.7342 | 0.9331 | 5 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:1901363 | 0.0026 | 1.7227 | 39.9603 | 55 | 5653 | heterocyclic compound binding |
GO:0061980 | 0.0032 | 11.0654 | 0.2969 | 3 | 42 | regulatory RNA binding |
GO:0097159 | 0.0035 | 1.6894 | 40.4692 | 55 | 5725 | organic cyclic compound binding |
GO:0004984 | 0.0041 | 4.239 | 1.5057 | 6 | 213 | olfactory receptor activity |
GO:0003730 | 0.0046 | 4.9142 | 1.0815 | 5 | 153 | mRNA 3'-UTR binding |
GO:0031707 | 0.0071 | Inf | 0.0071 | 1 | 1 | endothelin A receptor binding |
GO:0047444 | 0.0071 | Inf | 0.0071 | 1 | 1 | N-acylneuraminate-9-phosphate synthase activity |
GO:0050462 | 0.0071 | Inf | 0.0071 | 1 | 1 | N-acetylneuraminate synthase activity |
GO:0050591 | 0.0071 | Inf | 0.0071 | 1 | 1 | quinine 3-monooxygenase activity |
GO:0102320 | 0.0071 | Inf | 0.0071 | 1 | 1 | 1,8-cineole 2-exo-monooxygenase activity |
GO:0102390 | 0.0071 | Inf | 0.0071 | 1 | 1 | mycophenolic acid acyl-glucuronide esterase activity |
GO:0042288 | 0.0078 | 16.7977 | 0.1343 | 2 | 19 | MHC class I protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 15.396 | 2.468 | 28 | 300 | protein heterodimerization activity |
GO:0003677 | 0 | 2.7934 | 18.979 | 42 | 2307 | DNA binding |
GO:0005509 | 0 | 3.4411 | 5.5201 | 17 | 671 | calcium ion binding |
GO:0019904 | 3e-04 | 3.099 | 5.3144 | 15 | 646 | protein domain specific binding |
GO:0045296 | 4e-04 | 4.0273 | 2.6901 | 10 | 327 | cadherin binding |
GO:0030414 | 0.0026 | 4.6552 | 1.3739 | 6 | 167 | peptidase inhibitor activity |
GO:0061135 | 0.0034 | 4.4063 | 1.4479 | 6 | 176 | endopeptidase regulator activity |
GO:0033038 | 0.0057 | 20.3797 | 0.1152 | 2 | 14 | bitter taste receptor activity |
GO:0004867 | 0.0062 | 5.8159 | 0.7322 | 4 | 89 | serine-type endopeptidase inhibitor activity |
GO:0008191 | 0.0066 | 18.8109 | 0.1234 | 2 | 15 | metalloendopeptidase inhibitor activity |
GO:0008308 | 0.0066 | 18.8109 | 0.1234 | 2 | 15 | voltage-gated anion channel activity |
GO:0031707 | 0.0082 | Inf | 0.0082 | 1 | 1 | endothelin A receptor binding |
GO:0047150 | 0.0082 | Inf | 0.0082 | 1 | 1 | betaine-homocysteine S-methyltransferase activity |
GO:0047444 | 0.0082 | Inf | 0.0082 | 1 | 1 | N-acylneuraminate-9-phosphate synthase activity |
GO:0050462 | 0.0082 | Inf | 0.0082 | 1 | 1 | N-acetylneuraminate synthase activity |
GO:0050591 | 0.0082 | Inf | 0.0082 | 1 | 1 | quinine 3-monooxygenase activity |
GO:0102320 | 0.0082 | Inf | 0.0082 | 1 | 1 | 1,8-cineole 2-exo-monooxygenase activity |
GO:0003723 | 0.0091 | 1.8276 | 13.7139 | 23 | 1667 | RNA binding |
GO:0050840 | 0.0099 | 7.2299 | 0.4442 | 3 | 54 | extracellular matrix binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 8.0322 | 2.9616 | 20 | 300 | protein heterodimerization activity |
GO:0003677 | 2e-04 | 2.022 | 22.7748 | 40 | 2307 | DNA binding |
GO:0016503 | 3e-04 | 203.0875 | 0.0296 | 2 | 3 | pheromone receptor activity |
GO:0004888 | 3e-04 | 2.4697 | 9.8128 | 22 | 994 | transmembrane signaling receptor activity |
GO:0045296 | 4e-04 | 3.6728 | 3.2282 | 11 | 327 | cadherin binding |
GO:0060089 | 0.0016 | 2.1187 | 11.8464 | 23 | 1200 | molecular transducer activity |
GO:1903231 | 0.002 | 4.9212 | 1.3031 | 6 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0046703 | 0.0026 | 33.8375 | 0.079 | 2 | 8 | natural killer cell lectin-like receptor binding |
GO:0051378 | 0.005 | 22.5542 | 0.1086 | 2 | 11 | serotonin binding |
GO:0008227 | 0.0057 | 8.9978 | 0.3653 | 3 | 37 | G protein-coupled amine receptor activity |
GO:0042277 | 0.0073 | 3.0062 | 2.8037 | 8 | 284 | peptide binding |
GO:0001616 | 0.0099 | Inf | 0.0099 | 1 | 1 | growth hormone secretagogue receptor activity |
GO:0008663 | 0.0099 | Inf | 0.0099 | 1 | 1 | 2',3'-cyclic-nucleotide 2'-phosphodiesterase activity |
GO:0008828 | 0.0099 | Inf | 0.0099 | 1 | 1 | dATP pyrophosphohydrolase activity |
GO:0047693 | 0.0099 | Inf | 0.0099 | 1 | 1 | ATP diphosphatase activity |
GO:0047734 | 0.0099 | Inf | 0.0099 | 1 | 1 | CDP-glycerol diphosphatase activity |
GO:0050591 | 0.0099 | Inf | 0.0099 | 1 | 1 | quinine 3-monooxygenase activity |
GO:0102320 | 0.0099 | Inf | 0.0099 | 1 | 1 | 1,8-cineole 2-exo-monooxygenase activity |
GO:0106377 | 0.0099 | Inf | 0.0099 | 1 | 1 | 2-hydroxy-ATP hydrolase activity |
GO:0106378 | 0.0099 | Inf | 0.0099 | 1 | 1 | 2-hydroxy-dATP hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 15.513 | 3.1261 | 35 | 300 | protein heterodimerization activity |
GO:0003677 | 0 | 7.5036 | 6.2498 | 35 | 669 | DNA binding |
GO:0000978 | 0 | 2.9746 | 11.6084 | 30 | 1114 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0000981 | 0 | 2.5691 | 13.2548 | 30 | 1272 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0000976 | 0 | 2.4907 | 14.6512 | 32 | 1406 | transcription cis-regulatory region binding |
GO:0003690 | 1e-04 | 2.319 | 16.1622 | 33 | 1551 | double-stranded DNA binding |
GO:0097159 | 1e-04 | 1.814 | 59.6572 | 84 | 5725 | organic cyclic compound binding |
GO:1901363 | 1e-04 | 1.8066 | 58.9069 | 83 | 5653 | heterocyclic compound binding |
GO:0043565 | 1e-04 | 2.2229 | 16.2143 | 32 | 1556 | sequence-specific DNA binding |
GO:0004930 | 2e-04 | 2.9644 | 6.2523 | 17 | 600 | G protein-coupled receptor activity |
GO:0005179 | 0.001 | 5.6416 | 1.1463 | 6 | 110 | hormone activity |
GO:0019904 | 0.0012 | 2.5575 | 6.7316 | 16 | 646 | protein domain specific binding |
GO:0140110 | 0.0014 | 1.9134 | 18.5068 | 32 | 1776 | transcription regulator activity |
GO:0004984 | 0.0018 | 3.8388 | 2.2196 | 8 | 213 | olfactory receptor activity |
GO:0045296 | 0.0023 | 3.1197 | 3.4075 | 10 | 327 | cadherin binding |
GO:0030548 | 0.0067 | 19.2059 | 0.125 | 2 | 12 | acetylcholine receptor regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 11.2902 | 3.4186 | 30 | 300 | protein heterodimerization activity |
GO:0003677 | 0 | 6.0156 | 6.5215 | 31 | 669 | DNA binding |
GO:0003690 | 0 | 2.9138 | 17.6744 | 43 | 1551 | double-stranded DNA binding |
GO:0000976 | 0 | 2.7694 | 16.0221 | 38 | 1406 | transcription cis-regulatory region binding |
GO:0043565 | 0 | 2.6398 | 17.7314 | 40 | 1556 | sequence-specific DNA binding |
GO:0000978 | 0 | 2.889 | 12.6946 | 32 | 1114 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0004930 | 0 | 3.609 | 6.8373 | 22 | 600 | G protein-coupled receptor activity |
GO:0000981 | 0 | 3.1299 | 9.0334 | 25 | 834 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0004984 | 0 | 5.4659 | 2.4272 | 12 | 213 | olfactory receptor activity |
GO:0140110 | 0 | 2.345 | 20.2384 | 41 | 1776 | transcription regulator activity |
GO:0097159 | 1e-04 | 1.7434 | 65.2392 | 90 | 5725 | organic cyclic compound binding |
GO:1901363 | 1e-04 | 1.7398 | 64.4187 | 89 | 5653 | heterocyclic compound binding |
GO:0019904 | 3e-04 | 2.7335 | 7.1419 | 18 | 633 | protein domain specific binding |
GO:0001228 | 5e-04 | 3.0154 | 4.9912 | 14 | 438 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0001653 | 0.0013 | 4.6 | 1.6296 | 7 | 143 | peptide receptor activity |
GO:0008188 | 0.0013 | 9.3097 | 0.4786 | 4 | 42 | neuropeptide receptor activity |
GO:0045296 | 0.0013 | 3.1462 | 3.7263 | 11 | 327 | cadherin binding |
GO:0038023 | 0.0014 | 2.1327 | 11.6961 | 23 | 1057 | signaling receptor activity |
GO:0017083 | 0.0019 | 43.8351 | 0.0684 | 2 | 6 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO:0005004 | 0.0026 | 35.0659 | 0.0798 | 2 | 7 | GPI-linked ephrin receptor activity |
GO:0017046 | 0.0027 | 7.5228 | 0.5812 | 4 | 51 | peptide hormone binding |
GO:0030545 | 0.0032 | 2.5488 | 5.4129 | 13 | 475 | signaling receptor regulator activity |
GO:0001664 | 0.0033 | 3.1788 | 2.997 | 9 | 263 | G protein-coupled receptor binding |
GO:0051427 | 0.0035 | 11.0048 | 0.3077 | 3 | 27 | hormone receptor binding |
GO:0005184 | 0.0039 | 10.5639 | 0.3191 | 3 | 28 | neuropeptide hormone activity |
GO:0048018 | 0.0043 | 2.5551 | 4.9684 | 12 | 436 | receptor ligand activity |
GO:0008503 | 0.0044 | 25.044 | 0.1026 | 2 | 9 | benzodiazepine receptor activity |
GO:0098960 | 0.0048 | 6.3103 | 0.6837 | 4 | 60 | postsynaptic neurotransmitter receptor activity |
GO:0022851 | 0.0066 | 19.4763 | 0.1254 | 2 | 11 | GABA-gated chloride ion channel activity |
GO:0005237 | 0.0079 | 17.5276 | 0.1367 | 2 | 12 | inhibitory extracellular ligand-gated ion channel activity |
GO:0008417 | 0.0093 | 15.9332 | 0.1481 | 2 | 13 | fucosyltransferase activity |
GO:0070742 | 0.0093 | 15.9332 | 0.1481 | 2 | 13 | C2H2 zinc finger domain binding |
GO:1901681 | 0.0094 | 2.8672 | 2.9286 | 8 | 257 | sulfur compound binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 10.8863 | 1.5316 | 14 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 5.1897 | 4.3144 | 19 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.1091 | 8.6289 | 23 | 1200 | signaling receptor activity |
GO:1903231 | 0 | 8.1563 | 0.9492 | 7 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0005549 | 0.001 | 9.9938 | 0.4386 | 4 | 61 | odorant binding |
GO:0004321 | 0.0011 | 56.1621 | 0.0503 | 2 | 7 | fatty-acyl-CoA synthase activity |
GO:0004252 | 0.0012 | 5.4704 | 1.1793 | 6 | 164 | serine-type endopeptidase activity |
GO:0048018 | 0.0012 | 3.4485 | 3.1352 | 10 | 436 | receptor ligand activity |
GO:0031956 | 0.0018 | 40.1108 | 0.0647 | 2 | 9 | medium-chain fatty acid-CoA ligase activity |
GO:0047760 | 0.0018 | 40.1108 | 0.0647 | 2 | 9 | butyrate-CoA ligase activity |
GO:0017171 | 0.0022 | 4.8223 | 1.3303 | 6 | 185 | serine hydrolase activity |
GO:0030545 | 0.0023 | 3.1515 | 3.4156 | 10 | 475 | signaling receptor regulator activity |
GO:0045182 | 0.0024 | 4.1135 | 1.8193 | 7 | 253 | translation regulator activity |
GO:0001664 | 0.0029 | 3.9503 | 1.8912 | 7 | 263 | G protein-coupled receptor binding |
GO:0008009 | 0.0036 | 10.5991 | 0.3092 | 3 | 43 | chemokine activity |
GO:0008392 | 0.0038 | 25.5188 | 0.0935 | 2 | 13 | arachidonic acid epoxygenase activity |
GO:0003730 | 0.005 | 4.8266 | 1.1002 | 5 | 153 | mRNA 3'-UTR binding |
GO:0008201 | 0.0065 | 4.5183 | 1.1721 | 5 | 163 | heparin binding |
GO:0005126 | 0.0066 | 3.8084 | 1.6685 | 6 | 234 | cytokine receptor binding |
GO:0008389 | 0.0072 | Inf | 0.0072 | 1 | 1 | coumarin 7-hydroxylase activity |
GO:0035730 | 0.0072 | Inf | 0.0072 | 1 | 1 | S-nitrosoglutathione binding |
GO:0035731 | 0.0072 | Inf | 0.0072 | 1 | 1 | dinitrosyl-iron complex binding |
GO:0043185 | 0.0072 | Inf | 0.0072 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0045515 | 0.0072 | Inf | 0.0072 | 1 | 1 | interleukin-18 receptor binding |
GO:0051997 | 0.0072 | Inf | 0.0072 | 1 | 1 | 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity |
GO:0052722 | 0.0072 | Inf | 0.0072 | 1 | 1 | fatty acid in-chain hydroxylase activity |
GO:0045236 | 0.0073 | 17.5388 | 0.1294 | 2 | 18 | CXCR chemokine receptor binding |
GO:0070330 | 0.0098 | 14.7668 | 0.151 | 2 | 21 | aromatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 9.5863 | 1.7133 | 14 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 4.8331 | 4.8263 | 20 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.1557 | 9.6527 | 26 | 1200 | signaling receptor activity |
GO:0018685 | 2e-04 | 250.4154 | 0.0241 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0004252 | 4e-04 | 5.7502 | 1.3192 | 7 | 164 | serine-type endopeptidase activity |
GO:0017171 | 7e-04 | 5.0652 | 1.4881 | 7 | 185 | serine hydrolase activity |
GO:0017083 | 9e-04 | 62.5923 | 0.0483 | 2 | 6 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO:0102033 | 9e-04 | 62.5923 | 0.0483 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0004321 | 0.0013 | 50.0708 | 0.0563 | 2 | 7 | fatty-acyl-CoA synthase activity |
GO:0008233 | 0.0018 | 2.8923 | 4.4724 | 12 | 556 | peptidase activity |
GO:0031956 | 0.0022 | 35.7604 | 0.0724 | 2 | 9 | medium-chain fatty acid-CoA ligase activity |
GO:0047760 | 0.0022 | 35.7604 | 0.0724 | 2 | 9 | butyrate-CoA ligase activity |
GO:0046790 | 0.0034 | 27.8103 | 0.0885 | 2 | 11 | virion binding |
GO:0020037 | 0.0034 | 5.3012 | 1.0055 | 5 | 125 | heme binding |
GO:0008392 | 0.0047 | 22.751 | 0.1046 | 2 | 13 | arachidonic acid epoxygenase activity |
GO:0008417 | 0.0047 | 22.751 | 0.1046 | 2 | 13 | fucosyltransferase activity |
GO:0003690 | 0.0061 | 1.9292 | 12.4761 | 22 | 1551 | double-stranded DNA binding |
GO:0000978 | 0.008 | 2.0457 | 8.9609 | 17 | 1114 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0008389 | 0.008 | Inf | 0.008 | 1 | 1 | coumarin 7-hydroxylase activity |
GO:0035478 | 0.008 | Inf | 0.008 | 1 | 1 | chylomicron binding |
GO:0043185 | 0.008 | Inf | 0.008 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0102116 | 0.008 | Inf | 0.008 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.008 | Inf | 0.008 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0003746 | 0.0081 | 16.68 | 0.1367 | 2 | 17 | translation elongation factor activity |
GO:0042605 | 0.0081 | 16.68 | 0.1367 | 2 | 17 | peptide antigen binding |
GO:0000976 | 0.0087 | 1.9187 | 11.3097 | 20 | 1406 | transcription cis-regulatory region binding |
GO:0001228 | 0.009 | 2.7032 | 3.5232 | 9 | 438 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0003700 | 0.009 | 1.9421 | 10.5857 | 19 | 1316 | DNA-binding transcription factor activity |
GO:0004866 | 0.01 | 4.0426 | 1.3031 | 5 | 162 | endopeptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001632 | 0 | Inf | 0.0129 | 2 | 2 | leukotriene B4 receptor activity |
GO:0038187 | 4e-04 | 23.7146 | 0.1486 | 3 | 23 | pattern recognition receptor activity |
GO:0031730 | 6e-04 | 78.3654 | 0.0388 | 2 | 6 | CCR5 chemokine receptor binding |
GO:0060089 | 0.0017 | 2.4415 | 7.7514 | 17 | 1200 | molecular transducer activity |
GO:0048018 | 0.0021 | 3.4499 | 2.8163 | 9 | 436 | receptor ligand activity |
GO:0004953 | 0.0036 | 26.109 | 0.0904 | 2 | 14 | icosanoid receptor activity |
GO:0030545 | 0.0036 | 3.1534 | 3.0683 | 9 | 475 | signaling receptor regulator activity |
GO:0042379 | 0.006 | 8.7648 | 0.3682 | 3 | 57 | chemokine receptor binding |
GO:0001874 | 0.0065 | Inf | 0.0065 | 1 | 1 | (1->3)-beta-D-glucan immune receptor activity |
GO:0004997 | 0.0065 | Inf | 0.0065 | 1 | 1 | thyrotropin-releasing hormone receptor activity |
GO:0031703 | 0.0065 | Inf | 0.0065 | 1 | 1 | type 2 angiotensin receptor binding |
GO:0035730 | 0.0065 | Inf | 0.0065 | 1 | 1 | S-nitrosoglutathione binding |
GO:0035731 | 0.0065 | Inf | 0.0065 | 1 | 1 | dinitrosyl-iron complex binding |
GO:0046817 | 0.0065 | Inf | 0.0065 | 1 | 1 | chemokine receptor antagonist activity |
GO:0052722 | 0.0065 | Inf | 0.0065 | 1 | 1 | fatty acid in-chain hydroxylase activity |
GO:0005537 | 0.0073 | 17.3996 | 0.1292 | 2 | 20 | mannose binding |
GO:0004364 | 0.0096 | 14.9112 | 0.1486 | 2 | 23 | glutathione transferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 14.127 | 2.5411 | 27 | 300 | protein heterodimerization activity |
GO:0003677 | 0 | 2.867 | 19.5413 | 44 | 2307 | DNA binding |
GO:0045296 | 0 | 4.7862 | 2.7698 | 12 | 327 | cadherin binding |
GO:0019904 | 1e-04 | 3.2295 | 5.4719 | 16 | 646 | protein domain specific binding |
GO:0033038 | 2e-04 | 32.607 | 0.1186 | 3 | 14 | bitter taste receptor activity |
GO:0061980 | 0.0054 | 9.181 | 0.3558 | 3 | 42 | regulatory RNA binding |
GO:0001874 | 0.0085 | Inf | 0.0085 | 1 | 1 | (1->3)-beta-D-glucan immune receptor activity |
GO:0004304 | 0.0085 | Inf | 0.0085 | 1 | 1 | estrone sulfotransferase activity |
GO:0031707 | 0.0085 | Inf | 0.0085 | 1 | 1 | endothelin A receptor binding |
GO:0047444 | 0.0085 | Inf | 0.0085 | 1 | 1 | N-acylneuraminate-9-phosphate synthase activity |
GO:0047992 | 0.0085 | Inf | 0.0085 | 1 | 1 | hydroxylysine kinase activity |
GO:0050462 | 0.0085 | Inf | 0.0085 | 1 | 1 | N-acetylneuraminate synthase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 6.6341 | 1.5057 | 9 | 213 | olfactory receptor activity |
GO:0038023 | 0 | 3.0032 | 8.4826 | 22 | 1200 | signaling receptor activity |
GO:0004930 | 1e-04 | 3.6792 | 4.2413 | 14 | 600 | G protein-coupled receptor activity |
GO:0005126 | 3e-04 | 5.2429 | 1.6612 | 8 | 235 | cytokine receptor binding |
GO:0048020 | 0.0014 | 15.0231 | 0.2243 | 3 | 32 | CCR chemokine receptor binding |
GO:1903231 | 0.0025 | 5.7342 | 0.9331 | 5 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0046790 | 0.0026 | 31.7446 | 0.0778 | 2 | 11 | virion binding |
GO:0008009 | 0.0035 | 10.7881 | 0.304 | 3 | 43 | chemokine activity |
GO:0030545 | 0.0066 | 2.8569 | 3.3577 | 9 | 475 | signaling receptor regulator activity |
GO:0000121 | 0.0071 | Inf | 0.0071 | 1 | 1 | glycerol-1-phosphatase activity |
GO:0001874 | 0.0071 | Inf | 0.0071 | 1 | 1 | (1->3)-beta-D-glucan immune receptor activity |
GO:0004061 | 0.0071 | Inf | 0.0071 | 1 | 1 | arylformamidase activity |
GO:0031707 | 0.0071 | Inf | 0.0071 | 1 | 1 | endothelin A receptor binding |
GO:0031732 | 0.0071 | Inf | 0.0071 | 1 | 1 | CCR7 chemokine receptor binding |
GO:0052722 | 0.0071 | Inf | 0.0071 | 1 | 1 | fatty acid in-chain hydroxylase activity |
GO:0140616 | 0.0071 | Inf | 0.0071 | 1 | 1 | iodotyrosine deiodinase activity |
GO:0030246 | 0.0085 | 3.6029 | 1.7601 | 6 | 249 | carbohydrate binding |
GO:0045182 | 0.0092 | 3.5437 | 1.7884 | 6 | 253 | translation regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 11.0551 | 1.285 | 12 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 4.4803 | 3.5774 | 14 | 599 | G protein-coupled receptor activity |
GO:0030546 | 1e-04 | 4.5946 | 2.6726 | 11 | 443 | signaling receptor activator activity |
GO:0005179 | 5e-04 | 8.2097 | 0.6636 | 5 | 110 | hormone activity |
GO:0038023 | 8e-04 | 2.6511 | 7.2395 | 17 | 1200 | signaling receptor activity |
GO:1903231 | 0.0012 | 6.7784 | 0.7963 | 5 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0003730 | 0.0023 | 5.809 | 0.923 | 5 | 153 | mRNA 3'-UTR binding |
GO:0005102 | 0.0029 | 2.3181 | 8.1806 | 17 | 1356 | signaling receptor binding |
GO:0005549 | 0.006 | 8.757 | 0.368 | 3 | 61 | odorant binding |
GO:0000121 | 0.006 | Inf | 0.006 | 1 | 1 | glycerol-1-phosphatase activity |
GO:0001874 | 0.006 | Inf | 0.006 | 1 | 1 | (1->3)-beta-D-glucan immune receptor activity |
GO:0004997 | 0.006 | Inf | 0.006 | 1 | 1 | thyrotropin-releasing hormone receptor activity |
GO:0035730 | 0.006 | Inf | 0.006 | 1 | 1 | S-nitrosoglutathione binding |
GO:0035731 | 0.006 | Inf | 0.006 | 1 | 1 | dinitrosyl-iron complex binding |
GO:0045515 | 0.006 | Inf | 0.006 | 1 | 1 | interleukin-18 receptor binding |
GO:0052722 | 0.006 | Inf | 0.006 | 1 | 1 | fatty acid in-chain hydroxylase activity |
GO:0005125 | 0.0087 | 4.1998 | 1.2609 | 5 | 209 | cytokine activity |
GO:0004190 | 0.0091 | 15.2662 | 0.1448 | 2 | 24 | aspartic-type endopeptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 12.8405 | 1.4278 | 15 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 4.5806 | 4.0219 | 16 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0.001 | 2.5024 | 8.0439 | 18 | 1200 | signaling receptor activity |
GO:1903231 | 0.0019 | 6.0641 | 0.8848 | 5 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0004745 | 0.0057 | 20.1049 | 0.114 | 2 | 17 | NAD-retinol dehydrogenase activity |
GO:0000121 | 0.0067 | Inf | 0.0067 | 1 | 1 | glycerol-1-phosphatase activity |
GO:0000170 | 0.0067 | Inf | 0.0067 | 1 | 1 | sphingosine hydroxylase activity |
GO:0001874 | 0.0067 | Inf | 0.0067 | 1 | 1 | (1->3)-beta-D-glucan immune receptor activity |
GO:0004304 | 0.0067 | Inf | 0.0067 | 1 | 1 | estrone sulfotransferase activity |
GO:0008336 | 0.0067 | Inf | 0.0067 | 1 | 1 | gamma-butyrobetaine dioxygenase activity |
GO:0031707 | 0.0067 | Inf | 0.0067 | 1 | 1 | endothelin A receptor binding |
GO:0036131 | 0.0067 | Inf | 0.0067 | 1 | 1 | prostaglandin D2 11-ketoreductase activity |
GO:0045703 | 0.0067 | Inf | 0.0067 | 1 | 1 | ketoreductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 13.5751 | 2.8336 | 29 | 300 | protein heterodimerization activity |
GO:0003677 | 0 | 2.4509 | 21.7907 | 44 | 2307 | DNA binding |
GO:0045296 | 0 | 5.0572 | 3.0887 | 14 | 327 | cadherin binding |
GO:0019904 | 0 | 3.4822 | 6.1018 | 19 | 646 | protein domain specific binding |
GO:0003723 | 2e-04 | 2.234 | 15.7456 | 31 | 1667 | RNA binding |
GO:0032552 | 5e-04 | 106.2288 | 0.0378 | 2 | 4 | deoxyribonucleotide binding |
GO:0004857 | 7e-04 | 3.4512 | 3.4287 | 11 | 363 | enzyme inhibitor activity |
GO:0051373 | 9e-04 | 70.8148 | 0.0472 | 2 | 5 | FATZ binding |
GO:0004866 | 9e-04 | 4.9128 | 1.5302 | 7 | 162 | endopeptidase inhibitor activity |
GO:0061134 | 0.0036 | 3.7777 | 1.9647 | 7 | 208 | peptidase regulator activity |
GO:0004984 | 0.0041 | 3.6848 | 2.0119 | 7 | 213 | olfactory receptor activity |
GO:0004930 | 0.0046 | 2.4436 | 5.6673 | 13 | 600 | G protein-coupled receptor activity |
GO:0097677 | 0.0046 | 23.5962 | 0.1039 | 2 | 11 | STAT family protein binding |
GO:0033038 | 0.0075 | 17.6939 | 0.1322 | 2 | 14 | bitter taste receptor activity |
GO:0008308 | 0.0086 | 16.3318 | 0.1417 | 2 | 15 | voltage-gated anion channel activity |
GO:0032558 | 0.0094 | Inf | 0.0094 | 1 | 1 | adenyl deoxyribonucleotide binding |
GO:0001631 | 0.0094 | Inf | 0.0094 | 1 | 1 | cysteinyl leukotriene receptor activity |
GO:0002135 | 0.0094 | Inf | 0.0094 | 1 | 1 | CTP binding |
GO:0004113 | 0.0094 | Inf | 0.0094 | 1 | 1 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity |
GO:0031707 | 0.0094 | Inf | 0.0094 | 1 | 1 | endothelin A receptor binding |
GO:0032564 | 0.0094 | Inf | 0.0094 | 1 | 1 | dATP binding |
GO:0042586 | 0.0094 | Inf | 0.0094 | 1 | 1 | peptide deformylase activity |
GO:0046316 | 0.0094 | Inf | 0.0094 | 1 | 1 | gluconokinase activity |
GO:0047444 | 0.0094 | Inf | 0.0094 | 1 | 1 | N-acylneuraminate-9-phosphate synthase activity |
GO:0050462 | 0.0094 | Inf | 0.0094 | 1 | 1 | N-acetylneuraminate synthase activity |
GO:1990276 | 0.0094 | Inf | 0.0094 | 1 | 1 | RNA 5'-methyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 17.4719 | 2.7605 | 34 | 300 | protein heterodimerization activity |
GO:0004984 | 0 | 8.2471 | 1.96 | 14 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 4.7914 | 5.3516 | 22 | 589 | G protein-coupled receptor activity |
GO:0003677 | 0 | 2.7993 | 21.2283 | 47 | 2307 | DNA binding |
GO:0038023 | 0 | 2.9304 | 11.042 | 28 | 1200 | signaling receptor activity |
GO:1903231 | 2e-04 | 6.2743 | 1.2146 | 7 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0045296 | 2e-04 | 3.9641 | 3.009 | 11 | 327 | cadherin binding |
GO:0019904 | 3e-04 | 2.9402 | 5.9443 | 16 | 646 | protein domain specific binding |
GO:0005549 | 0.0024 | 7.7346 | 0.5613 | 4 | 61 | odorant binding |
GO:0008020 | 0.0044 | 24.2356 | 0.1012 | 2 | 11 | G protein-coupled photoreceptor activity |
GO:0030545 | 0.0045 | 2.6746 | 4.3708 | 11 | 475 | signaling receptor regulator activity |
GO:0030548 | 0.0052 | 21.8107 | 0.1104 | 2 | 12 | acetylcholine receptor regulator activity |
GO:0033038 | 0.0071 | 18.1734 | 0.1288 | 2 | 14 | bitter taste receptor activity |
GO:0008009 | 0.0072 | 8.2191 | 0.3957 | 3 | 43 | chemokine activity |
GO:0008308 | 0.0082 | 16.7744 | 0.138 | 2 | 15 | voltage-gated anion channel activity |
GO:0045182 | 0.009 | 3.1643 | 2.328 | 7 | 253 | translation regulator activity |
GO:0000332 | 0.0092 | Inf | 0.0092 | 1 | 1 | template for synthesis of G-rich strand of telomere DNA activity |
GO:0004607 | 0.0092 | Inf | 0.0092 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
GO:0008437 | 0.0092 | Inf | 0.0092 | 1 | 1 | thyrotropin-releasing hormone activity |
GO:0042164 | 0.0092 | Inf | 0.0092 | 1 | 1 | interleukin-12 alpha subunit binding |
GO:0047704 | 0.0092 | Inf | 0.0092 | 1 | 1 | bile-salt sulfotransferase activity |
GO:0070009 | 0.0092 | Inf | 0.0092 | 1 | 1 | serine-type aminopeptidase activity |
GO:0140489 | 0.0092 | Inf | 0.0092 | 1 | 1 | molecular template activity |
GO:0140616 | 0.0092 | Inf | 0.0092 | 1 | 1 | iodotyrosine deiodinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 31.9091 | 1.5186 | 31 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 11.3823 | 4.2779 | 34 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 5.7766 | 8.5558 | 36 | 1200 | signaling receptor activity |
GO:0005549 | 0 | 29.7636 | 0.4349 | 10 | 61 | odorant binding |
GO:1903231 | 0 | 9.5703 | 0.9411 | 8 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0045182 | 5e-04 | 4.8075 | 1.8038 | 8 | 253 | translation regulator activity |
GO:0031849 | 7e-04 | 70.8217 | 0.0428 | 2 | 6 | olfactory receptor binding |
GO:1902387 | 0.0014 | 47.2087 | 0.057 | 2 | 8 | ceramide 1-phosphate binding |
GO:0031707 | 0.0071 | Inf | 0.0071 | 1 | 1 | endothelin A receptor binding |
GO:0045515 | 0.0071 | Inf | 0.0071 | 1 | 1 | interleukin-18 receptor binding |
GO:0047704 | 0.0071 | Inf | 0.0071 | 1 | 1 | bile-salt sulfotransferase activity |
GO:0050113 | 0.0071 | Inf | 0.0071 | 1 | 1 | inositol oxygenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 18.154 | 1.5316 | 21 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 7.3478 | 4.3144 | 25 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.8243 | 8.6289 | 27 | 1200 | signaling receptor activity |
GO:0005549 | 0 | 15.8153 | 0.4386 | 6 | 61 | odorant binding |
GO:0030414 | 0.0013 | 5.3675 | 1.2009 | 6 | 167 | peptidase inhibitor activity |
GO:0061135 | 0.0017 | 5.0805 | 1.2656 | 6 | 176 | endopeptidase regulator activity |
GO:0004867 | 0.0039 | 6.6902 | 0.64 | 4 | 89 | serine-type endopeptidase inhibitor activity |
GO:0033038 | 0.0044 | 23.3908 | 0.1007 | 2 | 14 | bitter taste receptor activity |
GO:0008308 | 0.0051 | 21.5902 | 0.1079 | 2 | 15 | voltage-gated anion channel activity |
GO:0008336 | 0.0072 | Inf | 0.0072 | 1 | 1 | gamma-butyrobetaine dioxygenase activity |
GO:0031707 | 0.0072 | Inf | 0.0072 | 1 | 1 | endothelin A receptor binding |
GO:0047444 | 0.0072 | Inf | 0.0072 | 1 | 1 | N-acylneuraminate-9-phosphate synthase activity |
GO:0047704 | 0.0072 | Inf | 0.0072 | 1 | 1 | bile-salt sulfotransferase activity |
GO:0050462 | 0.0072 | Inf | 0.0072 | 1 | 1 | N-acetylneuraminate synthase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 17.785 | 1.5576 | 21 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 8.3632 | 4.3876 | 28 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 5.5692 | 8.7751 | 36 | 1200 | signaling receptor activity |
GO:1903231 | 1e-04 | 8.011 | 0.9653 | 7 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0008392 | 1e-04 | 41.7436 | 0.0951 | 3 | 13 | arachidonic acid epoxygenase activity |
GO:0018685 | 2e-04 | 276.0847 | 0.0219 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0017171 | 4e-04 | 5.6072 | 1.3528 | 7 | 185 | serine hydrolase activity |
GO:0070330 | 5e-04 | 23.1795 | 0.1536 | 3 | 21 | aromatase activity |
GO:0102033 | 8e-04 | 69.0085 | 0.0439 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0004252 | 0.0013 | 5.3738 | 1.1993 | 6 | 164 | serine-type endopeptidase activity |
GO:0020037 | 0.0022 | 5.8587 | 0.9141 | 5 | 125 | heme binding |
GO:0045182 | 0.0026 | 4.0401 | 1.8501 | 7 | 253 | translation regulator activity |
GO:0004497 | 0.0052 | 6.1383 | 0.6947 | 4 | 95 | monooxygenase activity |
GO:0035478 | 0.0073 | Inf | 0.0073 | 1 | 1 | chylomicron binding |
GO:0043185 | 0.0073 | Inf | 0.0073 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0070009 | 0.0073 | Inf | 0.0073 | 1 | 1 | serine-type aminopeptidase activity |
GO:0102116 | 0.0073 | Inf | 0.0073 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0073 | Inf | 0.0073 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0043395 | 0.0075 | 17.2394 | 0.1316 | 2 | 18 | heparan sulfate proteoglycan binding |
GO:0008233 | 0.0076 | 2.6214 | 4.0658 | 10 | 556 | peptidase activity |
GO:0030506 | 0.0084 | 16.2243 | 0.1389 | 2 | 19 | ankyrin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 31.6405 | 1.5835 | 32 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 12.1581 | 4.4607 | 37 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 7.1183 | 8.9214 | 43 | 1200 | signaling receptor activity |
GO:1903231 | 0 | 9.1477 | 0.9814 | 8 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0005549 | 1e-04 | 12.3871 | 0.4535 | 5 | 61 | odorant binding |
GO:0008392 | 1e-04 | 41.037 | 0.0966 | 3 | 13 | arachidonic acid epoxygenase activity |
GO:0018685 | 2e-04 | 271.45 | 0.0223 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0070330 | 5e-04 | 22.7871 | 0.1561 | 3 | 21 | aromatase activity |
GO:0045182 | 6e-04 | 4.5952 | 1.8809 | 8 | 253 | translation regulator activity |
GO:0102033 | 8e-04 | 67.85 | 0.0446 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0003730 | 0.001 | 5.6795 | 1.1375 | 6 | 153 | mRNA 3'-UTR binding |
GO:0004321 | 0.0011 | 54.2767 | 0.052 | 2 | 7 | fatty-acyl-CoA synthase activity |
GO:0004252 | 0.0014 | 5.2804 | 1.2193 | 6 | 164 | serine-type endopeptidase activity |
GO:0034235 | 0.0015 | 45.2278 | 0.0595 | 2 | 8 | GPI anchor binding |
GO:0031956 | 0.0019 | 38.7643 | 0.0669 | 2 | 9 | medium-chain fatty acid-CoA ligase activity |
GO:0047760 | 0.0019 | 38.7643 | 0.0669 | 2 | 9 | butyrate-CoA ligase activity |
GO:0020037 | 0.0024 | 5.7578 | 0.9293 | 5 | 125 | heme binding |
GO:0017171 | 0.0026 | 4.6549 | 1.3754 | 6 | 185 | serine hydrolase activity |
GO:0005506 | 0.0036 | 5.2305 | 1.0185 | 5 | 137 | iron ion binding |
GO:0033038 | 0.0047 | 22.6056 | 0.1041 | 2 | 14 | bitter taste receptor activity |
GO:0004890 | 0.0061 | 19.3738 | 0.119 | 2 | 16 | GABA-A receptor activity |
GO:0004511 | 0.0074 | Inf | 0.0074 | 1 | 1 | tyrosine 3-monooxygenase activity |
GO:0008389 | 0.0074 | Inf | 0.0074 | 1 | 1 | coumarin 7-hydroxylase activity |
GO:0052722 | 0.0074 | Inf | 0.0074 | 1 | 1 | fatty acid in-chain hydroxylase activity |
GO:0102116 | 0.0074 | Inf | 0.0074 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0074 | Inf | 0.0074 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0043395 | 0.0078 | 16.95 | 0.1338 | 2 | 18 | heparan sulfate proteoglycan binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 46.198 | 1.8431 | 46 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 17.6696 | 5.192 | 54 | 600 | G protein-coupled receptor activity |
GO:0005549 | 0 | 50.1469 | 0.5278 | 17 | 61 | odorant binding |
GO:0018685 | 2e-04 | 232.3857 | 0.026 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0048306 | 7e-04 | 7.7756 | 0.7009 | 5 | 81 | calcium-dependent protein binding |
GO:0038023 | 7e-04 | 6.054 | 1.0824 | 6 | 206 | signaling receptor activity |
GO:0003823 | 9e-04 | 10.2218 | 0.4327 | 4 | 50 | antigen binding |
GO:0102033 | 0.0011 | 58.0857 | 0.0519 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0048020 | 0.0029 | 11.682 | 0.2856 | 3 | 33 | CCR chemokine receptor binding |
GO:0030414 | 0.0033 | 4.4137 | 1.4451 | 6 | 167 | peptidase inhibitor activity |
GO:0008392 | 0.0054 | 21.113 | 0.1125 | 2 | 13 | arachidonic acid epoxygenase activity |
GO:1903231 | 0.0058 | 4.6385 | 1.1422 | 5 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0008009 | 0.0061 | 8.7561 | 0.3721 | 3 | 43 | chemokine activity |
GO:0004888 | 0.0064 | 3.4244 | 2.193 | 7 | 394 | transmembrane signaling receptor activity |
GO:0070492 | 0.0073 | 17.8626 | 0.1298 | 2 | 15 | oligosaccharide binding |
GO:0004618 | 0.0087 | Inf | 0.0087 | 1 | 1 | phosphoglycerate kinase activity |
GO:0004838 | 0.0087 | Inf | 0.0087 | 1 | 1 | L-tyrosine:2-oxoglutarate aminotransferase activity |
GO:0102116 | 0.0087 | Inf | 0.0087 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0087 | Inf | 0.0087 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0042834 | 0.0093 | 15.479 | 0.1471 | 2 | 17 | peptidoglycan binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 27.6633 | 1.3888 | 26 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 10.2436 | 3.9122 | 29 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 5.5288 | 7.8245 | 32 | 1200 | signaling receptor activity |
GO:0005549 | 0 | 32.8522 | 0.3977 | 10 | 61 | odorant binding |
GO:0019865 | 4e-04 | 24.7227 | 0.1434 | 3 | 22 | immunoglobulin binding |
GO:0008389 | 0.0065 | Inf | 0.0065 | 1 | 1 | coumarin 7-hydroxylase activity |
GO:0035730 | 0.0065 | Inf | 0.0065 | 1 | 1 | S-nitrosoglutathione binding |
GO:0035731 | 0.0065 | Inf | 0.0065 | 1 | 1 | dinitrosyl-iron complex binding |
GO:0004364 | 0.0097 | 14.7683 | 0.15 | 2 | 23 | glutathione transferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 13.7661 | 1.4408 | 16 | 213 | olfactory receptor activity |
GO:0046982 | 0 | 8.081 | 2.0293 | 14 | 300 | protein heterodimerization activity |
GO:0004930 | 0 | 4.5321 | 4.0585 | 16 | 600 | G protein-coupled receptor activity |
GO:1903231 | 0 | 10.1315 | 0.8929 | 8 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0005549 | 1e-04 | 13.6818 | 0.4126 | 5 | 61 | odorant binding |
GO:0019904 | 1e-04 | 3.5779 | 4.3697 | 14 | 646 | protein domain specific binding |
GO:0045182 | 3e-04 | 5.0894 | 1.7113 | 8 | 253 | translation regulator activity |
GO:0003723 | 7e-04 | 2.3299 | 11.2759 | 23 | 1667 | RNA binding |
GO:0047035 | 9e-04 | 59.7945 | 0.0473 | 2 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:0038023 | 0.0028 | 2.3109 | 8.117 | 17 | 1200 | signaling receptor activity |
GO:0044594 | 0.0034 | 27.1693 | 0.0879 | 2 | 13 | 17-beta-hydroxysteroid dehydrogenase (NAD+) activity |
GO:0004745 | 0.0058 | 19.9193 | 0.115 | 2 | 17 | NAD-retinol dehydrogenase activity |
GO:0031707 | 0.0068 | Inf | 0.0068 | 1 | 1 | endothelin A receptor binding |
GO:0036131 | 0.0068 | Inf | 0.0068 | 1 | 1 | prostaglandin D2 11-ketoreductase activity |
GO:0045703 | 0.0068 | Inf | 0.0068 | 1 | 1 | ketoreductase activity |
GO:0050591 | 0.0068 | Inf | 0.0068 | 1 | 1 | quinine 3-monooxygenase activity |
GO:0102320 | 0.0068 | Inf | 0.0068 | 1 | 1 | 1,8-cineole 2-exo-monooxygenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 10.429 | 2.1207 | 18 | 300 | protein heterodimerization activity |
GO:0019904 | 0 | 3.6865 | 4.5665 | 15 | 646 | protein domain specific binding |
GO:0004930 | 1e-04 | 3.6792 | 4.2413 | 14 | 600 | G protein-coupled receptor activity |
GO:0004984 | 1e-04 | 5.8136 | 1.5057 | 8 | 213 | olfactory receptor activity |
GO:0038023 | 7e-04 | 2.5066 | 8.4826 | 19 | 1200 | signaling receptor activity |
GO:0003677 | 0.0025 | 1.9567 | 16.3079 | 28 | 2307 | DNA binding |
GO:0042166 | 0.0026 | 31.7446 | 0.0778 | 2 | 11 | acetylcholine binding |
GO:0003723 | 0.0029 | 2.0842 | 11.7838 | 22 | 1667 | RNA binding |
GO:0004867 | 0.0036 | 6.8105 | 0.6291 | 4 | 89 | serine-type endopeptidase inhibitor activity |
GO:0008308 | 0.0049 | 21.9717 | 0.106 | 2 | 15 | voltage-gated anion channel activity |
GO:0030414 | 0.0067 | 4.4856 | 1.1805 | 5 | 167 | peptidase inhibitor activity |
GO:0031707 | 0.0071 | Inf | 0.0071 | 1 | 1 | endothelin A receptor binding |
GO:0036131 | 0.0071 | Inf | 0.0071 | 1 | 1 | prostaglandin D2 11-ketoreductase activity |
GO:0042164 | 0.0071 | Inf | 0.0071 | 1 | 1 | interleukin-12 alpha subunit binding |
GO:0045703 | 0.0071 | Inf | 0.0071 | 1 | 1 | ketoreductase activity |
GO:0047444 | 0.0071 | Inf | 0.0071 | 1 | 1 | N-acylneuraminate-9-phosphate synthase activity |
GO:0050462 | 0.0071 | Inf | 0.0071 | 1 | 1 | N-acetylneuraminate synthase activity |
GO:0050591 | 0.0071 | Inf | 0.0071 | 1 | 1 | quinine 3-monooxygenase activity |
GO:0102320 | 0.0071 | Inf | 0.0071 | 1 | 1 | 1,8-cineole 2-exo-monooxygenase activity |
GO:0061135 | 0.0083 | 4.2471 | 1.2441 | 5 | 176 | endopeptidase regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 10.2191 | 2.1572 | 18 | 300 | protein heterodimerization activity |
GO:0019904 | 0 | 4.1913 | 4.6452 | 17 | 646 | protein domain specific binding |
GO:0033038 | 1e-04 | 38.6111 | 0.1007 | 3 | 14 | bitter taste receptor activity |
GO:0004984 | 2e-04 | 5.7071 | 1.5316 | 8 | 213 | olfactory receptor activity |
GO:0015125 | 4e-04 | 24.9744 | 0.1438 | 3 | 20 | bile acid transmembrane transporter activity |
GO:0015349 | 8e-04 | 70.2069 | 0.0431 | 2 | 6 | thyroid hormone transmembrane transporter activity |
GO:0047035 | 0.0011 | 56.1621 | 0.0503 | 2 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:0003723 | 0.0016 | 2.1572 | 11.987 | 23 | 1667 | RNA binding |
GO:0044594 | 0.0038 | 25.5188 | 0.0935 | 2 | 13 | 17-beta-hydroxysteroid dehydrogenase (NAD+) activity |
GO:0004930 | 0.004 | 2.7408 | 4.3144 | 11 | 600 | G protein-coupled receptor activity |
GO:0004857 | 0.0047 | 3.2649 | 2.6102 | 8 | 363 | enzyme inhibitor activity |
GO:0008308 | 0.0051 | 21.5902 | 0.1079 | 2 | 15 | voltage-gated anion channel activity |
GO:0046943 | 0.0052 | 4.7617 | 1.1146 | 5 | 155 | carboxylic acid transmembrane transporter activity |
GO:0015347 | 0.0058 | 20.0468 | 0.1151 | 2 | 16 | sodium-independent organic anion transmembrane transporter activity |
GO:0004866 | 0.0063 | 4.5474 | 1.1649 | 5 | 162 | endopeptidase inhibitor activity |
GO:0001874 | 0.0072 | Inf | 0.0072 | 1 | 1 | (1->3)-beta-D-glucan immune receptor activity |
GO:0031707 | 0.0072 | Inf | 0.0072 | 1 | 1 | endothelin A receptor binding |
GO:0036131 | 0.0072 | Inf | 0.0072 | 1 | 1 | prostaglandin D2 11-ketoreductase activity |
GO:0045703 | 0.0072 | Inf | 0.0072 | 1 | 1 | ketoreductase activity |
GO:0047444 | 0.0072 | Inf | 0.0072 | 1 | 1 | N-acylneuraminate-9-phosphate synthase activity |
GO:0050462 | 0.0072 | Inf | 0.0072 | 1 | 1 | N-acetylneuraminate synthase activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007275 | 0 | 3.2179 | 41.8583 | 91 | 3167 | multicellular organism development |
GO:0006335 | 0 | 33.5974 | 0.4513 | 10 | 31 | DNA replication-dependent chromatin assembly |
GO:0022008 | 0 | 3.1987 | 14.2457 | 39 | 1040 | neurogenesis |
GO:0048870 | 0 | 2.5438 | 23.4385 | 51 | 1610 | cell motility |
GO:0030182 | 0 | 3.0724 | 13.0704 | 35 | 961 | neuron differentiation |
GO:0000904 | 0 | 3.3913 | 9.6374 | 29 | 662 | cell morphogenesis involved in differentiation |
GO:0120039 | 0 | 3.5129 | 8.6329 | 27 | 593 | plasma membrane bounded cell projection morphogenesis |
GO:0032990 | 0 | 3.3827 | 8.9387 | 27 | 614 | cell part morphogenesis |
GO:0006334 | 0 | 8.2551 | 1.5286 | 11 | 105 | nucleosome assembly |
GO:0040029 | 0 | 6.4023 | 1.9217 | 11 | 132 | regulation of gene expression, epigenetic |
GO:0072359 | 0 | 2.4718 | 16.2905 | 36 | 1119 | circulatory system development |
GO:0010975 | 0 | 3.5522 | 5.8669 | 19 | 403 | regulation of neuron projection development |
GO:2000179 | 0 | 11.3217 | 0.7279 | 7 | 50 | positive regulation of neural precursor cell proliferation |
GO:0051093 | 0 | 2.6409 | 12.5782 | 30 | 864 | negative regulation of developmental process |
GO:2000026 | 0 | 2.3369 | 18.7071 | 39 | 1285 | regulation of multicellular organismal development |
GO:0021537 | 0 | 4.4927 | 3.4211 | 14 | 235 | telencephalon development |
GO:0099560 | 0 | 20.313 | 0.3203 | 5 | 22 | synaptic membrane adhesion |
GO:0001655 | 0 | 3.6132 | 4.8187 | 16 | 331 | urogenital system development |
GO:0009888 | 0 | 2.75 | 9.2037 | 23 | 702 | tissue development |
GO:0048523 | 1e-04 | 1.7144 | 65.9918 | 94 | 4533 | negative regulation of cellular process |
GO:0048704 | 1e-04 | 6.6353 | 1.3393 | 8 | 92 | embryonic skeletal system morphogenesis |
GO:0032200 | 1e-04 | 4.8966 | 2.2274 | 10 | 153 | telomere organization |
GO:0150063 | 1e-04 | 3.2447 | 5.3283 | 16 | 366 | visual system development |
GO:0045944 | 1e-04 | 2.2066 | 16.4215 | 33 | 1128 | positive regulation of transcription by RNA polymerase II |
GO:0050767 | 1e-04 | 3.2767 | 4.9352 | 15 | 339 | regulation of neurogenesis |
GO:0031175 | 1e-04 | 2.9117 | 6.6904 | 18 | 487 | neuron projection development |
GO:0006338 | 2e-04 | 3.7651 | 3.4357 | 12 | 236 | chromatin remodeling |
GO:0007166 | 2e-04 | 1.7964 | 35.8273 | 57 | 2481 | cell surface receptor signaling pathway |
GO:0009719 | 2e-04 | 1.9988 | 21.5023 | 39 | 1477 | response to endogenous stimulus |
GO:0040017 | 2e-04 | 2.6651 | 8.0943 | 20 | 556 | positive regulation of locomotion |
GO:0002040 | 2e-04 | 4.3443 | 2.4894 | 10 | 171 | sprouting angiogenesis |
GO:0048665 | 2e-04 | 16.3131 | 0.3033 | 4 | 21 | neuron fate specification |
GO:0021823 | 2e-04 | Inf | 0.0291 | 2 | 2 | cerebral cortex tangential migration using cell-cell interactions |
GO:0021836 | 2e-04 | Inf | 0.0291 | 2 | 2 | chemorepulsion involved in postnatal olfactory bulb interneuron migration |
GO:0140039 | 2e-04 | Inf | 0.0291 | 2 | 2 | cell-cell adhesion in response to extracellular stimulus |
GO:0001568 | 2e-04 | 2.5731 | 8.8137 | 21 | 617 | blood vessel development |
GO:0006935 | 2e-04 | 2.6196 | 8.2253 | 20 | 565 | chemotaxis |
GO:0007423 | 2e-04 | 3.4305 | 4.0767 | 13 | 289 | sensory organ development |
GO:0043010 | 2e-04 | 3.2491 | 4.6295 | 14 | 318 | camera-type eye development |
GO:0071824 | 3e-04 | 3.874 | 3.0572 | 11 | 210 | protein-DNA complex subunit organization |
GO:0032502 | 3e-04 | 2.1603 | 17.9315 | 33 | 1758 | developmental process |
GO:0001657 | 3e-04 | 5.9961 | 1.2811 | 7 | 88 | ureteric bud development |
GO:1903508 | 3e-04 | 1.9496 | 21.9827 | 39 | 1510 | positive regulation of nucleic acid-templated transcription |
GO:0072163 | 3e-04 | 5.9226 | 1.2957 | 7 | 89 | mesonephric epithelium development |
GO:1901214 | 3e-04 | 3.3265 | 4.1927 | 13 | 288 | regulation of neuron death |
GO:0021936 | 3e-04 | 29.3662 | 0.1456 | 3 | 10 | regulation of cerebellar granule cell precursor proliferation |
GO:0060560 | 4e-04 | 3.7224 | 3.1737 | 11 | 218 | developmental growth involved in morphogenesis |
GO:0009792 | 4e-04 | 2.4627 | 9.1716 | 21 | 630 | embryo development ending in birth or egg hatching |
GO:2000679 | 4e-04 | 13.7515 | 0.3494 | 4 | 24 | positive regulation of transcription regulatory region DNA binding |
GO:0007411 | 4e-04 | 3.7042 | 3.1882 | 11 | 219 | axon guidance |
GO:0021953 | 4e-04 | 4.3335 | 2.2384 | 9 | 155 | central nervous system neuron differentiation |
GO:0060384 | 4e-04 | 13.0958 | 0.364 | 4 | 25 | innervation |
GO:0048839 | 4e-04 | 3.9252 | 2.7369 | 10 | 188 | inner ear development |
GO:0007409 | 4e-04 | 5.5667 | 1.3697 | 7 | 99 | axonogenesis |
GO:0050772 | 5e-04 | 6.6936 | 0.9899 | 6 | 68 | positive regulation of axonogenesis |
GO:0031344 | 5e-04 | 2.4648 | 8.7057 | 20 | 598 | regulation of cell projection organization |
GO:0051241 | 5e-04 | 2.0938 | 14.9948 | 29 | 1030 | negative regulation of multicellular organismal process |
GO:0051272 | 5e-04 | 2.5252 | 8.0652 | 19 | 554 | positive regulation of cellular component movement |
GO:0021536 | 5e-04 | 6.587 | 1.0045 | 6 | 69 | diencephalon development |
GO:0050789 | 5e-04 | 1.926 | 43.6766 | 61 | 3867 | regulation of biological process |
GO:0007169 | 5e-04 | 2.4472 | 8.764 | 20 | 602 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0045665 | 5e-04 | 6.4836 | 1.0191 | 6 | 70 | negative regulation of neuron differentiation |
GO:0007417 | 6e-04 | 4.1292 | 2.3437 | 9 | 172 | central nervous system development |
GO:0009968 | 6e-04 | 1.9958 | 17.3969 | 32 | 1195 | negative regulation of signal transduction |
GO:0038180 | 6e-04 | 22.8376 | 0.1747 | 3 | 12 | nerve growth factor signaling pathway |
GO:0072028 | 6e-04 | 6.2864 | 1.0482 | 6 | 72 | nephron morphogenesis |
GO:0007412 | 6e-04 | 136.5148 | 0.0437 | 2 | 3 | axon target recognition |
GO:0033092 | 6e-04 | 136.5148 | 0.0437 | 2 | 3 | positive regulation of immature T cell proliferation in thymus |
GO:0038091 | 6e-04 | 136.5148 | 0.0437 | 2 | 3 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
GO:0072275 | 6e-04 | 136.5148 | 0.0437 | 2 | 3 | metanephric glomerulus morphogenesis |
GO:0072277 | 6e-04 | 136.5148 | 0.0437 | 2 | 3 | metanephric glomerular capillary formation |
GO:0060562 | 6e-04 | 3.0758 | 4.513 | 13 | 310 | epithelial tube morphogenesis |
GO:0009887 | 6e-04 | 2.4737 | 8.2482 | 19 | 604 | animal organ morphogenesis |
GO:0072009 | 6e-04 | 5.2185 | 1.4558 | 7 | 100 | nephron epithelium development |
GO:0098916 | 6e-04 | 2.3502 | 9.5792 | 21 | 658 | anterograde trans-synaptic signaling |
GO:0048869 | 8e-04 | 1.9137 | 21.7853 | 37 | 1869 | cellular developmental process |
GO:0070848 | 8e-04 | 2.3198 | 9.6957 | 21 | 666 | response to growth factor |
GO:0007422 | 8e-04 | 6.0119 | 1.0919 | 6 | 75 | peripheral nervous system development |
GO:0021515 | 8e-04 | 7.6605 | 0.7279 | 5 | 50 | cell differentiation in spinal cord |
GO:0042127 | 8e-04 | 1.8442 | 23.0891 | 39 | 1586 | regulation of cell population proliferation |
GO:0048935 | 8e-04 | 20.5525 | 0.1893 | 3 | 13 | peripheral nervous system neuron development |
GO:0070374 | 8e-04 | 3.6168 | 2.9553 | 10 | 203 | positive regulation of ERK1 and ERK2 cascade |
GO:0051254 | 8e-04 | 1.8276 | 23.9189 | 40 | 1643 | positive regulation of RNA metabolic process |
GO:0007517 | 8e-04 | 2.9936 | 4.6295 | 13 | 318 | muscle organ development |
GO:0043524 | 9e-04 | 4.3425 | 1.9799 | 8 | 136 | negative regulation of neuron apoptotic process |
GO:0048598 | 9e-04 | 3.1294 | 4.0912 | 12 | 296 | embryonic morphogenesis |
GO:0045937 | 9e-04 | 2.1628 | 11.9085 | 24 | 818 | positive regulation of phosphate metabolic process |
GO:0042063 | 9e-04 | 3.1146 | 4.1054 | 12 | 282 | gliogenesis |
GO:0021987 | 9e-04 | 4.9004 | 1.5432 | 7 | 106 | cerebral cortex development |
GO:0033674 | 9e-04 | 2.609 | 6.5366 | 16 | 449 | positive regulation of kinase activity |
GO:0019222 | 9e-04 | 1.5155 | 92.9825 | 117 | 6387 | regulation of metabolic process |
GO:2001141 | 0.001 | 1.621 | 44.2857 | 64 | 3042 | regulation of RNA biosynthetic process |
GO:0048588 | 0.0011 | 3.4711 | 3.0718 | 10 | 211 | developmental cell growth |
GO:0007155 | 0.0011 | 1.8648 | 20.3522 | 35 | 1398 | cell adhesion |
GO:0099536 | 0.0011 | 2.2472 | 9.9868 | 21 | 686 | synaptic signaling |
GO:0001503 | 0.0011 | 4.1353 | 2.0722 | 8 | 147 | ossification |
GO:0010631 | 0.0012 | 2.8597 | 4.8333 | 13 | 332 | epithelial cell migration |
GO:0021924 | 0.0012 | 17.125 | 0.2184 | 3 | 15 | cell proliferation in external granule layer |
GO:0007519 | 0.0012 | 4.0851 | 2.0964 | 8 | 144 | skeletal muscle tissue development |
GO:0022028 | 0.0012 | 68.2532 | 0.0582 | 2 | 4 | tangential migration from the subventricular zone to the olfactory bulb |
GO:0050923 | 0.0012 | 68.2532 | 0.0582 | 2 | 4 | regulation of negative chemotaxis |
GO:0072278 | 0.0012 | 68.2532 | 0.0582 | 2 | 4 | metanephric comma-shaped body morphogenesis |
GO:0097476 | 0.0012 | 68.2532 | 0.0582 | 2 | 4 | spinal cord motor neuron migration |
GO:1990911 | 0.0012 | 68.2532 | 0.0582 | 2 | 4 | response to psychosocial stress |
GO:0034103 | 0.0012 | 5.4558 | 1.1938 | 6 | 82 | regulation of tissue remodeling |
GO:0051781 | 0.0012 | 5.4558 | 1.1938 | 6 | 82 | positive regulation of cell division |
GO:0090596 | 0.0013 | 3.1638 | 3.6978 | 11 | 254 | sensory organ morphogenesis |
GO:0001822 | 0.0013 | 3.1615 | 3.7005 | 11 | 257 | kidney development |
GO:0090130 | 0.0014 | 2.7971 | 4.9352 | 13 | 339 | tissue migration |
GO:1901701 | 0.0015 | 1.9401 | 16.0721 | 29 | 1104 | cellular response to oxygen-containing compound |
GO:0051130 | 0.0015 | 2.0151 | 13.8302 | 26 | 950 | positive regulation of cellular component organization |
GO:0032095 | 0.0015 | 15.8067 | 0.2329 | 3 | 16 | regulation of response to food |
GO:0061326 | 0.0015 | 5.2477 | 1.2374 | 6 | 85 | renal tubule development |
GO:0051216 | 0.0015 | 3.5783 | 2.6787 | 9 | 184 | cartilage development |
GO:0021885 | 0.0015 | 6.501 | 0.8444 | 5 | 58 | forebrain cell migration |
GO:0032835 | 0.0017 | 6.3802 | 0.8589 | 5 | 59 | glomerulus development |
GO:0010557 | 0.0017 | 1.7497 | 24.8506 | 40 | 1707 | positive regulation of macromolecule biosynthetic process |
GO:0030534 | 0.0017 | 4.3639 | 1.7189 | 7 | 119 | adult behavior |
GO:0014742 | 0.0018 | 8.5883 | 0.5241 | 4 | 36 | positive regulation of muscle hypertrophy |
GO:0070306 | 0.0018 | 8.5883 | 0.5241 | 4 | 36 | lens fiber cell differentiation |
GO:0023056 | 0.0018 | 1.7615 | 23.3803 | 38 | 1606 | positive regulation of signaling |
GO:0051962 | 0.0019 | 3.47 | 2.7573 | 9 | 192 | positive regulation of nervous system development |
GO:1905330 | 0.0019 | 6.1516 | 0.888 | 5 | 61 | regulation of morphogenesis of an epithelium |
GO:0048609 | 0.002 | 2.0972 | 11.1806 | 22 | 768 | multicellular organismal reproductive process |
GO:0001708 | 0.002 | 6.0859 | 0.8958 | 5 | 63 | cell fate specification |
GO:0003002 | 0.002 | 2.8127 | 4.5202 | 12 | 314 | regionalization |
GO:0021800 | 0.0021 | 45.4993 | 0.0728 | 2 | 5 | cerebral cortex tangential migration |
GO:0021891 | 0.0021 | 45.4993 | 0.0728 | 2 | 5 | olfactory bulb interneuron development |
GO:0021937 | 0.0021 | 45.4993 | 0.0728 | 2 | 5 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
GO:0035385 | 0.0021 | 45.4993 | 0.0728 | 2 | 5 | Roundabout signaling pathway |
GO:0060059 | 0.0021 | 45.4993 | 0.0728 | 2 | 5 | embryonic retina morphogenesis in camera-type eye |
GO:0060978 | 0.0021 | 45.4993 | 0.0728 | 2 | 5 | angiogenesis involved in coronary vascular morphogenesis |
GO:0072103 | 0.0021 | 45.4993 | 0.0728 | 2 | 5 | glomerulus vasculature morphogenesis |
GO:0090259 | 0.0021 | 45.4993 | 0.0728 | 2 | 5 | regulation of retinal ganglion cell axon guidance |
GO:0060644 | 0.0021 | 13.6975 | 0.262 | 3 | 18 | mammary gland epithelial cell differentiation |
GO:0061298 | 0.0021 | 13.6975 | 0.262 | 3 | 18 | retina vasculature development in camera-type eye |
GO:0022603 | 0.0021 | 2.0473 | 11.989 | 23 | 838 | regulation of anatomical structure morphogenesis |
GO:0071417 | 0.0022 | 2.254 | 8.4777 | 18 | 587 | cellular response to organonitrogen compound |
GO:0006351 | 0.0023 | 1.5565 | 45.7415 | 64 | 3142 | transcription, DNA-templated |
GO:0072210 | 0.0024 | 7.8507 | 0.5678 | 4 | 39 | metanephric nephron development |
GO:0055003 | 0.0025 | 12.8406 | 0.2766 | 3 | 19 | cardiac myofibril assembly |
GO:0043408 | 0.0025 | 2.1745 | 9.2735 | 19 | 637 | regulation of MAPK cascade |
GO:0031328 | 0.0026 | 1.692 | 26.2773 | 41 | 1805 | positive regulation of cellular biosynthetic process |
GO:0035239 | 0.0026 | 2.2802 | 7.9136 | 17 | 564 | tube morphogenesis |
GO:0044057 | 0.0026 | 2.2742 | 7.9196 | 17 | 544 | regulation of system process |
GO:0030030 | 0.0026 | 2.0471 | 11.4768 | 22 | 829 | cell projection organization |
GO:0048468 | 0.0027 | 2.0181 | 12.2555 | 23 | 969 | cell development |
GO:0050671 | 0.0027 | 4.004 | 1.8634 | 7 | 128 | positive regulation of lymphocyte proliferation |
GO:0003013 | 0.0028 | 2.2609 | 7.9633 | 17 | 547 | circulatory system process |
GO:0035270 | 0.0028 | 3.9709 | 1.878 | 7 | 129 | endocrine system development |
GO:0048732 | 0.0029 | 2.4734 | 5.9834 | 14 | 411 | gland development |
GO:0021516 | 0.0029 | 12.0845 | 0.2912 | 3 | 20 | dorsal spinal cord development |
GO:0072078 | 0.0029 | 5.5542 | 0.9754 | 5 | 67 | nephron tubule morphogenesis |
GO:0003278 | 0.003 | 34.1224 | 0.0873 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0021707 | 0.003 | 34.1224 | 0.0873 | 2 | 6 | cerebellar granule cell differentiation |
GO:0070100 | 0.003 | 34.1224 | 0.0873 | 2 | 6 | negative regulation of chemokine-mediated signaling pathway |
GO:0072284 | 0.003 | 34.1224 | 0.0873 | 2 | 6 | metanephric S-shaped body morphogenesis |
GO:0007399 | 0.0031 | 2.9963 | 3.551 | 10 | 306 | nervous system development |
GO:0035924 | 0.0031 | 5.4657 | 0.9899 | 5 | 68 | cellular response to vascular endothelial growth factor stimulus |
GO:0035850 | 0.0032 | 7.2296 | 0.6114 | 4 | 42 | epithelial cell differentiation involved in kidney development |
GO:0007420 | 0.0032 | 2.1714 | 8.7823 | 18 | 613 | brain development |
GO:0010647 | 0.0033 | 1.7079 | 23.3512 | 37 | 1604 | positive regulation of cell communication |
GO:0050890 | 0.0033 | 2.7797 | 4.1782 | 11 | 287 | cognition |
GO:0002089 | 0.0033 | 11.4124 | 0.3057 | 3 | 21 | lens morphogenesis in camera-type eye |
GO:0060973 | 0.0033 | 11.4124 | 0.3057 | 3 | 21 | cell migration involved in heart development |
GO:0051173 | 0.0034 | 1.5491 | 41.2139 | 58 | 2831 | positive regulation of nitrogen compound metabolic process |
GO:1904646 | 0.0035 | 7.0438 | 0.626 | 4 | 43 | cellular response to amyloid-beta |
GO:0060429 | 0.0035 | 2.2101 | 8.1577 | 17 | 596 | epithelium development |
GO:0090049 | 0.0035 | 5.2968 | 1.0191 | 5 | 70 | regulation of cell migration involved in sprouting angiogenesis |
GO:0010942 | 0.0035 | 2.2049 | 8.1525 | 17 | 560 | positive regulation of cell death |
GO:0021761 | 0.0036 | 4.3595 | 1.4704 | 6 | 101 | limbic system development |
GO:0006811 | 0.0036 | 1.7482 | 20.2503 | 33 | 1391 | ion transport |
GO:0098727 | 0.0036 | 3.7833 | 1.9653 | 7 | 135 | maintenance of cell number |
GO:0010721 | 0.0037 | 3.3817 | 2.504 | 8 | 172 | negative regulation of cell development |
GO:0007548 | 0.0038 | 2.8877 | 3.6541 | 10 | 251 | sex differentiation |
GO:0030539 | 0.0038 | 10.8111 | 0.3203 | 3 | 22 | male genitalia development |
GO:0019219 | 0.0039 | 1.4938 | 52.147 | 70 | 3582 | regulation of nucleobase-containing compound metabolic process |
GO:0061138 | 0.004 | 3.3405 | 2.5331 | 8 | 174 | morphogenesis of a branching epithelium |
GO:1901698 | 0.004 | 1.8587 | 14.8929 | 26 | 1023 | response to nitrogen compound |
GO:0030335 | 0.004 | 2.2313 | 7.5702 | 16 | 520 | positive regulation of cell migration |
GO:0010594 | 0.0041 | 3.0641 | 3.1009 | 9 | 213 | regulation of endothelial cell migration |
GO:0032944 | 0.0041 | 3.0641 | 3.1009 | 9 | 213 | regulation of mononuclear cell proliferation |
GO:0021517 | 0.0041 | 6.6993 | 0.6551 | 4 | 45 | ventral spinal cord development |
GO:0030001 | 0.0041 | 1.9617 | 11.894 | 22 | 817 | metal ion transport |
GO:0044691 | 0.0042 | 27.2962 | 0.1019 | 2 | 7 | tooth eruption |
GO:0060215 | 0.0042 | 27.2962 | 0.1019 | 2 | 7 | primitive hemopoiesis |
GO:0061438 | 0.0042 | 27.2962 | 0.1019 | 2 | 7 | renal system vasculature morphogenesis |
GO:0071420 | 0.0042 | 27.2962 | 0.1019 | 2 | 7 | cellular response to histamine |
GO:1900122 | 0.0042 | 27.2962 | 0.1019 | 2 | 7 | positive regulation of receptor binding |
GO:0000003 | 0.0042 | 1.7415 | 19.668 | 32 | 1351 | reproduction |
GO:0034329 | 0.0043 | 2.4441 | 5.6049 | 13 | 385 | cell junction assembly |
GO:0002009 | 0.0043 | 3.6568 | 2.029 | 7 | 145 | morphogenesis of an epithelium |
GO:0021697 | 0.0044 | 10.2699 | 0.3348 | 3 | 23 | cerebellar cortex formation |
GO:0021871 | 0.0044 | 10.2699 | 0.3348 | 3 | 23 | forebrain regionalization |
GO:0036303 | 0.0044 | 10.2699 | 0.3348 | 3 | 23 | lymph vessel morphogenesis |
GO:0001501 | 0.0044 | 3.0313 | 3.1337 | 9 | 229 | skeletal system development |
GO:0001934 | 0.0044 | 2.0599 | 9.7539 | 19 | 670 | positive regulation of protein phosphorylation |
GO:0007157 | 0.0044 | 6.5394 | 0.6697 | 4 | 46 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0048146 | 0.0044 | 6.5394 | 0.6697 | 4 | 46 | positive regulation of fibroblast proliferation |
GO:0072507 | 0.0044 | 2.2729 | 6.9588 | 15 | 478 | divalent inorganic cation homeostasis |
GO:0060840 | 0.0045 | 4.1403 | 1.5432 | 6 | 106 | artery development |
GO:0033993 | 0.0046 | 1.9437 | 11.9959 | 22 | 824 | response to lipid |
GO:0071248 | 0.0046 | 3.2611 | 2.5913 | 8 | 178 | cellular response to metal ion |
GO:0010043 | 0.0048 | 6.3869 | 0.6842 | 4 | 47 | response to zinc ion |
GO:0030857 | 0.0048 | 6.3869 | 0.6842 | 4 | 47 | negative regulation of epithelial cell differentiation |
GO:0048260 | 0.0048 | 6.3869 | 0.6842 | 4 | 47 | positive regulation of receptor-mediated endocytosis |
GO:0050885 | 0.0048 | 6.3869 | 0.6842 | 4 | 47 | neuromuscular process controlling balance |
GO:0014070 | 0.0048 | 1.9336 | 12.0541 | 22 | 828 | response to organic cyclic compound |
GO:0043069 | 0.0049 | 1.931 | 12.0686 | 22 | 829 | negative regulation of programmed cell death |
GO:0070665 | 0.0052 | 3.5328 | 2.0964 | 7 | 144 | positive regulation of leukocyte proliferation |
GO:0002761 | 0.0052 | 4.0189 | 1.5868 | 6 | 109 | regulation of myeloid leukocyte differentiation |
GO:0007626 | 0.0053 | 3.1854 | 2.6496 | 8 | 182 | locomotory behavior |
GO:0032102 | 0.0053 | 2.3786 | 5.7504 | 13 | 395 | negative regulation of response to external stimulus |
GO:0010468 | 0.0054 | 1.4478 | 63.9828 | 82 | 4570 | regulation of gene expression |
GO:0048675 | 0.0054 | 3.98 | 1.6014 | 6 | 110 | axon extension |
GO:0032104 | 0.0055 | 9.3351 | 0.364 | 3 | 25 | regulation of response to extracellular stimulus |
GO:0043931 | 0.0055 | 9.3351 | 0.364 | 3 | 25 | ossification involved in bone maturation |
GO:1904861 | 0.0055 | 9.3351 | 0.364 | 3 | 25 | excitatory synapse assembly |
GO:0021683 | 0.0056 | 22.7454 | 0.1165 | 2 | 8 | cerebellar granular layer morphogenesis |
GO:0033083 | 0.0056 | 22.7454 | 0.1165 | 2 | 8 | regulation of immature T cell proliferation |
GO:0071670 | 0.0056 | 22.7454 | 0.1165 | 2 | 8 | smooth muscle cell chemotaxis |
GO:0072239 | 0.0056 | 22.7454 | 0.1165 | 2 | 8 | metanephric glomerulus vasculature development |
GO:0048708 | 0.0056 | 4.714 | 1.1355 | 5 | 78 | astrocyte differentiation |
GO:0045664 | 0.0056 | 3.9541 | 1.6106 | 6 | 113 | regulation of neuron differentiation |
GO:0001649 | 0.0056 | 2.9053 | 3.261 | 9 | 224 | osteoblast differentiation |
GO:0051179 | 0.0057 | 1.4121 | 82.7918 | 102 | 5687 | localization |
GO:0043065 | 0.0058 | 2.2042 | 7.1626 | 15 | 492 | positive regulation of apoptotic process |
GO:0034654 | 0.0058 | 1.4692 | 51.1571 | 68 | 3514 | nucleobase-containing compound biosynthetic process |
GO:0048562 | 0.0059 | 3.1191 | 2.7027 | 8 | 191 | embryonic organ morphogenesis |
GO:0048584 | 0.0061 | 1.5907 | 28.4465 | 42 | 1954 | positive regulation of response to stimulus |
GO:0001706 | 0.0064 | 5.8419 | 0.7425 | 4 | 51 | endoderm formation |
GO:0007568 | 0.0064 | 3.3833 | 2.1837 | 7 | 150 | aging |
GO:0030326 | 0.0065 | 3.8317 | 1.6596 | 6 | 114 | embryonic limb morphogenesis |
GO:0050804 | 0.0068 | 2.3044 | 5.9251 | 13 | 407 | modulation of chemical synaptic transmission |
GO:0001658 | 0.0069 | 5.7199 | 0.757 | 4 | 52 | branching involved in ureteric bud morphogenesis |
GO:0061440 | 0.0069 | 8.5561 | 0.3931 | 3 | 27 | kidney vasculature development |
GO:0050877 | 0.0069 | 1.819 | 13.9938 | 24 | 990 | nervous system process |
GO:0051270 | 0.0071 | 2.2183 | 6.6431 | 14 | 479 | regulation of cellular component movement |
GO:0008343 | 0.0071 | 19.4949 | 0.131 | 2 | 9 | adult feeding behavior |
GO:0021520 | 0.0071 | 19.4949 | 0.131 | 2 | 9 | spinal cord motor neuron cell fate specification |
GO:0050861 | 0.0071 | 19.4949 | 0.131 | 2 | 9 | positive regulation of B cell receptor signaling pathway |
GO:0072203 | 0.0071 | 19.4949 | 0.131 | 2 | 9 | cell proliferation involved in metanephros development |
GO:1903244 | 0.0071 | 19.4949 | 0.131 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0001756 | 0.0071 | 5.6481 | 0.7656 | 4 | 53 | somitogenesis |
GO:0051965 | 0.0073 | 5.6028 | 0.7716 | 4 | 53 | positive regulation of synapse assembly |
GO:0042692 | 0.0074 | 2.3699 | 5.3137 | 12 | 365 | muscle cell differentiation |
GO:0001764 | 0.0074 | 3.2904 | 2.2419 | 7 | 154 | neuron migration |
GO:0034764 | 0.0074 | 2.9939 | 2.8097 | 8 | 193 | positive regulation of transmembrane transport |
GO:0006357 | 0.0076 | 1.7683 | 15.6969 | 26 | 1165 | regulation of transcription by RNA polymerase II |
GO:0030901 | 0.0076 | 4.3544 | 1.2229 | 5 | 84 | midbrain development |
GO:0055006 | 0.0076 | 4.3544 | 1.2229 | 5 | 84 | cardiac cell development |
GO:0003156 | 0.0076 | 8.2134 | 0.4076 | 3 | 28 | regulation of animal organ formation |
GO:0007190 | 0.0076 | 8.2134 | 0.4076 | 3 | 28 | activation of adenylate cyclase activity |
GO:0048639 | 0.0077 | 3.268 | 2.2565 | 7 | 155 | positive regulation of developmental growth |
GO:0010720 | 0.0077 | 2.5924 | 4.0471 | 10 | 278 | positive regulation of cell development |
GO:0045761 | 0.0078 | 5.4904 | 0.7861 | 4 | 54 | regulation of adenylate cyclase activity |
GO:0071902 | 0.0079 | 2.9615 | 2.8388 | 8 | 195 | positive regulation of protein serine/threonine kinase activity |
GO:0001525 | 0.0079 | 2.3491 | 5.3621 | 12 | 382 | angiogenesis |
GO:0014706 | 0.008 | 2.7374 | 3.4503 | 9 | 237 | striated muscle tissue development |
GO:0045859 | 0.0082 | 2.009 | 8.895 | 17 | 611 | regulation of protein kinase activity |
GO:0046686 | 0.0084 | 5.3824 | 0.8007 | 4 | 55 | response to cadmium ion |
GO:0045597 | 0.0084 | 2.108 | 7.4777 | 15 | 527 | positive regulation of cell differentiation |
GO:0048864 | 0.0084 | 4.2463 | 1.252 | 5 | 86 | stem cell development |
GO:0032148 | 0.0084 | 7.897 | 0.4222 | 3 | 29 | activation of protein kinase B activity |
GO:0060292 | 0.0084 | 7.897 | 0.4222 | 3 | 29 | long-term synaptic depression |
GO:0055065 | 0.0085 | 2.002 | 8.9241 | 17 | 613 | metal ion homeostasis |
GO:0048706 | 0.0086 | 7.8299 | 0.4245 | 3 | 30 | embryonic skeletal system development |
GO:0043534 | 0.0087 | 3.1812 | 2.3147 | 7 | 159 | blood vessel endothelial cell migration |
GO:0032525 | 0.0088 | 17.057 | 0.1456 | 2 | 10 | somite rostral/caudal axis specification |
GO:0048703 | 0.0088 | 17.057 | 0.1456 | 2 | 10 | embryonic viscerocranium morphogenesis |
GO:1902459 | 0.0088 | 17.057 | 0.1456 | 2 | 10 | positive regulation of stem cell population maintenance |
GO:1905205 | 0.0088 | 17.057 | 0.1456 | 2 | 10 | positive regulation of connective tissue replacement |
GO:0046579 | 0.0089 | 5.2786 | 0.8153 | 4 | 56 | positive regulation of Ras protein signal transduction |
GO:0035265 | 0.009 | 3.1602 | 2.3293 | 7 | 160 | organ growth |
GO:0030334 | 0.0092 | 2.3014 | 5.4708 | 12 | 390 | regulation of cell migration |
GO:0060828 | 0.0092 | 2.6778 | 3.5231 | 9 | 242 | regulation of canonical Wnt signaling pathway |
GO:0040012 | 0.0092 | 2.2166 | 6.1581 | 13 | 446 | regulation of locomotion |
GO:0002244 | 0.0092 | 3.5349 | 1.7906 | 6 | 123 | hematopoietic progenitor cell differentiation |
GO:0003206 | 0.0092 | 3.5349 | 1.7906 | 6 | 123 | cardiac chamber morphogenesis |
GO:0097106 | 0.0093 | 7.604 | 0.4367 | 3 | 30 | postsynaptic density organization |
GO:0040008 | 0.0094 | 1.9779 | 9.026 | 17 | 620 | regulation of growth |
GO:0030198 | 0.0095 | 2.5067 | 4.1782 | 10 | 287 | extracellular matrix organization |
GO:0003231 | 0.0096 | 3.5048 | 1.8052 | 6 | 124 | cardiac ventricle development |
GO:0008217 | 0.0096 | 3.119 | 2.3584 | 7 | 162 | regulation of blood pressure |
GO:0030316 | 0.0097 | 4.0939 | 1.2957 | 5 | 89 | osteoclast differentiation |
GO:0048661 | 0.0097 | 4.0939 | 1.2957 | 5 | 89 | positive regulation of smooth muscle cell proliferation |
GO:0051099 | 0.01 | 3.0989 | 2.373 | 7 | 163 | positive regulation of binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051674 | 0 | 3.5155 | 19.1235 | 53 | 1610 | localization of cell |
GO:0048869 | 0 | 2.2105 | 40.5097 | 70 | 3617 | cellular developmental process |
GO:0032879 | 0 | 2.273 | 30.942 | 58 | 2605 | regulation of localization |
GO:0045597 | 0 | 3.1903 | 9.5617 | 27 | 805 | positive regulation of cell differentiation |
GO:0006928 | 0 | 2.8233 | 14.0366 | 34 | 1288 | movement of cell or subcellular component |
GO:0045165 | 0 | 5.1075 | 3.0408 | 14 | 256 | cell fate commitment |
GO:0040011 | 0 | 3.1623 | 9.0018 | 25 | 856 | locomotion |
GO:0035239 | 0 | 3.2121 | 8.3778 | 24 | 729 | tube morphogenesis |
GO:0021543 | 0 | 6.4055 | 1.9123 | 11 | 161 | pallium development |
GO:0048598 | 0 | 3.388 | 6.8773 | 21 | 579 | embryonic morphogenesis |
GO:0043067 | 0 | 2.4839 | 16.0115 | 35 | 1348 | regulation of programmed cell death |
GO:0001568 | 0 | 3.2563 | 7.1493 | 21 | 617 | blood vessel development |
GO:0060548 | 0 | 2.7588 | 10.9277 | 27 | 920 | negative regulation of cell death |
GO:0022008 | 0 | 2.5451 | 13.7674 | 31 | 1203 | neurogenesis |
GO:0050678 | 0 | 3.9162 | 4.1929 | 15 | 353 | regulation of epithelial cell proliferation |
GO:0032501 | 0 | 2.0471 | 44.5349 | 68 | 4573 | multicellular organismal process |
GO:2000179 | 0 | 11.6724 | 0.5939 | 6 | 50 | positive regulation of neural precursor cell proliferation |
GO:2000145 | 0 | 2.6247 | 11.4384 | 27 | 963 | regulation of cell motility |
GO:0043066 | 0 | 2.7637 | 9.5974 | 24 | 808 | negative regulation of apoptotic process |
GO:0008284 | 0 | 2.9086 | 8.3636 | 22 | 740 | positive regulation of cell population proliferation |
GO:0042330 | 0 | 3.0761 | 6.7585 | 19 | 569 | taxis |
GO:0060644 | 1e-04 | 24.2453 | 0.2138 | 4 | 18 | mammary gland epithelial cell differentiation |
GO:0031175 | 1e-04 | 2.6108 | 10.5714 | 25 | 890 | neuron projection development |
GO:0021796 | 1e-04 | 63.3516 | 0.0831 | 3 | 7 | cerebral cortex regionalization |
GO:0051240 | 1e-04 | 2.3221 | 15.4219 | 32 | 1316 | positive regulation of multicellular organismal process |
GO:0055003 | 1e-04 | 22.6276 | 0.2257 | 4 | 19 | cardiac myofibril assembly |
GO:0051241 | 1e-04 | 2.5061 | 11.4794 | 26 | 995 | negative regulation of multicellular organismal process |
GO:0030198 | 1e-04 | 4.4712 | 2.6737 | 11 | 229 | extracellular matrix organization |
GO:0120039 | 1e-04 | 2.943 | 7.0436 | 19 | 593 | plasma membrane bounded cell projection morphogenesis |
GO:0072239 | 1e-04 | 50.6781 | 0.095 | 3 | 8 | metanephric glomerulus vasculature development |
GO:0007507 | 1e-04 | 3.0257 | 6.4824 | 18 | 551 | heart development |
GO:0001764 | 1e-04 | 5.365 | 1.8292 | 9 | 154 | neuron migration |
GO:0033674 | 1e-04 | 3.2594 | 5.3332 | 16 | 449 | positive regulation of kinase activity |
GO:0055082 | 1e-04 | 2.6872 | 8.9678 | 22 | 755 | cellular chemical homeostasis |
GO:0051272 | 1e-04 | 2.9761 | 6.5804 | 18 | 554 | positive regulation of cellular component movement |
GO:0048704 | 1e-04 | 7.0688 | 1.0928 | 7 | 92 | embryonic skeletal system morphogenesis |
GO:0042592 | 1e-04 | 2.1166 | 19.6342 | 37 | 1653 | homeostatic process |
GO:0060485 | 1e-04 | 3.9637 | 3.2783 | 12 | 276 | mesenchyme development |
GO:1901342 | 1e-04 | 3.7029 | 3.8009 | 13 | 320 | regulation of vasculature development |
GO:0000904 | 1e-04 | 2.7735 | 7.8632 | 20 | 662 | cell morphogenesis involved in differentiation |
GO:0008343 | 1e-04 | 42.2292 | 0.1069 | 3 | 9 | adult feeding behavior |
GO:0055065 | 1e-04 | 2.8403 | 7.2812 | 19 | 613 | metal ion homeostasis |
GO:0032990 | 1e-04 | 2.8353 | 7.293 | 19 | 614 | cell part morphogenesis |
GO:0072359 | 1e-04 | 3.0222 | 6.1373 | 17 | 556 | circulatory system development |
GO:0016477 | 1e-04 | 2.9221 | 6.7586 | 18 | 644 | cell migration |
GO:0045785 | 1e-04 | 3.2628 | 4.9769 | 15 | 419 | positive regulation of cell adhesion |
GO:0030030 | 2e-04 | 2.1668 | 16.9498 | 33 | 1427 | cell projection organization |
GO:0009792 | 2e-04 | 2.7582 | 7.4831 | 19 | 630 | embryo development ending in birth or egg hatching |
GO:0021761 | 2e-04 | 6.3884 | 1.1997 | 7 | 101 | limbic system development |
GO:0072001 | 2e-04 | 3.72 | 3.4802 | 12 | 293 | renal system development |
GO:0098727 | 2e-04 | 5.4217 | 1.6035 | 8 | 135 | maintenance of cell number |
GO:0050670 | 2e-04 | 4.3303 | 2.4944 | 10 | 210 | regulation of lymphocyte proliferation |
GO:0070482 | 2e-04 | 3.7065 | 3.4921 | 12 | 294 | response to oxygen levels |
GO:0090130 | 2e-04 | 3.4829 | 4.0266 | 13 | 339 | tissue migration |
GO:0045766 | 2e-04 | 4.7088 | 2.0668 | 9 | 174 | positive regulation of angiogenesis |
GO:0008637 | 2e-04 | 6.1897 | 1.2353 | 7 | 104 | apoptotic mitochondrial changes |
GO:0050801 | 3e-04 | 2.6081 | 8.3264 | 20 | 701 | ion homeostasis |
GO:0061440 | 3e-04 | 14.7498 | 0.3207 | 4 | 27 | kidney vasculature development |
GO:0070977 | 3e-04 | 14.7498 | 0.3207 | 4 | 27 | bone maturation |
GO:0048731 | 3e-04 | 2.0153 | 23.2678 | 40 | 2407 | system development |
GO:0009653 | 3e-04 | 2.9766 | 5.9076 | 16 | 597 | anatomical structure morphogenesis |
GO:0048589 | 3e-04 | 2.728 | 7.1386 | 18 | 601 | developmental growth |
GO:0030182 | 3e-04 | 2.3046 | 11.9155 | 25 | 1067 | neuron differentiation |
GO:0040017 | 4e-04 | 2.7789 | 6.6041 | 17 | 556 | positive regulation of locomotion |
GO:0001649 | 4e-04 | 4.0434 | 2.6607 | 10 | 224 | osteoblast differentiation |
GO:1990266 | 4e-04 | 5.661 | 1.3422 | 7 | 113 | neutrophil migration |
GO:0050794 | 4e-04 | 1.7427 | 106.1524 | 128 | 9475 | regulation of cellular process |
GO:0001525 | 4e-04 | 3.2399 | 4.3174 | 13 | 379 | angiogenesis |
GO:0048665 | 4e-04 | 13.0455 | 0.3563 | 4 | 30 | neuron fate specification |
GO:0061037 | 4e-04 | 13.0455 | 0.3563 | 4 | 30 | negative regulation of cartilage development |
GO:0007412 | 4e-04 | 168.0933 | 0.0356 | 2 | 3 | axon target recognition |
GO:0038091 | 4e-04 | 168.0933 | 0.0356 | 2 | 3 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
GO:0072275 | 4e-04 | 168.0933 | 0.0356 | 2 | 3 | metanephric glomerulus morphogenesis |
GO:0072277 | 4e-04 | 168.0933 | 0.0356 | 2 | 3 | metanephric glomerular capillary formation |
GO:1902869 | 4e-04 | 168.0933 | 0.0356 | 2 | 3 | regulation of amacrine cell differentiation |
GO:0034103 | 4e-04 | 6.7444 | 0.974 | 6 | 82 | regulation of tissue remodeling |
GO:0071695 | 4e-04 | 3.9317 | 2.7319 | 10 | 230 | anatomical structure maturation |
GO:0150063 | 4e-04 | 3.211 | 4.3473 | 13 | 366 | visual system development |
GO:0051216 | 5e-04 | 4.8057 | 1.795 | 8 | 154 | cartilage development |
GO:0030335 | 5e-04 | 2.7876 | 6.1765 | 16 | 520 | positive regulation of cell migration |
GO:0008015 | 5e-04 | 2.8812 | 5.5945 | 15 | 471 | blood circulation |
GO:0035630 | 5e-04 | 23.027 | 0.1663 | 3 | 14 | bone mineralization involved in bone maturation |
GO:0065007 | 6e-04 | 1.8529 | 92.9654 | 112 | 8539 | biological regulation |
GO:0048568 | 6e-04 | 2.9389 | 5.1075 | 14 | 430 | embryonic organ development |
GO:0007420 | 7e-04 | 2.475 | 8.2789 | 19 | 697 | brain development |
GO:0046326 | 7e-04 | 11.3033 | 0.4038 | 4 | 34 | positive regulation of glucose import |
GO:0061448 | 7e-04 | 7.7451 | 0.7102 | 5 | 63 | connective tissue development |
GO:0042102 | 8e-04 | 5.9564 | 1.0928 | 6 | 92 | positive regulation of T cell proliferation |
GO:0044057 | 8e-04 | 2.6568 | 6.4616 | 16 | 544 | regulation of system process |
GO:0030879 | 8e-04 | 4.9962 | 1.5085 | 7 | 127 | mammary gland development |
GO:0007409 | 8e-04 | 2.9946 | 4.6445 | 13 | 395 | axonogenesis |
GO:0032095 | 8e-04 | 19.482 | 0.19 | 3 | 16 | regulation of response to food |
GO:0055119 | 8e-04 | 19.482 | 0.19 | 3 | 16 | relaxation of cardiac muscle |
GO:0060749 | 8e-04 | 19.482 | 0.19 | 3 | 16 | mammary gland alveolus development |
GO:0060018 | 8e-04 | 84.0415 | 0.0475 | 2 | 4 | astrocyte fate commitment |
GO:0061754 | 8e-04 | 84.0415 | 0.0475 | 2 | 4 | negative regulation of circulating fibrinogen levels |
GO:0070093 | 8e-04 | 84.0415 | 0.0475 | 2 | 4 | negative regulation of glucagon secretion |
GO:2000491 | 8e-04 | 84.0415 | 0.0475 | 2 | 4 | positive regulation of hepatic stellate cell activation |
GO:2000697 | 8e-04 | 84.0415 | 0.0475 | 2 | 4 | negative regulation of epithelial cell differentiation involved in kidney development |
GO:0030003 | 9e-04 | 2.5529 | 7.1505 | 17 | 602 | cellular cation homeostasis |
GO:0045944 | 9e-04 | 2.1108 | 13.3983 | 26 | 1128 | positive regulation of transcription by RNA polymerase II |
GO:0032102 | 9e-04 | 2.9619 | 4.6918 | 13 | 395 | negative regulation of response to external stimulus |
GO:0051130 | 9e-04 | 2.2063 | 11.284 | 23 | 950 | positive regulation of cellular component organization |
GO:0032946 | 9e-04 | 4.8734 | 1.5441 | 7 | 130 | positive regulation of mononuclear cell proliferation |
GO:0045665 | 9e-04 | 7.2841 | 0.7527 | 5 | 64 | negative regulation of neuron differentiation |
GO:0097529 | 0.001 | 3.8374 | 2.5062 | 9 | 211 | myeloid leukocyte migration |
GO:0021542 | 0.001 | 18.0893 | 0.2019 | 3 | 17 | dentate gyrus development |
GO:0045859 | 0.001 | 2.5127 | 7.2574 | 17 | 611 | regulation of protein kinase activity |
GO:0010712 | 0.001 | 9.9711 | 0.4514 | 4 | 38 | regulation of collagen metabolic process |
GO:0010721 | 0.0011 | 4.1889 | 2.043 | 8 | 172 | negative regulation of cell development |
GO:0010942 | 0.0011 | 2.5761 | 6.6516 | 16 | 560 | positive regulation of cell death |
GO:0048534 | 0.0011 | 2.2553 | 10.0369 | 21 | 845 | hematopoietic or lymphoid organ development |
GO:0002521 | 0.0011 | 2.6532 | 6.0459 | 15 | 509 | leukocyte differentiation |
GO:0042755 | 0.0011 | 9.6856 | 0.4632 | 4 | 39 | eating behavior |
GO:0002064 | 0.0011 | 4.13 | 2.0705 | 8 | 176 | epithelial cell development |
GO:0001666 | 0.0011 | 3.4394 | 3.1001 | 10 | 261 | response to hypoxia |
GO:0043410 | 0.0012 | 2.7486 | 5.4401 | 14 | 458 | positive regulation of MAPK cascade |
GO:0043405 | 0.0012 | 4.1128 | 2.0786 | 8 | 175 | regulation of MAP kinase activity |
GO:0046851 | 0.0012 | 16.8823 | 0.2138 | 3 | 18 | negative regulation of bone remodeling |
GO:0042221 | 0.0012 | 1.6275 | 46.8703 | 66 | 3946 | response to chemical |
GO:0021953 | 0.0012 | 4.6419 | 1.6162 | 7 | 138 | central nervous system neuron differentiation |
GO:0014014 | 0.0013 | 9.4159 | 0.4751 | 4 | 40 | negative regulation of gliogenesis |
GO:0035924 | 0.0013 | 6.7498 | 0.8077 | 5 | 68 | cellular response to vascular endothelial growth factor stimulus |
GO:0021536 | 0.0014 | 6.6439 | 0.8196 | 5 | 69 | diencephalon development |
GO:0021855 | 0.0014 | 56.0242 | 0.0594 | 2 | 5 | hypothalamus cell migration |
GO:0033591 | 0.0014 | 56.0242 | 0.0594 | 2 | 5 | response to L-ascorbic acid |
GO:0060298 | 0.0014 | 56.0242 | 0.0594 | 2 | 5 | positive regulation of sarcomere organization |
GO:0060978 | 0.0014 | 56.0242 | 0.0594 | 2 | 5 | angiogenesis involved in coronary vascular morphogenesis |
GO:0070779 | 0.0014 | 56.0242 | 0.0594 | 2 | 5 | D-aspartate import across plasma membrane |
GO:0072103 | 0.0014 | 56.0242 | 0.0594 | 2 | 5 | glomerulus vasculature morphogenesis |
GO:1903845 | 0.0014 | 56.0242 | 0.0594 | 2 | 5 | negative regulation of cellular response to transforming growth factor beta stimulus |
GO:0072087 | 0.0014 | 15.8262 | 0.2257 | 3 | 19 | renal vesicle development |
GO:0043010 | 0.0015 | 3.0992 | 3.7772 | 11 | 318 | camera-type eye development |
GO:0048754 | 0.0015 | 4.4369 | 1.6867 | 7 | 142 | branching morphogenesis of an epithelial tube |
GO:0001938 | 0.0016 | 5.1701 | 1.2472 | 6 | 105 | positive regulation of endothelial cell proliferation |
GO:0006874 | 0.0016 | 2.7616 | 5.0125 | 13 | 422 | cellular calcium ion homeostasis |
GO:0045840 | 0.0017 | 8.69 | 0.5108 | 4 | 43 | positive regulation of mitotic nuclear division |
GO:0060840 | 0.0017 | 5.1181 | 1.2591 | 6 | 106 | artery development |
GO:0003002 | 0.0017 | 3.2421 | 3.2801 | 10 | 284 | regionalization |
GO:0045937 | 0.0018 | 2.209 | 9.7161 | 20 | 818 | positive regulation of phosphate metabolic process |
GO:0001656 | 0.0018 | 6.2234 | 0.8704 | 5 | 74 | metanephros development |
GO:0001763 | 0.0018 | 3.8343 | 2.2212 | 8 | 187 | morphogenesis of a branching structure |
GO:0035307 | 0.0018 | 8.4723 | 0.5226 | 4 | 44 | positive regulation of protein dephosphorylation |
GO:0010927 | 0.0019 | 4.9681 | 1.2947 | 6 | 109 | cellular component assembly involved in morphogenesis |
GO:0030856 | 0.002 | 4.2465 | 1.7579 | 7 | 148 | regulation of epithelial cell differentiation |
GO:0006029 | 0.002 | 6.0722 | 0.8908 | 5 | 75 | proteoglycan metabolic process |
GO:0010827 | 0.002 | 6.0722 | 0.8908 | 5 | 75 | regulation of glucose transmembrane transport |
GO:0042940 | 0.002 | 42.0155 | 0.0713 | 2 | 6 | D-amino acid transport |
GO:0046533 | 0.002 | 42.0155 | 0.0713 | 2 | 6 | negative regulation of photoreceptor cell differentiation |
GO:0060017 | 0.002 | 42.0155 | 0.0713 | 2 | 6 | parathyroid gland development |
GO:0072143 | 0.002 | 42.0155 | 0.0713 | 2 | 6 | mesangial cell development |
GO:0014706 | 0.0021 | 3.3943 | 2.8151 | 9 | 237 | striated muscle tissue development |
GO:0007169 | 0.0023 | 2.385 | 7.1505 | 16 | 602 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0043065 | 0.0023 | 2.5476 | 5.8439 | 14 | 492 | positive regulation of apoptotic process |
GO:0008645 | 0.0023 | 4.7812 | 1.3422 | 6 | 113 | hexose transmembrane transport |
GO:0021872 | 0.0023 | 7.8797 | 0.5583 | 4 | 47 | forebrain generation of neurons |
GO:0014068 | 0.0024 | 5.8216 | 0.9265 | 5 | 78 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0022603 | 0.0024 | 2.1092 | 10.6783 | 21 | 899 | regulation of anatomical structure morphogenesis |
GO:0021871 | 0.0025 | 12.6578 | 0.2732 | 3 | 23 | forebrain regionalization |
GO:0021895 | 0.0025 | 12.6578 | 0.2732 | 3 | 23 | cerebral cortex neuron differentiation |
GO:0097150 | 0.0025 | 12.6578 | 0.2732 | 3 | 23 | neuronal stem cell population maintenance |
GO:0050708 | 0.0025 | 3.3204 | 2.8745 | 9 | 242 | regulation of protein secretion |
GO:0050767 | 0.0025 | 2.8969 | 4.0266 | 11 | 339 | regulation of neurogenesis |
GO:0055007 | 0.0025 | 4.6929 | 1.366 | 6 | 115 | cardiac muscle cell differentiation |
GO:0010628 | 0.0026 | 2.0204 | 12.2343 | 23 | 1030 | positive regulation of gene expression |
GO:0070664 | 0.0028 | 5.5907 | 0.9621 | 5 | 81 | negative regulation of leukocyte proliferation |
GO:0048745 | 0.0028 | 12.0543 | 0.2851 | 3 | 24 | smooth muscle tissue development |
GO:2000679 | 0.0028 | 12.0543 | 0.2851 | 3 | 24 | positive regulation of transcription regulatory region DNA binding |
GO:0033084 | 0.0028 | 33.6104 | 0.0831 | 2 | 7 | regulation of immature T cell proliferation in thymus |
GO:0060215 | 0.0028 | 33.6104 | 0.0831 | 2 | 7 | primitive hemopoiesis |
GO:0061438 | 0.0028 | 33.6104 | 0.0831 | 2 | 7 | renal system vasculature morphogenesis |
GO:0072197 | 0.0028 | 33.6104 | 0.0831 | 2 | 7 | ureter morphogenesis |
GO:2001258 | 0.0029 | 7.3644 | 0.5939 | 4 | 50 | negative regulation of cation channel activity |
GO:2000026 | 0.0029 | 2.1583 | 9.4458 | 19 | 848 | regulation of multicellular organismal development |
GO:0007204 | 0.003 | 3.0012 | 3.5277 | 10 | 297 | positive regulation of cytosolic calcium ion concentration |
GO:0045137 | 0.003 | 3.5161 | 2.4112 | 8 | 203 | development of primary sexual characteristics |
GO:0040008 | 0.003 | 2.3113 | 7.3643 | 16 | 620 | regulation of growth |
GO:0060993 | 0.0031 | 5.4467 | 0.9859 | 5 | 83 | kidney morphogenesis |
GO:0007498 | 0.0031 | 4.4857 | 1.4254 | 6 | 120 | mesoderm development |
GO:0032355 | 0.0031 | 4.4857 | 1.4254 | 6 | 120 | response to estradiol |
GO:0061005 | 0.0031 | 7.2073 | 0.6058 | 4 | 51 | cell differentiation involved in kidney development |
GO:0032104 | 0.0031 | 11.5057 | 0.2969 | 3 | 25 | regulation of response to extracellular stimulus |
GO:0060384 | 0.0031 | 11.5057 | 0.2969 | 3 | 25 | innervation |
GO:0072273 | 0.0031 | 11.5057 | 0.2969 | 3 | 25 | metanephric nephron morphogenesis |
GO:0008285 | 0.0032 | 2.295 | 7.4204 | 16 | 638 | negative regulation of cell population proliferation |
GO:0055006 | 0.0032 | 5.3774 | 0.9977 | 5 | 84 | cardiac cell development |
GO:0090200 | 0.0035 | 11.0048 | 0.3088 | 3 | 26 | positive regulation of release of cytochrome c from mitochondria |
GO:1903508 | 0.0035 | 1.8111 | 17.9357 | 30 | 1510 | positive regulation of nucleic acid-templated transcription |
GO:0002042 | 0.0036 | 5.244 | 1.0215 | 5 | 86 | cell migration involved in sprouting angiogenesis |
GO:0002065 | 0.0036 | 5.244 | 1.0215 | 5 | 86 | columnar/cuboidal epithelial cell differentiation |
GO:0048864 | 0.0036 | 5.244 | 1.0215 | 5 | 86 | stem cell development |
GO:0071495 | 0.0037 | 1.8818 | 14.8712 | 26 | 1252 | cellular response to endogenous stimulus |
GO:0008584 | 0.0038 | 4.2959 | 1.4847 | 6 | 125 | male gonad development |
GO:0010595 | 0.0038 | 4.2959 | 1.4847 | 6 | 125 | positive regulation of endothelial cell migration |
GO:1902430 | 0.0039 | 10.5456 | 0.3207 | 3 | 27 | negative regulation of amyloid-beta formation |
GO:0034219 | 0.0039 | 4.2598 | 1.4966 | 6 | 126 | carbohydrate transmembrane transport |
GO:0006812 | 0.004 | 1.9481 | 12.65 | 23 | 1065 | cation transport |
GO:0001657 | 0.004 | 5.117 | 1.0453 | 5 | 88 | ureteric bud development |
GO:0010001 | 0.004 | 3.3425 | 2.53 | 8 | 213 | glial cell differentiation |
GO:0022029 | 0.0041 | 6.6404 | 0.6533 | 4 | 55 | telencephalon cell migration |
GO:0043583 | 0.0041 | 3.3261 | 2.5419 | 8 | 214 | ear development |
GO:0030316 | 0.0042 | 5.0558 | 1.0571 | 5 | 89 | osteoclast differentiation |
GO:0048661 | 0.0042 | 5.0558 | 1.0571 | 5 | 89 | positive regulation of smooth muscle cell proliferation |
GO:0072163 | 0.0042 | 5.0558 | 1.0571 | 5 | 89 | mesonephric epithelium development |
GO:0070555 | 0.0043 | 4.1894 | 1.5204 | 6 | 128 | response to interleukin-1 |
GO:1901379 | 0.0044 | 4.996 | 1.069 | 5 | 90 | regulation of potassium ion transmembrane transport |
GO:1903532 | 0.0044 | 3.0298 | 3.1358 | 9 | 264 | positive regulation of secretion by cell |
GO:0003158 | 0.0044 | 4.1551 | 1.5323 | 6 | 129 | endothelium development |
GO:0098739 | 0.0045 | 3.6234 | 2.043 | 7 | 172 | import across plasma membrane |
GO:0043085 | 0.0045 | 1.9244 | 12.7925 | 23 | 1077 | positive regulation of catalytic activity |
GO:0014033 | 0.0046 | 4.9376 | 1.0809 | 5 | 91 | neural crest cell differentiation |
GO:0046620 | 0.0046 | 4.9376 | 1.0809 | 5 | 91 | regulation of organ growth |
GO:0072507 | 0.0048 | 2.4204 | 5.6777 | 13 | 478 | divalent inorganic cation homeostasis |
GO:0033079 | 0.0048 | 24.0044 | 0.1069 | 2 | 9 | immature T cell proliferation |
GO:0072172 | 0.0048 | 24.0044 | 0.1069 | 2 | 9 | mesonephric tubule formation |
GO:0072203 | 0.0048 | 24.0044 | 0.1069 | 2 | 9 | cell proliferation involved in metanephros development |
GO:1904238 | 0.0048 | 24.0044 | 0.1069 | 2 | 9 | pericyte cell differentiation |
GO:0007517 | 0.0048 | 2.7929 | 3.7772 | 10 | 318 | muscle organ development |
GO:0051338 | 0.0048 | 2.0487 | 9.8706 | 19 | 831 | regulation of transferase activity |
GO:0006026 | 0.0048 | 9.7332 | 0.3445 | 3 | 29 | aminoglycan catabolic process |
GO:0035025 | 0.0048 | 9.7332 | 0.3445 | 3 | 29 | positive regulation of Rho protein signal transduction |
GO:0090183 | 0.0048 | 9.7332 | 0.3445 | 3 | 29 | regulation of kidney development |
GO:0022414 | 0.0048 | 1.8204 | 15.9521 | 27 | 1343 | reproductive process |
GO:0097485 | 0.0048 | 3.2308 | 2.6131 | 8 | 220 | neuron projection guidance |
GO:0023052 | 0.0049 | 1.5366 | 49.9176 | 66 | 4466 | signaling |
GO:0010632 | 0.0049 | 2.9706 | 3.1952 | 9 | 269 | regulation of epithelial cell migration |
GO:0098662 | 0.0049 | 2.1337 | 8.4571 | 17 | 712 | inorganic cation transmembrane transport |
GO:0007423 | 0.005 | 2.7801 | 3.797 | 10 | 329 | sensory organ development |
GO:0030199 | 0.005 | 6.2703 | 0.6889 | 4 | 58 | collagen fibril organization |
GO:0002684 | 0.0051 | 2.0804 | 9.1935 | 18 | 774 | positive regulation of immune system process |
GO:0032835 | 0.0053 | 6.1559 | 0.7008 | 4 | 59 | glomerulus development |
GO:0010959 | 0.0053 | 2.6045 | 4.4542 | 11 | 375 | regulation of metal ion transport |
GO:0009967 | 0.0053 | 1.7877 | 16.8548 | 28 | 1419 | positive regulation of signal transduction |
GO:0072175 | 0.0053 | 3.9916 | 1.5916 | 6 | 134 | epithelial tube formation |
GO:0051173 | 0.0055 | 1.5768 | 33.6264 | 48 | 2831 | positive regulation of nitrogen compound metabolic process |
GO:0034766 | 0.0055 | 4.717 | 1.1284 | 5 | 95 | negative regulation of ion transmembrane transport |
GO:0045444 | 0.0055 | 3.1553 | 2.6725 | 8 | 225 | fat cell differentiation |
GO:1903039 | 0.0055 | 3.1553 | 2.6725 | 8 | 225 | positive regulation of leukocyte cell-cell adhesion |
GO:0051251 | 0.0056 | 2.9136 | 3.2546 | 9 | 274 | positive regulation of lymphocyte activation |
GO:0010648 | 0.0056 | 1.8175 | 15.3463 | 26 | 1292 | negative regulation of cell communication |
GO:0032147 | 0.0057 | 3.9297 | 1.6154 | 6 | 136 | activation of protein kinase activity |
GO:0021510 | 0.0057 | 4.6648 | 1.1403 | 5 | 96 | spinal cord development |
GO:0032410 | 0.0057 | 4.6648 | 1.1403 | 5 | 96 | negative regulation of transporter activity |
GO:0006952 | 0.0058 | 1.7584 | 17.7575 | 29 | 1495 | defense response |
GO:0048583 | 0.0058 | 1.5238 | 42.5824 | 58 | 3585 | regulation of response to stimulus |
GO:0023057 | 0.0059 | 1.8097 | 15.4057 | 26 | 1297 | negative regulation of signaling |
GO:0032966 | 0.0059 | 21.0026 | 0.1188 | 2 | 10 | negative regulation of collagen biosynthetic process |
GO:1900426 | 0.0059 | 21.0026 | 0.1188 | 2 | 10 | positive regulation of defense response to bacterium |
GO:0010631 | 0.006 | 5.924 | 0.7257 | 4 | 63 | epithelial cell migration |
GO:0010557 | 0.0062 | 1.705 | 20.2756 | 32 | 1707 | positive regulation of macromolecule biosynthetic process |
GO:0007166 | 0.0063 | 1.5956 | 29.5285 | 43 | 2486 | cell surface receptor signaling pathway |
GO:0006813 | 0.0063 | 3.0833 | 2.7319 | 8 | 230 | potassium ion transport |
GO:0045453 | 0.0063 | 5.8364 | 0.7364 | 4 | 62 | bone resorption |
GO:0046847 | 0.0063 | 5.8364 | 0.7364 | 4 | 62 | filopodium assembly |
GO:0001817 | 0.0063 | 2.0774 | 8.6709 | 17 | 730 | regulation of cytokine production |
GO:0001990 | 0.0064 | 8.7247 | 0.3801 | 3 | 32 | regulation of systemic arterial blood pressure by hormone |
GO:0009954 | 0.0064 | 8.7247 | 0.3801 | 3 | 32 | proximal/distal pattern formation |
GO:0043552 | 0.0064 | 8.7247 | 0.3801 | 3 | 32 | positive regulation of phosphatidylinositol 3-kinase activity |
GO:2000352 | 0.0064 | 8.7247 | 0.3801 | 3 | 32 | negative regulation of endothelial cell apoptotic process |
GO:0051254 | 0.0064 | 1.7132 | 19.5154 | 31 | 1643 | positive regulation of RNA metabolic process |
GO:0007218 | 0.0065 | 4.5151 | 1.1759 | 5 | 99 | neuropeptide signaling pathway |
GO:0009887 | 0.0066 | 1.9839 | 10.1852 | 19 | 884 | animal organ morphogenesis |
GO:0001756 | 0.0067 | 5.7372 | 0.7483 | 4 | 63 | somitogenesis |
GO:0051057 | 0.0067 | 5.7372 | 0.7483 | 4 | 63 | positive regulation of small GTPase mediated signal transduction |
GO:0002009 | 0.0069 | 2.3979 | 5.2734 | 12 | 450 | morphogenesis of an epithelium |
GO:0031128 | 0.0069 | 8.4333 | 0.392 | 3 | 33 | developmental induction |
GO:0110110 | 0.0069 | 8.4333 | 0.392 | 3 | 33 | positive regulation of animal organ morphogenesis |
GO:1905332 | 0.0069 | 8.4333 | 0.392 | 3 | 33 | positive regulation of morphogenesis of an epithelium |
GO:0060326 | 0.007 | 2.8059 | 3.3733 | 9 | 284 | cell chemotaxis |
GO:0045596 | 0.007 | 2.5019 | 4.6341 | 11 | 410 | negative regulation of cell differentiation |
GO:0002430 | 0.0072 | 18.6678 | 0.1307 | 2 | 11 | complement receptor mediated signaling pathway |
GO:0032099 | 0.0072 | 18.6678 | 0.1307 | 2 | 11 | negative regulation of appetite |
GO:0032108 | 0.0072 | 18.6678 | 0.1307 | 2 | 11 | negative regulation of response to nutrient levels |
GO:0048715 | 0.0072 | 18.6678 | 0.1307 | 2 | 11 | negative regulation of oligodendrocyte differentiation |
GO:0051133 | 0.0072 | 18.6678 | 0.1307 | 2 | 11 | regulation of NK T cell activation |
GO:0060009 | 0.0072 | 18.6678 | 0.1307 | 2 | 11 | Sertoli cell development |
GO:0072537 | 0.0072 | 18.6678 | 0.1307 | 2 | 11 | fibroblast activation |
GO:1902667 | 0.0072 | 18.6678 | 0.1307 | 2 | 11 | regulation of axon guidance |
GO:0051050 | 0.0073 | 2.1523 | 7.3698 | 15 | 636 | positive regulation of transport |
GO:0050905 | 0.0073 | 3.7273 | 1.6985 | 6 | 143 | neuromuscular process |
GO:0055002 | 0.0074 | 5.5484 | 0.7721 | 4 | 65 | striated muscle cell development |
GO:0031328 | 0.0078 | 1.6611 | 21.4397 | 33 | 1805 | positive regulation of cellular biosynthetic process |
GO:0071310 | 0.0079 | 1.6001 | 26.4997 | 39 | 2231 | cellular response to organic substance |
GO:0048863 | 0.0081 | 4.2706 | 1.2391 | 5 | 107 | stem cell differentiation |
GO:0042060 | 0.0081 | 2.4461 | 4.7274 | 11 | 398 | wound healing |
GO:0072078 | 0.0083 | 5.3716 | 0.7958 | 4 | 67 | nephron tubule morphogenesis |
GO:0002526 | 0.0083 | 4.2426 | 1.2472 | 5 | 105 | acute inflammatory response |
GO:0034764 | 0.0083 | 3.2101 | 2.2924 | 7 | 193 | positive regulation of transmembrane transport |
GO:0035556 | 0.0084 | 1.5702 | 29.1722 | 42 | 2456 | intracellular signal transduction |
GO:0065009 | 0.0085 | 1.5382 | 33.5314 | 47 | 2823 | regulation of molecular function |
GO:0046661 | 0.0085 | 3.5949 | 1.7579 | 6 | 148 | male sex differentiation |
GO:0008016 | 0.0086 | 3.1928 | 2.3043 | 7 | 194 | regulation of heart contraction |
GO:0003157 | 0.0086 | 16.8 | 0.1425 | 2 | 12 | endocardium development |
GO:0051549 | 0.0086 | 16.8 | 0.1425 | 2 | 12 | positive regulation of keratinocyte migration |
GO:0060576 | 0.0086 | 16.8 | 0.1425 | 2 | 12 | intestinal epithelial cell development |
GO:0071415 | 0.0086 | 16.8 | 0.1425 | 2 | 12 | cellular response to purine-containing compound |
GO:0051046 | 0.0086 | 2.1673 | 6.8061 | 14 | 573 | regulation of secretion |
GO:0070663 | 0.0088 | 3.5736 | 1.7679 | 6 | 152 | regulation of leukocyte proliferation |
GO:0071902 | 0.0088 | 3.1756 | 2.3162 | 7 | 195 | positive regulation of protein serine/threonine kinase activity |
GO:0003016 | 0.0088 | 7.6652 | 0.4276 | 3 | 36 | respiratory system process |
GO:0010863 | 0.0088 | 7.6652 | 0.4276 | 3 | 36 | positive regulation of phospholipase C activity |
GO:0035909 | 0.0088 | 7.6652 | 0.4276 | 3 | 36 | aorta morphogenesis |
GO:0060306 | 0.0088 | 7.6652 | 0.4276 | 3 | 36 | regulation of membrane repolarization |
GO:0070306 | 0.0088 | 7.6652 | 0.4276 | 3 | 36 | lens fiber cell differentiation |
GO:0002376 | 0.0089 | 1.7333 | 16.7688 | 27 | 1482 | immune system process |
GO:0034762 | 0.0089 | 2.6926 | 3.5109 | 9 | 304 | regulation of transmembrane transport |
GO:0001501 | 0.009 | 2.6881 | 3.5173 | 9 | 312 | skeletal system development |
GO:0003018 | 0.0091 | 2.8854 | 2.9101 | 8 | 245 | vascular process in circulatory system |
GO:0007568 | 0.0091 | 3.5445 | 1.7817 | 6 | 150 | aging |
GO:0003407 | 0.0092 | 5.2056 | 0.8196 | 4 | 69 | neural retina development |
GO:0072089 | 0.0092 | 5.2056 | 0.8196 | 4 | 69 | stem cell proliferation |
GO:0051094 | 0.0093 | 2.5259 | 4.1701 | 10 | 387 | positive regulation of developmental process |
GO:0032689 | 0.0095 | 7.4393 | 0.4395 | 3 | 37 | negative regulation of interferon-gamma production |
GO:0060421 | 0.0095 | 7.4393 | 0.4395 | 3 | 37 | positive regulation of heart growth |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 273.323 | 0.4286 | 24 | 31 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 26.3799 | 1.4518 | 26 | 105 | nucleosome assembly |
GO:0045653 | 0 | 265.9671 | 0.2489 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0032200 | 0 | 15.5302 | 2.1156 | 25 | 153 | telomere organization |
GO:0071824 | 0 | 11.8084 | 2.9037 | 27 | 210 | protein-DNA complex subunit organization |
GO:0006336 | 0 | 62.5302 | 0.4286 | 14 | 31 | DNA replication-independent chromatin assembly |
GO:0006338 | 0 | 10.8112 | 3.2632 | 28 | 236 | chromatin remodeling |
GO:0006352 | 0 | 10.635 | 1.6869 | 15 | 122 | DNA-templated transcription, initiation |
GO:0007218 | 0 | 9.3183 | 1.3689 | 11 | 99 | neuropeptide signaling pathway |
GO:0045637 | 0 | 5.8461 | 2.6825 | 14 | 194 | regulation of myeloid cell differentiation |
GO:2000026 | 0 | 2.4093 | 17.7679 | 38 | 1285 | regulation of multicellular organismal development |
GO:0040029 | 0 | 6.0694 | 1.8252 | 10 | 132 | regulation of gene expression, epigenetic |
GO:0032501 | 0 | 1.7524 | 92.8768 | 124 | 6717 | multicellular organismal process |
GO:0048731 | 0 | 1.7873 | 55.7372 | 83 | 4031 | system development |
GO:0065003 | 0 | 2.1732 | 19.4824 | 38 | 1409 | protein-containing complex assembly |
GO:0045596 | 1e-04 | 2.7224 | 8.7941 | 22 | 636 | negative regulation of cell differentiation |
GO:0065007 | 1e-04 | 1.8124 | 157.1039 | 182 | 11362 | biological regulation |
GO:0099538 | 6e-04 | 143.9022 | 0.0415 | 2 | 3 | synaptic signaling via neuropeptide |
GO:1901492 | 6e-04 | 143.9022 | 0.0415 | 2 | 3 | positive regulation of lymphangiogenesis |
GO:0035641 | 0.001 | 18.0558 | 0.2074 | 3 | 15 | locomotory exploration behavior |
GO:0040036 | 0.0011 | 9.996 | 0.4563 | 4 | 33 | regulation of fibroblast growth factor receptor signaling pathway |
GO:1904340 | 0.0011 | 71.9467 | 0.0553 | 2 | 4 | positive regulation of dopaminergic neuron differentiation |
GO:0061326 | 0.0012 | 5.5367 | 1.1753 | 6 | 85 | renal tubule development |
GO:0048869 | 0.0012 | 1.5775 | 53.5525 | 74 | 3873 | cellular developmental process |
GO:0048513 | 0.0012 | 1.7381 | 29.5036 | 46 | 2243 | animal organ development |
GO:0051952 | 0.0012 | 5.4672 | 1.1891 | 6 | 86 | regulation of amine transport |
GO:0014059 | 0.0013 | 9.3499 | 0.4839 | 4 | 35 | regulation of dopamine secretion |
GO:0007156 | 0.0015 | 3.9595 | 2.157 | 8 | 156 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0032502 | 0.0018 | 1.8121 | 23.7721 | 38 | 1949 | developmental process |
GO:0007268 | 0.002 | 2.223 | 9.0983 | 19 | 658 | chemical synaptic transmission |
GO:0099537 | 0.0023 | 2.198 | 9.195 | 19 | 665 | trans-synaptic signaling |
GO:1903792 | 0.0025 | 12.7413 | 0.2765 | 3 | 20 | negative regulation of anion transport |
GO:0050794 | 0.0025 | 1.507 | 138.3266 | 159 | 10004 | regulation of cellular process |
GO:0002322 | 0.0028 | 35.9689 | 0.083 | 2 | 6 | B cell proliferation involved in immune response |
GO:2000302 | 0.0028 | 35.9689 | 0.083 | 2 | 6 | positive regulation of synaptic vesicle exocytosis |
GO:2000481 | 0.0028 | 35.9689 | 0.083 | 2 | 6 | positive regulation of cAMP-dependent protein kinase activity |
GO:0001964 | 0.0033 | 11.3987 | 0.3042 | 3 | 22 | startle response |
GO:0007193 | 0.0036 | 5.2621 | 1.0232 | 5 | 74 | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO:0050859 | 0.0038 | 28.7733 | 0.0968 | 2 | 7 | negative regulation of B cell receptor signaling pathway |
GO:1900748 | 0.0038 | 28.7733 | 0.0968 | 2 | 7 | positive regulation of vascular endothelial growth factor signaling pathway |
GO:1990414 | 0.0038 | 28.7733 | 0.0968 | 2 | 7 | replication-born double-strand break repair via sister chromatid exchange |
GO:0015872 | 0.0046 | 6.4355 | 0.6775 | 4 | 49 | dopamine transport |
GO:0009887 | 0.0049 | 1.8756 | 13.6059 | 24 | 984 | animal organ morphogenesis |
GO:0060452 | 0.005 | 23.9763 | 0.1106 | 2 | 8 | positive regulation of cardiac muscle contraction |
GO:1903671 | 0.0054 | 9.414 | 0.3595 | 3 | 26 | negative regulation of sprouting angiogenesis |
GO:0051291 | 0.006 | 9.0212 | 0.3733 | 3 | 27 | protein heterooligomerization |
GO:0001993 | 0.0064 | 20.5498 | 0.1244 | 2 | 9 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
GO:1903244 | 0.0064 | 20.5498 | 0.1244 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0050432 | 0.007 | 5.6763 | 0.7605 | 4 | 55 | catecholamine secretion |
GO:1905205 | 0.008 | 17.98 | 0.1383 | 2 | 10 | positive regulation of connective tissue replacement |
GO:0001662 | 0.008 | 8.0174 | 0.4148 | 3 | 30 | behavioral fear response |
GO:0030097 | 0.0084 | 1.8935 | 11.1447 | 20 | 806 | hemopoiesis |
GO:0099601 | 0.0084 | 5.3599 | 0.802 | 4 | 58 | regulation of neurotransmitter receptor activity |
GO:0044085 | 0.0086 | 1.4853 | 40.4167 | 55 | 2923 | cellular component biogenesis |
GO:0071875 | 0.0088 | 7.7305 | 0.4286 | 3 | 31 | adrenergic receptor signaling pathway |
GO:0072073 | 0.0091 | 3.5464 | 1.7837 | 6 | 129 | kidney epithelium development |
GO:0019233 | 0.0094 | 4.1211 | 1.2859 | 5 | 93 | sensory perception of pain |
GO:0010739 | 0.0096 | 15.9812 | 0.1521 | 2 | 11 | positive regulation of protein kinase A signaling |
GO:0072017 | 0.0096 | 15.9812 | 0.1521 | 2 | 11 | distal tubule development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 271.9664 | 0.4305 | 24 | 31 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 24.7983 | 1.4582 | 25 | 105 | nucleosome assembly |
GO:0045653 | 0 | 264.7079 | 0.25 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0032200 | 0 | 14.6466 | 2.1249 | 24 | 153 | telomere organization |
GO:0006336 | 0 | 62.2342 | 0.4305 | 14 | 31 | DNA replication-independent chromatin assembly |
GO:0071824 | 0 | 10.6537 | 2.9165 | 25 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 9.3258 | 3.2776 | 25 | 236 | chromatin remodeling |
GO:2000026 | 0 | 3.5838 | 17.8461 | 52 | 1285 | regulation of multicellular organismal development |
GO:0045637 | 0 | 8.85 | 2.6943 | 20 | 194 | regulation of myeloid cell differentiation |
GO:0045596 | 0 | 4.3742 | 8.8328 | 33 | 636 | negative regulation of cell differentiation |
GO:0048869 | 0 | 2.4576 | 47.8954 | 88 | 3617 | cellular developmental process |
GO:0006352 | 0 | 9.741 | 1.6943 | 14 | 122 | DNA-templated transcription, initiation |
GO:0007399 | 0 | 2.6171 | 29.6251 | 63 | 2171 | nervous system development |
GO:0051674 | 0 | 2.5652 | 22.3597 | 49 | 1610 | localization of cell |
GO:0002520 | 0 | 3.0972 | 12.5131 | 34 | 901 | immune system development |
GO:0007275 | 0 | 2.4416 | 32.2318 | 61 | 2883 | multicellular organism development |
GO:0030097 | 0 | 4.7751 | 3.9767 | 17 | 297 | hemopoiesis |
GO:0048519 | 0 | 1.9429 | 72.6761 | 108 | 5233 | negative regulation of biological process |
GO:0050789 | 0 | 8.3514 | 1.7408 | 11 | 224 | regulation of biological process |
GO:0048513 | 0 | 2.6097 | 18.6019 | 41 | 1549 | animal organ development |
GO:0040011 | 0 | 2.8855 | 10.0533 | 26 | 771 | locomotion |
GO:0050794 | 0 | 2.0182 | 95.3727 | 123 | 7879 | regulation of cellular process |
GO:0045165 | 0 | 4.311 | 3.5553 | 14 | 256 | cell fate commitment |
GO:0040029 | 0 | 6.0411 | 1.8332 | 10 | 132 | regulation of gene expression, epigenetic |
GO:0048598 | 0 | 2.9584 | 7.7501 | 21 | 565 | embryonic morphogenesis |
GO:0007420 | 0 | 2.7124 | 9.68 | 24 | 697 | brain development |
GO:0048704 | 0 | 6.9719 | 1.2777 | 8 | 92 | embryonic skeletal system morphogenesis |
GO:0030182 | 0 | 6.9564 | 1.2781 | 8 | 102 | neuron differentiation |
GO:0010975 | 1e-04 | 3.2985 | 5.5969 | 17 | 403 | regulation of neuron projection development |
GO:0048665 | 1e-04 | 14.4969 | 0.4166 | 5 | 30 | neuron fate specification |
GO:0045597 | 1e-04 | 2.5462 | 11.1799 | 26 | 805 | positive regulation of cell differentiation |
GO:0072001 | 1e-04 | 3.7306 | 4.0692 | 14 | 293 | renal system development |
GO:0048880 | 1e-04 | 3.3566 | 5.1664 | 16 | 372 | sensory system development |
GO:0021542 | 1e-04 | 22.2198 | 0.2361 | 4 | 17 | dentate gyrus development |
GO:0035270 | 1e-04 | 5.5031 | 1.7916 | 9 | 129 | endocrine system development |
GO:0021543 | 1e-04 | 4.8721 | 2.236 | 10 | 161 | pallium development |
GO:1900122 | 1e-04 | 53.95 | 0.0972 | 3 | 7 | positive regulation of receptor binding |
GO:0009952 | 1e-04 | 4.2913 | 2.7776 | 11 | 200 | anterior/posterior pattern specification |
GO:0097659 | 1e-04 | 1.7733 | 43.664 | 67 | 3144 | nucleic acid-templated transcription |
GO:0009887 | 1e-04 | 2.3181 | 13.2078 | 28 | 967 | animal organ morphogenesis |
GO:0035239 | 2e-04 | 2.3717 | 11.9404 | 26 | 867 | tube morphogenesis |
GO:0001654 | 2e-04 | 3.2151 | 5.0275 | 15 | 362 | eye development |
GO:0006928 | 2e-04 | 2.328 | 12.7535 | 27 | 981 | movement of cell or subcellular component |
GO:0072272 | 2e-04 | Inf | 0.0278 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
GO:0140039 | 2e-04 | Inf | 0.0278 | 2 | 2 | cell-cell adhesion in response to extracellular stimulus |
GO:0001501 | 2e-04 | 2.8173 | 6.8885 | 18 | 496 | skeletal system development |
GO:0099560 | 2e-04 | 16.0427 | 0.3055 | 4 | 22 | synaptic membrane adhesion |
GO:0120039 | 2e-04 | 2.6205 | 8.2356 | 20 | 593 | plasma membrane bounded cell projection morphogenesis |
GO:0065003 | 3e-04 | 2.0233 | 19.5683 | 36 | 1409 | protein-containing complex assembly |
GO:0002682 | 3e-04 | 2.0819 | 17.3601 | 33 | 1250 | regulation of immune system process |
GO:0048666 | 3e-04 | 2.1924 | 13.8945 | 28 | 1013 | neuron development |
GO:0022603 | 3e-04 | 2.2582 | 12.4854 | 26 | 899 | regulation of anatomical structure morphogenesis |
GO:0048568 | 3e-04 | 2.8758 | 5.9719 | 16 | 430 | embryonic organ development |
GO:0060384 | 4e-04 | 13.7483 | 0.3472 | 4 | 25 | innervation |
GO:0032990 | 4e-04 | 2.5244 | 8.5273 | 20 | 614 | cell part morphogenesis |
GO:0002009 | 4e-04 | 2.7184 | 6.7079 | 17 | 483 | morphogenesis of an epithelium |
GO:0051270 | 5e-04 | 2.1152 | 14.3463 | 28 | 1033 | regulation of cellular component movement |
GO:0034654 | 6e-04 | 1.6395 | 48.8026 | 70 | 3514 | nucleobase-containing compound biosynthetic process |
GO:0048732 | 6e-04 | 2.8085 | 5.708 | 15 | 411 | gland development |
GO:0048935 | 7e-04 | 21.572 | 0.1805 | 3 | 13 | peripheral nervous system neuron development |
GO:1901701 | 7e-04 | 2.0489 | 15.3324 | 29 | 1104 | cellular response to oxygen-containing compound |
GO:0043200 | 7e-04 | 5.0961 | 1.486 | 7 | 107 | response to amino acid |
GO:0040012 | 7e-04 | 2.0961 | 13.9158 | 27 | 1002 | regulation of locomotion |
GO:0061053 | 9e-04 | 5.8068 | 1.1249 | 6 | 81 | somite development |
GO:0050767 | 9e-04 | 2.9422 | 4.708 | 13 | 339 | regulation of neurogenesis |
GO:0000904 | 0.001 | 2.3285 | 9.1939 | 20 | 662 | cell morphogenesis involved in differentiation |
GO:0060041 | 0.001 | 4.2607 | 2.0138 | 8 | 145 | retina development in camera-type eye |
GO:0010951 | 0.001 | 3.5244 | 3.0276 | 10 | 218 | negative regulation of endopeptidase activity |
GO:0051240 | 0.001 | 1.9126 | 18.735 | 33 | 1349 | positive regulation of multicellular organismal process |
GO:0001656 | 0.001 | 5.6553 | 1.1527 | 6 | 83 | metanephros development |
GO:0072086 | 0.0011 | 71.6239 | 0.0556 | 2 | 4 | specification of loop of Henle identity |
GO:0097476 | 0.0011 | 71.6239 | 0.0556 | 2 | 4 | spinal cord motor neuron migration |
GO:0001503 | 0.0011 | 2.7513 | 5.4163 | 14 | 390 | ossification |
GO:0001568 | 0.0012 | 2.2381 | 10.0411 | 21 | 723 | blood vessel development |
GO:0009719 | 0.0012 | 1.8546 | 20.5126 | 35 | 1477 | response to endogenous stimulus |
GO:0007379 | 0.0013 | 16.5908 | 0.2222 | 3 | 16 | segment specification |
GO:0001764 | 0.0014 | 3.9958 | 2.1388 | 8 | 154 | neuron migration |
GO:0032502 | 0.0016 | 2.074 | 14.2808 | 26 | 1473 | developmental process |
GO:0009888 | 0.0016 | 1.8245 | 20.8707 | 35 | 1541 | tissue development |
GO:0060255 | 0.0017 | 1.4991 | 82.1061 | 104 | 5912 | regulation of macromolecule metabolic process |
GO:0031344 | 0.0018 | 2.3067 | 8.305 | 18 | 598 | regulation of cell projection organization |
GO:0052547 | 0.0018 | 2.6091 | 5.6941 | 14 | 410 | regulation of peptidase activity |
GO:0060059 | 0.0019 | 47.7463 | 0.0694 | 2 | 5 | embryonic retina morphogenesis in camera-type eye |
GO:2000977 | 0.0019 | 47.7463 | 0.0694 | 2 | 5 | regulation of forebrain neuron differentiation |
GO:0007409 | 0.002 | 2.8271 | 4.5012 | 12 | 330 | axonogenesis |
GO:1901698 | 0.0021 | 1.9613 | 14.2075 | 26 | 1023 | response to nitrogen compound |
GO:0048863 | 0.0022 | 3.3883 | 2.8193 | 9 | 203 | stem cell differentiation |
GO:0042127 | 0.0023 | 2.0725 | 11.3774 | 22 | 867 | regulation of cell population proliferation |
GO:2000178 | 0.0025 | 12.6839 | 0.2778 | 3 | 20 | negative regulation of neural precursor cell proliferation |
GO:0035924 | 0.0025 | 5.7392 | 0.9444 | 5 | 68 | cellular response to vascular endothelial growth factor stimulus |
GO:0045123 | 0.0025 | 5.7392 | 0.9444 | 5 | 68 | cellular extravasation |
GO:0050772 | 0.0025 | 5.7392 | 0.9444 | 5 | 68 | positive regulation of axonogenesis |
GO:0014002 | 0.0027 | 7.5898 | 0.5833 | 4 | 42 | astrocyte development |
GO:0035850 | 0.0027 | 7.5898 | 0.5833 | 4 | 42 | epithelial cell differentiation involved in kidney development |
GO:0050793 | 0.0027 | 2.3487 | 7.3028 | 16 | 635 | regulation of developmental process |
GO:0072009 | 0.0027 | 4.6277 | 1.3888 | 6 | 100 | nephron epithelium development |
GO:0003278 | 0.0028 | 35.8075 | 0.0833 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0021707 | 0.0028 | 35.8075 | 0.0833 | 2 | 6 | cerebellar granule cell differentiation |
GO:0031547 | 0.0028 | 35.8075 | 0.0833 | 2 | 6 | brain-derived neurotrophic factor receptor signaling pathway |
GO:0055009 | 0.0028 | 35.8075 | 0.0833 | 2 | 6 | atrial cardiac muscle tissue morphogenesis |
GO:0016477 | 0.0028 | 2.5881 | 5.3344 | 13 | 417 | cell migration |
GO:0007631 | 0.0028 | 4.5787 | 1.4027 | 6 | 101 | feeding behavior |
GO:0021761 | 0.0028 | 4.5787 | 1.4027 | 6 | 101 | limbic system development |
GO:0061333 | 0.0029 | 5.5619 | 0.9722 | 5 | 70 | renal tubule morphogenesis |
GO:0035019 | 0.0029 | 7.3947 | 0.5972 | 4 | 43 | somatic stem cell population maintenance |
GO:1904646 | 0.0029 | 7.3947 | 0.5972 | 4 | 43 | cellular response to amyloid-beta |
GO:0045664 | 0.0033 | 3.4573 | 2.4511 | 8 | 178 | regulation of neuron differentiation |
GO:0072359 | 0.0036 | 1.8571 | 15.5407 | 27 | 1119 | circulatory system development |
GO:0008285 | 0.0036 | 2.1013 | 9.5917 | 19 | 699 | negative regulation of cell population proliferation |
GO:0048146 | 0.0037 | 6.8652 | 0.6388 | 4 | 46 | positive regulation of fibroblast proliferation |
GO:0021697 | 0.0038 | 10.7793 | 0.3194 | 3 | 23 | cerebellar cortex formation |
GO:0021871 | 0.0038 | 10.7793 | 0.3194 | 3 | 23 | forebrain regionalization |
GO:0021796 | 0.0039 | 28.6442 | 0.0972 | 2 | 7 | cerebral cortex regionalization |
GO:0060215 | 0.0039 | 28.6442 | 0.0972 | 2 | 7 | primitive hemopoiesis |
GO:0072197 | 0.0039 | 28.6442 | 0.0972 | 2 | 7 | ureter morphogenesis |
GO:0007422 | 0.0039 | 5.163 | 1.0416 | 5 | 75 | peripheral nervous system development |
GO:0071417 | 0.0039 | 2.18 | 8.2495 | 17 | 594 | cellular response to organonitrogen compound |
GO:0050885 | 0.004 | 6.7051 | 0.6527 | 4 | 47 | neuromuscular process controlling balance |
GO:0030334 | 0.0041 | 1.9355 | 12.6381 | 23 | 910 | regulation of cell migration |
GO:0048699 | 0.0041 | 10.3444 | 0.3272 | 3 | 27 | generation of neurons |
GO:2000679 | 0.0043 | 10.2654 | 0.3333 | 3 | 24 | positive regulation of transcription regulatory region DNA binding |
GO:0048589 | 0.0044 | 2.1529 | 8.3467 | 17 | 601 | developmental growth |
GO:0050807 | 0.0045 | 3.2709 | 2.5832 | 8 | 186 | regulation of synapse organization |
GO:0001525 | 0.0049 | 2.1871 | 7.7218 | 16 | 556 | angiogenesis |
GO:1990266 | 0.0049 | 4.0621 | 1.5693 | 6 | 113 | neutrophil migration |
GO:2000179 | 0.0051 | 6.2667 | 0.6944 | 4 | 50 | positive regulation of neural precursor cell proliferation |
GO:0021683 | 0.0051 | 23.8687 | 0.1111 | 2 | 8 | cerebellar granular layer morphogenesis |
GO:0035881 | 0.0051 | 23.8687 | 0.1111 | 2 | 8 | amacrine cell differentiation |
GO:1903998 | 0.0051 | 23.8687 | 0.1111 | 2 | 8 | regulation of eating behavior |
GO:2000739 | 0.0051 | 23.8687 | 0.1111 | 2 | 8 | regulation of mesenchymal stem cell differentiation |
GO:0002521 | 0.0051 | 2.2374 | 7.069 | 15 | 509 | leukocyte differentiation |
GO:0043009 | 0.0053 | 2.1116 | 8.4995 | 17 | 612 | chordate embryonic development |
GO:0001706 | 0.0054 | 6.133 | 0.7083 | 4 | 51 | endoderm formation |
GO:0033993 | 0.0055 | 1.9438 | 11.4437 | 21 | 824 | response to lipid |
GO:0007389 | 0.0055 | 2.3693 | 5.777 | 13 | 421 | pattern specification process |
GO:0016070 | 0.0056 | 1.4507 | 61.274 | 79 | 4412 | RNA metabolic process |
GO:0034103 | 0.0057 | 4.6916 | 1.1388 | 5 | 82 | regulation of tissue remodeling |
GO:0021953 | 0.0057 | 3.4635 | 2.1345 | 7 | 155 | central nervous system neuron differentiation |
GO:0061756 | 0.0058 | 6.0048 | 0.7222 | 4 | 52 | leukocyte adhesion to vascular endothelial cell |
GO:0045785 | 0.0059 | 2.3505 | 5.8191 | 13 | 419 | positive regulation of cell adhesion |
GO:0086011 | 0.006 | 8.9806 | 0.375 | 3 | 27 | membrane repolarization during action potential |
GO:0051346 | 0.0061 | 2.5463 | 4.5414 | 11 | 327 | negative regulation of hydrolase activity |
GO:0051965 | 0.0062 | 5.8819 | 0.7361 | 4 | 53 | positive regulation of synapse assembly |
GO:0046548 | 0.0065 | 20.4576 | 0.125 | 2 | 9 | retinal rod cell development |
GO:0061004 | 0.0065 | 20.4576 | 0.125 | 2 | 9 | pattern specification involved in kidney development |
GO:1903244 | 0.0065 | 20.4576 | 0.125 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0002042 | 0.0069 | 4.4588 | 1.1944 | 5 | 86 | cell migration involved in sprouting angiogenesis |
GO:0030198 | 0.007 | 2.635 | 3.9859 | 10 | 287 | extracellular matrix organization |
GO:0051055 | 0.0071 | 5.6506 | 0.7638 | 4 | 55 | negative regulation of lipid biosynthetic process |
GO:0003206 | 0.0074 | 3.7126 | 1.7082 | 6 | 123 | cardiac chamber morphogenesis |
GO:0045667 | 0.0074 | 3.7126 | 1.7082 | 6 | 123 | regulation of osteoblast differentiation |
GO:0045944 | 0.0076 | 1.7622 | 15.6657 | 26 | 1128 | positive regulation of transcription by RNA polymerase II |
GO:0061448 | 0.0078 | 2.7543 | 3.4303 | 9 | 247 | connective tissue development |
GO:0051099 | 0.0078 | 3.2553 | 2.2638 | 7 | 163 | positive regulation of binding |
GO:0030316 | 0.008 | 4.2988 | 1.236 | 5 | 89 | osteoclast differentiation |
GO:0032525 | 0.008 | 17.8993 | 0.1389 | 2 | 10 | somite rostral/caudal axis specification |
GO:0048703 | 0.008 | 17.8993 | 0.1389 | 2 | 10 | embryonic viscerocranium morphogenesis |
GO:0060536 | 0.008 | 17.8993 | 0.1389 | 2 | 10 | cartilage morphogenesis |
GO:1905205 | 0.008 | 17.8993 | 0.1389 | 2 | 10 | positive regulation of connective tissue replacement |
GO:0021885 | 0.0086 | 5.3356 | 0.8055 | 4 | 58 | forebrain cell migration |
GO:0046620 | 0.0087 | 4.1983 | 1.2638 | 5 | 91 | regulation of organ growth |
GO:0009991 | 0.009 | 2.2213 | 6.1385 | 13 | 442 | response to extracellular stimulus |
GO:0032835 | 0.0091 | 5.2383 | 0.8194 | 4 | 59 | glomerulus development |
GO:0045861 | 0.0096 | 2.5061 | 4.1803 | 10 | 301 | negative regulation of proteolysis |
GO:0009059 | 0.0096 | 1.417 | 58.8297 | 75 | 4236 | macromolecule biosynthetic process |
GO:1903238 | 0.0097 | 15.9095 | 0.1528 | 2 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0010001 | 0.0099 | 2.8353 | 2.9582 | 8 | 213 | glial cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051674 | 0 | 2.76 | 13.7297 | 32 | 1610 | localization of cell |
GO:0006952 | 1e-04 | 2.4104 | 12.749 | 27 | 1495 | defense response |
GO:0030198 | 2e-04 | 4.4432 | 2.4475 | 10 | 287 | extracellular matrix organization |
GO:0016477 | 3e-04 | 3.4398 | 4.1563 | 13 | 524 | cell migration |
GO:1990266 | 4e-04 | 6.7666 | 0.9636 | 6 | 113 | neutrophil migration |
GO:0051270 | 5e-04 | 2.5114 | 8.8092 | 20 | 1033 | regulation of cellular component movement |
GO:0019800 | 7e-04 | 78.6184 | 0.0426 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0060978 | 7e-04 | 78.6184 | 0.0426 | 2 | 5 | angiogenesis involved in coronary vascular morphogenesis |
GO:0070779 | 7e-04 | 78.6184 | 0.0426 | 2 | 5 | D-aspartate import across plasma membrane |
GO:0045766 | 7e-04 | 5.0772 | 1.4838 | 7 | 174 | positive regulation of angiogenesis |
GO:0040012 | 9e-04 | 2.4431 | 8.5448 | 19 | 1002 | regulation of locomotion |
GO:0045785 | 9e-04 | 3.3166 | 3.5731 | 11 | 419 | positive regulation of cell adhesion |
GO:0042940 | 0.0011 | 58.9601 | 0.0512 | 2 | 6 | D-amino acid transport |
GO:0060017 | 0.0011 | 58.9601 | 0.0512 | 2 | 6 | parathyroid gland development |
GO:0048514 | 0.0013 | 2.7281 | 5.5516 | 14 | 651 | blood vessel morphogenesis |
GO:0019730 | 0.0014 | 6.5877 | 0.8187 | 5 | 96 | antimicrobial humoral response |
GO:0035295 | 0.0016 | 2.3101 | 8.9968 | 19 | 1055 | tube development |
GO:0006026 | 0.0019 | 13.687 | 0.2473 | 3 | 29 | aminoglycan catabolic process |
GO:0030334 | 0.0019 | 2.381 | 7.7602 | 17 | 910 | regulation of cell migration |
GO:0002526 | 0.002 | 5.9915 | 0.8954 | 5 | 105 | acute inflammatory response |
GO:0007399 | 0.0021 | 1.882 | 19.1533 | 32 | 2246 | nervous system development |
GO:0061180 | 0.0023 | 7.8187 | 0.5543 | 4 | 65 | mammary gland epithelium development |
GO:0043534 | 0.0024 | 4.7188 | 1.3559 | 6 | 159 | blood vessel endothelial cell migration |
GO:0035924 | 0.0027 | 7.4508 | 0.5799 | 4 | 68 | cellular response to vascular endothelial growth factor stimulus |
GO:0040011 | 0.0029 | 2.5126 | 6.052 | 14 | 771 | locomotion |
GO:0003008 | 0.0029 | 1.8887 | 17.1152 | 29 | 2007 | system process |
GO:0090049 | 0.003 | 7.2242 | 0.5969 | 4 | 70 | regulation of cell migration involved in sprouting angiogenesis |
GO:0072359 | 0.0031 | 2.1665 | 9.5425 | 19 | 1119 | circulatory system development |
GO:0008285 | 0.0034 | 2.4542 | 6.1314 | 14 | 719 | negative regulation of cell population proliferation |
GO:0098739 | 0.0036 | 4.3457 | 1.4668 | 6 | 172 | import across plasma membrane |
GO:0002430 | 0.0038 | 26.1965 | 0.0938 | 2 | 11 | complement receptor mediated signaling pathway |
GO:0006029 | 0.0039 | 6.7133 | 0.6396 | 4 | 75 | proteoglycan metabolic process |
GO:0009605 | 0.0039 | 1.785 | 20.7309 | 33 | 2431 | response to external stimulus |
GO:0030154 | 0.0045 | 1.6794 | 29.5693 | 43 | 3593 | cell differentiation |
GO:0048699 | 0.0048 | 1.9996 | 11.4357 | 21 | 1341 | generation of neurons |
GO:0030534 | 0.0048 | 4.8642 | 1.0916 | 5 | 128 | adult behavior |
GO:0010623 | 0.0053 | 21.4308 | 0.1109 | 2 | 13 | programmed cell death involved in cell development |
GO:0061448 | 0.0053 | 3.5169 | 2.1064 | 7 | 247 | connective tissue development |
GO:0035850 | 0.0055 | 9.1173 | 0.3582 | 3 | 42 | epithelial cell differentiation involved in kidney development |
GO:1901342 | 0.0062 | 3.1012 | 2.7289 | 8 | 320 | regulation of vasculature development |
GO:0045165 | 0.0064 | 3.3879 | 2.1831 | 7 | 256 | cell fate commitment |
GO:0002070 | 0.007 | 18.1315 | 0.1279 | 2 | 15 | epithelial cell maturation |
GO:0006857 | 0.007 | 18.1315 | 0.1279 | 2 | 15 | oligopeptide transport |
GO:0033599 | 0.007 | 18.1315 | 0.1279 | 2 | 15 | regulation of mammary gland epithelial cell proliferation |
GO:0048712 | 0.007 | 18.1315 | 0.1279 | 2 | 15 | negative regulation of astrocyte differentiation |
GO:0042060 | 0.0071 | 2.806 | 3.394 | 9 | 398 | wound healing |
GO:0048260 | 0.0075 | 8.0788 | 0.4008 | 3 | 47 | positive regulation of receptor-mediated endocytosis |
GO:0001655 | 0.0075 | 2.9935 | 2.8227 | 8 | 331 | urogenital system development |
GO:0046620 | 0.0076 | 5.4733 | 0.776 | 4 | 91 | regulation of organ growth |
GO:0010631 | 0.0077 | 2.9841 | 2.8312 | 8 | 332 | epithelial cell migration |
GO:0010810 | 0.0079 | 3.6548 | 1.7311 | 6 | 203 | regulation of cell-substrate adhesion |
GO:0048704 | 0.0079 | 5.4108 | 0.7846 | 4 | 92 | embryonic skeletal system morphogenesis |
GO:0055119 | 0.008 | 16.8354 | 0.1364 | 2 | 16 | relaxation of cardiac muscle |
GO:0060749 | 0.008 | 16.8354 | 0.1364 | 2 | 16 | mammary gland alveolus development |
GO:1990573 | 0.0084 | 7.7266 | 0.4179 | 3 | 49 | potassium ion import across plasma membrane |
GO:0002435 | 0.0085 | Inf | 0.0085 | 1 | 1 | immune complex clearance by erythrocytes |
GO:0010625 | 0.0085 | Inf | 0.0085 | 1 | 1 | positive regulation of Schwann cell proliferation |
GO:0014843 | 0.0085 | Inf | 0.0085 | 1 | 1 | growth factor dependent regulation of skeletal muscle satellite cell proliferation |
GO:0014861 | 0.0085 | Inf | 0.0085 | 1 | 1 | regulation of skeletal muscle contraction via regulation of action potential |
GO:0032903 | 0.0085 | Inf | 0.0085 | 1 | 1 | regulation of nerve growth factor production |
GO:0036138 | 0.0085 | Inf | 0.0085 | 1 | 1 | peptidyl-histidine hydroxylation |
GO:0042265 | 0.0085 | Inf | 0.0085 | 1 | 1 | peptidyl-asparagine hydroxylation |
GO:0046521 | 0.0085 | Inf | 0.0085 | 1 | 1 | sphingoid catabolic process |
GO:0048572 | 0.0085 | Inf | 0.0085 | 1 | 1 | short-day photoperiodism |
GO:0050783 | 0.0085 | Inf | 0.0085 | 1 | 1 | cocaine metabolic process |
GO:0060404 | 0.0085 | Inf | 0.0085 | 1 | 1 | axonemal microtubule depolymerization |
GO:0060945 | 0.0085 | Inf | 0.0085 | 1 | 1 | cardiac neuron differentiation |
GO:0061682 | 0.0085 | Inf | 0.0085 | 1 | 1 | seminal vesicle morphogenesis |
GO:0070158 | 0.0085 | Inf | 0.0085 | 1 | 1 | mitochondrial seryl-tRNA aminoacylation |
GO:0070462 | 0.0085 | Inf | 0.0085 | 1 | 1 | plus-end specific microtubule depolymerization |
GO:0071449 | 0.0085 | Inf | 0.0085 | 1 | 1 | cellular response to lipid hydroperoxide |
GO:1900099 | 0.0085 | Inf | 0.0085 | 1 | 1 | negative regulation of plasma cell differentiation |
GO:1901170 | 0.0085 | Inf | 0.0085 | 1 | 1 | naphthalene catabolic process |
GO:1902203 | 0.0085 | Inf | 0.0085 | 1 | 1 | negative regulation of hepatocyte growth factor receptor signaling pathway |
GO:1902748 | 0.0085 | Inf | 0.0085 | 1 | 1 | positive regulation of lens fiber cell differentiation |
GO:1904445 | 0.0085 | Inf | 0.0085 | 1 | 1 | negative regulation of establishment of Sertoli cell barrier |
GO:1905364 | 0.0085 | Inf | 0.0085 | 1 | 1 | regulation of endosomal vesicle fusion |
GO:2001113 | 0.0085 | Inf | 0.0085 | 1 | 1 | negative regulation of cellular response to hepatocyte growth factor stimulus |
GO:0090130 | 0.0086 | 2.9197 | 2.8909 | 8 | 339 | tissue migration |
GO:2000179 | 0.0089 | 7.5617 | 0.4264 | 3 | 50 | positive regulation of neural precursor cell proliferation |
GO:0031175 | 0.009 | 2.1123 | 7.5897 | 15 | 890 | neuron projection development |
GO:0060291 | 0.0092 | 5.1742 | 0.8187 | 4 | 96 | long-term synaptic potentiation |
GO:0006812 | 0.0092 | 2.0084 | 9.082 | 17 | 1065 | cation transport |
GO:0006928 | 0.0093 | 2.1145 | 7.6521 | 15 | 981 | movement of cell or subcellular component |
GO:0006826 | 0.0094 | 7.4037 | 0.4349 | 3 | 51 | iron ion transport |
GO:0097529 | 0.0095 | 3.5104 | 1.7994 | 6 | 211 | myeloid leukocyte migration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048870 | 0 | 3.396 | 9.0149 | 26 | 1068 | cell motility |
GO:0031175 | 0 | 3.0018 | 7.8608 | 21 | 890 | neuron projection development |
GO:0030182 | 0 | 2.6502 | 11.1842 | 26 | 1275 | neuron differentiation |
GO:0022008 | 1e-04 | 2.4387 | 13.6194 | 29 | 1542 | neurogenesis |
GO:0048869 | 1e-04 | 1.9934 | 34.2075 | 55 | 3873 | cellular developmental process |
GO:0032827 | 1e-04 | Inf | 0.0177 | 2 | 2 | negative regulation of natural killer cell differentiation involved in immune response |
GO:0048252 | 1e-04 | Inf | 0.0177 | 2 | 2 | lauric acid metabolic process |
GO:0051270 | 1e-04 | 2.6999 | 9.1238 | 22 | 1033 | regulation of cellular component movement |
GO:0032501 | 1e-04 | 2.0373 | 38.2422 | 58 | 4710 | multicellular organismal process |
GO:0051179 | 1e-04 | 1.872 | 50.2293 | 72 | 5687 | localization |
GO:0040012 | 2e-04 | 2.6398 | 8.85 | 21 | 1002 | regulation of locomotion |
GO:0097377 | 2e-04 | 227.5664 | 0.0265 | 2 | 3 | spinal cord interneuron axon guidance |
GO:0030198 | 2e-04 | 4.2773 | 2.5349 | 10 | 287 | extracellular matrix organization |
GO:0120039 | 2e-04 | 3.133 | 5.2376 | 15 | 593 | plasma membrane bounded cell projection morphogenesis |
GO:0009653 | 3e-04 | 2.0041 | 22.6372 | 39 | 2563 | anatomical structure morphogenesis |
GO:0035924 | 3e-04 | 9.1888 | 0.6006 | 5 | 68 | cellular response to vascular endothelial growth factor stimulus |
GO:0032095 | 3e-04 | 26.4231 | 0.1413 | 3 | 16 | regulation of response to food |
GO:0032990 | 4e-04 | 3.0191 | 5.423 | 15 | 614 | cell part morphogenesis |
GO:2000026 | 4e-04 | 2.3611 | 11.3495 | 24 | 1285 | regulation of multicellular organismal development |
GO:0035295 | 4e-04 | 2.4958 | 9.3181 | 21 | 1055 | tube development |
GO:0001764 | 4e-04 | 5.5642 | 1.3602 | 7 | 154 | neuron migration |
GO:0097476 | 5e-04 | 113.7762 | 0.0353 | 2 | 4 | spinal cord motor neuron migration |
GO:0098742 | 5e-04 | 4.2759 | 2.2699 | 9 | 257 | cell-cell adhesion via plasma-membrane adhesion molecules |
GO:0019373 | 5e-04 | 22.8972 | 0.159 | 3 | 18 | epoxygenase P450 pathway |
GO:0043651 | 5e-04 | 22.8972 | 0.159 | 3 | 18 | linoleic acid metabolic process |
GO:0048731 | 5e-04 | 2.1186 | 17.9226 | 32 | 2385 | system development |
GO:0033273 | 6e-04 | 7.9251 | 0.6889 | 5 | 78 | response to vitamin |
GO:0048514 | 6e-04 | 2.8367 | 5.7498 | 15 | 651 | blood vessel morphogenesis |
GO:0048513 | 7e-04 | 1.8512 | 28.5019 | 45 | 3227 | animal organ development |
GO:0019800 | 8e-04 | 75.8462 | 0.0442 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0070779 | 8e-04 | 75.8462 | 0.0442 | 2 | 5 | D-aspartate import across plasma membrane |
GO:0007169 | 9e-04 | 2.8506 | 5.317 | 14 | 602 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0071715 | 0.001 | 10.0068 | 0.4416 | 4 | 50 | icosanoid transport |
GO:0061005 | 0.0011 | 9.7933 | 0.4504 | 4 | 51 | cell differentiation involved in kidney development |
GO:0042127 | 0.0011 | 2.2129 | 11.537 | 23 | 1353 | regulation of cell population proliferation |
GO:0001944 | 0.0011 | 2.5996 | 6.6861 | 16 | 757 | vasculature development |
GO:0009253 | 0.0011 | 56.8811 | 0.053 | 2 | 6 | peptidoglycan catabolic process |
GO:0042940 | 0.0011 | 56.8811 | 0.053 | 2 | 6 | D-amino acid transport |
GO:0070482 | 0.0012 | 3.7122 | 2.5967 | 9 | 294 | response to oxygen levels |
GO:0045785 | 0.0012 | 3.1918 | 3.7007 | 11 | 419 | positive regulation of cell adhesion |
GO:0042102 | 0.0013 | 6.6441 | 0.8126 | 5 | 92 | positive regulation of T cell proliferation |
GO:0048704 | 0.0013 | 6.6441 | 0.8126 | 5 | 92 | embryonic skeletal system morphogenesis |
GO:0032104 | 0.0013 | 15.605 | 0.2208 | 3 | 25 | regulation of response to extracellular stimulus |
GO:0030030 | 0.0016 | 2.1021 | 12.6037 | 24 | 1427 | cell projection organization |
GO:0051093 | 0.0016 | 2.4187 | 7.6311 | 17 | 864 | negative regulation of developmental process |
GO:0070977 | 0.0017 | 14.3028 | 0.2385 | 3 | 27 | bone maturation |
GO:0002694 | 0.002 | 2.8461 | 4.5221 | 12 | 512 | regulation of leukocyte activation |
GO:0030097 | 0.002 | 2.4307 | 7.1188 | 16 | 806 | hemopoiesis |
GO:0001666 | 0.0022 | 3.6973 | 2.3052 | 8 | 261 | response to hypoxia |
GO:0048665 | 0.0023 | 12.7113 | 0.265 | 3 | 30 | neuron fate specification |
GO:0002526 | 0.0024 | 5.7757 | 0.9274 | 5 | 105 | acute inflammatory response |
GO:0002520 | 0.0025 | 2.3119 | 7.9579 | 17 | 901 | immune system development |
GO:0048589 | 0.0026 | 2.6269 | 5.3082 | 13 | 601 | developmental growth |
GO:0050670 | 0.0026 | 4.0152 | 1.8548 | 7 | 210 | regulation of lymphocyte proliferation |
GO:0008343 | 0.0027 | 32.4975 | 0.0795 | 2 | 9 | adult feeding behavior |
GO:0032815 | 0.0027 | 32.4975 | 0.0795 | 2 | 9 | negative regulation of natural killer cell activation |
GO:0006690 | 0.0027 | 5.6064 | 0.9539 | 5 | 108 | icosanoid metabolic process |
GO:0050901 | 0.0028 | 11.8332 | 0.2826 | 3 | 32 | leukocyte tethering or rolling |
GO:0030334 | 0.0028 | 2.2873 | 8.0374 | 17 | 910 | regulation of cell migration |
GO:0060284 | 0.0032 | 2.8154 | 4.1688 | 11 | 472 | regulation of cell development |
GO:1901616 | 0.0032 | 7.0734 | 0.6094 | 4 | 69 | organic hydroxy compound catabolic process |
GO:0008645 | 0.0033 | 5.3452 | 0.9981 | 5 | 113 | hexose transmembrane transport |
GO:1990266 | 0.0033 | 5.3452 | 0.9981 | 5 | 113 | neutrophil migration |
GO:0046326 | 0.0033 | 11.0684 | 0.3003 | 3 | 34 | positive regulation of glucose import |
GO:0032823 | 0.0033 | 28.4336 | 0.0883 | 2 | 10 | regulation of natural killer cell differentiation |
GO:0048703 | 0.0033 | 28.4336 | 0.0883 | 2 | 10 | embryonic viscerocranium morphogenesis |
GO:0033210 | 0.004 | 25.2727 | 0.0972 | 2 | 11 | leptin-mediated signaling pathway |
GO:0021954 | 0.0042 | 6.5662 | 0.6536 | 4 | 74 | central nervous system neuron development |
GO:0051049 | 0.0043 | 1.9051 | 14.3878 | 25 | 1629 | regulation of transport |
GO:0006029 | 0.0044 | 6.4733 | 0.6624 | 4 | 75 | proteoglycan metabolic process |
GO:0010827 | 0.0044 | 6.4733 | 0.6624 | 4 | 75 | regulation of glucose transmembrane transport |
GO:0050900 | 0.0044 | 3.0371 | 3.1443 | 9 | 356 | leukocyte migration |
GO:0072001 | 0.0045 | 3.2756 | 2.5879 | 8 | 293 | renal system development |
GO:0150077 | 0.0045 | 9.801 | 0.3356 | 3 | 38 | regulation of neuroinflammatory response |
GO:0070663 | 0.0047 | 3.6014 | 2.0579 | 7 | 233 | regulation of leukocyte proliferation |
GO:0006112 | 0.0048 | 6.2952 | 0.6801 | 4 | 77 | energy reserve metabolic process |
GO:0002864 | 0.0048 | 22.7441 | 0.106 | 2 | 12 | regulation of acute inflammatory response to antigenic stimulus |
GO:0016045 | 0.0048 | 22.7441 | 0.106 | 2 | 12 | detection of bacterium |
GO:0032874 | 0.0049 | 4.8478 | 1.0952 | 5 | 124 | positive regulation of stress-activated MAPK cascade |
GO:0031670 | 0.0049 | 9.5282 | 0.3445 | 3 | 39 | cellular response to nutrient |
GO:0042755 | 0.0049 | 9.5282 | 0.3445 | 3 | 39 | eating behavior |
GO:0021537 | 0.0049 | 3.5694 | 2.0756 | 7 | 235 | telencephalon development |
GO:0014068 | 0.005 | 6.2097 | 0.6889 | 4 | 78 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0034219 | 0.0052 | 4.7671 | 1.1129 | 5 | 126 | carbohydrate transmembrane transport |
GO:2000696 | 0.0057 | 20.6751 | 0.1148 | 2 | 13 | regulation of epithelial cell differentiation involved in kidney development |
GO:0000904 | 0.0058 | 2.3708 | 5.847 | 13 | 662 | cell morphogenesis involved in differentiation |
GO:0032946 | 0.0059 | 4.6134 | 1.1482 | 5 | 130 | positive regulation of mononuclear cell proliferation |
GO:0001656 | 0.0063 | 5.8149 | 0.7331 | 4 | 83 | metanephros development |
GO:0045840 | 0.0064 | 8.5732 | 0.3798 | 3 | 43 | positive regulation of mitotic nuclear division |
GO:0035630 | 0.0066 | 18.951 | 0.1237 | 2 | 14 | bone mineralization involved in bone maturation |
GO:0043270 | 0.0068 | 3.3459 | 2.2081 | 7 | 250 | positive regulation of ion transport |
GO:0009605 | 0.0068 | 1.7047 | 21.4713 | 33 | 2431 | response to external stimulus |
GO:0045765 | 0.0069 | 3.0367 | 2.7822 | 8 | 315 | regulation of angiogenesis |
GO:0007409 | 0.007 | 3.3311 | 2.2191 | 7 | 258 | axonogenesis |
GO:0071495 | 0.007 | 1.9532 | 11.058 | 20 | 1252 | cellular response to endogenous stimulus |
GO:0002042 | 0.0071 | 5.6011 | 0.7596 | 4 | 86 | cell migration involved in sprouting angiogenesis |
GO:0034764 | 0.0074 | 3.7129 | 1.7046 | 6 | 193 | positive regulation of transmembrane transport |
GO:0002070 | 0.0075 | 17.4922 | 0.1325 | 2 | 15 | epithelial cell maturation |
GO:0033599 | 0.0075 | 17.4922 | 0.1325 | 2 | 15 | regulation of mammary gland epithelial cell proliferation |
GO:0048712 | 0.0075 | 17.4922 | 0.1325 | 2 | 15 | negative regulation of astrocyte differentiation |
GO:0072224 | 0.0075 | 17.4922 | 0.1325 | 2 | 15 | metanephric glomerulus development |
GO:0048146 | 0.0078 | 7.9736 | 0.4063 | 3 | 46 | positive regulation of fibroblast proliferation |
GO:0045595 | 0.0079 | 2.0953 | 8.2106 | 16 | 977 | regulation of cell differentiation |
GO:0050770 | 0.0081 | 4.269 | 1.2365 | 5 | 140 | regulation of axonogenesis |
GO:0042221 | 0.0082 | 1.5709 | 34.8523 | 48 | 3946 | response to chemical |
GO:0048260 | 0.0082 | 7.7919 | 0.4151 | 3 | 47 | positive regulation of receptor-mediated endocytosis |
GO:0032310 | 0.0086 | 16.2418 | 0.1413 | 2 | 16 | prostaglandin secretion |
GO:0055119 | 0.0086 | 16.2418 | 0.1413 | 2 | 16 | relaxation of cardiac muscle |
GO:0060749 | 0.0086 | 16.2418 | 0.1413 | 2 | 16 | mammary gland alveolus development |
GO:0006875 | 0.0087 | 2.4335 | 4.7871 | 11 | 542 | cellular metal ion homeostasis |
GO:2000147 | 0.0087 | 2.4335 | 4.7871 | 11 | 542 | positive regulation of cell motility |
GO:0050905 | 0.0088 | 4.1755 | 1.263 | 5 | 143 | neuromuscular process |
GO:0010625 | 0.0088 | Inf | 0.0088 | 1 | 1 | positive regulation of Schwann cell proliferation |
GO:0014861 | 0.0088 | Inf | 0.0088 | 1 | 1 | regulation of skeletal muscle contraction via regulation of action potential |
GO:0032903 | 0.0088 | Inf | 0.0088 | 1 | 1 | regulation of nerve growth factor production |
GO:0035847 | 0.0088 | Inf | 0.0088 | 1 | 1 | uterine epithelium development |
GO:0035849 | 0.0088 | Inf | 0.0088 | 1 | 1 | nephric duct elongation |
GO:0035852 | 0.0088 | Inf | 0.0088 | 1 | 1 | horizontal cell localization |
GO:0036138 | 0.0088 | Inf | 0.0088 | 1 | 1 | peptidyl-histidine hydroxylation |
GO:0042265 | 0.0088 | Inf | 0.0088 | 1 | 1 | peptidyl-asparagine hydroxylation |
GO:0046521 | 0.0088 | Inf | 0.0088 | 1 | 1 | sphingoid catabolic process |
GO:0048572 | 0.0088 | Inf | 0.0088 | 1 | 1 | short-day photoperiodism |
GO:0050783 | 0.0088 | Inf | 0.0088 | 1 | 1 | cocaine metabolic process |
GO:0060283 | 0.0088 | Inf | 0.0088 | 1 | 1 | negative regulation of oocyte development |
GO:0060945 | 0.0088 | Inf | 0.0088 | 1 | 1 | cardiac neuron differentiation |
GO:0061682 | 0.0088 | Inf | 0.0088 | 1 | 1 | seminal vesicle morphogenesis |
GO:0071298 | 0.0088 | Inf | 0.0088 | 1 | 1 | cellular response to L-ascorbic acid |
GO:0097379 | 0.0088 | Inf | 0.0088 | 1 | 1 | dorsal spinal cord interneuron posterior axon guidance |
GO:1901170 | 0.0088 | Inf | 0.0088 | 1 | 1 | naphthalene catabolic process |
GO:1902203 | 0.0088 | Inf | 0.0088 | 1 | 1 | negative regulation of hepatocyte growth factor receptor signaling pathway |
GO:1902870 | 0.0088 | Inf | 0.0088 | 1 | 1 | negative regulation of amacrine cell differentiation |
GO:1904075 | 0.0088 | Inf | 0.0088 | 1 | 1 | positive regulation of trophectodermal cell proliferation |
GO:1904445 | 0.0088 | Inf | 0.0088 | 1 | 1 | negative regulation of establishment of Sertoli cell barrier |
GO:1904651 | 0.0088 | Inf | 0.0088 | 1 | 1 | positive regulation of fat cell apoptotic process |
GO:1905364 | 0.0088 | Inf | 0.0088 | 1 | 1 | regulation of endosomal vesicle fusion |
GO:2000486 | 0.0088 | Inf | 0.0088 | 1 | 1 | negative regulation of glutamine transport |
GO:2000744 | 0.0088 | Inf | 0.0088 | 1 | 1 | positive regulation of anterior head development |
GO:2001113 | 0.0088 | Inf | 0.0088 | 1 | 1 | negative regulation of cellular response to hepatocyte growth factor stimulus |
GO:1903131 | 0.009 | 2.6949 | 3.5241 | 9 | 399 | mononuclear cell differentiation |
GO:0008015 | 0.0091 | 2.5405 | 4.16 | 10 | 471 | blood circulation |
GO:0003008 | 0.0092 | 1.7284 | 17.7264 | 28 | 2007 | system process |
GO:1990573 | 0.0092 | 7.4522 | 0.4328 | 3 | 49 | potassium ion import across plasma membrane |
GO:0006954 | 0.0094 | 2.309 | 5.5186 | 12 | 643 | inflammatory response |
GO:0001775 | 0.0096 | 2.0415 | 8.373 | 16 | 948 | cell activation |
GO:0051094 | 0.0097 | 1.9212 | 10.6316 | 19 | 1212 | positive regulation of developmental process |
GO:2000179 | 0.0098 | 7.2932 | 0.4416 | 3 | 50 | positive regulation of neural precursor cell proliferation |
GO:0015908 | 0.01 | 5.0443 | 0.8391 | 4 | 95 | fatty acid transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038098 | 2e-04 | 166.4796 | 0.0244 | 2 | 4 | sequestering of BMP from receptor via BMP binding |
GO:0035582 | 4e-04 | 110.9796 | 0.0305 | 2 | 5 | sequestering of BMP in extracellular matrix |
GO:0090027 | 8e-04 | 66.5796 | 0.0426 | 2 | 7 | negative regulation of monocyte chemotaxis |
GO:0009593 | 0.0016 | 3.9439 | 2.1928 | 8 | 360 | detection of chemical stimulus |
GO:0048263 | 0.0016 | 41.6046 | 0.0609 | 2 | 10 | determination of dorsal identity |
GO:0007606 | 0.002 | 3.811 | 2.2659 | 8 | 372 | sensory perception of chemical stimulus |
GO:1900116 | 0.0023 | 33.2796 | 0.0731 | 2 | 12 | extracellular negative regulation of signal transduction |
GO:0050906 | 0.0024 | 3.6866 | 2.339 | 8 | 384 | detection of stimulus involved in sensory perception |
GO:0008228 | 0.0032 | 27.7296 | 0.0853 | 2 | 14 | opsonization |
GO:0071599 | 0.0037 | 25.595 | 0.0914 | 2 | 15 | otic vesicle development |
GO:0007618 | 0.0061 | Inf | 0.0061 | 1 | 1 | mating |
GO:1903017 | 0.0061 | Inf | 0.0061 | 1 | 1 | positive regulation of exo-alpha-sialidase activity |
GO:1903496 | 0.0061 | Inf | 0.0061 | 1 | 1 | response to 11-deoxycorticosterone |
GO:0050922 | 0.007 | 8.242 | 0.3898 | 3 | 64 | negative regulation of chemotaxis |
GO:0030277 | 0.0072 | 17.5059 | 0.1279 | 2 | 21 | maintenance of gastrointestinal epithelium |
GO:0002685 | 0.0079 | 4.3067 | 1.2304 | 5 | 202 | regulation of leukocyte migration |
GO:0050911 | 0.0082 | 3.6426 | 1.7482 | 6 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0036303 | 0.0086 | 15.8367 | 0.1401 | 2 | 23 | lymph vessel morphogenesis |
GO:0051446 | 0.0093 | 15.116 | 0.1462 | 2 | 24 | positive regulation of meiotic cell cycle |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 11.6981 | 1.6957 | 16 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 9.1737 | 2.1271 | 16 | 360 | detection of chemical stimulus |
GO:0007606 | 0 | 8.8578 | 2.198 | 16 | 372 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 8.5625 | 2.2689 | 16 | 384 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 4.3635 | 6.2039 | 22 | 1050 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 3.7342 | 7.5452 | 23 | 1277 | nervous system process |
GO:0048252 | 0 | Inf | 0.0118 | 2 | 2 | lauric acid metabolic process |
GO:0019373 | 2e-04 | 34.6915 | 0.1064 | 3 | 18 | epoxygenase P450 pathway |
GO:0043651 | 2e-04 | 34.6915 | 0.1064 | 3 | 18 | linoleic acid metabolic process |
GO:0050896 | 5e-04 | 2.0215 | 46.4882 | 63 | 7868 | response to stimulus |
GO:0007154 | 8e-04 | 1.9493 | 34.3403 | 50 | 5812 | cell communication |
GO:0032501 | 0.0012 | 1.8984 | 39.6875 | 55 | 6717 | multicellular organismal process |
GO:0023052 | 0.0013 | 1.8948 | 34.0507 | 49 | 5763 | signaling |
GO:0016339 | 0.0019 | 13.3232 | 0.2482 | 3 | 42 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0032309 | 0.0021 | 12.9894 | 0.2541 | 3 | 43 | icosanoid secretion |
GO:0006690 | 0.0038 | 6.7064 | 0.6381 | 4 | 108 | icosanoid metabolic process |
GO:0042127 | 0.005 | 2.1436 | 9.3709 | 18 | 1586 | regulation of cell population proliferation |
GO:0010625 | 0.0059 | Inf | 0.0059 | 1 | 1 | positive regulation of Schwann cell proliferation |
GO:0046521 | 0.0059 | Inf | 0.0059 | 1 | 1 | sphingoid catabolic process |
GO:0050783 | 0.0059 | Inf | 0.0059 | 1 | 1 | cocaine metabolic process |
GO:0070130 | 0.0059 | Inf | 0.0059 | 1 | 1 | negative regulation of mitochondrial translation |
GO:0071298 | 0.0059 | Inf | 0.0059 | 1 | 1 | cellular response to L-ascorbic acid |
GO:1901170 | 0.0059 | Inf | 0.0059 | 1 | 1 | naphthalene catabolic process |
GO:1904156 | 0.0059 | Inf | 0.0059 | 1 | 1 | DN3 thymocyte differentiation |
GO:1904651 | 0.0059 | Inf | 0.0059 | 1 | 1 | positive regulation of fat cell apoptotic process |
GO:1905364 | 0.0059 | Inf | 0.0059 | 1 | 1 | regulation of endosomal vesicle fusion |
GO:2000486 | 0.0059 | Inf | 0.0059 | 1 | 1 | negative regulation of glutamine transport |
GO:0032874 | 0.0063 | 5.8065 | 0.7327 | 4 | 124 | positive regulation of stress-activated MAPK cascade |
GO:0006959 | 0.0069 | 4.448 | 1.1935 | 5 | 202 | humoral immune response |
GO:0015849 | 0.0075 | 3.723 | 1.7135 | 6 | 290 | organic acid transport |
GO:0045123 | 0.0076 | 7.9812 | 0.4018 | 3 | 68 | cellular extravasation |
GO:1903131 | 0.0094 | 3.1603 | 2.3575 | 7 | 399 | mononuclear cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 19.4957 | 1.888 | 26 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050906 | 0 | 15.6841 | 2.5262 | 28 | 384 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 15.992 | 2.3683 | 27 | 360 | detection of chemical stimulus |
GO:0007606 | 0 | 15.4242 | 2.4472 | 27 | 372 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 6.9159 | 6.9075 | 34 | 1050 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 5.0946 | 8.4008 | 32 | 1277 | nervous system process |
GO:0048252 | 0 | Inf | 0.0132 | 2 | 2 | lauric acid metabolic process |
GO:0007154 | 2e-04 | 2.0496 | 38.2345 | 57 | 5812 | cell communication |
GO:0032501 | 2e-04 | 2.0314 | 44.1881 | 63 | 6717 | multicellular organismal process |
GO:0023052 | 3e-04 | 2.0006 | 37.9122 | 56 | 5763 | signaling |
GO:0051716 | 3e-04 | 1.9934 | 43.6881 | 62 | 6641 | cellular response to stimulus |
GO:0022617 | 6e-04 | 11.5776 | 0.3816 | 4 | 58 | extracellular matrix disassembly |
GO:0000353 | 0.0019 | 38.4458 | 0.0658 | 2 | 10 | formation of quadruple SL/U4/U5/U6 snRNP |
GO:0000365 | 0.0019 | 38.4458 | 0.0658 | 2 | 10 | mRNA trans splicing, via spliceosome |
GO:0097267 | 0.0019 | 38.4458 | 0.0658 | 2 | 10 | omega-hydroxylase P450 pathway |
GO:0030574 | 0.0025 | 12.2338 | 0.2697 | 3 | 41 | collagen catabolic process |
GO:0032309 | 0.0028 | 11.6207 | 0.2829 | 3 | 43 | icosanoid secretion |
GO:0001977 | 0.0037 | 25.6242 | 0.0921 | 2 | 14 | renal system process involved in regulation of blood volume |
GO:0006816 | 0.0042 | 3.3355 | 2.5656 | 8 | 390 | calcium ion transport |
GO:0048245 | 0.0048 | 21.9609 | 0.1053 | 2 | 16 | eosinophil chemotaxis |
GO:0019373 | 0.0061 | 19.2134 | 0.1184 | 2 | 18 | epoxygenase P450 pathway |
GO:0043651 | 0.0061 | 19.2134 | 0.1184 | 2 | 18 | linoleic acid metabolic process |
GO:0016117 | 0.0066 | Inf | 0.0066 | 1 | 1 | carotenoid biosynthetic process |
GO:0052373 | 0.0066 | Inf | 0.0066 | 1 | 1 | suppression of symbiont entry into host |
GO:1901827 | 0.0066 | Inf | 0.0066 | 1 | 1 | zeaxanthin biosynthetic process |
GO:0015669 | 0.0068 | 18.0821 | 0.125 | 2 | 19 | gas transport |
GO:0003091 | 0.0083 | 16.1768 | 0.1381 | 2 | 21 | renal water homeostasis |
GO:0120254 | 0.0088 | 5.2413 | 0.808 | 4 | 125 | olefinic compound metabolic process |
GO:0030104 | 0.009 | 7.4871 | 0.4276 | 3 | 65 | water homeostasis |
GO:0002323 | 0.0091 | 15.367 | 0.1447 | 2 | 22 | natural killer cell activation involved in immune response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 6.4074 | 6.5112 | 33 | 673 | G protein-coupled receptor activity |
GO:0038023 | 0 | 4.3027 | 12.1806 | 41 | 1259 | signaling receptor activity |
GO:0004984 | 0 | 8.1742 | 2.7573 | 19 | 285 | olfactory receptor activity |
GO:0046982 | 0 | 6.6974 | 2.9315 | 17 | 303 | protein heterodimerization activity |
GO:0005549 | 2e-04 | 8.2515 | 0.803 | 6 | 83 | odorant binding |
GO:0045296 | 3e-04 | 3.8673 | 3.0766 | 11 | 318 | cadherin binding |
GO:0031849 | 0.0014 | 51.8237 | 0.058 | 2 | 6 | olfactory receptor binding |
GO:0004935 | 0.0032 | 29.6081 | 0.0871 | 2 | 9 | adrenergic receptor activity |
GO:1904315 | 0.0063 | 8.6758 | 0.3773 | 3 | 39 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential |
GO:0008188 | 0.0066 | 8.4956 | 0.3846 | 3 | 40 | neuropeptide receptor activity |
GO:0008191 | 0.009 | 15.9369 | 0.1451 | 2 | 15 | metalloendopeptidase inhibitor activity |
GO:0004941 | 0.0097 | Inf | 0.0097 | 1 | 1 | beta2-adrenergic receptor activity |
GO:0004946 | 0.0097 | Inf | 0.0097 | 1 | 1 | bombesin receptor activity |
GO:0005043 | 0.0097 | Inf | 0.0097 | 1 | 1 | netrin receptor activity involved in chemorepulsion |
GO:0010844 | 0.0097 | Inf | 0.0097 | 1 | 1 | recombination hotspot binding |
GO:0043185 | 0.0097 | Inf | 0.0097 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 10.5451 | 1.8499 | 16 | 285 | olfactory receptor activity |
GO:0005549 | 0 | 17.5782 | 0.5387 | 8 | 83 | odorant binding |
GO:0004930 | 0 | 4.8622 | 4.3683 | 18 | 673 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.5525 | 8.1718 | 24 | 1259 | signaling receptor activity |
GO:0031731 | 2e-04 | 155.9904 | 0.026 | 2 | 4 | CCR6 chemokine receptor binding |
GO:0008467 | 9e-04 | 62.3846 | 0.0454 | 2 | 7 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity |
GO:0032393 | 0.0022 | 34.6496 | 0.0714 | 2 | 11 | MHC class I receptor activity |
GO:0098960 | 0.0057 | 8.8873 | 0.3635 | 3 | 56 | postsynaptic neurotransmitter receptor activity |
GO:0030296 | 0.006 | 19.482 | 0.1168 | 2 | 18 | protein tyrosine kinase activator activity |
GO:0000140 | 0.0065 | Inf | 0.0065 | 1 | 1 | acylglycerone-phosphate reductase activity |
GO:0003912 | 0.0065 | Inf | 0.0065 | 1 | 1 | DNA nucleotidylexotransferase activity |
GO:0015052 | 0.0065 | Inf | 0.0065 | 1 | 1 | beta3-adrenergic receptor activity |
GO:0018858 | 0.0065 | Inf | 0.0065 | 1 | 1 | benzoate-CoA ligase activity |
GO:0030107 | 0.0065 | Inf | 0.0065 | 1 | 1 | HLA-A specific inhibitory MHC class I receptor activity |
GO:0033871 | 0.0065 | Inf | 0.0065 | 1 | 1 | [heparan sulfate]-glucosamine 3-sulfotransferase 2 activity |
GO:0043795 | 0.0065 | Inf | 0.0065 | 1 | 1 | glyceraldehyde oxidoreductase activity |
GO:0099077 | 0.0065 | Inf | 0.0065 | 1 | 1 | histone-dependent DNA binding |
GO:0099609 | 0.0065 | Inf | 0.0065 | 1 | 1 | microtubule lateral binding |
GO:0106261 | 0.0065 | Inf | 0.0065 | 1 | 1 | tRNA uridine(34) acetyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 9.7908 | 4.1375 | 32 | 303 | protein heterodimerization activity |
GO:0003677 | 0 | 4.3072 | 8.5267 | 31 | 664 | DNA binding |
GO:0001653 | 0 | 7.2137 | 1.8844 | 12 | 138 | peptide receptor activity |
GO:0004930 | 0 | 2.8727 | 9.1898 | 24 | 673 | G protein-coupled receptor activity |
GO:0019904 | 2e-04 | 2.6413 | 8.6163 | 21 | 631 | protein domain specific binding |
GO:0001785 | 2e-04 | Inf | 0.0273 | 2 | 2 | prostaglandin J receptor activity |
GO:0004956 | 2e-04 | Inf | 0.0273 | 2 | 2 | prostaglandin D receptor activity |
GO:0004983 | 2e-04 | 36.5955 | 0.1229 | 3 | 9 | neuropeptide Y receptor activity |
GO:0060089 | 5e-04 | 2.0319 | 17.1917 | 32 | 1259 | molecular transducer activity |
GO:0000976 | 6e-04 | 1.9698 | 18.8712 | 34 | 1382 | transcription cis-regulatory region binding |
GO:0003700 | 7e-04 | 1.9743 | 17.6423 | 32 | 1292 | DNA-binding transcription factor activity |
GO:0001228 | 8e-04 | 2.7338 | 5.858 | 15 | 429 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0008188 | 9e-04 | 10.631 | 0.4313 | 4 | 32 | neuropeptide receptor activity |
GO:0000978 | 0.001 | 2.0262 | 14.9386 | 28 | 1094 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0003690 | 0.0029 | 1.7636 | 20.8239 | 34 | 1525 | double-stranded DNA binding |
GO:0043565 | 0.0032 | 1.7545 | 20.9195 | 34 | 1532 | sequence-specific DNA binding |
GO:0016493 | 0.0032 | 11.5471 | 0.3004 | 3 | 22 | C-C chemokine receptor activity |
GO:0008467 | 0.0037 | 29.1457 | 0.0956 | 2 | 7 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity |
GO:0005244 | 0.0044 | 3.2926 | 2.5671 | 8 | 188 | voltage-gated ion channel activity |
GO:0045296 | 0.0044 | 2.6706 | 4.3423 | 11 | 318 | cadherin binding |
GO:0001637 | 0.0046 | 9.9707 | 0.3414 | 3 | 25 | G protein-coupled chemoattractant receptor activity |
GO:0004972 | 0.0049 | 24.2866 | 0.1092 | 2 | 8 | NMDA glutamate receptor activity |
GO:0004935 | 0.0063 | 20.8158 | 0.1229 | 2 | 9 | adrenergic receptor activity |
GO:0042923 | 0.0078 | 8.1217 | 0.4097 | 3 | 30 | neuropeptide binding |
GO:0019956 | 0.0085 | 7.8312 | 0.4233 | 3 | 31 | chemokine binding |
GO:0004954 | 0.0094 | 16.188 | 0.1502 | 2 | 11 | prostanoid receptor activity |
GO:0030548 | 0.0094 | 16.188 | 0.1502 | 2 | 11 | acetylcholine receptor regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003690 | 0 | 2.5695 | 21.2908 | 47 | 1525 | double-stranded DNA binding |
GO:0000976 | 0 | 2.6388 | 19.2943 | 44 | 1382 | transcription cis-regulatory region binding |
GO:0000978 | 0 | 2.7575 | 15.2735 | 37 | 1094 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0001228 | 0 | 3.9026 | 5.9893 | 21 | 429 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0043565 | 0 | 2.417 | 21.3885 | 45 | 1532 | sequence-specific DNA binding |
GO:0140110 | 0 | 2.2102 | 24.2924 | 47 | 1740 | transcription regulator activity |
GO:0048407 | 0 | 41.0612 | 0.1536 | 4 | 11 | platelet-derived growth factor binding |
GO:0008198 | 3e-04 | 15.1165 | 0.3211 | 4 | 23 | ferrous iron binding |
GO:0000981 | 4e-04 | 2.3397 | 10.6611 | 23 | 819 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0030546 | 6e-04 | 2.7378 | 6.2546 | 16 | 448 | signaling receptor activator activity |
GO:0005017 | 6e-04 | 142.4956 | 0.0419 | 2 | 3 | platelet-derived growth factor-activated receptor activity |
GO:0005163 | 0.0011 | 71.2434 | 0.0558 | 2 | 4 | nerve growth factor receptor binding |
GO:0038085 | 0.0011 | 71.2434 | 0.0558 | 2 | 4 | vascular endothelial growth factor binding |
GO:0046982 | 0.0012 | 3.0187 | 4.2302 | 12 | 303 | protein heterodimerization activity |
GO:0005178 | 0.0012 | 4.1166 | 2.0802 | 8 | 149 | integrin binding |
GO:0022836 | 0.0015 | 2.9365 | 4.3419 | 12 | 311 | gated channel activity |
GO:0043237 | 0.0028 | 35.6173 | 0.0838 | 2 | 6 | laminin-1 binding |
GO:0022843 | 0.0034 | 3.8323 | 1.9406 | 7 | 139 | voltage-gated cation channel activity |
GO:0008467 | 0.0039 | 28.492 | 0.0977 | 2 | 7 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity |
GO:0005104 | 0.0044 | 10.2108 | 0.3351 | 3 | 24 | fibroblast growth factor receptor binding |
GO:0008083 | 0.0051 | 3.5351 | 2.0942 | 7 | 150 | growth factor activity |
GO:0045296 | 0.0052 | 2.6082 | 4.4397 | 11 | 318 | cadherin binding |
GO:0032396 | 0.0065 | 20.3489 | 0.1257 | 2 | 9 | inhibitory MHC class I receptor activity |
GO:0050840 | 0.0068 | 5.7332 | 0.7539 | 4 | 54 | extracellular matrix binding |
GO:0005201 | 0.0073 | 3.302 | 2.2338 | 7 | 160 | extracellular matrix structural constituent |
GO:0022851 | 0.0098 | 15.825 | 0.1536 | 2 | 11 | GABA-gated chloride ion channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0020037 | 1e-04 | 7.399 | 1.0402 | 7 | 124 | heme binding |
GO:0038023 | 1e-04 | 2.5726 | 10.5617 | 24 | 1259 | signaling receptor activity |
GO:0008745 | 4e-04 | 119.9407 | 0.0336 | 2 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0018685 | 4e-04 | 119.9407 | 0.0336 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0004984 | 7e-04 | 4.0552 | 2.3909 | 9 | 285 | olfactory receptor activity |
GO:0016019 | 7e-04 | 79.9556 | 0.0419 | 2 | 5 | peptidoglycan immune receptor activity |
GO:0005506 | 0.001 | 5.6597 | 1.1409 | 6 | 136 | iron ion binding |
GO:0102033 | 0.0014 | 47.9674 | 0.0587 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0005242 | 0.0015 | 15.084 | 0.2265 | 3 | 27 | inward rectifier potassium channel activity |
GO:0005518 | 0.0025 | 7.5799 | 0.5704 | 4 | 68 | collagen binding |
GO:0019825 | 0.0029 | 11.6728 | 0.2852 | 3 | 34 | oxygen binding |
GO:0016712 | 0.0031 | 11.3074 | 0.2936 | 3 | 35 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
GO:0005267 | 0.0032 | 5.3905 | 0.9899 | 5 | 118 | potassium channel activity |
GO:0004930 | 0.0043 | 2.4675 | 5.6458 | 13 | 673 | G protein-coupled receptor activity |
GO:0022836 | 0.0047 | 3.2524 | 2.609 | 8 | 311 | gated channel activity |
GO:0015276 | 0.0051 | 4.7921 | 1.1073 | 5 | 132 | ligand-gated ion channel activity |
GO:0005313 | 0.006 | 19.9778 | 0.1174 | 2 | 14 | L-glutamate transmembrane transporter activity |
GO:0042834 | 0.006 | 19.9778 | 0.1174 | 2 | 14 | peptidoglycan binding |
GO:0022843 | 0.0063 | 4.5398 | 1.1661 | 5 | 139 | voltage-gated cation channel activity |
GO:0008392 | 0.0068 | 18.4399 | 0.1258 | 2 | 15 | arachidonic acid epoxygenase activity |
GO:0031798 | 0.0084 | Inf | 0.0084 | 1 | 1 | type 1 metabotropic glutamate receptor binding |
GO:0043795 | 0.0084 | Inf | 0.0084 | 1 | 1 | glyceraldehyde oxidoreductase activity |
GO:0102116 | 0.0084 | Inf | 0.0084 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0084 | Inf | 0.0084 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0015459 | 0.0085 | 7.6915 | 0.4194 | 3 | 50 | potassium channel regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045182 | 0.0014 | 4.0196 | 2.1507 | 8 | 341 | translation regulator activity |
GO:1903231 | 0.0028 | 4.607 | 1.3939 | 6 | 221 | mRNA base-pairing post-transcriptional repressor activity |
GO:0004953 | 0.0034 | 26.7591 | 0.0883 | 2 | 14 | icosanoid receptor activity |
GO:0016501 | 0.0063 | Inf | 0.0063 | 1 | 1 | prostacyclin receptor activity |
GO:0018858 | 0.0063 | Inf | 0.0063 | 1 | 1 | benzoate-CoA ligase activity |
GO:0030184 | 0.0063 | Inf | 0.0063 | 1 | 1 | nitric oxide transmembrane transporter activity |
GO:0099077 | 0.0063 | Inf | 0.0063 | 1 | 1 | histone-dependent DNA binding |
GO:0099609 | 0.0063 | Inf | 0.0063 | 1 | 1 | microtubule lateral binding |
GO:0031418 | 0.007 | 17.8328 | 0.1261 | 2 | 20 | L-ascorbic acid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003876 | 1e-04 | 331.2245 | 0.0184 | 2 | 3 | AMP deaminase activity |
GO:0038023 | 6e-04 | 2.6515 | 7.7093 | 18 | 1259 | signaling receptor activity |
GO:0032394 | 0.001 | 55.1871 | 0.049 | 2 | 8 | MHC class Ib receptor activity |
GO:0042608 | 0.001 | 55.1871 | 0.049 | 2 | 8 | T cell receptor binding |
GO:0016004 | 0.002 | 36.7846 | 0.0674 | 2 | 11 | phospholipase activator activity |
GO:0089720 | 0.0024 | 33.1041 | 0.0735 | 2 | 12 | caspase binding |
GO:1903231 | 0.0024 | 4.7549 | 1.3533 | 6 | 221 | mRNA base-pairing post-transcriptional repressor activity |
GO:0030234 | 0.0031 | 2.4298 | 6.8214 | 15 | 1114 | enzyme regulator activity |
GO:0071837 | 0.0032 | 27.5833 | 0.0857 | 2 | 14 | HMG box domain binding |
GO:0019209 | 0.0034 | 6.9304 | 0.6185 | 4 | 101 | kinase activator activity |
GO:0050700 | 0.0042 | 23.6399 | 0.098 | 2 | 16 | CARD domain binding |
GO:0004364 | 0.0048 | 22.0626 | 0.1041 | 2 | 17 | glutathione transferase activity |
GO:0030296 | 0.0053 | 20.6824 | 0.1102 | 2 | 18 | protein tyrosine kinase activator activity |
GO:0043274 | 0.0053 | 20.6824 | 0.1102 | 2 | 18 | phospholipase binding |
GO:0016501 | 0.0061 | Inf | 0.0061 | 1 | 1 | prostacyclin receptor activity |
GO:0030184 | 0.0061 | Inf | 0.0061 | 1 | 1 | nitric oxide transmembrane transporter activity |
GO:0035757 | 0.0061 | Inf | 0.0061 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
GO:0035758 | 0.0061 | Inf | 0.0061 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
GO:0038117 | 0.0061 | Inf | 0.0061 | 1 | 1 | C-C motif chemokine 19 receptor activity |
GO:0038121 | 0.0061 | Inf | 0.0061 | 1 | 1 | C-C motif chemokine 21 receptor activity |
GO:0046817 | 0.0061 | Inf | 0.0061 | 1 | 1 | chemokine receptor antagonist activity |
GO:0042288 | 0.0066 | 18.3821 | 0.1225 | 2 | 20 | MHC class I protein binding |
GO:0005125 | 0.0091 | 4.1556 | 1.2737 | 5 | 208 | cytokine activity |
GO:0005085 | 0.0094 | 4.1145 | 1.2859 | 5 | 210 | guanyl-nucleotide exchange factor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000978 | 1e-04 | 2.3847 | 12.9959 | 28 | 1094 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0005518 | 2e-04 | 8.2747 | 0.8078 | 6 | 68 | collagen binding |
GO:0000976 | 2e-04 | 2.1636 | 16.4171 | 32 | 1382 | transcription cis-regulatory region binding |
GO:0003690 | 2e-04 | 2.0874 | 18.1159 | 34 | 1525 | double-stranded DNA binding |
GO:0005017 | 4e-04 | 168.0833 | 0.0356 | 2 | 3 | platelet-derived growth factor-activated receptor activity |
GO:0071837 | 5e-04 | 23.0262 | 0.1663 | 3 | 14 | HMG box domain binding |
GO:0043565 | 6e-04 | 2.0016 | 18.199 | 33 | 1532 | sequence-specific DNA binding |
GO:0038085 | 8e-04 | 84.0365 | 0.0475 | 2 | 4 | vascular endothelial growth factor binding |
GO:0070851 | 0.0011 | 4.7567 | 1.5799 | 7 | 133 | growth factor receptor binding |
GO:0140110 | 0.0013 | 1.8633 | 20.6699 | 35 | 1740 | transcription regulator activity |
GO:0001228 | 0.0019 | 2.7143 | 5.0962 | 13 | 429 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0016849 | 0.0022 | 13.3243 | 0.2613 | 3 | 22 | phosphorus-oxygen lyase activity |
GO:0008198 | 0.0025 | 12.6573 | 0.2732 | 3 | 23 | ferrous iron binding |
GO:0000981 | 0.0025 | 2.1875 | 9.322 | 19 | 819 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0005267 | 0.0029 | 4.5664 | 1.4018 | 6 | 118 | potassium channel activity |
GO:0005102 | 0.0035 | 1.9168 | 14.0614 | 25 | 1218 | signaling receptor binding |
GO:0030297 | 0.0038 | 28.0052 | 0.095 | 2 | 8 | transmembrane receptor protein tyrosine kinase activator activity |
GO:0005242 | 0.0039 | 10.5452 | 0.3207 | 3 | 27 | inward rectifier potassium channel activity |
GO:0005539 | 0.0042 | 3.31 | 2.554 | 8 | 215 | glycosaminoglycan binding |
GO:0019864 | 0.0048 | 24.003 | 0.1069 | 2 | 9 | IgG binding |
GO:0043184 | 0.0048 | 24.003 | 0.1069 | 2 | 9 | vascular endothelial growth factor receptor 2 binding |
GO:0030545 | 0.0052 | 2.3942 | 5.7377 | 13 | 483 | signaling receptor regulator activity |
GO:0004875 | 0.0059 | 21.0013 | 0.1188 | 2 | 10 | complement receptor activity |
GO:0022843 | 0.0063 | 3.8403 | 1.6512 | 6 | 139 | voltage-gated cation channel activity |
GO:0048407 | 0.0072 | 18.6667 | 0.1307 | 2 | 11 | platelet-derived growth factor binding |
GO:1901681 | 0.0099 | 2.8369 | 2.9579 | 8 | 249 | sulfur compound binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 9.0566 | 2.3934 | 18 | 303 | protein heterodimerization activity |
GO:0005509 | 0 | 4.7512 | 5.1976 | 21 | 658 | calcium ion binding |
GO:0019904 | 0 | 4.1684 | 4.9382 | 18 | 630 | protein domain specific binding |
GO:0003730 | 8e-04 | 5.0225 | 1.5008 | 7 | 190 | mRNA 3'-UTR binding |
GO:0047035 | 0.0013 | 51.0142 | 0.0553 | 2 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:0019531 | 0.0021 | 36.4342 | 0.0711 | 2 | 9 | oxalate transmembrane transporter activity |
GO:0003723 | 0.0024 | 2.0187 | 13.8155 | 25 | 1749 | RNA binding |
GO:0005095 | 0.0039 | 25.4992 | 0.0948 | 2 | 12 | GTPase inhibitor activity |
GO:0008271 | 0.0039 | 25.4992 | 0.0948 | 2 | 12 | secondary active sulfate transmembrane transporter activity |
GO:0044594 | 0.0046 | 23.1797 | 0.1027 | 2 | 13 | 17-beta-hydroxysteroid dehydrogenase (NAD+) activity |
GO:0004503 | 0.0079 | Inf | 0.0079 | 1 | 1 | tyrosinase activity |
GO:0031751 | 0.0079 | Inf | 0.0079 | 1 | 1 | D4 dopamine receptor binding |
GO:0032089 | 0.0079 | Inf | 0.0079 | 1 | 1 | NACHT domain binding |
GO:0047743 | 0.0079 | Inf | 0.0079 | 1 | 1 | chlordecone reductase activity |
GO:0047969 | 0.0079 | Inf | 0.0079 | 1 | 1 | glyoxylate oxidase activity |
GO:0052665 | 0.0079 | Inf | 0.0079 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GO:1903231 | 0.0082 | 3.6272 | 1.7457 | 6 | 221 | mRNA base-pairing post-transcriptional repressor activity |
GO:0000979 | 0.0097 | 14.9931 | 0.1501 | 2 | 19 | RNA polymerase II core promoter sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 13.2197 | 2.579 | 26 | 303 | protein heterodimerization activity |
GO:0005509 | 0 | 5.3903 | 5.6005 | 25 | 658 | calcium ion binding |
GO:0019904 | 0 | 4.0308 | 5.3707 | 19 | 631 | protein domain specific binding |
GO:0045296 | 0 | 4.9054 | 2.7066 | 12 | 318 | cadherin binding |
GO:0003677 | 6e-04 | 2.0137 | 19.3805 | 34 | 2277 | DNA binding |
GO:0016803 | 0.0025 | 33.7539 | 0.0766 | 2 | 9 | ether hydrolase activity |
GO:0048020 | 0.0038 | 10.4831 | 0.3149 | 3 | 37 | CCR chemokine receptor binding |
GO:0008859 | 0.0085 | Inf | 0.0085 | 1 | 1 | exoribonuclease II activity |
GO:0043185 | 0.0085 | Inf | 0.0085 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0052665 | 0.0085 | Inf | 0.0085 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GO:0102483 | 0.0085 | Inf | 0.0085 | 1 | 1 | scopolin beta-glucosidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 10.2625 | 4.2488 | 34 | 303 | protein heterodimerization activity |
GO:0003677 | 0 | 2.2752 | 31.929 | 61 | 2277 | DNA binding |
GO:0001653 | 0 | 7.0116 | 1.9351 | 12 | 138 | peptide receptor activity |
GO:0004930 | 0 | 2.7876 | 9.4371 | 24 | 673 | G protein-coupled receptor activity |
GO:0001785 | 2e-04 | Inf | 0.028 | 2 | 2 | prostaglandin J receptor activity |
GO:0004956 | 2e-04 | Inf | 0.028 | 2 | 2 | prostaglandin D receptor activity |
GO:0005139 | 2e-04 | Inf | 0.028 | 2 | 2 | interleukin-7 receptor binding |
GO:0019904 | 2e-04 | 2.5641 | 8.8481 | 21 | 631 | protein domain specific binding |
GO:0001601 | 6e-04 | 141.859 | 0.0421 | 2 | 3 | peptide YY receptor activity |
GO:0060089 | 8e-04 | 1.9692 | 17.6542 | 32 | 1259 | molecular transducer activity |
GO:0042923 | 8e-04 | 10.9921 | 0.4207 | 4 | 30 | neuropeptide binding |
GO:0008188 | 9e-04 | 10.3872 | 0.4411 | 4 | 32 | neuropeptide receptor activity |
GO:0004983 | 0.0028 | 35.7711 | 0.0834 | 2 | 6 | neuropeptide Y receptor activity |
GO:0016493 | 0.0034 | 11.2364 | 0.3085 | 3 | 22 | C-C chemokine receptor activity |
GO:0050750 | 0.0034 | 11.2364 | 0.3085 | 3 | 22 | low-density lipoprotein particle receptor binding |
GO:0008467 | 0.0039 | 28.3648 | 0.0982 | 2 | 7 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity |
GO:0001637 | 0.005 | 9.7023 | 0.3506 | 3 | 25 | G protein-coupled chemoattractant receptor activity |
GO:0045296 | 0.0054 | 2.5961 | 4.4591 | 11 | 318 | cadherin binding |
GO:0004935 | 0.0066 | 20.258 | 0.1262 | 2 | 9 | adrenergic receptor activity |
GO:0001228 | 0.0077 | 2.2694 | 6.0156 | 13 | 429 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0004954 | 0.0099 | 15.7543 | 0.1542 | 2 | 11 | prostanoid receptor activity |
GO:0030548 | 0.0099 | 15.7543 | 0.1542 | 2 | 11 | acetylcholine receptor regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 6.9845 | 4.0633 | 24 | 303 | protein heterodimerization activity |
GO:0003677 | 0 | 3.9289 | 7.9853 | 27 | 664 | DNA binding |
GO:0000978 | 0 | 2.7991 | 14.6706 | 36 | 1094 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0001228 | 0 | 3.8587 | 5.7529 | 20 | 429 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0000976 | 0 | 2.4594 | 18.5327 | 40 | 1382 | transcription cis-regulatory region binding |
GO:0003690 | 0 | 2.3407 | 20.4504 | 42 | 1525 | double-stranded DNA binding |
GO:0043565 | 0 | 2.2587 | 20.5442 | 41 | 1532 | sequence-specific DNA binding |
GO:0019904 | 1e-04 | 2.6953 | 8.4618 | 21 | 631 | protein domain specific binding |
GO:1901363 | 3e-04 | 1.6209 | 76.0217 | 101 | 5669 | heterocyclic compound binding |
GO:0097159 | 3e-04 | 1.6196 | 76.9739 | 102 | 5740 | organic cyclic compound binding |
GO:0048407 | 4e-04 | 27.9583 | 0.1475 | 3 | 11 | platelet-derived growth factor binding |
GO:0022834 | 4e-04 | 4.8885 | 1.7701 | 8 | 132 | ligand-gated channel activity |
GO:0140110 | 5e-04 | 1.8944 | 23.3335 | 40 | 1740 | transcription regulator activity |
GO:0030414 | 0.0012 | 4.0897 | 2.092 | 8 | 156 | peptidase inhibitor activity |
GO:0061135 | 0.0018 | 3.8284 | 2.2261 | 8 | 166 | endopeptidase regulator activity |
GO:0001665 | 0.0026 | 37.1152 | 0.0805 | 2 | 6 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity |
GO:0015272 | 0.0026 | 37.1152 | 0.0805 | 2 | 6 | ATP-activated inward rectifier potassium channel activity |
GO:0000981 | 0.0033 | 2.0842 | 10.2491 | 20 | 819 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0099094 | 0.0033 | 4.4214 | 1.4483 | 6 | 108 | ligand-gated cation channel activity |
GO:0008198 | 0.0035 | 11.175 | 0.3084 | 3 | 23 | ferrous iron binding |
GO:0045296 | 0.0039 | 2.7226 | 4.2644 | 11 | 318 | cadherin binding |
GO:0005244 | 0.0039 | 3.3559 | 2.5211 | 8 | 188 | voltage-gated ion channel activity |
GO:0004867 | 0.0049 | 4.8656 | 1.0996 | 5 | 82 | serine-type endopeptidase inhibitor activity |
GO:0005201 | 0.0059 | 3.4441 | 2.1456 | 7 | 160 | extracellular matrix structural constituent |
GO:0004983 | 0.0061 | 21.2047 | 0.1207 | 2 | 9 | neuropeptide Y receptor activity |
GO:0005249 | 0.0066 | 4.5122 | 1.1801 | 5 | 88 | voltage-gated potassium channel activity |
GO:0005216 | 0.0092 | 2.3007 | 5.4713 | 12 | 408 | ion channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005242 | 0.0015 | 15.084 | 0.2265 | 3 | 27 | inward rectifier potassium channel activity |
GO:0005539 | 0.0023 | 4.1384 | 1.8036 | 7 | 215 | glycosaminoglycan binding |
GO:0005518 | 0.0025 | 7.5799 | 0.5704 | 4 | 68 | collagen binding |
GO:0019825 | 0.0029 | 11.6728 | 0.2852 | 3 | 34 | oxygen binding |
GO:0005267 | 0.0032 | 5.3905 | 0.9899 | 5 | 118 | potassium channel activity |
GO:0004888 | 0.0033 | 2.2018 | 8.8839 | 18 | 1059 | transmembrane signaling receptor activity |
GO:0060089 | 0.0042 | 2.0633 | 10.5617 | 20 | 1259 | molecular transducer activity |
GO:0005102 | 0.0043 | 2.0232 | 11.3335 | 21 | 1351 | signaling receptor binding |
GO:0022836 | 0.0047 | 3.2524 | 2.609 | 8 | 311 | gated channel activity |
GO:1901681 | 0.0051 | 3.5494 | 2.0888 | 7 | 249 | sulfur compound binding |
GO:0015276 | 0.0051 | 4.7921 | 1.1073 | 5 | 132 | ligand-gated ion channel activity |
GO:0022843 | 0.0063 | 4.5398 | 1.1661 | 5 | 139 | voltage-gated cation channel activity |
GO:0001861 | 0.0084 | Inf | 0.0084 | 1 | 1 | complement component C4b receptor activity |
GO:0004877 | 0.0084 | Inf | 0.0084 | 1 | 1 | complement component C3b receptor activity |
GO:0031767 | 0.0084 | Inf | 0.0084 | 1 | 1 | gastric inhibitory polypeptide receptor binding |
GO:0031798 | 0.0084 | Inf | 0.0084 | 1 | 1 | type 1 metabotropic glutamate receptor binding |
GO:0036139 | 0.0084 | Inf | 0.0084 | 1 | 1 | peptidyl-histidine dioxygenase activity |
GO:0036140 | 0.0084 | Inf | 0.0084 | 1 | 1 | peptidyl-asparagine 3-dioxygenase activity |
GO:0043795 | 0.0084 | Inf | 0.0084 | 1 | 1 | glyceraldehyde oxidoreductase activity |
GO:0102113 | 0.0084 | Inf | 0.0084 | 1 | 1 | hypoxia-inducible factor-asparagine oxygenase activity |
GO:0015459 | 0.0085 | 7.6915 | 0.4194 | 3 | 50 | potassium channel regulator activity |
GO:0004364 | 0.0087 | 15.9793 | 0.1426 | 2 | 17 | glutathione transferase activity |
GO:0031690 | 0.0098 | 14.9796 | 0.151 | 2 | 18 | adrenergic receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0033612 | 0.0014 | 15.5975 | 0.2219 | 3 | 24 | receptor serine/threonine kinase binding |
GO:0030547 | 0.0032 | 11.2891 | 0.2959 | 3 | 32 | signaling receptor inhibitor activity |
GO:0005102 | 0.0042 | 1.9874 | 12.0437 | 22 | 1327 | signaling receptor binding |
GO:0004954 | 0.0044 | 24.1178 | 0.1017 | 2 | 11 | prostanoid receptor activity |
GO:0016004 | 0.0044 | 24.1178 | 0.1017 | 2 | 11 | phospholipase activator activity |
GO:0070700 | 0.0072 | 18.085 | 0.1294 | 2 | 14 | BMP receptor binding |
GO:0046906 | 0.0081 | 4.2612 | 1.239 | 5 | 134 | tetrapyrrole binding |
GO:0046983 | 0.0087 | 2.0181 | 9.0058 | 17 | 974 | protein dimerization activity |
GO:0004411 | 0.0092 | Inf | 0.0092 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
GO:0004912 | 0.0092 | Inf | 0.0092 | 1 | 1 | interleukin-3 receptor activity |
GO:0016501 | 0.0092 | Inf | 0.0092 | 1 | 1 | prostacyclin receptor activity |
GO:0046538 | 0.0092 | Inf | 0.0092 | 1 | 1 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
GO:0046817 | 0.0092 | Inf | 0.0092 | 1 | 1 | chemokine receptor antagonist activity |
GO:0046911 | 0.0092 | Inf | 0.0092 | 1 | 1 | metal chelating activity |
GO:1903924 | 0.0092 | Inf | 0.0092 | 1 | 1 | estradiol binding |
GO:1905060 | 0.0092 | Inf | 0.0092 | 1 | 1 | calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 14.9065 | 2.6346 | 29 | 303 | protein heterodimerization activity |
GO:0005509 | 0 | 4.2372 | 5.7214 | 21 | 658 | calcium ion binding |
GO:0019904 | 0 | 3.9317 | 5.4866 | 19 | 631 | protein domain specific binding |
GO:0045296 | 0 | 5.2482 | 2.765 | 13 | 318 | cadherin binding |
GO:0003677 | 9e-04 | 1.9574 | 19.7988 | 34 | 2277 | DNA binding |
GO:0019531 | 0.0026 | 33.0245 | 0.0783 | 2 | 9 | oxalate transmembrane transporter activity |
GO:0008271 | 0.0047 | 23.1129 | 0.1043 | 2 | 12 | secondary active sulfate transmembrane transporter activity |
GO:0004411 | 0.0087 | Inf | 0.0087 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
GO:0031751 | 0.0087 | Inf | 0.0087 | 1 | 1 | D4 dopamine receptor binding |
GO:0046539 | 0.0087 | Inf | 0.0087 | 1 | 1 | histamine N-methyltransferase activity |
GO:0047969 | 0.0087 | Inf | 0.0087 | 1 | 1 | glyoxylate oxidase activity |
GO:0052665 | 0.0087 | Inf | 0.0087 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030546 | 1e-04 | 4.058 | 3.2645 | 12 | 448 | signaling receptor activator activity |
GO:0016015 | 0.0011 | 55.4085 | 0.051 | 2 | 7 | morphogen activity |
GO:0005131 | 0.0014 | 46.1709 | 0.0583 | 2 | 8 | growth hormone receptor binding |
GO:0036122 | 0.0067 | 18.4581 | 0.1239 | 2 | 17 | BMP binding |
GO:0004912 | 0.0073 | Inf | 0.0073 | 1 | 1 | interleukin-3 receptor activity |
GO:0046539 | 0.0073 | Inf | 0.0073 | 1 | 1 | histamine N-methyltransferase activity |
GO:0047058 | 0.0073 | Inf | 0.0073 | 1 | 1 | vitamin-K-epoxide reductase (warfarin-insensitive) activity |
GO:0050479 | 0.0073 | Inf | 0.0073 | 1 | 1 | glyceryl-ether monooxygenase activity |
GO:0072591 | 0.0073 | Inf | 0.0073 | 1 | 1 | citrate-L-glutamate ligase activity |
GO:0102758 | 0.0073 | Inf | 0.0073 | 1 | 1 | very-long-chain enoyl-CoA reductase activity |
GO:0140616 | 0.0073 | Inf | 0.0073 | 1 | 1 | iodotyrosine deiodinase activity |
GO:0098772 | 0.008 | 1.8876 | 12.832 | 22 | 1761 | molecular function regulator activity |
GO:0005179 | 0.0097 | 5.0915 | 0.8307 | 4 | 114 | hormone activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0033612 | 0.0012 | 16.3789 | 0.2116 | 3 | 24 | receptor serine/threonine kinase binding |
GO:0016015 | 0.0016 | 45.5831 | 0.0617 | 2 | 7 | morphogen activity |
GO:0070700 | 0.0066 | 18.9847 | 0.1234 | 2 | 14 | BMP receptor binding |
GO:0004411 | 0.0088 | Inf | 0.0088 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
GO:0004912 | 0.0088 | Inf | 0.0088 | 1 | 1 | interleukin-3 receptor activity |
GO:0016495 | 0.0088 | Inf | 0.0088 | 1 | 1 | C-X3-C chemokine receptor activity |
GO:0018549 | 0.0088 | Inf | 0.0088 | 1 | 1 | methanethiol oxidase activity |
GO:0046538 | 0.0088 | Inf | 0.0088 | 1 | 1 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
GO:0052597 | 0.0088 | Inf | 0.0088 | 1 | 1 | diamine oxidase activity |
GO:0052598 | 0.0088 | Inf | 0.0088 | 1 | 1 | histamine oxidase activity |
GO:0052599 | 0.0088 | Inf | 0.0088 | 1 | 1 | methylputrescine oxidase activity |
GO:0052600 | 0.0088 | Inf | 0.0088 | 1 | 1 | propane-1,3-diamine oxidase activity |
GO:0061657 | 0.0088 | Inf | 0.0088 | 1 | 1 | UFM1 conjugating enzyme activity |
GO:0103069 | 0.0088 | Inf | 0.0088 | 1 | 1 | 17-hydroxyprogesterone 21-hydroxylase activity |
GO:0106309 | 0.0088 | Inf | 0.0088 | 1 | 1 | progesterone 21-hydroxylase activity |
GO:0036122 | 0.0096 | 15.185 | 0.1499 | 2 | 17 | BMP binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016015 | 0.001 | 58.4252 | 0.0484 | 2 | 7 | morphogen activity |
GO:0019531 | 0.0017 | 41.7272 | 0.0623 | 2 | 9 | oxalate transmembrane transporter activity |
GO:0008271 | 0.003 | 29.2036 | 0.083 | 2 | 12 | secondary active sulfate transmembrane transporter activity |
GO:0004984 | 0.0037 | 3.7865 | 1.972 | 7 | 285 | olfactory receptor activity |
GO:0036122 | 0.006 | 19.4631 | 0.1176 | 2 | 17 | BMP binding |
GO:0001512 | 0.0069 | Inf | 0.0069 | 1 | 1 | dihydronicotinamide riboside quinone reductase activity |
GO:0004034 | 0.0069 | Inf | 0.0069 | 1 | 1 | aldose 1-epimerase activity |
GO:0004411 | 0.0069 | Inf | 0.0069 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
GO:0031751 | 0.0069 | Inf | 0.0069 | 1 | 1 | D4 dopamine receptor binding |
GO:0046538 | 0.0069 | Inf | 0.0069 | 1 | 1 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
GO:0061657 | 0.0069 | Inf | 0.0069 | 1 | 1 | UFM1 conjugating enzyme activity |
GO:0071667 | 0.0069 | Inf | 0.0069 | 1 | 1 | DNA/RNA hybrid binding |
GO:0102483 | 0.0069 | Inf | 0.0069 | 1 | 1 | scopolin beta-glucosidase activity |
GO:0103069 | 0.0069 | Inf | 0.0069 | 1 | 1 | 17-hydroxyprogesterone 21-hydroxylase activity |
GO:0106309 | 0.0069 | Inf | 0.0069 | 1 | 1 | progesterone 21-hydroxylase activity |
GO:1904408 | 0.0069 | Inf | 0.0069 | 1 | 1 | melatonin binding |
GO:1905594 | 0.0069 | Inf | 0.0069 | 1 | 1 | resveratrol binding |
GO:0000979 | 0.0075 | 17.1712 | 0.1315 | 2 | 19 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0015106 | 0.0091 | 15.3618 | 0.1453 | 2 | 21 | bicarbonate transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 15.9107 | 2.2264 | 26 | 303 | protein heterodimerization activity |
GO:0019904 | 0 | 6.085 | 4.6366 | 23 | 631 | protein domain specific binding |
GO:0045296 | 0 | 5.7752 | 2.3367 | 12 | 318 | cadherin binding |
GO:0003677 | 2e-04 | 2.2622 | 16.7314 | 32 | 2277 | DNA binding |
GO:0044325 | 0.0018 | 6.1939 | 0.8671 | 5 | 118 | transmembrane transporter binding |
GO:0005095 | 0.0034 | 27.4593 | 0.0882 | 2 | 12 | GTPase inhibitor activity |
GO:0031432 | 0.004 | 24.9615 | 0.0955 | 2 | 13 | titin binding |
GO:0003723 | 0.004 | 1.9899 | 12.8516 | 23 | 1749 | RNA binding |
GO:0004854 | 0.0073 | Inf | 0.0073 | 1 | 1 | xanthine dehydrogenase activity |
GO:0004855 | 0.0073 | Inf | 0.0073 | 1 | 1 | xanthine oxidase activity |
GO:0043185 | 0.0073 | Inf | 0.0073 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0052665 | 0.0073 | Inf | 0.0073 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GO:0070674 | 0.0073 | Inf | 0.0073 | 1 | 1 | hypoxanthine dehydrogenase activity |
GO:0070675 | 0.0073 | Inf | 0.0073 | 1 | 1 | hypoxanthine oxidase activity |
GO:0102483 | 0.0073 | Inf | 0.0073 | 1 | 1 | scopolin beta-glucosidase activity |
GO:0005509 | 0.0091 | 2.4276 | 4.835 | 11 | 658 | calcium ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 9.448 | 2.579 | 20 | 303 | protein heterodimerization activity |
GO:0004930 | 0 | 3.5287 | 5.7282 | 18 | 673 | G protein-coupled receptor activity |
GO:0045296 | 0 | 4.9054 | 2.7066 | 12 | 318 | cadherin binding |
GO:0004984 | 0 | 4.9925 | 2.4258 | 11 | 285 | olfactory receptor activity |
GO:0038023 | 4e-04 | 2.3992 | 10.7159 | 23 | 1259 | signaling receptor activity |
GO:0031849 | 0.0011 | 59.0803 | 0.0511 | 2 | 6 | olfactory receptor binding |
GO:0016015 | 0.0015 | 47.2613 | 0.0596 | 2 | 7 | morphogen activity |
GO:0003677 | 0.0025 | 1.8579 | 19.3805 | 32 | 2277 | DNA binding |
GO:0010181 | 0.0053 | 21.4745 | 0.1106 | 2 | 13 | FMN binding |
GO:0005549 | 0.0055 | 6.0433 | 0.7064 | 4 | 83 | odorant binding |
GO:0043185 | 0.0085 | Inf | 0.0085 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0047704 | 0.0085 | Inf | 0.0085 | 1 | 1 | bile-salt sulfotransferase activity |
GO:0050479 | 0.0085 | Inf | 0.0085 | 1 | 1 | glyceryl-ether monooxygenase activity |
GO:0060175 | 0.0085 | Inf | 0.0085 | 1 | 1 | brain-derived neurotrophic factor-activated receptor activity |
GO:0072591 | 0.0085 | Inf | 0.0085 | 1 | 1 | citrate-L-glutamate ligase activity |
GO:0102483 | 0.0085 | Inf | 0.0085 | 1 | 1 | scopolin beta-glucosidase activity |
GO:0102758 | 0.0085 | Inf | 0.0085 | 1 | 1 | very-long-chain enoyl-CoA reductase activity |
GO:0140616 | 0.0085 | Inf | 0.0085 | 1 | 1 | iodotyrosine deiodinase activity |
GO:0036122 | 0.009 | 15.744 | 0.1447 | 2 | 17 | BMP binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 1e-04 | 5.3616 | 1.8499 | 9 | 285 | olfactory receptor activity |
GO:0031849 | 6e-04 | 77.9856 | 0.0389 | 2 | 6 | olfactory receptor binding |
GO:0016015 | 9e-04 | 62.3846 | 0.0454 | 2 | 7 | morphogen activity |
GO:0005549 | 0.0021 | 8.0149 | 0.5387 | 4 | 83 | odorant binding |
GO:0004930 | 0.0043 | 2.7221 | 4.3683 | 11 | 673 | G protein-coupled receptor activity |
GO:0036122 | 0.0053 | 20.7821 | 0.1103 | 2 | 17 | BMP binding |
GO:0001512 | 0.0065 | Inf | 0.0065 | 1 | 1 | dihydronicotinamide riboside quinone reductase activity |
GO:0015094 | 0.0065 | Inf | 0.0065 | 1 | 1 | lead ion transmembrane transporter activity |
GO:0015099 | 0.0065 | Inf | 0.0065 | 1 | 1 | nickel cation transmembrane transporter activity |
GO:0031770 | 0.0065 | Inf | 0.0065 | 1 | 1 | growth hormone-releasing hormone receptor binding |
GO:0047704 | 0.0065 | Inf | 0.0065 | 1 | 1 | bile-salt sulfotransferase activity |
GO:0072591 | 0.0065 | Inf | 0.0065 | 1 | 1 | citrate-L-glutamate ligase activity |
GO:0102483 | 0.0065 | Inf | 0.0065 | 1 | 1 | scopolin beta-glucosidase activity |
GO:0102758 | 0.0065 | Inf | 0.0065 | 1 | 1 | very-long-chain enoyl-CoA reductase activity |
GO:1904408 | 0.0065 | Inf | 0.0065 | 1 | 1 | melatonin binding |
GO:1905594 | 0.0065 | Inf | 0.0065 | 1 | 1 | resveratrol binding |
GO:0038023 | 0.0071 | 2.1428 | 8.1718 | 16 | 1259 | signaling receptor activity |
GO:0004806 | 0.0089 | 15.5817 | 0.1428 | 2 | 22 | triglyceride lipase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0036122 | 1e-04 | 37.3756 | 0.0999 | 3 | 17 | BMP binding |
GO:0016015 | 7e-04 | 69.0638 | 0.0411 | 2 | 7 | morphogen activity |
GO:0030280 | 0.0011 | 16.3337 | 0.2057 | 3 | 35 | structural constituent of skin epidermis |
GO:0005095 | 0.0022 | 34.5213 | 0.0705 | 2 | 12 | GTPase inhibitor activity |
GO:0030546 | 0.0049 | 3.2634 | 2.6335 | 8 | 448 | signaling receptor activator activity |
GO:0001512 | 0.0059 | Inf | 0.0059 | 1 | 1 | dihydronicotinamide riboside quinone reductase activity |
GO:0043185 | 0.0059 | Inf | 0.0059 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0102483 | 0.0059 | Inf | 0.0059 | 1 | 1 | scopolin beta-glucosidase activity |
GO:1904408 | 0.0059 | Inf | 0.0059 | 1 | 1 | melatonin binding |
GO:1905594 | 0.0059 | Inf | 0.0059 | 1 | 1 | resveratrol binding |
GO:0004984 | 0.0067 | 3.8127 | 1.6753 | 6 | 285 | olfactory receptor activity |
GO:0004806 | 0.0073 | 17.25 | 0.1293 | 2 | 22 | triglyceride lipase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 9.6341 | 1.8673 | 15 | 285 | olfactory receptor activity |
GO:0004930 | 0 | 5.1402 | 4.4095 | 19 | 673 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.3203 | 8.2489 | 23 | 1259 | signaling receptor activity |
GO:0018685 | 3e-04 | 154.4952 | 0.0262 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0005509 | 4e-04 | 3.3404 | 4.3112 | 13 | 658 | calcium ion binding |
GO:0102033 | 9e-04 | 61.7867 | 0.0459 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0030621 | 0.0015 | 44.1279 | 0.059 | 2 | 9 | U4 snRNA binding |
GO:0004866 | 0.0032 | 5.3611 | 0.9959 | 5 | 152 | endopeptidase inhibitor activity |
GO:0004497 | 0.0034 | 6.9618 | 0.6159 | 4 | 94 | monooxygenase activity |
GO:0008392 | 0.0042 | 23.7524 | 0.0983 | 2 | 15 | arachidonic acid epoxygenase activity |
GO:0008403 | 0.0066 | Inf | 0.0066 | 1 | 1 | 25-hydroxycholecalciferol-24-hydroxylase activity |
GO:0030342 | 0.0066 | Inf | 0.0066 | 1 | 1 | 1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity |
GO:0045237 | 0.0066 | Inf | 0.0066 | 1 | 1 | CXCR1 chemokine receptor binding |
GO:0062180 | 0.0066 | Inf | 0.0066 | 1 | 1 | 25-hydroxycholecalciferol-23-hydroxylase activity |
GO:0102116 | 0.0066 | Inf | 0.0066 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0066 | Inf | 0.0066 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0070696 | 0.0075 | 17.1492 | 0.131 | 2 | 20 | transmembrane receptor protein serine/threonine kinase binding |
GO:0070330 | 0.0082 | 16.2456 | 0.1376 | 2 | 21 | aromatase activity |
GO:0020037 | 0.009 | 5.2117 | 0.8124 | 4 | 124 | heme binding |
GO:0061134 | 0.0092 | 4.1367 | 1.2776 | 5 | 195 | peptidase regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 11.5797 | 1.7102 | 16 | 285 | olfactory receptor activity |
GO:0004930 | 0 | 6.4071 | 3.8828 | 20 | 660 | G protein-coupled receptor activity |
GO:0038023 | 0 | 4.3617 | 7.2759 | 25 | 1236 | signaling receptor activity |
GO:0008392 | 1e-04 | 42.6868 | 0.09 | 3 | 15 | arachidonic acid epoxygenase activity |
GO:0018685 | 2e-04 | 169.0729 | 0.024 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0070330 | 3e-04 | 28.4474 | 0.126 | 3 | 21 | aromatase activity |
GO:0102033 | 7e-04 | 67.6167 | 0.042 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0004497 | 0.0025 | 7.6326 | 0.5641 | 4 | 94 | monooxygenase activity |
GO:0045125 | 0.0027 | 30.7235 | 0.078 | 2 | 13 | bioactive lipid receptor activity |
GO:0000993 | 0.003 | 11.36 | 0.288 | 3 | 48 | RNA polymerase II complex binding |
GO:0097153 | 0.0031 | 28.1615 | 0.084 | 2 | 14 | cysteine-type endopeptidase activity involved in apoptotic process |
GO:0031798 | 0.006 | Inf | 0.006 | 1 | 1 | type 1 metabotropic glutamate receptor binding |
GO:0102116 | 0.006 | Inf | 0.006 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.006 | Inf | 0.006 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0070696 | 0.0063 | 18.7674 | 0.12 | 2 | 20 | transmembrane receptor protein serine/threonine kinase binding |
GO:0020037 | 0.0066 | 5.7138 | 0.7441 | 4 | 124 | heme binding |
GO:0019865 | 0.0069 | 17.7785 | 0.126 | 2 | 21 | immunoglobulin binding |
GO:0001098 | 0.0079 | 7.8549 | 0.4081 | 3 | 68 | basal transcription machinery binding |
GO:0070063 | 0.0082 | 7.7354 | 0.4141 | 3 | 69 | RNA polymerase binding |
GO:0038187 | 0.0083 | 16.0833 | 0.138 | 2 | 23 | pattern recognition receptor activity |
GO:0005506 | 0.0091 | 5.1905 | 0.8161 | 4 | 136 | iron ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 18.8501 | 1.9371 | 26 | 285 | olfactory receptor activity |
GO:0004930 | 0 | 9.4026 | 4.5743 | 31 | 673 | G protein-coupled receptor activity |
GO:0038023 | 0 | 6.6598 | 8.5573 | 39 | 1259 | signaling receptor activity |
GO:0005549 | 0 | 16.7197 | 0.5641 | 8 | 83 | odorant binding |
GO:0042834 | 1e-04 | 40.9318 | 0.0952 | 3 | 14 | peptidoglycan binding |
GO:0018685 | 3e-04 | 148.789 | 0.0272 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0004252 | 7e-04 | 6.0406 | 1.0739 | 6 | 158 | serine-type endopeptidase activity |
GO:0102033 | 9e-04 | 59.5046 | 0.0476 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0017171 | 0.0014 | 5.3316 | 1.2098 | 6 | 178 | serine hydrolase activity |
GO:0020037 | 0.0016 | 6.3822 | 0.8428 | 5 | 124 | heme binding |
GO:0030621 | 0.0016 | 42.498 | 0.0612 | 2 | 9 | U4 snRNA binding |
GO:0004497 | 0.0039 | 6.6999 | 0.6389 | 4 | 94 | monooxygenase activity |
GO:0008392 | 0.0045 | 22.8751 | 0.102 | 2 | 15 | arachidonic acid epoxygenase activity |
GO:0004744 | 0.0068 | Inf | 0.0068 | 1 | 1 | retinal isomerase activity |
GO:0052884 | 0.0068 | Inf | 0.0068 | 1 | 1 | all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity |
GO:0052885 | 0.0068 | Inf | 0.0068 | 1 | 1 | all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity |
GO:0102116 | 0.0068 | Inf | 0.0068 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0068 | Inf | 0.0068 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0070330 | 0.0088 | 15.6456 | 0.1427 | 2 | 21 | aromatase activity |
GO:0004806 | 0.0097 | 14.8624 | 0.1495 | 2 | 22 | triglyceride lipase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 11.6908 | 1.9197 | 18 | 285 | olfactory receptor activity |
GO:0004930 | 0 | 6.696 | 4.5331 | 24 | 673 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.9577 | 8.4802 | 27 | 1259 | signaling receptor activity |
GO:0005549 | 0 | 12.0959 | 0.5591 | 6 | 83 | odorant binding |
GO:0004252 | 1e-04 | 7.2327 | 1.0642 | 7 | 158 | serine-type endopeptidase activity |
GO:0017171 | 2e-04 | 6.3788 | 1.1989 | 7 | 178 | serine hydrolase activity |
GO:0004875 | 0.002 | 37.5301 | 0.0674 | 2 | 10 | complement receptor activity |
GO:0008233 | 0.0034 | 2.978 | 3.617 | 10 | 537 | peptidase activity |
GO:0034185 | 0.0051 | 21.4378 | 0.1078 | 2 | 16 | apolipoprotein binding |
GO:0000140 | 0.0067 | Inf | 0.0067 | 1 | 1 | acylglycerone-phosphate reductase activity |
GO:0099077 | 0.0067 | Inf | 0.0067 | 1 | 1 | histone-dependent DNA binding |
GO:0099609 | 0.0067 | Inf | 0.0067 | 1 | 1 | microtubule lateral binding |
GO:0000979 | 0.0071 | 17.6514 | 0.128 | 2 | 19 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0005179 | 0.0074 | 5.5269 | 0.7679 | 4 | 114 | hormone activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 10.2961 | 2.0224 | 17 | 303 | protein heterodimerization activity |
GO:0019904 | 0 | 4.6972 | 4.2116 | 17 | 631 | protein domain specific binding |
GO:0003723 | 2e-04 | 2.5028 | 11.6736 | 25 | 1749 | RNA binding |
GO:1903231 | 7e-04 | 5.1336 | 1.475 | 7 | 221 | mRNA base-pairing post-transcriptional repressor activity |
GO:0005509 | 0.0015 | 2.9829 | 4.3918 | 12 | 658 | calcium ion binding |
GO:0019531 | 0.0015 | 43.2977 | 0.0601 | 2 | 9 | oxalate transmembrane transporter activity |
GO:0045182 | 0.002 | 3.7794 | 2.276 | 8 | 341 | translation regulator activity |
GO:0005095 | 0.0028 | 30.3028 | 0.0801 | 2 | 12 | GTPase inhibitor activity |
GO:0008271 | 0.0028 | 30.3028 | 0.0801 | 2 | 12 | secondary active sulfate transmembrane transporter activity |
GO:0004984 | 0.003 | 3.936 | 1.9022 | 7 | 285 | olfactory receptor activity |
GO:0000140 | 0.0067 | Inf | 0.0067 | 1 | 1 | acylglycerone-phosphate reductase activity |
GO:0001512 | 0.0067 | Inf | 0.0067 | 1 | 1 | dihydronicotinamide riboside quinone reductase activity |
GO:0004411 | 0.0067 | Inf | 0.0067 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
GO:0031751 | 0.0067 | Inf | 0.0067 | 1 | 1 | D4 dopamine receptor binding |
GO:0071667 | 0.0067 | Inf | 0.0067 | 1 | 1 | DNA/RNA hybrid binding |
GO:0102483 | 0.0067 | Inf | 0.0067 | 1 | 1 | scopolin beta-glucosidase activity |
GO:1904408 | 0.0067 | Inf | 0.0067 | 1 | 1 | melatonin binding |
GO:1905594 | 0.0067 | Inf | 0.0067 | 1 | 1 | resveratrol binding |
GO:0000979 | 0.007 | 17.8175 | 0.1268 | 2 | 19 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0015106 | 0.0085 | 15.94 | 0.1402 | 2 | 21 | bicarbonate transmembrane transporter activity |
GO:0015301 | 0.0093 | 15.1421 | 0.1468 | 2 | 22 | anion:anion antiporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 9.252 | 2.078 | 16 | 303 | protein heterodimerization activity |
GO:0019904 | 0 | 4.548 | 4.3275 | 17 | 631 | protein domain specific binding |
GO:0005509 | 6e-04 | 3.1707 | 4.5126 | 13 | 658 | calcium ion binding |
GO:0031751 | 0.0069 | Inf | 0.0069 | 1 | 1 | D4 dopamine receptor binding |
GO:0043185 | 0.0069 | Inf | 0.0069 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0071667 | 0.0069 | Inf | 0.0069 | 1 | 1 | DNA/RNA hybrid binding |
GO:0102483 | 0.0069 | Inf | 0.0069 | 1 | 1 | scopolin beta-glucosidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 10.4458 | 2.245 | 19 | 303 | protein heterodimerization activity |
GO:0005509 | 0 | 5.134 | 4.8753 | 21 | 658 | calcium ion binding |
GO:0019904 | 0 | 3.864 | 4.6752 | 16 | 631 | protein domain specific binding |
GO:0003723 | 9e-04 | 2.1882 | 12.9587 | 25 | 1749 | RNA binding |
GO:0005095 | 0.0034 | 27.2269 | 0.0889 | 2 | 12 | GTPase inhibitor activity |
GO:0001512 | 0.0074 | Inf | 0.0074 | 1 | 1 | dihydronicotinamide riboside quinone reductase activity |
GO:0031751 | 0.0074 | Inf | 0.0074 | 1 | 1 | D4 dopamine receptor binding |
GO:0043185 | 0.0074 | Inf | 0.0074 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0052665 | 0.0074 | Inf | 0.0074 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GO:0102483 | 0.0074 | Inf | 0.0074 | 1 | 1 | scopolin beta-glucosidase activity |
GO:0106137 | 0.0074 | Inf | 0.0074 | 1 | 1 | IkappaB kinase complex binding |
GO:1904408 | 0.0074 | Inf | 0.0074 | 1 | 1 | melatonin binding |
GO:1905594 | 0.0074 | Inf | 0.0074 | 1 | 1 | resveratrol binding |
GO:0000979 | 0.0086 | 16.0089 | 0.1408 | 2 | 19 | RNA polymerase II core promoter sequence-specific DNA binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 138.1744 | 0.726 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0050911 | 0 | 12.8518 | 4.8779 | 45 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051606 | 0 | 7.7643 | 9.7785 | 58 | 431 | detection of stimulus |
GO:0007186 | 0 | 4.3066 | 21.8932 | 75 | 970 | G protein-coupled receptor signaling pathway |
GO:0006334 | 0 | 16.2214 | 2.3596 | 27 | 104 | nucleosome assembly |
GO:0007600 | 0 | 5.1088 | 14.0492 | 58 | 631 | sensory perception |
GO:0045653 | 0 | 156.6893 | 0.4084 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006336 | 0 | 34.7891 | 0.726 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0032200 | 0 | 8.7469 | 3.5393 | 25 | 156 | telomere organization |
GO:0003008 | 0 | 2.6926 | 44.4005 | 97 | 1957 | system process |
GO:0071824 | 0 | 7.0905 | 4.7645 | 28 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 6.1639 | 5.3771 | 28 | 237 | chromatin remodeling |
GO:0045637 | 0 | 5.0607 | 4.4922 | 20 | 198 | regulation of myeloid cell differentiation |
GO:0006352 | 0 | 6.1373 | 2.8133 | 15 | 124 | DNA-templated transcription, initiation |
GO:0042221 | 0 | 1.68 | 88.7556 | 127 | 3912 | response to chemical |
GO:0001580 | 0 | 11.4069 | 0.658 | 6 | 29 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0040029 | 1e-04 | 4.3823 | 3.0175 | 12 | 133 | regulation of gene expression, epigenetic |
GO:0050907 | 1e-04 | 9.5559 | 0.7467 | 6 | 37 | detection of chemical stimulus involved in sensory perception |
GO:0019233 | 3e-04 | 4.5428 | 2.1781 | 9 | 96 | sensory perception of pain |
GO:0016441 | 3e-04 | 2.6843 | 7.1694 | 18 | 316 | post-transcriptional gene silencing |
GO:0035195 | 6e-04 | 2.6267 | 6.8972 | 17 | 304 | miRNA-mediated gene silencing |
GO:0002682 | 0.001 | 1.7179 | 28.655 | 46 | 1263 | regulation of immune system process |
GO:0050909 | 0.0011 | 5.6952 | 1.1798 | 6 | 52 | sensory perception of taste |
GO:0002227 | 0.0014 | 9.6667 | 0.4991 | 4 | 22 | innate immune response in mucosa |
GO:0035821 | 0.0014 | 9.6667 | 0.4991 | 4 | 22 | modulation of process of another organism |
GO:0042361 | 0.0015 | 86.6175 | 0.0681 | 2 | 3 | menaquinone catabolic process |
GO:0042376 | 0.0015 | 86.6175 | 0.0681 | 2 | 3 | phylloquinone catabolic process |
GO:0044245 | 0.0015 | 86.6175 | 0.0681 | 2 | 3 | polysaccharide digestion |
GO:0002520 | 0.0017 | 1.7904 | 20.7369 | 35 | 914 | immune system development |
GO:0031047 | 0.0019 | 2.3433 | 7.6686 | 17 | 338 | gene silencing by RNA |
GO:0010960 | 0.0022 | 14.4685 | 0.2723 | 3 | 12 | magnesium ion homeostasis |
GO:0036101 | 0.003 | 43.306 | 0.0908 | 2 | 4 | leukotriene B4 catabolic process |
GO:0061737 | 0.003 | 43.306 | 0.0908 | 2 | 4 | leukotriene signaling pathway |
GO:0050789 | 0.003 | 1.4027 | 201.1827 | 225 | 9345 | regulation of biological process |
GO:0030097 | 0.0035 | 1.7656 | 18.5134 | 31 | 816 | hemopoiesis |
GO:0050830 | 0.0038 | 3.7754 | 1.9965 | 7 | 88 | defense response to Gram-positive bacterium |
GO:0019373 | 0.0043 | 10.8493 | 0.3403 | 3 | 15 | epoxygenase P450 pathway |
GO:1904862 | 0.0043 | 10.8493 | 0.3403 | 3 | 15 | inhibitory synapse assembly |
GO:0045596 | 0.0049 | 1.84 | 14.2708 | 25 | 629 | negative regulation of cell differentiation |
GO:0014050 | 0.0049 | 28.8689 | 0.1134 | 2 | 5 | negative regulation of glutamate secretion |
GO:0048006 | 0.0049 | 28.8689 | 0.1134 | 2 | 5 | antigen processing and presentation, endogenous lipid antigen via MHC class Ib |
GO:0031341 | 0.0052 | 3.5548 | 2.11 | 7 | 93 | regulation of cell killing |
GO:0050829 | 0.0054 | 4.0256 | 1.6109 | 6 | 71 | defense response to Gram-negative bacterium |
GO:0010951 | 0.0058 | 2.4516 | 5.1502 | 12 | 227 | negative regulation of endopeptidase activity |
GO:0000038 | 0.0063 | 5.9958 | 0.7487 | 4 | 33 | very long-chain fatty acid metabolic process |
GO:0002251 | 0.0063 | 5.9958 | 0.7487 | 4 | 33 | organ or tissue specific immune response |
GO:0019228 | 0.0071 | 5.7956 | 0.7714 | 4 | 34 | neuronal action potential |
GO:0034105 | 0.0086 | 8.1349 | 0.4311 | 3 | 19 | positive regulation of tissue remodeling |
GO:0042373 | 0.01 | 17.3191 | 0.1588 | 2 | 7 | vitamin K metabolic process |
GO:0048007 | 0.01 | 17.3191 | 0.1588 | 2 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
GO:0086043 | 0.01 | 17.3191 | 0.1588 | 2 | 7 | bundle of His cell action potential |
GO:1904628 | 0.01 | 17.3191 | 0.1588 | 2 | 7 | cellular response to phorbol 13-acetate 12-myristate |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 141.5357 | 0.7102 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 21.393 | 2.3083 | 32 | 104 | nucleosome assembly |
GO:0045653 | 0 | 160.3931 | 0.3995 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0071824 | 0 | 8.9417 | 4.6609 | 33 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 7.7449 | 5.2602 | 33 | 237 | chromatin remodeling |
GO:0006336 | 0 | 35.6114 | 0.7102 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0032200 | 0 | 8.5108 | 3.4624 | 24 | 156 | telomere organization |
GO:0045637 | 0 | 5.4888 | 4.3946 | 21 | 198 | regulation of myeloid cell differentiation |
GO:0006352 | 0 | 5.7935 | 2.7522 | 14 | 124 | DNA-templated transcription, initiation |
GO:2000026 | 0 | 2.1738 | 28.7423 | 56 | 1295 | regulation of multicellular organismal development |
GO:0045596 | 0 | 2.7805 | 12.2318 | 31 | 558 | negative regulation of cell differentiation |
GO:0007389 | 0 | 2.9953 | 9.8767 | 27 | 445 | pattern specification process |
GO:0010468 | 0 | 1.661 | 96.0634 | 134 | 4428 | regulation of gene expression |
GO:0002227 | 0 | 16.7839 | 0.4883 | 6 | 22 | innate immune response in mucosa |
GO:0006351 | 0 | 1.7039 | 65.8423 | 98 | 3063 | transcription, DNA-templated |
GO:0002118 | 0 | 44.5393 | 0.1776 | 4 | 8 | aggressive behavior |
GO:0032501 | 0 | 1.6783 | 88.909 | 122 | 4421 | multicellular organismal process |
GO:0032774 | 0 | 1.6913 | 66.2292 | 98 | 3081 | RNA biosynthetic process |
GO:0009952 | 0 | 3.644 | 4.4834 | 15 | 202 | anterior/posterior pattern specification |
GO:0035195 | 1e-04 | 3.045 | 6.7472 | 19 | 304 | miRNA-mediated gene silencing |
GO:0048513 | 1e-04 | 1.6972 | 54.408 | 82 | 2558 | animal organ development |
GO:0021854 | 1e-04 | 14.8779 | 0.4439 | 5 | 20 | hypothalamus development |
GO:0018130 | 1e-04 | 1.5849 | 80.545 | 112 | 3629 | heterocycle biosynthetic process |
GO:0031047 | 1e-04 | 2.875 | 7.5018 | 20 | 338 | gene silencing by RNA |
GO:0048869 | 1e-04 | 1.5665 | 87.0037 | 119 | 3920 | cellular developmental process |
GO:0019438 | 1e-04 | 1.5786 | 80.7891 | 112 | 3640 | aromatic compound biosynthetic process |
GO:0002251 | 1e-04 | 9.9391 | 0.7324 | 6 | 33 | organ or tissue specific immune response |
GO:0016441 | 1e-04 | 2.9197 | 7.0136 | 19 | 316 | post-transcriptional gene silencing |
GO:1901362 | 1e-04 | 1.5619 | 83.8964 | 115 | 3780 | organic cyclic compound biosynthetic process |
GO:0002520 | 1e-04 | 2.0186 | 20.2861 | 38 | 914 | immune system development |
GO:0030097 | 2e-04 | 2.0792 | 18.111 | 35 | 816 | hemopoiesis |
GO:0040029 | 2e-04 | 4.0659 | 2.9519 | 11 | 133 | regulation of gene expression, epigenetic |
GO:0014744 | 2e-04 | 17.809 | 0.3107 | 4 | 14 | positive regulation of muscle adaptation |
GO:1904862 | 3e-04 | 16.189 | 0.3329 | 4 | 15 | inhibitory synapse assembly |
GO:0021543 | 3e-04 | 3.6115 | 3.5956 | 12 | 162 | pallium development |
GO:0099537 | 4e-04 | 2.0938 | 14.7818 | 29 | 666 | trans-synaptic signaling |
GO:0048663 | 5e-04 | 5.5963 | 1.3983 | 7 | 63 | neuron fate commitment |
GO:0045944 | 5e-04 | 1.8184 | 25.3909 | 43 | 1144 | positive regulation of transcription by RNA polymerase II |
GO:0021985 | 5e-04 | Inf | 0.0444 | 2 | 2 | neurohypophysis development |
GO:0061032 | 5e-04 | Inf | 0.0444 | 2 | 2 | visceral serous pericardium development |
GO:0061379 | 5e-04 | Inf | 0.0444 | 2 | 2 | inferior colliculus development |
GO:0072166 | 5e-04 | Inf | 0.0444 | 2 | 2 | posterior mesonephric tubule development |
GO:0046717 | 5e-04 | 6.7034 | 1.021 | 6 | 46 | acid secretion |
GO:0007420 | 5e-04 | 2.0451 | 15.6473 | 30 | 705 | brain development |
GO:0072507 | 5e-04 | 2.2747 | 10.7645 | 23 | 485 | divalent inorganic cation homeostasis |
GO:0001714 | 6e-04 | 26.6471 | 0.1776 | 3 | 8 | endodermal cell fate specification |
GO:0065003 | 6e-04 | 1.7252 | 31.2059 | 50 | 1406 | protein-containing complex assembly |
GO:0006357 | 6e-04 | 1.8108 | 25.0219 | 42 | 1190 | regulation of transcription by RNA polymerase II |
GO:0050795 | 8e-04 | 5.136 | 1.5092 | 7 | 68 | regulation of behavior |
GO:0048562 | 8e-04 | 2.6457 | 6.4365 | 16 | 290 | embryonic organ morphogenesis |
GO:0010658 | 8e-04 | 6.0924 | 1.1097 | 6 | 50 | striated muscle cell apoptotic process |
GO:0019731 | 8e-04 | 6.0924 | 1.1097 | 6 | 50 | antibacterial humoral response |
GO:1903244 | 8e-04 | 22.2045 | 0.1998 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0007631 | 8e-04 | 4.4087 | 1.9821 | 8 | 90 | feeding behavior |
GO:0061351 | 0.0011 | 3.4842 | 3.0851 | 10 | 139 | neural precursor cell proliferation |
GO:0007399 | 0.0011 | 1.5425 | 50.693 | 72 | 2284 | nervous system development |
GO:0042756 | 0.0012 | 19.0312 | 0.2219 | 3 | 10 | drinking behavior |
GO:0050789 | 0.0013 | 1.436 | 230.3504 | 257 | 10540 | regulation of biological process |
GO:0030003 | 0.0014 | 2.0112 | 13.6942 | 26 | 617 | cellular cation homeostasis |
GO:0006579 | 0.0015 | 88.5978 | 0.0666 | 2 | 3 | amino-acid betaine catabolic process |
GO:0022029 | 0.0015 | 5.3593 | 1.2429 | 6 | 56 | telencephalon cell migration |
GO:0021871 | 0.0015 | 9.3678 | 0.5105 | 4 | 23 | forebrain regionalization |
GO:0021895 | 0.0015 | 9.3678 | 0.5105 | 4 | 23 | cerebral cortex neuron differentiation |
GO:0051252 | 0.0016 | 1.4496 | 74.3748 | 98 | 3351 | regulation of RNA metabolic process |
GO:1902667 | 0.0016 | 16.6513 | 0.2441 | 3 | 11 | regulation of axon guidance |
GO:0010660 | 0.0016 | 4.4731 | 1.709 | 7 | 77 | regulation of muscle cell apoptotic process |
GO:0007218 | 0.0016 | 3.9383 | 2.1973 | 8 | 99 | neuropeptide signaling pathway |
GO:0055082 | 0.0019 | 1.8681 | 17.0012 | 30 | 766 | cellular chemical homeostasis |
GO:0010273 | 0.0021 | 14.8002 | 0.2663 | 3 | 12 | detoxification of copper ion |
GO:1900747 | 0.0021 | 14.8002 | 0.2663 | 3 | 12 | negative regulation of vascular endothelial growth factor signaling pathway |
GO:0007214 | 0.0021 | 8.4746 | 0.5549 | 4 | 25 | gamma-aminobutyric acid signaling pathway |
GO:0090596 | 0.0022 | 2.5577 | 5.7928 | 14 | 261 | sensory organ morphogenesis |
GO:0044271 | 0.0025 | 1.3924 | 94.7941 | 119 | 4271 | cellular nitrogen compound biosynthetic process |
GO:0035270 | 0.0025 | 3.3352 | 2.8853 | 9 | 130 | endocrine system development |
GO:0010453 | 0.0028 | 7.7367 | 0.5993 | 4 | 27 | regulation of cell fate commitment |
GO:0043503 | 0.0029 | 44.2961 | 0.0888 | 2 | 4 | skeletal muscle fiber adaptation |
GO:2000697 | 0.0029 | 44.2961 | 0.0888 | 2 | 4 | negative regulation of epithelial cell differentiation involved in kidney development |
GO:0048645 | 0.0029 | 4.6178 | 1.4205 | 6 | 64 | animal organ formation |
GO:0001656 | 0.003 | 3.9612 | 1.9088 | 7 | 86 | metanephros development |
GO:0010665 | 0.0031 | 5.5704 | 0.9988 | 5 | 45 | regulation of cardiac muscle cell apoptotic process |
GO:1902692 | 0.0031 | 7.4539 | 0.6182 | 4 | 28 | regulation of neuroblast proliferation |
GO:0007204 | 0.0032 | 2.3592 | 6.7028 | 15 | 302 | positive regulation of cytosolic calcium ion concentration |
GO:0043278 | 0.0032 | 7.4139 | 0.6215 | 4 | 28 | response to morphine |
GO:0010556 | 0.0033 | 1.4017 | 78.8582 | 101 | 3553 | regulation of macromolecule biosynthetic process |
GO:0035987 | 0.0034 | 5.4342 | 1.021 | 5 | 46 | endodermal cell differentiation |
GO:0031326 | 0.004 | 1.385 | 82.143 | 104 | 3701 | regulation of cellular biosynthetic process |
GO:0060911 | 0.004 | 11.098 | 0.3329 | 3 | 15 | cardiac cell fate commitment |
GO:0097501 | 0.004 | 11.098 | 0.3329 | 3 | 15 | stress response to metal ion |
GO:0035107 | 0.0041 | 3.0787 | 3.1073 | 9 | 140 | appendage morphogenesis |
GO:0021872 | 0.0041 | 5.1808 | 1.0654 | 5 | 48 | forebrain generation of neurons |
GO:0051932 | 0.0041 | 5.1808 | 1.0654 | 5 | 48 | synaptic transmission, GABAergic |
GO:0007268 | 0.0044 | 1.8812 | 13.4124 | 24 | 611 | chemical synaptic transmission |
GO:1903506 | 0.0044 | 1.5655 | 32.7952 | 48 | 1544 | regulation of nucleic acid-templated transcription |
GO:0001662 | 0.0047 | 6.5888 | 0.688 | 4 | 31 | behavioral fear response |
GO:0021764 | 0.0047 | 29.5289 | 0.111 | 2 | 5 | amygdala development |
GO:0021853 | 0.0047 | 29.5289 | 0.111 | 2 | 5 | cerebral cortex GABAergic interneuron migration |
GO:0021869 | 0.0047 | 29.5289 | 0.111 | 2 | 5 | forebrain ventricular zone progenitor cell division |
GO:0045665 | 0.0049 | 4.1186 | 1.5758 | 6 | 71 | negative regulation of neuron differentiation |
GO:0061844 | 0.0049 | 4.1186 | 1.5758 | 6 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0006584 | 0.0049 | 4.9499 | 1.1097 | 5 | 50 | catecholamine metabolic process |
GO:0002029 | 0.0049 | 10.2437 | 0.3551 | 3 | 16 | desensitization of G protein-coupled receptor signaling pathway |
GO:0023058 | 0.0049 | 10.2437 | 0.3551 | 3 | 16 | adaptation of signaling pathway |
GO:0046631 | 0.0051 | 2.9646 | 3.2182 | 9 | 145 | alpha-beta T cell activation |
GO:0014888 | 0.0053 | 4.842 | 1.1319 | 5 | 51 | striated muscle adaptation |
GO:0050801 | 0.0054 | 1.7799 | 15.9359 | 27 | 718 | ion homeostasis |
GO:0015837 | 0.0055 | 3.5139 | 2.1307 | 7 | 96 | amine transport |
GO:0003008 | 0.0057 | 1.4721 | 43.4353 | 60 | 1957 | system process |
GO:0010612 | 0.0059 | 9.5114 | 0.3773 | 3 | 17 | regulation of cardiac muscle adaptation |
GO:0015812 | 0.0059 | 9.5114 | 0.3773 | 3 | 17 | gamma-aminobutyric acid transport |
GO:0021542 | 0.0059 | 9.5114 | 0.3773 | 3 | 17 | dentate gyrus development |
GO:0071276 | 0.0059 | 6.1337 | 0.7324 | 4 | 33 | cellular response to cadmium ion |
GO:0035282 | 0.0062 | 3.4363 | 2.1751 | 7 | 98 | segmentation |
GO:0045685 | 0.0064 | 3.8789 | 1.6646 | 6 | 75 | regulation of glial cell differentiation |
GO:0055065 | 0.0065 | 1.8167 | 13.8496 | 24 | 624 | metal ion homeostasis |
GO:0035137 | 0.0065 | 5.9288 | 0.7546 | 4 | 34 | hindlimb morphogenesis |
GO:0021761 | 0.0067 | 3.8408 | 1.6784 | 6 | 77 | limbic system development |
GO:0007492 | 0.0068 | 3.8232 | 1.6868 | 6 | 76 | endoderm development |
GO:0007530 | 0.0069 | 8.8768 | 0.3995 | 3 | 18 | sex determination |
GO:0007406 | 0.0069 | 22.1453 | 0.1332 | 2 | 6 | negative regulation of neuroblast proliferation |
GO:0014062 | 0.0069 | 22.1453 | 0.1332 | 2 | 6 | regulation of serotonin secretion |
GO:0016098 | 0.0069 | 22.1453 | 0.1332 | 2 | 6 | monoterpenoid metabolic process |
GO:0060527 | 0.0069 | 22.1453 | 0.1332 | 2 | 6 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
GO:2000543 | 0.0069 | 22.1453 | 0.1332 | 2 | 6 | positive regulation of gastrulation |
GO:0007267 | 0.0076 | 1.5151 | 32.7973 | 47 | 1492 | cell-cell signaling |
GO:0006874 | 0.0076 | 1.9784 | 9.5216 | 18 | 429 | cellular calcium ion homeostasis |
GO:0090288 | 0.0076 | 3.2907 | 2.2639 | 7 | 102 | negative regulation of cellular response to growth factor stimulus |
GO:0045761 | 0.0079 | 4.3659 | 1.2429 | 5 | 56 | regulation of adenylate cyclase activity |
GO:0050432 | 0.0079 | 4.3659 | 1.2429 | 5 | 56 | catecholamine secretion |
GO:0034105 | 0.0081 | 8.3214 | 0.4217 | 3 | 19 | positive regulation of tissue remodeling |
GO:2000243 | 0.0082 | 3.6654 | 1.7534 | 6 | 79 | positive regulation of reproductive process |
GO:0044106 | 0.0085 | 3.2225 | 2.3083 | 7 | 104 | cellular amine metabolic process |
GO:0015844 | 0.0087 | 3.6157 | 1.7756 | 6 | 80 | monoamine transport |
GO:0014059 | 0.0088 | 5.3888 | 0.8212 | 4 | 37 | regulation of dopamine secretion |
GO:0014742 | 0.0088 | 5.3888 | 0.8212 | 4 | 37 | positive regulation of muscle hypertrophy |
GO:1903508 | 0.009 | 1.4915 | 33.9803 | 48 | 1531 | positive regulation of nucleic acid-templated transcription |
GO:0035809 | 0.0093 | 7.8314 | 0.4439 | 3 | 20 | regulation of urine volume |
GO:0042693 | 0.0093 | 7.8314 | 0.4439 | 3 | 20 | muscle cell fate commitment |
GO:0072111 | 0.0093 | 7.8314 | 0.4439 | 3 | 20 | cell proliferation involved in kidney development |
GO:0003308 | 0.0096 | 17.7151 | 0.1554 | 2 | 7 | negative regulation of Wnt signaling pathway involved in heart development |
GO:0007198 | 0.0096 | 17.7151 | 0.1554 | 2 | 7 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0007597 | 0.0096 | 17.7151 | 0.1554 | 2 | 7 | blood coagulation, intrinsic pathway |
GO:0021796 | 0.0096 | 17.7151 | 0.1554 | 2 | 7 | cerebral cortex regionalization |
GO:0021902 | 0.0096 | 17.7151 | 0.1554 | 2 | 7 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0061026 | 0.0096 | 17.7151 | 0.1554 | 2 | 7 | cardiac muscle tissue regeneration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 121.2046 | 0.8187 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 14.214 | 2.6609 | 27 | 104 | nucleosome assembly |
GO:0045653 | 0 | 137.914 | 0.4605 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0007389 | 0 | 5.4517 | 9.4984 | 43 | 376 | pattern specification process |
GO:0006336 | 0 | 30.6204 | 0.8187 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0071824 | 0 | 6.7641 | 5.373 | 30 | 210 | protein-DNA complex subunit organization |
GO:0032200 | 0 | 7.6698 | 3.9914 | 25 | 156 | telomere organization |
GO:0022008 | 0 | 2.8656 | 30.5058 | 74 | 1220 | neurogenesis |
GO:0006338 | 0 | 5.6336 | 6.0638 | 29 | 237 | chromatin remodeling |
GO:0018130 | 0 | 2.0272 | 92.8505 | 151 | 3629 | heterocycle biosynthetic process |
GO:0019438 | 0 | 1.9974 | 93.1319 | 150 | 3640 | aromatic compound biosynthetic process |
GO:1901362 | 0 | 1.9818 | 96.7139 | 154 | 3780 | organic cyclic compound biosynthetic process |
GO:0006351 | 0 | 2.0447 | 75.5474 | 127 | 3063 | transcription, DNA-templated |
GO:0009790 | 0 | 2.7269 | 24.7058 | 59 | 978 | embryo development |
GO:0032774 | 0 | 2.0294 | 75.9914 | 127 | 3081 | RNA biosynthetic process |
GO:2000026 | 0 | 2.4587 | 33.1335 | 71 | 1295 | regulation of multicellular organismal development |
GO:0048869 | 0 | 2.2918 | 43.8423 | 84 | 1918 | cellular developmental process |
GO:0050877 | 0 | 2.4489 | 31.189 | 67 | 1219 | nervous system process |
GO:0048704 | 0 | 13.1734 | 1.2167 | 12 | 48 | embryonic skeletal system morphogenesis |
GO:0045596 | 0 | 3.349 | 12.7981 | 38 | 514 | negative regulation of cell differentiation |
GO:0045944 | 0 | 2.486 | 29.27 | 64 | 1144 | positive regulation of transcription by RNA polymerase II |
GO:0006352 | 0 | 6.715 | 3.1726 | 18 | 124 | DNA-templated transcription, initiation |
GO:0045637 | 0 | 4.9711 | 5.066 | 22 | 198 | regulation of myeloid cell differentiation |
GO:0009954 | 0 | 16.2356 | 0.8699 | 10 | 34 | proximal/distal pattern formation |
GO:0060322 | 0 | 2.7518 | 19.1381 | 47 | 748 | head development |
GO:0048665 | 0 | 24.0457 | 0.5337 | 8 | 21 | neuron fate specification |
GO:0044271 | 0 | 1.7662 | 109.2765 | 159 | 4271 | cellular nitrogen compound biosynthetic process |
GO:0001501 | 0 | 2.9855 | 12.9975 | 35 | 508 | skeletal system development |
GO:1903508 | 0 | 2.1004 | 39.1717 | 73 | 1531 | positive regulation of nucleic acid-templated transcription |
GO:0010468 | 0 | 1.728 | 111.4776 | 159 | 4428 | regulation of gene expression |
GO:0043009 | 0 | 2.821 | 14.0991 | 36 | 557 | chordate embryonic development |
GO:0009952 | 0 | 5.2849 | 3.4515 | 16 | 137 | anterior/posterior pattern specification |
GO:0010557 | 0 | 1.9816 | 44.2888 | 78 | 1731 | positive regulation of macromolecule biosynthetic process |
GO:0021895 | 0 | 16.9306 | 0.5885 | 7 | 23 | cerebral cortex neuron differentiation |
GO:0090304 | 0 | 1.6302 | 123.3486 | 168 | 4821 | nucleic acid metabolic process |
GO:0051254 | 0 | 1.9388 | 42.6002 | 74 | 1665 | positive regulation of RNA metabolic process |
GO:0072088 | 0 | 7.2666 | 1.791 | 11 | 70 | nephron epithelium morphogenesis |
GO:0045666 | 0 | 6.4491 | 2.1646 | 12 | 85 | positive regulation of neuron differentiation |
GO:0072080 | 0 | 6.33 | 2.2004 | 12 | 86 | nephron tubule development |
GO:0061333 | 0 | 7.0274 | 1.8422 | 11 | 72 | renal tubule morphogenesis |
GO:0006357 | 0 | 2.5689 | 15.4831 | 36 | 675 | regulation of transcription by RNA polymerase II |
GO:0060485 | 0 | 3.3601 | 7.1896 | 22 | 281 | mesenchyme development |
GO:0009058 | 0 | 1.587 | 135.3483 | 179 | 5290 | biosynthetic process |
GO:1903507 | 0 | 2.0504 | 29.4491 | 55 | 1151 | negative regulation of nucleic acid-templated transcription |
GO:0031328 | 0 | 1.825 | 46.8474 | 77 | 1831 | positive regulation of cellular biosynthetic process |
GO:0051253 | 0 | 1.9881 | 32.0333 | 58 | 1252 | negative regulation of RNA metabolic process |
GO:0021527 | 0 | 27.5226 | 0.307 | 5 | 12 | spinal cord association neuron differentiation |
GO:0097154 | 0 | 27.5226 | 0.307 | 5 | 12 | GABAergic neuron differentiation |
GO:0035115 | 0 | 11.2814 | 0.7932 | 7 | 31 | embryonic forelimb morphogenesis |
GO:0001764 | 0 | 4.166 | 3.9914 | 15 | 156 | neuron migration |
GO:0048935 | 0 | 24.0808 | 0.3326 | 5 | 13 | peripheral nervous system neuron development |
GO:0061138 | 0 | 3.8964 | 4.5287 | 16 | 177 | morphogenesis of a branching epithelium |
GO:0060795 | 0 | 10.8294 | 0.8187 | 7 | 32 | cell fate commitment involved in formation of primary germ layer |
GO:0010558 | 0 | 1.8991 | 35.82 | 62 | 1400 | negative regulation of macromolecule biosynthetic process |
GO:0021902 | 0 | 51.2636 | 0.1791 | 4 | 7 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0060993 | 0 | 5.5615 | 2.2515 | 11 | 88 | kidney morphogenesis |
GO:0048562 | 0 | 4.0492 | 4.0876 | 15 | 167 | embryonic organ morphogenesis |
GO:0000122 | 0 | 2.1427 | 21.799 | 43 | 852 | negative regulation of transcription by RNA polymerase II |
GO:0021543 | 0 | 3.9944 | 4.1449 | 15 | 162 | pallium development |
GO:0001657 | 0 | 5.42 | 2.3027 | 11 | 90 | ureteric bud development |
GO:0021879 | 0 | 10.0734 | 0.866 | 7 | 34 | forebrain neuron differentiation |
GO:0031327 | 0 | 1.8623 | 37.0778 | 63 | 1456 | negative regulation of cellular biosynthetic process |
GO:0072163 | 0 | 5.3519 | 2.3283 | 11 | 91 | mesonephric epithelium development |
GO:0014033 | 0 | 5.2207 | 2.3795 | 11 | 93 | neural crest cell differentiation |
GO:0007422 | 0 | 5.7999 | 1.9701 | 10 | 77 | peripheral nervous system development |
GO:0070365 | 0 | 19.2622 | 0.3838 | 5 | 15 | hepatocyte differentiation |
GO:0021516 | 0 | 38.9015 | 0.2024 | 4 | 8 | dorsal spinal cord development |
GO:0048664 | 0 | 38.4453 | 0.2047 | 4 | 8 | neuron fate determination |
GO:0000904 | 0 | 2.2507 | 17.2959 | 36 | 676 | cell morphogenesis involved in differentiation |
GO:0061448 | 0 | 3.1927 | 6.4732 | 19 | 253 | connective tissue development |
GO:0050794 | 0 | 1.5798 | 205.2097 | 242 | 8461 | regulation of cellular process |
GO:0043583 | 0 | 3.3841 | 5.4753 | 17 | 214 | ear development |
GO:0050911 | 0 | 3.3668 | 5.5009 | 17 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0035113 | 0 | 4.41 | 3.0191 | 12 | 118 | embryonic appendage morphogenesis |
GO:0097376 | 1e-04 | 115.0777 | 0.1023 | 3 | 4 | interneuron axon guidance |
GO:0014031 | 1e-04 | 5.0435 | 2.226 | 10 | 87 | mesenchymal cell development |
GO:0048864 | 1e-04 | 5.0435 | 2.226 | 10 | 87 | stem cell development |
GO:0120039 | 1e-04 | 2.2291 | 15.4282 | 32 | 603 | plasma membrane bounded cell projection morphogenesis |
GO:0007606 | 1e-04 | 2.8384 | 7.599 | 20 | 297 | sensory perception of chemical stimulus |
GO:0035295 | 1e-04 | 1.9213 | 26.4158 | 47 | 1039 | tube development |
GO:0007186 | 1e-04 | 2.0043 | 22.0365 | 41 | 875 | G protein-coupled receptor signaling pathway |
GO:0099537 | 1e-04 | 2.1424 | 17.0401 | 34 | 666 | trans-synaptic signaling |
GO:0007409 | 1e-04 | 2.5042 | 10.2887 | 24 | 404 | axonogenesis |
GO:1902667 | 1e-04 | 21.9645 | 0.2814 | 4 | 11 | regulation of axon guidance |
GO:0035270 | 1e-04 | 3.9585 | 3.3261 | 12 | 130 | endocrine system development |
GO:0021517 | 1e-04 | 7.1187 | 1.1514 | 7 | 45 | ventral spinal cord development |
GO:0090596 | 1e-04 | 2.9036 | 6.6779 | 18 | 261 | sensory organ morphogenesis |
GO:0032501 | 1e-04 | 1.792 | 40.7269 | 63 | 2183 | multicellular organismal process |
GO:0050789 | 2e-04 | 3.2187 | 5.735 | 16 | 321 | regulation of biological process |
GO:0032990 | 2e-04 | 2.1433 | 15.9911 | 32 | 625 | cell part morphogenesis |
GO:0014016 | 2e-04 | 57.5352 | 0.1279 | 3 | 5 | neuroblast differentiation |
GO:0060537 | 2e-04 | 2.496 | 9.8761 | 23 | 386 | muscle tissue development |
GO:0048519 | 2e-04 | 1.4563 | 130.3335 | 165 | 5094 | negative regulation of biological process |
GO:0048513 | 2e-04 | 1.7428 | 38.5695 | 61 | 1757 | animal organ development |
GO:0030182 | 2e-04 | 1.9403 | 22.7558 | 41 | 967 | neuron differentiation |
GO:0007268 | 2e-04 | 2.0947 | 16.861 | 33 | 659 | chemical synaptic transmission |
GO:0021761 | 2e-04 | 4.8199 | 2.0804 | 9 | 82 | limbic system development |
GO:0007517 | 2e-04 | 2.608 | 8.213 | 20 | 321 | muscle organ development |
GO:0034103 | 2e-04 | 4.7772 | 2.098 | 9 | 82 | regulation of tissue remodeling |
GO:0015671 | 3e-04 | 17.0814 | 0.3326 | 4 | 13 | oxygen transport |
GO:0035108 | 3e-04 | 3.6469 | 3.582 | 12 | 140 | limb morphogenesis |
GO:0007275 | 3e-04 | 1.689 | 43.6099 | 66 | 2107 | multicellular organism development |
GO:0021978 | 3e-04 | 38.6259 | 0.1525 | 3 | 6 | telencephalon regionalization |
GO:0001658 | 3e-04 | 7.5136 | 0.9408 | 6 | 37 | branching involved in ureteric bud morphogenesis |
GO:0030902 | 3e-04 | 3.5627 | 3.6588 | 12 | 143 | hindbrain development |
GO:0003278 | 3e-04 | 38.3544 | 0.1535 | 3 | 6 | apoptotic process involved in heart morphogenesis |
GO:0030917 | 3e-04 | 38.3544 | 0.1535 | 3 | 6 | midbrain-hindbrain boundary development |
GO:0048663 | 3e-04 | 9.9759 | 0.618 | 5 | 25 | neuron fate commitment |
GO:0080090 | 3e-04 | 1.425 | 135.86 | 169 | 5310 | regulation of primary metabolic process |
GO:0030855 | 3e-04 | 2.075 | 15.9395 | 31 | 630 | epithelial cell differentiation |
GO:0035051 | 3e-04 | 3.5355 | 3.6843 | 12 | 144 | cardiocyte differentiation |
GO:0003207 | 3e-04 | 15.3723 | 0.3582 | 4 | 14 | cardiac chamber formation |
GO:0021515 | 4e-04 | 7.3171 | 0.9613 | 6 | 38 | cell differentiation in spinal cord |
GO:0051094 | 4e-04 | 1.7526 | 31.2401 | 51 | 1221 | positive regulation of developmental process |
GO:0051055 | 4e-04 | 5.8777 | 1.356 | 7 | 53 | negative regulation of lipid biosynthetic process |
GO:0048332 | 4e-04 | 4.991 | 1.791 | 8 | 70 | mesoderm morphogenesis |
GO:0061351 | 4e-04 | 4.399 | 2.2566 | 9 | 89 | neural precursor cell proliferation |
GO:0009593 | 4e-04 | 2.6186 | 7.3431 | 18 | 287 | detection of chemical stimulus |
GO:0042221 | 5e-04 | 1.4688 | 90.3235 | 119 | 3625 | response to chemical |
GO:0050906 | 5e-04 | 2.5313 | 8.0083 | 19 | 313 | detection of stimulus involved in sensory perception |
GO:0006939 | 5e-04 | 3.9172 | 2.7888 | 10 | 109 | smooth muscle contraction |
GO:0051965 | 5e-04 | 5.5168 | 1.4328 | 7 | 56 | positive regulation of synapse assembly |
GO:0021796 | 5e-04 | 28.764 | 0.1791 | 3 | 7 | cerebral cortex regionalization |
GO:0060415 | 5e-04 | 4.7598 | 1.8678 | 8 | 73 | muscle tissue morphogenesis |
GO:0042744 | 5e-04 | 8.7489 | 0.6908 | 5 | 27 | hydrogen peroxide catabolic process |
GO:0030097 | 5e-04 | 1.8881 | 20.8779 | 37 | 816 | hemopoiesis |
GO:0048738 | 6e-04 | 2.8396 | 5.6544 | 15 | 221 | cardiac muscle tissue development |
GO:0021536 | 6e-04 | 6.5124 | 1.0609 | 6 | 42 | diencephalon development |
GO:0006540 | 7e-04 | Inf | 0.0512 | 2 | 2 | glutamate decarboxylation to succinate |
GO:0021893 | 7e-04 | Inf | 0.0512 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:0021985 | 7e-04 | Inf | 0.0512 | 2 | 2 | neurohypophysis development |
GO:0070858 | 7e-04 | Inf | 0.0512 | 2 | 2 | negative regulation of bile acid biosynthetic process |
GO:0097378 | 7e-04 | Inf | 0.0512 | 2 | 2 | dorsal spinal cord interneuron axon guidance |
GO:1902871 | 7e-04 | Inf | 0.0512 | 2 | 2 | positive regulation of amacrine cell differentiation |
GO:1905652 | 7e-04 | Inf | 0.0512 | 2 | 2 | negative regulation of artery morphogenesis |
GO:0001755 | 7e-04 | 5.2998 | 1.484 | 7 | 58 | neural crest cell migration |
GO:0035296 | 7e-04 | 3.4432 | 3.4541 | 11 | 135 | regulation of tube diameter |
GO:0007611 | 7e-04 | 2.6684 | 6.3964 | 16 | 250 | learning or memory |
GO:0048870 | 8e-04 | 1.6107 | 41.3465 | 62 | 1616 | cell motility |
GO:0007625 | 8e-04 | 11.8226 | 0.435 | 4 | 17 | grooming behavior |
GO:0097485 | 8e-04 | 2.7582 | 5.808 | 15 | 227 | neuron projection guidance |
GO:0043524 | 8e-04 | 3.3881 | 3.5052 | 11 | 137 | negative regulation of neuron apoptotic process |
GO:1903506 | 8e-04 | 1.8711 | 20.6547 | 36 | 898 | regulation of nucleic acid-templated transcription |
GO:0060429 | 8e-04 | 2.2027 | 11.0962 | 23 | 456 | epithelium development |
GO:0048793 | 8e-04 | 23.0097 | 0.2047 | 3 | 8 | pronephros development |
GO:0061743 | 8e-04 | 23.0097 | 0.2047 | 3 | 8 | motor learning |
GO:0042472 | 9e-04 | 4.3941 | 2.0045 | 8 | 79 | inner ear morphogenesis |
GO:0042053 | 0.001 | 10.9774 | 0.4605 | 4 | 18 | regulation of dopamine metabolic process |
GO:0031175 | 0.001 | 1.7937 | 23.1039 | 39 | 903 | neuron projection development |
GO:0007218 | 0.001 | 3.8707 | 2.533 | 9 | 99 | neuropeptide signaling pathway |
GO:0072006 | 0.001 | 3.8673 | 2.5338 | 9 | 100 | nephron development |
GO:0010556 | 0.0012 | 1.7978 | 22.7017 | 38 | 994 | regulation of macromolecule biosynthetic process |
GO:0072087 | 0.0012 | 10.2449 | 0.4861 | 4 | 19 | renal vesicle development |
GO:0002520 | 0.0012 | 1.7698 | 23.3853 | 39 | 914 | immune system development |
GO:0048333 | 0.0012 | 7.1265 | 0.8187 | 5 | 32 | mesodermal cell differentiation |
GO:0021520 | 0.0012 | 19.1735 | 0.2303 | 3 | 9 | spinal cord motor neuron cell fate specification |
GO:0042127 | 0.0013 | 1.5849 | 40.5022 | 60 | 1583 | regulation of cell population proliferation |
GO:0045665 | 0.0013 | 4.6798 | 1.6557 | 7 | 65 | negative regulation of neuron differentiation |
GO:0031326 | 0.0014 | 1.7779 | 22.9414 | 38 | 1004 | regulation of cellular biosynthetic process |
GO:0021854 | 0.0015 | 9.604 | 0.5117 | 4 | 20 | hypothalamus development |
GO:0007631 | 0.0015 | 5.3591 | 1.2554 | 6 | 50 | feeding behavior |
GO:0072359 | 0.0016 | 1.6765 | 28.5025 | 45 | 1114 | circulatory system development |
GO:1902692 | 0.0016 | 6.6341 | 0.8699 | 5 | 34 | regulation of neuroblast proliferation |
GO:0035148 | 0.0017 | 3.0687 | 3.8379 | 11 | 150 | tube formation |
GO:0042756 | 0.0017 | 16.4334 | 0.2559 | 3 | 10 | drinking behavior |
GO:0060536 | 0.0017 | 16.4334 | 0.2559 | 3 | 10 | cartilage morphogenesis |
GO:0070472 | 0.0017 | 16.4334 | 0.2559 | 3 | 10 | regulation of uterine smooth muscle contraction |
GO:0072171 | 0.0018 | 5.1868 | 1.293 | 6 | 51 | mesonephric tubule morphogenesis |
GO:0048736 | 0.0018 | 2.8753 | 4.4519 | 12 | 174 | appendage development |
GO:0048048 | 0.0018 | 6.4126 | 0.8955 | 5 | 35 | embryonic eye morphogenesis |
GO:0046849 | 0.0019 | 3.8636 | 2.2515 | 8 | 88 | bone remodeling |
GO:0051952 | 0.0019 | 3.8636 | 2.2515 | 8 | 88 | regulation of amine transport |
GO:0009880 | 0.0019 | 4.3565 | 1.7654 | 7 | 69 | embryonic pattern specification |
GO:0072172 | 0.0019 | 76.8856 | 0.0764 | 2 | 3 | mesonephric tubule formation |
GO:0001661 | 0.0019 | 76.5327 | 0.0768 | 2 | 3 | conditioned taste aversion |
GO:0001705 | 0.0019 | 76.5327 | 0.0768 | 2 | 3 | ectoderm formation |
GO:0002025 | 0.0019 | 76.5327 | 0.0768 | 2 | 3 | norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure |
GO:0007412 | 0.0019 | 76.5327 | 0.0768 | 2 | 3 | axon target recognition |
GO:0021530 | 0.0019 | 76.5327 | 0.0768 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0021797 | 0.0019 | 76.5327 | 0.0768 | 2 | 3 | forebrain anterior/posterior pattern specification |
GO:0055005 | 0.0019 | 76.5327 | 0.0768 | 2 | 3 | ventricular cardiac myofibril assembly |
GO:0072180 | 0.0019 | 76.5327 | 0.0768 | 2 | 3 | mesonephric duct morphogenesis |
GO:2001260 | 0.0019 | 76.5327 | 0.0768 | 2 | 3 | regulation of semaphorin-plexin signaling pathway |
GO:0051172 | 0.002 | 1.4756 | 56.8258 | 78 | 2221 | negative regulation of nitrogen compound metabolic process |
GO:0071542 | 0.0021 | 6.2054 | 0.9211 | 5 | 36 | dopaminergic neuron differentiation |
GO:0090103 | 0.0021 | 8.5358 | 0.5629 | 4 | 22 | cochlea morphogenesis |
GO:0051937 | 0.0022 | 4.2198 | 1.8166 | 7 | 71 | catecholamine transport |
GO:0040029 | 0.0022 | 3.148 | 3.4029 | 10 | 133 | regulation of gene expression, epigenetic |
GO:0051480 | 0.0023 | 2.2368 | 8.4945 | 18 | 332 | regulation of cytosolic calcium ion concentration |
GO:0021794 | 0.0024 | 14.3783 | 0.2814 | 3 | 11 | thalamus development |
GO:0030432 | 0.0024 | 14.3783 | 0.2814 | 3 | 11 | peristalsis |
GO:1903238 | 0.0024 | 14.3783 | 0.2814 | 3 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0048729 | 0.0024 | 2.0498 | 11.3163 | 22 | 456 | tissue morphogenesis |
GO:0021544 | 0.0025 | 8.0861 | 0.5885 | 4 | 23 | subpallium development |
GO:0032502 | 0.0025 | 1.6098 | 35.5452 | 52 | 1814 | developmental process |
GO:0042755 | 0.0027 | 5.8285 | 0.9723 | 5 | 38 | eating behavior |
GO:0043069 | 0.0028 | 1.7321 | 21.3129 | 35 | 833 | negative regulation of programmed cell death |
GO:0045761 | 0.003 | 4.6225 | 1.4328 | 6 | 56 | regulation of adenylate cyclase activity |
GO:0045939 | 0.003 | 7.6813 | 0.6141 | 4 | 24 | negative regulation of steroid metabolic process |
GO:0072202 | 0.003 | 7.6813 | 0.6141 | 4 | 24 | cell differentiation involved in metanephros development |
GO:2000679 | 0.003 | 7.6813 | 0.6141 | 4 | 24 | positive regulation of transcription regulatory region DNA binding |
GO:0072210 | 0.003 | 5.6567 | 0.9978 | 5 | 39 | metanephric nephron development |
GO:0002024 | 0.0031 | 12.7799 | 0.307 | 3 | 12 | diet induced thermogenesis |
GO:0007501 | 0.0031 | 12.7799 | 0.307 | 3 | 12 | mesodermal cell fate specification |
GO:0010273 | 0.0031 | 12.7799 | 0.307 | 3 | 12 | detoxification of copper ion |
GO:0071695 | 0.0031 | 2.4507 | 6.0382 | 14 | 236 | anatomical structure maturation |
GO:0019233 | 0.0032 | 3.5106 | 2.4562 | 8 | 96 | sensory perception of pain |
GO:0120162 | 0.0032 | 3.5106 | 2.4562 | 8 | 96 | positive regulation of cold-induced thermogenesis |
GO:0030514 | 0.0033 | 4.5316 | 1.4584 | 6 | 57 | negative regulation of BMP signaling pathway |
GO:0050767 | 0.0033 | 2.1596 | 8.7759 | 18 | 343 | regulation of neurogenesis |
GO:0048713 | 0.0034 | 5.4948 | 1.0234 | 5 | 40 | regulation of oligodendrocyte differentiation |
GO:1902742 | 0.0034 | 5.4948 | 1.0234 | 5 | 40 | apoptotic process involved in development |
GO:0044057 | 0.0035 | 1.8918 | 13.893 | 25 | 543 | regulation of system process |
GO:0007214 | 0.0035 | 7.315 | 0.6396 | 4 | 25 | gamma-aminobutyric acid signaling pathway |
GO:0071880 | 0.0035 | 7.315 | 0.6396 | 4 | 25 | adenylate cyclase-activating adrenergic receptor signaling pathway |
GO:1903671 | 0.0035 | 7.315 | 0.6396 | 4 | 25 | negative regulation of sprouting angiogenesis |
GO:0030500 | 0.0035 | 3.8566 | 1.9701 | 7 | 77 | regulation of bone mineralization |
GO:0042733 | 0.0036 | 4.4441 | 1.484 | 6 | 58 | embryonic digit morphogenesis |
GO:0042981 | 0.0037 | 1.5571 | 33.9778 | 50 | 1328 | regulation of apoptotic process |
GO:0045124 | 0.0038 | 5.3418 | 1.049 | 5 | 41 | regulation of bone resorption |
GO:0003219 | 0.0038 | 38.2639 | 0.1023 | 2 | 4 | cardiac right ventricle formation |
GO:0021779 | 0.0038 | 38.2639 | 0.1023 | 2 | 4 | oligodendrocyte cell fate commitment |
GO:0021780 | 0.0038 | 38.2639 | 0.1023 | 2 | 4 | glial cell fate specification |
GO:0061113 | 0.0038 | 38.2639 | 0.1023 | 2 | 4 | pancreas morphogenesis |
GO:0061183 | 0.0038 | 38.2639 | 0.1023 | 2 | 4 | regulation of dermatome development |
GO:0072268 | 0.0038 | 38.2639 | 0.1023 | 2 | 4 | pattern specification involved in metanephros development |
GO:0090500 | 0.0038 | 38.2639 | 0.1023 | 2 | 4 | endocardial cushion to mesenchymal transition |
GO:0097476 | 0.0038 | 38.2639 | 0.1023 | 2 | 4 | spinal cord motor neuron migration |
GO:0010001 | 0.0038 | 2.4854 | 5.5265 | 13 | 216 | glial cell differentiation |
GO:0033605 | 0.0039 | 11.5012 | 0.3326 | 3 | 13 | positive regulation of catecholamine secretion |
GO:0042136 | 0.0039 | 11.5012 | 0.3326 | 3 | 13 | neurotransmitter biosynthetic process |
GO:0048484 | 0.0039 | 11.5012 | 0.3326 | 3 | 13 | enteric nervous system development |
GO:0042330 | 0.0041 | 1.84 | 14.8397 | 26 | 580 | taxis |
GO:0007399 | 0.0043 | 1.819 | 15.6792 | 27 | 711 | nervous system development |
GO:0072503 | 0.0043 | 1.9412 | 11.8973 | 22 | 465 | cellular divalent inorganic cation homeostasis |
GO:0001838 | 0.0044 | 3.0511 | 3.147 | 9 | 123 | embryonic epithelial tube formation |
GO:2000027 | 0.0044 | 3.0511 | 3.147 | 9 | 123 | regulation of animal organ morphogenesis |
GO:0003151 | 0.0044 | 3.6974 | 2.0469 | 7 | 80 | outflow tract morphogenesis |
GO:0051252 | 0.0044 | 1.6732 | 22.8442 | 36 | 986 | regulation of RNA metabolic process |
GO:0009887 | 0.0044 | 1.9721 | 11.1918 | 21 | 476 | animal organ morphogenesis |
GO:0042311 | 0.0045 | 5.0845 | 1.0951 | 5 | 43 | vasodilation |
GO:0060560 | 0.0046 | 2.4249 | 5.6544 | 13 | 221 | developmental growth involved in morphogenesis |
GO:0035116 | 0.0046 | 6.6781 | 0.6908 | 4 | 27 | embryonic hindlimb morphogenesis |
GO:0048732 | 0.0048 | 1.9905 | 10.5427 | 20 | 414 | gland development |
GO:0007369 | 0.0049 | 2.6416 | 4.4066 | 11 | 173 | gastrulation |
GO:0007171 | 0.0049 | 10.455 | 0.3582 | 3 | 14 | activation of transmembrane receptor protein tyrosine kinase activity |
GO:0001756 | 0.005 | 4.1257 | 1.5863 | 6 | 62 | somitogenesis |
GO:0072001 | 0.005 | 2.1759 | 7.7269 | 16 | 302 | renal system development |
GO:0048468 | 0.0051 | 1.5665 | 30.4054 | 45 | 1273 | cell development |
GO:0045776 | 0.0051 | 4.93 | 1.1258 | 5 | 44 | negative regulation of blood pressure |
GO:0001659 | 0.0052 | 2.6129 | 4.4519 | 11 | 174 | temperature homeostasis |
GO:0050679 | 0.0053 | 2.4869 | 5.0916 | 12 | 199 | positive regulation of epithelial cell proliferation |
GO:0007190 | 0.0053 | 6.3994 | 0.7164 | 4 | 28 | activation of adenylate cyclase activity |
GO:0060292 | 0.0053 | 6.3994 | 0.7164 | 4 | 28 | long-term synaptic depression |
GO:0030901 | 0.0053 | 3.5508 | 2.1236 | 7 | 83 | midbrain development |
GO:0008344 | 0.0055 | 4.8458 | 1.1424 | 5 | 45 | adult locomotory behavior |
GO:0042220 | 0.0056 | 4.8064 | 1.1514 | 5 | 45 | response to cocaine |
GO:0048701 | 0.0056 | 4.8064 | 1.1514 | 5 | 45 | embryonic cranial skeleton morphogenesis |
GO:0048645 | 0.0058 | 3.9829 | 1.6375 | 6 | 64 | animal organ formation |
GO:0019373 | 0.006 | 9.5831 | 0.3838 | 3 | 15 | epoxygenase P450 pathway |
GO:0035358 | 0.006 | 9.5831 | 0.3838 | 3 | 15 | regulation of peroxisome proliferator activated receptor signaling pathway |
GO:0072176 | 0.006 | 9.5831 | 0.3838 | 3 | 15 | nephric duct development |
GO:0072283 | 0.006 | 9.5831 | 0.3838 | 3 | 15 | metanephric renal vesicle morphogenesis |
GO:0097501 | 0.006 | 9.5831 | 0.3838 | 3 | 15 | stress response to metal ion |
GO:1990403 | 0.006 | 9.5831 | 0.3838 | 3 | 15 | embryonic brain development |
GO:0010667 | 0.006 | 6.1431 | 0.742 | 4 | 29 | negative regulation of cardiac muscle cell apoptotic process |
GO:0001837 | 0.006 | 2.7043 | 3.9146 | 10 | 153 | epithelial to mesenchymal transition |
GO:0002028 | 0.0061 | 3.4593 | 2.1748 | 7 | 85 | regulation of sodium ion transport |
GO:0002062 | 0.0062 | 3.1184 | 2.7377 | 8 | 107 | chondrocyte differentiation |
GO:0009996 | 0.0062 | 25.5077 | 0.1279 | 2 | 5 | negative regulation of cell fate specification |
GO:0021853 | 0.0062 | 25.5077 | 0.1279 | 2 | 5 | cerebral cortex GABAergic interneuron migration |
GO:0021869 | 0.0062 | 25.5077 | 0.1279 | 2 | 5 | forebrain ventricular zone progenitor cell division |
GO:0060059 | 0.0062 | 25.5077 | 0.1279 | 2 | 5 | embryonic retina morphogenesis in camera-type eye |
GO:0060406 | 0.0062 | 25.5077 | 0.1279 | 2 | 5 | positive regulation of penile erection |
GO:0061217 | 0.0062 | 25.5077 | 0.1279 | 2 | 5 | regulation of mesonephros development |
GO:0071242 | 0.0062 | 25.5077 | 0.1279 | 2 | 5 | cellular response to ammonium ion |
GO:0072081 | 0.0062 | 25.5077 | 0.1279 | 2 | 5 | specification of nephron tubule identity |
GO:0090185 | 0.0062 | 25.5077 | 0.1279 | 2 | 5 | negative regulation of kidney development |
GO:1905700 | 0.0062 | 25.5077 | 0.1279 | 2 | 5 | negative regulation of xenobiotic detoxification by transmembrane export across the plasma membrane |
GO:2000977 | 0.0062 | 25.5077 | 0.1279 | 2 | 5 | regulation of forebrain neuron differentiation |
GO:0009953 | 0.0063 | 3.4313 | 2.1906 | 7 | 86 | dorsal/ventral pattern formation |
GO:0010662 | 0.0068 | 4.5769 | 1.2025 | 5 | 47 | regulation of striated muscle cell apoptotic process |
GO:0045668 | 0.0068 | 4.5769 | 1.2025 | 5 | 47 | negative regulation of osteoblast differentiation |
GO:0050885 | 0.0068 | 4.5769 | 1.2025 | 5 | 47 | neuromuscular process controlling balance |
GO:0055010 | 0.0068 | 4.5769 | 1.2025 | 5 | 47 | ventricular cardiac muscle tissue morphogenesis |
GO:0007628 | 0.0068 | 5.9064 | 0.7676 | 4 | 30 | adult walking behavior |
GO:0021772 | 0.0068 | 5.9064 | 0.7676 | 4 | 30 | olfactory bulb development |
GO:0061037 | 0.0068 | 5.9064 | 0.7676 | 4 | 30 | negative regulation of cartilage development |
GO:0032095 | 0.0073 | 8.8454 | 0.4094 | 3 | 16 | regulation of response to food |
GO:0090190 | 0.0073 | 8.8454 | 0.4094 | 3 | 16 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:2000725 | 0.0073 | 8.8454 | 0.4094 | 3 | 16 | regulation of cardiac muscle cell differentiation |
GO:0032410 | 0.0073 | 3.3305 | 2.2515 | 7 | 88 | negative regulation of transporter activity |
GO:0023061 | 0.0076 | 1.9012 | 11.0018 | 20 | 430 | signal release |
GO:0021510 | 0.0077 | 5.6739 | 0.7923 | 4 | 32 | spinal cord development |
GO:0050795 | 0.0078 | 3.725 | 1.7398 | 6 | 68 | regulation of behavior |
GO:0040007 | 0.008 | 1.6065 | 22.8224 | 35 | 892 | growth |
GO:0060021 | 0.0083 | 3.2499 | 2.3027 | 7 | 90 | roof of mouth development |
GO:0098754 | 0.0083 | 2.7366 | 3.4797 | 9 | 136 | detoxification |
GO:0035567 | 0.0084 | 3.6656 | 1.7654 | 6 | 69 | non-canonical Wnt signaling pathway |
GO:0033238 | 0.0086 | 5.4838 | 0.8187 | 4 | 32 | regulation of cellular amine metabolic process |
GO:0021542 | 0.0087 | 8.2131 | 0.435 | 3 | 17 | dentate gyrus development |
GO:0006584 | 0.0088 | 4.271 | 1.2793 | 5 | 50 | catecholamine metabolic process |
GO:2000179 | 0.0088 | 4.271 | 1.2793 | 5 | 50 | positive regulation of neural precursor cell proliferation |
GO:0060562 | 0.0089 | 2.223 | 6.1296 | 13 | 245 | epithelial tube morphogenesis |
GO:0008291 | 0.0091 | 19.1295 | 0.1535 | 2 | 6 | acetylcholine metabolic process |
GO:0010668 | 0.0091 | 19.1295 | 0.1535 | 2 | 6 | ectodermal cell differentiation |
GO:0016098 | 0.0091 | 19.1295 | 0.1535 | 2 | 6 | monoterpenoid metabolic process |
GO:0021798 | 0.0091 | 19.1295 | 0.1535 | 2 | 6 | forebrain dorsal/ventral pattern formation |
GO:0046533 | 0.0091 | 19.1295 | 0.1535 | 2 | 6 | negative regulation of photoreceptor cell differentiation |
GO:0060455 | 0.0091 | 19.1295 | 0.1535 | 2 | 6 | negative regulation of gastric acid secretion |
GO:0060676 | 0.0091 | 19.1295 | 0.1535 | 2 | 6 | ureteric bud formation |
GO:0072143 | 0.0091 | 19.1295 | 0.1535 | 2 | 6 | mesangial cell development |
GO:1902338 | 0.0091 | 19.1295 | 0.1535 | 2 | 6 | negative regulation of apoptotic process involved in morphogenesis |
GO:2000252 | 0.0091 | 19.1295 | 0.1535 | 2 | 6 | negative regulation of feeding behavior |
GO:2000543 | 0.0091 | 19.1295 | 0.1535 | 2 | 6 | positive regulation of gastrulation |
GO:2000698 | 0.0091 | 19.1295 | 0.1535 | 2 | 6 | positive regulation of epithelial cell differentiation involved in kidney development |
GO:2001023 | 0.0091 | 19.1295 | 0.1535 | 2 | 6 | regulation of response to drug |
GO:0030900 | 0.0094 | 2.3961 | 4.8214 | 11 | 198 | forebrain development |
GO:0010467 | 0.0094 | 1.586 | 24.9608 | 37 | 1183 | gene expression |
GO:0021953 | 0.0094 | 3.1596 | 2.3594 | 7 | 96 | central nervous system neuron differentiation |
GO:0033555 | 0.0096 | 3.5524 | 1.8166 | 6 | 71 | multicellular organismal response to stress |
GO:0031128 | 0.0096 | 5.2944 | 0.8443 | 4 | 33 | developmental induction |
GO:0007267 | 0.0096 | 1.5467 | 26.4532 | 39 | 1064 | cell-cell signaling |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 8.9766 | 4.1621 | 30 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051606 | 0 | 5.4347 | 8.3436 | 38 | 431 | detection of stimulus |
GO:0007600 | 0 | 4.153 | 14.0739 | 49 | 727 | sensory perception |
GO:0007186 | 0 | 3.4312 | 15.61 | 46 | 831 | G protein-coupled receptor signaling pathway |
GO:0003008 | 0 | 2.2962 | 37.8852 | 74 | 1957 | system process |
GO:0042221 | 0 | 2.0996 | 43.7109 | 77 | 2367 | response to chemical |
GO:0048252 | 0 | Inf | 0.0581 | 3 | 3 | lauric acid metabolic process |
GO:0042756 | 0 | 34.1935 | 0.1936 | 4 | 10 | drinking behavior |
GO:1903238 | 0 | 29.3069 | 0.2129 | 4 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0006690 | 0 | 5.3061 | 2.0908 | 10 | 108 | icosanoid metabolic process |
GO:0050909 | 1e-04 | 8.0367 | 1.0067 | 7 | 52 | sensory perception of taste |
GO:0014016 | 1e-04 | 76.7074 | 0.0968 | 3 | 5 | neuroblast differentiation |
GO:0023052 | 1e-04 | 1.5563 | 111.3132 | 144 | 5750 | signaling |
GO:0007218 | 1e-04 | 5.1856 | 1.9165 | 9 | 99 | neuropeptide signaling pathway |
GO:0019373 | 2e-04 | 18.6452 | 0.2904 | 4 | 15 | epoxygenase P450 pathway |
GO:0002673 | 2e-04 | 7.9256 | 0.8711 | 6 | 45 | regulation of acute inflammatory response |
GO:0050482 | 3e-04 | 9.883 | 0.6001 | 5 | 31 | arachidonic acid secretion |
GO:0007154 | 3e-04 | 1.4942 | 111.5289 | 141 | 5797 | cell communication |
GO:0032827 | 4e-04 | Inf | 0.0387 | 2 | 2 | negative regulation of natural killer cell differentiation involved in immune response |
GO:0034125 | 4e-04 | Inf | 0.0387 | 2 | 2 | negative regulation of MyD88-dependent toll-like receptor signaling pathway |
GO:0048704 | 4e-04 | 4.8661 | 1.8004 | 8 | 93 | embryonic skeletal system morphogenesis |
GO:0071715 | 4e-04 | 8.9368 | 0.6527 | 5 | 34 | icosanoid transport |
GO:1902692 | 5e-04 | 8.8589 | 0.6582 | 5 | 34 | regulation of neuroblast proliferation |
GO:0050907 | 5e-04 | 8.7864 | 0.6565 | 5 | 37 | detection of chemical stimulus involved in sensory perception |
GO:0009952 | 6e-04 | 3.2867 | 3.9105 | 12 | 202 | anterior/posterior pattern specification |
GO:0055078 | 6e-04 | 6.4359 | 1.0454 | 6 | 54 | sodium ion homeostasis |
GO:0031640 | 6e-04 | 8.2864 | 0.6969 | 5 | 36 | killing of cells of another organism |
GO:0032303 | 6e-04 | 12.06 | 0.4065 | 4 | 21 | regulation of icosanoid secretion |
GO:0120254 | 6e-04 | 4.0882 | 2.3802 | 9 | 124 | olefinic compound metabolic process |
GO:0060429 | 7e-04 | 1.8633 | 21.3141 | 37 | 1101 | epithelium development |
GO:0001755 | 9e-04 | 5.9393 | 1.1228 | 6 | 58 | neural crest cell migration |
GO:0021871 | 9e-04 | 10.7891 | 0.4453 | 4 | 23 | forebrain regionalization |
GO:2000193 | 0.0011 | 10.249 | 0.4646 | 4 | 24 | positive regulation of fatty acid transport |
GO:0001705 | 0.0011 | 101.9551 | 0.0581 | 2 | 3 | ectoderm formation |
GO:0007412 | 0.0011 | 101.9551 | 0.0581 | 2 | 3 | axon target recognition |
GO:0046968 | 0.0011 | 101.9551 | 0.0581 | 2 | 3 | peptide antigen transport |
GO:0097377 | 0.0011 | 101.9551 | 0.0581 | 2 | 3 | spinal cord interneuron axon guidance |
GO:0007389 | 0.0011 | 2.3404 | 8.6147 | 19 | 445 | pattern specification process |
GO:0051716 | 0.0014 | 1.4177 | 128.4651 | 155 | 6636 | cellular response to stimulus |
GO:0014031 | 0.0015 | 4.5107 | 1.6842 | 7 | 87 | mesenchymal cell development |
GO:0048864 | 0.0015 | 4.5107 | 1.6842 | 7 | 87 | stem cell development |
GO:0031424 | 0.0015 | 5.2645 | 1.2509 | 6 | 65 | keratinization |
GO:1903793 | 0.0017 | 6.4183 | 0.8711 | 5 | 45 | positive regulation of anion transport |
GO:0035815 | 0.0018 | 15.3338 | 0.2517 | 3 | 13 | positive regulation of renal sodium excretion |
GO:0048484 | 0.0018 | 15.3338 | 0.2517 | 3 | 13 | enteric nervous system development |
GO:0035176 | 0.0019 | 6.2613 | 0.8905 | 5 | 46 | social behavior |
GO:0014033 | 0.0022 | 4.1944 | 1.8004 | 7 | 93 | neural crest cell differentiation |
GO:0097022 | 0.0022 | 50.9744 | 0.0774 | 2 | 4 | lymphocyte migration into lymph node |
GO:0051241 | 0.0022 | 1.7984 | 19.5137 | 33 | 1008 | negative regulation of multicellular organismal process |
GO:0032308 | 0.0022 | 13.9389 | 0.271 | 3 | 14 | positive regulation of prostaglandin secretion |
GO:0001580 | 0.0022 | 8.1966 | 0.5614 | 4 | 29 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0021536 | 0.0023 | 4.822 | 1.3551 | 6 | 70 | diencephalon development |
GO:0061138 | 0.0024 | 3.1002 | 3.4265 | 10 | 177 | morphogenesis of a branching epithelium |
GO:0006805 | 0.0028 | 4.0069 | 1.8778 | 7 | 97 | xenobiotic metabolic process |
GO:0009617 | 0.0028 | 2.0234 | 11.4798 | 22 | 593 | response to bacterium |
GO:0072507 | 0.003 | 2.134 | 9.389 | 19 | 485 | divalent inorganic cation homeostasis |
GO:0009605 | 0.0032 | 1.5006 | 47.6614 | 66 | 2462 | response to external stimulus |
GO:0060795 | 0.0032 | 7.3171 | 0.6195 | 4 | 32 | cell fate commitment involved in formation of primary germ layer |
GO:0014070 | 0.0033 | 1.8365 | 16.1259 | 28 | 833 | response to organic cyclic compound |
GO:0032095 | 0.0033 | 11.793 | 0.3097 | 3 | 16 | regulation of response to food |
GO:0045596 | 0.0034 | 2.0635 | 10.2183 | 20 | 535 | negative regulation of cell differentiation |
GO:0001658 | 0.0035 | 5.3459 | 1.026 | 5 | 53 | branching involved in ureteric bud morphogenesis |
GO:0003331 | 0.0036 | 33.9808 | 0.0968 | 2 | 5 | positive regulation of extracellular matrix constituent secretion |
GO:0035470 | 0.0036 | 33.9808 | 0.0968 | 2 | 5 | positive regulation of vascular wound healing |
GO:0060406 | 0.0036 | 33.9808 | 0.0968 | 2 | 5 | positive regulation of penile erection |
GO:1903598 | 0.0036 | 33.9808 | 0.0968 | 2 | 5 | positive regulation of gap junction assembly |
GO:1904994 | 0.0036 | 7.0643 | 0.6388 | 4 | 33 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0060562 | 0.0036 | 2.4031 | 6.1367 | 14 | 317 | epithelial tube morphogenesis |
GO:0097006 | 0.0038 | 4.3447 | 1.4906 | 6 | 77 | regulation of plasma lipoprotein particle levels |
GO:0007625 | 0.004 | 10.9499 | 0.3291 | 3 | 17 | grooming behavior |
GO:0009404 | 0.004 | 10.9499 | 0.3291 | 3 | 17 | toxin metabolic process |
GO:0050789 | 0.0041 | 1.4067 | 200.926 | 223 | 10531 | regulation of biological process |
GO:0007187 | 0.0042 | 5.1314 | 1.0647 | 5 | 55 | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0046883 | 0.0042 | 2.6875 | 4.317 | 11 | 223 | regulation of hormone secretion |
GO:0072009 | 0.0043 | 3.678 | 2.0327 | 7 | 105 | nephron epithelium development |
GO:0051384 | 0.0044 | 3.3006 | 2.5747 | 8 | 133 | response to glucocorticoid |
GO:0002683 | 0.0044 | 2.2056 | 7.6274 | 16 | 394 | negative regulation of immune system process |
GO:0002691 | 0.0045 | 6.6077 | 0.6776 | 4 | 35 | regulation of cellular extravasation |
GO:0071466 | 0.0045 | 5.0191 | 1.0853 | 5 | 57 | cellular response to xenobiotic stimulus |
GO:0043066 | 0.0046 | 1.8073 | 15.7581 | 27 | 814 | negative regulation of apoptotic process |
GO:0010744 | 0.0047 | 10.2193 | 0.3485 | 3 | 18 | positive regulation of macrophage derived foam cell differentiation |
GO:0043651 | 0.0047 | 10.2193 | 0.3485 | 3 | 18 | linoleic acid metabolic process |
GO:0010951 | 0.0048 | 2.6371 | 4.3945 | 11 | 227 | negative regulation of endopeptidase activity |
GO:0043407 | 0.0052 | 4.84 | 1.1228 | 5 | 58 | negative regulation of MAP kinase activity |
GO:0050866 | 0.0053 | 2.7502 | 3.833 | 10 | 198 | negative regulation of cell activation |
GO:0002361 | 0.0053 | 25.484 | 0.1162 | 2 | 6 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0009253 | 0.0053 | 25.484 | 0.1162 | 2 | 6 | peptidoglycan catabolic process |
GO:0010536 | 0.0053 | 25.484 | 0.1162 | 2 | 6 | positive regulation of activation of Janus kinase activity |
GO:0035771 | 0.0053 | 25.484 | 0.1162 | 2 | 6 | interleukin-4-mediated signaling pathway |
GO:0060455 | 0.0053 | 25.484 | 0.1162 | 2 | 6 | negative regulation of gastric acid secretion |
GO:1902338 | 0.0053 | 25.484 | 0.1162 | 2 | 6 | negative regulation of apoptotic process involved in morphogenesis |
GO:2000252 | 0.0053 | 25.484 | 0.1162 | 2 | 6 | negative regulation of feeding behavior |
GO:0007612 | 0.0055 | 3.1726 | 2.6715 | 8 | 138 | learning |
GO:0002323 | 0.0055 | 9.58 | 0.3678 | 3 | 19 | natural killer cell activation involved in immune response |
GO:0002523 | 0.0055 | 9.58 | 0.3678 | 3 | 19 | leukocyte migration involved in inflammatory response |
GO:0015732 | 0.0055 | 9.58 | 0.3678 | 3 | 19 | prostaglandin transport |
GO:0070233 | 0.0055 | 9.58 | 0.3678 | 3 | 19 | negative regulation of T cell apoptotic process |
GO:0033559 | 0.0055 | 3.9881 | 1.6124 | 6 | 84 | unsaturated fatty acid metabolic process |
GO:0006952 | 0.0058 | 1.5747 | 29.0189 | 43 | 1499 | defense response |
GO:0072171 | 0.006 | 4.6634 | 1.1615 | 5 | 60 | mesonephric tubule morphogenesis |
GO:0042886 | 0.0061 | 2.4349 | 5.1766 | 12 | 269 | amide transport |
GO:0009607 | 0.0061 | 1.6129 | 24.9535 | 38 | 1289 | response to biotic stimulus |
GO:0072001 | 0.0061 | 2.3339 | 5.8464 | 13 | 302 | renal system development |
GO:0035809 | 0.0064 | 9.0159 | 0.3872 | 3 | 20 | regulation of urine volume |
GO:0035195 | 0.0065 | 2.3175 | 5.8851 | 13 | 304 | miRNA-mediated gene silencing |
GO:0070328 | 0.0066 | 5.8511 | 0.755 | 4 | 39 | triglyceride homeostasis |
GO:0002791 | 0.0069 | 2.8151 | 3.3684 | 9 | 174 | regulation of peptide secretion |
GO:0051250 | 0.007 | 3.0315 | 2.7877 | 8 | 144 | negative regulation of lymphocyte activation |
GO:0033993 | 0.007 | 1.7442 | 16.2808 | 27 | 841 | response to lipid |
GO:0015711 | 0.0072 | 2.2095 | 6.6401 | 14 | 343 | organic anion transport |
GO:0060993 | 0.0072 | 3.7593 | 1.7036 | 6 | 88 | kidney morphogenesis |
GO:0032787 | 0.0073 | 1.9137 | 10.9571 | 20 | 566 | monocarboxylic acid metabolic process |
GO:0002933 | 0.0074 | 20.3859 | 0.1355 | 2 | 7 | lipid hydroxylation |
GO:0015840 | 0.0074 | 20.3859 | 0.1355 | 2 | 7 | urea transport |
GO:0021796 | 0.0074 | 20.3859 | 0.1355 | 2 | 7 | cerebral cortex regionalization |
GO:0032808 | 0.0074 | 20.3859 | 0.1355 | 2 | 7 | lacrimal gland development |
GO:0046222 | 0.0074 | 20.3859 | 0.1355 | 2 | 7 | aflatoxin metabolic process |
GO:0048752 | 0.0074 | 20.3859 | 0.1355 | 2 | 7 | semicircular canal morphogenesis |
GO:0051971 | 0.0074 | 20.3859 | 0.1355 | 2 | 7 | positive regulation of transmission of nerve impulse |
GO:0072197 | 0.0074 | 20.3859 | 0.1355 | 2 | 7 | ureter morphogenesis |
GO:0120252 | 0.0074 | 20.3859 | 0.1355 | 2 | 7 | hydrocarbon metabolic process |
GO:2000726 | 0.0074 | 20.3859 | 0.1355 | 2 | 7 | negative regulation of cardiac muscle cell differentiation |
GO:0010894 | 0.0074 | 8.5145 | 0.4065 | 3 | 21 | negative regulation of steroid biosynthetic process |
GO:0051769 | 0.0074 | 8.5145 | 0.4065 | 3 | 21 | regulation of nitric-oxide synthase biosynthetic process |
GO:0006629 | 0.0074 | 1.5908 | 25.2633 | 38 | 1305 | lipid metabolic process |
GO:0033674 | 0.0075 | 2.0262 | 8.7889 | 17 | 454 | positive regulation of kinase activity |
GO:0010605 | 0.0075 | 1.4228 | 53.0238 | 70 | 2739 | negative regulation of macromolecule metabolic process |
GO:0090277 | 0.0076 | 3.7137 | 1.7229 | 6 | 89 | positive regulation of peptide hormone secretion |
GO:0055082 | 0.0077 | 1.7704 | 14.8289 | 25 | 766 | cellular chemical homeostasis |
GO:0070371 | 0.0078 | 2.2621 | 6.0206 | 13 | 311 | ERK1 and ERK2 cascade |
GO:0060548 | 0.0078 | 1.6946 | 18.0037 | 29 | 930 | negative regulation of cell death |
GO:0015909 | 0.0079 | 4.3462 | 1.239 | 5 | 64 | long-chain fatty acid transport |
GO:0001657 | 0.008 | 3.6693 | 1.7423 | 6 | 90 | ureteric bud development |
GO:0009914 | 0.0081 | 2.3363 | 5.3818 | 12 | 278 | hormone transport |
GO:0045861 | 0.0084 | 2.2391 | 6.0787 | 13 | 314 | negative regulation of proteolysis |
GO:0002438 | 0.0084 | 8.0658 | 0.4259 | 3 | 22 | acute inflammatory response to antigenic stimulus |
GO:0003071 | 0.0084 | 8.0658 | 0.4259 | 3 | 22 | renal system process involved in regulation of systemic arterial blood pressure |
GO:0007342 | 0.0084 | 8.0658 | 0.4259 | 3 | 22 | fusion of sperm to egg plasma membrane involved in single fertilization |
GO:0042745 | 0.0084 | 8.0658 | 0.4259 | 3 | 22 | circadian sleep/wake cycle |
GO:0098581 | 0.0084 | 8.0658 | 0.4259 | 3 | 22 | detection of external biotic stimulus |
GO:0006801 | 0.0084 | 4.2735 | 1.2583 | 5 | 65 | superoxide metabolic process |
GO:0014823 | 0.0084 | 4.2735 | 1.2583 | 5 | 65 | response to activity |
GO:0072163 | 0.0085 | 3.6259 | 1.7617 | 6 | 91 | mesonephric epithelium development |
GO:0007162 | 0.0086 | 2.3186 | 5.4205 | 12 | 280 | negative regulation of cell adhesion |
GO:0022407 | 0.0087 | 2.0395 | 8.2081 | 16 | 424 | regulation of cell-cell adhesion |
GO:0006959 | 0.0087 | 2.5446 | 4.1234 | 10 | 213 | humoral immune response |
GO:0016441 | 0.0088 | 2.224 | 6.1174 | 13 | 316 | post-transcriptional gene silencing |
GO:0032890 | 0.009 | 4.2031 | 1.2777 | 5 | 66 | regulation of organic acid transport |
GO:0140353 | 0.0094 | 5.2496 | 0.8324 | 4 | 43 | lipid export from cell |
GO:0044062 | 0.0096 | 7.6621 | 0.4453 | 3 | 23 | regulation of excretion |
GO:0009913 | 0.0096 | 2.507 | 4.1815 | 10 | 216 | epidermal cell differentiation |
GO:0006874 | 0.0097 | 2.0141 | 8.3049 | 16 | 429 | cellular calcium ion homeostasis |
GO:1901700 | 0.0097 | 1.5216 | 29.9094 | 43 | 1545 | response to oxygen-containing compound |
GO:0009820 | 0.0097 | 16.9872 | 0.1549 | 2 | 8 | alkaloid metabolic process |
GO:0019062 | 0.0097 | 16.9872 | 0.1549 | 2 | 8 | virion attachment to host cell |
GO:0048664 | 0.0097 | 16.9872 | 0.1549 | 2 | 8 | neuron fate determination |
GO:0048793 | 0.0097 | 16.9872 | 0.1549 | 2 | 8 | pronephros development |
GO:0050859 | 0.0097 | 16.9872 | 0.1549 | 2 | 8 | negative regulation of B cell receptor signaling pathway |
GO:0070268 | 0.0097 | 16.9872 | 0.1549 | 2 | 8 | cornification |
GO:0072177 | 0.0097 | 16.9872 | 0.1549 | 2 | 8 | mesonephric duct development |
GO:1902106 | 0.0098 | 3.5016 | 1.8197 | 6 | 94 | negative regulation of leukocyte differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002520 | 0 | 2.7431 | 14.3129 | 35 | 914 | immune system development |
GO:0035195 | 0 | 4.1816 | 4.7605 | 18 | 304 | miRNA-mediated gene silencing |
GO:0016441 | 0 | 4.0101 | 4.9485 | 18 | 316 | post-transcriptional gene silencing |
GO:0002683 | 0 | 3.5632 | 6.1699 | 20 | 394 | negative regulation of immune system process |
GO:0031047 | 0 | 3.7292 | 5.293 | 18 | 338 | gene silencing by RNA |
GO:0002761 | 0 | 6.3742 | 1.7539 | 10 | 112 | regulation of myeloid leukocyte differentiation |
GO:0001775 | 0 | 2.4253 | 15.0176 | 33 | 959 | cell activation |
GO:0007204 | 0 | 3.6857 | 4.7292 | 16 | 302 | positive regulation of cytosolic calcium ion concentration |
GO:0010536 | 1e-04 | 63.5976 | 0.094 | 3 | 6 | positive regulation of activation of Janus kinase activity |
GO:0045638 | 1e-04 | 6.3776 | 1.3937 | 8 | 89 | negative regulation of myeloid cell differentiation |
GO:0072507 | 1e-04 | 2.8492 | 7.5949 | 20 | 485 | divalent inorganic cation homeostasis |
GO:0045671 | 1e-04 | 12.804 | 0.4698 | 5 | 30 | negative regulation of osteoclast differentiation |
GO:0048704 | 1e-04 | 6.0759 | 1.4564 | 8 | 93 | embryonic skeletal system morphogenesis |
GO:0043651 | 2e-04 | 18.2309 | 0.2819 | 4 | 18 | linoleic acid metabolic process |
GO:0030101 | 2e-04 | 6.6257 | 1.1745 | 7 | 75 | natural killer cell activation |
GO:0060326 | 2e-04 | 3.3408 | 4.51 | 14 | 288 | cell chemotaxis |
GO:2000566 | 2e-04 | Inf | 0.0313 | 2 | 2 | positive regulation of CD8-positive, alpha-beta T cell proliferation |
GO:0042330 | 3e-04 | 2.4841 | 9.0826 | 21 | 580 | taxis |
GO:0055065 | 3e-04 | 2.4202 | 9.7716 | 22 | 624 | metal ion homeostasis |
GO:0002689 | 3e-04 | 14.176 | 0.3445 | 4 | 22 | negative regulation of leukocyte chemotaxis |
GO:1901623 | 3e-04 | 14.176 | 0.3445 | 4 | 22 | regulation of lymphocyte chemotaxis |
GO:0009952 | 4e-04 | 3.7387 | 3.1633 | 11 | 202 | anterior/posterior pattern specification |
GO:0051674 | 4e-04 | 1.8647 | 25.306 | 43 | 1616 | localization of cell |
GO:0046427 | 4e-04 | 9.14 | 0.6264 | 5 | 40 | positive regulation of receptor signaling pathway via JAK-STAT |
GO:0030154 | 4e-04 | 1.7638 | 35.3404 | 55 | 2411 | cell differentiation |
GO:1903706 | 4e-04 | 2.9374 | 5.4652 | 15 | 349 | regulation of hemopoiesis |
GO:0035589 | 4e-04 | 27.2493 | 0.1566 | 3 | 10 | G protein-coupled purinergic nucleotide receptor signaling pathway |
GO:0051093 | 4e-04 | 2.1691 | 13.4203 | 27 | 857 | negative regulation of developmental process |
GO:0006874 | 4e-04 | 2.708 | 6.718 | 17 | 429 | cellular calcium ion homeostasis |
GO:0051241 | 5e-04 | 2.0525 | 15.785 | 30 | 1008 | negative regulation of multicellular organismal process |
GO:1902106 | 7e-04 | 5.1726 | 1.472 | 7 | 94 | negative regulation of leukocyte differentiation |
GO:0048513 | 7e-04 | 1.6735 | 40.2783 | 60 | 2694 | animal organ development |
GO:0036023 | 7e-04 | 126.7063 | 0.047 | 2 | 3 | embryonic skeletal limb joint morphogenesis |
GO:0048252 | 7e-04 | 126.7063 | 0.047 | 2 | 3 | lauric acid metabolic process |
GO:2000502 | 7e-04 | 126.7063 | 0.047 | 2 | 3 | negative regulation of natural killer cell chemotaxis |
GO:0032817 | 8e-04 | 21.1912 | 0.1879 | 3 | 12 | regulation of natural killer cell proliferation |
GO:0032729 | 9e-04 | 5.9185 | 1.1118 | 6 | 71 | positive regulation of interferon-gamma production |
GO:0046649 | 9e-04 | 2.3479 | 9.1028 | 20 | 595 | lymphocyte activation |
GO:0031214 | 9e-04 | 3.8995 | 2.4742 | 9 | 158 | biomineral tissue development |
GO:0002230 | 0.0012 | 9.8092 | 0.4698 | 4 | 30 | positive regulation of defense response to virus by host |
GO:0071310 | 0.0012 | 1.6595 | 35.109 | 53 | 2242 | cellular response to organic substance |
GO:0006928 | 0.0012 | 1.6884 | 31.7735 | 49 | 2029 | movement of cell or subcellular component |
GO:0035106 | 0.0014 | 63.3492 | 0.0626 | 2 | 4 | operant conditioning |
GO:0097476 | 0.0014 | 63.3492 | 0.0626 | 2 | 4 | spinal cord motor neuron migration |
GO:0071675 | 0.0015 | 4.4964 | 1.6756 | 7 | 107 | regulation of mononuclear cell migration |
GO:0046640 | 0.0015 | 9.1074 | 0.5011 | 4 | 32 | regulation of alpha-beta T cell proliferation |
GO:1903131 | 0.0017 | 2.5265 | 6.2952 | 15 | 402 | mononuclear cell differentiation |
GO:0030003 | 0.0017 | 2.2003 | 9.662 | 20 | 617 | cellular cation homeostasis |
GO:0007389 | 0.0018 | 2.4347 | 6.9686 | 16 | 445 | pattern specification process |
GO:0010666 | 0.0018 | 14.6672 | 0.2506 | 3 | 16 | positive regulation of cardiac muscle cell apoptotic process |
GO:0006954 | 0.0019 | 2.0662 | 11.8544 | 23 | 757 | inflammatory response |
GO:0001817 | 0.002 | 2.0868 | 11.2123 | 22 | 716 | regulation of cytokine production |
GO:0043368 | 0.0021 | 8.2245 | 0.5481 | 4 | 35 | positive T cell selection |
GO:2000145 | 0.0021 | 1.9319 | 14.9237 | 27 | 953 | regulation of cell motility |
GO:0050801 | 0.0021 | 2.0805 | 11.2436 | 22 | 718 | ion homeostasis |
GO:2001185 | 0.0022 | 13.6187 | 0.2662 | 3 | 17 | regulation of CD8-positive, alpha-beta T cell activation |
GO:0032944 | 0.0022 | 3.1354 | 3.3825 | 10 | 216 | regulation of mononuclear cell proliferation |
GO:0045595 | 0.0024 | 1.7426 | 22.8631 | 37 | 1460 | regulation of cell differentiation |
GO:0002684 | 0.0028 | 1.9976 | 12.2302 | 23 | 781 | positive regulation of immune system process |
GO:0046635 | 0.0028 | 5.6045 | 0.9709 | 5 | 62 | positive regulation of alpha-beta T cell activation |
GO:0006607 | 0.0031 | 11.9148 | 0.2975 | 3 | 19 | NLS-bearing protein import into nucleus |
GO:0034105 | 0.0031 | 11.9148 | 0.2975 | 3 | 19 | positive regulation of tissue remodeling |
GO:0090026 | 0.0031 | 11.9148 | 0.2975 | 3 | 19 | positive regulation of monocyte chemotaxis |
GO:0019722 | 0.0031 | 3.2036 | 2.9753 | 9 | 190 | calcium-mediated signaling |
GO:0031349 | 0.0031 | 2.8002 | 4.1498 | 11 | 265 | positive regulation of defense response |
GO:0002694 | 0.0034 | 2.2096 | 8.1274 | 17 | 519 | regulation of leukocyte activation |
GO:0097696 | 0.0035 | 3.4289 | 2.4742 | 8 | 158 | receptor signaling pathway via STAT |
GO:2000543 | 0.0035 | 31.6706 | 0.094 | 2 | 6 | positive regulation of gastrulation |
GO:0042474 | 0.0036 | 11.2133 | 0.3132 | 3 | 20 | middle ear morphogenesis |
GO:0019221 | 0.0037 | 2.4894 | 5.508 | 13 | 357 | cytokine-mediated signaling pathway |
GO:0007194 | 0.0041 | 10.5896 | 0.3289 | 3 | 21 | negative regulation of adenylate cyclase activity |
GO:0002250 | 0.0041 | 2.3671 | 6.2326 | 14 | 398 | adaptive immune response |
GO:0060759 | 0.0042 | 3.3173 | 2.5525 | 8 | 163 | regulation of response to cytokine stimulus |
GO:0032102 | 0.0042 | 2.3608 | 6.2482 | 14 | 399 | negative regulation of response to external stimulus |
GO:0050863 | 0.0043 | 2.5547 | 4.9485 | 12 | 316 | regulation of T cell activation |
GO:0050671 | 0.0046 | 3.6207 | 2.0514 | 7 | 131 | positive regulation of lymphocyte proliferation |
GO:0050921 | 0.0046 | 3.6207 | 2.0514 | 7 | 131 | positive regulation of chemotaxis |
GO:0050900 | 0.0048 | 2.4138 | 5.6688 | 13 | 362 | leukocyte migration |
GO:0002933 | 0.0049 | 25.3349 | 0.1096 | 2 | 7 | lipid hydroxylation |
GO:0007597 | 0.0049 | 25.3349 | 0.1096 | 2 | 7 | blood coagulation, intrinsic pathway |
GO:0048752 | 0.0049 | 25.3349 | 0.1096 | 2 | 7 | semicircular canal morphogenesis |
GO:0030097 | 0.0049 | 2.2489 | 7.0325 | 15 | 467 | hemopoiesis |
GO:0042127 | 0.0051 | 1.6421 | 24.7893 | 38 | 1583 | regulation of cell population proliferation |
GO:0021871 | 0.0053 | 9.5295 | 0.3602 | 3 | 23 | forebrain regionalization |
GO:0071622 | 0.0057 | 6.0663 | 0.7203 | 4 | 46 | regulation of granulocyte chemotaxis |
GO:0043086 | 0.0057 | 1.9309 | 11.4785 | 21 | 733 | negative regulation of catalytic activity |
GO:0002253 | 0.0058 | 2.5639 | 4.51 | 11 | 288 | activation of immune response |
GO:0044344 | 0.0059 | 3.9174 | 1.6286 | 6 | 104 | cellular response to fibroblast growth factor stimulus |
GO:0002429 | 0.0059 | 2.8812 | 3.2885 | 9 | 210 | immune response-activating cell surface receptor signaling pathway |
GO:0002407 | 0.006 | 9.0751 | 0.3758 | 3 | 24 | dendritic cell chemotaxis |
GO:0045954 | 0.006 | 9.0751 | 0.3758 | 3 | 24 | positive regulation of natural killer cell mediated cytotoxicity |
GO:0050860 | 0.006 | 9.0751 | 0.3758 | 3 | 24 | negative regulation of T cell receptor signaling pathway |
GO:0045088 | 0.0061 | 2.8668 | 3.3042 | 9 | 211 | regulation of innate immune response |
GO:0010662 | 0.0062 | 5.9248 | 0.736 | 4 | 47 | regulation of striated muscle cell apoptotic process |
GO:0048523 | 0.0063 | 1.4109 | 71.4238 | 90 | 4561 | negative regulation of cellular process |
GO:0042742 | 0.0063 | 2.6741 | 3.9306 | 10 | 251 | defense response to bacterium |
GO:0042221 | 0.0064 | 1.429 | 61.2607 | 79 | 3912 | response to chemical |
GO:0002118 | 0.0064 | 21.1111 | 0.1253 | 2 | 8 | aggressive behavior |
GO:0048793 | 0.0064 | 21.1111 | 0.1253 | 2 | 8 | pronephros development |
GO:0072177 | 0.0064 | 21.1111 | 0.1253 | 2 | 8 | mesonephric duct development |
GO:0009617 | 0.0065 | 2.413 | 5.2256 | 12 | 342 | response to bacterium |
GO:0030217 | 0.0065 | 2.6629 | 3.9462 | 10 | 252 | T cell differentiation |
GO:0014065 | 0.0066 | 3.3737 | 2.1924 | 7 | 140 | phosphatidylinositol 3-kinase signaling |
GO:0030857 | 0.0067 | 5.7898 | 0.7517 | 4 | 48 | negative regulation of epithelial cell differentiation |
GO:0002675 | 0.0068 | 8.6621 | 0.3915 | 3 | 25 | positive regulation of acute inflammatory response |
GO:0043270 | 0.0069 | 2.6408 | 3.9776 | 10 | 254 | positive regulation of ion transport |
GO:0050920 | 0.0073 | 4.4025 | 1.2128 | 5 | 79 | regulation of chemotaxis |
GO:2000406 | 0.0076 | 8.2849 | 0.4072 | 3 | 26 | positive regulation of T cell migration |
GO:0030335 | 0.0076 | 2.0752 | 8.0961 | 16 | 517 | positive regulation of cell migration |
GO:0001655 | 0.0077 | 2.3568 | 5.34 | 12 | 341 | urogenital system development |
GO:0021515 | 0.0077 | 5.5374 | 0.783 | 4 | 50 | cell differentiation in spinal cord |
GO:2000179 | 0.0077 | 5.5374 | 0.783 | 4 | 50 | positive regulation of neural precursor cell proliferation |
GO:0010572 | 0.0082 | 18.0941 | 0.1409 | 2 | 9 | positive regulation of platelet activation |
GO:0021520 | 0.0082 | 18.0941 | 0.1409 | 2 | 9 | spinal cord motor neuron cell fate specification |
GO:0022605 | 0.0082 | 18.0941 | 0.1409 | 2 | 9 | mammalian oogenesis stage |
GO:0031666 | 0.0082 | 18.0941 | 0.1409 | 2 | 9 | positive regulation of lipopolysaccharide-mediated signaling pathway |
GO:0070103 | 0.0082 | 18.0941 | 0.1409 | 2 | 9 | regulation of interleukin-6-mediated signaling pathway |
GO:0008625 | 0.0084 | 4.2546 | 1.2528 | 5 | 80 | extrinsic apoptotic signaling pathway via death domain receptors |
GO:0003298 | 0.0084 | 7.9392 | 0.4228 | 3 | 27 | physiological muscle hypertrophy |
GO:0061049 | 0.0084 | 7.9392 | 0.4228 | 3 | 27 | cell growth involved in cardiac muscle cell development |
GO:0070665 | 0.0085 | 3.2036 | 2.302 | 7 | 147 | positive regulation of leukocyte proliferation |
GO:0030336 | 0.0088 | 2.413 | 4.7762 | 11 | 305 | negative regulation of cell migration |
GO:0070098 | 0.0088 | 4.1984 | 1.2684 | 5 | 81 | chemokine-mediated signaling pathway |
GO:0007275 | 0.0089 | 1.4127 | 61.3142 | 78 | 4064 | multicellular organism development |
GO:0055082 | 0.0092 | 1.8414 | 11.9953 | 21 | 766 | cellular chemical homeostasis |
GO:0002825 | 0.0093 | 7.6212 | 0.4385 | 3 | 28 | regulation of T-helper 1 type immune response |
GO:0042098 | 0.0094 | 2.8681 | 2.9284 | 8 | 187 | T cell proliferation |
GO:0048568 | 0.0095 | 2.1331 | 6.8746 | 14 | 439 | embryonic organ development |
GO:0007589 | 0.0098 | 4.0902 | 1.2998 | 5 | 83 | body fluid secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007389 | 0 | 6.5084 | 6.3027 | 34 | 311 | pattern specification process |
GO:0048704 | 0 | 9.5298 | 1.915 | 15 | 93 | embryonic skeletal system morphogenesis |
GO:0045944 | 0 | 2.7398 | 23.5571 | 56 | 1144 | positive regulation of transcription by RNA polymerase II |
GO:0022008 | 0 | 2.664 | 24.2817 | 56 | 1220 | neurogenesis |
GO:0006351 | 0 | 1.9877 | 65.6263 | 108 | 3187 | transcription, DNA-templated |
GO:0009952 | 0 | 6.4955 | 2.8419 | 16 | 140 | anterior/posterior pattern specification |
GO:0032774 | 0 | 1.9734 | 65.9969 | 108 | 3205 | RNA biosynthetic process |
GO:0007420 | 0 | 3.2698 | 11.3065 | 33 | 561 | brain development |
GO:0009790 | 0 | 2.6526 | 20.0141 | 47 | 986 | embryo development |
GO:1903508 | 0 | 2.2832 | 31.5261 | 63 | 1531 | positive regulation of nucleic acid-templated transcription |
GO:0010557 | 0 | 2.1447 | 35.6445 | 67 | 1731 | positive regulation of macromolecule biosynthetic process |
GO:0072507 | 0 | 3.2174 | 9.9871 | 29 | 485 | divalent inorganic cation homeostasis |
GO:0048731 | 0 | 1.9314 | 61.361 | 98 | 3274 | system development |
GO:0031328 | 0 | 2.0872 | 37.7037 | 69 | 1831 | positive regulation of cellular biosynthetic process |
GO:0051674 | 0 | 2.1455 | 33.2764 | 63 | 1616 | localization of cell |
GO:1901362 | 0 | 1.7991 | 77.8372 | 117 | 3780 | organic cyclic compound biosynthetic process |
GO:0006357 | 0 | 2.9162 | 12.2845 | 32 | 675 | regulation of transcription by RNA polymerase II |
GO:0050801 | 0 | 2.6931 | 14.785 | 36 | 718 | ion homeostasis |
GO:0043067 | 0 | 2.21 | 27.9226 | 55 | 1356 | regulation of programmed cell death |
GO:0018130 | 0 | 1.7989 | 74.7279 | 113 | 3629 | heterocycle biosynthetic process |
GO:0006874 | 0 | 3.2432 | 8.8339 | 26 | 429 | cellular calcium ion homeostasis |
GO:0051254 | 0 | 2.0728 | 34.2855 | 63 | 1665 | positive regulation of RNA metabolic process |
GO:0030003 | 0 | 2.7714 | 12.7052 | 32 | 617 | cellular cation homeostasis |
GO:0019438 | 0 | 1.7672 | 74.9544 | 112 | 3640 | aromatic compound biosynthetic process |
GO:0001501 | 0 | 2.9369 | 10.4607 | 28 | 508 | skeletal system development |
GO:0021527 | 0 | 34.4746 | 0.2471 | 5 | 12 | spinal cord association neuron differentiation |
GO:0048665 | 0 | 19.5877 | 0.4275 | 6 | 21 | neuron fate specification |
GO:0055082 | 0 | 2.5081 | 15.7734 | 36 | 766 | cellular chemical homeostasis |
GO:0009653 | 0 | 1.9742 | 38.6557 | 67 | 1993 | anatomical structure morphogenesis |
GO:0007204 | 0 | 3.5244 | 6.2187 | 20 | 302 | positive regulation of cytosolic calcium ion concentration |
GO:0009954 | 0 | 12.5737 | 0.7001 | 7 | 34 | proximal/distal pattern formation |
GO:0009410 | 0 | 3.1805 | 7.9073 | 23 | 384 | response to xenobiotic stimulus |
GO:0040011 | 0 | 2.5048 | 15.4246 | 35 | 788 | locomotion |
GO:0010817 | 0 | 2.9359 | 9.6782 | 26 | 470 | regulation of hormone levels |
GO:0048252 | 0 | Inf | 0.0618 | 3 | 3 | lauric acid metabolic process |
GO:0043009 | 0 | 2.6996 | 11.3068 | 28 | 557 | chordate embryonic development |
GO:0048869 | 0 | 1.7165 | 69.729 | 102 | 3661 | cellular developmental process |
GO:0055065 | 0 | 2.643 | 11.5298 | 28 | 570 | metal ion homeostasis |
GO:0001659 | 0 | 4.3001 | 3.583 | 14 | 174 | temperature homeostasis |
GO:0035295 | 0 | 2.1686 | 21.2224 | 42 | 1039 | tube development |
GO:0061138 | 0 | 4.2201 | 3.6448 | 14 | 177 | morphogenesis of a branching epithelium |
GO:0021520 | 0 | 38.4994 | 0.1853 | 4 | 9 | spinal cord motor neuron cell fate specification |
GO:0060485 | 0 | 3.3837 | 5.7863 | 18 | 281 | mesenchyme development |
GO:0043524 | 0 | 4.6989 | 2.8211 | 12 | 137 | negative regulation of neuron apoptotic process |
GO:0042592 | 0 | 1.8932 | 34.512 | 59 | 1676 | homeostatic process |
GO:0042756 | 0 | 32.0808 | 0.2059 | 4 | 10 | drinking behavior |
GO:0002673 | 0 | 8.9277 | 0.9266 | 7 | 45 | regulation of acute inflammatory response |
GO:0021517 | 0 | 8.9277 | 0.9266 | 7 | 45 | ventral spinal cord development |
GO:0060429 | 0 | 2.7947 | 8.9297 | 23 | 456 | epithelium development |
GO:0044271 | 0 | 1.6065 | 87.9478 | 121 | 4271 | cellular nitrogen compound biosynthetic process |
GO:0060795 | 0 | 11.1585 | 0.6589 | 6 | 32 | cell fate commitment involved in formation of primary germ layer |
GO:1903238 | 1e-04 | 27.4961 | 0.2265 | 4 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0032303 | 1e-04 | 15.0741 | 0.4324 | 5 | 21 | regulation of icosanoid secretion |
GO:0072001 | 1e-04 | 3.1293 | 6.2187 | 18 | 302 | renal system development |
GO:0032890 | 1e-04 | 6.6968 | 1.3591 | 8 | 66 | regulation of organic acid transport |
GO:0008284 | 1e-04 | 2.214 | 16.6432 | 34 | 823 | positive regulation of cell population proliferation |
GO:0001656 | 1e-04 | 5.6856 | 1.7709 | 9 | 86 | metanephros development |
GO:0072080 | 1e-04 | 5.6856 | 1.7709 | 9 | 86 | nephron tubule development |
GO:2000179 | 1e-04 | 7.8871 | 1.0296 | 7 | 50 | positive regulation of neural precursor cell proliferation |
GO:0097154 | 1e-04 | 24.0576 | 0.2471 | 4 | 12 | GABAergic neuron differentiation |
GO:0000122 | 1e-04 | 2.159 | 17.5443 | 35 | 852 | negative regulation of transcription by RNA polymerase II |
GO:0060993 | 1e-04 | 5.5409 | 1.8121 | 9 | 88 | kidney morphogenesis |
GO:0042327 | 1e-04 | 2.2352 | 15.4645 | 32 | 751 | positive regulation of phosphorylation |
GO:0009996 | 1e-04 | 71.9819 | 0.103 | 3 | 5 | negative regulation of cell fate specification |
GO:0014016 | 1e-04 | 71.9819 | 0.103 | 3 | 5 | neuroblast differentiation |
GO:0021544 | 1e-04 | 13.3975 | 0.4736 | 5 | 23 | subpallium development |
GO:0021895 | 1e-04 | 13.3975 | 0.4736 | 5 | 23 | cerebral cortex neuron differentiation |
GO:0072088 | 1e-04 | 6.2632 | 1.4414 | 8 | 70 | nephron epithelium morphogenesis |
GO:0001657 | 1e-04 | 5.4034 | 1.8533 | 9 | 90 | ureteric bud development |
GO:0001658 | 1e-04 | 7.3714 | 1.0914 | 7 | 53 | branching involved in ureteric bud morphogenesis |
GO:1903507 | 1e-04 | 1.9708 | 23.7012 | 43 | 1151 | negative regulation of nucleic acid-templated transcription |
GO:0072163 | 1e-04 | 5.3372 | 1.8739 | 9 | 91 | mesonephric epithelium development |
GO:0021515 | 1e-04 | 9.1991 | 0.7713 | 6 | 38 | cell differentiation in spinal cord |
GO:0045672 | 1e-04 | 12.6916 | 0.4942 | 5 | 24 | positive regulation of osteoclast differentiation |
GO:2000193 | 1e-04 | 12.6916 | 0.4942 | 5 | 24 | positive regulation of fatty acid transport |
GO:0061333 | 1e-04 | 6.0667 | 1.4826 | 8 | 72 | renal tubule morphogenesis |
GO:0010468 | 1e-04 | 1.6124 | 69.1713 | 97 | 3509 | regulation of gene expression |
GO:0032308 | 2e-04 | 19.2436 | 0.2883 | 4 | 14 | positive regulation of prostaglandin secretion |
GO:0048562 | 2e-04 | 3.6074 | 3.8968 | 13 | 197 | embryonic organ morphogenesis |
GO:0080090 | 2e-04 | 1.5147 | 109.3428 | 141 | 5310 | regulation of primary metabolic process |
GO:0021978 | 2e-04 | 48.4116 | 0.1225 | 3 | 6 | telencephalon regionalization |
GO:0010536 | 2e-04 | 47.9849 | 0.1236 | 3 | 6 | positive regulation of activation of Janus kinase activity |
GO:0021766 | 2e-04 | 5.7084 | 1.565 | 8 | 76 | hippocampus development |
GO:0061061 | 2e-04 | 2.2922 | 12.6434 | 27 | 614 | muscle structure development |
GO:0051047 | 2e-04 | 3.0389 | 5.6572 | 16 | 277 | positive regulation of secretion |
GO:0048729 | 2e-04 | 2.4075 | 10.6908 | 24 | 528 | tissue morphogenesis |
GO:0009058 | 2e-04 | 1.5044 | 108.9309 | 140 | 5290 | biosynthetic process |
GO:0007218 | 2e-04 | 4.8603 | 2.0386 | 9 | 99 | neuropeptide signaling pathway |
GO:0007611 | 2e-04 | 3.1317 | 5.148 | 15 | 250 | learning or memory |
GO:0031327 | 2e-04 | 1.8103 | 30.0229 | 50 | 1458 | negative regulation of cellular biosynthetic process |
GO:0050905 | 2e-04 | 3.944 | 3.027 | 11 | 147 | neuromuscular process |
GO:0031175 | 2e-04 | 2.0253 | 18.5945 | 35 | 903 | neuron projection development |
GO:0009617 | 3e-04 | 2.2807 | 12.211 | 26 | 593 | response to bacterium |
GO:0010721 | 3e-04 | 3.5948 | 3.6036 | 12 | 175 | negative regulation of cell development |
GO:0050767 | 3e-04 | 2.7273 | 7.063 | 18 | 343 | regulation of neurogenesis |
GO:0019530 | 3e-04 | 35.9864 | 0.1441 | 3 | 7 | taurine metabolic process |
GO:0021796 | 3e-04 | 35.9864 | 0.1441 | 3 | 7 | cerebral cortex regionalization |
GO:1903793 | 3e-04 | 7.4329 | 0.9266 | 6 | 45 | positive regulation of anion transport |
GO:0051347 | 3e-04 | 2.3247 | 11.0372 | 24 | 536 | positive regulation of transferase activity |
GO:0010959 | 3e-04 | 2.6162 | 7.7631 | 19 | 377 | regulation of metal ion transport |
GO:0048645 | 3e-04 | 5.9447 | 1.3179 | 7 | 64 | animal organ formation |
GO:0051253 | 3e-04 | 1.8435 | 25.781 | 44 | 1252 | negative regulation of RNA metabolic process |
GO:1904948 | 3e-04 | 14.8 | 0.3501 | 4 | 17 | midbrain dopaminergic neuron differentiation |
GO:0030097 | 4e-04 | 2.0411 | 16.803 | 32 | 816 | hemopoiesis |
GO:0021536 | 4e-04 | 9.3639 | 0.6322 | 5 | 31 | diencephalon development |
GO:0014706 | 4e-04 | 3.1011 | 4.8391 | 14 | 235 | striated muscle tissue development |
GO:0031644 | 4e-04 | 3.9881 | 2.7181 | 10 | 132 | regulation of nervous system process |
GO:0010562 | 4e-04 | 2.0248 | 16.9265 | 32 | 822 | positive regulation of phosphorus metabolic process |
GO:0021893 | 4e-04 | Inf | 0.0412 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:0048343 | 4e-04 | Inf | 0.0412 | 2 | 2 | paraxial mesodermal cell fate commitment |
GO:1902871 | 4e-04 | Inf | 0.0412 | 2 | 2 | positive regulation of amacrine cell differentiation |
GO:0043651 | 4e-04 | 13.742 | 0.3707 | 4 | 18 | linoleic acid metabolic process |
GO:0033278 | 4e-04 | 28.7873 | 0.1647 | 3 | 8 | cell proliferation in midbrain |
GO:0048664 | 4e-04 | 28.7873 | 0.1647 | 3 | 8 | neuron fate determination |
GO:0048793 | 4e-04 | 28.7873 | 0.1647 | 3 | 8 | pronephros development |
GO:0048333 | 5e-04 | 8.9266 | 0.6589 | 5 | 32 | mesodermal cell differentiation |
GO:0030182 | 5e-04 | 1.9676 | 18.5865 | 34 | 972 | neuron differentiation |
GO:1903522 | 5e-04 | 3.0046 | 4.9832 | 14 | 242 | regulation of blood circulation |
GO:0006936 | 5e-04 | 2.6595 | 6.8159 | 17 | 331 | muscle contraction |
GO:1904994 | 5e-04 | 8.6073 | 0.6795 | 5 | 33 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0015732 | 5e-04 | 12.8251 | 0.3912 | 4 | 19 | prostaglandin transport |
GO:0008544 | 5e-04 | 2.6509 | 6.8365 | 17 | 332 | epidermis development |
GO:0043066 | 6e-04 | 2.193 | 12.1689 | 25 | 613 | negative regulation of apoptotic process |
GO:0043549 | 6e-04 | 2.0627 | 15.0115 | 29 | 729 | regulation of kinase activity |
GO:0033138 | 6e-04 | 4.6723 | 1.8739 | 8 | 91 | positive regulation of peptidyl-serine phosphorylation |
GO:0010558 | 6e-04 | 1.759 | 28.8286 | 47 | 1400 | negative regulation of macromolecule biosynthetic process |
GO:0048332 | 6e-04 | 5.3765 | 1.4414 | 7 | 70 | mesoderm morphogenesis |
GO:0051961 | 6e-04 | 3.77 | 2.8623 | 10 | 139 | negative regulation of nervous system development |
GO:1902692 | 6e-04 | 8.3099 | 0.7001 | 5 | 34 | regulation of neuroblast proliferation |
GO:0009953 | 6e-04 | 4.6164 | 1.8945 | 8 | 92 | dorsal/ventral pattern formation |
GO:0015718 | 6e-04 | 4.6141 | 1.8943 | 8 | 93 | monocarboxylic acid transport |
GO:0061042 | 7e-04 | 12.0227 | 0.4118 | 4 | 20 | vascular wound healing |
GO:0014033 | 7e-04 | 4.5618 | 1.915 | 8 | 93 | neural crest cell differentiation |
GO:0045639 | 7e-04 | 4.5618 | 1.915 | 8 | 93 | positive regulation of myeloid cell differentiation |
GO:1904238 | 7e-04 | 23.9879 | 0.1853 | 3 | 9 | pericyte cell differentiation |
GO:0060548 | 7e-04 | 2.0645 | 14.4828 | 28 | 732 | negative regulation of cell death |
GO:0007507 | 7e-04 | 2.1917 | 11.655 | 24 | 566 | heart development |
GO:0030902 | 8e-04 | 3.6557 | 2.9446 | 10 | 143 | hindbrain development |
GO:0007200 | 8e-04 | 4.4564 | 1.9562 | 8 | 95 | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO:0003008 | 8e-04 | 1.7662 | 26.9017 | 44 | 1365 | system process |
GO:0006805 | 9e-04 | 4.3557 | 1.9974 | 8 | 97 | xenobiotic metabolic process |
GO:0007369 | 9e-04 | 3.3253 | 3.5424 | 11 | 173 | gastrulation |
GO:0061005 | 9e-04 | 5.9123 | 1.1326 | 6 | 55 | cell differentiation involved in kidney development |
GO:1902260 | 9e-04 | 20.5598 | 0.2059 | 3 | 10 | negative regulation of delayed rectifier potassium channel activity |
GO:0045664 | 9e-04 | 4.2972 | 2.0207 | 8 | 100 | regulation of neuron differentiation |
GO:0048145 | 0.001 | 4.9071 | 1.565 | 7 | 76 | regulation of fibroblast proliferation |
GO:0050678 | 0.001 | 2.5124 | 7.1866 | 17 | 349 | regulation of epithelial cell proliferation |
GO:0003071 | 0.001 | 10.6855 | 0.453 | 4 | 22 | renal system process involved in regulation of systemic arterial blood pressure |
GO:0120254 | 0.001 | 3.8416 | 2.5256 | 9 | 124 | olefinic compound metabolic process |
GO:1903506 | 0.001 | 1.9668 | 16.4342 | 30 | 898 | regulation of nucleic acid-templated transcription |
GO:0002573 | 0.0011 | 3.491 | 3.0719 | 10 | 151 | myeloid leukocyte differentiation |
GO:0072171 | 0.0011 | 5.7142 | 1.1669 | 6 | 57 | mesonephric tubule morphogenesis |
GO:0090596 | 0.0011 | 2.7701 | 5.3745 | 14 | 261 | sensory organ morphogenesis |
GO:0001759 | 0.0011 | 10.1225 | 0.4736 | 4 | 23 | organ induction |
GO:0021879 | 0.0012 | 7.0856 | 0.8031 | 5 | 39 | forebrain neuron differentiation |
GO:0001755 | 0.0012 | 5.5701 | 1.1943 | 6 | 58 | neural crest cell migration |
GO:0043407 | 0.0012 | 5.5701 | 1.1943 | 6 | 58 | negative regulation of MAP kinase activity |
GO:0001938 | 0.0012 | 4.1227 | 2.1004 | 8 | 102 | positive regulation of endothelial cell proliferation |
GO:2000026 | 0.0012 | 1.7528 | 25.0481 | 41 | 1234 | regulation of multicellular organismal development |
GO:0030855 | 0.0012 | 2.097 | 12.1453 | 24 | 597 | epithelial cell differentiation |
GO:0050673 | 0.0012 | 5.5377 | 1.1984 | 6 | 60 | epithelial cell proliferation |
GO:0032990 | 0.0012 | 2.0612 | 12.8699 | 25 | 625 | cell part morphogenesis |
GO:0045596 | 0.0012 | 2.4506 | 7.36 | 17 | 373 | negative regulation of cell differentiation |
GO:0001661 | 0.0013 | 95.6928 | 0.0618 | 2 | 3 | conditioned taste aversion |
GO:0001705 | 0.0013 | 95.6928 | 0.0618 | 2 | 3 | ectoderm formation |
GO:0002019 | 0.0013 | 95.6928 | 0.0618 | 2 | 3 | regulation of renal output by angiotensin |
GO:0003335 | 0.0013 | 95.6928 | 0.0618 | 2 | 3 | corneocyte development |
GO:0007412 | 0.0013 | 95.6928 | 0.0618 | 2 | 3 | axon target recognition |
GO:0060375 | 0.0013 | 95.6928 | 0.0618 | 2 | 3 | regulation of mast cell differentiation |
GO:0061184 | 0.0013 | 95.6928 | 0.0618 | 2 | 3 | positive regulation of dermatome development |
GO:0072011 | 0.0013 | 95.6928 | 0.0618 | 2 | 3 | glomerular endothelium development |
GO:0072180 | 0.0013 | 95.6928 | 0.0618 | 2 | 3 | mesonephric duct morphogenesis |
GO:0097377 | 0.0013 | 95.6928 | 0.0618 | 2 | 3 | spinal cord interneuron axon guidance |
GO:2000295 | 0.0013 | 95.6928 | 0.0618 | 2 | 3 | regulation of hydrogen peroxide catabolic process |
GO:1902105 | 0.0013 | 2.7142 | 5.4774 | 14 | 266 | regulation of leukocyte differentiation |
GO:0048644 | 0.0013 | 4.637 | 1.6473 | 7 | 80 | muscle organ morphogenesis |
GO:0046427 | 0.0013 | 6.8828 | 0.8237 | 5 | 40 | positive regulation of receptor signaling pathway via JAK-STAT |
GO:0022407 | 0.0013 | 2.3056 | 8.7309 | 19 | 424 | regulation of cell-cell adhesion |
GO:0003013 | 0.0013 | 2.1179 | 11.5109 | 23 | 559 | circulatory system process |
GO:0042886 | 0.0013 | 2.6978 | 5.5084 | 14 | 269 | amide transport |
GO:0071280 | 0.0014 | 9.6158 | 0.4942 | 4 | 24 | cellular response to copper ion |
GO:0070661 | 0.0014 | 2.5925 | 6.1364 | 15 | 298 | leukocyte proliferation |
GO:0002682 | 0.0014 | 1.7276 | 26.0075 | 42 | 1263 | regulation of immune system process |
GO:0015850 | 0.0014 | 2.8062 | 4.9215 | 13 | 239 | organic hydroxy compound transport |
GO:0051173 | 0.0014 | 1.5021 | 59.1398 | 81 | 2872 | positive regulation of nitrogen compound metabolic process |
GO:0055008 | 0.0014 | 5.3631 | 1.2355 | 6 | 60 | cardiac muscle tissue morphogenesis |
GO:0060562 | 0.0015 | 2.791 | 4.9461 | 13 | 245 | epithelial tube morphogenesis |
GO:0006928 | 0.0015 | 1.7327 | 25.4097 | 41 | 1299 | movement of cell or subcellular component |
GO:0042633 | 0.0016 | 3.9534 | 2.1827 | 8 | 106 | hair cycle |
GO:0045995 | 0.0016 | 5.2653 | 1.2561 | 6 | 61 | regulation of embryonic development |
GO:0003401 | 0.0016 | 9.1573 | 0.5148 | 4 | 25 | axis elongation |
GO:0006811 | 0.0016 | 1.6723 | 29.467 | 46 | 1431 | ion transport |
GO:0120039 | 0.0016 | 2.0467 | 12.4169 | 24 | 603 | plasma membrane bounded cell projection morphogenesis |
GO:0031650 | 0.0017 | 15.9889 | 0.2471 | 3 | 12 | regulation of heat generation |
GO:0001756 | 0.0017 | 5.1709 | 1.2767 | 6 | 62 | somitogenesis |
GO:0065007 | 0.0017 | 1.5065 | 160.5421 | 183 | 8408 | biological regulation |
GO:0006690 | 0.0018 | 3.8739 | 2.2239 | 8 | 108 | icosanoid metabolic process |
GO:0021543 | 0.0018 | 4.3718 | 1.7366 | 7 | 86 | pallium development |
GO:0140353 | 0.0018 | 6.3382 | 0.8855 | 5 | 43 | lipid export from cell |
GO:0001942 | 0.0018 | 4.3384 | 1.7503 | 7 | 85 | hair follicle development |
GO:0030878 | 0.0018 | 8.7405 | 0.5354 | 4 | 26 | thyroid gland development |
GO:1902624 | 0.0018 | 8.7405 | 0.5354 | 4 | 26 | positive regulation of neutrophil migration |
GO:0007588 | 0.0018 | 5.0799 | 1.2973 | 6 | 63 | excretion |
GO:0002790 | 0.0018 | 2.8507 | 4.4684 | 12 | 217 | peptide secretion |
GO:0035296 | 0.0019 | 3.4637 | 2.7799 | 9 | 135 | regulation of tube diameter |
GO:0140352 | 0.0019 | 1.91 | 15.5379 | 28 | 764 | export from cell |
GO:0032101 | 0.002 | 1.8266 | 18.5945 | 32 | 903 | regulation of response to external stimulus |
GO:0006935 | 0.002 | 2.4004 | 7.0485 | 16 | 349 | chemotaxis |
GO:0015711 | 0.0021 | 2.394 | 7.063 | 16 | 343 | organic anion transport |
GO:0014031 | 0.0021 | 4.2294 | 1.7915 | 7 | 87 | mesenchymal cell development |
GO:0048864 | 0.0021 | 4.2294 | 1.7915 | 7 | 87 | stem cell development |
GO:0035815 | 0.0021 | 14.3891 | 0.2677 | 3 | 13 | positive regulation of renal sodium excretion |
GO:0042362 | 0.0021 | 14.3891 | 0.2677 | 3 | 13 | fat-soluble vitamin biosynthetic process |
GO:0048484 | 0.0021 | 14.3891 | 0.2677 | 3 | 13 | enteric nervous system development |
GO:0048935 | 0.0021 | 14.3891 | 0.2677 | 3 | 13 | peripheral nervous system neuron development |
GO:0010453 | 0.0021 | 8.3599 | 0.556 | 4 | 27 | regulation of cell fate commitment |
GO:0006801 | 0.0022 | 4.9071 | 1.3385 | 6 | 65 | superoxide metabolic process |
GO:0051962 | 0.0022 | 2.6627 | 5.1686 | 13 | 251 | positive regulation of nervous system development |
GO:0043303 | 0.0022 | 6.0205 | 0.9266 | 5 | 45 | mast cell degranulation |
GO:0097305 | 0.0022 | 2.7819 | 4.5714 | 12 | 222 | response to alcohol |
GO:0032147 | 0.0022 | 3.3825 | 2.8417 | 9 | 138 | activation of protein kinase activity |
GO:0055123 | 0.0022 | 3.3825 | 2.8417 | 9 | 138 | digestive system development |
GO:0022404 | 0.0022 | 4.177 | 1.8121 | 7 | 88 | molting cycle process |
GO:0032410 | 0.0022 | 4.177 | 1.8121 | 7 | 88 | negative regulation of transporter activity |
GO:0010556 | 0.0023 | 1.8383 | 18.1177 | 31 | 994 | regulation of macromolecule biosynthetic process |
GO:0040012 | 0.0024 | 8.014 | 0.5742 | 4 | 29 | regulation of locomotion |
GO:0001660 | 0.0024 | 48.1182 | 0.0819 | 2 | 4 | fever generation |
GO:0035176 | 0.0025 | 5.8733 | 0.9472 | 5 | 46 | social behavior |
GO:0042311 | 0.0025 | 5.8733 | 0.9472 | 5 | 46 | vasodilation |
GO:0042743 | 0.0025 | 5.8733 | 0.9472 | 5 | 46 | hydrogen peroxide metabolic process |
GO:0035106 | 0.0025 | 47.8434 | 0.0824 | 2 | 4 | operant conditioning |
GO:0061737 | 0.0025 | 47.8434 | 0.0824 | 2 | 4 | leukotriene signaling pathway |
GO:0097022 | 0.0025 | 47.8434 | 0.0824 | 2 | 4 | lymphocyte migration into lymph node |
GO:0097476 | 0.0025 | 47.8434 | 0.0824 | 2 | 4 | spinal cord motor neuron migration |
GO:1904954 | 0.0025 | 47.8434 | 0.0824 | 2 | 4 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation |
GO:0040017 | 0.0026 | 2.0351 | 11.4079 | 22 | 554 | positive regulation of locomotion |
GO:0003207 | 0.0027 | 13.0802 | 0.2883 | 3 | 14 | cardiac chamber formation |
GO:1905207 | 0.0028 | 7.6902 | 0.5972 | 4 | 29 | regulation of cardiocyte differentiation |
GO:0048771 | 0.0028 | 3.2571 | 2.9426 | 9 | 144 | tissue remodeling |
GO:0090276 | 0.0029 | 3.0145 | 3.5212 | 10 | 171 | regulation of peptide hormone secretion |
GO:2000027 | 0.003 | 3.5405 | 2.416 | 8 | 118 | regulation of animal organ morphogenesis |
GO:0002762 | 0.003 | 5.5994 | 0.9884 | 5 | 48 | negative regulation of myeloid leukocyte differentiation |
GO:0030857 | 0.003 | 5.5994 | 0.9884 | 5 | 48 | negative regulation of epithelial cell differentiation |
GO:0048546 | 0.003 | 5.5994 | 0.9884 | 5 | 48 | digestive tract morphogenesis |
GO:0060047 | 0.003 | 2.6784 | 4.7361 | 12 | 230 | heart contraction |
GO:0021953 | 0.003 | 3.9434 | 1.9078 | 7 | 96 | central nervous system neuron differentiation |
GO:0051172 | 0.003 | 1.5087 | 45.7345 | 64 | 2221 | negative regulation of nitrogen compound metabolic process |
GO:0035113 | 0.0031 | 3.5195 | 2.4298 | 8 | 118 | embryonic appendage morphogenesis |
GO:0071900 | 0.0031 | 2.2937 | 7.3513 | 16 | 357 | regulation of protein serine/threonine kinase activity |
GO:0065009 | 0.0031 | 1.4567 | 58.9957 | 79 | 2865 | regulation of molecular function |
GO:0021772 | 0.0032 | 7.3939 | 0.6178 | 4 | 30 | olfactory bulb development |
GO:0032355 | 0.0032 | 3.4875 | 2.4504 | 8 | 119 | response to estradiol |
GO:0051239 | 0.0032 | 1.8658 | 15.3884 | 27 | 813 | regulation of multicellular organismal process |
GO:0046850 | 0.0033 | 5.4718 | 1.009 | 5 | 49 | regulation of bone remodeling |
GO:0019373 | 0.0033 | 11.9894 | 0.3089 | 3 | 15 | epoxygenase P450 pathway |
GO:0072176 | 0.0033 | 11.9894 | 0.3089 | 3 | 15 | nephric duct development |
GO:0072224 | 0.0033 | 11.9894 | 0.3089 | 3 | 15 | metanephric glomerulus development |
GO:0007219 | 0.0033 | 2.9588 | 3.583 | 10 | 174 | Notch signaling pathway |
GO:0030073 | 0.0033 | 2.9588 | 3.583 | 10 | 174 | insulin secretion |
GO:0060173 | 0.0033 | 2.9588 | 3.583 | 10 | 174 | limb development |
GO:0043154 | 0.0034 | 4.4524 | 1.462 | 6 | 71 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0010628 | 0.0035 | 1.7114 | 21.6626 | 35 | 1052 | positive regulation of gene expression |
GO:0045321 | 0.0035 | 1.8049 | 16.9677 | 29 | 824 | leukocyte activation |
GO:0000904 | 0.0035 | 1.8934 | 13.9201 | 25 | 676 | cell morphogenesis involved in differentiation |
GO:0070374 | 0.0036 | 2.7547 | 4.2213 | 11 | 205 | positive regulation of ERK1 and ERK2 cascade |
GO:0061098 | 0.0036 | 5.3499 | 1.0296 | 5 | 50 | positive regulation of protein tyrosine kinase activity |
GO:0035115 | 0.0036 | 7.1196 | 0.6383 | 4 | 31 | embryonic forelimb morphogenesis |
GO:0050482 | 0.0036 | 7.1196 | 0.6383 | 4 | 31 | arachidonic acid secretion |
GO:0098801 | 0.0036 | 7.1196 | 0.6383 | 4 | 31 | regulation of renal system process |
GO:2001240 | 0.0036 | 7.1196 | 0.6383 | 4 | 31 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0001764 | 0.0036 | 3.1329 | 3.0511 | 9 | 149 | neuron migration |
GO:0050794 | 0.0036 | 1.3963 | 185.987 | 209 | 9492 | regulation of cellular process |
GO:0006955 | 0.0037 | 1.6024 | 29.8994 | 45 | 1452 | immune response |
GO:0045165 | 0.0037 | 3.4052 | 2.5014 | 8 | 129 | cell fate commitment |
GO:0015837 | 0.0037 | 3.7996 | 1.9768 | 7 | 96 | amine transport |
GO:0019233 | 0.0037 | 3.7996 | 1.9768 | 7 | 96 | sensory perception of pain |
GO:0120162 | 0.0037 | 3.7996 | 1.9768 | 7 | 96 | positive regulation of cold-induced thermogenesis |
GO:0090087 | 0.0037 | 2.9051 | 3.6448 | 10 | 177 | regulation of peptide transport |
GO:0031424 | 0.0039 | 4.319 | 1.5032 | 6 | 73 | keratinization |
GO:0055078 | 0.0039 | 6.9196 | 0.6539 | 4 | 32 | sodium ion homeostasis |
GO:0007368 | 0.0039 | 3.3654 | 2.5328 | 8 | 123 | determination of left/right symmetry |
GO:0032095 | 0.004 | 11.0665 | 0.3295 | 3 | 16 | regulation of response to food |
GO:0045780 | 0.004 | 11.0665 | 0.3295 | 3 | 16 | positive regulation of bone resorption |
GO:0045940 | 0.004 | 6.8649 | 0.6589 | 4 | 32 | positive regulation of steroid metabolic process |
GO:0003331 | 0.0041 | 31.8936 | 0.103 | 2 | 5 | positive regulation of extracellular matrix constituent secretion |
GO:0042482 | 0.0041 | 31.8936 | 0.103 | 2 | 5 | positive regulation of odontogenesis |
GO:0042661 | 0.0041 | 31.8936 | 0.103 | 2 | 5 | regulation of mesodermal cell fate specification |
GO:0060406 | 0.0041 | 31.8936 | 0.103 | 2 | 5 | positive regulation of penile erection |
GO:0060664 | 0.0041 | 31.8936 | 0.103 | 2 | 5 | epithelial cell proliferation involved in salivary gland morphogenesis |
GO:0060971 | 0.0041 | 31.8936 | 0.103 | 2 | 5 | embryonic heart tube left/right pattern formation |
GO:0072592 | 0.0041 | 31.8936 | 0.103 | 2 | 5 | oxygen metabolic process |
GO:0090185 | 0.0041 | 31.8936 | 0.103 | 2 | 5 | negative regulation of kidney development |
GO:1903598 | 0.0041 | 31.8936 | 0.103 | 2 | 5 | positive regulation of gap junction assembly |
GO:0046879 | 0.0041 | 2.7036 | 4.2955 | 11 | 211 | hormone secretion |
GO:0051341 | 0.0041 | 3.7156 | 2.018 | 7 | 98 | regulation of oxidoreductase activity |
GO:0007409 | 0.0042 | 2.1612 | 8.2708 | 17 | 404 | axonogenesis |
GO:0001666 | 0.0042 | 2.4531 | 5.5804 | 13 | 271 | response to hypoxia |
GO:0002027 | 0.0044 | 3.675 | 2.0386 | 7 | 99 | regulation of heart rate |
GO:0070482 | 0.0045 | 2.3446 | 6.2805 | 14 | 305 | response to oxygen levels |
GO:0008344 | 0.0045 | 4.1933 | 1.5444 | 6 | 75 | adult locomotory behavior |
GO:0030307 | 0.0045 | 3.0273 | 3.1506 | 9 | 153 | positive regulation of cell growth |
GO:0016477 | 0.0045 | 1.8349 | 14.9661 | 26 | 771 | cell migration |
GO:0045599 | 0.0046 | 5.0146 | 1.0914 | 5 | 53 | negative regulation of fat cell differentiation |
GO:0150063 | 0.0046 | 2.1949 | 7.6602 | 16 | 372 | visual system development |
GO:0031326 | 0.0046 | 1.7627 | 18.1898 | 30 | 1004 | regulation of cellular biosynthetic process |
GO:0050730 | 0.0046 | 2.5256 | 5.0038 | 12 | 243 | regulation of peptidyl-tyrosine phosphorylation |
GO:0007625 | 0.0047 | 10.2754 | 0.3501 | 3 | 17 | grooming behavior |
GO:1901701 | 0.0048 | 1.6611 | 22.9187 | 36 | 1113 | cellular response to oxygen-containing compound |
GO:0051252 | 0.0048 | 1.7555 | 18.2184 | 30 | 986 | regulation of RNA metabolic process |
GO:0071715 | 0.0048 | 6.4789 | 0.6925 | 4 | 34 | icosanoid transport |
GO:1990845 | 0.0049 | 2.9855 | 3.1917 | 9 | 155 | adaptive thermogenesis |
GO:0043583 | 0.0049 | 2.631 | 4.4067 | 11 | 214 | ear development |
GO:0048588 | 0.0049 | 2.631 | 4.4067 | 11 | 214 | developmental cell growth |
GO:0008210 | 0.005 | 6.4065 | 0.7001 | 4 | 34 | estrogen metabolic process |
GO:0035137 | 0.005 | 6.4065 | 0.7001 | 4 | 34 | hindlimb morphogenesis |
GO:0043243 | 0.005 | 6.4065 | 0.7001 | 4 | 34 | positive regulation of protein-containing complex disassembly |
GO:0045777 | 0.005 | 6.4065 | 0.7001 | 4 | 34 | positive regulation of blood pressure |
GO:0035637 | 0.0051 | 2.965 | 3.2123 | 9 | 156 | multicellular organismal signaling |
GO:0051272 | 0.0052 | 1.9439 | 11.3461 | 21 | 551 | positive regulation of cellular component movement |
GO:0010001 | 0.0053 | 2.605 | 4.4478 | 11 | 216 | glial cell differentiation |
GO:0032944 | 0.0053 | 2.605 | 4.4478 | 11 | 216 | regulation of mononuclear cell proliferation |
GO:0043588 | 0.0053 | 2.3781 | 5.7451 | 13 | 279 | skin development |
GO:0008306 | 0.0053 | 6.2801 | 0.7118 | 4 | 35 | associative learning |
GO:0030335 | 0.0054 | 1.9722 | 10.646 | 20 | 517 | positive regulation of cell migration |
GO:0050433 | 0.0054 | 4.8134 | 1.1326 | 5 | 55 | regulation of catecholamine secretion |
GO:0002691 | 0.0056 | 6.1994 | 0.7207 | 4 | 35 | regulation of cellular extravasation |
GO:0021532 | 0.0056 | 6.1994 | 0.7207 | 4 | 35 | neural tube patterning |
GO:0010744 | 0.0056 | 9.5897 | 0.3707 | 3 | 18 | positive regulation of macrophage derived foam cell differentiation |
GO:0052695 | 0.0056 | 9.5897 | 0.3707 | 3 | 18 | cellular glucuronidation |
GO:0097623 | 0.0056 | 9.5897 | 0.3707 | 3 | 18 | potassium ion export across plasma membrane |
GO:0040007 | 0.0057 | 1.72 | 18.3679 | 30 | 892 | growth |
GO:0050671 | 0.0058 | 3.1449 | 2.6975 | 8 | 131 | positive regulation of lymphocyte proliferation |
GO:0046890 | 0.006 | 2.8857 | 3.2947 | 9 | 160 | regulation of lipid biosynthetic process |
GO:0002361 | 0.006 | 23.9187 | 0.1236 | 2 | 6 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0003278 | 0.006 | 23.9187 | 0.1236 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0010193 | 0.006 | 23.9187 | 0.1236 | 2 | 6 | response to ozone |
GO:0030917 | 0.006 | 23.9187 | 0.1236 | 2 | 6 | midbrain-hindbrain boundary development |
GO:0038001 | 0.006 | 23.9187 | 0.1236 | 2 | 6 | paracrine signaling |
GO:0046533 | 0.006 | 23.9187 | 0.1236 | 2 | 6 | negative regulation of photoreceptor cell differentiation |
GO:0060017 | 0.006 | 23.9187 | 0.1236 | 2 | 6 | parathyroid gland development |
GO:0060455 | 0.006 | 23.9187 | 0.1236 | 2 | 6 | negative regulation of gastric acid secretion |
GO:0061046 | 0.006 | 23.9187 | 0.1236 | 2 | 6 | regulation of branching involved in lung morphogenesis |
GO:0072008 | 0.006 | 23.9187 | 0.1236 | 2 | 6 | glomerular mesangial cell differentiation |
GO:0072143 | 0.006 | 23.9187 | 0.1236 | 2 | 6 | mesangial cell development |
GO:1902338 | 0.006 | 23.9187 | 0.1236 | 2 | 6 | negative regulation of apoptotic process involved in morphogenesis |
GO:2000543 | 0.006 | 23.9187 | 0.1236 | 2 | 6 | positive regulation of gastrulation |
GO:0015844 | 0.0061 | 3.9087 | 1.6473 | 6 | 80 | monoamine transport |
GO:0006954 | 0.0062 | 1.8815 | 12.277 | 22 | 609 | inflammatory response |
GO:0072009 | 0.0062 | 9.1962 | 0.3827 | 3 | 19 | nephron epithelium development |
GO:0008207 | 0.0062 | 6.0053 | 0.7413 | 4 | 36 | C21-steroid hormone metabolic process |
GO:0001708 | 0.0062 | 4.6326 | 1.1702 | 5 | 59 | cell fate specification |
GO:0048863 | 0.0063 | 3.4099 | 2.1838 | 7 | 108 | stem cell differentiation |
GO:0061448 | 0.0064 | 2.4193 | 5.2097 | 12 | 253 | connective tissue development |
GO:0002523 | 0.0066 | 8.9898 | 0.3912 | 3 | 19 | leukocyte migration involved in inflammatory response |
GO:0006607 | 0.0066 | 8.9898 | 0.3912 | 3 | 19 | NLS-bearing protein import into nucleus |
GO:0032930 | 0.0066 | 8.9898 | 0.3912 | 3 | 19 | positive regulation of superoxide anion generation |
GO:0051546 | 0.0066 | 8.9898 | 0.3912 | 3 | 19 | keratinocyte migration |
GO:0009799 | 0.0066 | 3.0694 | 2.7593 | 8 | 134 | specification of symmetry |
GO:0032526 | 0.0066 | 3.3793 | 2.2033 | 7 | 107 | response to retinoic acid |
GO:0019932 | 0.0067 | 2.3075 | 5.9099 | 13 | 287 | second-messenger-mediated signaling |
GO:0007267 | 0.0068 | 1.5418 | 30.9394 | 45 | 1511 | cell-cell signaling |
GO:2000377 | 0.0069 | 3.0451 | 2.7799 | 8 | 135 | regulation of reactive oxygen species metabolic process |
GO:0045860 | 0.007 | 2.6338 | 3.9944 | 10 | 199 | positive regulation of protein kinase activity |
GO:0021537 | 0.007 | 4.4843 | 1.2053 | 5 | 61 | telencephalon development |
GO:1903039 | 0.0071 | 2.494 | 4.6332 | 11 | 225 | positive regulation of leukocyte cell-cell adhesion |
GO:0043010 | 0.0071 | 2.2128 | 6.6306 | 14 | 322 | camera-type eye development |
GO:0098754 | 0.0072 | 3.0211 | 2.8005 | 8 | 136 | detoxification |
GO:0021885 | 0.0072 | 4.4557 | 1.2149 | 5 | 59 | forebrain cell migration |
GO:0045576 | 0.0072 | 4.4557 | 1.2149 | 5 | 59 | mast cell activation |
GO:0046888 | 0.0072 | 4.4557 | 1.2149 | 5 | 59 | negative regulation of hormone secretion |
GO:0007589 | 0.0073 | 3.7557 | 1.7091 | 6 | 83 | body fluid secretion |
GO:0021510 | 0.0074 | 5.6623 | 0.7794 | 4 | 39 | spinal cord development |
GO:1901215 | 0.0074 | 4.4234 | 1.2213 | 5 | 61 | negative regulation of neuron death |
GO:0097485 | 0.0076 | 2.4706 | 4.6744 | 11 | 227 | neuron projection guidance |
GO:0048534 | 0.0076 | 5.6174 | 0.7842 | 4 | 40 | hematopoietic or lymphoid organ development |
GO:0003081 | 0.0076 | 8.4605 | 0.4118 | 3 | 20 | regulation of systemic arterial blood pressure by renin-angiotensin |
GO:0003228 | 0.0076 | 8.4605 | 0.4118 | 3 | 20 | atrial cardiac muscle tissue development |
GO:0006063 | 0.0076 | 8.4605 | 0.4118 | 3 | 20 | uronic acid metabolic process |
GO:0033630 | 0.0076 | 8.4605 | 0.4118 | 3 | 20 | positive regulation of cell adhesion mediated by integrin |
GO:0042474 | 0.0076 | 8.4605 | 0.4118 | 3 | 20 | middle ear morphogenesis |
GO:0042693 | 0.0076 | 8.4605 | 0.4118 | 3 | 20 | muscle cell fate commitment |
GO:0051171 | 0.0076 | 1.6707 | 20.5252 | 32 | 1104 | regulation of nitrogen compound metabolic process |
GO:0050729 | 0.0078 | 2.9742 | 2.8417 | 8 | 138 | positive regulation of inflammatory response |
GO:0045670 | 0.0079 | 5.5673 | 0.7922 | 4 | 39 | regulation of osteoclast differentiation |
GO:0090304 | 0.0079 | 1.3342 | 99.2734 | 120 | 4821 | nucleic acid metabolic process |
GO:0045666 | 0.0079 | 3.6826 | 1.74 | 6 | 85 | positive regulation of neuron differentiation |
GO:2000145 | 0.008 | 1.6605 | 19.624 | 31 | 953 | regulation of cell motility |
GO:0032879 | 0.008 | 1.4118 | 53.9713 | 71 | 2621 | regulation of localization |
GO:1903530 | 0.0081 | 1.9654 | 9.5861 | 18 | 471 | regulation of secretion by cell |
GO:0051928 | 0.0081 | 3.2485 | 2.2857 | 7 | 111 | positive regulation of calcium ion transport |
GO:0021983 | 0.0082 | 5.4895 | 0.8031 | 4 | 39 | pituitary gland development |
GO:0002933 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | lipid hydroxylation |
GO:0015840 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | urea transport |
GO:0021902 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0031622 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | positive regulation of fever generation |
GO:0032808 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | lacrimal gland development |
GO:0033864 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | positive regulation of NAD(P)H oxidase activity |
GO:0035726 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | common myeloid progenitor cell proliferation |
GO:0048341 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | paraxial mesoderm formation |
GO:0048752 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | semicircular canal morphogenesis |
GO:0051971 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | positive regulation of transmission of nerve impulse |
GO:0060215 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | primitive hemopoiesis |
GO:0060452 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | positive regulation of cardiac muscle contraction |
GO:0060556 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | regulation of vitamin D biosynthetic process |
GO:0060558 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | regulation of calcidiol 1-monooxygenase activity |
GO:0072197 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | ureter morphogenesis |
GO:0120252 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | hydrocarbon metabolic process |
GO:1904936 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | interneuron migration |
GO:2000726 | 0.0083 | 19.1337 | 0.1441 | 2 | 7 | negative regulation of cardiac muscle cell differentiation |
GO:0038034 | 0.0083 | 4.296 | 1.2561 | 5 | 61 | signal transduction in absence of ligand |
GO:1901016 | 0.0083 | 4.296 | 1.2561 | 5 | 61 | regulation of potassium ion transmembrane transporter activity |
GO:0007631 | 0.0084 | 3.6342 | 1.7607 | 6 | 87 | feeding behavior |
GO:0097530 | 0.0085 | 2.9288 | 2.8829 | 8 | 140 | granulocyte migration |
GO:0042475 | 0.0086 | 3.6142 | 1.7709 | 6 | 86 | odontogenesis of dentin-containing tooth |
GO:0007423 | 0.0087 | 2.5449 | 4.126 | 10 | 206 | sensory organ development |
GO:0007194 | 0.0087 | 7.9899 | 0.4324 | 3 | 21 | negative regulation of adenylate cyclase activity |
GO:0010894 | 0.0087 | 7.9899 | 0.4324 | 3 | 21 | negative regulation of steroid biosynthetic process |
GO:0015874 | 0.0087 | 7.9899 | 0.4324 | 3 | 21 | norepinephrine transport |
GO:0031290 | 0.0087 | 7.9899 | 0.4324 | 3 | 21 | retinal ganglion cell axon guidance |
GO:0008542 | 0.009 | 5.3367 | 0.8237 | 4 | 40 | visual learning |
GO:0120178 | 0.009 | 5.3367 | 0.8237 | 4 | 40 | steroid hormone biosynthetic process |
GO:1902742 | 0.009 | 5.3367 | 0.8237 | 4 | 40 | apoptotic process involved in development |
GO:0016053 | 0.0091 | 2.2169 | 6.1364 | 13 | 298 | organic acid biosynthetic process |
GO:0030030 | 0.0091 | 1.5254 | 29.7758 | 43 | 1446 | cell projection organization |
GO:0001947 | 0.0095 | 4.1474 | 1.2973 | 5 | 63 | heart looping |
GO:0051241 | 0.0096 | 1.6969 | 16.6932 | 27 | 840 | negative regulation of multicellular organismal process |
GO:0097237 | 0.0097 | 3.1274 | 2.3681 | 7 | 115 | cellular response to toxic substance |
GO:0014014 | 0.0098 | 5.1921 | 0.8443 | 4 | 41 | negative regulation of gliogenesis |
GO:0035592 | 0.0099 | 2.1214 | 6.8983 | 14 | 335 | establishment of protein localization to extracellular region |
GO:0071695 | 0.01 | 2.3704 | 4.8597 | 11 | 236 | anatomical structure maturation |
GO:0002438 | 0.01 | 7.5689 | 0.453 | 3 | 22 | acute inflammatory response to antigenic stimulus |
GO:0006833 | 0.01 | 7.5689 | 0.453 | 3 | 22 | water transport |
GO:0006883 | 0.01 | 7.5689 | 0.453 | 3 | 22 | cellular sodium ion homeostasis |
GO:0021846 | 0.01 | 7.5689 | 0.453 | 3 | 22 | cell proliferation in forebrain |
GO:0034104 | 0.01 | 7.5689 | 0.453 | 3 | 22 | negative regulation of tissue remodeling |
GO:0048169 | 0.01 | 7.5689 | 0.453 | 3 | 22 | regulation of long-term neuronal synaptic plasticity |
GO:2001236 | 0.01 | 2.8419 | 2.9652 | 8 | 144 | regulation of extrinsic apoptotic signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 132.2758 | 0.7556 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 21.9434 | 2.4557 | 34 | 104 | nucleosome assembly |
GO:0071824 | 0 | 9.339 | 4.9587 | 36 | 210 | protein-DNA complex subunit organization |
GO:0045653 | 0 | 150.1775 | 0.425 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006338 | 0 | 8.0705 | 5.5962 | 36 | 237 | chromatin remodeling |
GO:0006336 | 0 | 33.3433 | 0.7556 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0032200 | 0 | 7.9539 | 3.6836 | 24 | 156 | telomere organization |
GO:0048869 | 0 | 2.1076 | 92.5623 | 152 | 3920 | cellular developmental process |
GO:0007389 | 0 | 3.8677 | 9.992 | 34 | 426 | pattern specification process |
GO:0048665 | 0 | 21.2024 | 0.7084 | 10 | 30 | neuron fate specification |
GO:0065007 | 0 | 1.9897 | 266.1874 | 313 | 11273 | biological regulation |
GO:0048704 | 0 | 7.5679 | 2.196 | 14 | 93 | embryonic skeletal system morphogenesis |
GO:1903706 | 0 | 3.4981 | 8.2409 | 26 | 349 | regulation of hemopoiesis |
GO:0010468 | 0 | 1.7249 | 102.3942 | 146 | 4428 | regulation of gene expression |
GO:0009653 | 0 | 1.9561 | 45.4172 | 78 | 1993 | anatomical structure morphogenesis |
GO:0006352 | 0 | 5.4244 | 2.928 | 14 | 124 | DNA-templated transcription, initiation |
GO:0048731 | 0 | 1.8954 | 52.338 | 85 | 2516 | system development |
GO:0019731 | 0 | 9.2712 | 1.1806 | 9 | 50 | antibacterial humoral response |
GO:1903238 | 0 | 34.9008 | 0.2597 | 5 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0032501 | 0 | 1.9102 | 56.8658 | 88 | 3103 | multicellular organismal process |
GO:0006959 | 0 | 3.9558 | 5.0295 | 18 | 213 | humoral immune response |
GO:0006351 | 0 | 1.7406 | 70.2191 | 106 | 3063 | transcription, DNA-templated |
GO:0018130 | 0 | 1.6845 | 85.6909 | 124 | 3629 | heterocycle biosynthetic process |
GO:1901362 | 0 | 1.6748 | 89.2565 | 128 | 3780 | organic cyclic compound biosynthetic process |
GO:0032774 | 0 | 1.7276 | 70.6318 | 106 | 3081 | RNA biosynthetic process |
GO:0006357 | 0 | 2.5223 | 14.8341 | 34 | 675 | regulation of transcription by RNA polymerase II |
GO:0061844 | 0 | 6.9336 | 1.6765 | 10 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0045666 | 0 | 6.1323 | 2.0543 | 11 | 87 | positive regulation of neuron differentiation |
GO:0019438 | 0 | 1.6572 | 85.9507 | 123 | 3640 | aromatic compound biosynthetic process |
GO:0022008 | 0 | 2.0485 | 29.1129 | 54 | 1278 | neurogenesis |
GO:0050911 | 0 | 3.6687 | 5.0768 | 17 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0048534 | 0 | 2.1467 | 20.2126 | 40 | 856 | hematopoietic or lymphoid organ development |
GO:0019222 | 0 | 1.5246 | 148.3594 | 187 | 6283 | regulation of metabolic process |
GO:0002376 | 0 | 1.7086 | 54.0734 | 83 | 2290 | immune system process |
GO:0045944 | 0 | 1.9751 | 27.0131 | 49 | 1144 | positive regulation of transcription by RNA polymerase II |
GO:0072088 | 0 | 6.2235 | 1.6529 | 9 | 70 | nephron epithelium morphogenesis |
GO:0050794 | 0 | 1.561 | 237.1672 | 274 | 10044 | regulation of cellular process |
GO:0061333 | 0 | 6.0252 | 1.7001 | 9 | 72 | renal tubule morphogenesis |
GO:0021510 | 1e-04 | 5.7513 | 1.7686 | 9 | 76 | spinal cord development |
GO:0000904 | 1e-04 | 2.228 | 15.9623 | 33 | 676 | cell morphogenesis involved in differentiation |
GO:0009952 | 1e-04 | 3.4863 | 4.6753 | 15 | 199 | anterior/posterior pattern specification |
GO:0050678 | 1e-04 | 2.743 | 8.2409 | 21 | 349 | regulation of epithelial cell proliferation |
GO:0002251 | 1e-04 | 9.3192 | 0.7792 | 6 | 33 | organ or tissue specific immune response |
GO:0009954 | 1e-04 | 8.9858 | 0.8028 | 6 | 34 | proximal/distal pattern formation |
GO:0002227 | 1e-04 | 12.3094 | 0.5195 | 5 | 22 | innate immune response in mucosa |
GO:0009058 | 1e-04 | 1.4811 | 124.9118 | 159 | 5290 | biosynthetic process |
GO:0051960 | 2e-04 | 2.4977 | 9.8702 | 23 | 418 | regulation of nervous system development |
GO:0051216 | 2e-04 | 3.3956 | 4.4628 | 14 | 189 | cartilage development |
GO:0035295 | 2e-04 | 1.9054 | 24.8879 | 44 | 1054 | tube development |
GO:0009593 | 2e-04 | 2.854 | 6.7769 | 18 | 287 | detection of chemical stimulus |
GO:0043583 | 2e-04 | 3.2031 | 5.0531 | 15 | 214 | ear development |
GO:0010557 | 2e-04 | 1.7054 | 40.8738 | 64 | 1731 | positive regulation of macromolecule biosynthetic process |
GO:0021978 | 2e-04 | 18.5611 | 0.307 | 4 | 13 | telencephalon regionalization |
GO:0072080 | 2e-04 | 4.9253 | 2.0307 | 9 | 86 | nephron tubule development |
GO:0008284 | 2e-04 | 1.9789 | 20.614 | 38 | 873 | positive regulation of cell population proliferation |
GO:0044271 | 2e-04 | 1.4863 | 100.8504 | 132 | 4271 | cellular nitrogen compound biosynthetic process |
GO:0060993 | 2e-04 | 4.8 | 2.0779 | 9 | 88 | kidney morphogenesis |
GO:0021536 | 2e-04 | 5.428 | 1.6529 | 8 | 70 | diencephalon development |
GO:0007420 | 3e-04 | 2.0848 | 16.4252 | 32 | 699 | brain development |
GO:0007606 | 3e-04 | 2.75 | 7.013 | 18 | 297 | sensory perception of chemical stimulus |
GO:0007631 | 3e-04 | 4.6721 | 2.1275 | 9 | 91 | feeding behavior |
GO:0060429 | 3e-04 | 1.8586 | 24.8527 | 43 | 1064 | epithelium development |
GO:0040029 | 3e-04 | 3.8089 | 3.1405 | 11 | 133 | regulation of gene expression, epigenetic |
GO:0048663 | 3e-04 | 9.7783 | 0.6206 | 5 | 27 | neuron fate commitment |
GO:0051094 | 3e-04 | 1.7912 | 28.8313 | 48 | 1221 | positive regulation of developmental process |
GO:0070365 | 3e-04 | 15.1845 | 0.3542 | 4 | 15 | hepatocyte differentiation |
GO:0030182 | 3e-04 | 1.8519 | 24.9882 | 43 | 1120 | neuron differentiation |
GO:1903508 | 4e-04 | 1.7037 | 36.1512 | 57 | 1531 | positive regulation of nucleic acid-templated transcription |
GO:0031175 | 4e-04 | 1.9065 | 21.3224 | 38 | 903 | neuron projection development |
GO:0009790 | 4e-04 | 2.4269 | 9.2394 | 21 | 409 | embryo development |
GO:0009888 | 4e-04 | 2.1263 | 14.0981 | 28 | 639 | tissue development |
GO:0032095 | 4e-04 | 13.9182 | 0.3778 | 4 | 16 | regulation of response to food |
GO:0050906 | 5e-04 | 2.5982 | 7.3908 | 18 | 313 | detection of stimulus involved in sensory perception |
GO:0072171 | 5e-04 | 5.5444 | 1.4168 | 7 | 60 | mesonephric tubule morphogenesis |
GO:0003008 | 5e-04 | 1.6159 | 44.9863 | 67 | 1921 | system process |
GO:0120039 | 5e-04 | 2.0935 | 14.2385 | 28 | 603 | plasma membrane bounded cell projection morphogenesis |
GO:0006540 | 6e-04 | Inf | 0.0472 | 2 | 2 | glutamate decarboxylation to succinate |
GO:0032812 | 6e-04 | Inf | 0.0472 | 2 | 2 | positive regulation of epinephrine secretion |
GO:0070858 | 6e-04 | Inf | 0.0472 | 2 | 2 | negative regulation of bile acid biosynthetic process |
GO:0072272 | 6e-04 | Inf | 0.0472 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
GO:1905652 | 6e-04 | Inf | 0.0472 | 2 | 2 | negative regulation of artery morphogenesis |
GO:0007409 | 6e-04 | 2.3536 | 9.4915 | 21 | 404 | axonogenesis |
GO:0019219 | 6e-04 | 1.4639 | 85.809 | 113 | 3634 | regulation of nucleobase-containing compound metabolic process |
GO:0021516 | 7e-04 | 25.1825 | 0.1876 | 3 | 8 | dorsal spinal cord development |
GO:0048664 | 7e-04 | 24.9979 | 0.1889 | 3 | 8 | neuron fate determination |
GO:0001938 | 7e-04 | 4.0738 | 2.4085 | 9 | 102 | positive regulation of endothelial cell proliferation |
GO:0014032 | 7e-04 | 4.5443 | 1.9363 | 8 | 82 | neural crest cell development |
GO:0042311 | 7e-04 | 6.2853 | 1.0862 | 6 | 46 | vasodilation |
GO:0035115 | 7e-04 | 8.0439 | 0.732 | 5 | 31 | embryonic forelimb morphogenesis |
GO:0043009 | 8e-04 | 2.0347 | 14.6163 | 28 | 619 | chordate embryonic development |
GO:0007186 | 8e-04 | 1.9159 | 18.3374 | 33 | 795 | G protein-coupled receptor signaling pathway |
GO:0031328 | 8e-04 | 1.5975 | 43.2351 | 64 | 1831 | positive regulation of cellular biosynthetic process |
GO:0021537 | 9e-04 | 2.8389 | 5.2616 | 14 | 225 | telencephalon development |
GO:0072079 | 9e-04 | 11.1325 | 0.4486 | 4 | 19 | nephron tubule formation |
GO:0032990 | 9e-04 | 2.0134 | 14.758 | 28 | 625 | cell part morphogenesis |
GO:0051254 | 0.001 | 1.6136 | 39.3154 | 59 | 1665 | positive regulation of RNA metabolic process |
GO:1904994 | 0.001 | 7.4683 | 0.7792 | 5 | 33 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0035360 | 0.001 | 20.8303 | 0.2125 | 3 | 9 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
GO:0061004 | 0.001 | 20.8303 | 0.2125 | 3 | 9 | pattern specification involved in kidney development |
GO:0048729 | 0.001 | 2.0277 | 14.1205 | 27 | 598 | tissue morphogenesis |
GO:0006939 | 0.0011 | 3.787 | 2.5738 | 9 | 109 | smooth muscle contraction |
GO:0048762 | 0.0012 | 2.731 | 5.4546 | 14 | 231 | mesenchymal cell differentiation |
GO:0048863 | 0.0013 | 2.8479 | 4.8642 | 13 | 206 | stem cell differentiation |
GO:0002691 | 0.0013 | 6.9696 | 0.8264 | 5 | 35 | regulation of cellular extravasation |
GO:0042472 | 0.0013 | 4.0801 | 2.1333 | 8 | 91 | inner ear morphogenesis |
GO:1901700 | 0.0013 | 1.6146 | 36.4818 | 55 | 1545 | response to oxygen-containing compound |
GO:0071600 | 0.0014 | 17.8534 | 0.2361 | 3 | 10 | otic vesicle morphogenesis |
GO:0090596 | 0.0014 | 2.5833 | 6.1629 | 15 | 261 | sensory organ morphogenesis |
GO:0009953 | 0.0015 | 4.0008 | 2.1724 | 8 | 92 | dorsal/ventral pattern formation |
GO:0001658 | 0.0015 | 5.3468 | 1.2515 | 6 | 53 | branching involved in ureteric bud morphogenesis |
GO:0051055 | 0.0015 | 5.3468 | 1.2515 | 6 | 53 | negative regulation of lipid biosynthetic process |
GO:0042063 | 0.0015 | 2.9249 | 4.3726 | 12 | 188 | gliogenesis |
GO:0001661 | 0.0016 | 83.1286 | 0.0708 | 2 | 3 | conditioned taste aversion |
GO:0007412 | 0.0016 | 83.1286 | 0.0708 | 2 | 3 | axon target recognition |
GO:0021530 | 0.0016 | 83.1286 | 0.0708 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0021797 | 0.0016 | 83.1286 | 0.0708 | 2 | 3 | forebrain anterior/posterior pattern specification |
GO:0048252 | 0.0016 | 83.1286 | 0.0708 | 2 | 3 | lauric acid metabolic process |
GO:0072190 | 0.0016 | 83.1286 | 0.0708 | 2 | 3 | ureter urothelium development |
GO:1902869 | 0.0016 | 83.1286 | 0.0708 | 2 | 3 | regulation of amacrine cell differentiation |
GO:0072006 | 0.0017 | 3.2645 | 3.2822 | 10 | 139 | nephron development |
GO:0031279 | 0.0018 | 4.3819 | 1.7473 | 7 | 74 | regulation of cyclase activity |
GO:0032099 | 0.0019 | 15.6207 | 0.2597 | 3 | 11 | negative regulation of appetite |
GO:0032108 | 0.0019 | 15.6207 | 0.2597 | 3 | 11 | negative regulation of response to nutrient levels |
GO:0040011 | 0.0019 | 1.5518 | 42.1253 | 61 | 1784 | locomotion |
GO:0021895 | 0.0019 | 8.7866 | 0.5431 | 4 | 23 | cerebral cortex neuron differentiation |
GO:0099560 | 0.0019 | 8.7866 | 0.5431 | 4 | 23 | synaptic membrane adhesion |
GO:0120162 | 0.002 | 3.8179 | 2.2668 | 8 | 96 | positive regulation of cold-induced thermogenesis |
GO:0000122 | 0.002 | 1.7887 | 20.1181 | 34 | 852 | negative regulation of transcription by RNA polymerase II |
GO:0051965 | 0.002 | 5.025 | 1.3223 | 6 | 56 | positive regulation of synapse assembly |
GO:0014013 | 0.0021 | 3.7748 | 2.2904 | 8 | 97 | regulation of gliogenesis |
GO:0090304 | 0.0021 | 1.3731 | 113.8374 | 140 | 4821 | nucleic acid metabolic process |
GO:0045939 | 0.0022 | 8.3467 | 0.5667 | 4 | 24 | negative regulation of steroid metabolic process |
GO:2000026 | 0.0023 | 2.0259 | 12.0047 | 23 | 553 | regulation of multicellular organismal development |
GO:0007218 | 0.0024 | 3.6914 | 2.3377 | 8 | 99 | neuropeptide signaling pathway |
GO:0002024 | 0.0025 | 13.8842 | 0.2834 | 3 | 12 | diet induced thermogenesis |
GO:0010273 | 0.0025 | 13.8842 | 0.2834 | 3 | 12 | detoxification of copper ion |
GO:0021527 | 0.0025 | 13.8842 | 0.2834 | 3 | 12 | spinal cord association neuron differentiation |
GO:0097154 | 0.0025 | 13.8842 | 0.2834 | 3 | 12 | GABAergic neuron differentiation |
GO:0007600 | 0.0025 | 2.2257 | 8.536 | 18 | 371 | sensory perception |
GO:0032104 | 0.0026 | 7.9487 | 0.5903 | 4 | 25 | regulation of response to extracellular stimulus |
GO:1903671 | 0.0026 | 7.9487 | 0.5903 | 4 | 25 | negative regulation of sprouting angiogenesis |
GO:0033993 | 0.003 | 1.7537 | 19.8584 | 33 | 841 | response to lipid |
GO:0048513 | 0.0031 | 1.6254 | 29.7365 | 45 | 1458 | animal organ development |
GO:0042136 | 0.0031 | 12.495 | 0.307 | 3 | 13 | neurotransmitter biosynthetic process |
GO:0021779 | 0.0032 | 41.5617 | 0.0945 | 2 | 4 | oligodendrocyte cell fate commitment |
GO:0021780 | 0.0032 | 41.5617 | 0.0945 | 2 | 4 | glial cell fate specification |
GO:0060018 | 0.0032 | 41.5617 | 0.0945 | 2 | 4 | astrocyte fate commitment |
GO:0061113 | 0.0032 | 41.5617 | 0.0945 | 2 | 4 | pancreas morphogenesis |
GO:0072086 | 0.0032 | 41.5617 | 0.0945 | 2 | 4 | specification of loop of Henle identity |
GO:0097022 | 0.0032 | 41.5617 | 0.0945 | 2 | 4 | lymphocyte migration into lymph node |
GO:0051240 | 0.0032 | 1.628 | 28.0102 | 43 | 1224 | positive regulation of multicellular organismal process |
GO:0045933 | 0.0033 | 5.4995 | 1.0154 | 5 | 43 | positive regulation of muscle contraction |
GO:0045596 | 0.0033 | 2.2769 | 7.4052 | 16 | 337 | negative regulation of cell differentiation |
GO:0016477 | 0.0033 | 1.5692 | 33.8372 | 50 | 1433 | cell migration |
GO:0051953 | 0.0035 | 7.2566 | 0.6375 | 4 | 27 | negative regulation of amine transport |
GO:0045453 | 0.0036 | 4.406 | 1.4876 | 6 | 63 | bone resorption |
GO:0048519 | 0.0038 | 1.3781 | 92.3997 | 115 | 4086 | negative regulation of biological process |
GO:0009617 | 0.0038 | 1.8772 | 14.0024 | 25 | 593 | response to bacterium |
GO:0003207 | 0.0039 | 11.3584 | 0.3306 | 3 | 14 | cardiac chamber formation |
GO:0030534 | 0.0041 | 3.0743 | 3.1169 | 9 | 132 | adult behavior |
GO:0048562 | 0.0043 | 2.6884 | 4.3257 | 11 | 190 | embryonic organ morphogenesis |
GO:0051241 | 0.0043 | 1.6572 | 23.5452 | 37 | 1002 | negative regulation of multicellular organismal process |
GO:0021522 | 0.0046 | 6.6753 | 0.6848 | 4 | 29 | spinal cord motor neuron differentiation |
GO:1905606 | 0.0046 | 6.6753 | 0.6848 | 4 | 29 | regulation of presynapse assembly |
GO:0031326 | 0.0047 | 1.5033 | 41.4574 | 58 | 1870 | regulation of cellular biosynthetic process |
GO:0014070 | 0.0047 | 1.7114 | 19.6695 | 32 | 833 | response to organic cyclic compound |
GO:0007417 | 0.0048 | 2.7995 | 3.7813 | 10 | 171 | central nervous system development |
GO:0007379 | 0.0048 | 10.4112 | 0.3542 | 3 | 15 | segment specification |
GO:0019373 | 0.0048 | 10.4112 | 0.3542 | 3 | 15 | epoxygenase P450 pathway |
GO:0097501 | 0.0048 | 10.4112 | 0.3542 | 3 | 15 | stress response to metal ion |
GO:1990403 | 0.0048 | 10.4112 | 0.3542 | 3 | 15 | embryonic brain development |
GO:0016053 | 0.005 | 2.2403 | 7.0366 | 15 | 298 | organic acid biosynthetic process |
GO:0048588 | 0.005 | 2.5035 | 5.0531 | 12 | 214 | developmental cell growth |
GO:0007628 | 0.0052 | 6.4181 | 0.7084 | 4 | 30 | adult walking behavior |
GO:0021772 | 0.0052 | 6.4181 | 0.7084 | 4 | 30 | olfactory bulb development |
GO:0009605 | 0.0052 | 1.4193 | 58.1348 | 77 | 2462 | response to external stimulus |
GO:0014016 | 0.0053 | 27.706 | 0.1181 | 2 | 5 | neuroblast differentiation |
GO:0014050 | 0.0053 | 27.706 | 0.1181 | 2 | 5 | negative regulation of glutamate secretion |
GO:0060406 | 0.0053 | 27.706 | 0.1181 | 2 | 5 | positive regulation of penile erection |
GO:0071242 | 0.0053 | 27.706 | 0.1181 | 2 | 5 | cellular response to ammonium ion |
GO:0072592 | 0.0053 | 27.706 | 0.1181 | 2 | 5 | oxygen metabolic process |
GO:1905700 | 0.0053 | 27.706 | 0.1181 | 2 | 5 | negative regulation of xenobiotic detoxification by transmembrane export across the plasma membrane |
GO:2000977 | 0.0053 | 27.706 | 0.1181 | 2 | 5 | regulation of forebrain neuron differentiation |
GO:0030857 | 0.0053 | 4.8585 | 1.1334 | 5 | 48 | negative regulation of epithelial cell differentiation |
GO:0021782 | 0.0053 | 3.1963 | 2.6682 | 8 | 113 | glial cell development |
GO:0001657 | 0.0054 | 3.5336 | 2.1252 | 7 | 90 | ureteric bud development |
GO:0045638 | 0.0055 | 4.0097 | 1.617 | 6 | 71 | negative regulation of myeloid cell differentiation |
GO:0051674 | 0.0056 | 1.5 | 38.1583 | 54 | 1616 | localization of cell |
GO:0072001 | 0.0056 | 2.2085 | 7.1311 | 15 | 302 | renal system development |
GO:0072163 | 0.0057 | 3.4914 | 2.1488 | 7 | 91 | mesonephric epithelium development |
GO:0060425 | 0.0063 | 4.642 | 1.1806 | 5 | 50 | lung morphogenesis |
GO:1903506 | 0.0064 | 1.5226 | 34.2667 | 49 | 1544 | regulation of nucleic acid-templated transcription |
GO:0051930 | 0.0065 | 5.9589 | 0.7556 | 4 | 32 | regulation of sensory perception of pain |
GO:0007625 | 0.0069 | 8.9227 | 0.4014 | 3 | 17 | grooming behavior |
GO:0007200 | 0.0072 | 3.3318 | 2.2432 | 7 | 95 | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO:0001501 | 0.0073 | 2.1407 | 7.3427 | 15 | 319 | skeletal system development |
GO:0031128 | 0.0073 | 5.7531 | 0.7792 | 4 | 33 | developmental induction |
GO:1903039 | 0.0074 | 2.3726 | 5.3129 | 12 | 225 | positive regulation of leukocyte cell-cell adhesion |
GO:0048708 | 0.0078 | 3.7099 | 1.7387 | 6 | 74 | astrocyte differentiation |
GO:0002361 | 0.0078 | 20.7782 | 0.1417 | 2 | 6 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0008291 | 0.0078 | 20.7782 | 0.1417 | 2 | 6 | acetylcholine metabolic process |
GO:0030917 | 0.0078 | 20.7782 | 0.1417 | 2 | 6 | midbrain-hindbrain boundary development |
GO:0046533 | 0.0078 | 20.7782 | 0.1417 | 2 | 6 | negative regulation of photoreceptor cell differentiation |
GO:0060017 | 0.0078 | 20.7782 | 0.1417 | 2 | 6 | parathyroid gland development |
GO:2000252 | 0.0078 | 20.7782 | 0.1417 | 2 | 6 | negative regulation of feeding behavior |
GO:2001023 | 0.0078 | 20.7782 | 0.1417 | 2 | 6 | regulation of response to drug |
GO:1903587 | 0.0081 | 5.5609 | 0.8028 | 4 | 34 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO:0007530 | 0.0082 | 8.3274 | 0.425 | 3 | 18 | sex determination |
GO:0043651 | 0.0082 | 8.3274 | 0.425 | 3 | 18 | linoleic acid metabolic process |
GO:1905563 | 0.0082 | 8.3274 | 0.425 | 3 | 18 | negative regulation of vascular endothelial cell proliferation |
GO:0009410 | 0.0083 | 2.0016 | 8.8823 | 17 | 378 | response to xenobiotic stimulus |
GO:0010817 | 0.0084 | 1.8839 | 11.098 | 20 | 470 | regulation of hormone levels |
GO:0001659 | 0.0084 | 2.5621 | 4.1086 | 10 | 174 | temperature homeostasis |
GO:0048732 | 0.0085 | 1.9532 | 9.6343 | 18 | 410 | gland development |
GO:0016331 | 0.0086 | 2.7177 | 3.4947 | 9 | 148 | morphogenesis of embryonic epithelium |
GO:0009792 | 0.0086 | 8.1126 | 0.4323 | 3 | 19 | embryo development ending in birth or egg hatching |
GO:0010721 | 0.0088 | 2.5464 | 4.1322 | 10 | 175 | negative regulation of cell development |
GO:0035270 | 0.009 | 2.906 | 2.9138 | 8 | 124 | endocrine system development |
GO:0045823 | 0.009 | 5.3812 | 0.8264 | 4 | 35 | positive regulation of heart contraction |
GO:0021766 | 0.0091 | 3.5848 | 1.7946 | 6 | 76 | hippocampus development |
GO:0051047 | 0.0093 | 2.1391 | 6.8477 | 14 | 290 | positive regulation of secretion |
GO:0035148 | 0.0093 | 2.6788 | 3.5419 | 9 | 150 | tube formation |
GO:0002523 | 0.0096 | 7.8064 | 0.4486 | 3 | 19 | leukocyte migration involved in inflammatory response |
GO:0003016 | 0.0099 | 5.2127 | 0.8501 | 4 | 36 | respiratory system process |
GO:0060428 | 0.0099 | 5.2127 | 0.8501 | 4 | 36 | lung epithelium development |
GO:0071542 | 0.0099 | 5.2127 | 0.8501 | 4 | 36 | dopaminergic neuron differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 9.7819 | 3.8573 | 30 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 7.5896 | 5.3284 | 33 | 297 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 7.5943 | 5.149 | 32 | 287 | detection of chemical stimulus |
GO:0050906 | 0 | 7.1486 | 5.6155 | 33 | 313 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 3.2255 | 13.8274 | 39 | 795 | G protein-coupled receptor signaling pathway |
GO:0050896 | 0 | 2.9492 | 19.4107 | 45 | 1232 | response to stimulus |
GO:0032501 | 0 | 1.8326 | 87.0309 | 122 | 5371 | multicellular organismal process |
GO:0007417 | 0 | 2.3413 | 17.4026 | 37 | 970 | central nervous system development |
GO:1903238 | 0 | 31.7013 | 0.1973 | 4 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0007389 | 1e-04 | 2.8442 | 7.9837 | 21 | 445 | pattern specification process |
GO:0045165 | 1e-04 | 3.4936 | 4.6467 | 15 | 259 | cell fate commitment |
GO:0048704 | 3e-04 | 5.2693 | 1.6685 | 8 | 93 | embryonic skeletal system morphogenesis |
GO:1904994 | 3e-04 | 9.9282 | 0.592 | 5 | 33 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0021893 | 3e-04 | Inf | 0.0359 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:1902871 | 3e-04 | Inf | 0.0359 | 2 | 2 | positive regulation of amacrine cell differentiation |
GO:1905652 | 3e-04 | Inf | 0.0359 | 2 | 2 | negative regulation of artery morphogenesis |
GO:1905949 | 3e-04 | Inf | 0.0359 | 2 | 2 | negative regulation of calcium ion import across plasma membrane |
GO:0009954 | 3e-04 | 9.5852 | 0.61 | 5 | 34 | proximal/distal pattern formation |
GO:0007218 | 4e-04 | 4.92 | 1.7761 | 8 | 99 | neuropeptide signaling pathway |
GO:0035195 | 4e-04 | 2.9412 | 5.454 | 15 | 304 | miRNA-mediated gene silencing |
GO:0045596 | 4e-04 | 2.2768 | 11.2848 | 24 | 629 | negative regulation of cell differentiation |
GO:0021520 | 4e-04 | 27.6441 | 0.1615 | 3 | 9 | spinal cord motor neuron cell fate specification |
GO:0048665 | 5e-04 | 13.1781 | 0.3731 | 4 | 21 | neuron fate specification |
GO:0021537 | 5e-04 | 3.3763 | 3.8097 | 12 | 215 | telencephalon development |
GO:0016477 | 6e-04 | 1.8136 | 25.7092 | 43 | 1433 | cell migration |
GO:0048699 | 6e-04 | 1.8384 | 24.1502 | 41 | 1355 | generation of neurons |
GO:0016441 | 6e-04 | 2.8218 | 5.6693 | 15 | 316 | post-transcriptional gene silencing |
GO:0070328 | 6e-04 | 8.1731 | 0.6997 | 5 | 39 | triglyceride homeostasis |
GO:0019730 | 7e-04 | 4.5201 | 1.9197 | 8 | 107 | antimicrobial humoral response |
GO:0021544 | 7e-04 | 11.6706 | 0.4126 | 4 | 23 | subpallium development |
GO:0055065 | 9e-04 | 2.1888 | 11.1951 | 23 | 624 | metal ion homeostasis |
GO:1901215 | 9e-04 | 3.3071 | 3.5523 | 11 | 198 | negative regulation of neuron death |
GO:0007412 | 0.001 | 110.2284 | 0.0538 | 2 | 3 | axon target recognition |
GO:0051241 | 0.001 | 1.9197 | 17.8598 | 32 | 1002 | negative regulation of multicellular organismal process |
GO:0060322 | 0.001 | 2.0665 | 13.4197 | 26 | 748 | head development |
GO:0097154 | 0.0011 | 18.4259 | 0.2153 | 3 | 12 | GABAergic neuron differentiation |
GO:0031047 | 0.0012 | 2.6259 | 6.064 | 15 | 338 | gene silencing by RNA |
GO:0002673 | 0.0012 | 6.9445 | 0.8073 | 5 | 45 | regulation of acute inflammatory response |
GO:0072507 | 0.0013 | 2.3179 | 8.7013 | 19 | 485 | divalent inorganic cation homeostasis |
GO:1901700 | 0.0014 | 1.7123 | 27.7186 | 44 | 1545 | response to oxygen-containing compound |
GO:0007631 | 0.0015 | 4.5189 | 1.6755 | 7 | 94 | feeding behavior |
GO:0023052 | 0.0015 | 1.4397 | 103.1597 | 128 | 5750 | signaling |
GO:0032148 | 0.0019 | 8.5248 | 0.5382 | 4 | 30 | activation of protein kinase B activity |
GO:0021515 | 0.002 | 6.1709 | 0.897 | 5 | 50 | cell differentiation in spinal cord |
GO:0006874 | 0.002 | 2.3367 | 7.6966 | 17 | 429 | cellular calcium ion homeostasis |
GO:0050877 | 0.002 | 2.3398 | 7.7168 | 17 | 492 | nervous system process |
GO:0055088 | 0.002 | 3.4264 | 2.7988 | 9 | 156 | lipid homeostasis |
GO:0048598 | 0.0023 | 2.0958 | 10.603 | 21 | 591 | embryonic morphogenesis |
GO:0021766 | 0.0024 | 4.7696 | 1.3635 | 6 | 76 | hippocampus development |
GO:0008306 | 0.0026 | 4.7021 | 1.3814 | 6 | 77 | associative learning |
GO:0050801 | 0.0026 | 1.9733 | 12.8815 | 24 | 718 | ion homeostasis |
GO:0032095 | 0.0027 | 12.7532 | 0.2871 | 3 | 16 | regulation of response to food |
GO:1901386 | 0.0027 | 12.7532 | 0.2871 | 3 | 16 | negative regulation of voltage-gated calcium channel activity |
GO:0040011 | 0.0027 | 1.615 | 32.0064 | 48 | 1784 | locomotion |
GO:0009636 | 0.0027 | 2.8579 | 4.0726 | 11 | 227 | response to toxic substance |
GO:0007600 | 0.003 | 2.4611 | 6.0103 | 14 | 371 | sensory perception |
GO:0035296 | 0.003 | 3.5173 | 2.422 | 8 | 135 | regulation of tube diameter |
GO:1903587 | 0.0031 | 7.3863 | 0.61 | 4 | 34 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO:0014016 | 0.0031 | 36.7382 | 0.0897 | 2 | 5 | neuroblast differentiation |
GO:0072592 | 0.0031 | 36.7382 | 0.0897 | 2 | 5 | oxygen metabolic process |
GO:0019935 | 0.0031 | 4.5107 | 1.4353 | 6 | 80 | cyclic-nucleotide-mediated signaling |
GO:0009404 | 0.0032 | 11.8415 | 0.305 | 3 | 17 | toxin metabolic process |
GO:0043066 | 0.0032 | 1.8852 | 14.6038 | 26 | 814 | negative regulation of apoptotic process |
GO:0007154 | 0.0033 | 1.3981 | 103.3072 | 126 | 5797 | cell communication |
GO:0051674 | 0.0033 | 1.6269 | 28.9924 | 44 | 1616 | localization of cell |
GO:0002691 | 0.0034 | 7.1476 | 0.6279 | 4 | 35 | regulation of cellular extravasation |
GO:0010744 | 0.0038 | 11.0514 | 0.3229 | 3 | 18 | positive regulation of macrophage derived foam cell differentiation |
GO:1905563 | 0.0038 | 11.0514 | 0.3229 | 3 | 18 | negative regulation of vascular endothelial cell proliferation |
GO:0030003 | 0.0039 | 2.001 | 11.0695 | 21 | 617 | cellular cation homeostasis |
GO:0030902 | 0.0043 | 3.3072 | 2.5655 | 8 | 143 | hindbrain development |
GO:0002001 | 0.0046 | 27.5519 | 0.1076 | 2 | 6 | renin secretion into blood stream |
GO:0008291 | 0.0046 | 27.5519 | 0.1076 | 2 | 6 | acetylcholine metabolic process |
GO:0009414 | 0.0046 | 27.5519 | 0.1076 | 2 | 6 | response to water deprivation |
GO:0046533 | 0.0046 | 27.5519 | 0.1076 | 2 | 6 | negative regulation of photoreceptor cell differentiation |
GO:0051142 | 0.0046 | 27.5519 | 0.1076 | 2 | 6 | positive regulation of NK T cell proliferation |
GO:0060017 | 0.0046 | 27.5519 | 0.1076 | 2 | 6 | parathyroid gland development |
GO:2000252 | 0.0046 | 27.5519 | 0.1076 | 2 | 6 | negative regulation of feeding behavior |
GO:0090049 | 0.0047 | 4.9554 | 1.0944 | 5 | 61 | regulation of cell migration involved in sprouting angiogenesis |
GO:0001501 | 0.0048 | 2.0775 | 9.1139 | 18 | 508 | skeletal system development |
GO:0006954 | 0.005 | 1.8635 | 13.5812 | 24 | 757 | inflammatory response |
GO:0021879 | 0.0051 | 6.3291 | 0.6997 | 4 | 39 | forebrain neuron differentiation |
GO:0021516 | 0.0052 | 9.75 | 0.3588 | 3 | 20 | dorsal spinal cord development |
GO:0097529 | 0.0052 | 2.7569 | 3.8214 | 10 | 213 | myeloid leukocyte migration |
GO:0050789 | 0.0054 | 1.4034 | 190.3162 | 211 | 10608 | regulation of biological process |
GO:0007611 | 0.0056 | 2.579 | 4.4852 | 11 | 250 | learning or memory |
GO:0043536 | 0.0058 | 4.7025 | 1.1482 | 5 | 64 | positive regulation of blood vessel endothelial cell migration |
GO:0008015 | 0.0059 | 2.0818 | 8.5757 | 17 | 478 | blood circulation |
GO:0043207 | 0.0059 | 1.6513 | 22.4798 | 35 | 1253 | response to external biotic stimulus |
GO:0007194 | 0.006 | 9.2078 | 0.3768 | 3 | 21 | negative regulation of adenylate cyclase activity |
GO:0051769 | 0.006 | 9.2078 | 0.3768 | 3 | 21 | regulation of nitric-oxide synthase biosynthetic process |
GO:0014014 | 0.0061 | 5.9863 | 0.7356 | 4 | 41 | negative regulation of gliogenesis |
GO:0015840 | 0.0063 | 22.0401 | 0.1256 | 2 | 7 | urea transport |
GO:0021902 | 0.0063 | 22.0401 | 0.1256 | 2 | 7 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0035726 | 0.0063 | 22.0401 | 0.1256 | 2 | 7 | common myeloid progenitor cell proliferation |
GO:0060452 | 0.0063 | 22.0401 | 0.1256 | 2 | 7 | positive regulation of cardiac muscle contraction |
GO:0120252 | 0.0063 | 22.0401 | 0.1256 | 2 | 7 | hydrocarbon metabolic process |
GO:0071466 | 0.0067 | 3.0559 | 2.7629 | 8 | 154 | cellular response to xenobiotic stimulus |
GO:0045664 | 0.0067 | 2.8241 | 3.3549 | 9 | 187 | regulation of neuron differentiation |
GO:0006833 | 0.0068 | 8.7226 | 0.3947 | 3 | 22 | water transport |
GO:0016338 | 0.0068 | 8.7226 | 0.3947 | 3 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
GO:0036315 | 0.0068 | 8.7226 | 0.3947 | 3 | 22 | cellular response to sterol |
GO:0042745 | 0.0068 | 8.7226 | 0.3947 | 3 | 22 | circadian sleep/wake cycle |
GO:0045933 | 0.0072 | 5.6785 | 0.7715 | 4 | 43 | positive regulation of muscle contraction |
GO:0051716 | 0.0072 | 1.3463 | 119.0552 | 140 | 6636 | cellular response to stimulus |
GO:0007200 | 0.0073 | 3.7469 | 1.7044 | 6 | 95 | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO:0008283 | 0.0073 | 1.5268 | 32.8697 | 47 | 1844 | cell population proliferation |
GO:0019835 | 0.0078 | 8.2859 | 0.4126 | 3 | 23 | cytolysis |
GO:0021895 | 0.0078 | 8.2859 | 0.4126 | 3 | 23 | cerebral cortex neuron differentiation |
GO:0099560 | 0.0078 | 8.2859 | 0.4126 | 3 | 23 | synaptic membrane adhesion |
GO:0048066 | 0.0078 | 5.5362 | 0.7894 | 4 | 44 | developmental pigmentation |
GO:0099172 | 0.0078 | 5.5362 | 0.7894 | 4 | 44 | presynapse organization |
GO:0006935 | 0.0081 | 1.9278 | 10.3339 | 19 | 576 | chemotaxis |
GO:0045944 | 0.0083 | 1.6463 | 20.5243 | 32 | 1144 | positive regulation of transcription by RNA polymerase II |
GO:0035295 | 0.0083 | 1.6731 | 18.9096 | 30 | 1054 | tube development |
GO:0009820 | 0.0084 | 18.3656 | 0.1435 | 2 | 8 | alkaloid metabolic process |
GO:0021517 | 0.0085 | 5.4009 | 0.8073 | 4 | 45 | ventral spinal cord development |
GO:0007204 | 0.0086 | 2.3195 | 5.4181 | 12 | 302 | positive regulation of cytosolic calcium ion concentration |
GO:0008016 | 0.0087 | 2.7013 | 3.4985 | 9 | 195 | regulation of heart contraction |
GO:0002052 | 0.0088 | 7.8909 | 0.4306 | 3 | 24 | positive regulation of neuroblast proliferation |
GO:0071280 | 0.0088 | 7.8909 | 0.4306 | 3 | 24 | cellular response to copper ion |
GO:0035176 | 0.0092 | 5.2719 | 0.8253 | 4 | 46 | social behavior |
GO:0042311 | 0.0092 | 5.2719 | 0.8253 | 4 | 46 | vasodilation |
GO:0044057 | 0.0094 | 1.9346 | 9.7419 | 18 | 543 | regulation of system process |
GO:0032413 | 0.0094 | 4.1389 | 1.2917 | 5 | 72 | negative regulation of ion transmembrane transporter activity |
GO:0045765 | 0.0097 | 2.2794 | 5.5078 | 12 | 307 | regulation of angiogenesis |
GO:0030318 | 0.0098 | 7.5317 | 0.4485 | 3 | 25 | melanocyte differentiation |
GO:0032104 | 0.0098 | 7.5317 | 0.4485 | 3 | 25 | regulation of response to extracellular stimulus |
GO:1903671 | 0.0098 | 7.5317 | 0.4485 | 3 | 25 | negative regulation of sprouting angiogenesis |
GO:0050679 | 0.0099 | 2.6437 | 3.5702 | 9 | 199 | positive regulation of epithelial cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 7.3008 | 4.2682 | 26 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 5.5049 | 5.6975 | 27 | 287 | detection of chemical stimulus |
GO:0050906 | 0 | 5.2174 | 6.2137 | 28 | 313 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 5.2976 | 5.8961 | 27 | 297 | sensory perception of chemical stimulus |
GO:0050877 | 0 | 2.7887 | 24.1996 | 58 | 1219 | nervous system process |
GO:0007389 | 0 | 3.5357 | 8.8342 | 28 | 445 | pattern specification process |
GO:0007186 | 0 | 2.6079 | 17.0973 | 40 | 875 | G protein-coupled receptor signaling pathway |
GO:0048665 | 0 | 15.3382 | 0.5956 | 7 | 30 | neuron fate specification |
GO:0048704 | 0 | 6.8221 | 1.8462 | 11 | 93 | embryonic skeletal system morphogenesis |
GO:0009952 | 0 | 4.4169 | 4.0101 | 16 | 202 | anterior/posterior pattern specification |
GO:0032501 | 0 | 1.7927 | 89.1074 | 124 | 5230 | multicellular organismal process |
GO:0048869 | 0 | 1.7511 | 70.1877 | 104 | 3661 | cellular developmental process |
GO:0048252 | 0 | Inf | 0.0596 | 3 | 3 | lauric acid metabolic process |
GO:0048568 | 0 | 2.8628 | 8.715 | 23 | 439 | embryonic organ development |
GO:0048731 | 0 | 1.6793 | 69.4536 | 100 | 3675 | system development |
GO:0022008 | 0 | 1.9213 | 31.0287 | 54 | 1563 | neurogenesis |
GO:1903238 | 0 | 28.5553 | 0.2184 | 4 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0048513 | 1e-04 | 1.8589 | 36.3524 | 60 | 1982 | animal organ development |
GO:0014070 | 1e-04 | 2.2309 | 16.5367 | 34 | 833 | response to organic cyclic compound |
GO:0045165 | 1e-04 | 3.3686 | 5.1417 | 16 | 259 | cell fate commitment |
GO:0072088 | 1e-04 | 6.5075 | 1.3896 | 8 | 70 | nephron epithelium morphogenesis |
GO:0021871 | 1e-04 | 13.9152 | 0.4566 | 5 | 23 | forebrain regionalization |
GO:0014016 | 1e-04 | 74.7461 | 0.0993 | 3 | 5 | neuroblast differentiation |
GO:0061333 | 1e-04 | 6.3033 | 1.4293 | 8 | 72 | renal tubule morphogenesis |
GO:0050896 | 1e-04 | 2.0838 | 21.596 | 39 | 1232 | response to stimulus |
GO:2000252 | 1e-04 | 49.8276 | 0.1191 | 3 | 6 | negative regulation of feeding behavior |
GO:0023052 | 2e-04 | 1.5044 | 114.1492 | 145 | 5750 | signaling |
GO:0002673 | 2e-04 | 7.721 | 0.8933 | 6 | 45 | regulation of acute inflammatory response |
GO:0021796 | 3e-04 | 37.3683 | 0.139 | 3 | 7 | cerebral cortex regionalization |
GO:0072080 | 3e-04 | 5.1674 | 1.7073 | 8 | 86 | nephron tubule development |
GO:0048878 | 3e-04 | 1.9194 | 21.9166 | 39 | 1104 | chemical homeostasis |
GO:0014031 | 3e-04 | 5.1017 | 1.7271 | 8 | 87 | mesenchymal cell development |
GO:0048864 | 3e-04 | 5.1017 | 1.7271 | 8 | 87 | stem cell development |
GO:0050789 | 4e-04 | 2.7288 | 8.1242 | 19 | 513 | regulation of biological process |
GO:0060993 | 4e-04 | 5.0376 | 1.747 | 8 | 88 | kidney morphogenesis |
GO:0048729 | 4e-04 | 2.2513 | 11.8715 | 25 | 598 | tissue morphogenesis |
GO:1905652 | 4e-04 | Inf | 0.0397 | 2 | 2 | negative regulation of artery morphogenesis |
GO:0035195 | 4e-04 | 2.8341 | 6.035 | 16 | 304 | miRNA-mediated gene silencing |
GO:0048793 | 4e-04 | 29.8928 | 0.1588 | 3 | 8 | pronephros development |
GO:0001657 | 4e-04 | 4.9141 | 1.7867 | 8 | 90 | ureteric bud development |
GO:0072163 | 5e-04 | 4.8546 | 1.8065 | 8 | 91 | mesonephric epithelium development |
GO:0048598 | 5e-04 | 2.5393 | 7.9878 | 19 | 412 | embryonic morphogenesis |
GO:0072006 | 5e-04 | 3.918 | 2.7594 | 10 | 139 | nephron development |
GO:0021536 | 5e-04 | 5.5855 | 1.3896 | 7 | 70 | diencephalon development |
GO:0009954 | 5e-04 | 8.631 | 0.675 | 5 | 34 | proximal/distal pattern formation |
GO:1902692 | 5e-04 | 8.631 | 0.675 | 5 | 34 | regulation of neuroblast proliferation |
GO:0014033 | 5e-04 | 4.7398 | 1.8462 | 8 | 93 | neural crest cell differentiation |
GO:0007498 | 6e-04 | 4.1651 | 2.3425 | 9 | 118 | mesoderm development |
GO:0043069 | 6e-04 | 2.0052 | 16.5367 | 31 | 833 | negative regulation of programmed cell death |
GO:0016441 | 6e-04 | 2.7186 | 6.2732 | 16 | 316 | post-transcriptional gene silencing |
GO:0001658 | 6e-04 | 6.4036 | 1.0522 | 6 | 53 | branching involved in ureteric bud morphogenesis |
GO:0045596 | 6e-04 | 2.4061 | 8.8565 | 20 | 454 | negative regulation of cell differentiation |
GO:0010605 | 7e-04 | 1.5627 | 54.3747 | 77 | 2739 | negative regulation of macromolecule metabolic process |
GO:0007154 | 8e-04 | 1.4448 | 114.3886 | 142 | 5797 | cell communication |
GO:0042756 | 8e-04 | 21.3493 | 0.1985 | 3 | 10 | drinking behavior |
GO:0007420 | 9e-04 | 2.0546 | 13.9957 | 27 | 705 | brain development |
GO:0001755 | 0.001 | 5.786 | 1.1514 | 6 | 58 | neural crest cell migration |
GO:0072001 | 0.0011 | 2.6577 | 5.9953 | 15 | 302 | renal system development |
GO:0051133 | 0.0011 | 18.6795 | 0.2184 | 3 | 11 | regulation of NK T cell activation |
GO:0030855 | 0.0011 | 2.0742 | 12.8046 | 25 | 645 | epithelial cell differentiation |
GO:0001705 | 0.0012 | 99.3562 | 0.0596 | 2 | 3 | ectoderm formation |
GO:0007412 | 0.0012 | 99.3562 | 0.0596 | 2 | 3 | axon target recognition |
GO:0046968 | 0.0012 | 99.3562 | 0.0596 | 2 | 3 | peptide antigen transport |
GO:0060375 | 0.0012 | 99.3562 | 0.0596 | 2 | 3 | regulation of mast cell differentiation |
GO:0072180 | 0.0012 | 99.3562 | 0.0596 | 2 | 3 | mesonephric duct morphogenesis |
GO:0097377 | 0.0012 | 99.3562 | 0.0596 | 2 | 3 | spinal cord interneuron axon guidance |
GO:0031047 | 0.0012 | 2.5293 | 6.71 | 16 | 338 | gene silencing by RNA |
GO:0019730 | 0.0013 | 4.0659 | 2.1242 | 8 | 107 | antimicrobial humoral response |
GO:1903671 | 0.0014 | 9.51 | 0.4963 | 4 | 25 | negative regulation of sprouting angiogenesis |
GO:0006690 | 0.0014 | 4.025 | 2.144 | 8 | 108 | icosanoid metabolic process |
GO:0010273 | 0.0015 | 16.6029 | 0.2382 | 3 | 12 | detoxification of copper ion |
GO:0021543 | 0.0015 | 3.3203 | 3.216 | 10 | 162 | pallium development |
GO:0021953 | 0.0016 | 3.2983 | 3.2359 | 10 | 163 | central nervous system neuron differentiation |
GO:0009888 | 0.0017 | 1.8196 | 19.9942 | 34 | 1067 | tissue development |
GO:0007612 | 0.0017 | 3.5149 | 2.7396 | 9 | 138 | learning |
GO:0048771 | 0.0018 | 3.2343 | 3.2954 | 10 | 166 | tissue remodeling |
GO:0061351 | 0.0018 | 3.4876 | 2.7594 | 9 | 139 | neural precursor cell proliferation |
GO:0048484 | 0.0019 | 14.9417 | 0.2581 | 3 | 13 | enteric nervous system development |
GO:0030182 | 0.002 | 2.9942 | 3.9071 | 11 | 206 | neuron differentiation |
GO:1901700 | 0.0021 | 1.6429 | 30.6714 | 47 | 1545 | response to oxygen-containing compound |
GO:0007157 | 0.0021 | 6.1003 | 0.9132 | 5 | 46 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0035176 | 0.0021 | 6.1003 | 0.9132 | 5 | 46 | social behavior |
GO:0002573 | 0.0021 | 2.9556 | 3.9506 | 11 | 199 | myeloid leukocyte differentiation |
GO:0001707 | 0.0023 | 4.8497 | 1.3499 | 6 | 68 | mesoderm formation |
GO:0072268 | 0.0023 | 49.675 | 0.0794 | 2 | 4 | pattern specification involved in metanephros development |
GO:0097022 | 0.0023 | 49.675 | 0.0794 | 2 | 4 | lymphocyte migration into lymph node |
GO:0097476 | 0.0023 | 49.675 | 0.0794 | 2 | 4 | spinal cord motor neuron migration |
GO:0072503 | 0.0025 | 2.1725 | 9.2312 | 19 | 465 | cellular divalent inorganic cation homeostasis |
GO:0010817 | 0.0028 | 2.1477 | 9.3305 | 19 | 470 | regulation of hormone levels |
GO:0032148 | 0.0028 | 7.6788 | 0.5956 | 4 | 30 | activation of protein kinase B activity |
GO:0046850 | 0.0028 | 5.6833 | 0.9727 | 5 | 49 | regulation of bone remodeling |
GO:0061138 | 0.0029 | 3.0192 | 3.5138 | 10 | 177 | morphogenesis of a branching epithelium |
GO:0019373 | 0.003 | 12.4498 | 0.2978 | 3 | 15 | epoxygenase P450 pathway |
GO:0051412 | 0.003 | 12.4498 | 0.2978 | 3 | 15 | response to corticosterone |
GO:0072176 | 0.003 | 12.4498 | 0.2978 | 3 | 15 | nephric duct development |
GO:0097501 | 0.003 | 12.4498 | 0.2978 | 3 | 15 | stress response to metal ion |
GO:0043009 | 0.003 | 1.975 | 12.2884 | 23 | 619 | chordate embryonic development |
GO:0021515 | 0.003 | 5.5566 | 0.9926 | 5 | 50 | cell differentiation in spinal cord |
GO:0031424 | 0.0033 | 4.4864 | 1.4492 | 6 | 73 | keratinization |
GO:0050794 | 0.0034 | 1.3938 | 199.3938 | 223 | 10044 | regulation of cellular process |
GO:0006875 | 0.0035 | 2.0191 | 10.9583 | 21 | 552 | cellular metal ion homeostasis |
GO:0007218 | 0.0036 | 3.8179 | 1.9654 | 7 | 99 | neuropeptide signaling pathway |
GO:0032095 | 0.0036 | 11.4914 | 0.3176 | 3 | 16 | regulation of response to food |
GO:0045780 | 0.0036 | 11.4914 | 0.3176 | 3 | 16 | positive regulation of bone resorption |
GO:1903588 | 0.0036 | 11.4914 | 0.3176 | 3 | 16 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO:0060406 | 0.0038 | 33.1146 | 0.0993 | 2 | 5 | positive regulation of penile erection |
GO:0071242 | 0.0038 | 33.1146 | 0.0993 | 2 | 5 | cellular response to ammonium ion |
GO:0072081 | 0.0038 | 33.1146 | 0.0993 | 2 | 5 | specification of nephron tubule identity |
GO:0090185 | 0.0038 | 33.1146 | 0.0993 | 2 | 5 | negative regulation of kidney development |
GO:0009617 | 0.0038 | 1.9684 | 11.7723 | 22 | 593 | response to bacterium |
GO:0002682 | 0.0039 | 1.6521 | 25.0731 | 39 | 1263 | regulation of immune system process |
GO:0071715 | 0.0039 | 5.2083 | 1.0522 | 5 | 53 | icosanoid transport |
GO:1904994 | 0.004 | 6.8831 | 0.6551 | 4 | 33 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0060485 | 0.0042 | 2.4536 | 5.5784 | 13 | 281 | mesenchyme development |
GO:0001938 | 0.0042 | 3.6966 | 2.0249 | 7 | 102 | positive regulation of endothelial cell proliferation |
GO:0021761 | 0.0042 | 3.6966 | 2.0249 | 7 | 102 | limbic system development |
GO:2000351 | 0.0043 | 5.1017 | 1.072 | 5 | 54 | regulation of endothelial cell apoptotic process |
GO:0001710 | 0.0043 | 10.67 | 0.3375 | 3 | 17 | mesodermal cell fate commitment |
GO:0007625 | 0.0043 | 10.67 | 0.3375 | 3 | 17 | grooming behavior |
GO:0050678 | 0.0043 | 2.2768 | 6.9284 | 15 | 349 | regulation of epithelial cell proliferation |
GO:0009410 | 0.0044 | 2.2066 | 7.6232 | 16 | 384 | response to xenobiotic stimulus |
GO:0051216 | 0.0046 | 2.8146 | 3.752 | 10 | 189 | cartilage development |
GO:0008284 | 0.0047 | 1.7654 | 17.3308 | 29 | 873 | positive regulation of cell population proliferation |
GO:0002691 | 0.0049 | 6.4382 | 0.6948 | 4 | 35 | regulation of cellular extravasation |
GO:0048048 | 0.0049 | 6.4382 | 0.6948 | 4 | 35 | embryonic eye morphogenesis |
GO:0010744 | 0.0051 | 9.958 | 0.3573 | 3 | 18 | positive regulation of macrophage derived foam cell differentiation |
GO:0043651 | 0.0051 | 9.958 | 0.3573 | 3 | 18 | linoleic acid metabolic process |
GO:1905563 | 0.0051 | 9.958 | 0.3573 | 3 | 18 | negative regulation of vascular endothelial cell proliferation |
GO:0072171 | 0.0052 | 4.8367 | 1.1247 | 5 | 57 | mesonephric tubule morphogenesis |
GO:0050853 | 0.0054 | 4.8065 | 1.1316 | 5 | 57 | B cell receptor signaling pathway |
GO:0008207 | 0.0054 | 6.2366 | 0.7147 | 4 | 36 | C21-steroid hormone metabolic process |
GO:0051241 | 0.0055 | 1.7605 | 16.7684 | 28 | 864 | negative regulation of multicellular organismal process |
GO:0002361 | 0.0056 | 24.8344 | 0.1191 | 2 | 6 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0010668 | 0.0056 | 24.8344 | 0.1191 | 2 | 6 | ectodermal cell differentiation |
GO:0051142 | 0.0056 | 24.8344 | 0.1191 | 2 | 6 | positive regulation of NK T cell proliferation |
GO:0060017 | 0.0056 | 24.8344 | 0.1191 | 2 | 6 | parathyroid gland development |
GO:0060455 | 0.0056 | 24.8344 | 0.1191 | 2 | 6 | negative regulation of gastric acid secretion |
GO:0072143 | 0.0056 | 24.8344 | 0.1191 | 2 | 6 | mesangial cell development |
GO:1902338 | 0.0056 | 24.8344 | 0.1191 | 2 | 6 | negative regulation of apoptotic process involved in morphogenesis |
GO:2000543 | 0.0056 | 24.8344 | 0.1191 | 2 | 6 | positive regulation of gastrulation |
GO:2000026 | 0.0059 | 1.6065 | 25.7084 | 39 | 1295 | regulation of multicellular organismal development |
GO:0002523 | 0.0059 | 9.335 | 0.3772 | 3 | 19 | leukocyte migration involved in inflammatory response |
GO:0043524 | 0.0061 | 3.1144 | 2.7197 | 8 | 137 | negative regulation of neuron apoptotic process |
GO:0090596 | 0.0061 | 2.4328 | 5.1814 | 12 | 261 | sensory organ morphogenesis |
GO:0006357 | 0.0062 | 1.4596 | 46.3346 | 63 | 2334 | regulation of transcription by RNA polymerase II |
GO:0055080 | 0.0062 | 1.8276 | 13.7972 | 24 | 695 | cation homeostasis |
GO:0051961 | 0.0066 | 3.0665 | 2.7594 | 8 | 139 | negative regulation of nervous system development |
GO:0042755 | 0.0066 | 5.869 | 0.7544 | 4 | 38 | eating behavior |
GO:0051716 | 0.0066 | 1.3316 | 131.7381 | 154 | 6636 | cellular response to stimulus |
GO:0016477 | 0.0068 | 1.5644 | 28.448 | 42 | 1433 | cell migration |
GO:1903532 | 0.0069 | 2.3937 | 5.2608 | 12 | 265 | positive regulation of secretion by cell |
GO:0021516 | 0.0069 | 8.7854 | 0.397 | 3 | 20 | dorsal spinal cord development |
GO:0032305 | 0.0069 | 8.7854 | 0.397 | 3 | 20 | positive regulation of icosanoid secretion |
GO:0035239 | 0.007 | 1.7271 | 17.053 | 28 | 864 | tube morphogenesis |
GO:0071396 | 0.0071 | 1.9165 | 10.9385 | 20 | 551 | cellular response to lipid |
GO:0090049 | 0.0072 | 4.462 | 1.211 | 5 | 61 | regulation of cell migration involved in sprouting angiogenesis |
GO:0070328 | 0.0073 | 5.701 | 0.7742 | 4 | 39 | triglyceride homeostasis |
GO:0098771 | 0.0073 | 1.7996 | 13.9957 | 24 | 705 | inorganic ion homeostasis |
GO:0007369 | 0.0075 | 2.7757 | 3.4143 | 9 | 173 | gastrulation |
GO:0070663 | 0.0077 | 2.4638 | 4.6851 | 11 | 236 | regulation of leukocyte proliferation |
GO:0015840 | 0.0077 | 19.8663 | 0.139 | 2 | 7 | urea transport |
GO:0019530 | 0.0077 | 19.8663 | 0.139 | 2 | 7 | taurine metabolic process |
GO:0021902 | 0.0077 | 19.8663 | 0.139 | 2 | 7 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0051971 | 0.0077 | 19.8663 | 0.139 | 2 | 7 | positive regulation of transmission of nerve impulse |
GO:0060215 | 0.0077 | 19.8663 | 0.139 | 2 | 7 | primitive hemopoiesis |
GO:0072197 | 0.0077 | 19.8663 | 0.139 | 2 | 7 | ureter morphogenesis |
GO:0120252 | 0.0077 | 19.8663 | 0.139 | 2 | 7 | hydrocarbon metabolic process |
GO:2000726 | 0.0077 | 19.8663 | 0.139 | 2 | 7 | negative regulation of cardiac muscle cell differentiation |
GO:0098609 | 0.0079 | 1.7094 | 17.2117 | 28 | 867 | cell-cell adhesion |
GO:0006873 | 0.0079 | 1.8379 | 12.5465 | 22 | 632 | cellular ion homeostasis |
GO:0051674 | 0.0079 | 1.521 | 32.0809 | 46 | 1616 | localization of cell |
GO:0010894 | 0.0079 | 8.2968 | 0.4169 | 3 | 21 | negative regulation of steroid biosynthetic process |
GO:0060065 | 0.0079 | 8.2968 | 0.4169 | 3 | 21 | uterus development |
GO:0071294 | 0.0079 | 8.2968 | 0.4169 | 3 | 21 | cellular response to zinc ion |
GO:0010721 | 0.0083 | 2.725 | 3.4741 | 9 | 175 | negative regulation of cell development |
GO:0014014 | 0.0087 | 5.3921 | 0.8139 | 4 | 41 | negative regulation of gliogenesis |
GO:0048645 | 0.0088 | 4.2343 | 1.2705 | 5 | 64 | animal organ formation |
GO:0042981 | 0.0088 | 1.5619 | 26.3635 | 39 | 1328 | regulation of apoptotic process |
GO:0002438 | 0.009 | 7.8596 | 0.4367 | 3 | 22 | acute inflammatory response to antigenic stimulus |
GO:0042745 | 0.009 | 7.8596 | 0.4367 | 3 | 22 | circadian sleep/wake cycle |
GO:0043302 | 0.009 | 7.8596 | 0.4367 | 3 | 22 | positive regulation of leukocyte degranulation |
GO:0048666 | 0.0094 | 1.6265 | 20.6858 | 32 | 1042 | neuron development |
GO:0043207 | 0.0098 | 1.5675 | 24.8746 | 37 | 1253 | response to external biotic stimulus |
GO:0031960 | 0.0099 | 2.8472 | 2.958 | 8 | 149 | response to corticosteroid |
GO:0009953 | 0.01 | 3.491 | 1.8264 | 6 | 92 | dorsal/ventral pattern formation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0010536 | 1e-04 | 64.379 | 0.0928 | 3 | 6 | positive regulation of activation of Janus kinase activity |
GO:0009607 | 1e-04 | 2.0989 | 19.9469 | 38 | 1289 | response to biotic stimulus |
GO:0006954 | 1e-04 | 2.4088 | 11.7144 | 26 | 757 | inflammatory response |
GO:0031640 | 2e-04 | 10.4498 | 0.5571 | 5 | 36 | killing of cells of another organism |
GO:0051122 | 3e-04 | 32.1835 | 0.1393 | 3 | 9 | hepoxilin biosynthetic process |
GO:0007342 | 3e-04 | 14.3509 | 0.3404 | 4 | 22 | fusion of sperm to egg plasma membrane involved in single fertilization |
GO:0046427 | 4e-04 | 9.2532 | 0.619 | 5 | 40 | positive regulation of receptor signaling pathway via JAK-STAT |
GO:0042742 | 6e-04 | 3.3046 | 3.8842 | 12 | 251 | defense response to bacterium |
GO:1901687 | 7e-04 | 128.257 | 0.0464 | 2 | 3 | glutathione derivative biosynthetic process |
GO:0045087 | 8e-04 | 2.2203 | 11.0954 | 23 | 717 | innate immune response |
GO:0071347 | 0.001 | 4.845 | 1.5629 | 7 | 101 | cellular response to interleukin-1 |
GO:0008284 | 0.0011 | 2.0631 | 13.5094 | 26 | 873 | positive regulation of cell population proliferation |
GO:0006952 | 0.0012 | 2.1852 | 10.7967 | 22 | 742 | defense response |
GO:0098754 | 0.0013 | 4.0743 | 2.1046 | 8 | 136 | detoxification |
GO:0018916 | 0.0014 | 64.1245 | 0.0619 | 2 | 4 | nitrobenzene metabolic process |
GO:0061737 | 0.0014 | 64.1245 | 0.0619 | 2 | 4 | leukotriene signaling pathway |
GO:0048247 | 0.0016 | 6.4711 | 0.8511 | 5 | 55 | lymphocyte chemotaxis |
GO:0006575 | 0.0018 | 3.4979 | 2.739 | 9 | 177 | cellular modified amino acid metabolic process |
GO:0045069 | 0.0019 | 4.9893 | 1.2999 | 6 | 84 | regulation of viral genome replication |
GO:0051707 | 0.0022 | 1.9836 | 13.4695 | 25 | 894 | response to other organism |
GO:0070458 | 0.0023 | 42.747 | 0.0774 | 2 | 5 | cellular detoxification of nitrogen compound |
GO:0072144 | 0.0023 | 42.747 | 0.0774 | 2 | 5 | glomerular mesangial cell development |
GO:0120317 | 0.0023 | 42.747 | 0.0774 | 2 | 5 | sperm mitochondrial sheath assembly |
GO:0052695 | 0.0025 | 12.8661 | 0.2785 | 3 | 18 | cellular glucuronidation |
GO:0008037 | 0.0025 | 3.618 | 2.3522 | 8 | 152 | cell recognition |
GO:0006607 | 0.003 | 12.0612 | 0.294 | 3 | 19 | NLS-bearing protein import into nucleus |
GO:0010544 | 0.003 | 12.0612 | 0.294 | 3 | 19 | negative regulation of platelet activation |
GO:0032930 | 0.003 | 12.0612 | 0.294 | 3 | 19 | positive regulation of superoxide anion generation |
GO:0090026 | 0.003 | 12.0612 | 0.294 | 3 | 19 | positive regulation of monocyte chemotaxis |
GO:0051170 | 0.0032 | 3.4719 | 2.445 | 8 | 158 | import into nucleus |
GO:0097696 | 0.0032 | 3.4719 | 2.445 | 8 | 158 | receptor signaling pathway via STAT |
GO:0071393 | 0.0034 | 32.0582 | 0.0928 | 2 | 6 | cellular response to progesterone stimulus |
GO:2000501 | 0.0034 | 32.0582 | 0.0928 | 2 | 6 | regulation of natural killer cell chemotaxis |
GO:0006063 | 0.0034 | 11.351 | 0.3095 | 3 | 20 | uronic acid metabolic process |
GO:0006883 | 0.0045 | 10.1549 | 0.3404 | 3 | 22 | cellular sodium ion homeostasis |
GO:0098581 | 0.0045 | 10.1549 | 0.3404 | 3 | 22 | detection of external biotic stimulus |
GO:0060267 | 0.0048 | 25.645 | 0.1083 | 2 | 7 | positive regulation of respiratory burst |
GO:0072007 | 0.0048 | 25.645 | 0.1083 | 2 | 7 | mesangial cell differentiation |
GO:0032729 | 0.0048 | 4.8975 | 1.0987 | 5 | 71 | positive regulation of interferon-gamma production |
GO:0050832 | 0.0051 | 6.2913 | 0.6964 | 4 | 45 | defense response to fungus |
GO:0042178 | 0.0052 | 9.6466 | 0.3559 | 3 | 23 | xenobiotic catabolic process |
GO:0071622 | 0.0055 | 6.1411 | 0.7118 | 4 | 46 | regulation of granulocyte chemotaxis |
GO:0009820 | 0.0063 | 21.3695 | 0.1238 | 2 | 8 | alkaloid metabolic process |
GO:0060768 | 0.0063 | 21.3695 | 0.1238 | 2 | 8 | regulation of epithelial cell proliferation involved in prostate gland development |
GO:0035036 | 0.0064 | 5.8612 | 0.7428 | 4 | 48 | sperm-egg recognition |
GO:0009605 | 0.0069 | 1.5067 | 38.0988 | 53 | 2462 | response to external stimulus |
GO:0007186 | 0.0078 | 1.7741 | 14.8945 | 25 | 970 | G protein-coupled receptor signaling pathway |
GO:0035195 | 0.0079 | 2.4522 | 4.7043 | 11 | 304 | miRNA-mediated gene silencing |
GO:0007168 | 0.008 | 18.3155 | 0.1393 | 2 | 9 | receptor guanylyl cyclase signaling pathway |
GO:0051593 | 0.008 | 18.3155 | 0.1393 | 2 | 9 | response to folic acid |
GO:0070383 | 0.008 | 18.3155 | 0.1393 | 2 | 9 | DNA cytosine deamination |
GO:0097237 | 0.009 | 3.5634 | 1.7796 | 6 | 115 | cellular response to toxic substance |
GO:0050792 | 0.0092 | 3.1527 | 2.3367 | 7 | 151 | regulation of viral process |
GO:0001816 | 0.0098 | 1.8607 | 11.2965 | 20 | 730 | cytokine production |
GO:0003330 | 0.0099 | 16.0251 | 0.1547 | 2 | 10 | regulation of extracellular matrix constituent secretion |
GO:0009615 | 0.0099 | 2.2738 | 5.5245 | 12 | 357 | response to virus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0061844 | 0 | 13.4347 | 1.2169 | 13 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0006959 | 0 | 5.9549 | 3.6507 | 19 | 213 | humoral immune response |
GO:0019731 | 0 | 15.7664 | 0.732 | 9 | 43 | antibacterial humoral response |
GO:0002227 | 0 | 27.4266 | 0.3771 | 7 | 22 | innate immune response in mucosa |
GO:0007186 | 0 | 2.7006 | 16.6937 | 40 | 974 | G protein-coupled receptor signaling pathway |
GO:0002251 | 0 | 15.8121 | 0.5656 | 7 | 33 | organ or tissue specific immune response |
GO:0050830 | 0 | 6.7181 | 1.5083 | 9 | 88 | defense response to Gram-positive bacterium |
GO:0050911 | 0 | 4.153 | 3.685 | 14 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0070098 | 1e-04 | 6.441 | 1.3883 | 8 | 81 | chemokine-mediated signaling pathway |
GO:0050921 | 1e-04 | 4.8788 | 2.2453 | 10 | 131 | positive regulation of chemotaxis |
GO:0009593 | 1e-04 | 3.2858 | 4.919 | 15 | 287 | detection of chemical stimulus |
GO:1990868 | 1e-04 | 5.8019 | 1.5254 | 8 | 89 | response to chemokine |
GO:0048245 | 2e-04 | 17.8877 | 0.2914 | 4 | 17 | eosinophil chemotaxis |
GO:0009617 | 2e-04 | 2.4324 | 10.1636 | 23 | 593 | response to bacterium |
GO:0016441 | 4e-04 | 2.9637 | 5.416 | 15 | 316 | post-transcriptional gene silencing |
GO:0072676 | 4e-04 | 4.84 | 1.7996 | 8 | 105 | lymphocyte migration |
GO:0022604 | 5e-04 | 2.999 | 4.9875 | 14 | 291 | regulation of cell morphogenesis |
GO:0051345 | 5e-04 | 2.3854 | 9.4095 | 21 | 549 | positive regulation of hydrolase activity |
GO:0090630 | 5e-04 | 4.6939 | 1.851 | 8 | 108 | activation of GTPase activity |
GO:0032731 | 6e-04 | 6.4902 | 1.0284 | 6 | 60 | positive regulation of interleukin-1 beta production |
GO:0007606 | 6e-04 | 2.9343 | 5.0904 | 14 | 297 | sensory perception of chemical stimulus |
GO:0097530 | 7e-04 | 4.0381 | 2.3995 | 9 | 140 | granulocyte migration |
GO:0031047 | 8e-04 | 2.7579 | 5.7931 | 15 | 338 | gene silencing by RNA |
GO:0035195 | 8e-04 | 2.8622 | 5.2104 | 14 | 304 | miRNA-mediated gene silencing |
GO:0032652 | 9e-04 | 4.344 | 1.9882 | 8 | 116 | regulation of interleukin-1 production |
GO:0060474 | 9e-04 | 115.5145 | 0.0514 | 2 | 3 | positive regulation of flagellated sperm motility involved in capacitation |
GO:0040012 | 0.001 | 1.9479 | 17.0708 | 31 | 996 | regulation of locomotion |
GO:0050832 | 0.001 | 7.2811 | 0.7713 | 5 | 45 | defense response to fungus |
GO:0050906 | 0.0011 | 2.7744 | 5.3646 | 14 | 313 | detection of stimulus involved in sensory perception |
GO:0051497 | 0.0013 | 9.6825 | 0.4799 | 4 | 28 | negative regulation of stress fiber assembly |
GO:0050930 | 0.0013 | 17.3804 | 0.2228 | 3 | 13 | induction of positive chemotaxis |
GO:0006954 | 0.0013 | 2.0532 | 12.9745 | 25 | 757 | inflammatory response |
GO:0051674 | 0.0013 | 1.7189 | 27.6972 | 44 | 1616 | localization of cell |
GO:0050829 | 0.0014 | 5.3881 | 1.2169 | 6 | 71 | defense response to Gram-negative bacterium |
GO:0043207 | 0.0015 | 1.7999 | 21.4756 | 36 | 1253 | response to external biotic stimulus |
GO:0007586 | 0.0016 | 3.9067 | 2.1938 | 8 | 128 | digestion |
GO:0014826 | 0.0017 | 57.7536 | 0.0686 | 2 | 4 | vein smooth muscle contraction |
GO:0018120 | 0.0017 | 57.7536 | 0.0686 | 2 | 4 | peptidyl-arginine ADP-ribosylation |
GO:0060585 | 0.0017 | 57.7536 | 0.0686 | 2 | 4 | positive regulation of prostaglandin-endoperoxide synthase activity |
GO:0044419 | 0.0017 | 1.7482 | 23.9951 | 39 | 1400 | biological process involved in interspecies interaction between organisms |
GO:0071347 | 0.0018 | 4.3549 | 1.7311 | 7 | 101 | cellular response to interleukin-1 |
GO:1905517 | 0.0023 | 5.9404 | 0.9255 | 5 | 54 | macrophage migration |
GO:0140131 | 0.0024 | 13.367 | 0.2742 | 3 | 16 | positive regulation of lymphocyte chemotaxis |
GO:0045765 | 0.0025 | 2.611 | 5.2618 | 13 | 307 | regulation of angiogenesis |
GO:0043308 | 0.0028 | 38.5 | 0.0857 | 2 | 5 | eosinophil degranulation |
GO:0106001 | 0.0028 | 38.5 | 0.0857 | 2 | 5 | intestinal hexose absorption |
GO:0002688 | 0.0037 | 3.787 | 1.971 | 7 | 115 | regulation of leukocyte chemotaxis |
GO:0090189 | 0.0039 | 10.8586 | 0.3256 | 3 | 19 | regulation of branching involved in ureteric bud morphogenesis |
GO:0098542 | 0.0041 | 1.8502 | 14.8863 | 26 | 882 | defense response to other organism |
GO:0010631 | 0.0041 | 2.4575 | 5.5703 | 13 | 325 | epithelial cell migration |
GO:0060326 | 0.0042 | 2.5606 | 4.9361 | 12 | 288 | cell chemotaxis |
GO:0001878 | 0.0042 | 28.8732 | 0.1028 | 2 | 6 | response to yeast |
GO:0003100 | 0.0042 | 28.8732 | 0.1028 | 2 | 6 | regulation of systemic arterial blood pressure by endothelin |
GO:0014034 | 0.0042 | 28.8732 | 0.1028 | 2 | 6 | neural crest cell fate commitment |
GO:0043307 | 0.0042 | 28.8732 | 0.1028 | 2 | 6 | eosinophil activation |
GO:1902083 | 0.0042 | 28.8732 | 0.1028 | 2 | 6 | negative regulation of peptidyl-cysteine S-nitrosylation |
GO:0002548 | 0.0045 | 5.0158 | 1.0798 | 5 | 63 | monocyte chemotaxis |
GO:0090130 | 0.0049 | 2.4025 | 5.6903 | 13 | 332 | tissue migration |
GO:0090023 | 0.0053 | 9.6509 | 0.3599 | 3 | 21 | positive regulation of neutrophil chemotaxis |
GO:2000147 | 0.0055 | 2.0492 | 9.2381 | 18 | 539 | positive regulation of cell motility |
GO:0002778 | 0.0058 | 23.0971 | 0.12 | 2 | 7 | antibacterial peptide production |
GO:1902732 | 0.0058 | 23.0971 | 0.12 | 2 | 7 | positive regulation of chondrocyte proliferation |
GO:0050900 | 0.0061 | 2.6918 | 3.9075 | 10 | 232 | leukocyte migration |
GO:0043087 | 0.0061 | 2.3353 | 5.8445 | 13 | 341 | regulation of GTPase activity |
GO:0061041 | 0.0063 | 3.4057 | 2.1767 | 7 | 127 | regulation of wound healing |
GO:0030334 | 0.0063 | 1.7831 | 15.3911 | 26 | 898 | regulation of cell migration |
GO:0032760 | 0.0068 | 3.8004 | 1.6797 | 6 | 98 | positive regulation of tumor necrosis factor production |
GO:0010818 | 0.0068 | 8.6847 | 0.3942 | 3 | 23 | T cell chemotaxis |
GO:0002687 | 0.0071 | 3.322 | 2.2281 | 7 | 130 | positive regulation of leukocyte migration |
GO:0014824 | 0.0077 | 19.2464 | 0.1371 | 2 | 8 | artery smooth muscle contraction |
GO:0015014 | 0.0077 | 19.2464 | 0.1371 | 2 | 8 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process |
GO:0043615 | 0.0077 | 19.2464 | 0.1371 | 2 | 8 | astrocyte cell migration |
GO:0051673 | 0.0077 | 19.2464 | 0.1371 | 2 | 8 | membrane disruption in another organism |
GO:0048514 | 0.0078 | 1.903 | 11.0377 | 20 | 644 | blood vessel morphogenesis |
GO:0050873 | 0.0084 | 5.3977 | 0.8055 | 4 | 47 | brown fat cell differentiation |
GO:0050926 | 0.0087 | 7.8942 | 0.4285 | 3 | 25 | regulation of positive chemotaxis |
GO:0030593 | 0.0089 | 4.1942 | 1.2732 | 5 | 75 | neutrophil chemotaxis |
GO:0006334 | 0.009 | 3.5663 | 1.7825 | 6 | 104 | nucleosome assembly |
GO:0010460 | 0.0097 | 7.5505 | 0.4456 | 3 | 26 | positive regulation of heart rate |
GO:0060354 | 0.0097 | 16.4959 | 0.1543 | 2 | 9 | negative regulation of cell adhesion molecule production |
GO:1903977 | 0.0097 | 16.4959 | 0.1543 | 2 | 9 | positive regulation of glial cell migration |
GO:0051270 | 0.0098 | 1.6807 | 17.5507 | 28 | 1024 | regulation of cellular component movement |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009593 | 0 | 5.6018 | 4.7244 | 23 | 287 | detection of chemical stimulus |
GO:0050911 | 0 | 6.5433 | 3.5391 | 20 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 5.1193 | 4.889 | 22 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 4.5785 | 5.1523 | 21 | 313 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 2.8335 | 16.0332 | 40 | 974 | G protein-coupled receptor signaling pathway |
GO:0006952 | 0 | 2.3064 | 24.6753 | 50 | 1499 | defense response |
GO:0035195 | 0 | 3.4672 | 5.0042 | 16 | 304 | miRNA-mediated gene silencing |
GO:0016441 | 1e-04 | 3.326 | 5.2017 | 16 | 316 | post-transcriptional gene silencing |
GO:0009607 | 1e-04 | 2.0745 | 21.2184 | 40 | 1289 | response to biotic stimulus |
GO:0051707 | 1e-04 | 2.0804 | 20.5929 | 39 | 1251 | response to other organism |
GO:0050832 | 1e-04 | 9.3805 | 0.7408 | 6 | 45 | defense response to fungus |
GO:0045087 | 1e-04 | 2.3828 | 11.8027 | 26 | 717 | innate immune response |
GO:0060267 | 1e-04 | 45.3097 | 0.1152 | 3 | 7 | positive regulation of respiratory burst |
GO:0031047 | 2e-04 | 3.0944 | 5.5639 | 16 | 338 | gene silencing by RNA |
GO:0030593 | 2e-04 | 5.5686 | 1.5803 | 8 | 96 | neutrophil chemotaxis |
GO:1905949 | 3e-04 | Inf | 0.0329 | 2 | 2 | negative regulation of calcium ion import across plasma membrane |
GO:0097530 | 5e-04 | 4.2132 | 2.3046 | 9 | 140 | granulocyte migration |
GO:0042742 | 6e-04 | 4.1579 | 2.3325 | 9 | 144 | defense response to bacterium |
GO:0030317 | 7e-04 | 4.5317 | 1.9095 | 8 | 116 | flagellated sperm motility |
GO:1901687 | 8e-04 | 120.3925 | 0.0494 | 2 | 3 | glutathione derivative biosynthetic process |
GO:0050829 | 0.0011 | 5.6191 | 1.1687 | 6 | 71 | defense response to Gram-negative bacterium |
GO:0014826 | 0.0016 | 60.1925 | 0.0658 | 2 | 4 | vein smooth muscle contraction |
GO:0051771 | 0.0016 | 60.1925 | 0.0658 | 2 | 4 | negative regulation of nitric-oxide synthase biosynthetic process |
GO:0060585 | 0.0016 | 60.1925 | 0.0658 | 2 | 4 | positive regulation of prostaglandin-endoperoxide synthase activity |
GO:0006690 | 0.0021 | 4.2256 | 1.7778 | 7 | 108 | icosanoid metabolic process |
GO:0048247 | 0.0021 | 6.0698 | 0.9054 | 5 | 55 | lymphocyte chemotaxis |
GO:1901386 | 0.0021 | 13.9336 | 0.2634 | 3 | 16 | negative regulation of voltage-gated calcium channel activity |
GO:0001539 | 0.0024 | 3.6464 | 2.3375 | 8 | 142 | cilium or flagellum-dependent cell motility |
GO:0009404 | 0.0025 | 12.9375 | 0.2798 | 3 | 17 | toxin metabolic process |
GO:0048245 | 0.0025 | 12.9375 | 0.2798 | 3 | 17 | eosinophil chemotaxis |
GO:0120317 | 0.0026 | 40.1258 | 0.0823 | 2 | 5 | sperm mitochondrial sheath assembly |
GO:0031640 | 0.0028 | 7.567 | 0.5926 | 4 | 36 | killing of cells of another organism |
GO:0002688 | 0.0029 | 3.95 | 1.893 | 7 | 115 | regulation of leukocyte chemotaxis |
GO:0002532 | 0.0029 | 4.5612 | 1.4157 | 6 | 86 | production of molecular mediator involved in inflammatory response |
GO:0048661 | 0.0031 | 4.5046 | 1.4321 | 6 | 87 | positive regulation of smooth muscle cell proliferation |
GO:0002523 | 0.0035 | 11.3189 | 0.3128 | 3 | 19 | leukocyte migration involved in inflammatory response |
GO:0002548 | 0.0038 | 5.23 | 1.0371 | 5 | 63 | monocyte chemotaxis |
GO:0001817 | 0.0038 | 1.9743 | 11.7862 | 22 | 716 | regulation of cytokine production |
GO:0001878 | 0.0039 | 30.0925 | 0.0988 | 2 | 6 | response to yeast |
GO:0003100 | 0.0039 | 30.0925 | 0.0988 | 2 | 6 | regulation of systemic arterial blood pressure by endothelin |
GO:0015670 | 0.0039 | 30.0925 | 0.0988 | 2 | 6 | carbon dioxide transport |
GO:0009988 | 0.0046 | 4.9718 | 1.0864 | 5 | 66 | cell-cell recognition |
GO:0046222 | 0.0054 | 24.0725 | 0.1152 | 2 | 7 | aflatoxin metabolic process |
GO:0060264 | 0.0054 | 24.0725 | 0.1152 | 2 | 7 | regulation of respiratory burst involved in inflammatory response |
GO:0006833 | 0.0054 | 9.5299 | 0.3621 | 3 | 22 | water transport |
GO:0002687 | 0.0057 | 3.465 | 2.14 | 7 | 130 | positive regulation of leukocyte migration |
GO:0045840 | 0.0058 | 6.0506 | 0.7243 | 4 | 44 | positive regulation of mitotic nuclear division |
GO:0050921 | 0.006 | 3.4368 | 2.1564 | 7 | 131 | positive regulation of chemotaxis |
GO:0019835 | 0.0061 | 9.0528 | 0.3786 | 3 | 23 | cytolysis |
GO:0032496 | 0.0061 | 2.4306 | 5.1853 | 12 | 315 | response to lipopolysaccharide |
GO:0061844 | 0.0063 | 4.5937 | 1.1687 | 5 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0033559 | 0.0068 | 3.7972 | 1.679 | 6 | 102 | unsaturated fatty acid metabolic process |
GO:0006693 | 0.0068 | 5.7617 | 0.7572 | 4 | 46 | prostaglandin metabolic process |
GO:0071624 | 0.0069 | 8.6212 | 0.3951 | 3 | 24 | positive regulation of granulocyte chemotaxis |
GO:0014824 | 0.0071 | 20.0591 | 0.1317 | 2 | 8 | artery smooth muscle contraction |
GO:0051673 | 0.0071 | 20.0591 | 0.1317 | 2 | 8 | membrane disruption in another organism |
GO:0010543 | 0.0074 | 5.6274 | 0.7737 | 4 | 47 | regulation of platelet activation |
GO:0002526 | 0.0074 | 3.7192 | 1.712 | 6 | 104 | acute inflammatory response |
GO:0032717 | 0.0078 | 8.2288 | 0.4115 | 3 | 25 | negative regulation of interleukin-8 production |
GO:0003008 | 0.0079 | 1.5294 | 32.2145 | 46 | 1957 | system process |
GO:0006959 | 0.0089 | 2.6931 | 3.5062 | 9 | 213 | humoral immune response |
GO:0051122 | 0.009 | 17.1925 | 0.1482 | 2 | 9 | hepoxilin biosynthetic process |
GO:0061051 | 0.009 | 17.1925 | 0.1482 | 2 | 9 | positive regulation of cell growth involved in cardiac muscle cell development |
GO:0019731 | 0.0091 | 5.2594 | 0.8231 | 4 | 50 | antibacterial humoral response |
GO:0071346 | 0.0093 | 3.5376 | 1.7943 | 6 | 109 | cellular response to interferon-gamma |
GO:0003341 | 0.0094 | 2.8677 | 2.9301 | 8 | 178 | cilium movement |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 180.9545 | 0.5682 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0045653 | 0 | 203.4599 | 0.3196 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006334 | 0 | 18.0136 | 1.8466 | 24 | 104 | nucleosome assembly |
GO:0006336 | 0 | 45.1736 | 0.5682 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0032200 | 0 | 10.8815 | 2.7699 | 24 | 156 | telomere organization |
GO:0009593 | 0 | 6.8023 | 5.0959 | 29 | 287 | detection of chemical stimulus |
GO:0050906 | 0 | 6.4299 | 5.5576 | 30 | 313 | detection of stimulus involved in sensory perception |
GO:0050911 | 0 | 7.8757 | 3.8175 | 25 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 7.2369 | 4.2884 | 26 | 245 | sensory perception of chemical stimulus |
GO:0071824 | 0 | 7.696 | 3.7287 | 24 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 6.7089 | 4.2081 | 24 | 237 | chromatin remodeling |
GO:0006352 | 0 | 7.3493 | 2.2017 | 14 | 124 | DNA-templated transcription, initiation |
GO:0007186 | 0 | 2.6685 | 17.2942 | 41 | 974 | G protein-coupled receptor signaling pathway |
GO:0045637 | 0 | 4.7286 | 3.5157 | 15 | 198 | regulation of myeloid cell differentiation |
GO:0040029 | 0 | 5.1462 | 2.3615 | 11 | 133 | regulation of gene expression, epigenetic |
GO:0050877 | 0 | 2.1403 | 21.6444 | 42 | 1219 | nervous system process |
GO:0035195 | 1e-04 | 3.1953 | 5.3978 | 16 | 304 | miRNA-mediated gene silencing |
GO:0016441 | 2e-04 | 3.0651 | 5.6109 | 16 | 316 | post-transcriptional gene silencing |
GO:0036345 | 3e-04 | Inf | 0.0355 | 2 | 2 | platelet maturation |
GO:0031047 | 4e-04 | 2.8517 | 6.0015 | 16 | 338 | gene silencing by RNA |
GO:0034696 | 9e-04 | 111.4056 | 0.0533 | 2 | 3 | response to prostaglandin F |
GO:0070543 | 9e-04 | 111.4056 | 0.0533 | 2 | 3 | response to linoleic acid |
GO:0065003 | 0.002 | 1.7199 | 24.9647 | 40 | 1406 | protein-containing complex assembly |
GO:0045596 | 0.002 | 2.0881 | 11.1684 | 22 | 629 | negative regulation of cell differentiation |
GO:0050909 | 0.0022 | 5.9714 | 0.9233 | 5 | 52 | sensory perception of taste |
GO:0071398 | 0.0027 | 7.7237 | 0.5859 | 4 | 33 | cellular response to fatty acid |
GO:0019730 | 0.003 | 3.9439 | 1.8999 | 7 | 107 | antimicrobial humoral response |
GO:0006640 | 0.003 | 37.1305 | 0.0888 | 2 | 5 | monoacylglycerol biosynthetic process |
GO:0098543 | 0.0031 | 11.9684 | 0.3018 | 3 | 17 | detection of other organism |
GO:0002361 | 0.0045 | 27.8462 | 0.1065 | 2 | 6 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:1905460 | 0.0045 | 27.8462 | 0.1065 | 2 | 6 | negative regulation of vascular associated smooth muscle cell apoptotic process |
GO:0042742 | 0.0054 | 2.5965 | 4.4567 | 11 | 251 | defense response to bacterium |
GO:0032501 | 0.0054 | 1.3643 | 119.2838 | 141 | 6718 | multicellular organismal process |
GO:0030277 | 0.0058 | 9.3064 | 0.3729 | 3 | 21 | maintenance of gastrointestinal epithelium |
GO:0043535 | 0.0064 | 3.3965 | 2.184 | 7 | 123 | regulation of blood vessel endothelial cell migration |
GO:0046460 | 0.0064 | 5.891 | 0.7457 | 4 | 42 | neutral lipid biosynthetic process |
GO:0010951 | 0.0075 | 2.605 | 4.0306 | 10 | 227 | negative regulation of endopeptidase activity |
GO:0050832 | 0.0082 | 5.4589 | 0.799 | 4 | 45 | defense response to fungus |
GO:0010543 | 0.0095 | 5.2044 | 0.8345 | 4 | 47 | regulation of platelet activation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 146.8889 | 0.6866 | 24 | 32 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 23.3147 | 2.2313 | 33 | 104 | nucleosome assembly |
GO:0071824 | 0 | 10.03 | 4.5055 | 35 | 210 | protein-DNA complex subunit organization |
GO:0045653 | 0 | 166.2814 | 0.3862 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006338 | 0 | 8.996 | 5.0848 | 36 | 237 | chromatin remodeling |
GO:0032200 | 0 | 10.2649 | 3.347 | 27 | 156 | telomere organization |
GO:0006336 | 0 | 36.9188 | 0.6866 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0050911 | 0 | 6.0814 | 4.6128 | 24 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051606 | 0 | 4.0731 | 9.2471 | 33 | 431 | detection of stimulus |
GO:0006959 | 0 | 5.2446 | 4.5699 | 21 | 213 | humoral immune response |
GO:0007186 | 0 | 2.7143 | 20.8972 | 50 | 974 | G protein-coupled receptor signaling pathway |
GO:0006352 | 0 | 7.0344 | 2.6604 | 16 | 124 | DNA-templated transcription, initiation |
GO:0061844 | 0 | 9.572 | 1.5233 | 12 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0007600 | 0 | 2.8706 | 15.5978 | 40 | 727 | sensory perception |
GO:0002227 | 0 | 17.386 | 0.472 | 6 | 22 | innate immune response in mucosa |
GO:0040029 | 0 | 5.0939 | 2.8535 | 13 | 133 | regulation of gene expression, epigenetic |
GO:0045637 | 0 | 4.1546 | 4.2481 | 16 | 198 | regulation of myeloid cell differentiation |
GO:0065003 | 0 | 1.9726 | 30.1657 | 54 | 1406 | protein-containing complex assembly |
GO:0002251 | 1e-04 | 10.2956 | 0.708 | 6 | 33 | organ or tissue specific immune response |
GO:0035821 | 1e-04 | 13.5954 | 0.472 | 5 | 22 | modulation of process of another organism |
GO:0030185 | 1e-04 | 69 | 0.1073 | 3 | 5 | nitric oxide transport |
GO:0050830 | 1e-04 | 5.3074 | 1.888 | 9 | 88 | defense response to Gram-positive bacterium |
GO:0003008 | 1e-04 | 1.7304 | 41.9874 | 66 | 1957 | system process |
GO:0030593 | 2e-04 | 4.8169 | 2.0597 | 9 | 96 | neutrophil chemotaxis |
GO:0048245 | 4e-04 | 14.1852 | 0.3647 | 4 | 17 | eosinophil chemotaxis |
GO:0070488 | 5e-04 | Inf | 0.0429 | 2 | 2 | neutrophil aggregation |
GO:0032119 | 5e-04 | 27.5948 | 0.1716 | 3 | 8 | sequestering of zinc ion |
GO:1903659 | 5e-04 | 27.5948 | 0.1716 | 3 | 8 | regulation of complement-dependent cytotoxicity |
GO:0019731 | 7e-04 | 6.311 | 1.0727 | 6 | 50 | antibacterial humoral response |
GO:0097530 | 9e-04 | 3.5826 | 3.0037 | 10 | 140 | granulocyte migration |
GO:0051615 | 0.0014 | 91.7399 | 0.0644 | 2 | 3 | histamine uptake |
GO:0010460 | 0.0021 | 8.3774 | 0.5578 | 4 | 26 | positive regulation of heart rate |
GO:0090630 | 0.0023 | 3.7111 | 2.3171 | 8 | 108 | activation of GTPase activity |
GO:0045596 | 0.0024 | 1.9565 | 13.4952 | 25 | 629 | negative regulation of cell differentiation |
GO:0043087 | 0.0029 | 2.3054 | 7.3162 | 16 | 341 | regulation of GTPase activity |
GO:0001580 | 0.0032 | 7.3707 | 0.6222 | 4 | 29 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0090370 | 0.0037 | 11.4928 | 0.3218 | 3 | 15 | negative regulation of cholesterol efflux |
GO:0014050 | 0.0044 | 30.5761 | 0.1073 | 2 | 5 | negative regulation of glutamate secretion |
GO:0021869 | 0.0044 | 30.5761 | 0.1073 | 2 | 5 | forebrain ventricular zone progenitor cell division |
GO:0009617 | 0.0047 | 1.8998 | 12.7228 | 23 | 593 | response to bacterium |
GO:0002682 | 0.0051 | 1.6011 | 27.0977 | 41 | 1263 | regulation of immune system process |
GO:0043267 | 0.0058 | 6.1403 | 0.7295 | 4 | 34 | negative regulation of potassium ion transport |
GO:0035195 | 0.0062 | 2.2522 | 6.5223 | 14 | 304 | miRNA-mediated gene silencing |
GO:0050907 | 0.0064 | 5.9273 | 0.749 | 4 | 37 | detection of chemical stimulus involved in sensory perception |
GO:0001692 | 0.0065 | 22.9306 | 0.1287 | 2 | 6 | histamine metabolic process |
GO:0002860 | 0.0065 | 22.9306 | 0.1287 | 2 | 6 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
GO:0035425 | 0.0065 | 22.9306 | 0.1287 | 2 | 6 | autocrine signaling |
GO:1903524 | 0.0071 | 5.7558 | 0.7724 | 4 | 36 | positive regulation of blood circulation |
GO:0072676 | 0.0075 | 3.3041 | 2.2528 | 7 | 105 | lymphocyte migration |
GO:0070098 | 0.0079 | 3.6952 | 1.7379 | 6 | 81 | chemokine-mediated signaling pathway |
GO:0016441 | 0.0085 | 2.161 | 6.7798 | 14 | 316 | post-transcriptional gene silencing |
GO:0030595 | 0.0086 | 2.4227 | 4.763 | 11 | 222 | leukocyte chemotaxis |
GO:2000535 | 0.009 | 18.3434 | 0.1502 | 2 | 7 | regulation of entry of bacterium into host cell |
GO:0043524 | 0.0095 | 2.8715 | 2.9393 | 8 | 137 | negative regulation of neuron apoptotic process |
GO:0098542 | 0.0096 | 1.6345 | 19.8888 | 31 | 927 | defense response to other organism |
GO:0032891 | 0.0098 | 7.6589 | 0.4506 | 3 | 21 | negative regulation of organic acid transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 20.5124 | 3.7512 | 50 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 15.8932 | 5.0075 | 54 | 287 | detection of chemical stimulus |
GO:0007606 | 0 | 15.2295 | 5.1819 | 54 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 13.8943 | 5.4611 | 53 | 313 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 5.1401 | 16.994 | 67 | 974 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 3.6615 | 21.2686 | 63 | 1219 | nervous system process |
GO:0006959 | 0 | 5.4834 | 3.7163 | 18 | 213 | humoral immune response |
GO:0035195 | 0 | 3.9525 | 5.3041 | 19 | 304 | miRNA-mediated gene silencing |
GO:0016441 | 0 | 3.7899 | 5.5134 | 19 | 316 | post-transcriptional gene silencing |
GO:0031047 | 0 | 3.5236 | 5.8973 | 19 | 338 | gene silencing by RNA |
GO:0006952 | 1e-04 | 1.9867 | 26.1539 | 47 | 1499 | defense response |
GO:0051707 | 1e-04 | 2.062 | 21.8269 | 41 | 1251 | response to other organism |
GO:0009607 | 1e-04 | 1.9941 | 22.49 | 41 | 1289 | response to biotic stimulus |
GO:0045087 | 1e-04 | 2.3306 | 12.5099 | 27 | 717 | innate immune response |
GO:0061844 | 2e-04 | 6.2903 | 1.2388 | 7 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0032501 | 2e-04 | 1.5376 | 113.9942 | 143 | 6645 | multicellular organismal process |
GO:0032416 | 3e-04 | Inf | 0.0349 | 2 | 2 | negative regulation of sodium:proton antiporter activity |
GO:0042742 | 5e-04 | 3.8584 | 2.7887 | 10 | 163 | defense response to bacterium |
GO:0050778 | 7e-04 | 2.4378 | 8.3051 | 19 | 476 | positive regulation of immune response |
GO:0050830 | 9e-04 | 4.9648 | 1.5354 | 7 | 88 | defense response to Gram-positive bacterium |
GO:0051702 | 9e-04 | 4.9039 | 1.5528 | 7 | 89 | biological process involved in interaction with symbiont |
GO:0044793 | 0.001 | 18.9619 | 0.2094 | 3 | 12 | negative regulation by host of viral process |
GO:0031424 | 0.0017 | 5.1307 | 1.2737 | 6 | 73 | keratinization |
GO:0002752 | 0.0018 | 56.7082 | 0.0698 | 2 | 4 | cell surface pattern recognition receptor signaling pathway |
GO:0014826 | 0.0018 | 56.7082 | 0.0698 | 2 | 4 | vein smooth muscle contraction |
GO:0060585 | 0.0018 | 56.7082 | 0.0698 | 2 | 4 | positive regulation of prostaglandin-endoperoxide synthase activity |
GO:0007154 | 0.002 | 1.4306 | 101.1961 | 125 | 5800 | cell communication |
GO:0090370 | 0.002 | 14.2188 | 0.2617 | 3 | 15 | negative regulation of cholesterol efflux |
GO:0023052 | 0.0021 | 1.4293 | 100.3237 | 124 | 5750 | signaling |
GO:0001906 | 0.0021 | 3.4111 | 2.8091 | 9 | 161 | cell killing |
GO:0070098 | 0.0029 | 4.5811 | 1.4133 | 6 | 81 | chemokine-mediated signaling pathway |
GO:0048245 | 0.003 | 12.186 | 0.2966 | 3 | 17 | eosinophil chemotaxis |
GO:0002376 | 0.0032 | 1.5478 | 39.955 | 57 | 2290 | immune system process |
GO:0022617 | 0.0034 | 5.3903 | 1.012 | 5 | 58 | extracellular matrix disassembly |
GO:0006958 | 0.0034 | 7.1259 | 0.6281 | 4 | 36 | complement activation, classical pathway |
GO:0032731 | 0.0039 | 5.1936 | 1.0469 | 5 | 60 | positive regulation of interleukin-1 beta production |
GO:0003100 | 0.0043 | 28.3505 | 0.1047 | 2 | 6 | regulation of systemic arterial blood pressure by endothelin |
GO:1990868 | 0.0046 | 4.1374 | 1.5528 | 6 | 89 | response to chemokine |
GO:0150077 | 0.0051 | 6.3325 | 0.6979 | 4 | 40 | regulation of neuroinflammatory response |
GO:0045630 | 0.006 | 22.679 | 0.1221 | 2 | 7 | positive regulation of T-helper 2 cell differentiation |
GO:0003044 | 0.0066 | 5.8443 | 0.7502 | 4 | 43 | regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0030593 | 0.0067 | 3.814 | 1.675 | 6 | 96 | neutrophil chemotaxis |
GO:0006953 | 0.0071 | 5.6978 | 0.7677 | 4 | 44 | acute-phase response |
GO:0044062 | 0.0072 | 8.527 | 0.4013 | 3 | 23 | regulation of excretion |
GO:0014824 | 0.0079 | 18.898 | 0.1396 | 2 | 8 | artery smooth muscle contraction |
GO:0032119 | 0.0079 | 18.898 | 0.1396 | 2 | 8 | sequestering of zinc ion |
GO:0051673 | 0.0079 | 18.898 | 0.1396 | 2 | 8 | membrane disruption in another organism |
GO:0051838 | 0.0079 | 18.898 | 0.1396 | 2 | 8 | cytolysis by host of symbiont cells |
GO:0060158 | 0.0079 | 18.898 | 0.1396 | 2 | 8 | phospholipase C-activating dopamine receptor signaling pathway |
GO:1902389 | 0.0079 | 18.898 | 0.1396 | 2 | 8 | ceramide 1-phosphate transport |
GO:1903659 | 0.0079 | 18.898 | 0.1396 | 2 | 8 | regulation of complement-dependent cytotoxicity |
GO:1903671 | 0.0091 | 7.7508 | 0.4362 | 3 | 25 | negative regulation of sprouting angiogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051606 | 0 | 7.6387 | 7.8654 | 47 | 431 | detection of stimulus |
GO:0050911 | 0 | 11.7292 | 3.9236 | 35 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007600 | 0 | 4.6954 | 13.2671 | 51 | 727 | sensory perception |
GO:0007186 | 0 | 3.3832 | 17.7746 | 51 | 974 | G protein-coupled receptor signaling pathway |
GO:0003008 | 0 | 2.5321 | 35.7134 | 75 | 1957 | system process |
GO:0042221 | 0 | 1.7234 | 71.3904 | 104 | 3912 | response to chemical |
GO:0001580 | 0 | 14.3037 | 0.5292 | 6 | 29 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0050907 | 0 | 11.9264 | 0.6034 | 6 | 37 | detection of chemical stimulus involved in sensory perception |
GO:0030185 | 1e-04 | 81.5119 | 0.0912 | 3 | 5 | nitric oxide transport |
GO:0010951 | 1e-04 | 3.6619 | 4.1425 | 14 | 227 | negative regulation of endopeptidase activity |
GO:0050909 | 4e-04 | 7.1415 | 0.949 | 6 | 52 | sensory perception of taste |
GO:0051346 | 5e-04 | 2.7953 | 6.1134 | 16 | 335 | negative regulation of hydrolase activity |
GO:0045861 | 7e-04 | 2.7895 | 5.7302 | 15 | 314 | negative regulation of proteolysis |
GO:0034696 | 0.001 | 108.3197 | 0.0547 | 2 | 3 | response to prostaglandin F |
GO:0051615 | 0.001 | 108.3197 | 0.0547 | 2 | 3 | histamine uptake |
GO:0034391 | 0.0016 | 9.0753 | 0.511 | 4 | 28 | regulation of smooth muscle cell apoptotic process |
GO:0014826 | 0.0019 | 54.1565 | 0.073 | 2 | 4 | vein smooth muscle contraction |
GO:0060585 | 0.0019 | 54.1565 | 0.073 | 2 | 4 | positive regulation of prostaglandin-endoperoxide synthase activity |
GO:0015721 | 0.002 | 8.3762 | 0.5475 | 4 | 30 | bile acid and bile salt transport |
GO:0052547 | 0.0021 | 2.323 | 7.7376 | 17 | 424 | regulation of peptidase activity |
GO:0070293 | 0.004 | 10.8594 | 0.3285 | 3 | 18 | renal absorption |
GO:0002860 | 0.0047 | 27.0748 | 0.1095 | 2 | 6 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
GO:0003100 | 0.0047 | 27.0748 | 0.1095 | 2 | 6 | regulation of systemic arterial blood pressure by endothelin |
GO:1905460 | 0.0047 | 27.0748 | 0.1095 | 2 | 6 | negative regulation of vascular associated smooth muscle cell apoptotic process |
GO:0030277 | 0.0063 | 9.0478 | 0.3832 | 3 | 21 | maintenance of gastrointestinal epithelium |
GO:0086043 | 0.0066 | 21.6585 | 0.1277 | 2 | 7 | bundle of His cell action potential |
GO:1904628 | 0.0066 | 21.6585 | 0.1277 | 2 | 7 | cellular response to phorbol 13-acetate 12-myristate |
GO:0042471 | 0.0068 | 3.3591 | 2.2081 | 7 | 121 | ear morphogenesis |
GO:0003018 | 0.0069 | 2.5011 | 4.617 | 11 | 253 | vascular process in circulatory system |
GO:0045214 | 0.0071 | 5.7267 | 0.7665 | 4 | 42 | sarcomere organization |
GO:0071230 | 0.0071 | 4.4682 | 1.2044 | 5 | 66 | cellular response to amino acid stimulus |
GO:0042908 | 0.0077 | 5.5796 | 0.7847 | 4 | 43 | xenobiotic transport |
GO:0097305 | 0.0078 | 2.5914 | 4.0513 | 10 | 222 | response to alcohol |
GO:0051620 | 0.0086 | 18.0476 | 0.146 | 2 | 8 | norepinephrine uptake |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 17.0151 | 3.9501 | 46 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 12.9681 | 5.2729 | 49 | 287 | detection of chemical stimulus |
GO:0007606 | 0 | 12.4373 | 5.4566 | 49 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 11.3439 | 5.7506 | 48 | 313 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 5.3094 | 15.8489 | 65 | 875 | G protein-coupled receptor signaling pathway |
GO:0045653 | 0 | 196.1725 | 0.3307 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0050877 | 0 | 4.3047 | 16.7127 | 58 | 931 | nervous system process |
GO:0006335 | 0 | 43.5556 | 0.5879 | 14 | 32 | DNA replication-dependent chromatin assembly |
GO:0006336 | 0 | 43.5556 | 0.5879 | 14 | 32 | DNA replication-independent chromatin assembly |
GO:0032501 | 0 | 2.4771 | 120.1672 | 184 | 6645 | multicellular organismal process |
GO:0006334 | 0 | 9.4293 | 1.9107 | 15 | 104 | nucleosome assembly |
GO:0006352 | 0 | 7.6894 | 2.2782 | 15 | 124 | DNA-templated transcription, initiation |
GO:0045596 | 0 | 3.2022 | 11.5562 | 33 | 629 | negative regulation of cell differentiation |
GO:0045637 | 0 | 5.2613 | 3.6377 | 17 | 198 | regulation of myeloid cell differentiation |
GO:0032200 | 0 | 5.4781 | 2.8661 | 14 | 156 | telomere organization |
GO:2000252 | 0 | 108.2993 | 0.1102 | 4 | 6 | negative regulation of feeding behavior |
GO:0071824 | 0 | 4.5998 | 3.8582 | 16 | 210 | protein-DNA complex subunit organization |
GO:0007154 | 0 | 1.7206 | 106.5598 | 145 | 5800 | cell communication |
GO:0023052 | 0 | 1.7207 | 105.6412 | 144 | 5750 | signaling |
GO:0019373 | 0 | 27.1536 | 0.2756 | 5 | 15 | epoxygenase P450 pathway |
GO:0048252 | 0 | Inf | 0.0551 | 3 | 3 | lauric acid metabolic process |
GO:0006338 | 0 | 4.0309 | 4.3543 | 16 | 237 | chromatin remodeling |
GO:0035195 | 0 | 3.5146 | 5.5852 | 18 | 304 | miRNA-mediated gene silencing |
GO:0016441 | 0 | 3.3705 | 5.8057 | 18 | 316 | post-transcriptional gene silencing |
GO:0051716 | 0 | 1.6008 | 121.9191 | 156 | 6636 | cellular response to stimulus |
GO:0031047 | 1e-04 | 3.1343 | 6.2099 | 18 | 338 | gene silencing by RNA |
GO:0048513 | 1e-04 | 1.6824 | 59.9491 | 88 | 3263 | animal organ development |
GO:0002682 | 1e-04 | 2.6253 | 9.0518 | 22 | 511 | regulation of immune system process |
GO:0006690 | 2e-04 | 4.9774 | 1.9842 | 9 | 108 | icosanoid metabolic process |
GO:0050789 | 2e-04 | 2.9767 | 7.1772 | 18 | 511 | regulation of biological process |
GO:2000026 | 4e-04 | 1.8661 | 23.7922 | 41 | 1295 | regulation of multicellular organismal development |
GO:0030097 | 5e-04 | 2.0733 | 14.9919 | 29 | 816 | hemopoiesis |
GO:0006959 | 6e-04 | 3.2817 | 3.9133 | 12 | 213 | humoral immune response |
GO:0070269 | 6e-04 | 12.0212 | 0.4042 | 4 | 22 | pyroptosis |
GO:0010986 | 7e-04 | 23.1211 | 0.1837 | 3 | 10 | positive regulation of lipoprotein particle clearance |
GO:0019835 | 8e-04 | 11.3878 | 0.4226 | 4 | 23 | cytolysis |
GO:1903238 | 9e-04 | 20.2297 | 0.2021 | 3 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0048869 | 9e-04 | 1.5035 | 72.0197 | 96 | 3920 | cellular developmental process |
GO:0046968 | 0.001 | 107.5743 | 0.0551 | 2 | 3 | peptide antigen transport |
GO:0072503 | 0.001 | 2.3631 | 8.5432 | 19 | 465 | cellular divalent inorganic cation homeostasis |
GO:0048878 | 0.0011 | 1.8491 | 20.2831 | 35 | 1104 | chemical homeostasis |
GO:0050794 | 0.0011 | 1.4773 | 184.5322 | 210 | 10044 | regulation of cellular process |
GO:0002673 | 0.0014 | 6.7756 | 0.8268 | 5 | 45 | regulation of acute inflammatory response |
GO:0006875 | 0.0014 | 2.1974 | 10.1416 | 21 | 552 | cellular metal ion homeostasis |
GO:0035176 | 0.0015 | 6.6099 | 0.8451 | 5 | 46 | social behavior |
GO:0002520 | 0.0015 | 1.9043 | 16.7924 | 30 | 914 | immune system development |
GO:0050795 | 0.0015 | 5.2563 | 1.2493 | 6 | 68 | regulation of behavior |
GO:0050896 | 0.0019 | 1.9164 | 18.2538 | 31 | 1232 | response to stimulus |
GO:0072268 | 0.002 | 53.7838 | 0.0735 | 2 | 4 | pattern specification involved in metanephros development |
GO:0097022 | 0.002 | 53.7838 | 0.0735 | 2 | 4 | lymphocyte migration into lymph node |
GO:0150062 | 0.002 | 53.7838 | 0.0735 | 2 | 4 | complement-mediated synapse pruning |
GO:0019725 | 0.0021 | 1.9001 | 15.6533 | 28 | 852 | cellular homeostasis |
GO:0031424 | 0.0022 | 4.8625 | 1.3412 | 6 | 73 | keratinization |
GO:0002253 | 0.0027 | 2.5954 | 5.2912 | 13 | 288 | activation of immune response |
GO:0060795 | 0.0027 | 7.723 | 0.5879 | 4 | 32 | cell fate commitment involved in formation of primary germ layer |
GO:0006873 | 0.0032 | 2.0009 | 11.6113 | 22 | 632 | cellular ion homeostasis |
GO:0072081 | 0.0032 | 35.8536 | 0.0919 | 2 | 5 | specification of nephron tubule identity |
GO:0110089 | 0.0032 | 35.8536 | 0.0919 | 2 | 5 | regulation of hippocampal neuron apoptotic process |
GO:0009954 | 0.0034 | 7.2073 | 0.6247 | 4 | 34 | proximal/distal pattern formation |
GO:0055074 | 0.0034 | 2.2113 | 8.1022 | 17 | 441 | calcium ion homeostasis |
GO:0033993 | 0.0035 | 1.8492 | 15.4512 | 27 | 841 | response to lipid |
GO:0006631 | 0.0037 | 2.3176 | 6.8162 | 15 | 371 | fatty acid metabolic process |
GO:0007612 | 0.004 | 3.3511 | 2.5354 | 8 | 138 | learning |
GO:0035902 | 0.0041 | 10.7844 | 0.3307 | 3 | 18 | response to immobilization stress |
GO:0043651 | 0.0041 | 10.7844 | 0.3307 | 3 | 18 | linoleic acid metabolic process |
GO:0002523 | 0.0048 | 10.1097 | 0.3491 | 3 | 19 | leukocyte migration involved in inflammatory response |
GO:0055080 | 0.0048 | 1.898 | 12.7688 | 23 | 695 | cation homeostasis |
GO:0002361 | 0.0048 | 26.8885 | 0.1102 | 2 | 6 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0010668 | 0.0048 | 26.8885 | 0.1102 | 2 | 6 | ectodermal cell differentiation |
GO:0009410 | 0.0051 | 2.234 | 7.055 | 15 | 384 | response to xenobiotic stimulus |
GO:0070328 | 0.0055 | 6.1757 | 0.7165 | 4 | 39 | triglyceride homeostasis |
GO:0098771 | 0.0057 | 1.8689 | 12.9525 | 23 | 705 | inorganic ion homeostasis |
GO:0050776 | 0.0062 | 1.8281 | 13.816 | 24 | 752 | regulation of immune response |
GO:0030501 | 0.0066 | 5.8411 | 0.7533 | 4 | 41 | positive regulation of bone mineralization |
GO:0002933 | 0.0066 | 21.5095 | 0.1286 | 2 | 7 | lipid hydroxylation |
GO:0120252 | 0.0066 | 21.5095 | 0.1286 | 2 | 7 | hydrocarbon metabolic process |
GO:0140507 | 0.0066 | 21.5095 | 0.1286 | 2 | 7 | granzyme-mediated programmed cell death signaling pathway |
GO:0050890 | 0.0072 | 2.3785 | 5.2912 | 12 | 288 | cognition |
GO:0002438 | 0.0073 | 8.5119 | 0.4042 | 3 | 22 | acute inflammatory response to antigenic stimulus |
GO:0001936 | 0.008 | 2.9604 | 2.8477 | 8 | 155 | regulation of endothelial cell proliferation |
GO:0090279 | 0.0085 | 5.402 | 0.8084 | 4 | 44 | regulation of calcium ion import |
GO:0051480 | 0.0086 | 2.2311 | 6.0996 | 13 | 332 | regulation of cytosolic calcium ion concentration |
GO:0009820 | 0.0088 | 17.9234 | 0.147 | 2 | 8 | alkaloid metabolic process |
GO:0019062 | 0.0088 | 17.9234 | 0.147 | 2 | 8 | virion attachment to host cell |
GO:0034351 | 0.0088 | 17.9234 | 0.147 | 2 | 8 | negative regulation of glial cell apoptotic process |
GO:0071281 | 0.0088 | 17.9234 | 0.147 | 2 | 8 | cellular response to iron ion |
GO:1903998 | 0.0088 | 17.9234 | 0.147 | 2 | 8 | regulation of eating behavior |
GO:2000427 | 0.0088 | 17.9234 | 0.147 | 2 | 8 | positive regulation of apoptotic cell clearance |
GO:0050673 | 0.0089 | 2.0889 | 7.5143 | 15 | 409 | epithelial cell proliferation |
GO:0006805 | 0.009 | 3.5747 | 1.7821 | 6 | 97 | xenobiotic metabolic process |
GO:0009888 | 0.0092 | 1.5029 | 33.2724 | 47 | 1811 | tissue development |
GO:0002009 | 0.0097 | 1.9674 | 9.0392 | 17 | 492 | morphogenesis of an epithelium |
GO:0007218 | 0.0098 | 3.4973 | 1.8189 | 6 | 99 | neuropeptide signaling pathway |
GO:0007157 | 0.0099 | 5.1442 | 0.8451 | 4 | 46 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 24.701 | 3.7247 | 56 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 18.4492 | 5.1453 | 61 | 297 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 18.3134 | 4.9721 | 59 | 287 | detection of chemical stimulus |
GO:0050906 | 0 | 16.4116 | 5.4225 | 59 | 313 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 6.6981 | 16.8739 | 80 | 974 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 4.7085 | 21.1183 | 75 | 1219 | nervous system process |
GO:0035195 | 0 | 4.4683 | 5.2666 | 21 | 304 | miRNA-mediated gene silencing |
GO:0016441 | 0 | 4.2832 | 5.4745 | 21 | 316 | post-transcriptional gene silencing |
GO:0032501 | 0 | 1.8366 | 116.3846 | 158 | 6718 | multicellular organismal process |
GO:0031047 | 0 | 3.9804 | 5.8556 | 21 | 338 | gene silencing by RNA |
GO:0023052 | 0 | 1.7502 | 99.6147 | 137 | 5750 | signaling |
GO:0007154 | 0 | 1.7264 | 100.4809 | 137 | 5800 | cell communication |
GO:0048252 | 0 | Inf | 0.052 | 3 | 3 | lauric acid metabolic process |
GO:0045087 | 0 | 2.551 | 12.4215 | 29 | 717 | innate immune response |
GO:0050896 | 1e-04 | 2.7108 | 10.842 | 25 | 853 | response to stimulus |
GO:0051716 | 1e-04 | 1.5976 | 114.964 | 147 | 6636 | cellular response to stimulus |
GO:0006959 | 1e-04 | 3.8173 | 3.6901 | 13 | 213 | humoral immune response |
GO:0006952 | 1e-04 | 1.9515 | 25.9691 | 46 | 1499 | defense response |
GO:0019373 | 1e-04 | 20.9097 | 0.2599 | 4 | 15 | epoxygenase P450 pathway |
GO:0042742 | 1e-04 | 3.4739 | 4.3484 | 14 | 251 | defense response to bacterium |
GO:0009607 | 2e-04 | 1.9521 | 22.331 | 40 | 1289 | response to biotic stimulus |
GO:0051707 | 2e-04 | 1.9582 | 21.6727 | 39 | 1251 | response to other organism |
GO:0034125 | 3e-04 | Inf | 0.0346 | 2 | 2 | negative regulation of MyD88-dependent toll-like receptor signaling pathway |
GO:1905949 | 3e-04 | Inf | 0.0346 | 2 | 2 | negative regulation of calcium ion import across plasma membrane |
GO:0070328 | 5e-04 | 8.4745 | 0.6756 | 5 | 39 | triglyceride homeostasis |
GO:0006690 | 6e-04 | 4.6415 | 1.871 | 8 | 108 | icosanoid metabolic process |
GO:0002682 | 6e-04 | 1.8783 | 21.8806 | 38 | 1263 | regulation of immune system process |
GO:0046968 | 9e-04 | 114.2509 | 0.052 | 2 | 3 | peptide antigen transport |
GO:0002695 | 0.001 | 3.5277 | 3.0318 | 10 | 175 | negative regulation of leukocyte activation |
GO:0001676 | 0.0018 | 4.353 | 1.7324 | 7 | 100 | long-chain fatty acid metabolic process |
GO:0050482 | 0.0019 | 8.5102 | 0.5371 | 4 | 31 | arachidonic acid secretion |
GO:0033559 | 0.002 | 4.2608 | 1.7671 | 7 | 102 | unsaturated fatty acid metabolic process |
GO:0071715 | 0.0022 | 5.9975 | 0.9182 | 5 | 53 | icosanoid transport |
GO:0050913 | 0.0024 | 7.9223 | 0.5717 | 4 | 33 | sensory perception of bitter taste |
GO:1901386 | 0.0024 | 13.2203 | 0.2772 | 3 | 16 | negative regulation of voltage-gated calcium channel activity |
GO:1903588 | 0.0024 | 13.2203 | 0.2772 | 3 | 16 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO:0014016 | 0.0029 | 38.0789 | 0.0866 | 2 | 5 | neuroblast differentiation |
GO:0009404 | 0.0029 | 12.2752 | 0.2945 | 3 | 17 | toxin metabolic process |
GO:0010668 | 0.0043 | 28.5573 | 0.1039 | 2 | 6 | ectodermal cell differentiation |
GO:0035771 | 0.0043 | 28.5573 | 0.1039 | 2 | 6 | interleukin-4-mediated signaling pathway |
GO:2000252 | 0.0043 | 28.5573 | 0.1039 | 2 | 6 | negative regulation of feeding behavior |
GO:0120254 | 0.0045 | 3.6455 | 2.0425 | 7 | 119 | olefinic compound metabolic process |
GO:0006700 | 0.0047 | 10.1071 | 0.3465 | 3 | 20 | C21-steroid hormone biosynthetic process |
GO:0065007 | 0.0052 | 1.4379 | 195.2967 | 215 | 11273 | biological regulation |
GO:0015908 | 0.0058 | 3.93 | 1.6285 | 6 | 94 | fatty acid transport |
GO:0055088 | 0.0059 | 3.1266 | 2.7026 | 8 | 156 | lipid homeostasis |
GO:0002933 | 0.0059 | 22.8444 | 0.1213 | 2 | 7 | lipid hydroxylation |
GO:0046222 | 0.0059 | 22.8444 | 0.1213 | 2 | 7 | aflatoxin metabolic process |
GO:0120252 | 0.0059 | 22.8444 | 0.1213 | 2 | 7 | hydrocarbon metabolic process |
GO:0140507 | 0.0059 | 22.8444 | 0.1213 | 2 | 7 | granzyme-mediated programmed cell death signaling pathway |
GO:0003071 | 0.0062 | 9.042 | 0.3811 | 3 | 22 | renal system process involved in regulation of systemic arterial blood pressure |
GO:0036315 | 0.0062 | 9.042 | 0.3811 | 3 | 22 | cellular response to sterol |
GO:0042745 | 0.0062 | 9.042 | 0.3811 | 3 | 22 | circadian sleep/wake cycle |
GO:0070269 | 0.0062 | 9.042 | 0.3811 | 3 | 22 | pyroptosis |
GO:0050795 | 0.0065 | 4.5652 | 1.1781 | 5 | 68 | regulation of behavior |
GO:0019835 | 0.007 | 8.5894 | 0.3985 | 3 | 23 | cytolysis |
GO:0120255 | 0.007 | 8.5894 | 0.3985 | 3 | 23 | olefinic compound biosynthetic process |
GO:0022407 | 0.0073 | 2.1412 | 7.3455 | 15 | 424 | regulation of cell-cell adhesion |
GO:0002673 | 0.0075 | 5.5994 | 0.7796 | 4 | 45 | regulation of acute inflammatory response |
GO:0061844 | 0.0077 | 4.3569 | 1.23 | 5 | 71 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0009820 | 0.0078 | 19.0358 | 0.1386 | 2 | 8 | alkaloid metabolic process |
GO:0019062 | 0.0078 | 19.0358 | 0.1386 | 2 | 8 | virion attachment to host cell |
GO:0070268 | 0.0078 | 19.0358 | 0.1386 | 2 | 8 | cornification |
GO:1903979 | 0.0078 | 19.0358 | 0.1386 | 2 | 8 | negative regulation of microglial cell activation |
GO:0007157 | 0.0081 | 5.4657 | 0.7969 | 4 | 46 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0032413 | 0.0082 | 4.2916 | 1.2473 | 5 | 72 | negative regulation of ion transmembrane transporter activity |
GO:0010466 | 0.0085 | 2.5541 | 4.1059 | 10 | 237 | negative regulation of peptidase activity |
GO:0051384 | 0.0085 | 3.2062 | 2.3041 | 7 | 133 | response to glucocorticoid |
GO:1903671 | 0.0089 | 7.8076 | 0.4331 | 3 | 25 | negative regulation of sprouting angiogenesis |
GO:0097267 | 0.0099 | 16.3154 | 0.1559 | 2 | 9 | omega-hydroxylase P450 pathway |
GO:1903244 | 0.0099 | 16.3154 | 0.1559 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 30.2486 | 4.0163 | 67 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 21.2477 | 5.5482 | 71 | 297 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 21.7361 | 5.3613 | 70 | 287 | detection of chemical stimulus |
GO:0050906 | 0 | 18.9407 | 5.847 | 69 | 313 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 7.3084 | 18.1949 | 91 | 974 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 4.7384 | 22.7717 | 81 | 1219 | nervous system process |
GO:0045087 | 0 | 2.7219 | 13.394 | 33 | 717 | innate immune response |
GO:0035195 | 0 | 3.6695 | 5.6789 | 19 | 304 | miRNA-mediated gene silencing |
GO:0031047 | 0 | 3.4667 | 6.3141 | 20 | 338 | gene silencing by RNA |
GO:0016441 | 0 | 3.5185 | 5.9031 | 19 | 316 | post-transcriptional gene silencing |
GO:0007154 | 0 | 1.621 | 108.3477 | 143 | 5800 | cell communication |
GO:0023052 | 0 | 1.6213 | 107.4137 | 142 | 5750 | signaling |
GO:0031424 | 0 | 7.5943 | 1.2068 | 8 | 65 | keratinization |
GO:0006956 | 1e-04 | 7.9852 | 1.0088 | 7 | 54 | complement activation |
GO:0009607 | 1e-04 | 2.002 | 24.0793 | 44 | 1289 | response to biotic stimulus |
GO:0048247 | 1e-04 | 7.8183 | 1.0274 | 7 | 55 | lymphocyte chemotaxis |
GO:0051716 | 1e-04 | 1.5455 | 123.9647 | 156 | 6636 | cellular response to stimulus |
GO:0070098 | 1e-04 | 5.8859 | 1.5131 | 8 | 81 | chemokine-mediated signaling pathway |
GO:0019373 | 1e-04 | 19.3445 | 0.2802 | 4 | 15 | epoxygenase P450 pathway |
GO:0002548 | 2e-04 | 6.6981 | 1.1769 | 7 | 63 | monocyte chemotaxis |
GO:0048245 | 2e-04 | 16.3663 | 0.3176 | 4 | 17 | eosinophil chemotaxis |
GO:1990868 | 3e-04 | 5.3019 | 1.6626 | 8 | 89 | response to chemokine |
GO:0006952 | 3e-04 | 1.829 | 28.0023 | 47 | 1499 | defense response |
GO:0032501 | 3e-04 | 1.5115 | 117.2052 | 146 | 6559 | multicellular organismal process |
GO:1903945 | 3e-04 | Inf | 0.0374 | 2 | 2 | positive regulation of hepatocyte apoptotic process |
GO:0051707 | 6e-04 | 1.8983 | 21.0156 | 37 | 1144 | response to other organism |
GO:0071347 | 6e-04 | 4.6143 | 1.8867 | 8 | 101 | cellular response to interleukin-1 |
GO:0033861 | 0.001 | 105.7542 | 0.056 | 2 | 3 | negative regulation of NAD(P)H oxidase activity |
GO:0048252 | 0.001 | 105.7542 | 0.056 | 2 | 3 | lauric acid metabolic process |
GO:1901670 | 0.001 | 105.7542 | 0.056 | 2 | 3 | negative regulation of superoxide dismutase activity |
GO:0002674 | 0.0013 | 17.6756 | 0.2242 | 3 | 12 | negative regulation of acute inflammatory response |
GO:0097530 | 0.0013 | 3.6889 | 2.6153 | 9 | 140 | granulocyte migration |
GO:0015939 | 0.002 | 52.8738 | 0.0747 | 2 | 4 | pantothenate metabolic process |
GO:0036101 | 0.002 | 52.8738 | 0.0747 | 2 | 4 | leukotriene B4 catabolic process |
GO:0044278 | 0.002 | 52.8738 | 0.0747 | 2 | 4 | cell wall disruption in another organism |
GO:0030593 | 0.0021 | 4.2057 | 1.7933 | 7 | 96 | neutrophil chemotaxis |
GO:0009913 | 0.0025 | 2.8873 | 4.035 | 11 | 216 | epidermal cell differentiation |
GO:0042742 | 0.0028 | 2.7051 | 4.6888 | 12 | 251 | defense response to bacterium |
GO:2001170 | 0.0034 | 35.247 | 0.0934 | 2 | 5 | negative regulation of ATP biosynthetic process |
GO:0002250 | 0.0034 | 2.2672 | 7.4349 | 16 | 398 | adaptive immune response |
GO:0019730 | 0.0039 | 3.7405 | 1.9988 | 7 | 107 | antimicrobial humoral response |
GO:0032691 | 0.004 | 6.8555 | 0.6538 | 4 | 35 | negative regulation of interleukin-1 beta production |
GO:0071346 | 0.0044 | 3.6667 | 2.0362 | 7 | 109 | cellular response to interferon-gamma |
GO:1900408 | 0.005 | 26.4336 | 0.1121 | 2 | 6 | negative regulation of cellular response to oxidative stress |
GO:0002532 | 0.0054 | 3.9992 | 1.6065 | 6 | 86 | production of molecular mediator involved in inflammatory response |
GO:0071356 | 0.006 | 2.6957 | 3.9043 | 10 | 209 | cellular response to tumor necrosis factor |
GO:0002684 | 0.0063 | 1.8034 | 14.5896 | 25 | 781 | positive regulation of immune system process |
GO:0043588 | 0.0064 | 2.4171 | 5.2119 | 12 | 279 | skin development |
GO:0002933 | 0.0069 | 21.1455 | 0.1308 | 2 | 7 | lipid hydroxylation |
GO:1900226 | 0.0069 | 21.1455 | 0.1308 | 2 | 7 | negative regulation of NLRP3 inflammasome complex assembly |
GO:1900748 | 0.0069 | 21.1455 | 0.1308 | 2 | 7 | positive regulation of vascular endothelial growth factor signaling pathway |
GO:0140632 | 0.0076 | 8.3674 | 0.411 | 3 | 22 | inflammasome complex assembly |
GO:1900015 | 0.0078 | 4.3613 | 1.2329 | 5 | 66 | regulation of cytokine production involved in inflammatory response |
GO:0008037 | 0.0078 | 2.9704 | 2.8395 | 8 | 152 | cell recognition |
GO:0030809 | 0.009 | 17.6202 | 0.1494 | 2 | 8 | negative regulation of nucleotide biosynthetic process |
GO:0070268 | 0.009 | 17.6202 | 0.1494 | 2 | 8 | cornification |
GO:0006805 | 0.0097 | 3.5134 | 1.812 | 6 | 97 | xenobiotic metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 13.7272 | 4.6079 | 45 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 7.2339 | 12.0694 | 66 | 563 | G protein-coupled receptor activity |
GO:0038023 | 0 | 4.1343 | 22.4824 | 74 | 1057 | signaling receptor activity |
GO:0005549 | 0 | 18.302 | 1.3196 | 17 | 61 | odorant binding |
GO:0046982 | 0 | 5.6148 | 6.4899 | 31 | 300 | protein heterodimerization activity |
GO:0033038 | 2e-04 | 18.2849 | 0.3029 | 4 | 14 | bitter taste receptor activity |
GO:1903231 | 6e-04 | 3.7855 | 2.8556 | 10 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0008503 | 8e-04 | 22.7969 | 0.1947 | 3 | 9 | benzodiazepine receptor activity |
GO:0070330 | 0.001 | 10.7511 | 0.4543 | 4 | 21 | aromatase activity |
GO:0030414 | 0.001 | 3.259 | 3.6127 | 11 | 167 | peptidase inhibitor activity |
GO:0033782 | 0.0014 | 90.9575 | 0.0649 | 2 | 3 | 24-hydroxycholesterol 7alpha-hydroxylase activity |
GO:0022851 | 0.0015 | 17.0955 | 0.238 | 3 | 11 | GABA-gated chloride ion channel activity |
GO:0061135 | 0.0016 | 3.0795 | 3.8074 | 11 | 176 | endopeptidase regulator activity |
GO:0005237 | 0.0019 | 15.1951 | 0.2596 | 3 | 12 | inhibitory extracellular ligand-gated ion channel activity |
GO:0008188 | 0.002 | 6.1846 | 0.9086 | 5 | 42 | neuropeptide receptor activity |
GO:0008392 | 0.0024 | 13.6747 | 0.2812 | 3 | 13 | arachidonic acid epoxygenase activity |
GO:0050051 | 0.0027 | 45.4759 | 0.0865 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0003677 | 0.0029 | 1.4895 | 49.9077 | 69 | 2307 | DNA binding |
GO:0004867 | 0.0032 | 3.9182 | 1.9254 | 7 | 89 | serine-type endopeptidase inhibitor activity |
GO:0001653 | 0.0039 | 3.0905 | 3.0935 | 9 | 143 | peptide receptor activity |
GO:0019863 | 0.0045 | 30.3154 | 0.1082 | 2 | 5 | IgE binding |
GO:0030883 | 0.0045 | 30.3154 | 0.1082 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0045 | 30.3154 | 0.1082 | 2 | 5 | exogenous lipid antigen binding |
GO:0004890 | 0.0046 | 10.517 | 0.3461 | 3 | 16 | GABA-A receptor activity |
GO:0008395 | 0.006 | 6.0874 | 0.7355 | 4 | 34 | steroid hydroxylase activity |
GO:0030021 | 0.0064 | 9.1136 | 0.3894 | 3 | 18 | extracellular matrix structural constituent conferring compression resistance |
GO:0031849 | 0.0066 | 22.7351 | 0.1298 | 2 | 6 | olfactory receptor binding |
GO:0005253 | 0.0077 | 3.7128 | 1.7307 | 6 | 80 | anion channel activity |
GO:0008227 | 0.0081 | 5.5329 | 0.8004 | 4 | 37 | G protein-coupled amine receptor activity |
GO:0005506 | 0.0099 | 2.8463 | 2.9637 | 8 | 137 | iron ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 20.4643 | 4.0367 | 53 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 8.3593 | 11.3711 | 69 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 5.4287 | 19.6234 | 79 | 1057 | signaling receptor activity |
GO:0008392 | 0 | 61.7604 | 0.2464 | 7 | 13 | arachidonic acid epoxygenase activity |
GO:0070330 | 0 | 32.6702 | 0.398 | 8 | 21 | aromatase activity |
GO:0005506 | 0 | 6.6364 | 2.5964 | 15 | 137 | iron ion binding |
GO:0020037 | 0 | 6.7896 | 2.369 | 14 | 125 | heme binding |
GO:0018685 | 0 | Inf | 0.0569 | 3 | 3 | alkane 1-monooxygenase activity |
GO:0005549 | 0 | 7.9935 | 1.1561 | 8 | 61 | odorant binding |
GO:0050051 | 0 | 156.7987 | 0.0758 | 3 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0008395 | 0 | 11.2911 | 0.6444 | 6 | 34 | steroid hydroxylase activity |
GO:0019825 | 0 | 10.9011 | 0.6633 | 6 | 35 | oxygen binding |
GO:1903231 | 2e-04 | 4.3508 | 2.5016 | 10 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0004321 | 2e-04 | 39.1924 | 0.1327 | 3 | 7 | fatty-acyl-CoA synthase activity |
GO:0047760 | 5e-04 | 26.125 | 0.1706 | 3 | 9 | butyrate-CoA ligase activity |
GO:0008401 | 7e-04 | 22.3915 | 0.1895 | 3 | 10 | retinoic acid 4-hydroxylase activity |
GO:0018858 | 0.0011 | 104.1942 | 0.0569 | 2 | 3 | benzoate-CoA ligase activity |
GO:0045182 | 0.0011 | 2.8826 | 4.7948 | 13 | 253 | translation regulator activity |
GO:0008188 | 0.0011 | 7.0933 | 0.796 | 5 | 42 | neuropeptide receptor activity |
GO:0001653 | 0.0016 | 3.5506 | 2.7101 | 9 | 143 | peptide receptor activity |
GO:0008391 | 0.002 | 53.2815 | 0.0742 | 2 | 4 | arachidonic acid monooxygenase activity |
GO:0102391 | 0.0021 | 52.0939 | 0.0758 | 2 | 4 | decanoate-CoA ligase activity |
GO:0003730 | 0.0026 | 3.3019 | 2.8996 | 9 | 153 | mRNA 3'-UTR binding |
GO:0004890 | 0.0031 | 12.0524 | 0.3032 | 3 | 16 | GABA-A receptor activity |
GO:0030883 | 0.0034 | 34.7271 | 0.0948 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0034 | 34.7271 | 0.0948 | 2 | 5 | exogenous lipid antigen binding |
GO:0043395 | 0.0045 | 10.4442 | 0.3411 | 3 | 18 | heparan sulfate proteoglycan binding |
GO:0017083 | 0.0051 | 26.0437 | 0.1137 | 2 | 6 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO:0102033 | 0.0051 | 26.0437 | 0.1137 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0015645 | 0.007 | 8.7018 | 0.398 | 3 | 21 | fatty acid ligase activity |
GO:0008236 | 0.0077 | 2.7596 | 3.4303 | 9 | 181 | serine-type peptidase activity |
GO:0019865 | 0.0079 | 8.2433 | 0.4169 | 3 | 22 | immunoglobulin binding |
GO:1904315 | 0.008 | 5.5069 | 0.796 | 4 | 42 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential |
GO:0034235 | 0.0093 | 17.3603 | 0.1516 | 2 | 8 | GPI anchor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 7.9525 | 7.1298 | 43 | 600 | G protein-coupled receptor activity |
GO:0004984 | 0 | 13.1863 | 2.5311 | 26 | 213 | olfactory receptor activity |
GO:0038023 | 0 | 4.9733 | 12.2159 | 47 | 1057 | signaling receptor activity |
GO:0005549 | 0 | 17.132 | 0.7249 | 10 | 61 | odorant binding |
GO:1903231 | 0 | 7.9516 | 1.5686 | 11 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0070330 | 0 | 26.6431 | 0.2495 | 5 | 21 | aromatase activity |
GO:0045182 | 2e-04 | 3.9459 | 3.0064 | 11 | 253 | translation regulator activity |
GO:0008392 | 4e-04 | 25.3203 | 0.1545 | 3 | 13 | arachidonic acid epoxygenase activity |
GO:0033038 | 5e-04 | 23.017 | 0.1664 | 3 | 14 | bitter taste receptor activity |
GO:0020037 | 7e-04 | 5.0793 | 1.4854 | 7 | 125 | heme binding |
GO:0004982 | 8e-04 | 84.0052 | 0.0475 | 2 | 4 | N-formyl peptide receptor activity |
GO:0005124 | 8e-04 | 84.0052 | 0.0475 | 2 | 4 | scavenger receptor binding |
GO:0034875 | 8e-04 | 84.0052 | 0.0475 | 2 | 4 | caffeine oxidase activity |
GO:0051380 | 8e-04 | 84.0052 | 0.0475 | 2 | 4 | norepinephrine binding |
GO:0005506 | 0.0013 | 4.607 | 1.628 | 7 | 137 | iron ion binding |
GO:0030883 | 0.0014 | 56 | 0.0594 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0014 | 56 | 0.0594 | 2 | 5 | exogenous lipid antigen binding |
GO:0099104 | 0.0014 | 56 | 0.0594 | 2 | 5 | potassium channel activator activity |
GO:0016709 | 0.0015 | 8.9154 | 0.4991 | 4 | 42 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GO:0001653 | 0.0016 | 4.4021 | 1.6993 | 7 | 143 | peptide receptor activity |
GO:0051379 | 0.002 | 41.9974 | 0.0713 | 2 | 6 | epinephrine binding |
GO:0030247 | 0.0022 | 13.3191 | 0.2614 | 3 | 22 | polysaccharide binding |
GO:0008395 | 0.0034 | 11.1117 | 0.3059 | 3 | 26 | steroid hydroxylase activity |
GO:0046703 | 0.0038 | 27.9948 | 0.0951 | 2 | 8 | natural killer cell lectin-like receptor binding |
GO:0101020 | 0.0038 | 27.9948 | 0.0951 | 2 | 8 | estrogen 16-alpha-hydroxylase activity |
GO:0001664 | 0.0043 | 3.0406 | 3.1252 | 9 | 263 | G protein-coupled receptor binding |
GO:0004935 | 0.0048 | 23.9941 | 0.1069 | 2 | 9 | adrenergic receptor activity |
GO:0008503 | 0.0048 | 23.9941 | 0.1069 | 2 | 9 | benzodiazepine receptor activity |
GO:0016725 | 0.0048 | 23.9941 | 0.1069 | 2 | 9 | oxidoreductase activity, acting on CH or CH2 groups |
GO:0030246 | 0.0054 | 3.1719 | 2.6595 | 8 | 227 | carbohydrate binding |
GO:0004875 | 0.0059 | 20.9935 | 0.1188 | 2 | 10 | complement receptor activity |
GO:0008401 | 0.0059 | 20.9935 | 0.1188 | 2 | 10 | retinoic acid 4-hydroxylase activity |
GO:0071723 | 0.0059 | 20.9935 | 0.1188 | 2 | 10 | lipopeptide binding |
GO:0022851 | 0.0072 | 18.6598 | 0.1307 | 2 | 11 | GABA-gated chloride ion channel activity |
GO:0005237 | 0.0086 | 16.7927 | 0.1426 | 2 | 12 | inhibitory extracellular ligand-gated ion channel activity |
GO:0003730 | 0.01 | 3.47 | 1.8181 | 6 | 153 | mRNA 3'-UTR binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003677 | 0 | 3.2468 | 57.0775 | 137 | 2307 | DNA binding |
GO:1990837 | 0 | 3.4723 | 36.0971 | 99 | 1459 | sequence-specific double-stranded DNA binding |
GO:0001067 | 0 | 3.4178 | 34.8353 | 95 | 1408 | transcription regulatory region nucleic acid binding |
GO:0140110 | 0 | 2.7938 | 43.94 | 100 | 1776 | transcription regulator activity |
GO:0000978 | 0 | 3.2361 | 26.1255 | 71 | 1066 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0000981 | 0 | 4.2835 | 13.2981 | 48 | 584 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0046982 | 0 | 5.2145 | 7.4223 | 33 | 300 | protein heterodimerization activity |
GO:0001228 | 0 | 3.5292 | 10.8366 | 34 | 438 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0004930 | 0 | 3.0141 | 14.8446 | 40 | 600 | G protein-coupled receptor activity |
GO:0000977 | 0 | 4.3395 | 4.358 | 17 | 202 | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO:0097159 | 0 | 1.5973 | 141.6423 | 186 | 5725 | organic cyclic compound binding |
GO:1901363 | 0 | 1.5643 | 139.8609 | 182 | 5653 | heterocyclic compound binding |
GO:0019825 | 0 | 10.01 | 0.8659 | 7 | 35 | oxygen binding |
GO:0004984 | 0 | 3.5247 | 5.2698 | 17 | 213 | olfactory receptor activity |
GO:0031720 | 0 | 39.801 | 0.1979 | 4 | 8 | haptoglobin binding |
GO:0038023 | 1e-04 | 1.9009 | 29.6892 | 52 | 1200 | signaling receptor activity |
GO:0030545 | 1e-04 | 2.4737 | 11.752 | 27 | 475 | signaling receptor regulator activity |
GO:0051380 | 1e-04 | 119.129 | 0.099 | 3 | 4 | norepinephrine binding |
GO:0001227 | 1e-04 | 2.8076 | 7.6697 | 20 | 310 | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO:0005344 | 2e-04 | 19.8955 | 0.2969 | 4 | 12 | oxygen carrier activity |
GO:0048018 | 2e-04 | 2.3777 | 10.7871 | 24 | 436 | receptor ligand activity |
GO:0071837 | 3e-04 | 15.9144 | 0.3464 | 4 | 14 | HMG box domain binding |
GO:0005184 | 6e-04 | 8.6637 | 0.6927 | 5 | 28 | neuropeptide hormone activity |
GO:0004351 | 6e-04 | Inf | 0.0495 | 2 | 2 | glutamate decarboxylase activity |
GO:0017147 | 7e-04 | 8.3022 | 0.7175 | 5 | 29 | Wnt-protein binding |
GO:0020037 | 0.0011 | 3.489 | 3.0926 | 10 | 125 | heme binding |
GO:0008503 | 0.0011 | 19.8486 | 0.2227 | 3 | 9 | benzodiazepine receptor activity |
GO:0004939 | 0.0018 | 79.2228 | 0.0742 | 2 | 3 | beta-adrenergic receptor activity |
GO:0031721 | 0.0018 | 79.2228 | 0.0742 | 2 | 3 | hemoglobin alpha binding |
GO:0033265 | 0.0018 | 79.2228 | 0.0742 | 2 | 3 | choline binding |
GO:0120319 | 0.0018 | 79.2228 | 0.0742 | 2 | 3 | long-chain fatty acid omega-1 hydroxylase activity |
GO:0022851 | 0.0021 | 14.8846 | 0.2722 | 3 | 11 | GABA-gated chloride ion channel activity |
GO:0005237 | 0.0028 | 13.2299 | 0.2969 | 3 | 12 | inhibitory extracellular ligand-gated ion channel activity |
GO:0090722 | 0.0035 | 39.6089 | 0.099 | 2 | 4 | receptor-receptor interaction |
GO:0008392 | 0.0036 | 11.9062 | 0.3216 | 3 | 13 | arachidonic acid epoxygenase activity |
GO:0008188 | 0.0036 | 5.3808 | 1.0391 | 5 | 42 | neuropeptide receptor activity |
GO:0042813 | 0.0055 | 9.9206 | 0.3711 | 3 | 15 | Wnt-activated receptor activity |
GO:0001664 | 0.006 | 2.2598 | 6.5069 | 14 | 263 | G protein-coupled receptor binding |
GO:0070888 | 0.0065 | 4.6283 | 1.1876 | 5 | 48 | E-box binding |
GO:0004890 | 0.0066 | 9.1569 | 0.3959 | 3 | 16 | GABA-A receptor activity |
GO:0019904 | 0.0072 | 1.7559 | 15.4955 | 26 | 632 | protein domain specific binding |
GO:0051379 | 0.0086 | 19.802 | 0.1484 | 2 | 6 | epinephrine binding |
GO:0051428 | 0.0093 | 7.935 | 0.4453 | 3 | 18 | peptide hormone receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 9.1527 | 4.0887 | 30 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 4.9288 | 11.5174 | 47 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.2581 | 19.9483 | 55 | 1057 | signaling receptor activity |
GO:0070330 | 0 | 20.8155 | 0.4031 | 6 | 21 | aromatase activity |
GO:0008392 | 0 | 32.4335 | 0.2495 | 5 | 13 | arachidonic acid epoxygenase activity |
GO:0020037 | 0 | 5.0725 | 2.3995 | 11 | 125 | heme binding |
GO:0019825 | 0 | 10.7573 | 0.6718 | 6 | 35 | oxygen binding |
GO:0005506 | 1e-04 | 4.5859 | 2.6298 | 11 | 137 | iron ion binding |
GO:0030414 | 1e-04 | 4.0728 | 3.2057 | 12 | 167 | peptidase inhibitor activity |
GO:0030545 | 1e-04 | 2.5927 | 9.1179 | 22 | 475 | signaling receptor regulator activity |
GO:0047498 | 2e-04 | 17.2379 | 0.3071 | 4 | 16 | calcium-dependent phospholipase A2 activity |
GO:0008395 | 4e-04 | 8.9355 | 0.6527 | 5 | 34 | steroid hydroxylase activity |
GO:0061135 | 6e-04 | 3.4934 | 3.3784 | 11 | 176 | endopeptidase regulator activity |
GO:0019865 | 7e-04 | 11.4877 | 0.4223 | 4 | 22 | immunoglobulin binding |
GO:0008401 | 8e-04 | 22.0989 | 0.192 | 3 | 10 | retinoic acid 4-hydroxylase activity |
GO:0017171 | 9e-04 | 3.3109 | 3.5512 | 11 | 185 | serine hydrolase activity |
GO:0018685 | 0.0011 | 102.8371 | 0.0576 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0030298 | 0.0011 | 102.8371 | 0.0576 | 2 | 3 | receptor signaling protein tyrosine kinase activator activity |
GO:0051431 | 0.0011 | 102.8371 | 0.0576 | 2 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0004252 | 0.0013 | 3.3939 | 3.1481 | 10 | 164 | serine-type endopeptidase activity |
GO:0052689 | 0.0018 | 3.5033 | 2.745 | 9 | 143 | carboxylic ester hydrolase activity |
GO:0008745 | 0.0021 | 51.4153 | 0.0768 | 2 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0004869 | 0.0024 | 5.8838 | 0.9406 | 5 | 49 | cysteine-type endopeptidase inhibitor activity |
GO:0016019 | 0.0035 | 34.2748 | 0.096 | 2 | 5 | peptidoglycan immune receptor activity |
GO:0048018 | 0.0038 | 2.3932 | 6.16 | 14 | 326 | receptor ligand activity |
GO:0017083 | 0.0052 | 25.7045 | 0.1152 | 2 | 6 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO:0031702 | 0.0052 | 25.7045 | 0.1152 | 2 | 6 | type 1 angiotensin receptor binding |
GO:0102033 | 0.0052 | 25.7045 | 0.1152 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0005179 | 0.0053 | 3.5287 | 2.1115 | 7 | 110 | hormone activity |
GO:0008527 | 0.0054 | 9.6629 | 0.3647 | 3 | 19 | taste receptor activity |
GO:0008233 | 0.0055 | 1.968 | 10.6728 | 20 | 556 | peptidase activity |
GO:0005539 | 0.0056 | 2.7248 | 3.865 | 10 | 203 | glycosaminoglycan binding |
GO:0001653 | 0.0064 | 3.0807 | 2.745 | 8 | 143 | peptide receptor activity |
GO:0004321 | 0.0072 | 20.5623 | 0.1344 | 2 | 7 | fatty-acyl-CoA synthase activity |
GO:0016714 | 0.0072 | 20.5623 | 0.1344 | 2 | 7 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen |
GO:0004867 | 0.0073 | 3.7459 | 1.7084 | 6 | 89 | serine-type endopeptidase inhibitor activity |
GO:0008188 | 0.0084 | 5.4348 | 0.8062 | 4 | 42 | neuropeptide receptor activity |
GO:0005540 | 0.0093 | 7.7284 | 0.4415 | 3 | 23 | hyaluronic acid binding |
GO:0030215 | 0.0093 | 7.7284 | 0.4415 | 3 | 23 | semaphorin receptor binding |
GO:0034235 | 0.0095 | 17.1342 | 0.1536 | 2 | 8 | GPI anchor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038023 | 0 | 3.0636 | 17.2578 | 45 | 1200 | signaling receptor activity |
GO:1903231 | 0 | 6.4861 | 1.8984 | 11 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0004930 | 0 | 3.0656 | 8.6289 | 24 | 600 | G protein-coupled receptor activity |
GO:0001632 | 2e-04 | Inf | 0.0288 | 2 | 2 | leukotriene B4 receptor activity |
GO:0004984 | 3e-04 | 3.8656 | 3.0633 | 11 | 213 | olfactory receptor activity |
GO:0045182 | 3e-04 | 3.5417 | 3.6385 | 12 | 253 | translation regulator activity |
GO:0001875 | 0.002 | 46.0712 | 0.0719 | 2 | 5 | lipopolysaccharide immune receptor activity |
GO:0008527 | 0.0024 | 13.0027 | 0.2732 | 3 | 19 | taste receptor activity |
GO:0031730 | 0.003 | 34.5513 | 0.0863 | 2 | 6 | CCR5 chemokine receptor binding |
GO:0032394 | 0.0041 | 27.6393 | 0.1007 | 2 | 7 | MHC class Ib receptor activity |
GO:0046703 | 0.0054 | 23.0313 | 0.1151 | 2 | 8 | natural killer cell lectin-like receptor binding |
GO:0003730 | 0.0067 | 3.3557 | 2.2004 | 7 | 153 | mRNA 3'-UTR binding |
GO:0042056 | 0.0081 | 7.9967 | 0.4171 | 3 | 29 | chemoattractant activity |
GO:0043295 | 0.0086 | 17.2714 | 0.1438 | 2 | 10 | glutathione binding |
GO:0042379 | 0.0091 | 5.2443 | 0.8197 | 4 | 57 | chemokine receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1990837 | 0 | 3.4012 | 29.7846 | 81 | 1459 | sequence-specific double-stranded DNA binding |
GO:0001067 | 0 | 3.306 | 28.7434 | 77 | 1408 | transcription regulatory region nucleic acid binding |
GO:0000981 | 0 | 4.4869 | 11.1065 | 42 | 584 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0140110 | 0 | 2.7055 | 36.2559 | 81 | 1776 | transcription regulator activity |
GO:0000978 | 0 | 3.1094 | 22.7416 | 60 | 1114 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0030545 | 0 | 3.59 | 9.6968 | 31 | 475 | signaling receptor regulator activity |
GO:0003677 | 0 | 2.0513 | 47.096 | 83 | 2307 | DNA binding |
GO:0048018 | 0 | 4.145 | 4.5257 | 17 | 227 | receptor ligand activity |
GO:0001228 | 0 | 3.0583 | 8.9415 | 25 | 438 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0000977 | 1e-04 | 3.8939 | 3.6317 | 13 | 202 | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO:0008392 | 1e-04 | 21.5723 | 0.2654 | 4 | 13 | arachidonic acid epoxygenase activity |
GO:0071837 | 1e-04 | 19.4139 | 0.2858 | 4 | 14 | HMG box domain binding |
GO:0005184 | 2e-04 | 10.5744 | 0.5716 | 5 | 28 | neuropeptide hormone activity |
GO:0001632 | 4e-04 | Inf | 0.0408 | 2 | 2 | leukotriene B4 receptor activity |
GO:0005506 | 5e-04 | 3.8638 | 2.7968 | 10 | 137 | iron ion binding |
GO:0070330 | 8e-04 | 11.415 | 0.4287 | 4 | 21 | aromatase activity |
GO:0030295 | 8e-04 | 4.3943 | 1.9802 | 8 | 97 | protein kinase activator activity |
GO:0020037 | 0.0011 | 3.7982 | 2.5518 | 9 | 125 | heme binding |
GO:0018685 | 0.0012 | 96.5405 | 0.0612 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0030298 | 0.0012 | 96.5405 | 0.0612 | 2 | 3 | receptor signaling protein tyrosine kinase activator activity |
GO:0005125 | 0.0013 | 2.9944 | 4.2666 | 12 | 209 | cytokine activity |
GO:0001664 | 0.0022 | 2.7823 | 4.5689 | 12 | 226 | G protein-coupled receptor binding |
GO:0004953 | 0.0026 | 13.1961 | 0.2858 | 3 | 14 | icosanoid receptor activity |
GO:0052689 | 0.0027 | 3.2842 | 2.9193 | 9 | 143 | carboxylic ester hydrolase activity |
GO:0047498 | 0.0039 | 11.1645 | 0.3266 | 3 | 16 | calcium-dependent phospholipase A2 activity |
GO:0001227 | 0.0048 | 2.3249 | 6.3285 | 14 | 310 | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO:0019825 | 0.0054 | 6.2544 | 0.7145 | 4 | 35 | oxygen binding |
GO:0051428 | 0.0055 | 9.6747 | 0.3675 | 3 | 18 | peptide hormone receptor binding |
GO:0016209 | 0.0055 | 3.9977 | 1.6127 | 6 | 79 | antioxidant activity |
GO:0004620 | 0.0057 | 3.4793 | 2.1435 | 7 | 105 | phospholipase activity |
GO:0015129 | 0.0059 | 24.1306 | 0.1225 | 2 | 6 | lactate transmembrane transporter activity |
GO:0017083 | 0.0059 | 24.1306 | 0.1225 | 2 | 6 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO:0031702 | 0.0059 | 24.1306 | 0.1225 | 2 | 6 | type 1 angiotensin receptor binding |
GO:0031730 | 0.0059 | 24.1306 | 0.1225 | 2 | 6 | CCR5 chemokine receptor binding |
GO:0102033 | 0.0059 | 24.1306 | 0.1225 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0019207 | 0.0065 | 2.5283 | 4.5728 | 11 | 224 | kinase regulator activity |
GO:0005109 | 0.0066 | 5.8746 | 0.7553 | 4 | 37 | frizzled binding |
GO:1901681 | 0.0067 | 2.4005 | 5.2465 | 12 | 257 | sulfur compound binding |
GO:0005539 | 0.0069 | 2.5045 | 4.6137 | 11 | 226 | glycosaminoglycan binding |
GO:1903136 | 0.0082 | 19.3033 | 0.1429 | 2 | 7 | cuprous ion binding |
GO:0001653 | 0.0091 | 2.8887 | 2.9193 | 8 | 143 | peptide receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 7.9792 | 5.2651 | 34 | 300 | protein heterodimerization activity |
GO:1903231 | 0 | 5.7978 | 2.3166 | 12 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0045296 | 2e-04 | 2.9905 | 5.7389 | 16 | 327 | cadherin binding |
GO:0003730 | 4e-04 | 4.0195 | 2.6852 | 10 | 153 | mRNA 3'-UTR binding |
GO:0045182 | 6e-04 | 3.1283 | 4.4402 | 13 | 253 | translation regulator activity |
GO:0033038 | 0.0017 | 15.4172 | 0.2457 | 3 | 14 | bitter taste receptor activity |
GO:0003677 | 0.0027 | 1.5555 | 40.4885 | 58 | 2307 | DNA binding |
GO:0030021 | 0.0036 | 11.3032 | 0.3159 | 3 | 18 | extracellular matrix structural constituent conferring compression resistance |
GO:0042288 | 0.0042 | 10.5961 | 0.3335 | 3 | 19 | MHC class I protein binding |
GO:0004062 | 0.0044 | 28.1783 | 0.1053 | 2 | 6 | aryl sulfotransferase activity |
GO:0004984 | 0.0045 | 2.8208 | 3.7382 | 10 | 213 | olfactory receptor activity |
GO:0004930 | 0.0047 | 1.9997 | 10.5302 | 20 | 600 | G protein-coupled receptor activity |
GO:0032394 | 0.0061 | 22.5413 | 0.1229 | 2 | 7 | MHC class Ib receptor activity |
GO:0047035 | 0.0061 | 22.5413 | 0.1229 | 2 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:0030414 | 0.0094 | 2.8685 | 2.9309 | 8 | 167 | peptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 8.0259 | 6.2706 | 40 | 300 | protein heterodimerization activity |
GO:0005509 | 0 | 2.6653 | 14.0252 | 34 | 671 | calcium ion binding |
GO:0045296 | 1e-04 | 3.0005 | 6.8349 | 19 | 327 | cadherin binding |
GO:0032558 | 4e-04 | Inf | 0.0418 | 2 | 2 | adenyl deoxyribonucleotide binding |
GO:0015125 | 7e-04 | 11.837 | 0.418 | 4 | 20 | bile acid transmembrane transporter activity |
GO:0003677 | 7e-04 | 1.5852 | 48.2207 | 70 | 2307 | DNA binding |
GO:1903231 | 0.0018 | 3.4929 | 2.759 | 9 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0032552 | 0.0025 | 47.1114 | 0.0836 | 2 | 4 | deoxyribonucleotide binding |
GO:0004867 | 0.0026 | 4.0612 | 1.8603 | 7 | 89 | serine-type endopeptidase inhibitor activity |
GO:0033038 | 0.0028 | 12.8791 | 0.2926 | 3 | 14 | bitter taste receptor activity |
GO:0019904 | 0.0048 | 1.8682 | 13.5026 | 24 | 646 | protein domain specific binding |
GO:0015349 | 0.0062 | 23.5528 | 0.1254 | 2 | 6 | thyroid hormone transmembrane transporter activity |
GO:0019955 | 0.0063 | 3.0955 | 2.7381 | 8 | 131 | cytokine binding |
GO:0042288 | 0.0068 | 8.8517 | 0.3971 | 3 | 19 | MHC class I protein binding |
GO:0032394 | 0.0085 | 18.8411 | 0.1463 | 2 | 7 | MHC class Ib receptor activity |
GO:0030414 | 0.0086 | 2.7132 | 3.4906 | 9 | 167 | peptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 7.8093 | 7.3309 | 45 | 300 | protein heterodimerization activity |
GO:0003677 | 0 | 1.9643 | 56.3746 | 96 | 2307 | DNA binding |
GO:0019904 | 0 | 2.3308 | 15.7859 | 34 | 646 | protein domain specific binding |
GO:0045296 | 0.0012 | 2.3879 | 7.9907 | 18 | 327 | cadherin binding |
GO:0016503 | 0.0018 | 80.2406 | 0.0733 | 2 | 3 | pheromone receptor activity |
GO:0097159 | 0.0036 | 1.3279 | 139.8979 | 166 | 5725 | organic cyclic compound binding |
GO:1901363 | 0.0038 | 1.3262 | 138.1385 | 164 | 5653 | heterocyclic compound binding |
GO:0005164 | 0.0051 | 6.4419 | 0.7087 | 4 | 29 | tumor necrosis factor receptor binding |
GO:0008528 | 0.0068 | 2.8263 | 3.3722 | 9 | 138 | G protein-coupled peptide receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 8.1911 | 6.1609 | 40 | 300 | protein heterodimerization activity |
GO:0003677 | 0 | 3.6374 | 12.4543 | 39 | 669 | DNA binding |
GO:0000978 | 0 | 2.6405 | 22.8774 | 53 | 1114 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0000976 | 0 | 2.37 | 28.874 | 60 | 1406 | transcription cis-regulatory region binding |
GO:0003690 | 0 | 2.2082 | 31.8517 | 62 | 1551 | double-stranded DNA binding |
GO:0043565 | 0 | 2.1552 | 31.9544 | 61 | 1556 | sequence-specific DNA binding |
GO:0000981 | 0 | 2.6127 | 16.6048 | 39 | 834 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0004930 | 0 | 2.5562 | 12.3218 | 29 | 600 | G protein-coupled receptor activity |
GO:0140110 | 0 | 1.8503 | 36.4724 | 61 | 1776 | transcription regulator activity |
GO:0038023 | 2e-04 | 1.8856 | 24.6435 | 43 | 1200 | signaling receptor activity |
GO:0030546 | 9e-04 | 2.3342 | 9.0976 | 20 | 443 | signaling receptor activator activity |
GO:0001228 | 0.0019 | 2.2322 | 8.9949 | 19 | 438 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0005179 | 0.0019 | 3.8074 | 2.259 | 8 | 110 | hormone activity |
GO:0004984 | 0.0047 | 2.6511 | 4.3742 | 11 | 213 | olfactory receptor activity |
GO:0042289 | 0.006 | 23.9836 | 0.1232 | 2 | 6 | MHC class II protein binding |
GO:0004866 | 0.0063 | 2.8551 | 3.3269 | 9 | 162 | endopeptidase inhibitor activity |
GO:0042609 | 0.0082 | 19.1857 | 0.1438 | 2 | 7 | CD4 receptor binding |
GO:0023026 | 0.0087 | 8.0115 | 0.4313 | 3 | 21 | MHC class II protein complex binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003677 | 0 | 3.3365 | 52.2976 | 128 | 2307 | DNA binding |
GO:0046982 | 0 | 8.0255 | 6.8007 | 43 | 300 | protein heterodimerization activity |
GO:1990837 | 0 | 2.9613 | 33.0742 | 81 | 1459 | sequence-specific double-stranded DNA binding |
GO:0001067 | 0 | 2.8841 | 31.9181 | 77 | 1408 | transcription regulatory region nucleic acid binding |
GO:0000981 | 0 | 3.4623 | 17.9624 | 53 | 834 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0000978 | 0 | 3.0253 | 25.2534 | 65 | 1114 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0140110 | 0 | 2.5128 | 40.2603 | 85 | 1776 | transcription regulator activity |
GO:0001228 | 0 | 3.1026 | 9.9291 | 28 | 438 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0004930 | 0 | 2.6561 | 13.6015 | 33 | 600 | G protein-coupled receptor activity |
GO:0004984 | 0 | 3.8706 | 4.8285 | 17 | 213 | olfactory receptor activity |
GO:0097159 | 0 | 1.5882 | 129.7806 | 170 | 5725 | organic cyclic compound binding |
GO:0071837 | 0 | 24.2643 | 0.3174 | 5 | 14 | HMG box domain binding |
GO:1901363 | 0 | 1.5844 | 128.1484 | 168 | 5653 | heterocyclic compound binding |
GO:0005184 | 0 | 11.9344 | 0.6347 | 6 | 28 | neuropeptide hormone activity |
GO:0030545 | 1e-04 | 2.4957 | 10.7678 | 25 | 475 | signaling receptor regulator activity |
GO:0048018 | 2e-04 | 2.4933 | 9.8837 | 23 | 436 | receptor ligand activity |
GO:0038023 | 2e-04 | 1.867 | 27.2029 | 47 | 1200 | signaling receptor activity |
GO:0004351 | 5e-04 | Inf | 0.0453 | 2 | 2 | glutamate decarboxylase activity |
GO:0051428 | 6e-04 | 12.441 | 0.408 | 4 | 18 | peptide hormone receptor binding |
GO:0005506 | 0.0011 | 3.4609 | 3.1057 | 10 | 137 | iron ion binding |
GO:0010855 | 0.0015 | 86.6865 | 0.068 | 2 | 3 | adenylate cyclase inhibitor activity |
GO:0018685 | 0.0015 | 86.6865 | 0.068 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0033265 | 0.0015 | 86.6865 | 0.068 | 2 | 3 | choline binding |
GO:0000977 | 0.0026 | 2.8792 | 4.0543 | 11 | 202 | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO:0010852 | 0.003 | 43.3405 | 0.0907 | 2 | 4 | cyclase inhibitor activity |
GO:0017046 | 0.0058 | 4.7364 | 1.1561 | 5 | 51 | peptide hormone binding |
GO:0008391 | 0.0062 | 9.3055 | 0.3854 | 3 | 17 | arachidonic acid monooxygenase activity |
GO:0017083 | 0.0072 | 21.6676 | 0.136 | 2 | 6 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO:0102033 | 0.0072 | 21.6676 | 0.136 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0020037 | 0.0076 | 2.9907 | 2.8336 | 8 | 125 | heme binding |
GO:0008236 | 0.0084 | 2.5632 | 4.1031 | 10 | 181 | serine-type peptidase activity |
GO:0005004 | 0.01 | 17.333 | 0.1587 | 2 | 7 | GPI-linked ephrin receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 9.9706 | 3.7901 | 30 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 4.6847 | 10.6764 | 42 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 2.9642 | 21.3528 | 54 | 1200 | signaling receptor activity |
GO:0005549 | 0 | 9.8256 | 1.0854 | 9 | 61 | odorant binding |
GO:1903231 | 0 | 5.1753 | 2.3488 | 11 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0004252 | 0 | 4.5017 | 2.9182 | 12 | 164 | serine-type endopeptidase activity |
GO:0017171 | 1e-04 | 3.95 | 3.2919 | 12 | 185 | serine hydrolase activity |
GO:0045182 | 2e-04 | 3.3459 | 4.5019 | 14 | 253 | translation regulator activity |
GO:0003700 | 3e-04 | 1.9016 | 23.4169 | 41 | 1316 | DNA-binding transcription factor activity |
GO:0001228 | 3e-04 | 2.6076 | 7.7938 | 19 | 438 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0019825 | 4e-04 | 9.3426 | 0.6228 | 5 | 35 | oxygen binding |
GO:0003690 | 4e-04 | 1.8156 | 27.5985 | 46 | 1551 | double-stranded DNA binding |
GO:0003730 | 4e-04 | 3.9615 | 2.7225 | 10 | 153 | mRNA 3'-UTR binding |
GO:0000978 | 7e-04 | 1.8982 | 19.8225 | 35 | 1114 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0033265 | 9e-04 | 111.1517 | 0.0534 | 2 | 3 | choline binding |
GO:0008233 | 0.001 | 2.2571 | 9.8935 | 21 | 556 | peptidase activity |
GO:0008392 | 0.0014 | 16.7211 | 0.2313 | 3 | 13 | arachidonic acid epoxygenase activity |
GO:0005184 | 0.0014 | 9.3137 | 0.4982 | 4 | 28 | neuropeptide hormone activity |
GO:0004497 | 0.0015 | 4.4741 | 1.6904 | 7 | 95 | monooxygenase activity |
GO:0000976 | 0.0021 | 1.7142 | 25.0184 | 40 | 1406 | transcription cis-regulatory region binding |
GO:0048018 | 0.0022 | 2.3162 | 7.7582 | 17 | 436 | receptor ligand activity |
GO:0043565 | 0.0024 | 1.667 | 27.6875 | 43 | 1556 | sequence-specific DNA binding |
GO:0051428 | 0.0037 | 11.1439 | 0.3203 | 3 | 18 | peptide hormone receptor binding |
GO:0030545 | 0.0051 | 2.1137 | 8.4522 | 17 | 475 | signaling receptor regulator activity |
GO:0070330 | 0.0058 | 9.2849 | 0.3737 | 3 | 21 | aromatase activity |
GO:0004321 | 0.0062 | 22.2248 | 0.1246 | 2 | 7 | fatty-acyl-CoA synthase activity |
GO:0020037 | 0.007 | 3.3304 | 2.2243 | 7 | 125 | heme binding |
GO:0005539 | 0.0074 | 2.6107 | 4.0215 | 10 | 226 | glycosaminoglycan binding |
GO:0031720 | 0.0082 | 18.5195 | 0.1424 | 2 | 8 | haptoglobin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 7.6804 | 4.0757 | 26 | 213 | olfactory receptor activity |
GO:0038023 | 0 | 3.0326 | 22.9616 | 59 | 1200 | signaling receptor activity |
GO:0004930 | 0 | 3.9272 | 11.4808 | 39 | 600 | G protein-coupled receptor activity |
GO:0000981 | 0 | 2.4783 | 24.3393 | 53 | 1272 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0003690 | 0 | 2.1677 | 29.6779 | 57 | 1551 | double-stranded DNA binding |
GO:0000976 | 0 | 2.2127 | 26.9034 | 53 | 1406 | transcription cis-regulatory region binding |
GO:0000978 | 0 | 2.2885 | 21.316 | 44 | 1114 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0043565 | 0 | 2.018 | 29.7736 | 54 | 1556 | sequence-specific DNA binding |
GO:0140110 | 1e-04 | 1.855 | 33.9832 | 57 | 1776 | transcription regulator activity |
GO:0008392 | 1e-04 | 23.0638 | 0.2488 | 4 | 13 | arachidonic acid epoxygenase activity |
GO:0004497 | 1e-04 | 5.4933 | 1.8178 | 9 | 95 | monooxygenase activity |
GO:0020037 | 1e-04 | 4.5712 | 2.3918 | 10 | 125 | heme binding |
GO:0017171 | 2e-04 | 3.6572 | 3.5399 | 12 | 185 | serine hydrolase activity |
GO:0005506 | 3e-04 | 4.5329 | 2.1635 | 9 | 114 | iron ion binding |
GO:0004252 | 3e-04 | 3.7829 | 3.1381 | 11 | 164 | serine-type endopeptidase activity |
GO:0070330 | 6e-04 | 12.2042 | 0.4018 | 4 | 21 | aromatase activity |
GO:0018685 | 0.0011 | 103.1731 | 0.0574 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0051431 | 0.0011 | 103.1731 | 0.0574 | 2 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:1904315 | 0.0012 | 7.0231 | 0.8037 | 5 | 42 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential |
GO:0048018 | 0.0019 | 2.2808 | 8.3427 | 18 | 436 | receptor ligand activity |
GO:0030545 | 0.0021 | 2.209 | 9.089 | 19 | 475 | signaling receptor regulator activity |
GO:0008233 | 0.0025 | 2.0847 | 10.6389 | 21 | 556 | peptidase activity |
GO:0004890 | 0.0032 | 11.934 | 0.3062 | 3 | 16 | GABA-A receptor activity |
GO:0016705 | 0.0039 | 3.0953 | 3.0807 | 9 | 161 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:1903231 | 0.0039 | 3.3675 | 2.5258 | 8 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0022835 | 0.0043 | 5.0907 | 1.0715 | 5 | 56 | transmitter-gated channel activity |
GO:0019825 | 0.0043 | 6.6868 | 0.6697 | 4 | 35 | oxygen binding |
GO:0017083 | 0.0052 | 25.7885 | 0.1148 | 2 | 6 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO:0102033 | 0.0052 | 25.7885 | 0.1148 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0098960 | 0.0057 | 4.7193 | 1.1481 | 5 | 60 | postsynaptic neurotransmitter receptor activity |
GO:0004321 | 0.0072 | 20.6295 | 0.1339 | 2 | 7 | fatty-acyl-CoA synthase activity |
GO:0008198 | 0.0093 | 7.7537 | 0.4401 | 3 | 23 | ferrous iron binding |
GO:0030215 | 0.0093 | 7.7537 | 0.4401 | 3 | 23 | semaphorin receptor binding |
GO:0005230 | 0.0097 | 4.118 | 1.3012 | 5 | 68 | extracellular ligand-gated ion channel activity |
GO:0045182 | 0.0097 | 2.3783 | 4.8411 | 11 | 253 | translation regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001632 | 2e-04 | Inf | 0.0312 | 2 | 2 | leukotriene B4 receptor activity |
GO:0038187 | 4e-04 | 13.4795 | 0.3588 | 4 | 23 | pattern recognition receptor activity |
GO:0030546 | 6e-04 | 2.6261 | 6.9109 | 17 | 443 | signaling receptor activator activity |
GO:0005126 | 0.0012 | 3.193 | 3.6661 | 11 | 235 | cytokine receptor binding |
GO:0004953 | 0.0012 | 17.4017 | 0.2184 | 3 | 14 | icosanoid receptor activity |
GO:0005179 | 0.0017 | 4.3809 | 1.716 | 7 | 110 | hormone activity |
GO:0060089 | 0.002 | 1.8329 | 18.7203 | 32 | 1200 | molecular transducer activity |
GO:0005102 | 0.0033 | 1.8243 | 16.9796 | 29 | 1121 | signaling receptor binding |
GO:0031730 | 0.0035 | 31.7913 | 0.0936 | 2 | 6 | CCR5 chemokine receptor binding |
GO:0005504 | 0.0052 | 6.2381 | 0.702 | 4 | 45 | fatty acid binding |
GO:0004364 | 0.0053 | 9.5656 | 0.3588 | 3 | 23 | glutathione transferase activity |
GO:0048020 | 0.0082 | 8.0309 | 0.4181 | 3 | 27 | CCR chemokine receptor binding |
GO:0048306 | 0.0087 | 4.2142 | 1.2636 | 5 | 81 | calcium-dependent protein binding |
GO:0005509 | 0.0091 | 1.9061 | 10.4678 | 19 | 671 | calcium ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 8.2193 | 6.1426 | 40 | 300 | protein heterodimerization activity |
GO:0016229 | 3e-04 | 10.102 | 0.5938 | 5 | 29 | steroid dehydrogenase activity |
GO:0015125 | 6e-04 | 12.0919 | 0.4095 | 4 | 20 | bile acid transmembrane transporter activity |
GO:0045296 | 0.0012 | 2.5342 | 6.6954 | 16 | 327 | cadherin binding |
GO:0015226 | 0.0012 | 96.2455 | 0.0614 | 2 | 3 | carnitine transmembrane transporter activity |
GO:0003677 | 0.0017 | 1.5382 | 47.2366 | 67 | 2307 | DNA binding |
GO:0035671 | 0.0024 | 48.1198 | 0.0819 | 2 | 4 | enone reductase activity |
GO:0033038 | 0.0026 | 13.1556 | 0.2867 | 3 | 14 | bitter taste receptor activity |
GO:0004857 | 0.0034 | 2.2661 | 7.4325 | 16 | 363 | enzyme inhibitor activity |
GO:0015347 | 0.0039 | 11.1303 | 0.3276 | 3 | 16 | sodium-independent organic anion transmembrane transporter activity |
GO:0004303 | 0.0047 | 10.3346 | 0.3481 | 3 | 17 | estradiol 17-beta-dehydrogenase activity |
GO:0005168 | 0.0059 | 24.0569 | 0.1229 | 2 | 6 | neurotrophin TRKA receptor binding |
GO:0015349 | 0.0059 | 24.0569 | 0.1229 | 2 | 6 | thyroid hormone transmembrane transporter activity |
GO:0047024 | 0.0059 | 24.0569 | 0.1229 | 2 | 6 | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity |
GO:0042288 | 0.0065 | 9.0417 | 0.389 | 3 | 19 | MHC class I protein binding |
GO:0032394 | 0.0082 | 19.2443 | 0.1433 | 2 | 7 | MHC class Ib receptor activity |
GO:0047035 | 0.0082 | 19.2443 | 0.1433 | 2 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:0051537 | 0.0098 | 7.6126 | 0.4505 | 3 | 22 | 2 iron, 2 sulfur cluster binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 2.8072 | 10.5302 | 27 | 600 | G protein-coupled receptor activity |
GO:0005126 | 0 | 3.9715 | 4.1243 | 15 | 235 | cytokine receptor binding |
GO:0048020 | 0 | 12.6832 | 0.5792 | 6 | 33 | CCR chemokine receptor binding |
GO:0004984 | 0 | 4.0884 | 3.7382 | 14 | 213 | olfactory receptor activity |
GO:0048018 | 1e-04 | 2.8175 | 7.6519 | 20 | 436 | receptor ligand activity |
GO:0008009 | 1e-04 | 9.2496 | 0.7547 | 6 | 43 | chemokine activity |
GO:0030545 | 1e-04 | 2.7143 | 8.3364 | 21 | 475 | signaling receptor regulator activity |
GO:0031531 | 3e-04 | Inf | 0.0351 | 2 | 2 | thyrotropin-releasing hormone receptor binding |
GO:1903231 | 5e-04 | 4.1959 | 2.3166 | 9 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0038023 | 6e-04 | 1.8961 | 21.0603 | 37 | 1200 | signaling receptor activity |
GO:0031708 | 9e-04 | 112.7343 | 0.0527 | 2 | 3 | endothelin B receptor binding |
GO:0044548 | 0.0017 | 15.4172 | 0.2457 | 3 | 14 | S100 protein binding |
GO:0015016 | 0.0018 | 56.3636 | 0.0702 | 2 | 4 | [heparan sulfate]-glucosamine N-sulfotransferase activity |
GO:0106274 | 0.0018 | 56.3636 | 0.0702 | 2 | 4 | NAD+-protein-arginine ADP-ribosyltransferase activity |
GO:0001664 | 0.0022 | 2.7918 | 4.5494 | 12 | 261 | G protein-coupled receptor binding |
GO:0048306 | 0.003 | 4.5523 | 1.4216 | 6 | 81 | calcium-dependent protein binding |
GO:1990763 | 0.008 | 18.7832 | 0.1404 | 2 | 8 | arrestin family protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 6.4785 | 3.5695 | 20 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 3.0843 | 10.0548 | 28 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 2.1974 | 20.1097 | 40 | 1200 | signaling receptor activity |
GO:0048020 | 2e-04 | 10.6528 | 0.553 | 5 | 33 | CCR chemokine receptor binding |
GO:0004252 | 5e-04 | 3.916 | 2.7483 | 10 | 164 | serine-type endopeptidase activity |
GO:0005549 | 5e-04 | 6.5211 | 1.0222 | 6 | 61 | odorant binding |
GO:0031708 | 8e-04 | 118.1978 | 0.0503 | 2 | 3 | endothelin B receptor binding |
GO:0003730 | 0.0011 | 3.7573 | 2.564 | 9 | 153 | mRNA 3'-UTR binding |
GO:0017171 | 0.0011 | 3.4415 | 3.1002 | 10 | 185 | serine hydrolase activity |
GO:1903231 | 0.0017 | 3.8688 | 2.2121 | 8 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0005179 | 0.0025 | 4.0655 | 1.8434 | 7 | 110 | hormone activity |
GO:0030546 | 0.0034 | 2.2725 | 7.4238 | 16 | 443 | signaling receptor activator activity |
GO:0070330 | 0.005 | 9.8756 | 0.3519 | 3 | 21 | aromatase activity |
GO:0004497 | 0.0053 | 4.0214 | 1.592 | 6 | 95 | monooxygenase activity |
GO:0008009 | 0.0057 | 6.0918 | 0.7206 | 4 | 43 | chemokine activity |
GO:0005126 | 0.0064 | 2.6683 | 3.9381 | 10 | 235 | cytokine receptor binding |
GO:0005504 | 0.0067 | 5.7939 | 0.7541 | 4 | 45 | fatty acid binding |
GO:0101020 | 0.0073 | 19.6935 | 0.1341 | 2 | 8 | estrogen 16-alpha-hydroxylase activity |
GO:0030246 | 0.0095 | 2.5098 | 4.1728 | 10 | 249 | carbohydrate binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 8.1511 | 3.6993 | 25 | 213 | olfactory receptor activity |
GO:0046982 | 0 | 6.3499 | 5.2102 | 28 | 300 | protein heterodimerization activity |
GO:0004930 | 0 | 3.3367 | 10.4205 | 31 | 600 | G protein-coupled receptor activity |
GO:0005549 | 1e-04 | 7.4938 | 1.0594 | 7 | 61 | odorant binding |
GO:1903231 | 5e-04 | 4.2423 | 2.2925 | 9 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0038023 | 5e-04 | 1.9272 | 20.1829 | 36 | 1177 | signaling receptor activity |
GO:0038187 | 6e-04 | 12.0667 | 0.3995 | 4 | 23 | pattern recognition receptor activity |
GO:0045296 | 6e-04 | 2.8157 | 5.6792 | 15 | 327 | cadherin binding |
GO:0015125 | 0.0047 | 10.0801 | 0.3473 | 3 | 20 | bile acid transmembrane transporter activity |
GO:0047035 | 0.006 | 22.7845 | 0.1216 | 2 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:0004866 | 0.0074 | 2.9952 | 2.8135 | 8 | 162 | endopeptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 8.3249 | 7.1115 | 46 | 300 | protein heterodimerization activity |
GO:0003677 | 0 | 1.9882 | 54.6876 | 94 | 2307 | DNA binding |
GO:0045296 | 1e-04 | 2.7743 | 7.7516 | 20 | 327 | cadherin binding |
GO:0019904 | 5e-04 | 2.0755 | 14.8788 | 29 | 632 | protein domain specific binding |
GO:0032558 | 6e-04 | Inf | 0.0474 | 2 | 2 | adenyl deoxyribonucleotide binding |
GO:0015125 | 0.0011 | 10.3929 | 0.4741 | 4 | 20 | bile acid transmembrane transporter activity |
GO:1901363 | 0.0017 | 1.3686 | 134.0047 | 162 | 5653 | heterocyclic compound binding |
GO:0004984 | 0.0018 | 2.735 | 5.0492 | 13 | 213 | olfactory receptor activity |
GO:0003723 | 0.0018 | 1.5695 | 39.5163 | 58 | 1667 | RNA binding |
GO:0097159 | 0.0022 | 1.3562 | 135.7115 | 163 | 5725 | organic cyclic compound binding |
GO:0032552 | 0.0033 | 41.3928 | 0.0948 | 2 | 4 | deoxyribonucleotide binding |
GO:0033038 | 0.004 | 11.3118 | 0.3319 | 3 | 14 | bitter taste receptor activity |
GO:0071837 | 0.004 | 11.3118 | 0.3319 | 3 | 14 | HMG box domain binding |
GO:0008121 | 0.0053 | 27.5935 | 0.1185 | 2 | 5 | ubiquinol-cytochrome-c reductase activity |
GO:0051373 | 0.0053 | 27.5935 | 0.1185 | 2 | 5 | FATZ binding |
GO:0030414 | 0.0066 | 2.6661 | 3.9587 | 10 | 167 | peptidase inhibitor activity |
GO:0004930 | 0.009 | 1.7631 | 14.223 | 24 | 600 | G protein-coupled receptor activity |
GO:0061135 | 0.0094 | 2.5201 | 4.1721 | 10 | 176 | endopeptidase regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 7.5158 | 6.2706 | 38 | 300 | protein heterodimerization activity |
GO:0004984 | 0 | 6.3205 | 4.4521 | 24 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 3.5459 | 12.5411 | 39 | 600 | G protein-coupled receptor activity |
GO:0005549 | 0 | 8.2989 | 1.275 | 9 | 61 | odorant binding |
GO:0038023 | 0 | 2.1599 | 25.0823 | 49 | 1200 | signaling receptor activity |
GO:0003677 | 0 | 1.7653 | 48.2207 | 76 | 2307 | DNA binding |
GO:0005096 | 3e-04 | 3.0031 | 5.3509 | 15 | 256 | GTPase activator activity |
GO:1903231 | 5e-04 | 3.9248 | 2.759 | 10 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0048306 | 0.0015 | 4.5025 | 1.6931 | 7 | 81 | calcium-dependent protein binding |
GO:0008009 | 0.0019 | 6.2399 | 0.8988 | 5 | 43 | chemokine activity |
GO:0030545 | 0.0025 | 2.1246 | 9.9284 | 20 | 475 | signaling receptor regulator activity |
GO:0035662 | 0.0025 | 47.1114 | 0.0836 | 2 | 4 | Toll-like receptor 4 binding |
GO:0031727 | 0.0042 | 31.4057 | 0.1045 | 2 | 5 | CCR2 chemokine receptor binding |
GO:0061134 | 0.0044 | 2.6691 | 4.3476 | 11 | 208 | peptidase regulator activity |
GO:0048018 | 0.0049 | 2.0735 | 9.1132 | 18 | 436 | receptor ligand activity |
GO:0031849 | 0.0062 | 23.5528 | 0.1254 | 2 | 6 | olfactory receptor binding |
GO:0050544 | 0.0062 | 23.5528 | 0.1254 | 2 | 6 | arachidonic acid binding |
GO:0004866 | 0.0071 | 2.8027 | 3.3861 | 9 | 162 | endopeptidase inhibitor activity |
GO:0019904 | 0.0093 | 1.7818 | 13.5026 | 23 | 646 | protein domain specific binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 21.7751 | 3.5695 | 50 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 7.8733 | 10.0548 | 59 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 4.2651 | 20.1097 | 67 | 1200 | signaling receptor activity |
GO:0005549 | 0 | 24.0968 | 1.0222 | 17 | 61 | odorant binding |
GO:1903231 | 0 | 6.678 | 2.2121 | 13 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:1902387 | 2e-04 | 35.5809 | 0.1341 | 3 | 8 | ceramide 1-phosphate binding |
GO:0003730 | 3e-04 | 4.2201 | 2.564 | 10 | 153 | mRNA 3'-UTR binding |
GO:0045182 | 4e-04 | 3.2862 | 4.2398 | 13 | 253 | translation regulator activity |
GO:0031708 | 8e-04 | 118.1978 | 0.0503 | 2 | 3 | endothelin B receptor binding |
GO:0004252 | 0.0018 | 3.4882 | 2.7483 | 9 | 164 | serine-type endopeptidase activity |
GO:0030280 | 0.0024 | 7.9237 | 0.5698 | 4 | 34 | structural constituent of skin epidermis |
GO:0005132 | 0.004 | 29.544 | 0.1005 | 2 | 6 | type I interferon receptor binding |
GO:0031849 | 0.004 | 29.544 | 0.1005 | 2 | 6 | olfactory receptor binding |
GO:0017171 | 0.0041 | 3.068 | 3.1002 | 9 | 185 | serine hydrolase activity |
GO:0001849 | 0.0073 | 19.6935 | 0.1341 | 2 | 8 | complement component C1q complex binding |
GO:1902388 | 0.0073 | 19.6935 | 0.1341 | 2 | 8 | ceramide 1-phosphate transfer activity |
GO:0030546 | 0.008 | 2.1172 | 7.4238 | 15 | 443 | signaling receptor activator activity |
GO:0005125 | 0.0088 | 2.6958 | 3.5024 | 9 | 209 | cytokine activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 12.244 | 3.7771 | 35 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 5.1299 | 10.6399 | 45 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.0478 | 21.2797 | 55 | 1200 | signaling receptor activity |
GO:0005549 | 0 | 9.8611 | 1.0817 | 9 | 61 | odorant binding |
GO:0030414 | 0 | 4.4298 | 2.9614 | 12 | 167 | peptidase inhibitor activity |
GO:0004867 | 2e-04 | 5.5972 | 1.5782 | 8 | 89 | serine-type endopeptidase inhibitor activity |
GO:0061135 | 3e-04 | 3.7986 | 3.121 | 11 | 176 | endopeptidase regulator activity |
GO:0015125 | 4e-04 | 14.027 | 0.3547 | 4 | 20 | bile acid transmembrane transporter activity |
GO:0042166 | 8e-04 | 20.9779 | 0.1951 | 3 | 11 | acetylcholine binding |
GO:0031708 | 9e-04 | 111.5433 | 0.0532 | 2 | 3 | endothelin B receptor binding |
GO:0033038 | 0.0017 | 15.2538 | 0.2483 | 3 | 14 | bitter taste receptor activity |
GO:0008121 | 0.003 | 37.1765 | 0.0887 | 2 | 5 | ubiquinol-cytochrome-c reductase activity |
GO:0051373 | 0.003 | 37.1765 | 0.0887 | 2 | 5 | FATZ binding |
GO:0048306 | 0.0032 | 4.5036 | 1.4364 | 6 | 81 | calcium-dependent protein binding |
GO:0015075 | 0.0042 | 1.8684 | 14.1333 | 25 | 797 | ion transmembrane transporter activity |
GO:0031849 | 0.0045 | 27.8806 | 0.1064 | 2 | 6 | olfactory receptor binding |
GO:0047024 | 0.0045 | 27.8806 | 0.1064 | 2 | 6 | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity |
GO:0015464 | 0.0066 | 8.8268 | 0.3901 | 3 | 22 | acetylcholine receptor activity |
GO:0005201 | 0.0081 | 2.9499 | 2.855 | 8 | 161 | extracellular matrix structural constituent |
GO:0019534 | 0.0082 | 18.5848 | 0.1419 | 2 | 8 | toxin transmembrane transporter activity |
GO:0031720 | 0.0082 | 18.5848 | 0.1419 | 2 | 8 | haptoglobin binding |
GO:0005248 | 0.0085 | 7.9851 | 0.4256 | 3 | 24 | voltage-gated sodium channel activity |
GO:0004601 | 0.0088 | 5.335 | 0.8157 | 4 | 46 | peroxidase activity |
GO:0015101 | 0.0095 | 7.6217 | 0.4433 | 3 | 25 | organic cation transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 17.5703 | 3.842 | 46 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 8.0175 | 10.8227 | 64 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 4.8253 | 18.5838 | 69 | 1057 | signaling receptor activity |
GO:0008392 | 0 | 47.6069 | 0.2345 | 6 | 13 | arachidonic acid epoxygenase activity |
GO:0005549 | 0 | 9.6863 | 1.1003 | 9 | 61 | odorant binding |
GO:0070330 | 0 | 22.2055 | 0.3788 | 6 | 21 | aromatase activity |
GO:0005506 | 0 | 5.4047 | 2.4712 | 12 | 137 | iron ion binding |
GO:0046982 | 0 | 3.6351 | 5.4113 | 18 | 300 | protein heterodimerization activity |
GO:0020037 | 0 | 5.4171 | 2.2547 | 11 | 125 | heme binding |
GO:0017171 | 0 | 4.2577 | 3.337 | 13 | 185 | serine hydrolase activity |
GO:0004252 | 0 | 4.4372 | 2.9582 | 12 | 164 | serine-type endopeptidase activity |
GO:0004321 | 2e-04 | 41.2372 | 0.1263 | 3 | 7 | fatty-acyl-CoA synthase activity |
GO:0001653 | 3e-04 | 4.2013 | 2.5794 | 10 | 143 | peptide receptor activity |
GO:0019825 | 4e-04 | 9.2119 | 0.6313 | 5 | 35 | oxygen binding |
GO:0047760 | 5e-04 | 27.4881 | 0.1623 | 3 | 9 | butyrate-CoA ligase activity |
GO:0016705 | 7e-04 | 3.6963 | 2.9041 | 10 | 161 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0004497 | 7e-04 | 6.114 | 1.0877 | 6 | 61 | monooxygenase activity |
GO:0046790 | 9e-04 | 20.6135 | 0.1984 | 3 | 11 | virion binding |
GO:0008188 | 9e-04 | 7.4659 | 0.7576 | 5 | 42 | neuropeptide receptor activity |
GO:0018685 | 0.001 | 109.6122 | 0.0541 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0018858 | 0.001 | 109.6122 | 0.0541 | 2 | 3 | benzoate-CoA ligase activity |
GO:0051431 | 0.001 | 109.6122 | 0.0541 | 2 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0102391 | 0.0019 | 54.8027 | 0.0722 | 2 | 4 | decanoate-CoA ligase activity |
GO:1903231 | 0.0027 | 3.582 | 2.381 | 8 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0008395 | 0.0031 | 7.3443 | 0.6133 | 4 | 34 | steroid hydroxylase activity |
GO:0043395 | 0.0039 | 10.9891 | 0.3247 | 3 | 18 | heparan sulfate proteoglycan binding |
GO:0017083 | 0.0046 | 27.398 | 0.1082 | 2 | 6 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO:0102033 | 0.0046 | 27.398 | 0.1082 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0042277 | 0.0056 | 2.461 | 5.1227 | 12 | 284 | peptide binding |
GO:0015645 | 0.0061 | 9.1559 | 0.3788 | 3 | 21 | fatty acid ligase activity |
GO:0045182 | 0.0064 | 2.5314 | 4.5636 | 11 | 253 | translation regulator activity |
GO:0019904 | 0.0069 | 1.8925 | 11.6524 | 21 | 646 | protein domain specific binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 25.0939 | 3.6733 | 56 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 9.875 | 10.3473 | 71 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 5.5767 | 20.6947 | 83 | 1200 | signaling receptor activity |
GO:0005549 | 0 | 14.5294 | 1.052 | 12 | 61 | odorant binding |
GO:0008392 | 0 | 36.2388 | 0.2242 | 5 | 13 | arachidonic acid epoxygenase activity |
GO:0005506 | 0 | 5.6686 | 2.3626 | 12 | 137 | iron ion binding |
GO:0020037 | 0 | 5.6806 | 2.1557 | 11 | 125 | heme binding |
GO:1903231 | 0 | 5.3496 | 2.2764 | 11 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0070330 | 0 | 18.1104 | 0.3622 | 5 | 21 | aromatase activity |
GO:0008395 | 3e-04 | 9.9839 | 0.5863 | 5 | 34 | steroid hydroxylase activity |
GO:0004252 | 6e-04 | 3.7993 | 2.8283 | 10 | 164 | serine-type endopeptidase activity |
GO:0046790 | 8e-04 | 21.5879 | 0.1897 | 3 | 11 | virion binding |
GO:0018685 | 9e-04 | 114.7758 | 0.0517 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0051431 | 9e-04 | 114.7758 | 0.0517 | 2 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0016705 | 0.0014 | 3.6459 | 2.6382 | 9 | 154 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0003730 | 0.0014 | 3.6458 | 2.6386 | 9 | 153 | mRNA 3'-UTR binding |
GO:0017171 | 0.0014 | 3.339 | 3.1904 | 10 | 185 | serine hydrolase activity |
GO:0045182 | 0.0015 | 2.9188 | 4.3631 | 12 | 253 | translation regulator activity |
GO:0047498 | 0.0024 | 13.2808 | 0.2759 | 3 | 16 | calcium-dependent phospholipase A2 activity |
GO:0019825 | 0.003 | 7.4441 | 0.6036 | 4 | 35 | oxygen binding |
GO:0052689 | 0.0034 | 3.4461 | 2.4661 | 8 | 143 | carboxylic ester hydrolase activity |
GO:0017083 | 0.0042 | 28.6886 | 0.1035 | 2 | 6 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO:0102033 | 0.0042 | 28.6886 | 0.1035 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0004321 | 0.0059 | 22.9495 | 0.1207 | 2 | 7 | fatty-acyl-CoA synthase activity |
GO:0016714 | 0.0059 | 22.9495 | 0.1207 | 2 | 7 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen |
GO:0016298 | 0.0062 | 3.4118 | 2.1729 | 7 | 126 | lipase activity |
GO:0008009 | 0.0063 | 5.9142 | 0.7416 | 4 | 43 | chemokine activity |
GO:0030215 | 0.007 | 8.6288 | 0.3966 | 3 | 23 | semaphorin receptor binding |
GO:0004866 | 0.0071 | 3.0173 | 2.7938 | 8 | 162 | endopeptidase inhibitor activity |
GO:0034235 | 0.0077 | 19.1234 | 0.138 | 2 | 8 | GPI anchor binding |
GO:0005126 | 0.0078 | 2.5888 | 4.0527 | 10 | 235 | cytokine receptor binding |
GO:0030545 | 0.0085 | 2.0455 | 8.1917 | 16 | 475 | signaling receptor regulator activity |
GO:0048018 | 0.0089 | 2.088 | 7.5191 | 15 | 436 | receptor ligand activity |
GO:0019864 | 0.0098 | 16.3904 | 0.1552 | 2 | 9 | IgG binding |
GO:0031956 | 0.0098 | 16.3904 | 0.1552 | 2 | 9 | medium-chain fatty acid-CoA ligase activity |
GO:0047760 | 0.0098 | 16.3904 | 0.1552 | 2 | 9 | butyrate-CoA ligase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 31.0363 | 3.9329 | 67 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 10.7534 | 11.0786 | 80 | 600 | G protein-coupled receptor activity |
GO:0005549 | 0 | 27.6928 | 1.1263 | 20 | 61 | odorant binding |
GO:0042834 | 0 | 22.5042 | 0.3139 | 5 | 17 | peptidoglycan binding |
GO:0048020 | 0 | 12.0314 | 0.6093 | 6 | 33 | CCR chemokine receptor binding |
GO:0070330 | 0 | 16.874 | 0.3878 | 5 | 21 | aromatase activity |
GO:0008392 | 1e-04 | 23.9287 | 0.24 | 4 | 13 | arachidonic acid epoxygenase activity |
GO:0008009 | 1e-04 | 8.7742 | 0.794 | 6 | 43 | chemokine activity |
GO:0003823 | 3e-04 | 7.3751 | 0.9232 | 6 | 50 | antigen binding |
GO:0034235 | 3e-04 | 32.204 | 0.1477 | 3 | 8 | GPI anchor binding |
GO:0017159 | 3e-04 | Inf | 0.0369 | 2 | 2 | pantetheine hydrolase activity |
GO:0008395 | 4e-04 | 9.3022 | 0.6278 | 5 | 34 | steroid hydroxylase activity |
GO:0004888 | 4e-04 | 2.9692 | 5.4257 | 15 | 388 | transmembrane signaling receptor activity |
GO:0017171 | 7e-04 | 3.4495 | 3.4159 | 11 | 185 | serine hydrolase activity |
GO:0008401 | 7e-04 | 23 | 0.1846 | 3 | 10 | retinoic acid 4-hydroxylase activity |
GO:1903231 | 8e-04 | 3.9781 | 2.4373 | 9 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0004252 | 0.001 | 3.5355 | 3.0282 | 10 | 164 | serine-type endopeptidase activity |
GO:0018685 | 0.001 | 107.0166 | 0.0554 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0030414 | 0.0011 | 3.4673 | 3.0835 | 10 | 167 | peptidase inhibitor activity |
GO:0008391 | 0.0019 | 54.1953 | 0.0729 | 2 | 4 | arachidonic acid monooxygenase activity |
GO:0050051 | 0.002 | 53.505 | 0.0739 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0004869 | 0.002 | 6.1253 | 0.9048 | 5 | 49 | cysteine-type endopeptidase inhibitor activity |
GO:0000146 | 0.0021 | 8.2742 | 0.5539 | 4 | 30 | microfilament motor activity |
GO:0020037 | 0.0022 | 3.7062 | 2.308 | 8 | 125 | heme binding |
GO:0070492 | 0.0024 | 13.4125 | 0.277 | 3 | 15 | oligosaccharide binding |
GO:0005506 | 0.0039 | 3.3589 | 2.5296 | 8 | 137 | iron ion binding |
GO:0032395 | 0.0049 | 26.7492 | 0.1108 | 2 | 6 | MHC class II receptor activity |
GO:0102033 | 0.0049 | 26.7492 | 0.1108 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0061135 | 0.0055 | 2.9219 | 3.2497 | 9 | 176 | endopeptidase regulator activity |
GO:0038023 | 0.0066 | 3.0634 | 2.7527 | 8 | 206 | signaling receptor activity |
GO:0034987 | 0.0067 | 21.398 | 0.1293 | 2 | 7 | immunoglobulin receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 19.631 | 3.3229 | 44 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 7.2591 | 9.3601 | 52 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 4.3113 | 18.7203 | 63 | 1200 | signaling receptor activity |
GO:0005549 | 0 | 26.0432 | 0.9516 | 17 | 61 | odorant binding |
GO:0004190 | 0 | 16.9165 | 0.3744 | 5 | 24 | aspartic-type endopeptidase activity |
GO:0004497 | 7e-04 | 5.1324 | 1.482 | 7 | 95 | monooxygenase activity |
GO:0019865 | 9e-04 | 19.2873 | 0.2013 | 3 | 13 | immunoglobulin binding |
GO:1903231 | 0.0011 | 4.1701 | 2.0592 | 8 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0035410 | 0.0014 | 63.5906 | 0.0624 | 2 | 4 | dihydrotestosterone 17-beta-dehydrogenase activity |
GO:0048020 | 0.0017 | 8.8259 | 0.5148 | 4 | 33 | CCR chemokine receptor binding |
GO:0047834 | 0.0022 | 13.6702 | 0.2652 | 3 | 17 | D-threo-aldose 1-dehydrogenase activity |
GO:0008508 | 0.0024 | 42.3911 | 0.078 | 2 | 5 | bile acid:sodium symporter activity |
GO:0047086 | 0.0024 | 42.3911 | 0.078 | 2 | 5 | ketosteroid monooxygenase activity |
GO:0020037 | 0.0035 | 3.8204 | 1.95 | 7 | 125 | heme binding |
GO:0047024 | 0.0035 | 31.7913 | 0.0936 | 2 | 6 | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity |
GO:0070330 | 0.0041 | 10.6298 | 0.3276 | 3 | 21 | aromatase activity |
GO:0004321 | 0.0048 | 25.4315 | 0.1092 | 2 | 7 | fatty-acyl-CoA synthase activity |
GO:0047023 | 0.0064 | 21.1916 | 0.1248 | 2 | 8 | androsterone dehydrogenase activity |
GO:0047044 | 0.0064 | 21.1916 | 0.1248 | 2 | 8 | androstan-3-alpha,17-beta-diol dehydrogenase activity |
GO:0047045 | 0.0064 | 21.1916 | 0.1248 | 2 | 8 | testosterone 17-beta-dehydrogenase (NADP+) activity |
GO:0101020 | 0.0064 | 21.1916 | 0.1248 | 2 | 8 | estrogen 16-alpha-hydroxylase activity |
GO:0019864 | 0.0081 | 18.1631 | 0.1404 | 2 | 9 | IgG binding |
GO:0030283 | 0.0081 | 18.1631 | 0.1404 | 2 | 9 | testosterone dehydrogenase [NAD(P)] activity |
GO:0031956 | 0.0081 | 18.1631 | 0.1404 | 2 | 9 | medium-chain fatty acid-CoA ligase activity |
GO:0047760 | 0.0081 | 18.1631 | 0.1404 | 2 | 9 | butyrate-CoA ligase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 10.9411 | 3.232 | 28 | 213 | olfactory receptor activity |
GO:0046982 | 0 | 7.0781 | 4.5521 | 27 | 300 | protein heterodimerization activity |
GO:0004930 | 0 | 4.0483 | 9.1042 | 32 | 600 | G protein-coupled receptor activity |
GO:0005549 | 0 | 11.6171 | 0.9256 | 9 | 61 | odorant binding |
GO:0038023 | 0 | 2.5514 | 18.2084 | 41 | 1200 | signaling receptor activity |
GO:1903231 | 0 | 6.7684 | 2.0029 | 12 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0030414 | 0 | 4.7418 | 2.534 | 11 | 167 | peptidase inhibitor activity |
GO:0004867 | 1e-04 | 6.5898 | 1.3505 | 8 | 89 | serine-type endopeptidase inhibitor activity |
GO:0061135 | 4e-04 | 4.0316 | 2.6706 | 10 | 176 | endopeptidase regulator activity |
GO:0030246 | 4e-04 | 3.402 | 3.7782 | 12 | 249 | carbohydrate binding |
GO:0045182 | 5e-04 | 3.3447 | 3.8389 | 12 | 253 | translation regulator activity |
GO:0015125 | 0.0033 | 11.5811 | 0.3035 | 3 | 20 | bile acid transmembrane transporter activity |
GO:0045296 | 0.0044 | 2.5471 | 4.9618 | 12 | 327 | cadherin binding |
GO:0032394 | 0.0046 | 26.1636 | 0.1062 | 2 | 7 | MHC class Ib receptor activity |
GO:0047035 | 0.0046 | 26.1636 | 0.1062 | 2 | 7 | testosterone dehydrogenase (NAD+) activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 7.4996 | 3.4656 | 22 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 4.1595 | 9.7623 | 35 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 2.7775 | 19.5247 | 47 | 1200 | signaling receptor activity |
GO:0046982 | 0 | 4.8539 | 4.8812 | 21 | 300 | protein heterodimerization activity |
GO:0030414 | 0 | 6.2621 | 2.7172 | 15 | 167 | peptidase inhibitor activity |
GO:0005549 | 0 | 10.7945 | 0.9925 | 9 | 61 | odorant binding |
GO:0061135 | 0 | 5.4588 | 2.8636 | 14 | 176 | endopeptidase regulator activity |
GO:0004867 | 0 | 7.0042 | 1.4481 | 9 | 89 | serine-type endopeptidase inhibitor activity |
GO:0015125 | 3e-04 | 15.3298 | 0.3254 | 4 | 20 | bile acid transmembrane transporter activity |
GO:0005509 | 6e-04 | 2.254 | 10.9176 | 23 | 671 | calcium ion binding |
GO:0033038 | 0.0014 | 16.6653 | 0.2278 | 3 | 14 | bitter taste receptor activity |
GO:1903231 | 0.0014 | 3.9903 | 2.1477 | 8 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0015349 | 0.0038 | 30.4509 | 0.0976 | 2 | 6 | thyroid hormone transmembrane transporter activity |
GO:0047035 | 0.0052 | 24.3592 | 0.1139 | 2 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:0004869 | 0.0082 | 5.4408 | 0.7973 | 4 | 49 | cysteine-type endopeptidase inhibitor activity |
GO:0061783 | 0.0088 | 17.3973 | 0.1464 | 2 | 9 | peptidoglycan muralytic activity |
GO:0019904 | 0.0095 | 1.8959 | 10.5108 | 19 | 646 | protein domain specific binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 5.5268 | 6.1243 | 29 | 300 | protein heterodimerization activity |
GO:0030414 | 0 | 4.9105 | 3.4092 | 15 | 167 | peptidase inhibitor activity |
GO:0004984 | 0 | 4.0426 | 4.3483 | 16 | 213 | olfactory receptor activity |
GO:0004867 | 0 | 6.2302 | 1.8169 | 10 | 89 | serine-type endopeptidase inhibitor activity |
GO:0061135 | 0 | 4.2841 | 3.5929 | 14 | 176 | endopeptidase regulator activity |
GO:0015125 | 0 | 16.2222 | 0.4083 | 5 | 20 | bile acid transmembrane transporter activity |
GO:0045296 | 1e-04 | 2.8972 | 6.6755 | 18 | 327 | cadherin binding |
GO:0004930 | 3e-04 | 2.2723 | 12.2486 | 26 | 600 | G protein-coupled receptor activity |
GO:0005509 | 3e-04 | 2.1889 | 13.698 | 28 | 671 | calcium ion binding |
GO:0032558 | 4e-04 | Inf | 0.0408 | 2 | 2 | adenyl deoxyribonucleotide binding |
GO:1903231 | 0.0016 | 3.5804 | 2.6947 | 9 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0032552 | 0.0024 | 48.2673 | 0.0817 | 2 | 4 | deoxyribonucleotide binding |
GO:0033038 | 0.0026 | 13.1961 | 0.2858 | 3 | 14 | bitter taste receptor activity |
GO:0019904 | 0.0036 | 1.9172 | 13.1877 | 24 | 646 | protein domain specific binding |
GO:0015347 | 0.0039 | 11.1645 | 0.3266 | 3 | 16 | sodium-independent organic anion transmembrane transporter activity |
GO:0051373 | 0.004 | 32.1762 | 0.1021 | 2 | 5 | FATZ binding |
GO:0004303 | 0.0046 | 10.3664 | 0.347 | 3 | 17 | estradiol 17-beta-dehydrogenase activity |
GO:0030021 | 0.0055 | 9.6747 | 0.3675 | 3 | 18 | extracellular matrix structural constituent conferring compression resistance |
GO:0004062 | 0.0059 | 24.1306 | 0.1225 | 2 | 6 | aryl sulfotransferase activity |
GO:0015349 | 0.0059 | 24.1306 | 0.1225 | 2 | 6 | thyroid hormone transmembrane transporter activity |
GO:0047024 | 0.0059 | 24.1306 | 0.1225 | 2 | 6 | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity |
GO:0038023 | 0.0079 | 1.592 | 24.4973 | 37 | 1200 | signaling receptor activity |
GO:0032394 | 0.0082 | 19.3033 | 0.1429 | 2 | 7 | MHC class Ib receptor activity |
GO:0047035 | 0.0082 | 19.3033 | 0.1429 | 2 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:0030247 | 0.0097 | 7.636 | 0.4491 | 3 | 22 | polysaccharide binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 7.663 | 5.4543 | 34 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 6.574 | 6.8417 | 37 | 360 | detection of chemical stimulus |
GO:0050906 | 0 | 6.3166 | 7.2978 | 38 | 384 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 6.3337 | 7.0697 | 37 | 372 | sensory perception of chemical stimulus |
GO:0050877 | 0 | 3.1035 | 24.269 | 63 | 1277 | nervous system process |
GO:0006335 | 0 | 25.3611 | 0.5891 | 10 | 31 | DNA replication-dependent chromatin assembly |
GO:0007186 | 0 | 3.1377 | 17.7169 | 48 | 951 | G protein-coupled receptor signaling pathway |
GO:0006334 | 0 | 8.2674 | 1.9955 | 14 | 105 | nucleosome assembly |
GO:0032501 | 0 | 1.7945 | 127.6545 | 172 | 6717 | multicellular organismal process |
GO:0040029 | 0 | 5.8407 | 2.5086 | 13 | 132 | regulation of gene expression, epigenetic |
GO:0006338 | 0 | 3.9029 | 4.4851 | 16 | 236 | chromatin remodeling |
GO:0071824 | 0 | 4.1207 | 3.991 | 15 | 210 | protein-DNA complex subunit organization |
GO:2000243 | 5e-04 | 5.4127 | 1.4254 | 7 | 75 | positive regulation of reproductive process |
GO:0007218 | 6e-04 | 4.631 | 1.8815 | 8 | 99 | neuropeptide signaling pathway |
GO:0032200 | 7e-04 | 3.6961 | 2.9077 | 10 | 153 | telomere organization |
GO:0001964 | 7e-04 | 11.6068 | 0.4181 | 4 | 22 | startle response |
GO:0003044 | 0.001 | 7.2697 | 0.7792 | 5 | 41 | regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0140447 | 0.0011 | 103.8968 | 0.057 | 2 | 3 | cytokine precursor processing |
GO:1901295 | 0.0011 | 103.8968 | 0.057 | 2 | 3 | regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment |
GO:1903015 | 0.0011 | 103.8968 | 0.057 | 2 | 3 | regulation of exo-alpha-sialidase activity |
GO:0001867 | 0.0013 | 17.3635 | 0.2281 | 3 | 12 | complement activation, lectin pathway |
GO:2000300 | 0.0021 | 6.0836 | 0.9122 | 5 | 48 | regulation of synaptic vesicle exocytosis |
GO:1904340 | 0.0021 | 51.9452 | 0.076 | 2 | 4 | positive regulation of dopaminergic neuron differentiation |
GO:0035641 | 0.0026 | 13.0202 | 0.2851 | 3 | 15 | locomotory exploration behavior |
GO:0007129 | 0.003 | 5.5645 | 0.9882 | 5 | 52 | homologous chromosome pairing at meiosis |
GO:0080154 | 0.0032 | 12.0179 | 0.3041 | 3 | 16 | regulation of fertilization |
GO:0065007 | 0.0032 | 1.4401 | 215.9313 | 238 | 11362 | biological regulation |
GO:0023052 | 0.0033 | 1.3824 | 109.524 | 133 | 5763 | signaling |
GO:0006552 | 0.0035 | 34.628 | 0.095 | 2 | 5 | leucine catabolic process |
GO:0003128 | 0.0038 | 11.1588 | 0.3231 | 3 | 17 | heart field specification |
GO:0098742 | 0.0038 | 2.5894 | 4.8842 | 12 | 257 | cell-cell adhesion via plasma-membrane adhesion molecules |
GO:0031998 | 0.0045 | 10.4142 | 0.3421 | 3 | 18 | regulation of fatty acid beta-oxidation |
GO:0043011 | 0.0045 | 10.4142 | 0.3421 | 3 | 18 | myeloid dendritic cell differentiation |
GO:0007154 | 0.0046 | 1.3641 | 110.4553 | 133 | 5812 | cell communication |
GO:0003057 | 0.0051 | 25.9694 | 0.114 | 2 | 6 | regulation of the force of heart contraction by chemical signal |
GO:0051964 | 0.0051 | 25.9694 | 0.114 | 2 | 6 | negative regulation of synapse assembly |
GO:0061316 | 0.0051 | 25.9694 | 0.114 | 2 | 6 | canonical Wnt signaling pathway involved in heart development |
GO:2000481 | 0.0051 | 25.9694 | 0.114 | 2 | 6 | positive regulation of cAMP-dependent protein kinase activity |
GO:0003203 | 0.0052 | 6.3251 | 0.7032 | 4 | 37 | endocardial cushion morphogenesis |
GO:0006959 | 0.0054 | 2.7444 | 3.8389 | 10 | 202 | humoral immune response |
GO:0050896 | 0.006 | 1.3424 | 149.5289 | 172 | 7868 | response to stimulus |
GO:0003177 | 0.0061 | 9.1879 | 0.3801 | 3 | 20 | pulmonary valve development |
GO:0042730 | 0.0061 | 9.1879 | 0.3801 | 3 | 20 | fibrinolysis |
GO:0048645 | 0.0069 | 4.5061 | 1.1973 | 5 | 63 | animal organ formation |
GO:0007077 | 0.0071 | 20.7742 | 0.133 | 2 | 7 | mitotic nuclear membrane disassembly |
GO:1990414 | 0.0071 | 20.7742 | 0.133 | 2 | 7 | replication-born double-strand break repair via sister chromatid exchange |
GO:0060078 | 0.0077 | 3.2773 | 2.2616 | 7 | 119 | regulation of postsynaptic membrane potential |
GO:0072359 | 0.008 | 1.6358 | 21.2662 | 33 | 1119 | circulatory system development |
GO:0060412 | 0.0081 | 5.4911 | 0.7982 | 4 | 42 | ventricular septum morphogenesis |
GO:0061045 | 0.0089 | 4.2143 | 1.2733 | 5 | 67 | negative regulation of wound healing |
GO:0048477 | 0.009 | 3.5689 | 1.7864 | 6 | 94 | oogenesis |
GO:0036303 | 0.0091 | 7.8083 | 0.4371 | 3 | 23 | lymph vessel morphogenesis |
GO:0007127 | 0.0091 | 3.1635 | 2.3376 | 7 | 123 | meiosis I |
GO:0060839 | 0.0093 | 17.3108 | 0.152 | 2 | 8 | endothelial cell fate commitment |
GO:1905603 | 0.0093 | 17.3108 | 0.152 | 2 | 8 | regulation of blood-brain barrier permeability |
GO:0045776 | 0.0096 | 5.2159 | 0.8362 | 4 | 44 | negative regulation of blood pressure |
GO:1900047 | 0.0096 | 5.2159 | 0.8362 | 4 | 44 | negative regulation of hemostasis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 7.3848 | 4.9124 | 30 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 5.9706 | 6.3673 | 32 | 372 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 5.9577 | 6.1619 | 31 | 360 | detection of chemical stimulus |
GO:0050906 | 0 | 5.5442 | 6.5727 | 31 | 384 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 3.0304 | 17.9722 | 47 | 1050 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 2.4988 | 21.8576 | 48 | 1277 | nervous system process |
GO:0019373 | 0 | 29.3164 | 0.3081 | 6 | 18 | epoxygenase P450 pathway |
GO:0097267 | 0 | 38.8207 | 0.1712 | 4 | 10 | omega-hydroxylase P450 pathway |
GO:0032501 | 1e-04 | 1.5952 | 111.7603 | 143 | 6641 | multicellular organismal process |
GO:0048252 | 3e-04 | Inf | 0.0342 | 2 | 2 | lauric acid metabolic process |
GO:0001676 | 5e-04 | 5.5263 | 1.3901 | 7 | 82 | long-chain fatty acid metabolic process |
GO:0099560 | 5e-04 | 12.9306 | 0.3766 | 4 | 22 | synaptic membrane adhesion |
GO:0006690 | 5e-04 | 4.6992 | 1.8486 | 8 | 108 | icosanoid metabolic process |
GO:0042178 | 6e-04 | 12.2493 | 0.3937 | 4 | 23 | xenobiotic catabolic process |
GO:0033559 | 6e-04 | 5.2452 | 1.4579 | 7 | 86 | unsaturated fatty acid metabolic process |
GO:0032309 | 8e-04 | 7.6745 | 0.736 | 5 | 43 | icosanoid secretion |
GO:0003095 | 9e-04 | 115.6631 | 0.0513 | 2 | 3 | pressure natriuresis |
GO:0048665 | 0.0016 | 8.9475 | 0.5135 | 4 | 30 | neuron fate specification |
GO:0097476 | 0.0017 | 57.828 | 0.0685 | 2 | 4 | spinal cord motor neuron migration |
GO:0031424 | 0.0019 | 5.0076 | 1.3008 | 6 | 76 | keratinization |
GO:0006959 | 0.0026 | 3.0643 | 3.4575 | 10 | 202 | humoral immune response |
GO:0036101 | 0.0028 | 38.5496 | 0.0856 | 2 | 5 | leukotriene B4 catabolic process |
GO:0002523 | 0.0033 | 11.5978 | 0.3081 | 3 | 18 | leukocyte migration involved in inflammatory response |
GO:0043651 | 0.0033 | 11.5978 | 0.3081 | 3 | 18 | linoleic acid metabolic process |
GO:0016082 | 0.0039 | 10.8723 | 0.3252 | 3 | 19 | synaptic vesicle priming |
GO:0150077 | 0.0039 | 6.8388 | 0.6504 | 4 | 38 | regulation of neuroinflammatory response |
GO:0030198 | 0.004 | 2.5729 | 4.9124 | 12 | 287 | extracellular matrix organization |
GO:0010430 | 0.0042 | 28.9104 | 0.1027 | 2 | 6 | fatty acid omega-oxidation |
GO:0016098 | 0.0042 | 28.9104 | 0.1027 | 2 | 6 | monoterpenoid metabolic process |
GO:0048704 | 0.005 | 4.0719 | 1.5747 | 6 | 92 | embryonic skeletal system morphogenesis |
GO:0003091 | 0.0053 | 9.6631 | 0.3594 | 3 | 21 | renal water homeostasis |
GO:0071305 | 0.0053 | 9.6631 | 0.3594 | 3 | 21 | cellular response to vitamin D |
GO:0120254 | 0.0054 | 3.5031 | 2.119 | 7 | 125 | olefinic compound metabolic process |
GO:0035850 | 0.0056 | 6.1174 | 0.7189 | 4 | 42 | epithelial cell differentiation involved in kidney development |
GO:0048146 | 0.0078 | 5.5334 | 0.7874 | 4 | 46 | positive regulation of fibroblast proliferation |
GO:0006811 | 0.0082 | 1.6029 | 23.8089 | 36 | 1391 | ion transport |
GO:0038063 | 0.0097 | 16.5172 | 0.154 | 2 | 9 | collagen-activated tyrosine kinase receptor signaling pathway |
GO:1903244 | 0.0097 | 16.5172 | 0.154 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0001822 | 0.01 | 2.3673 | 4.8611 | 11 | 284 | kidney development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 140.9945 | 0.7799 | 24 | 31 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 15.8276 | 2.6415 | 29 | 105 | nucleosome assembly |
GO:0045653 | 0 | 140.3509 | 0.4528 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006336 | 0 | 32.9969 | 0.7799 | 14 | 31 | DNA replication-independent chromatin assembly |
GO:0071824 | 0 | 6.886 | 5.2829 | 30 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 6.2542 | 5.937 | 31 | 236 | chromatin remodeling |
GO:0032200 | 0 | 7.9917 | 3.849 | 25 | 153 | telomere organization |
GO:0006352 | 0 | 5.5994 | 3.0691 | 15 | 122 | DNA-templated transcription, initiation |
GO:0032501 | 0 | 1.6404 | 151.0244 | 197 | 6208 | multicellular organismal process |
GO:0045637 | 0 | 4.0982 | 4.8804 | 18 | 194 | regulation of myeloid cell differentiation |
GO:0098609 | 0 | 2.2998 | 21.4588 | 45 | 853 | cell-cell adhesion |
GO:0099537 | 0 | 2.2596 | 16.7293 | 35 | 665 | trans-synaptic signaling |
GO:0007218 | 0 | 4.949 | 2.4905 | 11 | 99 | neuropeptide signaling pathway |
GO:0007156 | 0 | 3.9194 | 3.9245 | 14 | 156 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0031295 | 0 | 8.6056 | 0.9811 | 7 | 39 | T cell costimulation |
GO:0007492 | 1e-04 | 5.7281 | 1.7861 | 9 | 71 | endoderm development |
GO:2000026 | 1e-04 | 1.8453 | 32.3266 | 55 | 1285 | regulation of multicellular organismal development |
GO:0045060 | 1e-04 | 22.35 | 0.2767 | 4 | 11 | negative thymic T cell selection |
GO:0040029 | 1e-04 | 3.9611 | 3.3207 | 12 | 132 | regulation of gene expression, epigenetic |
GO:0050789 | 1e-04 | 2.3551 | 14.344 | 29 | 666 | regulation of biological process |
GO:0001708 | 2e-04 | 4.9081 | 2.0443 | 9 | 82 | cell fate specification |
GO:0048731 | 2e-04 | 1.5401 | 76.2529 | 105 | 3130 | system development |
GO:0045596 | 4e-04 | 2.0655 | 15.9998 | 31 | 636 | negative regulation of cell differentiation |
GO:0050877 | 4e-04 | 1.7378 | 32.1253 | 52 | 1277 | nervous system process |
GO:0035641 | 4e-04 | 14.2192 | 0.3774 | 4 | 15 | locomotory exploration behavior |
GO:0072507 | 5e-04 | 2.2119 | 12.025 | 25 | 478 | divalent inorganic cation homeostasis |
GO:1990414 | 5e-04 | 29.2683 | 0.1761 | 3 | 7 | replication-born double-strand break repair via sister chromatid exchange |
GO:0099601 | 6e-04 | 5.3932 | 1.4591 | 7 | 58 | regulation of neurotransmitter receptor activity |
GO:0006540 | 6e-04 | Inf | 0.0503 | 2 | 2 | glutamate decarboxylation to succinate |
GO:0097214 | 6e-04 | Inf | 0.0503 | 2 | 2 | positive regulation of lysosomal membrane permeability |
GO:0050804 | 7e-04 | 2.2826 | 10.2388 | 22 | 407 | modulation of chemical synaptic transmission |
GO:0001714 | 8e-04 | 23.4132 | 0.2013 | 3 | 8 | endodermal cell fate specification |
GO:0090009 | 8e-04 | 23.4132 | 0.2013 | 3 | 8 | primitive streak formation |
GO:0021517 | 9e-04 | 6.0348 | 1.1321 | 6 | 45 | ventral spinal cord development |
GO:0048706 | 0.001 | 3.5209 | 3.0691 | 10 | 122 | embryonic skeletal system development |
GO:0033627 | 0.0011 | 4.1953 | 2.088 | 8 | 83 | cell adhesion mediated by integrin |
GO:0001993 | 0.0012 | 19.5098 | 0.2264 | 3 | 9 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
GO:0040036 | 0.0013 | 6.9923 | 0.8302 | 5 | 33 | regulation of fibroblast growth factor receptor signaling pathway |
GO:0048513 | 0.0015 | 1.4291 | 80.2299 | 105 | 3209 | animal organ development |
GO:0042428 | 0.0017 | 16.7216 | 0.2516 | 3 | 10 | serotonin metabolic process |
GO:0030718 | 0.0019 | 77.8735 | 0.0755 | 2 | 3 | germ-line stem cell population maintenance |
GO:0097477 | 0.0019 | 77.8735 | 0.0755 | 2 | 3 | lateral motor column neuron migration |
GO:2000547 | 0.0019 | 77.8735 | 0.0755 | 2 | 3 | regulation of dendritic cell dendrite assembly |
GO:0007188 | 0.0019 | 2.6013 | 5.7106 | 14 | 227 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
GO:0065003 | 0.002 | 1.5903 | 35.446 | 53 | 1409 | protein-containing complex assembly |
GO:0001964 | 0.0022 | 14.731 | 0.2749 | 3 | 11 | startle response |
GO:0010739 | 0.0022 | 14.6305 | 0.2767 | 3 | 11 | positive regulation of protein kinase A signaling |
GO:0033632 | 0.0022 | 14.6305 | 0.2767 | 3 | 11 | regulation of cell-cell adhesion mediated by integrin |
GO:0060134 | 0.0022 | 14.6305 | 0.2767 | 3 | 11 | prepulse inhibition |
GO:1902260 | 0.0022 | 14.6305 | 0.2767 | 3 | 11 | negative regulation of delayed rectifier potassium channel activity |
GO:0030097 | 0.0023 | 1.77 | 20.2764 | 34 | 806 | hemopoiesis |
GO:0048468 | 0.0027 | 1.4904 | 48.753 | 68 | 1950 | cell development |
GO:2000243 | 0.0028 | 4.0406 | 1.8868 | 7 | 75 | positive regulation of reproductive process |
GO:0001771 | 0.0029 | 13.0041 | 0.3019 | 3 | 12 | immunological synapse formation |
GO:0060078 | 0.0031 | 3.2189 | 2.9937 | 9 | 119 | regulation of postsynaptic membrane potential |
GO:0017158 | 0.0031 | 5.5914 | 1.0063 | 5 | 40 | regulation of calcium ion-dependent exocytosis |
GO:0022008 | 0.0032 | 1.5325 | 38.7919 | 56 | 1542 | neurogenesis |
GO:0036037 | 0.0033 | 7.4435 | 0.6289 | 4 | 25 | CD8-positive, alpha-beta T cell activation |
GO:0071880 | 0.0033 | 7.4435 | 0.6289 | 4 | 25 | adenylate cyclase-activating adrenergic receptor signaling pathway |
GO:0007204 | 0.0036 | 2.2551 | 7.4716 | 16 | 297 | positive regulation of cytosolic calcium ion concentration |
GO:0002408 | 0.0037 | 38.9343 | 0.1006 | 2 | 4 | myeloid dendritic cell chemotaxis |
GO:0014050 | 0.0037 | 38.9343 | 0.1006 | 2 | 4 | negative regulation of glutamate secretion |
GO:0038116 | 0.0037 | 38.9343 | 0.1006 | 2 | 4 | chemokine (C-C motif) ligand 21 signaling pathway |
GO:0048014 | 0.0037 | 38.9343 | 0.1006 | 2 | 4 | Tie signaling pathway |
GO:0048866 | 0.0037 | 38.9343 | 0.1006 | 2 | 4 | stem cell fate specification |
GO:0097241 | 0.0037 | 38.9343 | 0.1006 | 2 | 4 | hematopoietic stem cell migration to bone marrow |
GO:1990911 | 0.0037 | 38.9343 | 0.1006 | 2 | 4 | response to psychosocial stress |
GO:0015844 | 0.0037 | 3.8151 | 1.9874 | 7 | 79 | monoamine transport |
GO:0001768 | 0.0037 | 11.7029 | 0.327 | 3 | 13 | establishment of T cell polarity |
GO:0021978 | 0.0037 | 11.7029 | 0.327 | 3 | 13 | telencephalon regionalization |
GO:0042136 | 0.0037 | 11.7029 | 0.327 | 3 | 13 | neurotransmitter biosynthetic process |
GO:0035987 | 0.0039 | 5.2885 | 1.0566 | 5 | 42 | endodermal cell differentiation |
GO:0007389 | 0.004 | 1.9878 | 11.0942 | 21 | 441 | pattern specification process |
GO:0048869 | 0.0043 | 1.4941 | 43.83 | 61 | 1869 | cellular developmental process |
GO:1903039 | 0.0047 | 2.4209 | 5.6603 | 13 | 225 | positive regulation of leukocyte cell-cell adhesion |
GO:0048645 | 0.005 | 4.1244 | 1.5849 | 6 | 63 | animal organ formation |
GO:0090022 | 0.005 | 6.5118 | 0.7044 | 4 | 28 | regulation of neutrophil chemotaxis |
GO:0048870 | 0.0051 | 1.4899 | 40.5025 | 57 | 1610 | cell motility |
GO:0006874 | 0.0052 | 1.9751 | 10.6162 | 20 | 422 | cellular calcium ion homeostasis |
GO:0030182 | 0.0053 | 1.5438 | 32.1001 | 47 | 1276 | neuron differentiation |
GO:0009653 | 0.0056 | 1.393 | 64.477 | 84 | 2563 | anatomical structure morphogenesis |
GO:0003214 | 0.0057 | 9.7512 | 0.3774 | 3 | 15 | cardiac left ventricle morphogenesis |
GO:0060911 | 0.0057 | 9.7512 | 0.3774 | 3 | 15 | cardiac cell fate commitment |
GO:0050795 | 0.0058 | 3.9841 | 1.6352 | 6 | 65 | regulation of behavior |
GO:0097659 | 0.0058 | 1.3602 | 79.0931 | 100 | 3144 | nucleic acid-templated transcription |
GO:0051952 | 0.0059 | 3.4756 | 2.1635 | 7 | 86 | regulation of amine transport |
GO:0002682 | 0.0059 | 1.5407 | 31.4461 | 46 | 1250 | regulation of immune system process |
GO:0021937 | 0.006 | 25.9546 | 0.1258 | 2 | 5 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
GO:0048859 | 0.006 | 25.9546 | 0.1258 | 2 | 5 | formation of anatomical boundary |
GO:0060685 | 0.006 | 25.9546 | 0.1258 | 2 | 5 | regulation of prostatic bud formation |
GO:0097212 | 0.006 | 25.9546 | 0.1258 | 2 | 5 | lysosomal membrane organization |
GO:2000543 | 0.006 | 25.9546 | 0.1258 | 2 | 5 | positive regulation of gastrulation |
GO:0045058 | 0.0063 | 4.6574 | 1.1824 | 5 | 47 | T cell selection |
GO:0007267 | 0.0064 | 1.4913 | 37.5139 | 53 | 1498 | cell-cell signaling |
GO:0001662 | 0.0064 | 6.0102 | 0.7547 | 4 | 30 | behavioral fear response |
GO:0002520 | 0.0072 | 1.6186 | 22.6663 | 35 | 901 | immune system development |
GO:2000403 | 0.0073 | 5.7872 | 0.7799 | 4 | 31 | positive regulation of lymphocyte migration |
GO:0006584 | 0.0076 | 4.4452 | 1.2327 | 5 | 49 | catecholamine metabolic process |
GO:0015872 | 0.0076 | 4.4452 | 1.2327 | 5 | 49 | dopamine transport |
GO:0021536 | 0.0077 | 3.7302 | 1.7358 | 6 | 69 | diencephalon development |
GO:0007610 | 0.0081 | 1.8293 | 12.5694 | 22 | 505 | behavior |
GO:0050901 | 0.0081 | 5.5802 | 0.805 | 4 | 32 | leukocyte tethering or rolling |
GO:1905207 | 0.0081 | 5.5802 | 0.805 | 4 | 32 | regulation of cardiocyte differentiation |
GO:0017157 | 0.0081 | 2.4468 | 4.7295 | 11 | 188 | regulation of exocytosis |
GO:0033555 | 0.0083 | 3.6717 | 1.761 | 6 | 70 | multicellular organismal response to stress |
GO:0021513 | 0.0083 | 8.3571 | 0.4277 | 3 | 17 | spinal cord dorsal/ventral patterning |
GO:0042481 | 0.0083 | 8.3571 | 0.4277 | 3 | 17 | regulation of odontogenesis |
GO:0008015 | 0.0084 | 1.8517 | 11.8489 | 21 | 471 | blood circulation |
GO:0001996 | 0.0089 | 19.4647 | 0.1509 | 2 | 6 | positive regulation of heart rate by epinephrine-norepinephrine |
GO:0097475 | 0.0089 | 19.4647 | 0.1509 | 2 | 6 | motor neuron migration |
GO:1900454 | 0.0089 | 19.4647 | 0.1509 | 2 | 6 | positive regulation of long-term synaptic depression |
GO:2000481 | 0.0089 | 19.4647 | 0.1509 | 2 | 6 | positive regulation of cAMP-dependent protein kinase activity |
GO:2000669 | 0.0089 | 19.4647 | 0.1509 | 2 | 6 | negative regulation of dendritic cell apoptotic process |
GO:0006935 | 0.0089 | 1.7634 | 14.2136 | 24 | 565 | chemotaxis |
GO:0007268 | 0.0089 | 2.2226 | 6.13 | 13 | 251 | chemical synaptic transmission |
GO:0032502 | 0.0093 | 1.5674 | 26.6089 | 39 | 1229 | developmental process |
GO:0045055 | 0.0093 | 2.2949 | 5.4842 | 12 | 218 | regulated exocytosis |
GO:0050794 | 0.0094 | 1.2853 | 251.6691 | 275 | 10004 | regulation of cellular process |
GO:0001704 | 0.0094 | 2.8805 | 2.9434 | 8 | 117 | formation of primary germ layer |
GO:0007613 | 0.0094 | 2.8805 | 2.9434 | 8 | 117 | memory |
GO:0002076 | 0.0097 | 7.7995 | 0.4528 | 3 | 18 | osteoblast development |
GO:0042053 | 0.0097 | 7.7995 | 0.4528 | 3 | 18 | regulation of dopamine metabolic process |
GO:0072189 | 0.0097 | 7.7995 | 0.4528 | 3 | 18 | ureter development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 120.0452 | 0.9045 | 24 | 31 | DNA replication-dependent chromatin assembly |
GO:0045653 | 0 | 119.9333 | 0.5252 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006334 | 0 | 11.5219 | 3.0636 | 26 | 105 | nucleosome assembly |
GO:0006336 | 0 | 28.1966 | 0.9045 | 14 | 31 | DNA replication-independent chromatin assembly |
GO:0022008 | 0 | 2.721 | 32.0437 | 75 | 1135 | neurogenesis |
GO:0032200 | 0 | 6.4642 | 4.4641 | 24 | 153 | telomere organization |
GO:0048731 | 0 | 2.5032 | 41.6056 | 86 | 1727 | system development |
GO:0051674 | 0 | 2.3227 | 46.9751 | 94 | 1610 | localization of cell |
GO:0071824 | 0 | 5.1427 | 6.1272 | 27 | 210 | protein-DNA complex subunit organization |
GO:0048869 | 0 | 2.2697 | 44.7534 | 86 | 1764 | cellular developmental process |
GO:0006338 | 0 | 4.4955 | 6.8858 | 27 | 236 | chromatin remodeling |
GO:0045637 | 0 | 4.8925 | 5.6604 | 24 | 194 | regulation of myeloid cell differentiation |
GO:0009888 | 0 | 2.0828 | 48.0022 | 88 | 1668 | tissue development |
GO:0032501 | 0 | 1.9279 | 85.572 | 131 | 3496 | multicellular organismal process |
GO:0032879 | 0 | 1.8518 | 76.0063 | 122 | 2605 | regulation of localization |
GO:0045165 | 0 | 4.3842 | 5.9566 | 23 | 207 | cell fate commitment |
GO:0045596 | 0 | 2.9065 | 14.9071 | 39 | 525 | negative regulation of cell differentiation |
GO:2000026 | 0 | 2.4196 | 22.9037 | 50 | 825 | regulation of multicellular organismal development |
GO:0098916 | 0 | 2.5245 | 19.1985 | 44 | 658 | anterograde trans-synaptic signaling |
GO:0030182 | 0 | 5.3696 | 3.4214 | 16 | 129 | neuron differentiation |
GO:0099536 | 0 | 2.4744 | 20.0155 | 45 | 686 | synaptic signaling |
GO:0051240 | 0 | 2.031 | 39.3599 | 72 | 1349 | positive regulation of multicellular organismal process |
GO:2000145 | 0 | 2.194 | 28.0975 | 56 | 963 | regulation of cell motility |
GO:0002520 | 0 | 2.2139 | 26.2885 | 53 | 901 | immune system development |
GO:0050794 | 0 | 1.6645 | 229.3083 | 276 | 8418 | regulation of cellular process |
GO:0045944 | 0 | 2.0743 | 32.9117 | 62 | 1128 | positive regulation of transcription by RNA polymerase II |
GO:0072001 | 0 | 3.2197 | 8.5489 | 25 | 293 | renal system development |
GO:0061564 | 0 | 2.7249 | 12.8379 | 32 | 440 | axon development |
GO:0007389 | 0 | 2.7181 | 12.8671 | 32 | 441 | pattern specification process |
GO:0006352 | 0 | 4.783 | 3.5596 | 15 | 122 | DNA-templated transcription, initiation |
GO:0048812 | 0 | 2.4571 | 16.8643 | 38 | 578 | neuron projection morphogenesis |
GO:0051960 | 0 | 2.7282 | 11.9918 | 30 | 411 | regulation of nervous system development |
GO:0048513 | 0 | 2.0834 | 28.1846 | 53 | 1117 | animal organ development |
GO:0048858 | 0 | 2.3706 | 17.4187 | 38 | 597 | cell projection morphogenesis |
GO:0001568 | 0 | 2.2129 | 21.095 | 43 | 723 | blood vessel development |
GO:0048667 | 0 | 2.4605 | 14.997 | 34 | 514 | cell morphogenesis involved in neuron differentiation |
GO:0032989 | 0 | 2.2108 | 20.599 | 42 | 706 | cellular component morphogenesis |
GO:0021707 | 0 | 67.0989 | 0.1751 | 4 | 6 | cerebellar granule cell differentiation |
GO:0150063 | 0 | 2.7487 | 10.6788 | 27 | 366 | visual system development |
GO:0009887 | 0 | 2.5036 | 13.8794 | 32 | 498 | animal organ morphogenesis |
GO:0001501 | 0 | 2.9458 | 8.8797 | 24 | 312 | skeletal system development |
GO:0050804 | 0 | 2.8445 | 9.5607 | 25 | 331 | modulation of chemical synaptic transmission |
GO:0006928 | 0 | 1.9392 | 32.7135 | 58 | 1183 | movement of cell or subcellular component |
GO:0071495 | 0 | 1.8786 | 36.5297 | 63 | 1252 | cellular response to endogenous stimulus |
GO:0030097 | 0 | 2.2015 | 19.6592 | 40 | 683 | hemopoiesis |
GO:0034654 | 0 | 1.554 | 102.5282 | 141 | 3514 | nucleobase-containing compound biosynthetic process |
GO:0007423 | 0 | 3.0122 | 7.9559 | 22 | 280 | sensory organ development |
GO:0048665 | 0 | 10.2621 | 0.8753 | 7 | 30 | neuron fate specification |
GO:0007411 | 0 | 3.2502 | 6.3898 | 19 | 219 | axon guidance |
GO:0007626 | 0 | 3.5175 | 5.3102 | 17 | 182 | locomotory behavior |
GO:0048568 | 0 | 2.4969 | 12.5461 | 29 | 430 | embryonic organ development |
GO:0051216 | 0 | 3.475 | 5.3686 | 17 | 184 | cartilage development |
GO:0099560 | 0 | 12.6232 | 0.6419 | 6 | 22 | synaptic membrane adhesion |
GO:0007167 | 0 | 1.9808 | 26.7262 | 49 | 916 | enzyme linked receptor protein signaling pathway |
GO:0040011 | 0 | 2.1197 | 20.9568 | 41 | 771 | locomotion |
GO:0021683 | 0 | 33.5453 | 0.2334 | 4 | 8 | cerebellar granular layer morphogenesis |
GO:0120036 | 1e-04 | 1.7683 | 40.4686 | 66 | 1387 | plasma membrane bounded cell projection organization |
GO:0003206 | 1e-04 | 4.0141 | 3.5888 | 13 | 123 | cardiac chamber morphogenesis |
GO:2000027 | 1e-04 | 4.0141 | 3.5888 | 13 | 123 | regulation of animal organ morphogenesis |
GO:1903508 | 1e-04 | 1.7231 | 44.0574 | 70 | 1510 | positive regulation of nucleic acid-templated transcription |
GO:0071542 | 1e-04 | 8.1358 | 1.0504 | 7 | 36 | dopaminergic neuron differentiation |
GO:0048704 | 1e-04 | 4.6013 | 2.6843 | 11 | 92 | embryonic skeletal system morphogenesis |
GO:0048519 | 1e-04 | 1.4983 | 112.7624 | 148 | 4052 | negative regulation of biological process |
GO:0050789 | 1e-04 | 3.7539 | 4.2931 | 14 | 227 | regulation of biological process |
GO:2000179 | 1e-04 | 6.4285 | 1.4589 | 8 | 50 | positive regulation of neural precursor cell proliferation |
GO:0050877 | 1e-04 | 1.8131 | 32.6807 | 55 | 1134 | nervous system process |
GO:1905114 | 1e-04 | 2.2284 | 14.9095 | 31 | 511 | cell surface receptor signaling pathway involved in cell-cell signaling |
GO:0035113 | 1e-04 | 3.9894 | 3.3262 | 12 | 114 | embryonic appendage morphogenesis |
GO:0060284 | 1e-04 | 2.2541 | 13.7716 | 29 | 472 | regulation of cell development |
GO:0030901 | 2e-04 | 4.571 | 2.4509 | 10 | 84 | midbrain development |
GO:0021536 | 2e-04 | 5.0674 | 2.0132 | 9 | 69 | diencephalon development |
GO:0001503 | 2e-04 | 2.4307 | 10.5768 | 24 | 365 | ossification |
GO:0006811 | 2e-04 | 1.698 | 40.5853 | 64 | 1391 | ion transport |
GO:0006935 | 2e-04 | 2.8529 | 6.8027 | 18 | 239 | chemotaxis |
GO:0045665 | 2e-04 | 4.9841 | 2.0424 | 9 | 70 | negative regulation of neuron differentiation |
GO:0061333 | 2e-04 | 4.9841 | 2.0424 | 9 | 70 | renal tubule morphogenesis |
GO:0040017 | 2e-04 | 2.1058 | 16.2225 | 32 | 556 | positive regulation of locomotion |
GO:0021800 | 2e-04 | 50.2185 | 0.1459 | 3 | 5 | cerebral cortex tangential migration |
GO:0035385 | 2e-04 | 50.2185 | 0.1459 | 3 | 5 | Roundabout signaling pathway |
GO:0090288 | 3e-04 | 3.9198 | 3.0928 | 11 | 106 | negative regulation of cellular response to growth factor stimulus |
GO:0048754 | 3e-04 | 3.4188 | 4.1431 | 13 | 142 | branching morphogenesis of an epithelial tube |
GO:0003231 | 3e-04 | 3.6309 | 3.618 | 12 | 124 | cardiac ventricle development |
GO:0070848 | 3e-04 | 1.9746 | 19.4319 | 36 | 666 | response to growth factor |
GO:0021781 | 3e-04 | 16.7684 | 0.3501 | 4 | 12 | glial cell fate commitment |
GO:0051549 | 3e-04 | 16.7684 | 0.3501 | 4 | 12 | positive regulation of keratinocyte migration |
GO:0032835 | 3e-04 | 5.291 | 1.7214 | 8 | 59 | glomerulus development |
GO:0198738 | 3e-04 | 2.2468 | 12.3419 | 26 | 423 | cell-cell signaling by wnt |
GO:0008285 | 3e-04 | 1.9305 | 20.9783 | 38 | 719 | negative regulation of cell population proliferation |
GO:0048863 | 3e-04 | 2.9108 | 5.9229 | 16 | 203 | stem cell differentiation |
GO:0071310 | 3e-04 | 1.5336 | 65.094 | 92 | 2231 | cellular response to organic substance |
GO:0090132 | 3e-04 | 2.411 | 9.7451 | 22 | 334 | epithelium migration |
GO:0007157 | 3e-04 | 6.0459 | 1.3421 | 7 | 46 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0048146 | 3e-04 | 6.0459 | 1.3421 | 7 | 46 | positive regulation of fibroblast proliferation |
GO:0051046 | 4e-04 | 2.0374 | 16.7185 | 32 | 573 | regulation of secretion |
GO:0001763 | 4e-04 | 2.9632 | 5.4561 | 15 | 187 | morphogenesis of a branching structure |
GO:0045664 | 4e-04 | 3.7064 | 3.2489 | 11 | 113 | regulation of neuron differentiation |
GO:0048839 | 4e-04 | 2.9459 | 5.4853 | 15 | 188 | inner ear development |
GO:0051272 | 4e-04 | 2.0395 | 16.1641 | 31 | 554 | positive regulation of cellular component movement |
GO:0030336 | 4e-04 | 2.423 | 9.2491 | 21 | 317 | negative regulation of cell migration |
GO:0048736 | 4e-04 | 3.0657 | 4.9309 | 14 | 169 | appendage development |
GO:0001759 | 5e-04 | 9.3296 | 0.6711 | 5 | 23 | organ induction |
GO:0021697 | 5e-04 | 9.3296 | 0.6711 | 5 | 23 | cerebellar cortex formation |
GO:0045597 | 5e-04 | 1.9414 | 19.1758 | 35 | 670 | positive regulation of cell differentiation |
GO:0070100 | 5e-04 | 33.4769 | 0.1751 | 3 | 6 | negative regulation of chemokine-mediated signaling pathway |
GO:0097475 | 5e-04 | 33.4769 | 0.1751 | 3 | 6 | motor neuron migration |
GO:0048645 | 5e-04 | 4.905 | 1.8382 | 8 | 63 | animal organ formation |
GO:0051254 | 5e-04 | 1.5903 | 47.9379 | 71 | 1643 | positive regulation of RNA metabolic process |
GO:0043010 | 5e-04 | 2.6873 | 6.7764 | 17 | 235 | camera-type eye development |
GO:0040029 | 5e-04 | 3.3872 | 3.8514 | 12 | 132 | regulation of gene expression, epigenetic |
GO:0051241 | 5e-04 | 1.7374 | 30.0524 | 49 | 1030 | negative regulation of multicellular organismal process |
GO:0030001 | 5e-04 | 1.829 | 23.8377 | 41 | 817 | metal ion transport |
GO:0010557 | 5e-04 | 1.574 | 49.8053 | 73 | 1707 | positive regulation of macromolecule biosynthetic process |
GO:0090090 | 6e-04 | 3.3312 | 3.9097 | 12 | 134 | negative regulation of canonical Wnt signaling pathway |
GO:0007171 | 6e-04 | 13.4131 | 0.4085 | 4 | 14 | activation of transmembrane receptor protein tyrosine kinase activity |
GO:0060572 | 6e-04 | 13.4131 | 0.4085 | 4 | 14 | morphogenesis of an epithelial bud |
GO:0007218 | 6e-04 | 3.797 | 2.8885 | 10 | 99 | neuropeptide signaling pathway |
GO:0001667 | 6e-04 | 2.131 | 12.9546 | 26 | 444 | ameboidal-type cell migration |
GO:0034103 | 6e-04 | 4.1616 | 2.3925 | 9 | 82 | regulation of tissue remodeling |
GO:0060421 | 6e-04 | 6.509 | 1.0796 | 6 | 37 | positive regulation of heart growth |
GO:0023056 | 7e-04 | 1.5768 | 46.8584 | 69 | 1606 | positive regulation of signaling |
GO:0035640 | 7e-04 | 8.3956 | 0.7294 | 5 | 25 | exploration behavior |
GO:0060384 | 7e-04 | 8.3956 | 0.7294 | 5 | 25 | innervation |
GO:0060993 | 7e-04 | 4.1051 | 2.4217 | 9 | 83 | kidney morphogenesis |
GO:0060078 | 7e-04 | 3.4451 | 3.4721 | 11 | 119 | regulation of postsynaptic membrane potential |
GO:0021761 | 7e-04 | 3.7131 | 2.9469 | 10 | 101 | limbic system development |
GO:0032502 | 8e-04 | 1.6594 | 39.3496 | 59 | 1792 | developmental process |
GO:0001525 | 8e-04 | 1.9856 | 16.0143 | 30 | 551 | angiogenesis |
GO:1900122 | 8e-04 | 25.1061 | 0.2042 | 3 | 7 | positive regulation of receptor binding |
GO:0051965 | 8e-04 | 5.1236 | 1.5464 | 7 | 53 | positive regulation of synapse assembly |
GO:0021823 | 8e-04 | Inf | 0.0584 | 2 | 2 | cerebral cortex tangential migration using cell-cell interactions |
GO:0021836 | 8e-04 | Inf | 0.0584 | 2 | 2 | chemorepulsion involved in postnatal olfactory bulb interneuron migration |
GO:0021985 | 8e-04 | Inf | 0.0584 | 2 | 2 | neurohypophysis development |
GO:0060447 | 8e-04 | Inf | 0.0584 | 2 | 2 | bud outgrowth involved in lung branching |
GO:0097324 | 8e-04 | Inf | 0.0584 | 2 | 2 | melanocyte migration |
GO:0140039 | 8e-04 | Inf | 0.0584 | 2 | 2 | cell-cell adhesion in response to extracellular stimulus |
GO:2000768 | 8e-04 | Inf | 0.0584 | 2 | 2 | positive regulation of nephron tubule epithelial cell differentiation |
GO:0002682 | 9e-04 | 1.6348 | 36.4713 | 56 | 1250 | regulation of immune system process |
GO:0072507 | 9e-04 | 2.0512 | 13.9466 | 27 | 478 | divalent inorganic cation homeostasis |
GO:0072210 | 9e-04 | 6.1138 | 1.1379 | 6 | 39 | metanephric nephron development |
GO:0002042 | 9e-04 | 3.9444 | 2.5092 | 9 | 86 | cell migration involved in sprouting angiogenesis |
GO:0051271 | 9e-04 | 2.2667 | 9.8327 | 21 | 337 | negative regulation of cellular component movement |
GO:0048666 | 0.001 | 2.0333 | 14.0737 | 27 | 505 | neuron development |
GO:0050769 | 0.001 | 2.6938 | 5.9521 | 15 | 204 | positive regulation of neurogenesis |
GO:0035116 | 0.001 | 7.6314 | 0.7878 | 5 | 27 | embryonic hindlimb morphogenesis |
GO:1905606 | 0.001 | 7.6314 | 0.7878 | 5 | 27 | regulation of presynapse assembly |
GO:0033194 | 0.001 | 11.1761 | 0.4668 | 4 | 16 | response to hydroperoxide |
GO:0031328 | 0.001 | 1.5246 | 52.6646 | 75 | 1805 | positive regulation of cellular biosynthetic process |
GO:0010647 | 0.001 | 1.5513 | 46.8 | 68 | 1604 | positive regulation of cell communication |
GO:0001657 | 0.0011 | 3.8441 | 2.5676 | 9 | 88 | ureteric bud development |
GO:0051094 | 0.0011 | 2.2938 | 9.2593 | 20 | 337 | positive regulation of developmental process |
GO:0043067 | 0.0011 | 1.5965 | 39.3307 | 59 | 1348 | regulation of programmed cell death |
GO:0007517 | 0.0011 | 2.2869 | 9.2783 | 20 | 318 | muscle organ development |
GO:1905330 | 0.0011 | 4.8286 | 1.6276 | 7 | 56 | regulation of morphogenesis of an epithelium |
GO:0072163 | 0.0011 | 3.7958 | 2.5968 | 9 | 89 | mesonephric epithelium development |
GO:0007190 | 0.0012 | 7.2991 | 0.817 | 5 | 28 | activation of adenylate cyclase activity |
GO:0060021 | 0.0012 | 3.7487 | 2.6259 | 9 | 90 | roof of mouth development |
GO:0035881 | 0.0012 | 20.0836 | 0.2334 | 3 | 8 | amacrine cell differentiation |
GO:0072239 | 0.0012 | 20.0836 | 0.2334 | 3 | 8 | metanephric glomerulus vasculature development |
GO:0021542 | 0.0013 | 10.3158 | 0.496 | 4 | 17 | dentate gyrus development |
GO:0060412 | 0.0013 | 5.6032 | 1.2254 | 6 | 42 | ventricular septum morphogenesis |
GO:0042733 | 0.0013 | 4.7125 | 1.6631 | 7 | 57 | embryonic digit morphogenesis |
GO:0090596 | 0.0013 | 2.4377 | 7.411 | 17 | 254 | sensory organ morphogenesis |
GO:0090101 | 0.0013 | 3.1783 | 3.7347 | 11 | 128 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0046620 | 0.0013 | 3.7028 | 2.6551 | 9 | 91 | regulation of organ growth |
GO:0048871 | 0.0013 | 1.9833 | 14.3843 | 27 | 493 | multicellular organismal homeostasis |
GO:0021522 | 0.0014 | 6.9945 | 0.8461 | 5 | 29 | spinal cord motor neuron differentiation |
GO:0002009 | 0.0014 | 2.4251 | 7.4456 | 17 | 261 | morphogenesis of an epithelium |
GO:0030335 | 0.0014 | 1.9491 | 15.1721 | 28 | 520 | positive regulation of cell migration |
GO:0035019 | 0.0015 | 5.4515 | 1.2546 | 6 | 43 | somatic stem cell population maintenance |
GO:0009605 | 0.0015 | 1.4405 | 70.9295 | 95 | 2431 | response to external stimulus |
GO:0060255 | 0.0015 | 1.3295 | 172.4949 | 204 | 5912 | regulation of macromolecule metabolic process |
GO:0007507 | 0.0015 | 1.9149 | 15.9876 | 29 | 551 | heart development |
GO:0060548 | 0.0016 | 1.6937 | 26.8429 | 43 | 920 | negative regulation of cell death |
GO:0045860 | 0.0016 | 2.1254 | 10.9414 | 22 | 375 | positive regulation of protein kinase activity |
GO:0061298 | 0.0016 | 9.5783 | 0.5252 | 4 | 18 | retina vasculature development in camera-type eye |
GO:0045995 | 0.0016 | 4.5307 | 1.7214 | 7 | 59 | regulation of embryonic development |
GO:0030177 | 0.0016 | 3.0983 | 3.8222 | 11 | 131 | positive regulation of Wnt signaling pathway |
GO:0097106 | 0.0016 | 6.7143 | 0.8753 | 5 | 30 | postsynaptic density organization |
GO:0022414 | 0.0016 | 1.571 | 39.1848 | 58 | 1343 | reproductive process |
GO:0098655 | 0.0017 | 1.7342 | 23.7501 | 39 | 814 | cation transmembrane transport |
GO:0072203 | 0.0018 | 16.7353 | 0.2626 | 3 | 9 | cell proliferation involved in metanephros development |
GO:0007420 | 0.0018 | 1.9639 | 13.968 | 26 | 489 | brain development |
GO:0050900 | 0.0019 | 2.1356 | 10.387 | 21 | 356 | leukocyte migration |
GO:0010837 | 0.0019 | 6.4557 | 0.9045 | 5 | 31 | regulation of keratinocyte proliferation |
GO:0060560 | 0.0019 | 2.5058 | 6.3606 | 15 | 218 | developmental growth involved in morphogenesis |
GO:0014068 | 0.0019 | 3.8503 | 2.2758 | 8 | 78 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0021511 | 0.002 | 8.9392 | 0.5544 | 4 | 19 | spinal cord patterning |
GO:0043586 | 0.002 | 8.9392 | 0.5544 | 4 | 19 | tongue development |
GO:0048639 | 0.002 | 2.8382 | 4.5224 | 12 | 155 | positive regulation of developmental growth |
GO:0009889 | 0.002 | 1.3599 | 108.9472 | 136 | 3734 | regulation of biosynthetic process |
GO:0009952 | 0.0021 | 2.9905 | 3.9456 | 11 | 137 | anterior/posterior pattern specification |
GO:0043408 | 0.0021 | 1.8143 | 18.5858 | 32 | 637 | regulation of MAPK cascade |
GO:0043062 | 0.0021 | 2.2658 | 8.403 | 18 | 288 | extracellular structure organization |
GO:0097659 | 0.0021 | 1.5275 | 44.8317 | 64 | 1634 | nucleic acid-templated transcription |
GO:0046660 | 0.0021 | 3.1846 | 3.3845 | 10 | 116 | female sex differentiation |
GO:0003151 | 0.0021 | 3.7958 | 2.305 | 8 | 79 | outflow tract morphogenesis |
GO:0035239 | 0.0021 | 1.7607 | 20.9593 | 35 | 732 | tube morphogenesis |
GO:0021537 | 0.0022 | 2.6725 | 5.1815 | 13 | 180 | telencephalon development |
GO:0009954 | 0.0022 | 6.2162 | 0.9337 | 5 | 32 | proximal/distal pattern formation |
GO:0045229 | 0.0022 | 2.2489 | 8.4614 | 18 | 290 | external encapsulating structure organization |
GO:0072359 | 0.0023 | 1.8831 | 15.6763 | 28 | 556 | circulatory system development |
GO:0040013 | 0.0023 | 2.0972 | 10.5621 | 21 | 362 | negative regulation of locomotion |
GO:0009968 | 0.0023 | 1.62 | 30.656 | 47 | 1067 | negative regulation of signal transduction |
GO:0048260 | 0.0023 | 4.9184 | 1.3713 | 6 | 47 | positive regulation of receptor-mediated endocytosis |
GO:0055010 | 0.0023 | 4.9184 | 1.3713 | 6 | 47 | ventricular cardiac muscle tissue morphogenesis |
GO:0021516 | 0.0024 | 8.38 | 0.5835 | 4 | 20 | dorsal spinal cord development |
GO:0097530 | 0.0024 | 2.9262 | 4.0264 | 11 | 138 | granulocyte migration |
GO:0016079 | 0.0024 | 3.3719 | 2.8885 | 9 | 99 | synaptic vesicle exocytosis |
GO:0007412 | 0.0025 | 66.8218 | 0.0875 | 2 | 3 | axon target recognition |
GO:0033092 | 0.0025 | 66.8218 | 0.0875 | 2 | 3 | positive regulation of immature T cell proliferation in thymus |
GO:0038091 | 0.0025 | 66.8218 | 0.0875 | 2 | 3 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
GO:0042662 | 0.0025 | 66.8218 | 0.0875 | 2 | 3 | negative regulation of mesodermal cell fate specification |
GO:0061056 | 0.0025 | 66.8218 | 0.0875 | 2 | 3 | sclerotome development |
GO:0061364 | 0.0025 | 66.8218 | 0.0875 | 2 | 3 | apoptotic process involved in luteolysis |
GO:0072194 | 0.0025 | 66.8218 | 0.0875 | 2 | 3 | kidney smooth muscle tissue development |
GO:0072275 | 0.0025 | 66.8218 | 0.0875 | 2 | 3 | metanephric glomerulus morphogenesis |
GO:0072277 | 0.0025 | 66.8218 | 0.0875 | 2 | 3 | metanephric glomerular capillary formation |
GO:0097377 | 0.0025 | 66.8218 | 0.0875 | 2 | 3 | spinal cord interneuron axon guidance |
GO:0097477 | 0.0025 | 66.8218 | 0.0875 | 2 | 3 | lateral motor column neuron migration |
GO:0021936 | 0.0025 | 14.3436 | 0.2918 | 3 | 10 | regulation of cerebellar granule cell precursor proliferation |
GO:0060601 | 0.0025 | 14.3436 | 0.2918 | 3 | 10 | lateral sprouting from an epithelium |
GO:0040008 | 0.0026 | 1.8032 | 18.0898 | 31 | 620 | regulation of growth |
GO:0045137 | 0.0026 | 2.5088 | 5.9229 | 14 | 203 | development of primary sexual characteristics |
GO:0070374 | 0.0026 | 2.5088 | 5.9229 | 14 | 203 | positive regulation of ERK1 and ERK2 cascade |
GO:0023052 | 0.0027 | 1.3554 | 115.0746 | 141 | 4157 | signaling |
GO:0051781 | 0.0027 | 3.6412 | 2.3925 | 8 | 82 | positive regulation of cell division |
GO:0072080 | 0.0027 | 3.6412 | 2.3925 | 8 | 82 | nephron tubule development |
GO:0007498 | 0.0027 | 3.068 | 3.5012 | 10 | 120 | mesoderm development |
GO:0044057 | 0.0027 | 1.8555 | 15.8723 | 28 | 544 | regulation of system process |
GO:0071300 | 0.0028 | 4.0605 | 1.8965 | 7 | 65 | cellular response to retinoic acid |
GO:0002088 | 0.0029 | 3.5925 | 2.4217 | 8 | 83 | lens development in camera-type eye |
GO:2000310 | 0.0029 | 7.8866 | 0.6127 | 4 | 21 | regulation of NMDA receptor activity |
GO:0051932 | 0.0029 | 4.689 | 1.4297 | 6 | 49 | synaptic transmission, GABAergic |
GO:0035270 | 0.003 | 3.2508 | 2.9849 | 9 | 103 | endocrine system development |
GO:0048762 | 0.003 | 2.3753 | 6.6815 | 15 | 229 | mesenchymal cell differentiation |
GO:0048565 | 0.003 | 3.0129 | 3.5596 | 10 | 122 | digestive tract development |
GO:0030003 | 0.0031 | 1.7949 | 17.5646 | 30 | 602 | cellular cation homeostasis |
GO:0002244 | 0.0032 | 2.986 | 3.5888 | 10 | 123 | hematopoietic progenitor cell differentiation |
GO:0045667 | 0.0032 | 2.986 | 3.5888 | 10 | 123 | regulation of osteoblast differentiation |
GO:0050807 | 0.0032 | 2.5422 | 5.4269 | 13 | 186 | regulation of synapse organization |
GO:0009792 | 0.0033 | 1.772 | 18.3816 | 31 | 630 | embryo development ending in birth or egg hatching |
GO:0045060 | 0.0034 | 12.5499 | 0.3209 | 3 | 11 | negative thymic T cell selection |
GO:0048103 | 0.0034 | 12.5499 | 0.3209 | 3 | 11 | somatic stem cell division |
GO:0030539 | 0.0034 | 7.448 | 0.6419 | 4 | 22 | male genitalia development |
GO:0032925 | 0.0034 | 7.448 | 0.6419 | 4 | 22 | regulation of activin receptor signaling pathway |
GO:0022029 | 0.0035 | 4.4985 | 1.4822 | 6 | 51 | telencephalon cell migration |
GO:0048468 | 0.0036 | 1.7632 | 18.5293 | 31 | 700 | cell development |
GO:0035567 | 0.0036 | 3.8601 | 1.984 | 7 | 68 | non-canonical Wnt signaling pathway |
GO:0042698 | 0.0036 | 3.8601 | 1.984 | 7 | 68 | ovulation cycle |
GO:0033993 | 0.0036 | 1.6611 | 24.0419 | 38 | 824 | response to lipid |
GO:0048598 | 0.0037 | 2.0893 | 9.57 | 19 | 338 | embryonic morphogenesis |
GO:0035136 | 0.0037 | 5.4128 | 1.0504 | 5 | 36 | forelimb morphogenesis |
GO:0006355 | 0.0037 | 1.4489 | 53.728 | 73 | 1901 | regulation of transcription, DNA-templated |
GO:0021987 | 0.0038 | 3.1272 | 3.0928 | 9 | 106 | cerebral cortex development |
GO:0043542 | 0.0039 | 2.2414 | 7.5277 | 16 | 258 | endothelial cell migration |
GO:0072088 | 0.0039 | 3.7976 | 2.0132 | 7 | 69 | nephron epithelium morphogenesis |
GO:0016331 | 0.0039 | 2.731 | 4.289 | 11 | 147 | morphogenesis of embryonic epithelium |
GO:0042063 | 0.0039 | 2.1763 | 8.2279 | 17 | 282 | gliogenesis |
GO:0001764 | 0.0039 | 2.7279 | 4.2927 | 11 | 148 | neuron migration |
GO:0050673 | 0.0039 | 1.9581 | 11.8 | 22 | 406 | epithelial cell proliferation |
GO:2001141 | 0.0041 | 1.4431 | 53.9081 | 73 | 1907 | regulation of RNA biosynthetic process |
GO:0010942 | 0.0041 | 1.7979 | 16.3392 | 28 | 560 | positive regulation of cell death |
GO:0021871 | 0.0041 | 7.0555 | 0.6711 | 4 | 23 | forebrain regionalization |
GO:0055065 | 0.0041 | 1.7598 | 17.8855 | 30 | 613 | metal ion homeostasis |
GO:0019219 | 0.0042 | 1.3326 | 104.5123 | 129 | 3582 | regulation of nucleobase-containing compound metabolic process |
GO:1902622 | 0.0042 | 5.2433 | 1.0796 | 5 | 37 | regulation of neutrophil migration |
GO:0014706 | 0.0042 | 2.2886 | 6.915 | 15 | 237 | striated muscle tissue development |
GO:0050671 | 0.0043 | 2.8586 | 3.7347 | 10 | 128 | positive regulation of lymphocyte proliferation |
GO:0002573 | 0.0044 | 2.4422 | 5.6312 | 13 | 193 | myeloid leukocyte differentiation |
GO:0030324 | 0.0044 | 2.55 | 4.9893 | 12 | 171 | lung development |
GO:0003157 | 0.0045 | 11.1548 | 0.3501 | 3 | 12 | endocardium development |
GO:0038180 | 0.0045 | 11.1548 | 0.3501 | 3 | 12 | nerve growth factor signaling pathway |
GO:0042659 | 0.0045 | 11.1548 | 0.3501 | 3 | 12 | regulation of cell fate specification |
GO:1900452 | 0.0045 | 11.1548 | 0.3501 | 3 | 12 | regulation of long-term synaptic depression |
GO:0043066 | 0.0046 | 1.6467 | 23.5751 | 37 | 808 | negative regulation of apoptotic process |
GO:0030855 | 0.0046 | 1.8005 | 15.7229 | 27 | 550 | epithelial cell differentiation |
GO:0035850 | 0.0046 | 5.105 | 1.1044 | 5 | 38 | epithelial cell differentiation involved in kidney development |
GO:0021587 | 0.0047 | 5.0841 | 1.1087 | 5 | 38 | cerebellum morphogenesis |
GO:0021879 | 0.0047 | 5.0841 | 1.1087 | 5 | 38 | forebrain neuron differentiation |
GO:0045761 | 0.0047 | 4.1993 | 1.5756 | 6 | 54 | regulation of adenylate cyclase activity |
GO:0007214 | 0.0048 | 6.7023 | 0.7002 | 4 | 24 | gamma-aminobutyric acid signaling pathway |
GO:1905564 | 0.0048 | 6.7023 | 0.7002 | 4 | 24 | positive regulation of vascular endothelial cell proliferation |
GO:2000463 | 0.0048 | 6.7023 | 0.7002 | 4 | 24 | positive regulation of excitatory postsynaptic potential |
GO:2000679 | 0.0048 | 6.7023 | 0.7002 | 4 | 24 | positive regulation of transcription regulatory region DNA binding |
GO:1901214 | 0.0048 | 2.1273 | 8.403 | 17 | 288 | regulation of neuron death |
GO:0034765 | 0.0048 | 1.8913 | 12.7504 | 23 | 437 | regulation of ion transmembrane transport |
GO:0035701 | 0.0049 | 33.5453 | 0.1162 | 2 | 4 | hematopoietic stem cell migration |
GO:0014834 | 0.0049 | 33.4088 | 0.1167 | 2 | 4 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration |
GO:0022028 | 0.0049 | 33.4088 | 0.1167 | 2 | 4 | tangential migration from the subventricular zone to the olfactory bulb |
GO:0050923 | 0.0049 | 33.4088 | 0.1167 | 2 | 4 | regulation of negative chemotaxis |
GO:0061754 | 0.0049 | 33.4088 | 0.1167 | 2 | 4 | negative regulation of circulating fibrinogen levels |
GO:0072268 | 0.0049 | 33.4088 | 0.1167 | 2 | 4 | pattern specification involved in metanephros development |
GO:0072278 | 0.0049 | 33.4088 | 0.1167 | 2 | 4 | metanephric comma-shaped body morphogenesis |
GO:0090024 | 0.0049 | 33.4088 | 0.1167 | 2 | 4 | negative regulation of neutrophil chemotaxis |
GO:0090244 | 0.0049 | 33.4088 | 0.1167 | 2 | 4 | Wnt signaling pathway involved in somitogenesis |
GO:0090500 | 0.0049 | 33.4088 | 0.1167 | 2 | 4 | endocardial cushion to mesenchymal transition |
GO:0097241 | 0.0049 | 33.4088 | 0.1167 | 2 | 4 | hematopoietic stem cell migration to bone marrow |
GO:1990911 | 0.0049 | 33.4088 | 0.1167 | 2 | 4 | response to psychosocial stress |
GO:2000697 | 0.0049 | 33.4088 | 0.1167 | 2 | 4 | negative regulation of epithelial cell differentiation involved in kidney development |
GO:0031346 | 0.005 | 2.0705 | 9.1324 | 18 | 313 | positive regulation of cell projection organization |
GO:0048608 | 0.0052 | 1.9427 | 11.335 | 21 | 390 | reproductive structure development |
GO:0046686 | 0.0052 | 4.1133 | 1.6047 | 6 | 55 | response to cadmium ion |
GO:0048010 | 0.0052 | 4.1133 | 1.6047 | 6 | 55 | vascular endothelial growth factor receptor signaling pathway |
GO:0032504 | 0.0053 | 1.6411 | 22.9915 | 36 | 788 | multicellular organism reproduction |
GO:0060415 | 0.0053 | 3.5665 | 2.1299 | 7 | 73 | muscle tissue morphogenesis |
GO:0065008 | 0.0055 | 1.324 | 100.6901 | 124 | 3451 | regulation of biological quality |
GO:0043931 | 0.0056 | 6.3828 | 0.7294 | 4 | 25 | ossification involved in bone maturation |
GO:0046579 | 0.0057 | 4.0308 | 1.6339 | 6 | 56 | positive regulation of Ras protein signal transduction |
GO:0010273 | 0.0057 | 10.0387 | 0.3793 | 3 | 13 | detoxification of copper ion |
GO:0010623 | 0.0057 | 10.0387 | 0.3793 | 3 | 13 | programmed cell death involved in cell development |
GO:0045059 | 0.0057 | 10.0387 | 0.3793 | 3 | 13 | positive thymic T cell selection |
GO:0048935 | 0.0057 | 10.0387 | 0.3793 | 3 | 13 | peripheral nervous system neuron development |
GO:1904889 | 0.0057 | 10.0387 | 0.3793 | 3 | 13 | regulation of excitatory synapse assembly |
GO:0010632 | 0.0057 | 2.1424 | 7.8486 | 16 | 269 | regulation of epithelial cell migration |
GO:0051149 | 0.0058 | 3.5131 | 2.1591 | 7 | 74 | positive regulation of muscle cell differentiation |
GO:0040012 | 0.0059 | 9.7609 | 0.3829 | 3 | 14 | regulation of locomotion |
GO:0051056 | 0.0059 | 2.1338 | 7.8778 | 16 | 270 | regulation of small GTPase mediated signal transduction |
GO:0140352 | 0.006 | 1.6274 | 23.1666 | 36 | 794 | export from cell |
GO:0071248 | 0.0061 | 2.4414 | 5.1935 | 12 | 178 | cellular response to metal ion |
GO:0001570 | 0.0062 | 3.4612 | 2.1883 | 7 | 75 | vasculogenesis |
GO:0007422 | 0.0062 | 3.4612 | 2.1883 | 7 | 75 | peripheral nervous system development |
GO:0030878 | 0.0064 | 6.0922 | 0.7586 | 4 | 26 | thyroid gland development |
GO:0099068 | 0.0064 | 6.0922 | 0.7586 | 4 | 26 | postsynapse assembly |
GO:0006874 | 0.0065 | 1.87 | 12.3127 | 22 | 422 | cellular calcium ion homeostasis |
GO:0023061 | 0.0065 | 1.87 | 12.3127 | 22 | 422 | signal release |
GO:0055007 | 0.0065 | 2.8601 | 3.3554 | 9 | 115 | cardiac muscle cell differentiation |
GO:0007204 | 0.0065 | 2.0577 | 8.6656 | 17 | 297 | positive regulation of cytosolic calcium ion concentration |
GO:0001709 | 0.0065 | 4.6595 | 1.1963 | 5 | 41 | cell fate determination |
GO:0007611 | 0.0066 | 2.1695 | 7.2651 | 15 | 249 | learning or memory |
GO:0046928 | 0.0067 | 3.4108 | 2.2175 | 7 | 76 | regulation of neurotransmitter secretion |
GO:0030199 | 0.0067 | 3.8753 | 1.6923 | 6 | 58 | collagen fibril organization |
GO:0060291 | 0.007 | 3.0593 | 2.801 | 8 | 96 | long-term synaptic potentiation |
GO:0051347 | 0.007 | 1.7576 | 15.4638 | 26 | 530 | positive regulation of transferase activity |
GO:0070307 | 0.0071 | 9.1255 | 0.4085 | 3 | 14 | lens fiber cell development |
GO:0072075 | 0.0071 | 9.1255 | 0.4085 | 3 | 14 | metanephric mesenchyme development |
GO:0050919 | 0.0071 | 4.5519 | 1.2206 | 5 | 42 | negative chemotaxis |
GO:0042327 | 0.0072 | 1.6291 | 21.8245 | 34 | 748 | positive regulation of phosphorylation |
GO:0001756 | 0.0072 | 3.8176 | 1.7147 | 6 | 59 | somitogenesis |
GO:0099172 | 0.0072 | 4.5333 | 1.2254 | 5 | 42 | presynapse organization |
GO:0001704 | 0.0073 | 2.8067 | 3.4137 | 9 | 117 | formation of primary germ layer |
GO:0007405 | 0.0073 | 3.8019 | 1.7214 | 6 | 59 | neuroblast proliferation |
GO:0072171 | 0.0073 | 3.8019 | 1.7214 | 6 | 59 | mesonephric tubule morphogenesis |
GO:0060045 | 0.0074 | 5.827 | 0.7878 | 4 | 27 | positive regulation of cardiac muscle cell proliferation |
GO:0061440 | 0.0074 | 5.827 | 0.7878 | 4 | 27 | kidney vasculature development |
GO:0042127 | 0.0075 | 1.5919 | 24.3564 | 37 | 867 | regulation of cell population proliferation |
GO:0030857 | 0.0079 | 4.4319 | 1.2497 | 5 | 43 | negative regulation of epithelial cell differentiation |
GO:0045670 | 0.0079 | 3.7313 | 1.7506 | 6 | 60 | regulation of osteoclast differentiation |
GO:0035108 | 0.008 | 2.9837 | 2.8647 | 8 | 99 | limb morphogenesis |
GO:1904646 | 0.008 | 4.4137 | 1.2546 | 5 | 43 | cellular response to amyloid-beta |
GO:0050770 | 0.008 | 2.5928 | 4.0848 | 10 | 140 | regulation of axonogenesis |
GO:0003402 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | planar cell polarity pathway involved in axis elongation |
GO:0021891 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | olfactory bulb interneuron development |
GO:0021937 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
GO:0051414 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | response to cortisol |
GO:0060059 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | embryonic retina morphogenesis in camera-type eye |
GO:0060066 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | oviduct development |
GO:0060664 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | epithelial cell proliferation involved in salivary gland morphogenesis |
GO:0060685 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | regulation of prostatic bud formation |
GO:0060978 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | angiogenesis involved in coronary vascular morphogenesis |
GO:0071651 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | positive regulation of chemokine (C-C motif) ligand 5 production |
GO:0072081 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | specification of nephron tubule identity |
GO:0072103 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | glomerulus vasculature morphogenesis |
GO:0090259 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | regulation of retinal ganglion cell axon guidance |
GO:1904956 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | regulation of midbrain dopaminergic neuron differentiation |
GO:2000543 | 0.008 | 22.2711 | 0.1459 | 2 | 5 | positive regulation of gastrulation |
GO:0008543 | 0.0082 | 3.2681 | 2.305 | 7 | 79 | fibroblast growth factor receptor signaling pathway |
GO:0048844 | 0.0082 | 3.2681 | 2.305 | 7 | 79 | artery morphogenesis |
GO:0030902 | 0.0084 | 2.5728 | 4.114 | 10 | 141 | hindbrain development |
GO:0050801 | 0.0084 | 1.6339 | 20.4531 | 32 | 701 | ion homeostasis |
GO:0071805 | 0.0085 | 2.2406 | 6.098 | 13 | 209 | potassium ion transmembrane transport |
GO:0003214 | 0.0086 | 8.3645 | 0.4377 | 3 | 15 | cardiac left ventricle morphogenesis |
GO:0021924 | 0.0086 | 8.3645 | 0.4377 | 3 | 15 | cell proliferation in external granule layer |
GO:0060026 | 0.0086 | 8.3645 | 0.4377 | 3 | 15 | convergent extension |
GO:0072044 | 0.0086 | 8.3645 | 0.4377 | 3 | 15 | collecting duct development |
GO:1904862 | 0.0086 | 8.3645 | 0.4377 | 3 | 15 | inhibitory synapse assembly |
GO:0008585 | 0.0089 | 2.9255 | 2.9177 | 8 | 100 | female gonad development |
GO:0031623 | 0.0089 | 2.9255 | 2.9177 | 8 | 100 | receptor internalization |
GO:0045892 | 0.0091 | 1.4894 | 33.0284 | 47 | 1132 | negative regulation of transcription, DNA-templated |
GO:0050905 | 0.0092 | 2.5338 | 4.1723 | 10 | 143 | neuromuscular process |
GO:0045453 | 0.0093 | 3.5976 | 1.809 | 6 | 62 | bone resorption |
GO:0010562 | 0.0093 | 1.575 | 23.8668 | 36 | 818 | positive regulation of phosphorus metabolic process |
GO:0060326 | 0.0094 | 2.0206 | 8.2863 | 16 | 284 | cell chemotaxis |
GO:0016477 | 0.0095 | 2.1357 | 6.8728 | 14 | 258 | cell migration |
GO:0034329 | 0.0095 | 1.8591 | 11.2332 | 20 | 385 | cell junction assembly |
GO:0010975 | 0.0095 | 2.073 | 7.578 | 15 | 263 | regulation of neuron projection development |
GO:0032148 | 0.0095 | 5.3602 | 0.8461 | 4 | 29 | activation of protein kinase B activity |
GO:0098703 | 0.0095 | 5.3602 | 0.8461 | 4 | 29 | calcium ion import across plasma membrane |
GO:0098609 | 0.0095 | 1.5624 | 24.729 | 37 | 851 | cell-cell adhesion |
GO:0007154 | 0.0096 | 1.2936 | 116.1471 | 138 | 4206 | cell communication |
GO:1902679 | 0.0096 | 1.4849 | 33.116 | 47 | 1135 | negative regulation of RNA biosynthetic process |
GO:0070665 | 0.0097 | 2.5147 | 4.2015 | 10 | 144 | positive regulation of leukocyte proliferation |
GO:0032944 | 0.0099 | 2.1952 | 6.2147 | 13 | 213 | regulation of mononuclear cell proliferation |
GO:0055085 | 0.01 | 1.4389 | 40.0601 | 55 | 1373 | transmembrane transport |
GO:0042476 | 0.01 | 2.658 | 3.5888 | 9 | 123 | odontogenesis |
GO:0045600 | 0.01 | 3.5342 | 1.8382 | 6 | 63 | positive regulation of fat cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019373 | 0 | 21.3647 | 0.3234 | 5 | 18 | epoxygenase P450 pathway |
GO:0050911 | 0 | 3.5902 | 5.1572 | 17 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051674 | 0 | 1.9525 | 28.9304 | 51 | 1610 | localization of cell |
GO:0007606 | 0 | 3.0752 | 6.6845 | 19 | 372 | sensory perception of chemical stimulus |
GO:0007186 | 1e-04 | 2.139 | 18.8676 | 37 | 1050 | G protein-coupled receptor signaling pathway |
GO:0014068 | 1e-04 | 6.392 | 1.4016 | 8 | 78 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0009593 | 1e-04 | 2.9983 | 6.4689 | 18 | 360 | detection of chemical stimulus |
GO:0050906 | 2e-04 | 2.7974 | 6.9002 | 18 | 384 | detection of stimulus involved in sensory perception |
GO:0032501 | 3e-04 | 1.802 | 36.7246 | 57 | 2265 | multicellular organismal process |
GO:0032827 | 3e-04 | Inf | 0.0359 | 2 | 2 | negative regulation of natural killer cell differentiation involved in immune response |
GO:0034125 | 3e-04 | Inf | 0.0359 | 2 | 2 | negative regulation of MyD88-dependent toll-like receptor signaling pathway |
GO:0048252 | 3e-04 | Inf | 0.0359 | 2 | 2 | lauric acid metabolic process |
GO:0048706 | 4e-04 | 4.4582 | 2.1922 | 9 | 122 | embryonic skeletal system development |
GO:0006029 | 4e-04 | 5.7383 | 1.3477 | 7 | 75 | proteoglycan metabolic process |
GO:0006954 | 5e-04 | 2.152 | 13.4409 | 27 | 748 | inflammatory response |
GO:0150077 | 6e-04 | 8.406 | 0.6828 | 5 | 38 | regulation of neuroinflammatory response |
GO:0040012 | 6e-04 | 1.9696 | 18.0051 | 33 | 1002 | regulation of locomotion |
GO:0002042 | 9e-04 | 4.9359 | 1.5453 | 7 | 86 | cell migration involved in sprouting angiogenesis |
GO:0051270 | 0.001 | 1.9047 | 18.5622 | 33 | 1033 | regulation of cellular component movement |
GO:0051897 | 0.001 | 4.2117 | 2.0485 | 8 | 114 | positive regulation of protein kinase B signaling |
GO:0023052 | 0.0012 | 1.4466 | 103.5564 | 129 | 5763 | signaling |
GO:0070977 | 0.0013 | 9.6214 | 0.4852 | 4 | 27 | bone maturation |
GO:0048514 | 0.0016 | 2.0862 | 11.6979 | 23 | 651 | blood vessel morphogenesis |
GO:0006026 | 0.0017 | 8.8506 | 0.5211 | 4 | 29 | aminoglycan catabolic process |
GO:0035630 | 0.0018 | 15.0476 | 0.2516 | 3 | 14 | bone mineralization involved in bone maturation |
GO:0051216 | 0.0019 | 3.216 | 3.3063 | 10 | 184 | cartilage development |
GO:0070093 | 0.0019 | 55.0171 | 0.0719 | 2 | 4 | negative regulation of glucagon secretion |
GO:0030198 | 0.0021 | 2.6664 | 5.1572 | 13 | 287 | extracellular matrix organization |
GO:0008284 | 0.0023 | 1.8865 | 15.759 | 28 | 877 | positive regulation of cell population proliferation |
GO:2000352 | 0.0025 | 7.9008 | 0.575 | 4 | 32 | negative regulation of endothelial cell apoptotic process |
GO:0001649 | 0.0025 | 2.8929 | 4.0251 | 11 | 224 | osteoblast differentiation |
GO:0050877 | 0.0027 | 1.7212 | 22.9466 | 37 | 1277 | nervous system process |
GO:0032095 | 0.0027 | 12.731 | 0.2875 | 3 | 16 | regulation of response to food |
GO:0048708 | 0.0028 | 4.628 | 1.4016 | 6 | 78 | astrocyte differentiation |
GO:0046326 | 0.0031 | 7.3732 | 0.611 | 4 | 34 | positive regulation of glucose import |
GO:0070779 | 0.0031 | 36.6758 | 0.0898 | 2 | 5 | D-aspartate import across plasma membrane |
GO:0045860 | 0.0033 | 2.3455 | 6.7384 | 15 | 375 | positive regulation of protein kinase activity |
GO:0006690 | 0.0034 | 3.8554 | 1.9407 | 7 | 108 | icosanoid metabolic process |
GO:0048015 | 0.0034 | 3.1593 | 3.0188 | 9 | 168 | phosphatidylinositol-mediated signaling |
GO:0072359 | 0.0034 | 1.7439 | 20.1075 | 33 | 1119 | circulatory system development |
GO:0010562 | 0.0035 | 1.8708 | 14.6988 | 26 | 818 | positive regulation of phosphorus metabolic process |
GO:0034103 | 0.0036 | 4.3834 | 1.4735 | 6 | 82 | regulation of tissue remodeling |
GO:0007154 | 0.0037 | 1.3878 | 104.4369 | 127 | 5812 | cell communication |
GO:0043651 | 0.0038 | 11.0322 | 0.3234 | 3 | 18 | linoleic acid metabolic process |
GO:0046851 | 0.0038 | 11.0322 | 0.3234 | 3 | 18 | negative regulation of bone remodeling |
GO:0050765 | 0.0038 | 11.0322 | 0.3234 | 3 | 18 | negative regulation of phagocytosis |
GO:0030334 | 0.0039 | 1.812 | 16.352 | 28 | 910 | regulation of cell migration |
GO:0043410 | 0.0039 | 2.1744 | 8.2299 | 17 | 458 | positive regulation of MAPK cascade |
GO:0007275 | 0.004 | 1.4085 | 79.9988 | 101 | 4452 | multicellular organism development |
GO:0045766 | 0.0043 | 3.0433 | 3.1266 | 9 | 174 | positive regulation of angiogenesis |
GO:0016477 | 0.0043 | 2.105 | 9.0222 | 18 | 524 | cell migration |
GO:0042327 | 0.0045 | 1.8835 | 13.4409 | 24 | 748 | positive regulation of phosphorylation |
GO:1902259 | 0.0045 | 10.342 | 0.3414 | 3 | 19 | regulation of delayed rectifier potassium channel activity |
GO:0009253 | 0.0046 | 27.5051 | 0.1078 | 2 | 6 | peptidoglycan catabolic process |
GO:0010727 | 0.0046 | 27.5051 | 0.1078 | 2 | 6 | negative regulation of hydrogen peroxide metabolic process |
GO:0042940 | 0.0046 | 27.5051 | 0.1078 | 2 | 6 | D-amino acid transport |
GO:0046533 | 0.0046 | 27.5051 | 0.1078 | 2 | 6 | negative regulation of photoreceptor cell differentiation |
GO:0050896 | 0.0046 | 1.3679 | 141.3815 | 164 | 7868 | response to stimulus |
GO:0045453 | 0.0051 | 4.8593 | 1.1141 | 5 | 62 | bone resorption |
GO:0009653 | 0.0051 | 1.4796 | 46.055 | 63 | 2563 | anatomical structure morphogenesis |
GO:1901342 | 0.0054 | 2.3748 | 5.7501 | 13 | 320 | regulation of vasculature development |
GO:0048663 | 0.0054 | 4.7753 | 1.1321 | 5 | 63 | neuron fate commitment |
GO:0046628 | 0.006 | 9.1918 | 0.3774 | 3 | 21 | positive regulation of insulin receptor signaling pathway |
GO:0021796 | 0.0064 | 22.0027 | 0.1258 | 2 | 7 | cerebral cortex regionalization |
GO:0043654 | 0.0064 | 22.0027 | 0.1258 | 2 | 7 | recognition of apoptotic cell |
GO:0046222 | 0.0064 | 22.0027 | 0.1258 | 2 | 7 | aflatoxin metabolic process |
GO:1905150 | 0.0064 | 22.0027 | 0.1258 | 2 | 7 | regulation of voltage-gated sodium channel activity |
GO:0016339 | 0.0067 | 5.8181 | 0.7547 | 4 | 42 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0035850 | 0.0067 | 5.8181 | 0.7547 | 4 | 42 | epithelial cell differentiation involved in kidney development |
GO:0086013 | 0.0069 | 8.7075 | 0.3953 | 3 | 22 | membrane repolarization during cardiac muscle cell action potential |
GO:0007156 | 0.0073 | 3.0086 | 2.8032 | 8 | 156 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0014013 | 0.0073 | 3.7401 | 1.7071 | 6 | 95 | regulation of gliogenesis |
GO:0035924 | 0.0075 | 4.3949 | 1.2219 | 5 | 68 | cellular response to vascular endothelial growth factor stimulus |
GO:0001666 | 0.0078 | 2.459 | 4.69 | 11 | 261 | response to hypoxia |
GO:0021895 | 0.0078 | 8.2716 | 0.4133 | 3 | 23 | cerebral cortex neuron differentiation |
GO:0032331 | 0.0078 | 8.2716 | 0.4133 | 3 | 23 | negative regulation of chondrocyte differentiation |
GO:0042178 | 0.0078 | 8.2716 | 0.4133 | 3 | 23 | xenobiotic catabolic process |
GO:0048701 | 0.0079 | 5.5265 | 0.7906 | 4 | 44 | embryonic cranial skeleton morphogenesis |
GO:0051050 | 0.008 | 1.7641 | 14.8964 | 25 | 829 | positive regulation of transport |
GO:0030154 | 0.0088 | 1.3922 | 63.5769 | 81 | 3625 | cell differentiation |
GO:0070663 | 0.0097 | 2.5016 | 4.1868 | 10 | 233 | regulation of leukocyte proliferation |
GO:0010634 | 0.0097 | 2.8529 | 2.9469 | 8 | 164 | positive regulation of epithelial cell migration |
GO:0032104 | 0.0099 | 7.5187 | 0.4492 | 3 | 25 | regulation of response to extracellular stimulus |
GO:0060219 | 0.0099 | 7.5187 | 0.4492 | 3 | 25 | camera-type eye photoreceptor cell differentiation |
GO:0048260 | 0.0099 | 5.1399 | 0.8446 | 4 | 47 | positive regulation of receptor-mediated endocytosis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051674 | 0 | 2.6374 | 37.4624 | 83 | 1610 | localization of cell |
GO:0007275 | 0 | 2.2352 | 56.9322 | 102 | 2746 | multicellular organism development |
GO:0032502 | 0 | 2.0042 | 102.2989 | 155 | 4760 | developmental process |
GO:0007399 | 0 | 2.1906 | 49.4929 | 92 | 2168 | nervous system development |
GO:0007389 | 0 | 3.4931 | 10.2614 | 32 | 441 | pattern specification process |
GO:0048699 | 0 | 2.417 | 26.1368 | 56 | 1156 | generation of neurons |
GO:0032879 | 0 | 1.9423 | 60.6146 | 101 | 2605 | regulation of localization |
GO:0001655 | 0 | 3.7666 | 7.7019 | 26 | 331 | urogenital system development |
GO:0021953 | 0 | 5.1398 | 3.7462 | 17 | 161 | central nervous system neuron differentiation |
GO:0030154 | 0 | 2.1295 | 37.7077 | 69 | 1871 | cell differentiation |
GO:0048568 | 0 | 3.0759 | 10.0055 | 28 | 430 | embryonic organ development |
GO:2000145 | 0 | 2.3157 | 22.4076 | 47 | 963 | regulation of cell motility |
GO:0045944 | 0 | 2.1907 | 26.2469 | 52 | 1128 | positive regulation of transcription by RNA polymerase II |
GO:2000179 | 0 | 9.4125 | 1.1634 | 9 | 50 | positive regulation of neural precursor cell proliferation |
GO:0045597 | 0 | 2.4033 | 18.7312 | 41 | 805 | positive regulation of cell differentiation |
GO:0072210 | 0 | 11.043 | 0.9075 | 8 | 39 | metanephric nephron development |
GO:0051216 | 0 | 4.7179 | 3.5523 | 15 | 154 | cartilage development |
GO:0060429 | 0 | 2.1822 | 24.1867 | 48 | 1051 | epithelium development |
GO:0003338 | 0 | 12.9952 | 0.6981 | 7 | 30 | metanephros morphogenesis |
GO:0070848 | 0 | 2.4623 | 15.4969 | 35 | 666 | response to growth factor |
GO:0051272 | 0 | 2.6195 | 12.8908 | 31 | 554 | positive regulation of cellular component movement |
GO:0009954 | 0 | 11.9541 | 0.7446 | 7 | 32 | proximal/distal pattern formation |
GO:0040011 | 0 | 2.33 | 18.3902 | 39 | 856 | locomotion |
GO:0010562 | 0 | 2.2936 | 19.0337 | 40 | 818 | positive regulation of phosphorus metabolic process |
GO:0002064 | 0 | 4.0556 | 4.3512 | 16 | 187 | epithelial cell development |
GO:0001708 | 0 | 5.7683 | 2.164 | 11 | 93 | cell fate specification |
GO:0042221 | 0 | 1.6125 | 91.8177 | 128 | 3946 | response to chemical |
GO:0040017 | 0 | 2.5129 | 12.9373 | 30 | 556 | positive regulation of locomotion |
GO:0006928 | 0 | 2.0581 | 25.6547 | 48 | 1183 | movement of cell or subcellular component |
GO:0065007 | 0 | 1.6447 | 264.3774 | 300 | 11362 | biological regulation |
GO:0021536 | 0 | 6.4243 | 1.6055 | 9 | 69 | diencephalon development |
GO:0042327 | 0 | 2.2392 | 17.4049 | 36 | 748 | positive regulation of phosphorylation |
GO:0048663 | 0 | 7.3329 | 1.2703 | 8 | 55 | neuron fate commitment |
GO:0001568 | 0 | 2.3676 | 14.1474 | 31 | 617 | blood vessel development |
GO:0043408 | 0 | 2.3318 | 14.8221 | 32 | 637 | regulation of MAPK cascade |
GO:0043583 | 0 | 3.4966 | 4.9795 | 16 | 214 | ear development |
GO:0048598 | 0 | 2.8746 | 7.8923 | 21 | 352 | embryonic morphogenesis |
GO:0008284 | 0 | 2.2704 | 15.7101 | 33 | 705 | positive regulation of cell population proliferation |
GO:0060548 | 1e-04 | 2.0731 | 21.4071 | 41 | 920 | negative regulation of cell death |
GO:1903508 | 1e-04 | 1.8359 | 35.1355 | 59 | 1510 | positive regulation of nucleic acid-templated transcription |
GO:0032946 | 1e-04 | 4.3748 | 3.0249 | 12 | 130 | positive regulation of mononuclear cell proliferation |
GO:0022414 | 1e-04 | 1.8834 | 31.2497 | 54 | 1343 | reproductive process |
GO:0035239 | 1e-04 | 2.2277 | 16.4867 | 34 | 729 | tube morphogenesis |
GO:0048729 | 1e-04 | 2.3508 | 13.7517 | 30 | 591 | tissue morphogenesis |
GO:0072087 | 1e-04 | 15.1772 | 0.4421 | 5 | 19 | renal vesicle development |
GO:0045165 | 1e-04 | 4.2743 | 3.085 | 12 | 137 | cell fate commitment |
GO:0009952 | 1e-04 | 4.2046 | 3.1331 | 12 | 137 | anterior/posterior pattern specification |
GO:0009792 | 1e-04 | 2.2759 | 14.6592 | 31 | 630 | embryo development ending in birth or egg hatching |
GO:0051046 | 1e-04 | 2.3394 | 13.3329 | 29 | 573 | regulation of secretion |
GO:1905330 | 1e-04 | 6.4502 | 1.4194 | 8 | 61 | regulation of morphogenesis of an epithelium |
GO:0001501 | 1e-04 | 2.9364 | 6.9769 | 19 | 312 | skeletal system development |
GO:0051254 | 1e-04 | 1.7713 | 38.2302 | 62 | 1643 | positive regulation of RNA metabolic process |
GO:0001822 | 1e-04 | 3.2699 | 5.2936 | 16 | 231 | kidney development |
GO:0030335 | 1e-04 | 2.3977 | 12.0997 | 27 | 520 | positive regulation of cell migration |
GO:0090596 | 1e-04 | 3.1046 | 5.9102 | 17 | 254 | sensory organ morphogenesis |
GO:0021543 | 1e-04 | 3.7818 | 3.7462 | 13 | 161 | pallium development |
GO:0051093 | 1e-04 | 2.071 | 19.2379 | 37 | 834 | negative regulation of developmental process |
GO:0045665 | 1e-04 | 6.1348 | 1.4819 | 8 | 64 | negative regulation of neuron differentiation |
GO:0032989 | 1e-04 | 2.1583 | 16.4276 | 33 | 706 | cellular component morphogenesis |
GO:0070779 | 1e-04 | 63.4551 | 0.1163 | 3 | 5 | D-aspartate import across plasma membrane |
GO:0045785 | 1e-04 | 2.5302 | 9.7495 | 23 | 419 | positive regulation of cell adhesion |
GO:0030198 | 1e-04 | 2.8983 | 6.6781 | 18 | 287 | extracellular matrix organization |
GO:0150063 | 1e-04 | 2.6455 | 8.5163 | 21 | 366 | visual system development |
GO:0021515 | 1e-04 | 6.9423 | 1.1634 | 7 | 50 | cell differentiation in spinal cord |
GO:0007267 | 2e-04 | 1.7695 | 34.9727 | 57 | 1503 | cell-cell signaling |
GO:0097150 | 2e-04 | 11.8015 | 0.5352 | 5 | 23 | neuronal stem cell population maintenance |
GO:0042330 | 2e-04 | 2.2653 | 13.2398 | 28 | 569 | taxis |
GO:0060173 | 2e-04 | 3.586 | 3.9324 | 13 | 169 | limb development |
GO:0030879 | 2e-04 | 4.0689 | 2.9551 | 11 | 127 | mammary gland development |
GO:0007167 | 2e-04 | 1.9652 | 21.314 | 39 | 916 | enzyme linked receptor protein signaling pathway |
GO:0071310 | 2e-04 | 1.6269 | 51.9122 | 77 | 2231 | cellular response to organic substance |
GO:0035850 | 2e-04 | 8.0219 | 0.8798 | 6 | 38 | epithelial cell differentiation involved in kidney development |
GO:0048661 | 2e-04 | 4.8122 | 2.0709 | 9 | 89 | positive regulation of smooth muscle cell proliferation |
GO:0120036 | 2e-04 | 1.7753 | 32.2735 | 53 | 1387 | plasma membrane bounded cell projection organization |
GO:0042940 | 2e-04 | 42.3008 | 0.1396 | 3 | 6 | D-amino acid transport |
GO:0050678 | 2e-04 | 2.6051 | 8.2138 | 20 | 353 | regulation of epithelial cell proliferation |
GO:0010557 | 3e-04 | 1.6949 | 39.7194 | 62 | 1707 | positive regulation of macromolecule biosynthetic process |
GO:0018212 | 3e-04 | 2.5893 | 8.2603 | 20 | 355 | peptidyl-tyrosine modification |
GO:0048666 | 3e-04 | 2.3142 | 11.5581 | 25 | 512 | neuron development |
GO:0016477 | 3e-04 | 2.2983 | 11.6525 | 25 | 545 | cell migration |
GO:0051347 | 3e-04 | 2.2506 | 12.3323 | 26 | 530 | positive regulation of transferase activity |
GO:0007507 | 3e-04 | 2.6225 | 7.7459 | 19 | 339 | heart development |
GO:0035107 | 3e-04 | 3.8045 | 3.1413 | 11 | 135 | appendage morphogenesis |
GO:0098727 | 3e-04 | 3.8045 | 3.1413 | 11 | 135 | maintenance of cell number |
GO:0048534 | 3e-04 | 1.9582 | 19.6619 | 36 | 845 | hematopoietic or lymphoid organ development |
GO:0070977 | 4e-04 | 9.6534 | 0.6283 | 5 | 27 | bone maturation |
GO:0050920 | 4e-04 | 3.1227 | 4.8166 | 14 | 207 | regulation of chemotaxis |
GO:0031328 | 4e-04 | 1.6524 | 41.9998 | 64 | 1805 | positive regulation of cellular biosynthetic process |
GO:0021796 | 4e-04 | 31.7236 | 0.1629 | 3 | 7 | cerebral cortex regionalization |
GO:0072197 | 4e-04 | 31.7236 | 0.1629 | 3 | 7 | ureter morphogenesis |
GO:0032095 | 4e-04 | 14.1296 | 0.3723 | 4 | 16 | regulation of response to food |
GO:0032835 | 4e-04 | 5.7375 | 1.3728 | 7 | 59 | glomerulus development |
GO:0010001 | 5e-04 | 3.0274 | 4.9562 | 14 | 213 | glial cell differentiation |
GO:0007517 | 5e-04 | 2.5937 | 7.3994 | 18 | 318 | muscle organ development |
GO:0043010 | 5e-04 | 2.5937 | 7.3994 | 18 | 318 | camera-type eye development |
GO:0042472 | 5e-04 | 4.2748 | 2.3036 | 9 | 99 | inner ear morphogenesis |
GO:0048701 | 5e-04 | 6.7177 | 1.0238 | 6 | 44 | embryonic cranial skeleton morphogenesis |
GO:0032723 | 5e-04 | Inf | 0.0465 | 2 | 2 | positive regulation of connective tissue growth factor production |
GO:0048252 | 5e-04 | Inf | 0.0465 | 2 | 2 | lauric acid metabolic process |
GO:0060876 | 5e-04 | Inf | 0.0465 | 2 | 2 | semicircular canal formation |
GO:2000768 | 5e-04 | Inf | 0.0465 | 2 | 2 | positive regulation of nephron tubule epithelial cell differentiation |
GO:0070482 | 6e-04 | 2.6496 | 6.841 | 17 | 294 | response to oxygen levels |
GO:0042531 | 6e-04 | 5.4235 | 1.4427 | 7 | 62 | positive regulation of tyrosine phosphorylation of STAT protein |
GO:0021517 | 6e-04 | 6.545 | 1.0471 | 6 | 45 | ventral spinal cord development |
GO:0034103 | 6e-04 | 4.6137 | 1.908 | 8 | 82 | regulation of tissue remodeling |
GO:0048664 | 6e-04 | 25.3773 | 0.1861 | 3 | 8 | neuron fate determination |
GO:0072239 | 6e-04 | 25.3773 | 0.1861 | 3 | 8 | metanephric glomerulus vasculature development |
GO:1990266 | 6e-04 | 12.2703 | 0.4136 | 4 | 18 | neutrophil migration |
GO:0048146 | 7e-04 | 6.381 | 1.0704 | 6 | 46 | positive regulation of fibroblast proliferation |
GO:0072359 | 7e-04 | 2.1623 | 12.3096 | 25 | 556 | circulatory system development |
GO:0060644 | 7e-04 | 12.1096 | 0.4188 | 4 | 18 | mammary gland epithelial cell differentiation |
GO:0060537 | 7e-04 | 2.3719 | 8.9584 | 20 | 385 | muscle tissue development |
GO:0021872 | 7e-04 | 6.225 | 1.0936 | 6 | 47 | forebrain generation of neurons |
GO:0030901 | 7e-04 | 4.4917 | 1.9546 | 8 | 84 | midbrain development |
GO:0048704 | 8e-04 | 6.1602 | 1.1023 | 6 | 48 | embryonic skeletal system morphogenesis |
GO:0070663 | 8e-04 | 3.3906 | 3.4892 | 11 | 152 | regulation of leukocyte proliferation |
GO:0001649 | 8e-04 | 2.8668 | 5.2122 | 14 | 224 | osteoblast differentiation |
GO:0051240 | 8e-04 | 1.7043 | 30.8034 | 49 | 1333 | positive regulation of multicellular organismal process |
GO:0010631 | 8e-04 | 2.4758 | 7.7252 | 18 | 332 | epithelial cell migration |
GO:0090101 | 8e-04 | 3.6261 | 2.9784 | 10 | 128 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0055003 | 8e-04 | 11.3016 | 0.4421 | 4 | 19 | cardiac myofibril assembly |
GO:0008343 | 9e-04 | 21.1464 | 0.2094 | 3 | 9 | adult feeding behavior |
GO:0010533 | 9e-04 | 21.1464 | 0.2094 | 3 | 9 | regulation of activation of Janus kinase activity |
GO:0021520 | 9e-04 | 21.1464 | 0.2094 | 3 | 9 | spinal cord motor neuron cell fate specification |
GO:0071495 | 0.001 | 1.7487 | 26.2557 | 43 | 1145 | cellular response to endogenous stimulus |
GO:0001764 | 0.001 | 3.295 | 3.5834 | 11 | 154 | neuron migration |
GO:0006355 | 0.001 | 1.4756 | 70.5736 | 95 | 3033 | regulation of transcription, DNA-templated |
GO:0001657 | 0.001 | 4.266 | 2.0476 | 8 | 88 | ureteric bud development |
GO:0071715 | 0.001 | 5.7994 | 1.1634 | 6 | 50 | icosanoid transport |
GO:0010628 | 0.001 | 1.7774 | 23.9666 | 40 | 1030 | positive regulation of gene expression |
GO:0090130 | 0.001 | 2.4208 | 7.888 | 18 | 339 | tissue migration |
GO:0032305 | 0.001 | 10.5946 | 0.4654 | 4 | 20 | positive regulation of icosanoid secretion |
GO:0006812 | 0.001 | 1.7625 | 24.781 | 41 | 1065 | cation transport |
GO:0043406 | 0.0011 | 3.8066 | 2.5595 | 9 | 110 | positive regulation of MAP kinase activity |
GO:0048812 | 0.0011 | 2.0485 | 13.4492 | 26 | 578 | neuron projection morphogenesis |
GO:0072088 | 0.0011 | 4.8091 | 1.6055 | 7 | 69 | nephron epithelium morphogenesis |
GO:0150076 | 0.0011 | 4.8091 | 1.6055 | 7 | 69 | neuroinflammatory response |
GO:0072163 | 0.0011 | 4.2131 | 2.0709 | 8 | 89 | mesonephric epithelium development |
GO:2001141 | 0.0011 | 1.4701 | 70.783 | 95 | 3042 | regulation of RNA biosynthetic process |
GO:0051128 | 0.0011 | 1.5436 | 49.7249 | 71 | 2137 | regulation of cellular component organization |
GO:0001525 | 0.0012 | 2.3321 | 8.6349 | 19 | 379 | angiogenesis |
GO:0072175 | 0.0012 | 3.4493 | 3.118 | 10 | 134 | epithelial tube formation |
GO:0055065 | 0.0012 | 2.0051 | 14.2636 | 27 | 613 | metal ion homeostasis |
GO:0061333 | 0.0012 | 4.7324 | 1.6288 | 7 | 70 | renal tubule morphogenesis |
GO:0009967 | 0.0012 | 1.652 | 33.0181 | 51 | 1419 | positive regulation of signal transduction |
GO:0050670 | 0.0012 | 3.435 | 3.1289 | 10 | 136 | regulation of lymphocyte proliferation |
GO:1901214 | 0.0012 | 2.5334 | 6.7013 | 16 | 288 | regulation of neuron death |
GO:0060428 | 0.0012 | 7.0756 | 0.8144 | 5 | 35 | lung epithelium development |
GO:0051283 | 0.0012 | 3.7322 | 2.6061 | 9 | 112 | negative regulation of sequestering of calcium ion |
GO:0001666 | 0.0012 | 2.6233 | 6.0731 | 15 | 261 | response to hypoxia |
GO:0048754 | 0.0013 | 3.6948 | 2.6293 | 9 | 114 | branching morphogenesis of an epithelial tube |
GO:2000026 | 0.0013 | 1.7939 | 21.9414 | 37 | 965 | regulation of multicellular organismal development |
GO:0032147 | 0.0013 | 3.3941 | 3.1645 | 10 | 136 | activation of protein kinase activity |
GO:0009887 | 0.0013 | 1.9875 | 14.3991 | 27 | 643 | animal organ morphogenesis |
GO:0042102 | 0.0014 | 4.0619 | 2.1407 | 8 | 92 | positive regulation of T cell proliferation |
GO:0030326 | 0.0014 | 3.6607 | 2.6526 | 9 | 114 | embryonic limb morphogenesis |
GO:0023051 | 0.0014 | 1.4537 | 73.04 | 97 | 3139 | regulation of signaling |
GO:0051241 | 0.0014 | 1.7679 | 22.8373 | 38 | 995 | negative regulation of multicellular organismal process |
GO:0044093 | 0.0014 | 1.6362 | 33.2973 | 51 | 1431 | positive regulation of molecular function |
GO:0061564 | 0.0016 | 2.168 | 10.2382 | 21 | 440 | axon development |
GO:0001763 | 0.0016 | 3.2995 | 3.247 | 10 | 141 | morphogenesis of a branching structure |
GO:0007412 | 0.0016 | 84.3895 | 0.0698 | 2 | 3 | axon target recognition |
GO:0038091 | 0.0016 | 84.3895 | 0.0698 | 2 | 3 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
GO:0060480 | 0.0016 | 84.3895 | 0.0698 | 2 | 3 | lung goblet cell differentiation |
GO:0061056 | 0.0016 | 84.3895 | 0.0698 | 2 | 3 | sclerotome development |
GO:0072275 | 0.0016 | 84.3895 | 0.0698 | 2 | 3 | metanephric glomerulus morphogenesis |
GO:0072277 | 0.0016 | 84.3895 | 0.0698 | 2 | 3 | metanephric glomerular capillary formation |
GO:0097377 | 0.0016 | 84.3895 | 0.0698 | 2 | 3 | spinal cord interneuron axon guidance |
GO:1902869 | 0.0016 | 84.3895 | 0.0698 | 2 | 3 | regulation of amacrine cell differentiation |
GO:0008015 | 0.0016 | 2.1213 | 10.9595 | 22 | 471 | blood circulation |
GO:0032504 | 0.0016 | 1.8478 | 18.3356 | 32 | 788 | multicellular organism reproduction |
GO:0001704 | 0.0017 | 3.5583 | 2.7224 | 9 | 117 | formation of primary germ layer |
GO:0050708 | 0.0017 | 2.6375 | 5.631 | 14 | 242 | regulation of protein secretion |
GO:0040007 | 0.0017 | 1.793 | 20.6858 | 35 | 889 | growth |
GO:0048858 | 0.0017 | 1.9779 | 13.8913 | 26 | 597 | cell projection morphogenesis |
GO:0008285 | 0.0017 | 1.9492 | 14.6456 | 27 | 638 | negative regulation of cell population proliferation |
GO:0043066 | 0.0017 | 1.9236 | 15.3956 | 28 | 672 | negative regulation of apoptotic process |
GO:0006029 | 0.0018 | 4.3831 | 1.7451 | 7 | 75 | proteoglycan metabolic process |
GO:0048715 | 0.0018 | 15.8578 | 0.256 | 3 | 11 | negative regulation of oligodendrocyte differentiation |
GO:0051133 | 0.0018 | 15.8578 | 0.256 | 3 | 11 | regulation of NK T cell activation |
GO:0001759 | 0.0018 | 8.9201 | 0.5352 | 4 | 23 | organ induction |
GO:0021871 | 0.0018 | 8.9201 | 0.5352 | 4 | 23 | forebrain regionalization |
GO:0046579 | 0.0019 | 5.1016 | 1.303 | 6 | 56 | positive regulation of Ras protein signal transduction |
GO:0060541 | 0.0019 | 2.8408 | 4.4908 | 12 | 193 | respiratory system development |
GO:0007420 | 0.002 | 1.9565 | 14.0367 | 26 | 613 | brain development |
GO:0007498 | 0.002 | 3.4615 | 2.7922 | 9 | 120 | mesoderm development |
GO:0060255 | 0.002 | 1.3612 | 137.5637 | 165 | 5912 | regulation of macromolecule metabolic process |
GO:0043067 | 0.002 | 1.6289 | 31.366 | 48 | 1348 | regulation of programmed cell death |
GO:0048667 | 0.0022 | 2.0282 | 11.96 | 23 | 514 | cell morphogenesis involved in neuron differentiation |
GO:0048565 | 0.0022 | 3.3998 | 2.8388 | 9 | 122 | digestive tract development |
GO:0014068 | 0.0022 | 4.1971 | 1.8149 | 7 | 78 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0014014 | 0.0022 | 6.0629 | 0.9307 | 5 | 40 | negative regulation of gliogenesis |
GO:0048863 | 0.0023 | 2.932 | 3.9906 | 11 | 173 | stem cell differentiation |
GO:2000027 | 0.0023 | 3.3698 | 2.862 | 9 | 123 | regulation of animal organ morphogenesis |
GO:0016331 | 0.0023 | 3.1195 | 3.4205 | 10 | 147 | morphogenesis of embryonic epithelium |
GO:0010721 | 0.0023 | 2.9233 | 4.0022 | 11 | 172 | negative regulation of cell development |
GO:0038180 | 0.0024 | 14.095 | 0.2792 | 3 | 12 | nerve growth factor signaling pathway |
GO:0051549 | 0.0024 | 14.095 | 0.2792 | 3 | 12 | positive regulation of keratinocyte migration |
GO:0071415 | 0.0024 | 14.095 | 0.2792 | 3 | 12 | cellular response to purine-containing compound |
GO:0032102 | 0.0024 | 2.1798 | 9.1911 | 19 | 395 | negative regulation of response to external stimulus |
GO:0001756 | 0.0024 | 4.837 | 1.366 | 6 | 59 | somitogenesis |
GO:0072171 | 0.0024 | 4.8119 | 1.3728 | 6 | 59 | mesonephric tubule morphogenesis |
GO:0007155 | 0.0024 | 1.737 | 21.9691 | 36 | 979 | cell adhesion |
GO:0032104 | 0.0025 | 8.0695 | 0.5817 | 4 | 25 | regulation of response to extracellular stimulus |
GO:0060384 | 0.0025 | 8.0695 | 0.5817 | 4 | 25 | innervation |
GO:0045766 | 0.0026 | 2.8871 | 4.0487 | 11 | 174 | positive regulation of angiogenesis |
GO:0050767 | 0.0026 | 2.2728 | 7.888 | 17 | 339 | regulation of neurogenesis |
GO:0010646 | 0.0027 | 1.4201 | 72.7375 | 95 | 3126 | regulation of cell communication |
GO:0019220 | 0.0028 | 1.6165 | 30.2026 | 46 | 1298 | regulation of phosphate metabolic process |
GO:0070664 | 0.0028 | 4.0262 | 1.8848 | 7 | 81 | negative regulation of leukocyte proliferation |
GO:0046427 | 0.0028 | 5.7345 | 0.9773 | 5 | 42 | positive regulation of receptor signaling pathway via JAK-STAT |
GO:0048762 | 0.0028 | 2.5801 | 5.3285 | 13 | 229 | mesenchymal cell differentiation |
GO:0030878 | 0.0029 | 7.7023 | 0.605 | 4 | 26 | thyroid gland development |
GO:0045137 | 0.0029 | 2.6904 | 4.7235 | 12 | 203 | development of primary sexual characteristics |
GO:0070374 | 0.0029 | 2.6904 | 4.7235 | 12 | 203 | positive regulation of ERK1 and ERK2 cascade |
GO:0050905 | 0.0029 | 3.2509 | 2.9577 | 9 | 128 | neuromuscular process |
GO:0071695 | 0.0029 | 2.5681 | 5.3518 | 13 | 230 | anatomical structure maturation |
GO:0043549 | 0.0029 | 1.827 | 16.7301 | 29 | 719 | regulation of kinase activity |
GO:0051781 | 0.003 | 3.9723 | 1.908 | 7 | 82 | positive regulation of cell division |
GO:0030857 | 0.003 | 5.6123 | 0.9956 | 5 | 43 | negative regulation of epithelial cell differentiation |
GO:0055082 | 0.0031 | 1.7998 | 17.5678 | 30 | 755 | cellular chemical homeostasis |
GO:0001938 | 0.0031 | 3.5146 | 2.4432 | 8 | 105 | positive regulation of endothelial cell proliferation |
GO:0001757 | 0.0031 | 42.1921 | 0.0931 | 2 | 4 | somite specification |
GO:0048069 | 0.0031 | 42.1921 | 0.0931 | 2 | 4 | eye pigmentation |
GO:0060018 | 0.0031 | 42.1921 | 0.0931 | 2 | 4 | astrocyte fate commitment |
GO:0061754 | 0.0031 | 42.1921 | 0.0931 | 2 | 4 | negative regulation of circulating fibrinogen levels |
GO:0070093 | 0.0031 | 42.1921 | 0.0931 | 2 | 4 | negative regulation of glucagon secretion |
GO:0072278 | 0.0031 | 42.1921 | 0.0931 | 2 | 4 | metanephric comma-shaped body morphogenesis |
GO:0097476 | 0.0031 | 42.1921 | 0.0931 | 2 | 4 | spinal cord motor neuron migration |
GO:2000491 | 0.0031 | 42.1921 | 0.0931 | 2 | 4 | positive regulation of hepatic stellate cell activation |
GO:2000697 | 0.0031 | 42.1921 | 0.0931 | 2 | 4 | negative regulation of epithelial cell differentiation involved in kidney development |
GO:0061440 | 0.0033 | 7.3669 | 0.6283 | 4 | 27 | kidney vasculature development |
GO:0086011 | 0.0033 | 7.3669 | 0.6283 | 4 | 27 | membrane repolarization during action potential |
GO:0060840 | 0.0033 | 3.4786 | 2.4665 | 8 | 106 | artery development |
GO:0034763 | 0.0034 | 3.1734 | 3.0249 | 9 | 130 | negative regulation of transmembrane transport |
GO:0035307 | 0.0034 | 5.4397 | 1.0238 | 5 | 44 | positive regulation of protein dephosphorylation |
GO:0045860 | 0.0035 | 2.5129 | 5.4608 | 13 | 239 | positive regulation of protein kinase activity |
GO:1901342 | 0.0035 | 2.2622 | 7.4459 | 16 | 320 | regulation of vasculature development |
GO:0097529 | 0.0035 | 2.9359 | 3.6172 | 10 | 157 | myeloid leukocyte migration |
GO:0044344 | 0.0035 | 3.4432 | 2.4897 | 8 | 107 | cellular response to fibroblast growth factor stimulus |
GO:0035630 | 0.0038 | 11.5308 | 0.3258 | 3 | 14 | bone mineralization involved in bone maturation |
GO:0048070 | 0.0038 | 11.5308 | 0.3258 | 3 | 14 | regulation of developmental pigmentation |
GO:0060485 | 0.0038 | 5.3007 | 1.0458 | 5 | 46 | mesenchyme development |
GO:0060441 | 0.0038 | 7.0595 | 0.6515 | 4 | 28 | epithelial tube branching involved in lung morphogenesis |
GO:0002042 | 0.0039 | 3.7702 | 2.0011 | 7 | 86 | cell migration involved in sprouting angiogenesis |
GO:0002065 | 0.0039 | 3.7702 | 2.0011 | 7 | 86 | columnar/cuboidal epithelial cell differentiation |
GO:0007565 | 0.0039 | 2.8856 | 3.6764 | 10 | 158 | female pregnancy |
GO:0050801 | 0.0039 | 1.8055 | 16.3113 | 28 | 701 | ion homeostasis |
GO:0045595 | 0.004 | 1.8727 | 14.0664 | 25 | 644 | regulation of cell differentiation |
GO:0060688 | 0.0042 | 5.1737 | 1.0704 | 5 | 46 | regulation of morphogenesis of a branching structure |
GO:0050867 | 0.0042 | 2.2148 | 7.594 | 16 | 328 | positive regulation of cell activation |
GO:0090183 | 0.0043 | 6.7767 | 0.6748 | 4 | 29 | regulation of kidney development |
GO:0002684 | 0.0044 | 1.7516 | 18.0099 | 30 | 774 | positive regulation of immune system process |
GO:0043524 | 0.0046 | 3.0224 | 3.1645 | 9 | 136 | negative regulation of neuron apoptotic process |
GO:0048260 | 0.0046 | 5.0502 | 1.0936 | 5 | 47 | positive regulation of receptor-mediated endocytosis |
GO:0099072 | 0.0046 | 5.0502 | 1.0936 | 5 | 47 | regulation of postsynaptic membrane neurotransmitter receptor levels |
GO:0051173 | 0.0046 | 1.5586 | 32.8055 | 48 | 1470 | positive regulation of nitrogen compound metabolic process |
GO:0048712 | 0.0046 | 10.5693 | 0.349 | 3 | 15 | negative regulation of astrocyte differentiation |
GO:0050884 | 0.0046 | 10.5693 | 0.349 | 3 | 15 | neuromuscular process controlling posture |
GO:0060026 | 0.0046 | 10.5693 | 0.349 | 3 | 15 | convergent extension |
GO:0072283 | 0.0046 | 10.5693 | 0.349 | 3 | 15 | metanephric renal vesicle morphogenesis |
GO:0030316 | 0.0047 | 3.6316 | 2.0709 | 7 | 89 | osteoclast differentiation |
GO:0007276 | 0.0048 | 1.8189 | 15.0082 | 26 | 645 | gamete generation |
GO:0035592 | 0.0048 | 2.1816 | 7.7019 | 16 | 331 | establishment of protein localization to extracellular region |
GO:0006874 | 0.0048 | 2.0303 | 9.8193 | 19 | 422 | cellular calcium ion homeostasis |
GO:0060218 | 0.0049 | 6.5157 | 0.6981 | 4 | 30 | hematopoietic stem cell differentiation |
GO:0061037 | 0.0049 | 6.5157 | 0.6981 | 4 | 30 | negative regulation of cartilage development |
GO:0035924 | 0.005 | 4.1111 | 1.5823 | 6 | 68 | cellular response to vascular endothelial growth factor stimulus |
GO:1904063 | 0.005 | 3.5876 | 2.0942 | 7 | 90 | negative regulation of cation transmembrane transport |
GO:1905710 | 0.005 | 4.9325 | 1.1169 | 5 | 48 | positive regulation of membrane permeability |
GO:0043271 | 0.005 | 2.9751 | 3.2111 | 9 | 138 | negative regulation of ion transport |
GO:0051251 | 0.0051 | 2.3082 | 6.3756 | 14 | 274 | positive regulation of lymphocyte activation |
GO:0060560 | 0.0051 | 2.4921 | 5.0725 | 12 | 218 | developmental growth involved in morphogenesis |
GO:0003402 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | planar cell polarity pathway involved in axis elongation |
GO:0016199 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | axon midline choice point recognition |
GO:0019800 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0021855 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | hypothalamus cell migration |
GO:0033591 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | response to L-ascorbic acid |
GO:0060059 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | embryonic retina morphogenesis in camera-type eye |
GO:0060298 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | positive regulation of sarcomere organization |
GO:0060435 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | bronchiole development |
GO:0060482 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | lobar bronchus development |
GO:0060978 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | angiogenesis involved in coronary vascular morphogenesis |
GO:0072081 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | specification of nephron tubule identity |
GO:0072103 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | glomerulus vasculature morphogenesis |
GO:0072592 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | oxygen metabolic process |
GO:1903845 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | negative regulation of cellular response to transforming growth factor beta stimulus |
GO:2000543 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | positive regulation of gastrulation |
GO:2000977 | 0.0052 | 28.1263 | 0.1163 | 2 | 5 | regulation of forebrain neuron differentiation |
GO:0003407 | 0.0053 | 4.0456 | 1.6055 | 6 | 69 | neural retina development |
GO:0048608 | 0.0053 | 2.0538 | 9.1911 | 18 | 395 | reproductive structure development |
GO:0097696 | 0.0056 | 2.7362 | 3.8626 | 10 | 166 | receptor signaling pathway via STAT |
GO:0032310 | 0.0056 | 9.7556 | 0.3723 | 3 | 16 | prostaglandin secretion |
GO:0033194 | 0.0056 | 9.7556 | 0.3723 | 3 | 16 | response to hydroperoxide |
GO:0055119 | 0.0056 | 9.7556 | 0.3723 | 3 | 16 | relaxation of cardiac muscle |
GO:0060749 | 0.0056 | 9.7556 | 0.3723 | 3 | 16 | mammary gland alveolus development |
GO:0090190 | 0.0056 | 9.7556 | 0.3723 | 3 | 16 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0098712 | 0.0056 | 9.7556 | 0.3723 | 3 | 16 | L-glutamate import across plasma membrane |
GO:0034764 | 0.0056 | 2.5826 | 4.4908 | 11 | 193 | positive regulation of transmembrane transport |
GO:0051271 | 0.0057 | 2.14 | 7.8415 | 16 | 337 | negative regulation of cellular component movement |
GO:0090287 | 0.0057 | 2.5742 | 4.504 | 11 | 196 | regulation of cellular response to growth factor stimulus |
GO:0031401 | 0.0058 | 1.6862 | 19.9403 | 32 | 866 | positive regulation of protein modification process |
GO:0043270 | 0.0059 | 2.3484 | 5.8171 | 13 | 250 | positive regulation of ion transport |
GO:0032970 | 0.006 | 2.0751 | 8.5861 | 17 | 369 | regulation of actin filament-based process |
GO:0097553 | 0.006 | 2.8849 | 3.3041 | 9 | 142 | calcium ion transmembrane import into cytosol |
GO:2000191 | 0.0062 | 6.0495 | 0.7446 | 4 | 32 | regulation of fatty acid transport |
GO:2000352 | 0.0062 | 6.0495 | 0.7446 | 4 | 32 | negative regulation of endothelial cell apoptotic process |
GO:0140352 | 0.0063 | 1.7035 | 18.4752 | 30 | 794 | export from cell |
GO:0030323 | 0.0063 | 2.6811 | 3.9361 | 10 | 170 | respiratory tube development |
GO:0015837 | 0.0063 | 3.4218 | 2.1872 | 7 | 94 | amine transport |
GO:0048738 | 0.0064 | 2.4207 | 5.2122 | 12 | 224 | cardiac muscle tissue development |
GO:0007283 | 0.0064 | 1.9015 | 11.5645 | 21 | 497 | spermatogenesis |
GO:0010975 | 0.0065 | 2.0101 | 9.3772 | 18 | 403 | regulation of neuron projection development |
GO:0045444 | 0.0066 | 2.4091 | 5.2354 | 12 | 225 | fat cell differentiation |
GO:1903039 | 0.0066 | 2.4091 | 5.2354 | 12 | 225 | positive regulation of leukocyte cell-cell adhesion |
GO:0051247 | 0.0066 | 1.5325 | 31.6685 | 46 | 1361 | positive regulation of protein metabolic process |
GO:0021542 | 0.0067 | 9.0582 | 0.3956 | 3 | 17 | dentate gyrus development |
GO:0048557 | 0.0067 | 9.0582 | 0.3956 | 3 | 17 | embryonic digestive tract morphogenesis |
GO:0072234 | 0.0067 | 9.0582 | 0.3956 | 3 | 17 | metanephric nephron tubule development |
GO:0099590 | 0.0067 | 9.0582 | 0.3956 | 3 | 17 | neurotransmitter receptor internalization |
GO:0030593 | 0.0067 | 3.3827 | 2.2105 | 7 | 95 | neutrophil chemotaxis |
GO:0032963 | 0.0067 | 3.3827 | 2.2105 | 7 | 95 | collagen metabolic process |
GO:0019219 | 0.0067 | 1.3507 | 83.348 | 104 | 3582 | regulation of nucleobase-containing compound metabolic process |
GO:0032965 | 0.0069 | 5.8405 | 0.7679 | 4 | 33 | regulation of collagen biosynthetic process |
GO:0034765 | 0.007 | 1.9555 | 10.1684 | 19 | 437 | regulation of ion transmembrane transport |
GO:0032355 | 0.007 | 3.0411 | 2.7922 | 8 | 120 | response to estradiol |
GO:0010959 | 0.007 | 2.0396 | 8.7257 | 17 | 375 | regulation of metal ion transport |
GO:0048518 | 0.007 | 1.3765 | 77.6901 | 97 | 3741 | positive regulation of biological process |
GO:0098739 | 0.0071 | 2.6339 | 4.0022 | 10 | 172 | import across plasma membrane |
GO:0050866 | 0.0073 | 2.4859 | 4.6537 | 11 | 200 | negative regulation of cell activation |
GO:0021675 | 0.0074 | 4.4588 | 1.2222 | 5 | 53 | nerve development |
GO:0034654 | 0.0074 | 1.3477 | 81.7657 | 102 | 3514 | nucleobase-containing compound biosynthetic process |
GO:0050672 | 0.0075 | 3.7469 | 1.7219 | 6 | 74 | negative regulation of lymphocyte proliferation |
GO:0030003 | 0.0075 | 1.7928 | 14.0077 | 24 | 602 | cellular cation homeostasis |
GO:0030336 | 0.0076 | 2.1293 | 7.3761 | 15 | 317 | negative regulation of cell migration |
GO:0046533 | 0.0076 | 21.0934 | 0.1396 | 2 | 6 | negative regulation of photoreceptor cell differentiation |
GO:0051142 | 0.0076 | 21.0934 | 0.1396 | 2 | 6 | positive regulation of NK T cell proliferation |
GO:0055009 | 0.0076 | 21.0934 | 0.1396 | 2 | 6 | atrial cardiac muscle tissue morphogenesis |
GO:0060017 | 0.0076 | 21.0934 | 0.1396 | 2 | 6 | parathyroid gland development |
GO:0070100 | 0.0076 | 21.0934 | 0.1396 | 2 | 6 | negative regulation of chemokine-mediated signaling pathway |
GO:0072143 | 0.0076 | 21.0934 | 0.1396 | 2 | 6 | mesangial cell development |
GO:0072284 | 0.0076 | 21.0934 | 0.1396 | 2 | 6 | metanephric S-shaped body morphogenesis |
GO:1904465 | 0.0076 | 21.0934 | 0.1396 | 2 | 6 | negative regulation of matrix metallopeptidase secretion |
GO:0007610 | 0.0076 | 1.814 | 13.2631 | 23 | 570 | behavior |
GO:0046326 | 0.0077 | 5.6455 | 0.7911 | 4 | 34 | positive regulation of glucose import |
GO:0046661 | 0.0078 | 2.7593 | 3.4437 | 9 | 148 | male sex differentiation |
GO:0001946 | 0.0079 | 8.4538 | 0.4188 | 3 | 18 | lymphangiogenesis |
GO:0032693 | 0.0079 | 8.4538 | 0.4188 | 3 | 18 | negative regulation of interleukin-10 production |
GO:0043651 | 0.0079 | 8.4538 | 0.4188 | 3 | 18 | linoleic acid metabolic process |
GO:0046851 | 0.0079 | 8.4538 | 0.4188 | 3 | 18 | negative regulation of bone remodeling |
GO:0060231 | 0.0079 | 8.4538 | 0.4188 | 3 | 18 | mesenchymal to epithelial transition |
GO:0030510 | 0.0079 | 3.2706 | 2.2803 | 7 | 98 | regulation of BMP signaling pathway |
GO:0003008 | 0.0079 | 1.4315 | 46.7 | 63 | 2007 | system process |
GO:0051896 | 0.008 | 2.5855 | 4.072 | 10 | 175 | regulation of protein kinase B signaling |
GO:0032413 | 0.008 | 3.6924 | 1.7451 | 6 | 75 | negative regulation of ion transmembrane transporter activity |
GO:0010810 | 0.0081 | 2.4466 | 4.7235 | 11 | 203 | regulation of cell-substrate adhesion |
GO:1901615 | 0.0082 | 1.8572 | 11.8204 | 21 | 508 | organic hydroxy compound metabolic process |
GO:0015849 | 0.0082 | 2.1722 | 6.7479 | 14 | 290 | organic acid transport |
GO:0019748 | 0.0083 | 4.3269 | 1.2565 | 5 | 54 | secondary metabolic process |
GO:1905517 | 0.0083 | 4.3269 | 1.2565 | 5 | 54 | macrophage migration |
GO:0002521 | 0.0083 | 1.8533 | 11.8437 | 21 | 509 | leukocyte differentiation |
GO:0007218 | 0.0083 | 3.2348 | 2.3036 | 7 | 99 | neuropeptide signaling pathway |
GO:0050730 | 0.0084 | 2.3282 | 5.405 | 12 | 234 | regulation of peptidyl-tyrosine phosphorylation |
GO:0007568 | 0.0085 | 2.7199 | 3.4903 | 9 | 150 | aging |
GO:0072507 | 0.0086 | 1.8791 | 11.1224 | 20 | 478 | divalent inorganic cation homeostasis |
GO:0060070 | 0.0087 | 2.1563 | 6.7944 | 14 | 292 | canonical Wnt signaling pathway |
GO:0008584 | 0.0089 | 2.9102 | 2.9086 | 8 | 125 | male gonad development |
GO:0010595 | 0.0089 | 2.9102 | 2.9086 | 8 | 125 | positive regulation of endothelial cell migration |
GO:0022029 | 0.0089 | 4.2401 | 1.2798 | 5 | 55 | telencephalon cell migration |
GO:0006952 | 0.009 | 1.4846 | 34.7865 | 49 | 1495 | defense response |
GO:0071900 | 0.009 | 2.0302 | 8.2371 | 16 | 354 | regulation of protein serine/threonine kinase activity |
GO:1903532 | 0.0091 | 2.2154 | 6.1429 | 13 | 264 | positive regulation of secretion by cell |
GO:0072112 | 0.0092 | 7.925 | 0.4421 | 3 | 19 | glomerular visceral epithelial cell differentiation |
GO:0021761 | 0.0093 | 3.1656 | 2.3501 | 7 | 101 | limbic system development |
GO:0051281 | 0.0094 | 5.292 | 0.8377 | 4 | 36 | positive regulation of release of sequestered calcium ion into cytosol |
GO:0070306 | 0.0094 | 5.292 | 0.8377 | 4 | 36 | lens fiber cell differentiation |
GO:0071542 | 0.0094 | 5.292 | 0.8377 | 4 | 36 | dopaminergic neuron differentiation |
GO:0043030 | 0.0096 | 4.1567 | 1.303 | 5 | 56 | regulation of macrophage activation |
GO:0043388 | 0.0096 | 4.1567 | 1.303 | 5 | 56 | positive regulation of DNA binding |
GO:0071805 | 0.01 | 2.3715 | 4.8631 | 11 | 209 | potassium ion transmembrane transport |
GO:0007204 | 0.01 | 2.1175 | 6.9108 | 14 | 297 | positive regulation of cytosolic calcium ion concentration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 143.257 | 0.7685 | 24 | 31 | DNA replication-dependent chromatin assembly |
GO:0006334 | 0 | 14.513 | 2.6031 | 27 | 105 | nucleosome assembly |
GO:0045653 | 0 | 142.5471 | 0.4462 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006336 | 0 | 33.5132 | 0.7685 | 14 | 31 | DNA replication-independent chromatin assembly |
GO:0032200 | 0 | 8.1203 | 3.7931 | 25 | 153 | telomere organization |
GO:0071824 | 0 | 6.425 | 5.2062 | 28 | 210 | protein-DNA complex subunit organization |
GO:0006338 | 0 | 5.857 | 5.8508 | 29 | 236 | chromatin remodeling |
GO:0032501 | 0 | 1.7759 | 166.5237 | 223 | 6717 | multicellular organismal process |
GO:0006352 | 0 | 5.6872 | 3.0245 | 15 | 122 | DNA-templated transcription, initiation |
GO:2000026 | 0 | 2.0444 | 31.8569 | 59 | 1285 | regulation of multicellular organismal development |
GO:0007218 | 0 | 5.5602 | 2.4543 | 12 | 99 | neuropeptide signaling pathway |
GO:0045637 | 0 | 3.8992 | 4.8095 | 17 | 194 | regulation of myeloid cell differentiation |
GO:0048869 | 0 | 1.6252 | 92.3928 | 130 | 3780 | cellular developmental process |
GO:0065007 | 0 | 1.6305 | 281.6796 | 319 | 11362 | biological regulation |
GO:0045596 | 1e-04 | 2.1766 | 15.7673 | 32 | 636 | negative regulation of cell differentiation |
GO:0007156 | 1e-04 | 3.6611 | 3.8675 | 13 | 156 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0048731 | 1e-04 | 1.6005 | 64.3551 | 92 | 2752 | system development |
GO:0048513 | 2e-04 | 1.5973 | 60.9968 | 88 | 2530 | animal organ development |
GO:0014059 | 2e-04 | 8.2454 | 0.8677 | 6 | 35 | regulation of dopamine secretion |
GO:0003073 | 2e-04 | 4.8045 | 2.0825 | 9 | 84 | regulation of systemic arterial blood pressure |
GO:0051952 | 3e-04 | 4.6791 | 2.1321 | 9 | 86 | regulation of amine transport |
GO:1903305 | 3e-04 | 3.7733 | 3.1733 | 11 | 128 | regulation of regulated secretory pathway |
GO:0031295 | 4e-04 | 7.2442 | 0.9669 | 6 | 39 | T cell costimulation |
GO:0050432 | 4e-04 | 5.8195 | 1.3635 | 7 | 55 | catecholamine secretion |
GO:0040029 | 4e-04 | 3.6476 | 3.2725 | 11 | 132 | regulation of gene expression, epigenetic |
GO:0007268 | 5e-04 | 2.0228 | 16.3127 | 31 | 658 | chemical synaptic transmission |
GO:1990414 | 5e-04 | 29.7141 | 0.1735 | 3 | 7 | replication-born double-strand break repair via sister chromatid exchange |
GO:0072359 | 5e-04 | 1.7738 | 27.7415 | 46 | 1119 | circulatory system development |
GO:0050794 | 5e-04 | 1.4252 | 248.0129 | 280 | 10004 | regulation of cellular process |
GO:0099537 | 6e-04 | 1.9995 | 16.4863 | 31 | 665 | trans-synaptic signaling |
GO:0045956 | 7e-04 | 12.2138 | 0.4215 | 4 | 17 | positive regulation of calcium ion-dependent exocytosis |
GO:0071363 | 7e-04 | 2.0021 | 15.9161 | 30 | 642 | cellular response to growth factor stimulus |
GO:0022008 | 9e-04 | 1.6267 | 38.2283 | 58 | 1542 | neurogenesis |
GO:0045058 | 0.001 | 5.8277 | 1.1652 | 6 | 47 | T cell selection |
GO:0001990 | 0.0011 | 7.3627 | 0.7933 | 5 | 32 | regulation of systemic arterial blood pressure by hormone |
GO:0015872 | 0.0013 | 5.556 | 1.2148 | 6 | 49 | dopamine transport |
GO:0040011 | 0.0013 | 1.5614 | 43.9551 | 64 | 1773 | locomotion |
GO:1903792 | 0.0013 | 9.9218 | 0.4958 | 4 | 20 | negative regulation of anion transport |
GO:0007281 | 0.0014 | 2.4886 | 6.8176 | 16 | 275 | germ cell development |
GO:0065003 | 0.0015 | 1.618 | 34.931 | 53 | 1409 | protein-containing complex assembly |
GO:0050851 | 0.0016 | 3.0822 | 3.8179 | 11 | 154 | antigen receptor-mediated signaling pathway |
GO:0007186 | 0.0017 | 1.7499 | 23.0203 | 38 | 951 | G protein-coupled receptor signaling pathway |
GO:0097746 | 0.0017 | 3.2803 | 3.2725 | 10 | 132 | blood vessel diameter maintenance |
GO:0035150 | 0.0018 | 3.2535 | 3.2973 | 10 | 133 | regulation of tube size |
GO:0072156 | 0.0018 | 79.0568 | 0.0744 | 2 | 3 | distal tubule morphogenesis |
GO:0099502 | 0.0018 | 79.0568 | 0.0744 | 2 | 3 | calcium-dependent activation of synaptic vesicle fusion |
GO:0099538 | 0.0018 | 79.0568 | 0.0744 | 2 | 3 | synaptic signaling via neuropeptide |
GO:1901492 | 0.0018 | 79.0568 | 0.0744 | 2 | 3 | positive regulation of lymphangiogenesis |
GO:1901634 | 0.0018 | 79.0568 | 0.0744 | 2 | 3 | positive regulation of synaptic vesicle membrane organization |
GO:2000547 | 0.0018 | 79.0568 | 0.0744 | 2 | 3 | regulation of dendritic cell dendrite assembly |
GO:0035136 | 0.0018 | 6.4111 | 0.8925 | 5 | 36 | forelimb morphogenesis |
GO:0006811 | 0.0018 | 1.6049 | 34.4848 | 52 | 1391 | ion transport |
GO:0050855 | 0.0019 | 8.8183 | 0.5454 | 4 | 22 | regulation of B cell receptor signaling pathway |
GO:0003002 | 0.002 | 2.2761 | 8.3547 | 18 | 337 | regionalization |
GO:0044458 | 0.0021 | 4.9757 | 1.3387 | 6 | 54 | motile cilium assembly |
GO:0002863 | 0.0022 | 14.8533 | 0.2727 | 3 | 11 | positive regulation of inflammatory response to antigenic stimulus |
GO:0045060 | 0.0022 | 14.8533 | 0.2727 | 3 | 11 | negative thymic T cell selection |
GO:0099171 | 0.0022 | 14.8533 | 0.2727 | 3 | 11 | presynaptic modulation of chemical synaptic transmission |
GO:0001708 | 0.0022 | 3.7564 | 2.3056 | 8 | 93 | cell fate specification |
GO:0036303 | 0.0023 | 8.3537 | 0.5702 | 4 | 23 | lymph vessel morphogenesis |
GO:0051674 | 0.0023 | 1.5482 | 39.9141 | 58 | 1610 | localization of cell |
GO:0050877 | 0.0025 | 1.608 | 31.6586 | 48 | 1277 | nervous system process |
GO:0003013 | 0.0025 | 1.9418 | 13.5609 | 25 | 547 | circulatory system process |
GO:0019953 | 0.0027 | 1.7836 | 18.9158 | 32 | 763 | sexual reproduction |
GO:0001771 | 0.0028 | 13.2021 | 0.2975 | 3 | 12 | immunological synapse formation |
GO:0048609 | 0.0029 | 1.7709 | 19.0398 | 32 | 768 | multicellular organismal reproductive process |
GO:0007204 | 0.0031 | 2.2905 | 7.363 | 16 | 297 | positive regulation of cytosolic calcium ion concentration |
GO:0015844 | 0.0034 | 3.8738 | 1.9585 | 7 | 79 | monoamine transport |
GO:0002408 | 0.0036 | 39.5259 | 0.0992 | 2 | 4 | myeloid dendritic cell chemotaxis |
GO:0002457 | 0.0036 | 39.5259 | 0.0992 | 2 | 4 | T cell antigen processing and presentation |
GO:0002885 | 0.0036 | 39.5259 | 0.0992 | 2 | 4 | positive regulation of hypersensitivity |
GO:0038116 | 0.0036 | 39.5259 | 0.0992 | 2 | 4 | chemokine (C-C motif) ligand 21 signaling pathway |
GO:0048014 | 0.0036 | 39.5259 | 0.0992 | 2 | 4 | Tie signaling pathway |
GO:1901843 | 0.0036 | 39.5259 | 0.0992 | 2 | 4 | positive regulation of high voltage-gated calcium channel activity |
GO:1904340 | 0.0036 | 39.5259 | 0.0992 | 2 | 4 | positive regulation of dopaminergic neuron differentiation |
GO:0001768 | 0.0036 | 11.8812 | 0.3223 | 3 | 13 | establishment of T cell polarity |
GO:0001655 | 0.0038 | 2.1789 | 8.2059 | 17 | 331 | urogenital system development |
GO:0006935 | 0.0039 | 1.8749 | 14.0071 | 25 | 565 | chemotaxis |
GO:0072507 | 0.0041 | 1.9491 | 11.8503 | 22 | 478 | divalent inorganic cation homeostasis |
GO:0007288 | 0.0042 | 6.8991 | 0.6694 | 4 | 27 | sperm axoneme assembly |
GO:0051291 | 0.0042 | 6.8991 | 0.6694 | 4 | 27 | protein heterooligomerization |
GO:0045776 | 0.0045 | 5.0934 | 1.0908 | 5 | 44 | negative regulation of blood pressure |
GO:0051956 | 0.0045 | 10.8004 | 0.3471 | 3 | 14 | negative regulation of amino acid transport |
GO:0042391 | 0.0046 | 2.0417 | 9.7678 | 19 | 394 | regulation of membrane potential |
GO:0048663 | 0.0046 | 4.1877 | 1.5619 | 6 | 63 | neuron fate commitment |
GO:0016525 | 0.0049 | 2.9943 | 3.1981 | 9 | 129 | negative regulation of angiogenesis |
GO:0072073 | 0.0049 | 2.9943 | 3.1981 | 9 | 129 | kidney epithelium development |
GO:0046717 | 0.0049 | 4.9658 | 1.1156 | 5 | 45 | acid secretion |
GO:0061326 | 0.0051 | 3.5745 | 2.1073 | 7 | 85 | renal tubule development |
GO:0035641 | 0.0055 | 9.8998 | 0.3719 | 3 | 15 | locomotory exploration behavior |
GO:1901343 | 0.0056 | 2.9208 | 3.2725 | 9 | 132 | negative regulation of vasculature development |
GO:0030182 | 0.0058 | 1.5587 | 29.7428 | 44 | 1213 | neuron differentiation |
GO:0021529 | 0.0058 | 26.349 | 0.124 | 2 | 5 | spinal cord oligodendrocyte cell differentiation |
GO:0072014 | 0.0058 | 26.349 | 0.124 | 2 | 5 | proximal tubule development |
GO:0048646 | 0.006 | 1.5704 | 28.1382 | 42 | 1135 | anatomical structure formation involved in morphogenesis |
GO:0034694 | 0.0061 | 6.1019 | 0.7437 | 4 | 30 | response to prostaglandin |
GO:0035107 | 0.0065 | 2.8507 | 3.3468 | 9 | 135 | appendage morphogenesis |
GO:0007159 | 0.0066 | 2.0521 | 8.677 | 17 | 350 | leukocyte cell-cell adhesion |
GO:0010744 | 0.0067 | 9.1377 | 0.3967 | 3 | 16 | positive regulation of macrophage derived foam cell differentiation |
GO:0048729 | 0.0068 | 1.7857 | 14.6517 | 25 | 591 | tissue morphogenesis |
GO:0016486 | 0.0069 | 5.8756 | 0.7685 | 4 | 31 | peptide hormone processing |
GO:0050901 | 0.0077 | 5.6654 | 0.7933 | 4 | 32 | leukocyte tethering or rolling |
GO:0021513 | 0.0079 | 8.4844 | 0.4215 | 3 | 17 | spinal cord dorsal/ventral patterning |
GO:0033631 | 0.0079 | 8.4844 | 0.4215 | 3 | 17 | cell-cell adhesion mediated by integrin |
GO:0019233 | 0.0083 | 3.2403 | 2.3056 | 7 | 93 | sensory perception of pain |
GO:0030003 | 0.0085 | 1.7505 | 14.9244 | 25 | 602 | cellular cation homeostasis |
GO:0007420 | 0.0085 | 1.6941 | 17.2796 | 28 | 697 | brain development |
GO:0002001 | 0.0086 | 19.7605 | 0.1487 | 2 | 6 | renin secretion into blood stream |
GO:0002322 | 0.0086 | 19.7605 | 0.1487 | 2 | 6 | B cell proliferation involved in immune response |
GO:0003057 | 0.0086 | 19.7605 | 0.1487 | 2 | 6 | regulation of the force of heart contraction by chemical signal |
GO:0010754 | 0.0086 | 19.7605 | 0.1487 | 2 | 6 | negative regulation of cGMP-mediated signaling |
GO:2000302 | 0.0086 | 19.7605 | 0.1487 | 2 | 6 | positive regulation of synaptic vesicle exocytosis |
GO:2000481 | 0.0086 | 19.7605 | 0.1487 | 2 | 6 | positive regulation of cAMP-dependent protein kinase activity |
GO:2000669 | 0.0086 | 19.7605 | 0.1487 | 2 | 6 | negative regulation of dendritic cell apoptotic process |
GO:0040036 | 0.0086 | 5.4697 | 0.8181 | 4 | 33 | regulation of fibroblast growth factor receptor signaling pathway |
GO:0016477 | 0.0087 | 1.4801 | 35.5508 | 50 | 1434 | cell migration |
GO:0006874 | 0.0093 | 1.8964 | 10.462 | 19 | 422 | cellular calcium ion homeostasis |
GO:0002577 | 0.0094 | 7.9183 | 0.4462 | 3 | 18 | regulation of antigen processing and presentation |
GO:0032332 | 0.0094 | 7.9183 | 0.4462 | 3 | 18 | positive regulation of chondrocyte differentiation |
GO:0048232 | 0.0094 | 1.8023 | 12.7428 | 22 | 514 | male gamete generation |
GO:0032228 | 0.0096 | 5.287 | 0.8429 | 4 | 34 | regulation of synaptic transmission, GABAergic |
GO:0042573 | 0.0096 | 5.287 | 0.8429 | 4 | 34 | retinoic acid metabolic process |
GO:0060173 | 0.0096 | 2.5111 | 4.1897 | 10 | 169 | limb development |
GO:0098609 | 0.0097 | 1.8256 | 12.0139 | 21 | 496 | cell-cell adhesion |
GO:0008037 | 0.0098 | 2.6591 | 3.57 | 9 | 144 | cell recognition |
GO:0051965 | 0.0099 | 4.1361 | 1.3139 | 5 | 53 | positive regulation of synapse assembly |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 132.932 | 0.8233 | 24 | 31 | DNA replication-dependent chromatin assembly |
GO:0045653 | 0 | 132.5107 | 0.478 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006334 | 0 | 12.7648 | 2.7886 | 26 | 105 | nucleosome assembly |
GO:0006336 | 0 | 31.1536 | 0.8233 | 14 | 31 | DNA replication-independent chromatin assembly |
GO:0007275 | 0 | 2.3699 | 75.5543 | 137 | 3167 | multicellular organism development |
GO:0032200 | 0 | 7.5336 | 4.0633 | 25 | 153 | telomere organization |
GO:0007399 | 0 | 2.4918 | 47.2309 | 98 | 1845 | nervous system development |
GO:0071824 | 0 | 5.6989 | 5.5771 | 27 | 210 | protein-DNA complex subunit organization |
GO:2000026 | 0 | 2.5362 | 34.1268 | 75 | 1285 | regulation of multicellular organismal development |
GO:0006338 | 0 | 4.9817 | 6.2676 | 27 | 236 | chromatin remodeling |
GO:0045637 | 0 | 8.203 | 2.2308 | 15 | 85 | regulation of myeloid cell differentiation |
GO:0051674 | 0 | 2.1566 | 42.7581 | 81 | 1610 | localization of cell |
GO:0048869 | 0 | 2.098 | 41.3014 | 75 | 1764 | cellular developmental process |
GO:0040011 | 0 | 2.5538 | 19.6064 | 45 | 771 | locomotion |
GO:0045165 | 0 | 3.7976 | 6.4402 | 22 | 244 | cell fate commitment |
GO:0006352 | 0 | 5.2858 | 3.2401 | 15 | 122 | DNA-templated transcription, initiation |
GO:0009887 | 0 | 2.1866 | 26.1329 | 52 | 984 | animal organ morphogenesis |
GO:0007420 | 0 | 2.4248 | 18.5108 | 41 | 697 | brain development |
GO:0061564 | 0 | 2.8063 | 11.6854 | 30 | 440 | axon development |
GO:0021510 | 0 | 5.3561 | 2.5496 | 12 | 96 | spinal cord development |
GO:0048598 | 0 | 2.4301 | 15.1789 | 34 | 574 | embryonic morphogenesis |
GO:0048665 | 0 | 11.3212 | 0.7967 | 7 | 30 | neuron fate specification |
GO:0048812 | 0 | 2.4 | 15.3504 | 34 | 578 | neuron projection morphogenesis |
GO:0021537 | 0 | 3.3255 | 6.2411 | 19 | 235 | telencephalon development |
GO:0048667 | 0 | 2.456 | 13.6507 | 31 | 514 | cell morphogenesis involved in neuron differentiation |
GO:0048858 | 0 | 2.3162 | 15.855 | 34 | 597 | cell projection morphogenesis |
GO:0045596 | 0 | 2.4397 | 13.2798 | 30 | 514 | negative regulation of cell differentiation |
GO:0032989 | 0 | 2.1887 | 18.7498 | 38 | 706 | cellular component morphogenesis |
GO:1990266 | 0 | 4.4498 | 3.001 | 12 | 113 | neutrophil migration |
GO:0030097 | 1e-04 | 2.0646 | 21.4056 | 41 | 806 | hemopoiesis |
GO:0048880 | 1e-04 | 2.6168 | 9.8795 | 24 | 372 | sensory system development |
GO:0120036 | 1e-04 | 1.7978 | 36.8357 | 61 | 1387 | plasma membrane bounded cell projection organization |
GO:0021542 | 1e-04 | 15.4379 | 0.4515 | 5 | 17 | dentate gyrus development |
GO:0002520 | 1e-04 | 1.9809 | 23.9286 | 44 | 901 | immune system development |
GO:0007411 | 1e-04 | 3.1693 | 5.8162 | 17 | 219 | axon guidance |
GO:0006928 | 1e-04 | 1.959 | 24.8693 | 45 | 981 | movement of cell or subcellular component |
GO:0001654 | 1e-04 | 2.5696 | 9.6139 | 23 | 362 | eye development |
GO:0021953 | 1e-04 | 3.9884 | 3.3073 | 12 | 126 | central nervous system neuron differentiation |
GO:0042127 | 2e-04 | 1.6971 | 42.1207 | 66 | 1586 | regulation of cell population proliferation |
GO:0032502 | 2e-04 | 1.8487 | 31.5284 | 52 | 1529 | developmental process |
GO:0030182 | 2e-04 | 4.5403 | 2.4357 | 10 | 102 | neuron differentiation |
GO:0045597 | 2e-04 | 2.0435 | 18.8685 | 36 | 720 | positive regulation of cell differentiation |
GO:0035385 | 2e-04 | 55.3545 | 0.1328 | 3 | 5 | Roundabout signaling pathway |
GO:0001764 | 2e-04 | 3.4525 | 4.0899 | 13 | 154 | neuron migration |
GO:0007423 | 3e-04 | 3.2514 | 4.6561 | 14 | 181 | sensory organ development |
GO:0048729 | 3e-04 | 2.1078 | 15.6957 | 31 | 591 | tissue morphogenesis |
GO:0006935 | 3e-04 | 2.1333 | 15.0052 | 30 | 565 | chemotaxis |
GO:0048935 | 3e-04 | 16.4321 | 0.3453 | 4 | 13 | peripheral nervous system neuron development |
GO:0050767 | 3e-04 | 2.4924 | 9.0031 | 21 | 339 | regulation of neurogenesis |
GO:0031344 | 3e-04 | 2.0808 | 15.8816 | 31 | 598 | regulation of cell projection organization |
GO:2000179 | 3e-04 | 6.0479 | 1.3279 | 7 | 50 | positive regulation of neural precursor cell proliferation |
GO:0033993 | 3e-04 | 1.9017 | 21.8837 | 39 | 824 | response to lipid |
GO:0070100 | 4e-04 | 36.9007 | 0.1593 | 3 | 6 | negative regulation of chemokine-mediated signaling pathway |
GO:0021761 | 4e-04 | 4.099 | 2.6823 | 10 | 101 | limbic system development |
GO:0010976 | 4e-04 | 3.5052 | 3.7181 | 12 | 140 | positive regulation of neuron projection development |
GO:0050789 | 4e-04 | 3.345 | 4.3899 | 13 | 224 | regulation of biological process |
GO:0051270 | 4e-04 | 1.7918 | 27.4342 | 46 | 1033 | regulation of cellular component movement |
GO:0051216 | 4e-04 | 3.0855 | 4.8866 | 14 | 184 | cartilage development |
GO:0035270 | 4e-04 | 3.6836 | 3.2528 | 11 | 123 | endocrine system development |
GO:0045123 | 4e-04 | 4.9598 | 1.8059 | 8 | 68 | cellular extravasation |
GO:0001568 | 5e-04 | 1.9401 | 19.2013 | 35 | 723 | blood vessel development |
GO:0060429 | 5e-04 | 1.7899 | 26.8487 | 45 | 1021 | epithelium development |
GO:0003002 | 5e-04 | 2.5201 | 8.0415 | 19 | 305 | regionalization |
GO:0048666 | 5e-04 | 2.1617 | 12.8029 | 26 | 505 | neuron development |
GO:0048568 | 5e-04 | 2.2347 | 11.4199 | 24 | 430 | embryonic organ development |
GO:0050794 | 6e-04 | 1.4467 | 191.848 | 222 | 7879 | regulation of cellular process |
GO:0060215 | 6e-04 | 27.6738 | 0.1859 | 3 | 7 | primitive hemopoiesis |
GO:1900122 | 6e-04 | 27.6738 | 0.1859 | 3 | 7 | positive regulation of receptor binding |
GO:0048519 | 6e-04 | 1.3919 | 138.9772 | 171 | 5233 | negative regulation of biological process |
GO:0001822 | 6e-04 | 2.5441 | 7.5424 | 18 | 284 | kidney development |
GO:0072359 | 7e-04 | 1.7223 | 29.7182 | 48 | 1119 | circulatory system development |
GO:0021823 | 7e-04 | Inf | 0.0531 | 2 | 2 | cerebral cortex tangential migration using cell-cell interactions |
GO:0021836 | 7e-04 | Inf | 0.0531 | 2 | 2 | chemorepulsion involved in postnatal olfactory bulb interneuron migration |
GO:0021985 | 7e-04 | Inf | 0.0531 | 2 | 2 | neurohypophysis development |
GO:0032723 | 7e-04 | Inf | 0.0531 | 2 | 2 | positive regulation of connective tissue growth factor production |
GO:0048252 | 7e-04 | Inf | 0.0531 | 2 | 2 | lauric acid metabolic process |
GO:0072272 | 7e-04 | Inf | 0.0531 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
GO:0140039 | 7e-04 | Inf | 0.0531 | 2 | 2 | cell-cell adhesion in response to extracellular stimulus |
GO:0040012 | 7e-04 | 1.7602 | 26.611 | 44 | 1002 | regulation of locomotion |
GO:0034330 | 8e-04 | 1.9656 | 16.7314 | 31 | 630 | cell junction organization |
GO:0060412 | 8e-04 | 6.1802 | 1.1154 | 6 | 42 | ventricular septum morphogenesis |
GO:0040029 | 8e-04 | 3.3925 | 3.5056 | 11 | 132 | regulation of gene expression, epigenetic |
GO:0045944 | 8e-04 | 1.7069 | 29.9572 | 48 | 1128 | positive regulation of transcription by RNA polymerase II |
GO:0035239 | 9e-04 | 2.0191 | 14.7066 | 28 | 564 | tube morphogenesis |
GO:0007405 | 9e-04 | 4.9983 | 1.5669 | 7 | 59 | neuroblast proliferation |
GO:0001525 | 9e-04 | 2.0085 | 14.7662 | 28 | 556 | angiogenesis |
GO:0006811 | 0.0011 | 1.6167 | 36.942 | 56 | 1391 | ion transport |
GO:0003180 | 0.0012 | 7.119 | 0.8233 | 5 | 31 | aortic valve morphogenesis |
GO:0072001 | 0.0013 | 18.9265 | 0.2332 | 3 | 9 | renal system development |
GO:0001756 | 0.0014 | 4.6402 | 1.6731 | 7 | 63 | somitogenesis |
GO:0007167 | 0.0014 | 1.7417 | 24.327 | 40 | 916 | enzyme linked receptor protein signaling pathway |
GO:0001501 | 0.0014 | 2.3515 | 8.1109 | 18 | 312 | skeletal system development |
GO:0021872 | 0.0014 | 5.4248 | 1.2482 | 6 | 47 | forebrain generation of neurons |
GO:0050885 | 0.0014 | 5.4248 | 1.2482 | 6 | 47 | neuromuscular process controlling balance |
GO:0071495 | 0.0015 | 1.6302 | 33.2504 | 51 | 1252 | cellular response to endogenous stimulus |
GO:0034103 | 0.0015 | 4.0179 | 2.1777 | 8 | 82 | regulation of tissue remodeling |
GO:0010975 | 0.0015 | 2.4777 | 6.8509 | 16 | 263 | regulation of neuron projection development |
GO:0048704 | 0.0015 | 5.3445 | 1.2635 | 6 | 48 | embryonic skeletal system morphogenesis |
GO:0032774 | 0.0016 | 1.4279 | 78.4902 | 103 | 3038 | RNA biosynthetic process |
GO:0048839 | 0.0016 | 2.7758 | 4.9929 | 13 | 188 | inner ear development |
GO:0003206 | 0.0016 | 3.2964 | 3.2666 | 10 | 123 | cardiac chamber morphogenesis |
GO:0060041 | 0.0017 | 3.0609 | 3.8509 | 11 | 145 | retina development in camera-type eye |
GO:0018130 | 0.0018 | 1.3901 | 95.1036 | 121 | 3581 | heterocycle biosynthetic process |
GO:0045666 | 0.0019 | 3.8607 | 2.2574 | 8 | 85 | positive regulation of neuron differentiation |
GO:0006351 | 0.0019 | 1.4197 | 78.0252 | 102 | 3020 | transcription, DNA-templated |
GO:1905205 | 0.0019 | 15.8106 | 0.2656 | 3 | 10 | positive regulation of connective tissue replacement |
GO:0019438 | 0.002 | 1.3855 | 95.3426 | 121 | 3590 | aromatic compound biosynthetic process |
GO:0021987 | 0.002 | 3.4515 | 2.8151 | 9 | 106 | cerebral cortex development |
GO:0007412 | 0.0021 | 73.6406 | 0.0797 | 2 | 3 | axon target recognition |
GO:0060480 | 0.0021 | 73.6406 | 0.0797 | 2 | 3 | lung goblet cell differentiation |
GO:0061364 | 0.0021 | 73.6406 | 0.0797 | 2 | 3 | apoptotic process involved in luteolysis |
GO:0097377 | 0.0021 | 73.6406 | 0.0797 | 2 | 3 | spinal cord interneuron axon guidance |
GO:1902869 | 0.0021 | 73.6406 | 0.0797 | 2 | 3 | regulation of amacrine cell differentiation |
GO:0050772 | 0.0021 | 4.2585 | 1.8059 | 7 | 68 | positive regulation of axonogenesis |
GO:0048513 | 0.0022 | 1.6294 | 31.5626 | 48 | 1363 | animal organ development |
GO:0030534 | 0.0022 | 3.1557 | 3.3994 | 10 | 128 | adult behavior |
GO:0030334 | 0.0022 | 1.7042 | 24.1676 | 39 | 910 | regulation of cell migration |
GO:0021536 | 0.0023 | 4.1895 | 1.8325 | 7 | 69 | diencephalon development |
GO:0002682 | 0.0024 | 1.5955 | 33.1973 | 50 | 1250 | regulation of immune system process |
GO:0051962 | 0.0024 | 2.44 | 6.5067 | 15 | 245 | positive regulation of nervous system development |
GO:0099560 | 0.0025 | 8.2114 | 0.5843 | 4 | 22 | synaptic membrane adhesion |
GO:0045665 | 0.0025 | 4.1228 | 1.859 | 7 | 70 | negative regulation of neuron differentiation |
GO:0098916 | 0.0029 | 1.8065 | 17.4751 | 30 | 658 | anterograde trans-synaptic signaling |
GO:0003008 | 0.0031 | 1.4606 | 53.3016 | 73 | 2007 | system process |
GO:0048699 | 0.0031 | 42.1977 | 0.0931 | 2 | 4 | generation of neurons |
GO:0007214 | 0.0034 | 7.3894 | 0.6374 | 4 | 24 | gamma-aminobutyric acid signaling pathway |
GO:0043524 | 0.0034 | 2.9538 | 3.6119 | 10 | 136 | negative regulation of neuron apoptotic process |
GO:0021781 | 0.0034 | 12.2956 | 0.3187 | 3 | 12 | glial cell fate commitment |
GO:0038180 | 0.0034 | 12.2956 | 0.3187 | 3 | 12 | nerve growth factor signaling pathway |
GO:0007626 | 0.0035 | 2.6322 | 4.8335 | 12 | 182 | locomotory behavior |
GO:1905314 | 0.0035 | 5.4412 | 1.0358 | 5 | 39 | semi-lunar valve development |
GO:0045664 | 0.0036 | 5.4053 | 1.0397 | 5 | 40 | regulation of neuron differentiation |
GO:0007422 | 0.0037 | 3.8184 | 1.9918 | 7 | 75 | peripheral nervous system development |
GO:1903506 | 0.0038 | 1.3772 | 80.5765 | 103 | 3034 | regulation of nucleic acid-templated transcription |
GO:0007416 | 0.0039 | 2.7316 | 4.2758 | 11 | 161 | synapse assembly |
GO:0035640 | 0.004 | 7.037 | 0.6639 | 4 | 25 | exploration behavior |
GO:0060384 | 0.004 | 7.037 | 0.6639 | 4 | 25 | innervation |
GO:0001704 | 0.004 | 3.0978 | 3.1073 | 9 | 117 | formation of primary germ layer |
GO:0022028 | 0.0041 | 36.818 | 0.1062 | 2 | 4 | tangential migration from the subventricular zone to the olfactory bulb |
GO:0050923 | 0.0041 | 36.818 | 0.1062 | 2 | 4 | regulation of negative chemotaxis |
GO:0072086 | 0.0041 | 36.818 | 0.1062 | 2 | 4 | specification of loop of Henle identity |
GO:0090024 | 0.0041 | 36.818 | 0.1062 | 2 | 4 | negative regulation of neutrophil chemotaxis |
GO:0097241 | 0.0041 | 36.818 | 0.1062 | 2 | 4 | hematopoietic stem cell migration to bone marrow |
GO:0097476 | 0.0041 | 36.818 | 0.1062 | 2 | 4 | spinal cord motor neuron migration |
GO:2000741 | 0.0041 | 36.818 | 0.1062 | 2 | 4 | positive regulation of mesenchymal stem cell differentiation |
GO:0016477 | 0.0041 | 2.0233 | 10.3979 | 20 | 417 | cell migration |
GO:0021885 | 0.0043 | 4.2743 | 1.5404 | 6 | 58 | forebrain cell migration |
GO:1905208 | 0.0044 | 11.0654 | 0.3453 | 3 | 13 | negative regulation of cardiocyte differentiation |
GO:0030198 | 0.0044 | 2.2084 | 7.6221 | 16 | 287 | extracellular matrix organization |
GO:1901214 | 0.0045 | 2.2001 | 7.6487 | 16 | 288 | regulation of neuron death |
GO:0031589 | 0.0046 | 2.0875 | 9.0562 | 18 | 341 | cell-substrate adhesion |
GO:0007189 | 0.0046 | 2.8185 | 3.7712 | 10 | 142 | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO:0014002 | 0.0049 | 4.9991 | 1.1154 | 5 | 42 | astrocyte development |
GO:0035987 | 0.0049 | 4.9991 | 1.1154 | 5 | 42 | endodermal cell differentiation |
GO:0099536 | 0.0053 | 1.7262 | 18.2187 | 30 | 686 | synaptic signaling |
GO:1901362 | 0.0054 | 1.3324 | 99.0607 | 122 | 3730 | organic cyclic compound biosynthetic process |
GO:0070307 | 0.0054 | 10.0588 | 0.3718 | 3 | 14 | lens fiber cell development |
GO:0050793 | 0.0056 | 1.7987 | 15.207 | 26 | 635 | regulation of developmental process |
GO:0009792 | 0.0056 | 1.7532 | 16.7314 | 28 | 630 | embryo development ending in birth or egg hatching |
GO:0003231 | 0.0058 | 2.9079 | 3.2932 | 9 | 124 | cardiac ventricle development |
GO:0048701 | 0.006 | 4.7421 | 1.1685 | 5 | 44 | embryonic cranial skeleton morphogenesis |
GO:0050804 | 0.0063 | 1.9372 | 10.809 | 20 | 407 | modulation of chemical synaptic transmission |
GO:0002088 | 0.0065 | 3.4148 | 2.2043 | 7 | 83 | lens development in camera-type eye |
GO:0048871 | 0.0066 | 1.8379 | 13.093 | 23 | 493 | multicellular organismal homeostasis |
GO:0035881 | 0.0066 | 24.6559 | 0.1322 | 2 | 5 | amacrine cell differentiation |
GO:0045780 | 0.0067 | 9.22 | 0.3984 | 3 | 15 | positive regulation of bone resorption |
GO:0021529 | 0.0067 | 24.5438 | 0.1328 | 2 | 5 | spinal cord oligodendrocyte cell differentiation |
GO:0021800 | 0.0067 | 24.5438 | 0.1328 | 2 | 5 | cerebral cortex tangential migration |
GO:0021891 | 0.0067 | 24.5438 | 0.1328 | 2 | 5 | olfactory bulb interneuron development |
GO:0051414 | 0.0067 | 24.5438 | 0.1328 | 2 | 5 | response to cortisol |
GO:0060059 | 0.0067 | 24.5438 | 0.1328 | 2 | 5 | embryonic retina morphogenesis in camera-type eye |
GO:0060482 | 0.0067 | 24.5438 | 0.1328 | 2 | 5 | lobar bronchus development |
GO:0071651 | 0.0067 | 24.5438 | 0.1328 | 2 | 5 | positive regulation of chemokine (C-C motif) ligand 5 production |
GO:0090259 | 0.0067 | 24.5438 | 0.1328 | 2 | 5 | regulation of retinal ganglion cell axon guidance |
GO:2000977 | 0.0067 | 24.5438 | 0.1328 | 2 | 5 | regulation of forebrain neuron differentiation |
GO:0007219 | 0.0069 | 2.5117 | 4.6211 | 11 | 174 | Notch signaling pathway |
GO:0021522 | 0.0069 | 5.9096 | 0.7702 | 4 | 29 | spinal cord motor neuron differentiation |
GO:0007611 | 0.0069 | 2.2229 | 6.6129 | 14 | 249 | learning or memory |
GO:0071363 | 0.0072 | 1.7176 | 17.0501 | 28 | 642 | cellular response to growth factor stimulus |
GO:0002269 | 0.0072 | 4.5102 | 1.2217 | 5 | 46 | leukocyte activation involved in inflammatory response |
GO:0048146 | 0.0072 | 4.5102 | 1.2217 | 5 | 46 | positive regulation of fibroblast proliferation |
GO:0010001 | 0.0072 | 2.3803 | 5.3053 | 12 | 201 | glial cell differentiation |
GO:0061180 | 0.0075 | 3.7655 | 1.7263 | 6 | 65 | mammary gland epithelium development |
GO:0071300 | 0.0075 | 3.7655 | 1.7263 | 6 | 65 | cellular response to retinoic acid |
GO:0043200 | 0.0077 | 2.9986 | 2.8417 | 8 | 107 | response to amino acid |
GO:0051130 | 0.0078 | 1.5776 | 25.2299 | 38 | 950 | positive regulation of cellular component organization |
GO:0002042 | 0.0079 | 3.2845 | 2.284 | 7 | 86 | cell migration involved in sprouting angiogenesis |
GO:0030857 | 0.0079 | 4.4026 | 1.2482 | 5 | 47 | negative regulation of epithelial cell differentiation |
GO:0048260 | 0.0079 | 4.4026 | 1.2482 | 5 | 47 | positive regulation of receptor-mediated endocytosis |
GO:0055010 | 0.0079 | 4.4026 | 1.2482 | 5 | 47 | ventricular cardiac muscle tissue morphogenesis |
GO:0003184 | 0.0081 | 8.5102 | 0.4249 | 3 | 16 | pulmonary valve morphogenesis |
GO:0007379 | 0.0081 | 8.5102 | 0.4249 | 3 | 16 | segment specification |
GO:0033194 | 0.0081 | 8.5102 | 0.4249 | 3 | 16 | response to hydroperoxide |
GO:0060749 | 0.0081 | 8.5102 | 0.4249 | 3 | 16 | mammary gland alveolus development |
GO:1903236 | 0.0081 | 8.5102 | 0.4249 | 3 | 16 | regulation of leukocyte tethering or rolling |
GO:0048863 | 0.0082 | 2.3397 | 5.3912 | 12 | 203 | stem cell differentiation |
GO:0018209 | 0.0082 | 2.054 | 8.1533 | 16 | 307 | peptidyl-serine modification |
GO:0006357 | 0.0084 | 1.5306 | 29.565 | 43 | 1165 | regulation of transcription by RNA polymerase II |
GO:0002761 | 0.0085 | 2.9388 | 2.8948 | 8 | 109 | regulation of myeloid leukocyte differentiation |
GO:0060562 | 0.0089 | 2.0327 | 8.2329 | 16 | 310 | epithelial tube morphogenesis |
GO:0023052 | 0.009 | 1.2717 | 153.0528 | 177 | 5763 | signaling |
GO:0048468 | 0.0092 | 1.5917 | 23.0741 | 35 | 942 | cell development |
GO:0043542 | 0.0093 | 2.1397 | 6.8519 | 14 | 258 | endothelial cell migration |
GO:0022603 | 0.0093 | 1.5766 | 23.8755 | 36 | 899 | regulation of anatomical structure morphogenesis |
GO:0051932 | 0.0094 | 4.2019 | 1.3013 | 5 | 49 | synaptic transmission, GABAergic |
GO:1903978 | 0.0096 | 7.9018 | 0.4515 | 3 | 17 | regulation of microglial cell activation |
GO:1904948 | 0.0096 | 7.9018 | 0.4515 | 3 | 17 | midbrain dopaminergic neuron differentiation |
GO:0009954 | 0.0098 | 5.2755 | 0.8499 | 4 | 32 | proximal/distal pattern formation |
GO:0048333 | 0.0098 | 5.2755 | 0.8499 | 4 | 32 | mesodermal cell differentiation |
GO:2000352 | 0.0098 | 5.2755 | 0.8499 | 4 | 32 | negative regulation of endothelial cell apoptotic process |
GO:0003278 | 0.0098 | 18.4067 | 0.1593 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0008291 | 0.0098 | 18.4067 | 0.1593 | 2 | 6 | acetylcholine metabolic process |
GO:0021707 | 0.0098 | 18.4067 | 0.1593 | 2 | 6 | cerebellar granule cell differentiation |
GO:0031547 | 0.0098 | 18.4067 | 0.1593 | 2 | 6 | brain-derived neurotrophic factor receptor signaling pathway |
GO:0055009 | 0.0098 | 18.4067 | 0.1593 | 2 | 6 | atrial cardiac muscle tissue morphogenesis |
GO:0060017 | 0.0098 | 18.4067 | 0.1593 | 2 | 6 | parathyroid gland development |
GO:0150076 | 0.0099 | 3.5256 | 1.8325 | 6 | 69 | neuroinflammatory response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051674 | 0 | 2.0955 | 31.6763 | 59 | 1610 | localization of cell |
GO:0048731 | 0 | 1.7199 | 68.8645 | 101 | 3643 | system development |
GO:0048663 | 0 | 7.4062 | 1.2395 | 8 | 63 | neuron fate commitment |
GO:0022008 | 0 | 1.9254 | 30.3384 | 53 | 1542 | neurogenesis |
GO:0048468 | 1e-04 | 1.7878 | 38.3768 | 62 | 1962 | cell development |
GO:0035295 | 1e-04 | 2.038 | 20.7568 | 39 | 1055 | tube development |
GO:0034762 | 1e-04 | 2.4778 | 10.4079 | 24 | 529 | regulation of transmembrane transport |
GO:0048706 | 1e-04 | 4.559 | 2.4003 | 10 | 122 | embryonic skeletal system development |
GO:0001666 | 2e-04 | 3.1375 | 5.1351 | 15 | 261 | response to hypoxia |
GO:0048514 | 2e-04 | 2.2614 | 12.8082 | 27 | 651 | blood vessel morphogenesis |
GO:0023052 | 2e-04 | 1.4997 | 113.3855 | 144 | 5763 | signaling |
GO:0070482 | 2e-04 | 2.9651 | 5.7844 | 16 | 294 | response to oxygen levels |
GO:0051270 | 3e-04 | 1.9611 | 20.324 | 37 | 1033 | regulation of cellular component movement |
GO:0070848 | 3e-04 | 2.2062 | 13.1034 | 27 | 666 | response to growth factor |
GO:0040012 | 3e-04 | 1.9644 | 19.7141 | 36 | 1002 | regulation of locomotion |
GO:0031175 | 4e-04 | 2.0232 | 17.5105 | 33 | 890 | neuron projection development |
GO:2000352 | 4e-04 | 9.3565 | 0.6296 | 5 | 32 | negative regulation of endothelial cell apoptotic process |
GO:0048252 | 4e-04 | Inf | 0.0393 | 2 | 2 | lauric acid metabolic process |
GO:0045665 | 4e-04 | 5.6368 | 1.3772 | 7 | 70 | negative regulation of neuron differentiation |
GO:0040011 | 6e-04 | 2.093 | 14.3547 | 28 | 771 | locomotion |
GO:0021520 | 6e-04 | 25.1375 | 0.1771 | 3 | 9 | spinal cord motor neuron cell fate specification |
GO:0030198 | 6e-04 | 2.8329 | 5.6466 | 15 | 287 | extracellular matrix organization |
GO:0032410 | 6e-04 | 4.6193 | 1.8888 | 8 | 96 | negative regulation of transporter activity |
GO:0071310 | 7e-04 | 1.62 | 43.8943 | 65 | 2231 | cellular response to organic substance |
GO:0045766 | 7e-04 | 3.4458 | 3.4234 | 11 | 174 | positive regulation of angiogenesis |
GO:0032689 | 7e-04 | 7.8921 | 0.728 | 5 | 37 | negative regulation of interferon-gamma production |
GO:0098609 | 8e-04 | 1.9724 | 16.7825 | 31 | 853 | cell-cell adhesion |
GO:0032501 | 9e-04 | 1.6126 | 52.2587 | 73 | 3077 | multicellular organismal process |
GO:0006954 | 9e-04 | 2.0267 | 14.7167 | 28 | 748 | inflammatory response |
GO:0033993 | 9e-04 | 1.973 | 16.212 | 30 | 824 | response to lipid |
GO:0006812 | 0.0011 | 1.8364 | 20.9536 | 36 | 1065 | cation transport |
GO:0051240 | 0.0011 | 1.7389 | 26.5412 | 43 | 1349 | positive regulation of multicellular organismal process |
GO:0097377 | 0.0011 | 100.2679 | 0.059 | 2 | 3 | spinal cord interneuron axon guidance |
GO:0120253 | 0.0011 | 100.2679 | 0.059 | 2 | 3 | hydrocarbon catabolic process |
GO:1902869 | 0.0011 | 100.2679 | 0.059 | 2 | 3 | regulation of amacrine cell differentiation |
GO:2000177 | 0.0012 | 4.7314 | 1.6133 | 7 | 82 | regulation of neural precursor cell proliferation |
GO:0007565 | 0.0012 | 3.4423 | 3.1086 | 10 | 158 | female pregnancy |
GO:0008284 | 0.0012 | 1.9135 | 17.2547 | 31 | 877 | positive regulation of cell population proliferation |
GO:0007154 | 0.0012 | 1.4239 | 114.3495 | 141 | 5812 | cell communication |
GO:0009719 | 0.0012 | 1.7016 | 29.0596 | 46 | 1477 | response to endogenous stimulus |
GO:0007389 | 0.0012 | 2.3211 | 8.6766 | 19 | 441 | pattern specification process |
GO:0001817 | 0.0013 | 1.997 | 14.3626 | 27 | 730 | regulation of cytokine production |
GO:0032502 | 0.0014 | 1.4613 | 87.103 | 111 | 4687 | developmental process |
GO:0048562 | 0.0015 | 2.6654 | 5.5679 | 14 | 283 | embryonic organ morphogenesis |
GO:0048701 | 0.0017 | 6.4727 | 0.8657 | 5 | 44 | embryonic cranial skeleton morphogenesis |
GO:1901342 | 0.0017 | 2.5211 | 6.2959 | 15 | 320 | regulation of vasculature development |
GO:1990266 | 0.0018 | 3.8673 | 2.2232 | 8 | 113 | neutrophil migration |
GO:0007507 | 0.0018 | 2.1012 | 11.0769 | 22 | 563 | heart development |
GO:0021517 | 0.0018 | 6.3105 | 0.8854 | 5 | 45 | ventral spinal cord development |
GO:0038092 | 0.0019 | 15.0788 | 0.2558 | 3 | 13 | nodal signaling pathway |
GO:0043067 | 0.002 | 1.6924 | 26.5215 | 42 | 1348 | regulation of programmed cell death |
GO:0072001 | 0.0021 | 2.5682 | 5.7647 | 14 | 293 | renal system development |
GO:0051241 | 0.0021 | 1.8019 | 19.4667 | 33 | 1000 | negative regulation of multicellular organismal process |
GO:0016477 | 0.0021 | 2.4713 | 6.4284 | 15 | 347 | cell migration |
GO:0008285 | 0.0021 | 1.9455 | 14.1461 | 26 | 719 | negative regulation of cell population proliferation |
GO:0035924 | 0.0022 | 4.8943 | 1.3379 | 6 | 68 | cellular response to vascular endothelial growth factor stimulus |
GO:0002774 | 0.0023 | 50.1308 | 0.0787 | 2 | 4 | Fc receptor mediated inhibitory signaling pathway |
GO:0097476 | 0.0023 | 50.1308 | 0.0787 | 2 | 4 | spinal cord motor neuron migration |
GO:2000697 | 0.0023 | 50.1308 | 0.0787 | 2 | 4 | negative regulation of epithelial cell differentiation involved in kidney development |
GO:0007204 | 0.0023 | 2.5313 | 5.8434 | 14 | 297 | positive regulation of cytosolic calcium ion concentration |
GO:0001708 | 0.0024 | 4.1233 | 1.8297 | 7 | 93 | cell fate specification |
GO:0055065 | 0.0024 | 2.0146 | 12.0606 | 23 | 613 | metal ion homeostasis |
GO:0090132 | 0.0026 | 2.4083 | 6.5714 | 15 | 334 | epithelium migration |
GO:0044057 | 0.0026 | 2.0703 | 10.7031 | 21 | 544 | regulation of system process |
GO:0030856 | 0.0027 | 3.29 | 2.9119 | 9 | 148 | regulation of epithelial cell differentiation |
GO:0061037 | 0.0027 | 7.7492 | 0.5902 | 4 | 30 | negative regulation of cartilage development |
GO:0034766 | 0.0027 | 4.0291 | 1.8691 | 7 | 95 | negative regulation of ion transmembrane transport |
GO:0019730 | 0.0029 | 3.9836 | 1.8888 | 7 | 96 | antimicrobial humoral response |
GO:0035270 | 0.0029 | 3.5505 | 2.4059 | 8 | 123 | endocrine system development |
GO:0021515 | 0.0029 | 5.6076 | 0.9837 | 5 | 50 | cell differentiation in spinal cord |
GO:2001258 | 0.0029 | 5.6076 | 0.9837 | 5 | 50 | negative regulation of cation channel activity |
GO:0050801 | 0.0031 | 1.9134 | 13.792 | 25 | 701 | ion homeostasis |
GO:0061005 | 0.0032 | 5.4854 | 1.0034 | 5 | 51 | cell differentiation involved in kidney development |
GO:0010959 | 0.0032 | 2.2843 | 7.378 | 16 | 375 | regulation of metal ion transport |
GO:0065007 | 0.0032 | 1.4307 | 223.5443 | 246 | 11362 | biological regulation |
GO:0050673 | 0.0033 | 2.2138 | 8.0863 | 17 | 411 | epithelial cell proliferation |
GO:0048646 | 0.0034 | 1.7298 | 20.8448 | 34 | 1072 | anatomical structure formation involved in morphogenesis |
GO:0009410 | 0.0034 | 2.2714 | 7.4174 | 16 | 377 | response to xenobiotic stimulus |
GO:0034330 | 0.0034 | 1.9561 | 12.3951 | 23 | 630 | cell junction organization |
GO:0007218 | 0.0034 | 3.853 | 1.9478 | 7 | 99 | neuropeptide signaling pathway |
GO:0002701 | 0.0034 | 7.1948 | 0.6296 | 4 | 32 | negative regulation of production of molecular mediator of immune response |
GO:0009954 | 0.0034 | 7.1948 | 0.6296 | 4 | 32 | proximal/distal pattern formation |
GO:0001764 | 0.0035 | 3.1527 | 3.0299 | 9 | 154 | neuron migration |
GO:0032095 | 0.0035 | 11.5969 | 0.3148 | 3 | 16 | regulation of response to food |
GO:0055119 | 0.0035 | 11.5969 | 0.3148 | 3 | 16 | relaxation of cardiac muscle |
GO:0002042 | 0.0036 | 5.3135 | 1.0319 | 5 | 53 | cell migration involved in sprouting angiogenesis |
GO:0061448 | 0.0037 | 2.6039 | 4.8597 | 12 | 247 | connective tissue development |
GO:0019800 | 0.0037 | 33.4185 | 0.0984 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0033591 | 0.0037 | 33.4185 | 0.0984 | 2 | 5 | response to L-ascorbic acid |
GO:0060978 | 0.0037 | 33.4185 | 0.0984 | 2 | 5 | angiogenesis involved in coronary vascular morphogenesis |
GO:0070779 | 0.0037 | 33.4185 | 0.0984 | 2 | 5 | D-aspartate import across plasma membrane |
GO:2000543 | 0.0037 | 33.4185 | 0.0984 | 2 | 5 | positive regulation of gastrulation |
GO:0007156 | 0.0038 | 3.1094 | 3.0693 | 9 | 156 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0072132 | 0.0038 | 5.2562 | 1.0428 | 5 | 53 | mesenchyme morphogenesis |
GO:0090050 | 0.0038 | 6.9463 | 0.6493 | 4 | 33 | positive regulation of cell migration involved in sprouting angiogenesis |
GO:0030334 | 0.004 | 1.7702 | 17.904 | 30 | 910 | regulation of cell migration |
GO:0030003 | 0.0041 | 1.955 | 11.8442 | 22 | 602 | cellular cation homeostasis |
GO:0006874 | 0.0043 | 2.1521 | 8.3027 | 17 | 422 | cellular calcium ion homeostasis |
GO:0007160 | 0.0046 | 2.6539 | 4.3678 | 11 | 222 | cell-matrix adhesion |
GO:0021543 | 0.0046 | 3.0062 | 3.1676 | 9 | 161 | pallium development |
GO:0030182 | 0.0047 | 1.7191 | 19.7029 | 32 | 1042 | neuron differentiation |
GO:0001938 | 0.0047 | 3.6157 | 2.0658 | 7 | 105 | positive regulation of endothelial cell proliferation |
GO:1901385 | 0.0048 | 6.4973 | 0.6886 | 4 | 35 | regulation of voltage-gated calcium channel activity |
GO:0008217 | 0.0048 | 2.9863 | 3.1873 | 9 | 162 | regulation of blood pressure |
GO:0045597 | 0.0049 | 1.7957 | 15.8382 | 27 | 805 | positive regulation of cell differentiation |
GO:0002643 | 0.0049 | 10.0494 | 0.3541 | 3 | 18 | regulation of tolerance induction |
GO:0043651 | 0.0049 | 10.0494 | 0.3541 | 3 | 18 | linoleic acid metabolic process |
GO:1904062 | 0.0051 | 2.3069 | 6.3746 | 14 | 324 | regulation of cation transmembrane transport |
GO:0044344 | 0.0052 | 3.543 | 2.1052 | 7 | 107 | cellular response to fibroblast growth factor stimulus |
GO:0010634 | 0.0052 | 2.9474 | 3.2267 | 9 | 164 | positive regulation of epithelial cell migration |
GO:0032102 | 0.0053 | 2.161 | 7.7715 | 16 | 395 | negative regulation of response to external stimulus |
GO:0006936 | 0.0054 | 2.2918 | 6.414 | 14 | 326 | muscle contraction |
GO:0009952 | 0.0054 | 3.1822 | 2.6639 | 8 | 137 | anterior/posterior pattern specification |
GO:0032680 | 0.0054 | 2.9283 | 3.2463 | 9 | 165 | regulation of tumor necrosis factor production |
GO:2000147 | 0.0054 | 1.9691 | 10.6637 | 20 | 542 | positive regulation of cell motility |
GO:0042940 | 0.0055 | 25.0623 | 0.118 | 2 | 6 | D-amino acid transport |
GO:0051458 | 0.0055 | 25.0623 | 0.118 | 2 | 6 | corticotropin secretion |
GO:0060017 | 0.0055 | 25.0623 | 0.118 | 2 | 6 | parathyroid gland development |
GO:0060290 | 0.0055 | 25.0623 | 0.118 | 2 | 6 | transdifferentiation |
GO:0072143 | 0.0055 | 25.0623 | 0.118 | 2 | 6 | mesangial cell development |
GO:1904044 | 0.0055 | 25.0623 | 0.118 | 2 | 6 | response to aldosterone |
GO:0007423 | 0.0056 | 1.9652 | 10.6834 | 20 | 543 | sensory organ development |
GO:0021953 | 0.0057 | 3.1448 | 2.6937 | 8 | 138 | central nervous system neuron differentiation |
GO:0032835 | 0.006 | 4.6704 | 1.1608 | 5 | 59 | glomerulus development |
GO:0045995 | 0.006 | 4.6704 | 1.1608 | 5 | 59 | regulation of embryonic development |
GO:0045785 | 0.0061 | 2.3381 | 5.8357 | 13 | 301 | positive regulation of cell adhesion |
GO:0014070 | 0.0061 | 1.7646 | 16.0969 | 27 | 823 | response to organic cyclic compound |
GO:0030900 | 0.0062 | 2.2524 | 6.5195 | 14 | 334 | forebrain development |
GO:0002764 | 0.0063 | 2.178 | 7.2206 | 15 | 367 | immune response-regulating signaling pathway |
GO:0032879 | 0.0063 | 1.5704 | 29.2246 | 43 | 1572 | regulation of localization |
GO:0071706 | 0.0063 | 2.8544 | 3.325 | 9 | 169 | tumor necrosis factor superfamily cytokine production |
GO:0042130 | 0.0064 | 4.5852 | 1.1805 | 5 | 60 | negative regulation of T cell proliferation |
GO:0032989 | 0.0067 | 1.8139 | 13.8904 | 24 | 706 | cellular component morphogenesis |
GO:0032098 | 0.0067 | 8.866 | 0.3935 | 3 | 20 | regulation of appetite |
GO:0042221 | 0.0069 | 1.5399 | 32.8708 | 47 | 1829 | response to chemical |
GO:1901700 | 0.007 | 1.5469 | 30.1614 | 44 | 1533 | response to oxygen-containing compound |
GO:0001667 | 0.0071 | 2.0384 | 8.7356 | 17 | 444 | ameboidal-type cell migration |
GO:0098739 | 0.0071 | 2.8014 | 3.3841 | 9 | 172 | import across plasma membrane |
GO:0097553 | 0.0071 | 3.0249 | 2.7938 | 8 | 142 | calcium ion transmembrane import into cytosol |
GO:0051050 | 0.0072 | 1.7392 | 16.3103 | 27 | 829 | positive regulation of transport |
GO:0051130 | 0.0072 | 1.6888 | 18.691 | 30 | 950 | positive regulation of cellular component organization |
GO:0008015 | 0.0073 | 2.2828 | 5.969 | 13 | 309 | blood circulation |
GO:0032755 | 0.0074 | 3.7418 | 1.7117 | 6 | 87 | positive regulation of interleukin-6 production |
GO:0050905 | 0.0074 | 3.0023 | 2.8135 | 8 | 143 | neuromuscular process |
GO:0098662 | 0.0074 | 1.7974 | 14.0084 | 24 | 712 | inorganic cation transmembrane transport |
GO:0015840 | 0.0076 | 20.0486 | 0.1377 | 2 | 7 | urea transport |
GO:0060215 | 0.0076 | 20.0486 | 0.1377 | 2 | 7 | primitive hemopoiesis |
GO:0003008 | 0.0077 | 1.563 | 27.8351 | 41 | 1463 | system process |
GO:0061042 | 0.0077 | 8.3729 | 0.4132 | 3 | 21 | vascular wound healing |
GO:0055082 | 0.0079 | 1.7657 | 14.8544 | 25 | 755 | cellular chemical homeostasis |
GO:0051896 | 0.0079 | 2.7502 | 3.4431 | 9 | 175 | regulation of protein kinase B signaling |
GO:0001756 | 0.0079 | 4.3472 | 1.2395 | 5 | 63 | somitogenesis |
GO:0060548 | 0.0084 | 1.6831 | 18.1007 | 29 | 920 | negative regulation of cell death |
GO:0006935 | 0.0085 | 1.8832 | 11.1162 | 20 | 565 | chemotaxis |
GO:0010811 | 0.0088 | 3.1897 | 2.3216 | 7 | 118 | positive regulation of cell-substrate adhesion |
GO:0099560 | 0.0088 | 7.9317 | 0.4328 | 3 | 22 | synaptic membrane adhesion |
GO:0051716 | 0.0088 | 1.3157 | 130.6599 | 152 | 6641 | cellular response to stimulus |
GO:0050670 | 0.0088 | 2.539 | 4.1317 | 10 | 210 | regulation of lymphocyte proliferation |
GO:0032412 | 0.0089 | 2.4105 | 4.781 | 11 | 243 | regulation of ion transmembrane transporter activity |
GO:0007166 | 0.0089 | 1.4229 | 48.9114 | 65 | 2486 | cell surface receptor signaling pathway |
GO:0030030 | 0.009 | 1.5429 | 28.0758 | 41 | 1427 | cell projection organization |
GO:0061180 | 0.009 | 4.2018 | 1.2789 | 5 | 65 | mammary gland epithelium development |
GO:0150116 | 0.009 | 4.2018 | 1.2789 | 5 | 65 | regulation of cell-substrate junction organization |
GO:0043269 | 0.0092 | 2.3993 | 4.8035 | 11 | 251 | regulation of ion transport |
GO:0043410 | 0.0095 | 1.9719 | 9.011 | 17 | 458 | positive regulation of MAPK cascade |
GO:0043066 | 0.0096 | 1.7141 | 15.8972 | 26 | 808 | negative regulation of apoptotic process |
GO:0010594 | 0.0097 | 2.501 | 4.1907 | 10 | 213 | regulation of endothelial cell migration |
GO:0032309 | 0.0099 | 5.162 | 0.846 | 4 | 43 | icosanoid secretion |
GO:0001759 | 0.01 | 7.5347 | 0.4525 | 3 | 23 | organ induction |
GO:0021895 | 0.01 | 7.5347 | 0.4525 | 3 | 23 | cerebral cortex neuron differentiation |
GO:0032703 | 0.01 | 7.5347 | 0.4525 | 3 | 23 | negative regulation of interleukin-2 production |
GO:0048520 | 0.01 | 7.5347 | 0.4525 | 3 | 23 | positive regulation of behavior |
GO:0010890 | 0.01 | 16.7061 | 0.1574 | 2 | 8 | positive regulation of sequestering of triglyceride |
GO:0021940 | 0.01 | 16.7061 | 0.1574 | 2 | 8 | positive regulation of cerebellar granule cell precursor proliferation |
GO:0045959 | 0.01 | 16.7061 | 0.1574 | 2 | 8 | negative regulation of complement activation, classical pathway |
GO:0048793 | 0.01 | 16.7061 | 0.1574 | 2 | 8 | pronephros development |
GO:0072177 | 0.01 | 16.7061 | 0.1574 | 2 | 8 | mesonephric duct development |
GO:0072239 | 0.01 | 16.7061 | 0.1574 | 2 | 8 | metanephric glomerulus vasculature development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022008 | 0 | 2.4502 | 23.5692 | 51 | 1203 | neurogenesis |
GO:0001655 | 0 | 3.6594 | 6.6333 | 22 | 331 | urogenital system development |
GO:0030182 | 0 | 2.3689 | 20.6712 | 44 | 1067 | neuron differentiation |
GO:0032501 | 0 | 1.878 | 71.1789 | 105 | 4189 | multicellular organismal process |
GO:0048731 | 0 | 2.0105 | 38.3509 | 66 | 2255 | system development |
GO:0048468 | 0 | 2.2104 | 22.0981 | 44 | 1170 | cell development |
GO:0035239 | 0 | 2.5007 | 14.4376 | 33 | 732 | tube morphogenesis |
GO:0032095 | 0 | 22.5547 | 0.3206 | 5 | 16 | regulation of response to food |
GO:0048598 | 0 | 2.6651 | 11.4366 | 28 | 574 | embryonic morphogenesis |
GO:0001568 | 0 | 2.5924 | 12.1804 | 29 | 617 | blood vessel development |
GO:0045165 | 0 | 3.6133 | 5.1303 | 17 | 256 | cell fate commitment |
GO:0007389 | 0 | 2.8177 | 8.8377 | 23 | 441 | pattern specification process |
GO:0060429 | 0 | 2.1088 | 21.7637 | 42 | 1086 | epithelium development |
GO:0048568 | 1e-04 | 2.754 | 8.6173 | 22 | 430 | embryonic organ development |
GO:0099560 | 1e-04 | 14.5888 | 0.4409 | 5 | 22 | synaptic membrane adhesion |
GO:0048880 | 1e-04 | 2.8935 | 7.455 | 20 | 372 | sensory system development |
GO:0030198 | 1e-04 | 3.1921 | 5.7515 | 17 | 287 | extracellular matrix organization |
GO:0009792 | 1e-04 | 2.393 | 12.6253 | 28 | 630 | embryo development ending in birth or egg hatching |
GO:0060978 | 1e-04 | 74.0153 | 0.1002 | 3 | 5 | angiogenesis involved in coronary vascular morphogenesis |
GO:0021953 | 1e-04 | 4.0495 | 3.2265 | 12 | 161 | central nervous system neuron differentiation |
GO:0032104 | 1e-04 | 12.3981 | 0.501 | 5 | 25 | regulation of response to extracellular stimulus |
GO:0001654 | 1e-04 | 2.8135 | 7.2546 | 19 | 362 | eye development |
GO:0051272 | 1e-04 | 2.4188 | 11.1023 | 25 | 554 | positive regulation of cellular component movement |
GO:0060017 | 2e-04 | 49.3405 | 0.1202 | 3 | 6 | parathyroid gland development |
GO:0045597 | 2e-04 | 2.1347 | 16.1324 | 32 | 805 | positive regulation of cell differentiation |
GO:2000145 | 2e-04 | 2.0095 | 19.2987 | 36 | 963 | regulation of cell motility |
GO:0034103 | 2e-04 | 5.3933 | 1.6433 | 8 | 82 | regulation of tissue remodeling |
GO:0001525 | 2e-04 | 3.2529 | 4.6272 | 14 | 238 | angiogenesis |
GO:0048870 | 3e-04 | 2.28 | 12.2668 | 26 | 647 | cell motility |
GO:0048146 | 3e-04 | 7.4526 | 0.9218 | 6 | 46 | positive regulation of fibroblast proliferation |
GO:0048665 | 3e-04 | 9.9154 | 0.6012 | 5 | 30 | neuron fate specification |
GO:0061037 | 3e-04 | 9.9154 | 0.6012 | 5 | 30 | negative regulation of cartilage development |
GO:0007156 | 3e-04 | 3.8034 | 3.1263 | 11 | 156 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:2000026 | 3e-04 | 1.9359 | 21.1724 | 38 | 1083 | regulation of multicellular organismal development |
GO:0032879 | 3e-04 | 1.6105 | 52.2047 | 76 | 2605 | regulation of localization |
GO:0048704 | 3e-04 | 7.1909 | 0.9499 | 6 | 48 | embryonic skeletal system morphogenesis |
GO:0040017 | 4e-04 | 2.3009 | 11.1424 | 24 | 556 | positive regulation of locomotion |
GO:0032723 | 4e-04 | Inf | 0.0401 | 2 | 2 | positive regulation of connective tissue growth factor production |
GO:0032827 | 4e-04 | Inf | 0.0401 | 2 | 2 | negative regulation of natural killer cell differentiation involved in immune response |
GO:0048252 | 4e-04 | Inf | 0.0401 | 2 | 2 | lauric acid metabolic process |
GO:0009954 | 4e-04 | 9.1798 | 0.6413 | 5 | 32 | proximal/distal pattern formation |
GO:0001501 | 4e-04 | 2.8242 | 6.0543 | 16 | 312 | skeletal system development |
GO:0072239 | 4e-04 | 29.6006 | 0.1603 | 3 | 8 | metanephric glomerulus vasculature development |
GO:0007507 | 4e-04 | 2.27 | 11.2826 | 24 | 563 | heart development |
GO:2000179 | 5e-04 | 6.7734 | 1.002 | 6 | 50 | positive regulation of neural precursor cell proliferation |
GO:0046620 | 5e-04 | 4.8058 | 1.8237 | 8 | 91 | regulation of organ growth |
GO:0055003 | 5e-04 | 13.1881 | 0.3808 | 4 | 19 | cardiac myofibril assembly |
GO:0072359 | 5e-04 | 2.2978 | 10.6964 | 23 | 556 | circulatory system development |
GO:0008343 | 6e-04 | 24.6656 | 0.1804 | 3 | 9 | adult feeding behavior |
GO:0010613 | 6e-04 | 8.2603 | 0.7014 | 5 | 35 | positive regulation of cardiac muscle hypertrophy |
GO:0003013 | 7e-04 | 2.2325 | 10.962 | 23 | 547 | circulatory system process |
GO:0030335 | 8e-04 | 2.2434 | 10.4209 | 22 | 520 | positive regulation of cell migration |
GO:1905205 | 9e-04 | 21.1407 | 0.2004 | 3 | 10 | positive regulation of connective tissue replacement |
GO:0048729 | 9e-04 | 2.154 | 11.8438 | 24 | 591 | tissue morphogenesis |
GO:0048534 | 9e-04 | 1.952 | 16.934 | 31 | 845 | hematopoietic or lymphoid organ development |
GO:0120039 | 9e-04 | 2.1462 | 11.8838 | 24 | 593 | plasma membrane bounded cell projection morphogenesis |
GO:0030900 | 9e-04 | 2.5237 | 7.1544 | 17 | 357 | forebrain development |
GO:0001503 | 9e-04 | 2.4452 | 7.8157 | 18 | 390 | ossification |
GO:0006811 | 9e-04 | 1.821 | 22.3725 | 38 | 1141 | ion transport |
GO:0014068 | 0.001 | 4.9042 | 1.5631 | 7 | 78 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0060322 | 0.001 | 2.0089 | 14.8297 | 28 | 740 | head development |
GO:0072210 | 0.001 | 7.2867 | 0.7816 | 5 | 39 | metanephric nephron development |
GO:0030001 | 0.001 | 1.9507 | 16.3728 | 30 | 817 | metal ion transport |
GO:0048869 | 0.0011 | 1.7152 | 30.765 | 48 | 1793 | cellular developmental process |
GO:0051240 | 0.0011 | 1.7388 | 26.5323 | 43 | 1335 | positive regulation of multicellular organismal process |
GO:0032835 | 0.0011 | 5.6201 | 1.1824 | 6 | 59 | glomerulus development |
GO:0009653 | 0.0011 | 1.9726 | 15.7939 | 29 | 896 | anatomical structure morphogenesis |
GO:0032099 | 0.0012 | 18.4969 | 0.2204 | 3 | 11 | negative regulation of appetite |
GO:0032108 | 0.0012 | 18.4969 | 0.2204 | 3 | 11 | negative regulation of response to nutrient levels |
GO:0007412 | 0.0012 | 98.3914 | 0.0601 | 2 | 3 | axon target recognition |
GO:0038091 | 0.0012 | 98.3914 | 0.0601 | 2 | 3 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
GO:0060480 | 0.0012 | 98.3914 | 0.0601 | 2 | 3 | lung goblet cell differentiation |
GO:0072275 | 0.0012 | 98.3914 | 0.0601 | 2 | 3 | metanephric glomerulus morphogenesis |
GO:0072277 | 0.0012 | 98.3914 | 0.0601 | 2 | 3 | metanephric glomerular capillary formation |
GO:0097377 | 0.0012 | 98.3914 | 0.0601 | 2 | 3 | spinal cord interneuron axon guidance |
GO:1902869 | 0.0012 | 98.3914 | 0.0601 | 2 | 3 | regulation of amacrine cell differentiation |
GO:2000679 | 0.0012 | 9.888 | 0.481 | 4 | 24 | positive regulation of transcription regulatory region DNA binding |
GO:0043583 | 0.0013 | 2.977 | 4.2886 | 12 | 214 | ear development |
GO:0001822 | 0.0013 | 2.9733 | 4.2931 | 12 | 218 | kidney development |
GO:0010975 | 0.0013 | 2.3607 | 8.0762 | 18 | 403 | regulation of neuron projection development |
GO:0007600 | 0.0013 | 1.9389 | 15.8919 | 29 | 793 | sensory perception |
GO:0031175 | 0.0014 | 2.2423 | 9.4578 | 20 | 487 | neuron projection development |
GO:0016339 | 0.0015 | 6.6946 | 0.8417 | 5 | 42 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0032990 | 0.0015 | 2.067 | 12.3047 | 24 | 614 | cell part morphogenesis |
GO:0045860 | 0.0015 | 2.3941 | 7.5151 | 17 | 375 | positive regulation of protein kinase activity |
GO:0009952 | 0.0016 | 3.5611 | 2.7058 | 9 | 137 | anterior/posterior pattern specification |
GO:0001756 | 0.0016 | 5.2244 | 1.2625 | 6 | 63 | somitogenesis |
GO:0048701 | 0.0018 | 6.3505 | 0.8818 | 5 | 44 | embryonic cranial skeleton morphogenesis |
GO:0000904 | 0.0019 | 1.9947 | 13.2666 | 25 | 662 | cell morphogenesis involved in differentiation |
GO:0061440 | 0.0019 | 8.5967 | 0.5411 | 4 | 27 | kidney vasculature development |
GO:0048935 | 0.002 | 14.7957 | 0.2605 | 3 | 13 | peripheral nervous system neuron development |
GO:0046717 | 0.002 | 6.1914 | 0.9018 | 5 | 45 | acid secretion |
GO:0098609 | 0.002 | 1.861 | 17.0943 | 30 | 853 | cell-cell adhesion |
GO:0030316 | 0.0021 | 4.2434 | 1.7836 | 7 | 89 | osteoclast differentiation |
GO:0048661 | 0.0021 | 4.2434 | 1.7836 | 7 | 89 | positive regulation of smooth muscle cell proliferation |
GO:0045944 | 0.0021 | 1.7418 | 22.6053 | 37 | 1128 | positive regulation of transcription by RNA polymerase II |
GO:0010562 | 0.0021 | 1.8744 | 16.3929 | 29 | 818 | positive regulation of phosphorus metabolic process |
GO:0002269 | 0.0022 | 6.04 | 0.9218 | 5 | 46 | leukocyte activation involved in inflammatory response |
GO:0050727 | 0.0023 | 2.3677 | 7.1343 | 16 | 356 | regulation of inflammatory response |
GO:0070093 | 0.0023 | 49.1927 | 0.0802 | 2 | 4 | negative regulation of glucagon secretion |
GO:0072268 | 0.0023 | 49.1927 | 0.0802 | 2 | 4 | pattern specification involved in metanephros development |
GO:0072278 | 0.0023 | 49.1927 | 0.0802 | 2 | 4 | metanephric comma-shaped body morphogenesis |
GO:0097476 | 0.0023 | 49.1927 | 0.0802 | 2 | 4 | spinal cord motor neuron migration |
GO:2000491 | 0.0023 | 49.1927 | 0.0802 | 2 | 4 | positive regulation of hepatic stellate cell activation |
GO:2000697 | 0.0023 | 49.1927 | 0.0802 | 2 | 4 | negative regulation of epithelial cell differentiation involved in kidney development |
GO:0042327 | 0.0024 | 1.9055 | 14.9901 | 27 | 748 | positive regulation of phosphorylation |
GO:0033993 | 0.0024 | 1.8595 | 16.5131 | 29 | 824 | response to lipid |
GO:0035924 | 0.0024 | 4.8016 | 1.3627 | 6 | 68 | cellular response to vascular endothelial growth factor stimulus |
GO:0045123 | 0.0024 | 4.8016 | 1.3627 | 6 | 68 | cellular extravasation |
GO:0014744 | 0.0025 | 13.4498 | 0.2806 | 3 | 14 | positive regulation of muscle adaptation |
GO:0006026 | 0.0025 | 7.9079 | 0.5812 | 4 | 29 | aminoglycan catabolic process |
GO:0034330 | 0.0025 | 2.0057 | 12.1087 | 23 | 609 | cell junction organization |
GO:0009887 | 0.0026 | 1.8715 | 15.8451 | 28 | 812 | animal organ morphogenesis |
GO:0014743 | 0.0026 | 4.725 | 1.3828 | 6 | 69 | regulation of muscle hypertrophy |
GO:0007610 | 0.0026 | 2.0321 | 11.4229 | 22 | 570 | behavior |
GO:0034332 | 0.0027 | 5.7583 | 0.9619 | 5 | 48 | adherens junction organization |
GO:0070374 | 0.0027 | 2.8639 | 4.0682 | 11 | 203 | positive regulation of ERK1 and ERK2 cascade |
GO:0045665 | 0.0028 | 4.6509 | 1.4028 | 6 | 70 | negative regulation of neuron differentiation |
GO:0061333 | 0.0028 | 4.6509 | 1.4028 | 6 | 70 | renal tubule morphogenesis |
GO:0007276 | 0.0028 | 1.9599 | 12.9259 | 24 | 645 | gamete generation |
GO:0014897 | 0.0028 | 3.9983 | 1.8838 | 7 | 94 | striated muscle hypertrophy |
GO:0030856 | 0.003 | 3.2271 | 2.9659 | 9 | 148 | regulation of epithelial cell differentiation |
GO:0006875 | 0.0031 | 2.0372 | 10.8618 | 21 | 542 | cellular metal ion homeostasis |
GO:0061900 | 0.0032 | 5.5017 | 1.002 | 5 | 50 | glial cell activation |
GO:0072348 | 0.0032 | 5.5017 | 1.002 | 5 | 50 | sulfur compound transport |
GO:0072028 | 0.0032 | 4.5094 | 1.4429 | 6 | 72 | nephron morphogenesis |
GO:0002521 | 0.0033 | 2.0647 | 10.2005 | 20 | 509 | leukocyte differentiation |
GO:0042476 | 0.0034 | 3.4616 | 2.4649 | 8 | 123 | odontogenesis |
GO:0061005 | 0.0035 | 5.3818 | 1.0221 | 5 | 51 | cell differentiation involved in kidney development |
GO:0050670 | 0.0035 | 2.7619 | 4.2084 | 11 | 210 | regulation of lymphocyte proliferation |
GO:0042127 | 0.0036 | 1.6419 | 26.5851 | 41 | 1353 | regulation of cell population proliferation |
GO:0051216 | 0.0036 | 3.1366 | 3.0449 | 9 | 154 | cartilage development |
GO:0008344 | 0.0037 | 4.3763 | 1.483 | 6 | 74 | adult locomotory behavior |
GO:2000352 | 0.0037 | 7.0593 | 0.6413 | 4 | 32 | negative regulation of endothelial cell apoptotic process |
GO:0060749 | 0.0037 | 11.3792 | 0.3206 | 3 | 16 | mammary gland alveolus development |
GO:0019800 | 0.0038 | 32.7931 | 0.1002 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0021855 | 0.0038 | 32.7931 | 0.1002 | 2 | 5 | hypothalamus cell migration |
GO:0033591 | 0.0038 | 32.7931 | 0.1002 | 2 | 5 | response to L-ascorbic acid |
GO:0060059 | 0.0038 | 32.7931 | 0.1002 | 2 | 5 | embryonic retina morphogenesis in camera-type eye |
GO:0060298 | 0.0038 | 32.7931 | 0.1002 | 2 | 5 | positive regulation of sarcomere organization |
GO:0060482 | 0.0038 | 32.7931 | 0.1002 | 2 | 5 | lobar bronchus development |
GO:0070779 | 0.0038 | 32.7931 | 0.1002 | 2 | 5 | D-aspartate import across plasma membrane |
GO:0072081 | 0.0038 | 32.7931 | 0.1002 | 2 | 5 | specification of nephron tubule identity |
GO:0072103 | 0.0038 | 32.7931 | 0.1002 | 2 | 5 | glomerulus vasculature morphogenesis |
GO:2000543 | 0.0038 | 32.7931 | 0.1002 | 2 | 5 | positive regulation of gastrulation |
GO:0060041 | 0.0039 | 3.3728 | 2.5247 | 8 | 127 | retina development in camera-type eye |
GO:0006029 | 0.0039 | 4.3126 | 1.503 | 6 | 75 | proteoglycan metabolic process |
GO:0001764 | 0.0039 | 3.0924 | 3.0862 | 9 | 154 | neuron migration |
GO:0023052 | 0.004 | 1.3612 | 115.4917 | 139 | 5763 | signaling |
GO:0072009 | 0.004 | 3.7389 | 2.004 | 7 | 100 | nephron epithelium development |
GO:0021510 | 0.004 | 4.286 | 1.511 | 6 | 76 | spinal cord development |
GO:0030879 | 0.0041 | 3.3444 | 2.5451 | 8 | 127 | mammary gland development |
GO:1903978 | 0.0044 | 10.5657 | 0.3407 | 3 | 17 | regulation of microglial cell activation |
GO:0031346 | 0.0044 | 2.3469 | 6.2726 | 14 | 313 | positive regulation of cell projection organization |
GO:0022414 | 0.0045 | 1.6167 | 26.914 | 41 | 1343 | reproductive process |
GO:0001763 | 0.0045 | 2.818 | 3.7475 | 10 | 187 | morphogenesis of a branching structure |
GO:0002064 | 0.0045 | 2.818 | 3.7475 | 10 | 187 | epithelial cell development |
GO:0043410 | 0.0046 | 2.5261 | 5.0012 | 12 | 255 | positive regulation of MAPK cascade |
GO:0045765 | 0.0047 | 2.331 | 6.3127 | 14 | 315 | regulation of angiogenesis |
GO:0043270 | 0.0047 | 2.521 | 5.0101 | 12 | 250 | positive regulation of ion transport |
GO:0048708 | 0.0047 | 4.1321 | 1.5631 | 6 | 78 | astrocyte differentiation |
GO:0043069 | 0.0049 | 1.7753 | 16.6133 | 28 | 829 | negative regulation of programmed cell death |
GO:0048589 | 0.005 | 1.9195 | 12.0442 | 22 | 601 | developmental growth |
GO:0007517 | 0.0051 | 2.3076 | 6.3728 | 14 | 318 | muscle organ development |
GO:0002526 | 0.0052 | 3.547 | 2.1042 | 7 | 105 | acute inflammatory response |
GO:0002523 | 0.0052 | 9.8607 | 0.3607 | 3 | 18 | leukocyte migration involved in inflammatory response |
GO:0019373 | 0.0052 | 9.8607 | 0.3607 | 3 | 18 | epoxygenase P450 pathway |
GO:0043651 | 0.0052 | 9.8607 | 0.3607 | 3 | 18 | linoleic acid metabolic process |
GO:0060644 | 0.0052 | 9.8607 | 0.3607 | 3 | 18 | mammary gland epithelial cell differentiation |
GO:0061298 | 0.0052 | 9.8607 | 0.3607 | 3 | 18 | retina vasculature development in camera-type eye |
GO:0021543 | 0.0052 | 2.9487 | 3.2265 | 9 | 161 | pallium development |
GO:0008217 | 0.0054 | 2.9292 | 3.2465 | 9 | 162 | regulation of blood pressure |
GO:0060840 | 0.0055 | 3.511 | 2.1243 | 7 | 106 | artery development |
GO:0007283 | 0.0056 | 2.0016 | 9.96 | 19 | 497 | spermatogenesis |
GO:0051281 | 0.0056 | 6.1754 | 0.7214 | 4 | 36 | positive regulation of release of sequestered calcium ion into cytosol |
GO:0070306 | 0.0056 | 6.1754 | 0.7214 | 4 | 36 | lens fiber cell differentiation |
GO:0003278 | 0.0057 | 24.5933 | 0.1202 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0009253 | 0.0057 | 24.5933 | 0.1202 | 2 | 6 | peptidoglycan catabolic process |
GO:0042940 | 0.0057 | 24.5933 | 0.1202 | 2 | 6 | D-amino acid transport |
GO:0055009 | 0.0057 | 24.5933 | 0.1202 | 2 | 6 | atrial cardiac muscle tissue morphogenesis |
GO:0072143 | 0.0057 | 24.5933 | 0.1202 | 2 | 6 | mesangial cell development |
GO:0072284 | 0.0057 | 24.5933 | 0.1202 | 2 | 6 | metanephric S-shaped body morphogenesis |
GO:0007409 | 0.0059 | 2.1323 | 7.8692 | 16 | 395 | axonogenesis |
GO:0016082 | 0.0061 | 9.2439 | 0.3808 | 3 | 19 | synaptic vesicle priming |
GO:0043524 | 0.0061 | 3.1075 | 2.7255 | 8 | 136 | negative regulation of neuron apoptotic process |
GO:0098771 | 0.0061 | 1.8278 | 13.7877 | 24 | 688 | inorganic ion homeostasis |
GO:0060421 | 0.0062 | 5.9879 | 0.7415 | 4 | 37 | positive regulation of heart growth |
GO:0006952 | 0.0062 | 1.5574 | 29.9601 | 44 | 1495 | defense response |
GO:0007043 | 0.0064 | 3.0832 | 2.7455 | 8 | 137 | cell-cell junction assembly |
GO:0045995 | 0.0065 | 4.5822 | 1.1824 | 5 | 59 | regulation of embryonic development |
GO:0070482 | 0.0066 | 2.3142 | 5.8918 | 13 | 294 | response to oxygen levels |
GO:0006873 | 0.0066 | 1.8692 | 12.3448 | 22 | 616 | cellular ion homeostasis |
GO:0042221 | 0.0066 | 1.3696 | 79.0786 | 99 | 3946 | response to chemical |
GO:0030030 | 0.0066 | 1.6479 | 21.7902 | 34 | 1114 | cell projection organization |
GO:0015711 | 0.0066 | 2.2327 | 6.5732 | 14 | 328 | organic anion transport |
GO:0030901 | 0.0068 | 3.8128 | 1.6834 | 6 | 84 | midbrain development |
GO:0044057 | 0.0069 | 1.9225 | 10.9019 | 20 | 544 | regulation of system process |
GO:0021516 | 0.0071 | 8.6996 | 0.4008 | 3 | 20 | dorsal spinal cord development |
GO:0040008 | 0.0071 | 1.8562 | 12.4249 | 22 | 620 | regulation of growth |
GO:0034765 | 0.0072 | 2.0326 | 8.7576 | 17 | 437 | regulation of ion transmembrane transport |
GO:1905330 | 0.0075 | 4.418 | 1.2225 | 5 | 61 | regulation of morphogenesis of an epithelium |
GO:0070663 | 0.0075 | 2.4722 | 4.6694 | 11 | 233 | regulation of leukocyte proliferation |
GO:0002694 | 0.0076 | 1.9388 | 10.2606 | 19 | 512 | regulation of leukocyte activation |
GO:0002042 | 0.0076 | 3.717 | 1.7235 | 6 | 86 | cell migration involved in sprouting angiogenesis |
GO:0030324 | 0.0077 | 2.7649 | 3.4269 | 9 | 171 | lung development |
GO:1990266 | 0.0077 | 3.2777 | 2.2645 | 7 | 113 | neutrophil migration |
GO:0006959 | 0.0077 | 2.5954 | 4.0481 | 10 | 202 | humoral immune response |
GO:0015840 | 0.0079 | 19.6734 | 0.1403 | 2 | 7 | urea transport |
GO:0060215 | 0.0079 | 19.6734 | 0.1403 | 2 | 7 | primitive hemopoiesis |
GO:0061438 | 0.0079 | 19.6734 | 0.1403 | 2 | 7 | renal system vasculature morphogenesis |
GO:0048754 | 0.0079 | 2.9672 | 2.8457 | 8 | 142 | branching morphogenesis of an epithelial tube |
GO:0048863 | 0.008 | 2.5817 | 4.0682 | 10 | 203 | stem cell differentiation |
GO:1902414 | 0.008 | 3.6709 | 1.7435 | 6 | 87 | protein localization to cell junction |
GO:0030326 | 0.0081 | 3.2469 | 2.2846 | 7 | 114 | embryonic limb morphogenesis |
GO:0051897 | 0.0081 | 3.2469 | 2.2846 | 7 | 114 | positive regulation of protein kinase B signaling |
GO:0150146 | 0.0081 | 8.2157 | 0.4208 | 3 | 21 | cell junction disassembly |
GO:0032924 | 0.0082 | 5.4879 | 0.8016 | 4 | 40 | activin receptor signaling pathway |
GO:0050905 | 0.0082 | 2.9451 | 2.8657 | 8 | 143 | neuromuscular process |
GO:0051093 | 0.0083 | 1.7186 | 16.4897 | 27 | 834 | negative regulation of developmental process |
GO:0010941 | 0.0085 | 1.5329 | 29.6595 | 43 | 1480 | regulation of cell death |
GO:0048645 | 0.0085 | 4.2651 | 1.2625 | 5 | 63 | animal organ formation |
GO:0050767 | 0.0087 | 2.1556 | 6.7936 | 14 | 339 | regulation of neurogenesis |
GO:0032504 | 0.0089 | 1.7259 | 15.7917 | 26 | 788 | multicellular organism reproduction |
GO:0001504 | 0.0089 | 5.3392 | 0.8216 | 4 | 41 | neurotransmitter uptake |
GO:0010828 | 0.0089 | 5.3392 | 0.8216 | 4 | 41 | positive regulation of glucose transmembrane transport |
GO:0031589 | 0.0091 | 2.1422 | 6.8337 | 14 | 341 | cell-substrate adhesion |
GO:0034762 | 0.0093 | 3.5527 | 1.7962 | 6 | 92 | regulation of transmembrane transport |
GO:0086013 | 0.0093 | 7.7829 | 0.4409 | 3 | 22 | membrane repolarization during cardiac muscle cell action potential |
GO:0071805 | 0.0097 | 2.503 | 4.1884 | 10 | 209 | potassium ion transmembrane transport |
GO:0071300 | 0.0097 | 4.1224 | 1.3026 | 5 | 65 | cellular response to retinoic acid |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050878 | 5e-04 | 2.7837 | 6.1368 | 16 | 356 | regulation of body fluid levels |
GO:0043951 | 8e-04 | 21.5973 | 0.1896 | 3 | 11 | negative regulation of cAMP-mediated signaling |
GO:0021615 | 9e-04 | 114.8256 | 0.0517 | 2 | 3 | glossopharyngeal nerve morphogenesis |
GO:0035239 | 0.0012 | 1.9843 | 15.0662 | 28 | 874 | tube morphogenesis |
GO:0001944 | 0.0015 | 2.0389 | 13.0493 | 25 | 757 | vasculature development |
GO:0030879 | 0.0016 | 3.915 | 2.1893 | 8 | 127 | mammary gland development |
GO:0031508 | 0.0017 | 57.4093 | 0.069 | 2 | 4 | pericentric heterochromatin assembly |
GO:0036414 | 0.0017 | 57.4093 | 0.069 | 2 | 4 | histone citrullination |
GO:0042427 | 0.0017 | 57.4093 | 0.069 | 2 | 4 | serotonin biosynthetic process |
GO:1902340 | 0.0017 | 57.4093 | 0.069 | 2 | 4 | negative regulation of chromosome condensation |
GO:0007389 | 0.0017 | 2.368 | 7.6021 | 17 | 441 | pattern specification process |
GO:0009952 | 0.0025 | 3.0738 | 3.4476 | 10 | 200 | anterior/posterior pattern specification |
GO:0019935 | 0.0026 | 4.7009 | 1.3791 | 6 | 80 | cyclic-nucleotide-mediated signaling |
GO:0016199 | 0.0029 | 38.2705 | 0.0862 | 2 | 5 | axon midline choice point recognition |
GO:1902262 | 0.0029 | 38.2705 | 0.0862 | 2 | 5 | apoptotic process involved in blood vessel morphogenesis |
GO:0070166 | 0.0034 | 11.5136 | 0.3103 | 3 | 18 | enamel mineralization |
GO:0001525 | 0.0037 | 2.0903 | 9.5845 | 19 | 556 | angiogenesis |
GO:0007292 | 0.004 | 3.3475 | 2.534 | 8 | 147 | female gamete generation |
GO:0070233 | 0.004 | 10.7933 | 0.3275 | 3 | 19 | negative regulation of T cell apoptotic process |
GO:0008283 | 0.0042 | 1.582 | 31.908 | 47 | 1851 | cell population proliferation |
GO:0033634 | 0.0042 | 28.7011 | 0.1034 | 2 | 6 | positive regulation of cell-cell adhesion mediated by integrin |
GO:0070100 | 0.0042 | 28.7011 | 0.1034 | 2 | 6 | negative regulation of chemokine-mediated signaling pathway |
GO:0090230 | 0.0042 | 28.7011 | 0.1034 | 2 | 6 | regulation of centromere complex assembly |
GO:0051057 | 0.0046 | 4.9851 | 1.086 | 5 | 63 | positive regulation of small GTPase mediated signal transduction |
GO:0060444 | 0.0046 | 10.1578 | 0.3448 | 3 | 20 | branching involved in mammary gland duct morphogenesis |
GO:0031509 | 0.0059 | 22.9594 | 0.1207 | 2 | 7 | subtelomeric heterochromatin assembly |
GO:1902732 | 0.0059 | 22.9594 | 0.1207 | 2 | 7 | positive regulation of chondrocyte proliferation |
GO:0006833 | 0.0061 | 9.0874 | 0.3792 | 3 | 22 | water transport |
GO:0042430 | 0.007 | 8.6325 | 0.3965 | 3 | 23 | indole-containing compound metabolic process |
GO:0001955 | 0.0077 | 19.1317 | 0.1379 | 2 | 8 | blood vessel maturation |
GO:0015889 | 0.0077 | 19.1317 | 0.1379 | 2 | 8 | cobalamin transport |
GO:0038026 | 0.0077 | 19.1317 | 0.1379 | 2 | 8 | reelin-mediated signaling pathway |
GO:0048664 | 0.0077 | 19.1317 | 0.1379 | 2 | 8 | neuron fate determination |
GO:0097250 | 0.0077 | 19.1317 | 0.1379 | 2 | 8 | mitochondrial respirasome assembly |
GO:0021537 | 0.0078 | 2.59 | 4.051 | 10 | 235 | telencephalon development |
GO:0060324 | 0.008 | 5.4931 | 0.793 | 4 | 46 | face development |
GO:0043114 | 0.0086 | 5.365 | 0.8102 | 4 | 47 | regulation of vascular permeability |
GO:0099072 | 0.0086 | 5.365 | 0.8102 | 4 | 47 | regulation of postsynaptic membrane neurotransmitter receptor levels |
GO:2000107 | 0.0086 | 5.365 | 0.8102 | 4 | 47 | negative regulation of leukocyte apoptotic process |
GO:0050728 | 0.0088 | 2.9044 | 2.896 | 8 | 168 | negative regulation of inflammatory response |
GO:1904385 | 0.0088 | 7.8468 | 0.431 | 3 | 25 | cellular response to angiotensin |
GO:0007263 | 0.0098 | 7.5051 | 0.4482 | 3 | 26 | nitric oxide mediated signal transduction |
GO:0002676 | 0.0098 | 16.3976 | 0.1551 | 2 | 9 | regulation of chronic inflammatory response |
GO:0010533 | 0.0098 | 16.3976 | 0.1551 | 2 | 9 | regulation of activation of Janus kinase activity |
GO:0071313 | 0.0098 | 16.3976 | 0.1551 | 2 | 9 | cellular response to caffeine |
GO:0071492 | 0.0098 | 16.3976 | 0.1551 | 2 | 9 | cellular response to UV-A |
GO:2001223 | 0.0098 | 16.3976 | 0.1551 | 2 | 9 | negative regulation of neuron migration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 196.4878 | 0.33 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 46.1951 | 0.5684 | 14 | 31 | DNA replication-dependent chromatin assembly |
GO:0006336 | 0 | 46.1951 | 0.5684 | 14 | 31 | DNA replication-independent chromatin assembly |
GO:0006334 | 0 | 9.3392 | 1.9251 | 15 | 105 | nucleosome assembly |
GO:0006352 | 0 | 7.2304 | 2.2368 | 14 | 122 | DNA-templated transcription, initiation |
GO:0032200 | 0 | 6.0725 | 2.8052 | 15 | 153 | telomere organization |
GO:0071824 | 0 | 4.6076 | 3.8503 | 16 | 210 | protein-DNA complex subunit organization |
GO:0045637 | 0 | 4.6696 | 3.5569 | 15 | 194 | regulation of myeloid cell differentiation |
GO:0006338 | 0 | 4.0564 | 4.327 | 16 | 236 | chromatin remodeling |
GO:1904628 | 2e-04 | 40.5503 | 0.1283 | 3 | 7 | cellular response to phorbol 13-acetate 12-myristate |
GO:0070488 | 3e-04 | Inf | 0.0367 | 2 | 2 | neutrophil aggregation |
GO:2000026 | 4e-04 | 1.8852 | 23.56 | 41 | 1285 | regulation of multicellular organismal development |
GO:0045596 | 7e-04 | 2.1949 | 11.6608 | 24 | 636 | negative regulation of cell differentiation |
GO:2001214 | 9e-04 | 20.2701 | 0.2017 | 3 | 11 | positive regulation of vasculogenesis |
GO:0150128 | 0.001 | 107.7926 | 0.055 | 2 | 3 | negative regulation of interleukin-33 production |
GO:0050832 | 0.0011 | 7.147 | 0.7884 | 5 | 43 | defense response to fungus |
GO:0031053 | 0.0012 | 18.0168 | 0.22 | 3 | 12 | primary miRNA processing |
GO:0007183 | 0.0015 | 16.2141 | 0.2384 | 3 | 13 | SMAD protein complex assembly |
GO:0038098 | 0.002 | 53.893 | 0.0733 | 2 | 4 | sequestering of BMP from receptor via BMP binding |
GO:1903233 | 0.002 | 53.893 | 0.0733 | 2 | 4 | regulation of calcium ion-dependent exocytosis of neurotransmitter |
GO:2000741 | 0.002 | 53.893 | 0.0733 | 2 | 4 | positive regulation of mesenchymal stem cell differentiation |
GO:0002682 | 0.0026 | 1.7219 | 22.9183 | 37 | 1250 | regulation of immune system process |
GO:0035582 | 0.0032 | 35.9264 | 0.0917 | 2 | 5 | sequestering of BMP in extracellular matrix |
GO:0055059 | 0.0032 | 35.9264 | 0.0917 | 2 | 5 | asymmetric neuroblast division |
GO:0071655 | 0.0032 | 35.9264 | 0.0917 | 2 | 5 | regulation of granulocyte colony-stimulating factor production |
GO:2001244 | 0.0036 | 5.3209 | 1.0267 | 5 | 56 | positive regulation of intrinsic apoptotic signaling pathway |
GO:0090132 | 0.0036 | 2.4079 | 6.1238 | 14 | 334 | epithelium migration |
GO:0030097 | 0.0038 | 1.8589 | 14.7777 | 26 | 806 | hemopoiesis |
GO:0048870 | 0.0047 | 1.5907 | 29.5188 | 44 | 1610 | cell motility |
GO:0050731 | 0.0052 | 2.9436 | 3.2269 | 9 | 176 | positive regulation of peptidyl-tyrosine phosphorylation |
GO:0001502 | 0.0055 | 9.5336 | 0.3667 | 3 | 20 | cartilage condensation |
GO:0097529 | 0.0057 | 2.7209 | 3.8686 | 10 | 211 | myeloid leukocyte migration |
GO:0032722 | 0.0063 | 4.5972 | 1.1734 | 5 | 64 | positive regulation of chemokine production |
GO:0050922 | 0.0063 | 4.5972 | 1.1734 | 5 | 64 | negative regulation of chemotaxis |
GO:0035425 | 0.0066 | 21.5532 | 0.1283 | 2 | 7 | autocrine signaling |
GO:0036301 | 0.0066 | 21.5532 | 0.1283 | 2 | 7 | macrophage colony-stimulating factor production |
GO:0090027 | 0.0066 | 21.5532 | 0.1283 | 2 | 7 | negative regulation of monocyte chemotaxis |
GO:0030595 | 0.0069 | 2.6411 | 3.9786 | 10 | 217 | leukocyte chemotaxis |
GO:2000637 | 0.0073 | 8.529 | 0.4034 | 3 | 22 | positive regulation of miRNA-mediated gene silencing |
GO:0051881 | 0.0077 | 4.3739 | 1.2284 | 5 | 67 | regulation of mitochondrial membrane potential |
GO:0001667 | 0.0081 | 2.0578 | 8.1406 | 16 | 444 | ameboidal-type cell migration |
GO:0060148 | 0.0082 | 8.102 | 0.4217 | 3 | 23 | positive regulation of post-transcriptional gene silencing |
GO:0043542 | 0.0082 | 2.437 | 4.7303 | 11 | 258 | endothelial cell migration |
GO:0002520 | 0.0084 | 1.7185 | 16.5195 | 27 | 901 | immune system development |
GO:0007172 | 0.0087 | 17.9599 | 0.1467 | 2 | 8 | signal complex assembly |
GO:0032119 | 0.0087 | 17.9599 | 0.1467 | 2 | 8 | sequestering of zinc ion |
GO:0045955 | 0.0087 | 17.9599 | 0.1467 | 2 | 8 | negative regulation of calcium ion-dependent exocytosis |
GO:1904894 | 0.0091 | 5.2804 | 0.8251 | 4 | 45 | positive regulation of receptor signaling pathway via STAT |
GO:0032740 | 0.0093 | 7.7157 | 0.44 | 3 | 24 | positive regulation of interleukin-17 production |
GO:0071773 | 0.0094 | 2.8676 | 2.9335 | 8 | 160 | cellular response to BMP stimulus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045109 | 9e-04 | 5.8532 | 1.1305 | 6 | 64 | intermediate filament organization |
GO:0150128 | 9e-04 | 111.9861 | 0.053 | 2 | 3 | negative regulation of interleukin-33 production |
GO:1900272 | 0.0011 | 18.7201 | 0.212 | 3 | 12 | negative regulation of long-term synaptic potentiation |
GO:0038092 | 0.0014 | 16.847 | 0.2296 | 3 | 13 | nodal signaling pathway |
GO:0002250 | 0.0017 | 2.4462 | 6.9245 | 16 | 392 | adaptive immune response |
GO:0031508 | 0.0018 | 55.9896 | 0.0707 | 2 | 4 | pericentric heterochromatin assembly |
GO:0038098 | 0.0018 | 55.9896 | 0.0707 | 2 | 4 | sequestering of BMP from receptor via BMP binding |
GO:1902340 | 0.0018 | 55.9896 | 0.0707 | 2 | 4 | negative regulation of chromosome condensation |
GO:0009609 | 0.003 | 37.3241 | 0.0883 | 2 | 5 | response to symbiotic bacterium |
GO:0035582 | 0.003 | 37.3241 | 0.0883 | 2 | 5 | sequestering of BMP in extracellular matrix |
GO:0045103 | 0.0035 | 4.4037 | 1.4662 | 6 | 83 | intermediate filament-based process |
GO:0002076 | 0.0037 | 11.2279 | 0.318 | 3 | 18 | osteoblast development |
GO:0150105 | 0.0043 | 10.5255 | 0.3356 | 3 | 19 | protein localization to cell-cell junction |
GO:1902259 | 0.0043 | 10.5255 | 0.3356 | 3 | 19 | regulation of delayed rectifier potassium channel activity |
GO:0090230 | 0.0045 | 27.9913 | 0.106 | 2 | 6 | regulation of centromere complex assembly |
GO:0060444 | 0.005 | 9.9057 | 0.3533 | 3 | 20 | branching involved in mammary gland duct morphogenesis |
GO:0015840 | 0.0062 | 22.3917 | 0.1237 | 2 | 7 | urea transport |
GO:0031509 | 0.0062 | 22.3917 | 0.1237 | 2 | 7 | subtelomeric heterochromatin assembly |
GO:0090027 | 0.0062 | 22.3917 | 0.1237 | 2 | 7 | negative regulation of monocyte chemotaxis |
GO:0048477 | 0.0064 | 3.8506 | 1.6605 | 6 | 94 | oogenesis |
GO:0006833 | 0.0066 | 8.8619 | 0.3886 | 3 | 22 | water transport |
GO:0016064 | 0.0068 | 3.3558 | 2.2081 | 7 | 125 | immunoglobulin mediated immune response |
GO:0007266 | 0.0074 | 3.2994 | 2.2434 | 7 | 127 | Rho protein signal transduction |
GO:0045959 | 0.0081 | 18.6586 | 0.1413 | 2 | 8 | negative regulation of complement activation, classical pathway |
GO:0010447 | 0.0084 | 8.0169 | 0.424 | 3 | 24 | response to acidic pH |
GO:0030855 | 0.0086 | 1.8811 | 11.1464 | 20 | 631 | epithelial cell differentiation |
GO:0043114 | 0.0094 | 5.2314 | 0.8302 | 4 | 47 | regulation of vascular permeability |
GO:0045601 | 0.0094 | 5.2314 | 0.8302 | 4 | 47 | regulation of endothelial cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 9.7484 | 4.1432 | 32 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 8.1456 | 5.3703 | 35 | 372 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 8.1452 | 5.1971 | 34 | 360 | detection of chemical stimulus |
GO:0050906 | 0 | 7.5752 | 5.5435 | 34 | 384 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 3.0497 | 15.1581 | 40 | 1050 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 2.7637 | 18.4351 | 44 | 1277 | nervous system process |
GO:1903015 | 6e-04 | 137.6936 | 0.0433 | 2 | 3 | regulation of exo-alpha-sialidase activity |
GO:0006680 | 0.0012 | 68.8426 | 0.0577 | 2 | 4 | glucosylceramide catabolic process |
GO:0038098 | 0.0012 | 68.8426 | 0.0577 | 2 | 4 | sequestering of BMP from receptor via BMP binding |
GO:0006958 | 0.0014 | 9.2418 | 0.4908 | 4 | 34 | complement activation, classical pathway |
GO:0046466 | 0.0016 | 8.9431 | 0.5053 | 4 | 35 | membrane lipid catabolic process |
GO:0048525 | 0.0016 | 5.1624 | 1.256 | 6 | 87 | negative regulation of viral process |
GO:0035582 | 0.002 | 45.8922 | 0.0722 | 2 | 5 | sequestering of BMP in extracellular matrix |
GO:0045109 | 0.0023 | 5.8887 | 0.9239 | 5 | 64 | intermediate filament organization |
GO:0046514 | 0.0028 | 12.1893 | 0.2887 | 3 | 20 | ceramide catabolic process |
GO:0046597 | 0.0028 | 12.1893 | 0.2887 | 3 | 20 | negative regulation of viral entry into host cell |
GO:0008544 | 0.0029 | 2.6861 | 4.7207 | 12 | 327 | epidermis development |
GO:0046053 | 0.0042 | 27.5319 | 0.1011 | 2 | 7 | dAMP metabolic process |
GO:0090027 | 0.0042 | 27.5319 | 0.1011 | 2 | 7 | negative regulation of monocyte chemotaxis |
GO:0031424 | 0.0048 | 4.8898 | 1.0972 | 5 | 76 | keratinization |
GO:0006681 | 0.0055 | 22.9418 | 0.1155 | 2 | 8 | galactosylceramide metabolic process |
GO:1990264 | 0.0055 | 22.9418 | 0.1155 | 2 | 8 | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity |
GO:0048240 | 0.006 | 9.0061 | 0.3753 | 3 | 26 | sperm capacitation |
GO:0002686 | 0.0062 | 5.8928 | 0.7362 | 4 | 51 | negative regulation of leukocyte migration |
GO:0045103 | 0.007 | 4.449 | 1.1982 | 5 | 83 | intermediate filament-based process |
GO:0032501 | 0.0074 | 1.3937 | 94.285 | 113 | 6641 | multicellular organismal process |
GO:0048263 | 0.0087 | 17.2043 | 0.1444 | 2 | 10 | determination of dorsal identity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 6.8263 | 4.5103 | 26 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 5.8394 | 5.8461 | 29 | 372 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 5.5549 | 5.6576 | 27 | 360 | detection of chemical stimulus |
GO:0050906 | 0 | 5.1736 | 6.0347 | 27 | 384 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 3.2752 | 16.5012 | 46 | 1050 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 2.489 | 20.0686 | 44 | 1277 | nervous system process |
GO:0019373 | 0 | 24.5455 | 0.2829 | 5 | 18 | epoxygenase P450 pathway |
GO:0032501 | 2e-04 | 1.593 | 102.4131 | 131 | 6641 | multicellular organismal process |
GO:0048252 | 2e-04 | Inf | 0.0314 | 2 | 2 | lauric acid metabolic process |
GO:0048703 | 4e-04 | 27.1462 | 0.1572 | 3 | 10 | embryonic viscerocranium morphogenesis |
GO:0097267 | 4e-04 | 27.1462 | 0.1572 | 3 | 10 | omega-hydroxylase P450 pathway |
GO:1905205 | 4e-04 | 27.1462 | 0.1572 | 3 | 10 | positive regulation of connective tissue replacement |
GO:0048704 | 6e-04 | 5.2739 | 1.4458 | 7 | 92 | embryonic skeletal system morphogenesis |
GO:0043062 | 7e-04 | 3.0648 | 4.526 | 13 | 288 | extracellular structure organization |
GO:0045229 | 7e-04 | 3.0423 | 4.5575 | 13 | 290 | external encapsulating structure organization |
GO:0003095 | 7e-04 | 126.2344 | 0.0471 | 2 | 3 | pressure natriuresis |
GO:0071715 | 0.0011 | 7.0769 | 0.7858 | 5 | 50 | icosanoid transport |
GO:0014744 | 0.0012 | 17.2706 | 0.22 | 3 | 14 | positive regulation of muscle adaptation |
GO:0031424 | 0.0012 | 5.4724 | 1.1944 | 6 | 76 | keratinization |
GO:0009952 | 0.0013 | 3.389 | 3.1431 | 10 | 200 | anterior/posterior pattern specification |
GO:2000741 | 0.0014 | 63.1133 | 0.0629 | 2 | 4 | positive regulation of mesenchymal stem cell differentiation |
GO:0006690 | 0.0016 | 4.434 | 1.6973 | 7 | 108 | icosanoid metabolic process |
GO:0007379 | 0.0018 | 14.6118 | 0.2514 | 3 | 16 | segment specification |
GO:0032095 | 0.0018 | 14.6118 | 0.2514 | 3 | 16 | regulation of response to food |
GO:0022617 | 0.0021 | 6.0057 | 0.9115 | 5 | 58 | extracellular matrix disassembly |
GO:0014742 | 0.0024 | 7.9365 | 0.5658 | 4 | 36 | positive regulation of muscle hypertrophy |
GO:0036101 | 0.0024 | 42.0729 | 0.0786 | 2 | 5 | leukotriene B4 catabolic process |
GO:0055059 | 0.0024 | 42.0729 | 0.0786 | 2 | 5 | asymmetric neuroblast division |
GO:0043651 | 0.0026 | 12.662 | 0.2829 | 3 | 18 | linoleic acid metabolic process |
GO:0150077 | 0.0029 | 7.4687 | 0.5972 | 4 | 38 | regulation of neuroinflammatory response |
GO:0015669 | 0.0031 | 11.8699 | 0.2986 | 3 | 19 | gas transport |
GO:0010430 | 0.0035 | 31.5527 | 0.0943 | 2 | 6 | fatty acid omega-oxidation |
GO:0010727 | 0.0035 | 31.5527 | 0.0943 | 2 | 6 | negative regulation of hydrogen peroxide metabolic process |
GO:0060017 | 0.0035 | 31.5527 | 0.0943 | 2 | 6 | parathyroid gland development |
GO:0032305 | 0.0036 | 11.1709 | 0.3143 | 3 | 20 | positive regulation of icosanoid secretion |
GO:0015908 | 0.0039 | 4.2991 | 1.493 | 6 | 95 | fatty acid transport |
GO:0061035 | 0.004 | 5.131 | 1.0529 | 5 | 67 | regulation of cartilage development |
GO:0016339 | 0.0042 | 6.6809 | 0.66 | 4 | 42 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0035850 | 0.0042 | 6.6809 | 0.66 | 4 | 42 | epithelial cell differentiation involved in kidney development |
GO:0007154 | 0.0045 | 1.4076 | 91.338 | 112 | 5812 | cell communication |
GO:0060547 | 0.0047 | 9.9938 | 0.3457 | 3 | 22 | negative regulation of necrotic cell death |
GO:0023052 | 0.0048 | 1.4037 | 90.5679 | 111 | 5763 | signaling |
GO:1901342 | 0.0048 | 2.5105 | 5.0289 | 12 | 320 | regulation of vasculature development |
GO:0032331 | 0.0054 | 9.4935 | 0.3615 | 3 | 23 | negative regulation of chondrocyte differentiation |
GO:0001822 | 0.0054 | 2.5915 | 4.4632 | 11 | 284 | kidney development |
GO:0035239 | 0.0057 | 1.8472 | 13.7353 | 24 | 874 | tube morphogenesis |
GO:0001655 | 0.0063 | 2.4222 | 5.2018 | 12 | 331 | urogenital system development |
GO:0006811 | 0.0066 | 1.6557 | 21.8601 | 34 | 1391 | ion transport |
GO:0060429 | 0.0068 | 1.7376 | 17.0669 | 28 | 1086 | epithelium development |
GO:0032104 | 0.0068 | 8.6294 | 0.3929 | 3 | 25 | regulation of response to extracellular stimulus |
GO:0010951 | 0.0077 | 2.7584 | 3.426 | 9 | 218 | negative regulation of endopeptidase activity |
GO:2000179 | 0.0078 | 5.5163 | 0.7858 | 4 | 50 | positive regulation of neural precursor cell proliferation |
GO:0046548 | 0.0082 | 18.0268 | 0.1414 | 2 | 9 | retinal rod cell development |
GO:0071492 | 0.0082 | 18.0268 | 0.1414 | 2 | 9 | cellular response to UV-A |
GO:1903244 | 0.0082 | 18.0268 | 0.1414 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0001676 | 0.009 | 4.1732 | 1.2751 | 5 | 82 | long-chain fatty acid metabolic process |
GO:0035195 | 0.0095 | 2.0205 | 8.2977 | 16 | 528 | miRNA-mediated gene silencing |
GO:0048856 | 0.0099 | 1.364 | 83.8889 | 102 | 5338 | anatomical structure development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 8.6818 | 4.2656 | 30 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 6.7571 | 5.5289 | 31 | 372 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 6.7302 | 5.3506 | 30 | 360 | detection of chemical stimulus |
GO:0050906 | 0 | 6.2645 | 5.7073 | 30 | 384 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 3.3168 | 15.6058 | 44 | 1050 | G protein-coupled receptor signaling pathway |
GO:0003008 | 0 | 2.604 | 29.8293 | 64 | 2007 | system process |
GO:0019373 | 0 | 26.0058 | 0.2675 | 5 | 18 | epoxygenase P450 pathway |
GO:0032827 | 2e-04 | Inf | 0.0297 | 2 | 2 | negative regulation of natural killer cell differentiation involved in immune response |
GO:0048252 | 2e-04 | Inf | 0.0297 | 2 | 2 | lauric acid metabolic process |
GO:0050896 | 3e-04 | 1.5752 | 116.9393 | 144 | 7868 | response to stimulus |
GO:0032309 | 4e-04 | 8.883 | 0.6391 | 5 | 43 | icosanoid secretion |
GO:0030198 | 0.0013 | 2.9902 | 4.2656 | 12 | 287 | extracellular matrix organization |
GO:0051270 | 0.0015 | 1.9564 | 15.3531 | 28 | 1033 | regulation of cellular component movement |
GO:0051897 | 0.0016 | 4.4348 | 1.6943 | 7 | 114 | positive regulation of protein kinase B signaling |
GO:0002042 | 0.0018 | 5.0713 | 1.2782 | 6 | 86 | cell migration involved in sprouting angiogenesis |
GO:0023052 | 0.0018 | 1.477 | 85.6534 | 108 | 5763 | signaling |
GO:0040012 | 0.002 | 1.9395 | 14.8924 | 27 | 1002 | regulation of locomotion |
GO:0019800 | 0.0021 | 44.5455 | 0.0743 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0033591 | 0.0021 | 44.5455 | 0.0743 | 2 | 5 | response to L-ascorbic acid |
GO:0070779 | 0.0021 | 44.5455 | 0.0743 | 2 | 5 | D-aspartate import across plasma membrane |
GO:0043651 | 0.0022 | 13.4091 | 0.2675 | 3 | 18 | linoleic acid metabolic process |
GO:0050999 | 0.0024 | 7.9113 | 0.5648 | 4 | 38 | regulation of nitric-oxide synthase activity |
GO:0007154 | 0.0025 | 1.4575 | 86.3817 | 108 | 5812 | cell communication |
GO:0009253 | 0.0032 | 33.407 | 0.0892 | 2 | 6 | peptidoglycan catabolic process |
GO:0042940 | 0.0032 | 33.407 | 0.0892 | 2 | 6 | D-amino acid transport |
GO:0006959 | 0.0033 | 3.171 | 3.0023 | 9 | 202 | humoral immune response |
GO:0016339 | 0.0034 | 7.0768 | 0.6242 | 4 | 42 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0046628 | 0.0035 | 11.1722 | 0.3121 | 3 | 21 | positive regulation of insulin receptor signaling pathway |
GO:0015711 | 0.0038 | 2.5955 | 4.8749 | 12 | 328 | organic anion transport |
GO:0001525 | 0.004 | 2.1722 | 8.2636 | 17 | 556 | angiogenesis |
GO:0002323 | 0.0041 | 10.5835 | 0.327 | 3 | 22 | natural killer cell activation involved in immune response |
GO:0032331 | 0.0046 | 10.0537 | 0.3418 | 3 | 23 | negative regulation of chondrocyte differentiation |
GO:0042178 | 0.0046 | 10.0537 | 0.3418 | 3 | 23 | xenobiotic catabolic process |
GO:0030334 | 0.0047 | 1.8822 | 13.525 | 24 | 910 | regulation of cell migration |
GO:0006690 | 0.0055 | 3.9721 | 1.6052 | 6 | 108 | icosanoid metabolic process |
GO:0006111 | 0.0056 | 6.1095 | 0.7134 | 4 | 48 | regulation of gluconeogenesis |
GO:0015740 | 0.0066 | 8.7408 | 0.3864 | 3 | 26 | C4-dicarboxylate transport |
GO:0010466 | 0.007 | 2.8029 | 3.3738 | 9 | 227 | negative regulation of peptidase activity |
GO:2000147 | 0.0072 | 2.0875 | 8.0556 | 16 | 542 | positive regulation of cell motility |
GO:0042759 | 0.0073 | 8.376 | 0.4013 | 3 | 27 | long-chain fatty acid biosynthetic process |
GO:0032815 | 0.0074 | 19.0862 | 0.1338 | 2 | 9 | negative regulation of natural killer cell activation |
GO:0070874 | 0.0074 | 19.0862 | 0.1338 | 2 | 9 | negative regulation of glycogen metabolic process |
GO:0071466 | 0.0077 | 3.2648 | 2.2591 | 7 | 152 | cellular response to xenobiotic stimulus |
GO:0015813 | 0.0081 | 8.0405 | 0.4162 | 3 | 28 | L-glutamate transmembrane transport |
GO:0006954 | 0.0083 | 1.8943 | 11.1173 | 20 | 748 | inflammatory response |
GO:0051674 | 0.0085 | 1.6053 | 23.9289 | 36 | 1610 | localization of cell |
GO:1901342 | 0.0086 | 2.4238 | 4.756 | 11 | 320 | regulation of vasculature development |
GO:0032869 | 0.0088 | 2.8979 | 2.8982 | 8 | 195 | cellular response to insulin stimulus |
GO:0006026 | 0.0089 | 7.7308 | 0.431 | 3 | 29 | aminoglycan catabolic process |
GO:0006508 | 0.009 | 1.5986 | 24.018 | 36 | 1616 | proteolysis |
GO:0000353 | 0.0092 | 16.6994 | 0.1486 | 2 | 10 | formation of quadruple SL/U4/U5/U6 snRNP |
GO:0000365 | 0.0092 | 16.6994 | 0.1486 | 2 | 10 | mRNA trans splicing, via spliceosome |
GO:0032823 | 0.0092 | 16.6994 | 0.1486 | 2 | 10 | regulation of natural killer cell differentiation |
GO:0048703 | 0.0092 | 16.6994 | 0.1486 | 2 | 10 | embryonic viscerocranium morphogenesis |
GO:0097267 | 0.0092 | 16.6994 | 0.1486 | 2 | 10 | omega-hydroxylase P450 pathway |
GO:0007600 | 0.01 | 2.3723 | 4.8624 | 11 | 365 | sensory perception |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 14.8504 | 3.7411 | 40 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 12.1978 | 4.6927 | 42 | 360 | detection of chemical stimulus |
GO:0050906 | 0 | 11.697 | 5.0055 | 43 | 384 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 11.7453 | 4.8491 | 42 | 372 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 5.701 | 13.687 | 58 | 1050 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 4.1339 | 16.646 | 54 | 1277 | nervous system process |
GO:0007154 | 0 | 1.8401 | 75.761 | 107 | 5812 | cell communication |
GO:0032501 | 0 | 1.8235 | 87.5579 | 119 | 6717 | multicellular organismal process |
GO:0023052 | 0 | 1.7953 | 75.1223 | 105 | 5763 | signaling |
GO:0051716 | 0 | 1.7556 | 86.5672 | 116 | 6641 | cellular response to stimulus |
GO:0019373 | 1e-04 | 22.0259 | 0.2346 | 4 | 18 | epoxygenase P450 pathway |
GO:0120254 | 1e-04 | 5.2647 | 1.864 | 9 | 143 | olefinic compound metabolic process |
GO:0048252 | 2e-04 | Inf | 0.0261 | 2 | 2 | lauric acid metabolic process |
GO:0097267 | 2e-04 | 32.8964 | 0.1304 | 3 | 10 | omega-hydroxylase P450 pathway |
GO:0071715 | 5e-04 | 8.5901 | 0.6518 | 5 | 50 | icosanoid transport |
GO:0003095 | 5e-04 | 152.8491 | 0.0391 | 2 | 3 | pressure natriuresis |
GO:0008212 | 7e-04 | 20.9289 | 0.1825 | 3 | 14 | mineralocorticoid metabolic process |
GO:0022617 | 9e-04 | 7.2899 | 0.756 | 5 | 58 | extracellular matrix disassembly |
GO:0048245 | 0.0011 | 17.7069 | 0.2086 | 3 | 16 | eosinophil chemotaxis |
GO:0036101 | 0.0016 | 50.9434 | 0.0652 | 2 | 5 | leukotriene B4 catabolic process |
GO:0033559 | 0.0024 | 4.7405 | 1.3557 | 6 | 104 | unsaturated fatty acid metabolic process |
GO:0003091 | 0.0024 | 12.7844 | 0.2737 | 3 | 21 | renal water homeostasis |
GO:0035821 | 0.0024 | 12.7844 | 0.2737 | 3 | 21 | modulation of process of another organism |
GO:0006959 | 0.003 | 3.9159 | 1.8994 | 7 | 148 | humoral immune response |
GO:0003071 | 0.0032 | 11.5045 | 0.2998 | 3 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
GO:0010886 | 0.0034 | 30.5623 | 0.0912 | 2 | 7 | positive regulation of cholesterol storage |
GO:0006952 | 0.0036 | 1.7715 | 19.4877 | 32 | 1495 | defense response |
GO:0050896 | 0.0043 | 2.0354 | 12.3001 | 22 | 1227 | response to stimulus |
GO:0006956 | 0.0053 | 6.1535 | 0.7039 | 4 | 54 | complement activation |
GO:0002250 | 0.0054 | 2.4736 | 5.1098 | 12 | 392 | adaptive immune response |
GO:0050482 | 0.0056 | 9.2008 | 0.365 | 3 | 28 | arachidonic acid secretion |
GO:0060124 | 0.0057 | 21.8275 | 0.1173 | 2 | 9 | positive regulation of growth hormone secretion |
GO:0050830 | 0.0064 | 4.5364 | 1.1732 | 5 | 90 | defense response to Gram-positive bacterium |
GO:1905954 | 0.0064 | 4.5364 | 1.1732 | 5 | 90 | positive regulation of lipid localization |
GO:0000353 | 0.0071 | 19.0979 | 0.1304 | 2 | 10 | formation of quadruple SL/U4/U5/U6 snRNP |
GO:0000365 | 0.0071 | 19.0979 | 0.1304 | 2 | 10 | mRNA trans splicing, via spliceosome |
GO:0038007 | 0.0071 | 19.0979 | 0.1304 | 2 | 10 | netrin-activated signaling pathway |
GO:0015908 | 0.0081 | 4.2831 | 1.2384 | 5 | 95 | fatty acid transport |
GO:0001990 | 0.0082 | 7.9297 | 0.4171 | 3 | 32 | regulation of systemic arterial blood pressure by hormone |
GO:0032342 | 0.0086 | 16.9748 | 0.1434 | 2 | 11 | aldosterone biosynthetic process |
GO:0042446 | 0.0092 | 5.2119 | 0.8212 | 4 | 63 | hormone biosynthetic process |
GO:0001676 | 0.0099 | 4.0564 | 1.3035 | 5 | 100 | long-chain fatty acid metabolic process |
GO:0043588 | 0.01 | 2.6404 | 3.5717 | 9 | 274 | skin development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 5.29 | 12.4454 | 53 | 673 | G protein-coupled receptor activity |
GO:0004984 | 0 | 7.9748 | 5.2703 | 34 | 285 | olfactory receptor activity |
GO:0060089 | 0 | 3.8397 | 23.282 | 71 | 1259 | molecular transducer activity |
GO:0005549 | 0 | 12.2676 | 1.5349 | 15 | 83 | odorant binding |
GO:0046982 | 0 | 3.5013 | 5.6032 | 18 | 303 | protein heterodimerization activity |
GO:0008188 | 1e-04 | 9.2629 | 0.7582 | 6 | 41 | neuropeptide receptor activity |
GO:0005509 | 5e-04 | 2.1952 | 12.168 | 25 | 658 | calcium ion binding |
GO:0050839 | 8e-04 | 2.2973 | 9.727 | 21 | 526 | cell adhesion molecule binding |
GO:0001601 | 0.001 | 106.8533 | 0.0555 | 2 | 3 | peptide YY receptor activity |
GO:0015467 | 0.002 | 53.4233 | 0.074 | 2 | 4 | G-protein activated inward rectifier potassium channel activity |
GO:0009374 | 0.0033 | 35.6133 | 0.0925 | 2 | 5 | biotin binding |
GO:0019863 | 0.0033 | 35.6133 | 0.0925 | 2 | 5 | IgE binding |
GO:0016421 | 0.0049 | 26.7083 | 0.111 | 2 | 6 | CoA carboxylase activity |
GO:0031849 | 0.0049 | 26.7083 | 0.111 | 2 | 6 | olfactory receptor binding |
GO:0001849 | 0.0067 | 21.3653 | 0.1294 | 2 | 7 | complement component C1q complex binding |
GO:0004866 | 0.0074 | 3.0017 | 2.8109 | 8 | 152 | endopeptidase inhibitor activity |
GO:0101020 | 0.0089 | 17.8033 | 0.1479 | 2 | 8 | estrogen 16-alpha-hydroxylase activity |
GO:0004888 | 0.009 | 2.2205 | 6.1383 | 13 | 386 | transmembrane signaling receptor activity |
GO:0005201 | 0.0099 | 2.8423 | 2.9588 | 8 | 160 | extracellular matrix structural constituent |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 8.0193 | 4.5723 | 30 | 285 | olfactory receptor activity |
GO:0004930 | 0 | 4.3938 | 10.797 | 40 | 673 | G protein-coupled receptor activity |
GO:0038023 | 0 | 2.9735 | 20.1983 | 51 | 1259 | signaling receptor activity |
GO:0008392 | 0 | 41.8229 | 0.2406 | 6 | 15 | arachidonic acid epoxygenase activity |
GO:0018685 | 0 | 186.1158 | 0.0642 | 3 | 4 | alkane 1-monooxygenase activity |
GO:0070330 | 0 | 19.5197 | 0.3369 | 5 | 21 | aromatase activity |
GO:0020037 | 0 | 5.5538 | 1.9893 | 10 | 124 | heme binding |
GO:0102033 | 1e-04 | 46.5203 | 0.1123 | 3 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0018675 | 3e-04 | Inf | 0.0321 | 2 | 2 | (S)-limonene 6-monooxygenase activity |
GO:0018676 | 3e-04 | Inf | 0.0321 | 2 | 2 | (S)-limonene 7-monooxygenase activity |
GO:0052741 | 3e-04 | Inf | 0.0321 | 2 | 2 | (R)-limonene 6-monooxygenase activity |
GO:0005506 | 3e-04 | 4.4654 | 2.1819 | 9 | 136 | iron ion binding |
GO:0016709 | 5e-04 | 8.6646 | 0.6578 | 5 | 41 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GO:0048407 | 6e-04 | 23.2543 | 0.1765 | 3 | 11 | platelet-derived growth factor binding |
GO:0005518 | 8e-04 | 6.051 | 1.0909 | 6 | 68 | collagen binding |
GO:0045236 | 0.002 | 14.3059 | 0.2567 | 3 | 16 | CXCR chemokine receptor binding |
GO:0005549 | 0.0022 | 4.8677 | 1.3316 | 6 | 83 | odorant binding |
GO:0005509 | 0.0022 | 2.111 | 10.5564 | 21 | 658 | calcium ion binding |
GO:0008395 | 0.0023 | 8.021 | 0.5615 | 4 | 35 | steroid hydroxylase activity |
GO:0019863 | 0.0025 | 41.1949 | 0.0802 | 2 | 5 | IgE binding |
GO:0050051 | 0.0025 | 41.1949 | 0.0802 | 2 | 5 | leukotriene-B4 20-monooxygenase activity |
GO:0005201 | 0.0043 | 3.2982 | 2.5669 | 8 | 160 | extracellular matrix structural constituent |
GO:0030246 | 0.0065 | 2.6623 | 3.9466 | 10 | 246 | carbohydrate binding |
GO:0015101 | 0.0072 | 8.4488 | 0.4011 | 3 | 25 | organic cation transmembrane transporter activity |
GO:0048306 | 0.0079 | 4.3226 | 1.2353 | 5 | 77 | calcium-dependent protein binding |
GO:0030621 | 0.0086 | 17.6505 | 0.1444 | 2 | 9 | U4 snRNA binding |
GO:0005242 | 0.009 | 7.7437 | 0.4332 | 3 | 27 | inward rectifier potassium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 9.19 | 3.7695 | 28 | 285 | olfactory receptor activity |
GO:0004930 | 0 | 5.0308 | 8.9014 | 37 | 673 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.955 | 15.0674 | 48 | 1165 | signaling receptor activity |
GO:0005549 | 0 | 14.6787 | 1.0978 | 13 | 83 | odorant binding |
GO:0099583 | 5e-04 | 150.5981 | 0.0397 | 2 | 3 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration |
GO:0031731 | 0.001 | 75.2944 | 0.0529 | 2 | 4 | CCR6 chemokine receptor binding |
GO:0030594 | 0.0015 | 5.2036 | 1.2433 | 6 | 94 | neurotransmitter receptor activity |
GO:0030296 | 0.0016 | 15.1174 | 0.2381 | 3 | 18 | protein tyrosine kinase activator activity |
GO:0030883 | 0.0017 | 50.1931 | 0.0661 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0017 | 50.1931 | 0.0661 | 2 | 5 | exogenous lipid antigen binding |
GO:0004024 | 0.0035 | 30.1121 | 0.0926 | 2 | 7 | alcohol dehydrogenase activity, zinc-dependent |
GO:0008467 | 0.0035 | 30.1121 | 0.0926 | 2 | 7 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity |
GO:0004950 | 0.0042 | 10.3028 | 0.3307 | 3 | 25 | chemokine receptor activity |
GO:0008066 | 0.0042 | 10.3028 | 0.3307 | 3 | 25 | glutamate receptor activity |
GO:0032394 | 0.0046 | 25.0919 | 0.1058 | 2 | 8 | MHC class Ib receptor activity |
GO:0032396 | 0.0059 | 21.506 | 0.119 | 2 | 9 | inhibitory MHC class I receptor activity |
GO:0071723 | 0.0059 | 21.506 | 0.119 | 2 | 9 | lipopeptide binding |
GO:0018455 | 0.0073 | 18.8166 | 0.1323 | 2 | 10 | alcohol dehydrogenase [NAD(P)+] activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003677 | 0 | 1.9628 | 64.1369 | 109 | 2277 | DNA binding |
GO:1990837 | 0 | 2.1486 | 40.4201 | 77 | 1435 | sequence-specific double-stranded DNA binding |
GO:0001067 | 0 | 2.1309 | 38.9835 | 74 | 1384 | transcription regulatory region nucleic acid binding |
GO:0046982 | 0 | 3.3726 | 8.5347 | 26 | 303 | protein heterodimerization activity |
GO:0000978 | 0 | 2.1524 | 30.815 | 60 | 1094 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0140110 | 0 | 1.9177 | 49.0111 | 84 | 1740 | transcription regulator activity |
GO:0001228 | 0 | 2.8093 | 12.0838 | 31 | 429 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0000981 | 0 | 2.1674 | 22.0948 | 44 | 819 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0022843 | 0 | 3.9542 | 3.9153 | 14 | 139 | voltage-gated cation channel activity |
GO:0004983 | 1e-04 | 27.8351 | 0.2535 | 4 | 9 | neuropeptide Y receptor activity |
GO:0048407 | 2e-04 | 19.8797 | 0.3098 | 4 | 11 | platelet-derived growth factor binding |
GO:0046873 | 2e-04 | 2.3749 | 11.2669 | 25 | 400 | metal ion transmembrane transporter activity |
GO:0022832 | 3e-04 | 3.0586 | 5.2955 | 15 | 188 | voltage-gated channel activity |
GO:0015276 | 4e-04 | 3.5158 | 3.7181 | 12 | 132 | ligand-gated ion channel activity |
GO:0030546 | 7e-04 | 2.1546 | 12.3188 | 25 | 440 | signaling receptor activator activity |
GO:0004888 | 8e-04 | 1.7124 | 29.8292 | 48 | 1059 | transmembrane signaling receptor activity |
GO:0000977 | 8e-04 | 2.8725 | 5.2241 | 14 | 199 | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO:0015267 | 0.001 | 2.0989 | 12.6189 | 25 | 448 | channel activity |
GO:0008083 | 0.0011 | 3.0538 | 4.2251 | 12 | 150 | growth factor activity |
GO:0030297 | 0.0011 | 20.8306 | 0.2253 | 3 | 8 | transmembrane receptor protein tyrosine kinase activator activity |
GO:0005267 | 0.0018 | 3.2434 | 3.3237 | 10 | 118 | potassium channel activity |
GO:0060089 | 0.0021 | 1.5835 | 35.4626 | 53 | 1259 | molecular transducer activity |
GO:0019905 | 0.0023 | 4.2129 | 1.8309 | 7 | 65 | syntaxin binding |
GO:0005017 | 0.0023 | 69.3013 | 0.0845 | 2 | 3 | platelet-derived growth factor-activated receptor activity |
GO:0008502 | 0.0023 | 69.3013 | 0.0845 | 2 | 3 | melatonin receptor activity |
GO:0022851 | 0.0031 | 13.0167 | 0.3098 | 3 | 11 | GABA-gated chloride ion channel activity |
GO:0005178 | 0.0033 | 2.7931 | 4.1969 | 11 | 149 | integrin binding |
GO:0008198 | 0.0036 | 7.3186 | 0.6478 | 4 | 23 | ferrous iron binding |
GO:0005237 | 0.004 | 11.5697 | 0.338 | 3 | 12 | inhibitory extracellular ligand-gated ion channel activity |
GO:0005262 | 0.0041 | 3.0851 | 3.1266 | 9 | 111 | calcium channel activity |
GO:0005104 | 0.0042 | 6.9522 | 0.676 | 4 | 24 | fibroblast growth factor receptor binding |
GO:0008528 | 0.0044 | 2.8452 | 3.7462 | 10 | 133 | G protein-coupled peptide receptor activity |
GO:1904315 | 0.0045 | 5.1186 | 1.0985 | 5 | 39 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential |
GO:0008324 | 0.0046 | 1.782 | 16.4779 | 28 | 585 | cation transmembrane transporter activity |
GO:0005163 | 0.0046 | 34.6485 | 0.1127 | 2 | 4 | nerve growth factor receptor binding |
GO:0038085 | 0.0046 | 34.6485 | 0.1127 | 2 | 4 | vascular endothelial growth factor binding |
GO:0008201 | 0.0047 | 2.657 | 4.3941 | 11 | 156 | heparin binding |
GO:0098960 | 0.0048 | 4.1818 | 1.5774 | 6 | 56 | postsynaptic neurotransmitter receptor activity |
GO:0005125 | 0.0062 | 2.338 | 5.8588 | 13 | 208 | cytokine activity |
GO:0004890 | 0.0064 | 9.4649 | 0.3943 | 3 | 14 | GABA-A receptor activity |
GO:0071837 | 0.0064 | 9.4649 | 0.3943 | 3 | 14 | HMG box domain binding |
GO:0005242 | 0.0065 | 6.0442 | 0.7605 | 4 | 27 | inward rectifier potassium channel activity |
GO:0015318 | 0.0074 | 1.6795 | 18.6749 | 30 | 663 | inorganic molecular entity transmembrane transporter activity |
GO:0017147 | 0.0074 | 5.792 | 0.7887 | 4 | 28 | Wnt-protein binding |
GO:0019904 | 0.0085 | 1.6922 | 17.2807 | 28 | 617 | protein domain specific binding |
GO:0042923 | 0.0095 | 5.3458 | 0.845 | 4 | 30 | neuropeptide binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008392 | 0 | 27.5344 | 0.2719 | 5 | 15 | arachidonic acid epoxygenase activity |
GO:0020037 | 0 | 5.4383 | 2.2475 | 11 | 124 | heme binding |
GO:0004984 | 0 | 3.5848 | 5.1656 | 17 | 285 | olfactory receptor activity |
GO:0038023 | 2e-04 | 1.9559 | 22.8194 | 41 | 1259 | signaling receptor activity |
GO:0005506 | 2e-04 | 4.4148 | 2.465 | 10 | 136 | iron ion binding |
GO:0005518 | 2e-04 | 6.3428 | 1.2325 | 7 | 68 | collagen binding |
GO:0005179 | 2e-04 | 4.7576 | 2.0663 | 9 | 114 | hormone activity |
GO:0004930 | 2e-04 | 2.2903 | 12.1982 | 26 | 673 | G protein-coupled receptor activity |
GO:0008395 | 4e-04 | 9.1667 | 0.6344 | 5 | 35 | steroid hydroxylase activity |
GO:0070330 | 5e-04 | 12.9073 | 0.3806 | 4 | 21 | aromatase activity |
GO:0005102 | 8e-04 | 1.8092 | 23.8432 | 40 | 1327 | signaling receptor binding |
GO:0005242 | 0.0013 | 9.5366 | 0.4894 | 4 | 27 | inward rectifier potassium channel activity |
GO:0005267 | 0.0014 | 4.0215 | 2.1388 | 8 | 118 | potassium channel activity |
GO:0030546 | 0.0014 | 2.3498 | 8.12 | 18 | 448 | signaling receptor activator activity |
GO:0086008 | 0.0015 | 16.4078 | 0.2356 | 3 | 13 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization |
GO:0071837 | 0.0018 | 14.9153 | 0.2538 | 3 | 14 | HMG box domain binding |
GO:0008745 | 0.0019 | 54.534 | 0.0725 | 2 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0018685 | 0.0019 | 54.534 | 0.0725 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0062189 | 0.0019 | 54.534 | 0.0725 | 2 | 4 | anandamide 14,15 epoxidase activity |
GO:0015276 | 0.0028 | 3.5643 | 2.3925 | 8 | 132 | ligand-gated ion channel activity |
GO:0016019 | 0.0032 | 36.3537 | 0.0906 | 2 | 5 | peptidoglycan immune receptor activity |
GO:0022843 | 0.0039 | 3.3723 | 2.5194 | 8 | 139 | voltage-gated cation channel activity |
GO:0022836 | 0.0046 | 2.4258 | 5.6369 | 13 | 311 | gated channel activity |
GO:0070697 | 0.0047 | 27.2636 | 0.1088 | 2 | 6 | activin receptor binding |
GO:0017171 | 0.0052 | 2.944 | 3.2263 | 9 | 178 | serine hydrolase activity |
GO:0005539 | 0.006 | 2.7 | 3.8969 | 10 | 215 | glycosaminoglycan binding |
GO:0008083 | 0.0061 | 3.109 | 2.7188 | 8 | 150 | growth factor activity |
GO:0019865 | 0.0062 | 9.1109 | 0.3806 | 3 | 21 | immunoglobulin binding |
GO:0016709 | 0.0063 | 5.923 | 0.7431 | 4 | 41 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GO:0102033 | 0.0065 | 21.8095 | 0.1269 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0004252 | 0.0082 | 2.9417 | 2.8638 | 8 | 158 | serine-type endopeptidase activity |
GO:0033612 | 0.009 | 7.8079 | 0.435 | 3 | 24 | receptor serine/threonine kinase binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004953 | 9e-04 | 19.16 | 0.1989 | 3 | 14 | icosanoid receptor activity |
GO:0005096 | 0.0023 | 3.1079 | 3.4095 | 10 | 240 | GTPase activator activity |
GO:1903231 | 0.0044 | 3.0244 | 3.1396 | 9 | 221 | mRNA base-pairing post-transcriptional repressor activity |
GO:0015459 | 0.0055 | 6.1224 | 0.7103 | 4 | 50 | potassium channel regulator activity |
GO:0043295 | 0.0068 | 19.9901 | 0.1279 | 2 | 9 | glutathione binding |
GO:0005217 | 0.0079 | 8.0986 | 0.412 | 3 | 29 | intracellular ligand-gated ion channel activity |
GO:0004955 | 0.0084 | 17.4902 | 0.1421 | 2 | 10 | prostaglandin receptor activity |
GO:1902282 | 0.0084 | 17.4902 | 0.1421 | 2 | 10 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization |
GO:0030545 | 0.0093 | 2.1402 | 6.8616 | 14 | 483 | signaling receptor regulator activity |
GO:0005251 | 0.0095 | 7.5192 | 0.4404 | 3 | 31 | delayed rectifier potassium channel activity |
GO:0005102 | 0.0096 | 1.6614 | 19.1925 | 30 | 1351 | signaling receptor binding |
GO:0045182 | 0.0097 | 2.3784 | 4.8443 | 11 | 341 | translation regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 2e-04 | 3.829 | 3.3831 | 12 | 221 | mRNA base-pairing post-transcriptional repressor activity |
GO:0045182 | 3e-04 | 3.0848 | 5.2201 | 15 | 341 | translation regulator activity |
GO:0003876 | 7e-04 | 129.6774 | 0.0459 | 2 | 3 | AMP deaminase activity |
GO:0003730 | 7e-04 | 3.6808 | 2.9086 | 10 | 190 | mRNA 3'-UTR binding |
GO:0071837 | 0.0011 | 17.7438 | 0.2143 | 3 | 14 | HMG box domain binding |
GO:0038023 | 0.0017 | 1.8426 | 19.2732 | 33 | 1259 | signaling receptor activity |
GO:0004364 | 0.0021 | 13.939 | 0.2602 | 3 | 17 | glutathione transferase activity |
GO:0030881 | 0.0034 | 32.4133 | 0.0918 | 2 | 6 | beta-2-microglobulin binding |
GO:0005085 | 0.0051 | 2.9504 | 3.2147 | 9 | 210 | guanyl-nucleotide exchange factor activity |
GO:0030297 | 0.0061 | 21.6062 | 0.1225 | 2 | 8 | transmembrane receptor protein tyrosine kinase activator activity |
GO:0032394 | 0.0061 | 21.6062 | 0.1225 | 2 | 8 | MHC class Ib receptor activity |
GO:0042608 | 0.0061 | 21.6062 | 0.1225 | 2 | 8 | T cell receptor binding |
GO:0060589 | 0.0082 | 2.1748 | 6.751 | 14 | 441 | nucleoside-triphosphatase regulator activity |
GO:0008047 | 0.0087 | 2.0971 | 7.5011 | 15 | 490 | enzyme activator activity |
GO:0000981 | 0.0092 | 1.664 | 19.1048 | 30 | 1248 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0005217 | 0.0097 | 7.5 | 0.4439 | 3 | 29 | intracellular ligand-gated ion channel activity |
GO:0070566 | 0.0097 | 7.5 | 0.4439 | 3 | 29 | adenylyltransferase activity |
GO:0045028 | 0.0097 | 16.2026 | 0.1531 | 2 | 10 | G protein-coupled purinergic nucleotide receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 8.0499 | 4.3972 | 29 | 303 | protein heterodimerization activity |
GO:0005509 | 0 | 3.8571 | 9.5491 | 32 | 658 | calcium ion binding |
GO:1903231 | 0 | 5.2112 | 3.2072 | 15 | 221 | mRNA base-pairing post-transcriptional repressor activity |
GO:0003730 | 0 | 5.219 | 2.7573 | 13 | 190 | mRNA 3'-UTR binding |
GO:0045182 | 0 | 3.7611 | 4.9487 | 17 | 341 | translation regulator activity |
GO:0019904 | 0 | 2.8748 | 9.1572 | 24 | 631 | protein domain specific binding |
GO:0005095 | 6e-04 | 22.9131 | 0.1741 | 3 | 12 | GTPase inhibitor activity |
GO:0004303 | 0.0018 | 14.7253 | 0.2467 | 3 | 17 | estradiol 17-beta-dehydrogenase activity |
GO:0045296 | 0.0024 | 2.7517 | 4.6149 | 12 | 318 | cadherin binding |
GO:0047035 | 0.0042 | 27.3855 | 0.1016 | 2 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:0003723 | 0.0043 | 1.6568 | 25.382 | 39 | 1749 | RNA binding |
GO:0047045 | 0.0055 | 22.8199 | 0.1161 | 2 | 8 | testosterone 17-beta-dehydrogenase (NADP+) activity |
GO:0005132 | 0.0071 | 19.5587 | 0.1306 | 2 | 9 | type I interferon receptor binding |
GO:0016803 | 0.0071 | 19.5587 | 0.1306 | 2 | 9 | ether hydrolase activity |
GO:0019531 | 0.0071 | 19.5587 | 0.1306 | 2 | 9 | oxalate transmembrane transporter activity |
GO:0016229 | 0.0083 | 7.9231 | 0.4209 | 3 | 29 | steroid dehydrogenase activity |
GO:0097493 | 0.0087 | 17.1128 | 0.1451 | 2 | 10 | structural molecule activity conferring elasticity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 0 | 4.6039 | 10.6369 | 41 | 658 | calcium ion binding |
GO:0046982 | 0 | 6.518 | 4.8982 | 27 | 303 | protein heterodimerization activity |
GO:0019904 | 6e-04 | 2.3075 | 10.2005 | 22 | 631 | protein domain specific binding |
GO:0005095 | 8e-04 | 20.5083 | 0.194 | 3 | 12 | GTPase inhibitor activity |
GO:0048020 | 0.0029 | 7.4751 | 0.5981 | 4 | 37 | CCR chemokine receptor binding |
GO:0003730 | 0.0038 | 3.0977 | 3.0715 | 9 | 190 | mRNA 3'-UTR binding |
GO:0005126 | 0.0056 | 2.7229 | 3.8636 | 10 | 239 | cytokine receptor binding |
GO:0045296 | 0.0057 | 2.4527 | 5.1407 | 12 | 318 | cadherin binding |
GO:0005125 | 0.0068 | 2.8143 | 3.3624 | 9 | 208 | cytokine activity |
GO:0016803 | 0.0087 | 17.5136 | 0.1455 | 2 | 9 | ether hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 6.0771 | 6.4752 | 33 | 303 | protein heterodimerization activity |
GO:0003677 | 0 | 3.0944 | 13.5344 | 37 | 664 | DNA binding |
GO:0019904 | 0 | 2.7816 | 13.4847 | 34 | 631 | protein domain specific binding |
GO:0005509 | 0 | 2.6566 | 14.0617 | 34 | 658 | calcium ion binding |
GO:0051380 | 0 | 138.5636 | 0.0855 | 3 | 4 | norepinephrine binding |
GO:0003700 | 8e-04 | 1.7491 | 27.6106 | 45 | 1292 | DNA-binding transcription factor activity |
GO:0001227 | 9e-04 | 2.5999 | 6.5393 | 16 | 306 | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO:0005102 | 0.0011 | 1.7074 | 28.8714 | 46 | 1351 | signaling receptor binding |
GO:0001730 | 0.0013 | 92.1095 | 0.0641 | 2 | 3 | 2'-5'-oligoadenylate synthetase activity |
GO:0004939 | 0.0013 | 92.1095 | 0.0641 | 2 | 3 | beta-adrenergic receptor activity |
GO:0035663 | 0.0013 | 92.1095 | 0.0641 | 2 | 3 | Toll-like receptor 2 binding |
GO:0000976 | 0.0017 | 1.6643 | 29.5339 | 46 | 1382 | transcription cis-regulatory region binding |
GO:0005125 | 0.0018 | 2.8679 | 4.445 | 12 | 208 | cytokine activity |
GO:0000978 | 0.0021 | 1.727 | 23.3792 | 38 | 1094 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0008656 | 0.0024 | 13.8486 | 0.2778 | 3 | 13 | cysteine-type endopeptidase activator activity involved in apoptotic process |
GO:0043565 | 0.0028 | 1.5969 | 32.7395 | 49 | 1532 | sequence-specific DNA binding |
GO:0045296 | 0.0036 | 2.3239 | 6.7958 | 15 | 318 | cadherin binding |
GO:0038023 | 0.0045 | 1.6136 | 26.9053 | 41 | 1259 | signaling receptor activity |
GO:0001665 | 0.0065 | 23.0231 | 0.1282 | 2 | 6 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity |
GO:0042289 | 0.0065 | 23.0231 | 0.1282 | 2 | 6 | MHC class II protein binding |
GO:0051379 | 0.0065 | 23.0231 | 0.1282 | 2 | 6 | epinephrine binding |
GO:0003690 | 0.0067 | 1.5272 | 32.5899 | 47 | 1525 | double-stranded DNA binding |
GO:0001786 | 0.0073 | 4.4527 | 1.2181 | 5 | 57 | phosphatidylserine binding |
GO:0016504 | 0.0094 | 5.2827 | 0.8334 | 4 | 39 | peptidase activator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 5.6589 | 7.5885 | 36 | 303 | protein heterodimerization activity |
GO:0001653 | 0 | 5.2726 | 3.4561 | 16 | 138 | peptide receptor activity |
GO:0004930 | 0 | 2.6182 | 16.8549 | 40 | 673 | G protein-coupled receptor activity |
GO:0003677 | 0 | 2.4761 | 15.9706 | 36 | 664 | DNA binding |
GO:0003700 | 1e-04 | 1.8042 | 32.3574 | 54 | 1292 | DNA-binding transcription factor activity |
GO:0001228 | 5e-04 | 2.2772 | 10.744 | 23 | 429 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0001785 | 6e-04 | Inf | 0.0501 | 2 | 2 | prostaglandin J receptor activity |
GO:0004956 | 6e-04 | Inf | 0.0501 | 2 | 2 | prostaglandin D receptor activity |
GO:0005139 | 6e-04 | Inf | 0.0501 | 2 | 2 | interleukin-7 receptor binding |
GO:0000976 | 7e-04 | 1.6716 | 34.6114 | 54 | 1382 | transcription cis-regulatory region binding |
GO:0042923 | 8e-04 | 7.8698 | 0.7513 | 5 | 30 | neuropeptide binding |
GO:0000978 | 0.001 | 1.7269 | 27.125 | 44 | 1088 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0008188 | 0.0011 | 7.3565 | 0.794 | 5 | 32 | neuropeptide receptor activity |
GO:0001601 | 0.0018 | 78.2359 | 0.0751 | 2 | 3 | peptide YY receptor activity |
GO:0016493 | 0.002 | 8.7265 | 0.551 | 4 | 22 | C-C chemokine receptor activity |
GO:0050750 | 0.002 | 8.7265 | 0.551 | 4 | 22 | low-density lipoprotein particle receptor binding |
GO:0022843 | 0.0026 | 3.0683 | 3.4812 | 10 | 139 | voltage-gated cation channel activity |
GO:0005237 | 0.0029 | 13.0649 | 0.3005 | 3 | 12 | inhibitory extracellular ligand-gated ion channel activity |
GO:0001637 | 0.0032 | 7.4784 | 0.6261 | 4 | 25 | G protein-coupled chemoattractant receptor activity |
GO:0038023 | 0.0033 | 1.6325 | 27.2064 | 42 | 1121 | signaling receptor activity |
GO:0015467 | 0.0036 | 39.1155 | 0.1002 | 2 | 4 | G-protein activated inward rectifier potassium channel activity |
GO:0003690 | 0.0037 | 1.5275 | 38.1927 | 55 | 1525 | double-stranded DNA binding |
GO:0043565 | 0.0041 | 1.5195 | 38.368 | 55 | 1532 | sequence-specific DNA binding |
GO:0034483 | 0.0046 | 10.6881 | 0.3506 | 3 | 14 | heparan sulfate sulfotransferase activity |
GO:0099095 | 0.0057 | 9.7968 | 0.3757 | 3 | 15 | ligand-gated anion channel activity |
GO:0004185 | 0.006 | 26.0753 | 0.1252 | 2 | 5 | serine-type carboxypeptidase activity |
GO:0099626 | 0.006 | 26.0753 | 0.1252 | 2 | 5 | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels |
GO:0022834 | 0.006 | 2.8901 | 3.3059 | 9 | 132 | ligand-gated channel activity |
GO:0004115 | 0.0069 | 9.0426 | 0.4007 | 3 | 16 | 3',5'-cyclic-AMP phosphodiesterase activity |
GO:0019956 | 0.0071 | 5.8144 | 0.7764 | 4 | 31 | chemokine binding |
GO:0005544 | 0.0074 | 4.4661 | 1.2272 | 5 | 49 | calcium-dependent phospholipid binding |
GO:0022832 | 0.0079 | 2.4585 | 4.7083 | 11 | 188 | voltage-gated channel activity |
GO:0004983 | 0.0087 | 19.6506 | 0.1496 | 2 | 6 | neuropeptide Y receptor activity |
GO:0044323 | 0.0088 | 19.5553 | 0.1503 | 2 | 6 | retinoic acid-responsive element binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005518 | 0 | 6.9529 | 1.3075 | 8 | 68 | collagen binding |
GO:0005242 | 1e-04 | 11.7645 | 0.5191 | 5 | 27 | inward rectifier potassium channel activity |
GO:0022843 | 4e-04 | 4.0514 | 2.6726 | 10 | 139 | voltage-gated cation channel activity |
GO:0032184 | 0.0011 | 102.6667 | 0.0577 | 2 | 3 | SUMO polymer binding |
GO:0005267 | 0.002 | 3.7806 | 2.2688 | 8 | 118 | potassium channel activity |
GO:0018685 | 0.0022 | 51.3301 | 0.0769 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0022832 | 0.0035 | 2.9271 | 3.6147 | 10 | 188 | voltage-gated channel activity |
GO:0098973 | 0.0035 | 34.2179 | 0.0961 | 2 | 5 | structural constituent of postsynaptic actin cytoskeleton |
GO:0005201 | 0.0038 | 3.1005 | 3.0764 | 9 | 160 | extracellular matrix structural constituent |
GO:0030169 | 0.0039 | 11.0264 | 0.3269 | 3 | 17 | low-density lipoprotein particle binding |
GO:0015276 | 0.004 | 3.3508 | 2.538 | 8 | 132 | ligand-gated ion channel activity |
GO:0098918 | 0.0046 | 10.2907 | 0.3461 | 3 | 18 | structural constituent of synapse |
GO:0001664 | 0.0052 | 2.4858 | 5.076 | 12 | 264 | G protein-coupled receptor binding |
GO:0070697 | 0.0053 | 25.6619 | 0.1154 | 2 | 6 | activin receptor binding |
GO:0008391 | 0.0054 | 9.6469 | 0.3653 | 3 | 19 | arachidonic acid monooxygenase activity |
GO:0102033 | 0.0073 | 20.5282 | 0.1346 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0005102 | 0.0078 | 1.6525 | 20.4316 | 32 | 1087 | signaling receptor binding |
GO:0016849 | 0.0083 | 8.1222 | 0.423 | 3 | 22 | phosphorus-oxygen lyase activity |
GO:0005509 | 0.0086 | 1.8221 | 12.6515 | 22 | 658 | calcium ion binding |
GO:0005539 | 0.0089 | 2.5372 | 4.1339 | 10 | 215 | glycosaminoglycan binding |
GO:0001228 | 0.0091 | 2.0286 | 8.2485 | 16 | 429 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0008198 | 0.0094 | 7.7156 | 0.4422 | 3 | 23 | ferrous iron binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048407 | 0 | 29.3187 | 0.2128 | 4 | 11 | platelet-derived growth factor binding |
GO:0005267 | 1e-04 | 4.8133 | 2.2833 | 10 | 118 | potassium channel activity |
GO:0001228 | 3e-04 | 2.5781 | 8.301 | 20 | 429 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0005201 | 3e-04 | 3.8404 | 3.096 | 11 | 160 | extracellular matrix structural constituent |
GO:0005539 | 3e-04 | 3.3586 | 4.1602 | 13 | 215 | glycosaminoglycan binding |
GO:0005518 | 3e-04 | 5.9249 | 1.3158 | 7 | 68 | collagen binding |
GO:0030546 | 5e-04 | 2.4607 | 8.6687 | 20 | 448 | signaling receptor activator activity |
GO:0005178 | 7e-04 | 3.7325 | 2.8831 | 10 | 149 | integrin binding |
GO:0005017 | 0.0011 | 102 | 0.058 | 2 | 3 | platelet-derived growth factor-activated receptor activity |
GO:0003700 | 0.0012 | 1.7595 | 24.9998 | 41 | 1292 | DNA-binding transcription factor activity |
GO:0022843 | 0.0015 | 3.5822 | 2.6896 | 9 | 139 | voltage-gated cation channel activity |
GO:0005179 | 0.0017 | 3.8983 | 2.2059 | 8 | 114 | hormone activity |
GO:0086008 | 0.0018 | 15.3403 | 0.2515 | 3 | 13 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization |
GO:0008745 | 0.0022 | 50.9968 | 0.0774 | 2 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0018685 | 0.0022 | 50.9968 | 0.0774 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0038085 | 0.0022 | 50.9968 | 0.0774 | 2 | 4 | vascular endothelial growth factor binding |
GO:0071837 | 0.0022 | 13.9448 | 0.2709 | 3 | 14 | HMG box domain binding |
GO:0000978 | 0.0024 | 1.7591 | 21.1686 | 35 | 1094 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0008392 | 0.0027 | 12.7819 | 0.2902 | 3 | 15 | arachidonic acid epoxygenase activity |
GO:0016019 | 0.0036 | 33.9958 | 0.0967 | 2 | 5 | peptidoglycan immune receptor activity |
GO:0098973 | 0.0036 | 33.9958 | 0.0967 | 2 | 5 | structural constituent of postsynaptic actin cytoskeleton |
GO:0022832 | 0.0037 | 2.9076 | 3.6377 | 10 | 188 | voltage-gated channel activity |
GO:0098918 | 0.0047 | 10.2236 | 0.3483 | 3 | 18 | structural constituent of synapse |
GO:0015272 | 0.0053 | 25.4952 | 0.1161 | 2 | 6 | ATP-activated inward rectifier potassium channel activity |
GO:0070697 | 0.0053 | 25.4952 | 0.1161 | 2 | 6 | activin receptor binding |
GO:0001664 | 0.0055 | 2.4691 | 5.1083 | 12 | 264 | G protein-coupled receptor binding |
GO:0000976 | 0.0067 | 1.5846 | 26.7413 | 40 | 1382 | transcription cis-regulatory region binding |
GO:0005242 | 0.0073 | 8.5707 | 0.4039 | 3 | 21 | inward rectifier potassium channel activity |
GO:0102033 | 0.0074 | 20.3949 | 0.1354 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0070330 | 0.0074 | 8.5181 | 0.4063 | 3 | 21 | aromatase activity |
GO:0003690 | 0.0077 | 1.5446 | 29.5083 | 43 | 1525 | double-stranded DNA binding |
GO:1901681 | 0.0094 | 2.3908 | 4.8181 | 11 | 249 | sulfur compound binding |
GO:0008198 | 0.0095 | 7.6653 | 0.445 | 3 | 23 | ferrous iron binding |
GO:0004497 | 0.0098 | 3.503 | 1.8189 | 6 | 94 | monooxygenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004953 | 0.0018 | 15.179 | 0.2495 | 3 | 14 | icosanoid receptor activity |
GO:0004668 | 0.0019 | 55.4948 | 0.0713 | 2 | 4 | protein-arginine deiminase activity |
GO:0042169 | 0.005 | 6.3733 | 0.6949 | 4 | 39 | SH2 domain binding |
GO:0070696 | 0.0051 | 9.818 | 0.3564 | 3 | 20 | transmembrane receptor protein serine/threonine kinase binding |
GO:0005178 | 0.0053 | 3.1875 | 2.655 | 8 | 149 | integrin binding |
GO:0008083 | 0.0055 | 3.1649 | 2.6728 | 8 | 150 | growth factor activity |
GO:0005160 | 0.0086 | 7.9459 | 0.4277 | 3 | 24 | transforming growth factor beta receptor binding |
GO:0038023 | 0.0099 | 1.6 | 22.434 | 34 | 1259 | signaling receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 7.3851 | 4.9167 | 30 | 303 | protein heterodimerization activity |
GO:0005509 | 0 | 3.5142 | 10.6772 | 33 | 658 | calcium ion binding |
GO:0019904 | 0 | 2.7801 | 10.2391 | 26 | 631 | protein domain specific binding |
GO:0045296 | 1e-04 | 3.3541 | 5.1601 | 16 | 318 | cadherin binding |
GO:0030215 | 5e-04 | 12.9437 | 0.3732 | 4 | 23 | semaphorin receptor binding |
GO:0019531 | 0.0088 | 17.446 | 0.146 | 2 | 9 | oxalate transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 1e-04 | 3.2834 | 5.6032 | 17 | 303 | protein heterodimerization activity |
GO:0030545 | 1e-04 | 2.6534 | 8.9318 | 22 | 483 | signaling receptor regulator activity |
GO:0019904 | 3e-04 | 2.297 | 11.6687 | 25 | 631 | protein domain specific binding |
GO:0050786 | 5e-04 | 26.7943 | 0.1664 | 3 | 9 | RAGE receptor binding |
GO:0048018 | 0.0012 | 2.3948 | 7.976 | 18 | 434 | receptor ligand activity |
GO:0035662 | 0.002 | 53.4233 | 0.074 | 2 | 4 | Toll-like receptor 4 binding |
GO:0050544 | 0.0049 | 26.7083 | 0.111 | 2 | 6 | arachidonic acid binding |
GO:0016015 | 0.0067 | 21.3653 | 0.1294 | 2 | 7 | morphogen activity |
GO:0070410 | 0.0067 | 21.3653 | 0.1294 | 2 | 7 | co-SMAD binding |
GO:0005131 | 0.0089 | 17.8033 | 0.1479 | 2 | 8 | growth hormone receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1905576 | 0.001 | 109.4539 | 0.0542 | 2 | 3 | ganglioside GT1b binding |
GO:0016755 | 0.0027 | 12.6631 | 0.289 | 3 | 16 | aminoacyltransferase activity |
GO:0030546 | 0.0033 | 2.2141 | 8.0926 | 17 | 448 | signaling receptor activator activity |
GO:0019763 | 0.0046 | 27.3584 | 0.1084 | 2 | 6 | immunoglobulin receptor activity |
GO:0070696 | 0.0053 | 9.6811 | 0.3613 | 3 | 20 | transmembrane receptor protein serine/threonine kinase binding |
GO:0016015 | 0.0064 | 21.8853 | 0.1264 | 2 | 7 | morphogen activity |
GO:0005102 | 0.0072 | 1.6068 | 24.4042 | 37 | 1351 | signaling receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0036122 | 1e-04 | 20.9622 | 0.2498 | 4 | 17 | BMP binding |
GO:0005095 | 6e-04 | 22.6188 | 0.1764 | 3 | 12 | GTPase inhibitor activity |
GO:0004984 | 0.0034 | 2.7729 | 4.1884 | 11 | 285 | olfactory receptor activity |
GO:0016015 | 0.0043 | 27.0353 | 0.1029 | 2 | 7 | morphogen activity |
GO:0030546 | 0.0066 | 2.2348 | 6.5838 | 14 | 448 | signaling receptor activator activity |
GO:0019531 | 0.0072 | 19.3085 | 0.1323 | 2 | 9 | oxalate transmembrane transporter activity |
GO:0051219 | 0.0079 | 4.3124 | 1.2345 | 5 | 84 | phosphoprotein binding |
GO:0016653 | 0.009 | 16.8939 | 0.147 | 2 | 10 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 6.6224 | 4.6384 | 26 | 303 | protein heterodimerization activity |
GO:0005509 | 0 | 3.624 | 10.0729 | 32 | 658 | calcium ion binding |
GO:0019904 | 0 | 3.4394 | 7.7496 | 24 | 515 | protein domain specific binding |
GO:0045296 | 4e-04 | 3.0787 | 4.868 | 14 | 318 | cadherin binding |
GO:0035804 | 0.0014 | 64.8347 | 0.0612 | 2 | 4 | structural constituent of egg coat |
GO:0005134 | 0.0023 | 43.2204 | 0.0765 | 2 | 5 | interleukin-2 receptor binding |
GO:0032190 | 0.0023 | 43.2204 | 0.0765 | 2 | 5 | acrosin binding |
GO:0004857 | 0.0028 | 2.5782 | 5.3273 | 13 | 348 | enzyme inhibitor activity |
GO:0008307 | 0.0029 | 7.4546 | 0.597 | 4 | 39 | structural constituent of muscle |
GO:0140031 | 0.0034 | 32.4133 | 0.0918 | 2 | 6 | phosphorylation-dependent protein binding |
GO:0030215 | 0.005 | 9.7536 | 0.3521 | 3 | 23 | semaphorin receptor binding |
GO:0004867 | 0.0085 | 4.2417 | 1.2553 | 5 | 82 | serine-type endopeptidase inhibitor activity |
GO:0017124 | 0.0089 | 3.5703 | 1.7758 | 6 | 116 | SH3 domain binding |
GO:0044325 | 0.0096 | 3.5061 | 1.8064 | 6 | 118 | transmembrane transporter binding |
GO:0097493 | 0.0097 | 16.2026 | 0.1531 | 2 | 10 | structural molecule activity conferring elasticity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 8.274 | 5.6032 | 37 | 303 | protein heterodimerization activity |
GO:0004930 | 0 | 2.8452 | 12.4454 | 32 | 673 | G protein-coupled receptor activity |
GO:0004984 | 0 | 3.9785 | 5.2703 | 19 | 285 | olfactory receptor activity |
GO:0038023 | 0 | 2.0794 | 23.282 | 44 | 1259 | signaling receptor activity |
GO:0001601 | 0.001 | 106.8533 | 0.0555 | 2 | 3 | peptide YY receptor activity |
GO:0003677 | 0.0016 | 1.5777 | 42.1073 | 61 | 2277 | DNA binding |
GO:0019904 | 0.0034 | 1.9894 | 11.6687 | 22 | 631 | protein domain specific binding |
GO:0036122 | 0.0035 | 11.4775 | 0.3144 | 3 | 17 | BMP binding |
GO:0005549 | 0.0044 | 4.1994 | 1.5349 | 6 | 83 | odorant binding |
GO:0031849 | 0.0049 | 26.7083 | 0.111 | 2 | 6 | olfactory receptor binding |
GO:0016015 | 0.0067 | 21.3653 | 0.1294 | 2 | 7 | morphogen activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 9.9707 | 4.0662 | 32 | 285 | olfactory receptor activity |
GO:0004930 | 0 | 4.5894 | 9.6019 | 37 | 673 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.2766 | 17.9626 | 49 | 1259 | signaling receptor activity |
GO:0005549 | 0 | 13.5301 | 1.1842 | 13 | 83 | odorant binding |
GO:0030280 | 0 | 14.6459 | 0.4994 | 6 | 35 | structural constituent of skin epidermis |
GO:0031849 | 0.0029 | 34.8355 | 0.0856 | 2 | 6 | olfactory receptor binding |
GO:0001849 | 0.0041 | 27.8667 | 0.0999 | 2 | 7 | complement component C1q complex binding |
GO:0016015 | 0.0041 | 27.8667 | 0.0999 | 2 | 7 | morphogen activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 3e-04 | 3.5363 | 3.6474 | 12 | 285 | olfactory receptor activity |
GO:0005094 | 5e-04 | 155.7585 | 0.0384 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0035804 | 0.001 | 77.8744 | 0.0512 | 2 | 4 | structural constituent of egg coat |
GO:0030280 | 0.001 | 10.1281 | 0.4479 | 4 | 35 | structural constituent of skin epidermis |
GO:0004930 | 0.0011 | 2.3651 | 8.6129 | 19 | 673 | G protein-coupled receptor activity |
GO:0036122 | 0.0012 | 16.7559 | 0.2176 | 3 | 17 | BMP binding |
GO:0005134 | 0.0016 | 51.913 | 0.064 | 2 | 5 | interleukin-2 receptor binding |
GO:0032190 | 0.0016 | 51.913 | 0.064 | 2 | 5 | acrosin binding |
GO:0031849 | 0.0024 | 38.9324 | 0.0768 | 2 | 6 | olfactory receptor binding |
GO:0004806 | 0.0027 | 12.3426 | 0.2816 | 3 | 22 | triglyceride lipase activity |
GO:0016015 | 0.0033 | 31.144 | 0.0896 | 2 | 7 | morphogen activity |
GO:0016714 | 0.0033 | 31.144 | 0.0896 | 2 | 7 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen |
GO:0004869 | 0.0035 | 6.9711 | 0.6271 | 4 | 49 | cysteine-type endopeptidase inhibitor activity |
GO:0030414 | 0.004 | 3.7149 | 1.9964 | 7 | 156 | peptidase inhibitor activity |
GO:0005102 | 0.0041 | 1.8037 | 17.2898 | 29 | 1351 | signaling receptor binding |
GO:0030546 | 0.0052 | 2.3919 | 5.7334 | 13 | 448 | signaling receptor activator activity |
GO:0061135 | 0.0056 | 3.4791 | 2.1244 | 7 | 166 | endopeptidase regulator activity |
GO:0005095 | 0.0099 | 15.5671 | 0.1536 | 2 | 12 | GTPase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 7.1229 | 4.3454 | 26 | 285 | olfactory receptor activity |
GO:0004930 | 0 | 4.098 | 10.2613 | 36 | 673 | G protein-coupled receptor activity |
GO:0038023 | 0 | 2.6263 | 19.1961 | 44 | 1259 | signaling receptor activity |
GO:0008392 | 0 | 32.9344 | 0.2287 | 5 | 15 | arachidonic acid epoxygenase activity |
GO:0018685 | 0 | 196.1098 | 0.061 | 3 | 4 | alkane 1-monooxygenase activity |
GO:0102033 | 1e-04 | 49.0183 | 0.1067 | 3 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0020037 | 1e-04 | 5.2066 | 1.8906 | 9 | 124 | heme binding |
GO:0005506 | 2e-04 | 4.7111 | 2.0736 | 9 | 136 | iron ion binding |
GO:0070330 | 3e-04 | 15.4286 | 0.3202 | 4 | 21 | aromatase activity |
GO:0050051 | 0.0022 | 43.3981 | 0.0762 | 2 | 5 | leukotriene-B4 20-monooxygenase activity |
GO:0004866 | 0.0023 | 3.674 | 2.3176 | 8 | 152 | endopeptidase inhibitor activity |
GO:0005509 | 0.0027 | 2.1141 | 10.0326 | 20 | 658 | calcium ion binding |
GO:0061134 | 0.0031 | 3.2048 | 2.9732 | 9 | 195 | peptidase regulator activity |
GO:0070697 | 0.0033 | 32.5466 | 0.0915 | 2 | 6 | activin receptor binding |
GO:0016709 | 0.0034 | 7.08 | 0.6251 | 4 | 41 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GO:0033612 | 0.0056 | 9.3269 | 0.3659 | 3 | 24 | receptor serine/threonine kinase binding |
GO:0030621 | 0.0078 | 18.5946 | 0.1372 | 2 | 9 | U4 snRNA binding |
GO:0005242 | 0.0078 | 8.1596 | 0.4117 | 3 | 27 | inward rectifier potassium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 8.4243 | 4.3803 | 30 | 285 | olfactory receptor activity |
GO:0004930 | 0 | 4.3393 | 10.3437 | 38 | 673 | G protein-coupled receptor activity |
GO:0038023 | 0 | 2.9811 | 19.3503 | 49 | 1259 | signaling receptor activity |
GO:0008392 | 0 | 32.6626 | 0.2305 | 5 | 15 | arachidonic acid epoxygenase activity |
GO:0070330 | 3e-04 | 15.3017 | 0.3228 | 4 | 21 | aromatase activity |
GO:0020037 | 7e-04 | 4.5307 | 1.9058 | 8 | 124 | heme binding |
GO:0008745 | 0.0014 | 64.5703 | 0.0615 | 2 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0018685 | 0.0014 | 64.5703 | 0.0615 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0008233 | 0.0017 | 2.3163 | 8.2534 | 18 | 537 | peptidase activity |
GO:0015172 | 0.0017 | 14.9507 | 0.2459 | 3 | 16 | acidic amino acid transmembrane transporter activity |
GO:0017171 | 0.0018 | 3.5014 | 2.7358 | 9 | 178 | serine hydrolase activity |
GO:0008395 | 0.002 | 8.384 | 0.5379 | 4 | 35 | steroid hydroxylase activity |
GO:0005314 | 0.0023 | 43.0442 | 0.0768 | 2 | 5 | high-affinity glutamate transmembrane transporter activity |
GO:0016019 | 0.0023 | 43.0442 | 0.0768 | 2 | 5 | peptidoglycan immune receptor activity |
GO:0030414 | 0.0029 | 3.544 | 2.3976 | 8 | 156 | peptidase inhibitor activity |
GO:0004252 | 0.0031 | 3.4963 | 2.4284 | 8 | 158 | serine-type endopeptidase activity |
GO:0070697 | 0.0034 | 32.2811 | 0.0922 | 2 | 6 | activin receptor binding |
GO:0005518 | 0.0039 | 5.1674 | 1.0451 | 5 | 68 | collagen binding |
GO:0102033 | 0.0047 | 25.8233 | 0.1076 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0033612 | 0.0057 | 9.2506 | 0.3689 | 3 | 24 | receptor serine/threonine kinase binding |
GO:0019864 | 0.0079 | 18.4429 | 0.1383 | 2 | 9 | IgG binding |
GO:0030621 | 0.0079 | 18.4429 | 0.1383 | 2 | 9 | U4 snRNA binding |
GO:0005242 | 0.008 | 8.0927 | 0.415 | 3 | 27 | inward rectifier potassium channel activity |
GO:0004867 | 0.0086 | 4.2242 | 1.2603 | 5 | 82 | serine-type endopeptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 14.0745 | 3.9091 | 40 | 285 | olfactory receptor activity |
GO:0004930 | 0 | 7.1419 | 9.231 | 50 | 673 | G protein-coupled receptor activity |
GO:0038023 | 0 | 4.6573 | 17.2688 | 61 | 1259 | signaling receptor activity |
GO:0005549 | 0 | 12.7845 | 1.1384 | 12 | 83 | odorant binding |
GO:0020037 | 0 | 6.5556 | 1.7008 | 10 | 124 | heme binding |
GO:0018685 | 0 | 218.6335 | 0.0549 | 3 | 4 | alkane 1-monooxygenase activity |
GO:0008392 | 0 | 26.605 | 0.2057 | 4 | 15 | arachidonic acid epoxygenase activity |
GO:0102033 | 1e-04 | 54.6482 | 0.096 | 3 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0070330 | 2e-04 | 17.2086 | 0.288 | 4 | 21 | aromatase activity |
GO:0017171 | 2e-04 | 4.4334 | 2.4415 | 10 | 178 | serine hydrolase activity |
GO:0004873 | 2e-04 | Inf | 0.0274 | 2 | 2 | asialoglycoprotein receptor activity |
GO:0050251 | 2e-04 | Inf | 0.0274 | 2 | 2 | retinol isomerase activity |
GO:0004806 | 2e-04 | 16.2515 | 0.3018 | 4 | 22 | triglyceride lipase activity |
GO:0004252 | 3e-04 | 4.4833 | 2.1672 | 9 | 158 | serine-type endopeptidase activity |
GO:0042834 | 8e-04 | 19.8634 | 0.192 | 3 | 14 | peptidoglycan binding |
GO:0008395 | 0.0013 | 9.4287 | 0.4801 | 4 | 35 | steroid hydroxylase activity |
GO:0050051 | 0.0018 | 48.3604 | 0.0686 | 2 | 5 | leukotriene-B4 20-monooxygenase activity |
GO:0030246 | 0.0022 | 3.1425 | 3.3742 | 10 | 246 | carbohydrate binding |
GO:0005125 | 0.0023 | 3.3463 | 2.853 | 9 | 208 | cytokine activity |
GO:0016709 | 0.0023 | 7.8968 | 0.5624 | 4 | 41 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GO:0005506 | 0.0027 | 3.9955 | 1.8654 | 7 | 136 | iron ion binding |
GO:0008233 | 0.0031 | 2.3012 | 7.3656 | 16 | 537 | peptidase activity |
GO:0005102 | 0.0032 | 1.7993 | 18.5306 | 31 | 1351 | signaling receptor binding |
GO:0048306 | 0.0041 | 5.0847 | 1.0562 | 5 | 77 | calcium-dependent protein binding |
GO:0003823 | 0.0045 | 6.4897 | 0.6721 | 4 | 49 | antigen binding |
GO:0019864 | 0.0063 | 20.7207 | 0.1234 | 2 | 9 | IgG binding |
GO:0030621 | 0.0063 | 20.7207 | 0.1234 | 2 | 9 | U4 snRNA binding |
GO:0030546 | 0.0091 | 2.2197 | 6.1449 | 13 | 448 | signaling receptor activator activity |
GO:0005509 | 0.0094 | 1.9815 | 9.0253 | 17 | 658 | calcium ion binding |
GO:0016491 | 0.0095 | 1.9783 | 9.039 | 17 | 659 | oxidoreductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 7.8346 | 3.9964 | 26 | 285 | olfactory receptor activity |
GO:0004930 | 0 | 4.2193 | 9.4371 | 34 | 673 | G protein-coupled receptor activity |
GO:0038023 | 0 | 2.8301 | 17.6542 | 43 | 1259 | signaling receptor activity |
GO:0005549 | 0 | 8.8607 | 1.1639 | 9 | 83 | odorant binding |
GO:0005179 | 0.0011 | 4.7135 | 1.5986 | 7 | 114 | hormone activity |
GO:0042169 | 0.0021 | 8.161 | 0.5469 | 4 | 39 | SH2 domain binding |
GO:0033691 | 0.0026 | 12.5599 | 0.2804 | 3 | 20 | sialic acid binding |
GO:0019911 | 0.0039 | 28.3648 | 0.0982 | 2 | 7 | structural constituent of myelin sheath |
GO:0032394 | 0.0052 | 23.6358 | 0.1122 | 2 | 8 | MHC class Ib receptor activity |
GO:0003810 | 0.0066 | 20.258 | 0.1262 | 2 | 9 | protein-glutamine gamma-glutamyltransferase activity |
GO:0043295 | 0.0066 | 20.258 | 0.1262 | 2 | 9 | glutathione binding |
GO:0004252 | 0.007 | 3.3309 | 2.2155 | 7 | 158 | serine-type endopeptidase activity |
GO:0004875 | 0.0082 | 17.7247 | 0.1402 | 2 | 10 | complement receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 0 | 6.9481 | 2.9907 | 18 | 221 | mRNA base-pairing post-transcriptional repressor activity |
GO:0046982 | 0 | 5.2415 | 4.1004 | 19 | 303 | protein heterodimerization activity |
GO:0045182 | 0 | 4.6118 | 4.6146 | 19 | 341 | translation regulator activity |
GO:0004984 | 0 | 4.2718 | 3.8568 | 15 | 285 | olfactory receptor activity |
GO:0004930 | 1e-04 | 2.6252 | 9.1074 | 22 | 673 | G protein-coupled receptor activity |
GO:0005095 | 5e-04 | 24.6193 | 0.1624 | 3 | 12 | GTPase inhibitor activity |
GO:0005549 | 9e-04 | 5.8108 | 1.1232 | 6 | 83 | odorant binding |
GO:0003730 | 0.0011 | 3.7361 | 2.5712 | 9 | 190 | mRNA 3'-UTR binding |
GO:0005509 | 0.0016 | 2.2773 | 8.9044 | 19 | 658 | calcium ion binding |
GO:0003723 | 0.004 | 1.6912 | 23.6684 | 37 | 1749 | RNA binding |
GO:0019904 | 0.0055 | 2.1031 | 8.539 | 17 | 631 | protein domain specific binding |
GO:0019531 | 0.0062 | 21.0085 | 0.1218 | 2 | 9 | oxalate transmembrane transporter activity |
GO:0038023 | 0.0064 | 1.7535 | 17.0375 | 28 | 1259 | signaling receptor activity |
GO:0004955 | 0.0076 | 18.3813 | 0.1353 | 2 | 10 | prostaglandin receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 0 | 3.2608 | 9.267 | 27 | 658 | calcium ion binding |
GO:0046982 | 0 | 4.4134 | 4.2673 | 17 | 303 | protein heterodimerization activity |
GO:0019904 | 6e-04 | 2.4145 | 8.8868 | 20 | 631 | protein domain specific binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 7.5815 | 4.8054 | 30 | 303 | protein heterodimerization activity |
GO:0005509 | 0 | 3.741 | 10.4355 | 34 | 658 | calcium ion binding |
GO:0019904 | 1e-04 | 2.602 | 10.0073 | 24 | 631 | protein domain specific binding |
GO:0045296 | 6e-04 | 2.9639 | 5.0433 | 14 | 318 | cadherin binding |
GO:0004867 | 0.0019 | 4.9915 | 1.3005 | 6 | 82 | serine-type endopeptidase inhibitor activity |
GO:0044325 | 0.0028 | 3.9942 | 1.8714 | 7 | 118 | transmembrane transporter binding |
GO:0030414 | 0.0035 | 3.4293 | 2.4741 | 8 | 156 | peptidase inhibitor activity |
GO:0140031 | 0.0036 | 31.2607 | 0.0952 | 2 | 6 | phosphorylation-dependent protein binding |
GO:0061135 | 0.005 | 3.2102 | 2.6327 | 8 | 166 | endopeptidase regulator activity |
GO:0030215 | 0.0055 | 9.4055 | 0.3648 | 3 | 23 | semaphorin receptor binding |
GO:0019531 | 0.0084 | 17.8599 | 0.1427 | 2 | 9 | oxalate transmembrane transporter activity |
GO:0045499 | 0.0096 | 7.522 | 0.4441 | 3 | 28 | chemorepellent activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 10.825 | 1.7762 | 16 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051606 | 0 | 6.2855 | 3.5607 | 19 | 431 | detection of stimulus |
GO:0007186 | 0 | 4.0339 | 8.0466 | 27 | 974 | G protein-coupled receptor signaling pathway |
GO:0007600 | 0 | 4.5274 | 6.006 | 23 | 727 | sensory perception |
GO:0048252 | 0 | Inf | 0.0248 | 3 | 3 | lauric acid metabolic process |
GO:0003008 | 0 | 2.5041 | 16.1676 | 34 | 1957 | system process |
GO:0046968 | 2e-04 | 243.7121 | 0.0248 | 2 | 3 | peptide antigen transport |
GO:0031424 | 3e-04 | 9.1302 | 0.6031 | 5 | 73 | keratinization |
GO:0097022 | 4e-04 | 121.8485 | 0.033 | 2 | 4 | lymphocyte migration into lymph node |
GO:0002361 | 0.001 | 60.9167 | 0.0496 | 2 | 6 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:2000252 | 0.001 | 60.9167 | 0.0496 | 2 | 6 | negative regulation of feeding behavior |
GO:0015840 | 0.0014 | 48.7303 | 0.0578 | 2 | 7 | urea transport |
GO:0032808 | 0.0014 | 48.7303 | 0.0578 | 2 | 7 | lacrimal gland development |
GO:0048752 | 0.0014 | 48.7303 | 0.0578 | 2 | 7 | semicircular canal morphogenesis |
GO:0001580 | 0.0017 | 14.1456 | 0.2396 | 3 | 29 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0009820 | 0.0018 | 40.6061 | 0.0661 | 2 | 8 | alkaloid metabolic process |
GO:0019062 | 0.0018 | 40.6061 | 0.0661 | 2 | 8 | virion attachment to host cell |
GO:0042355 | 0.0023 | 34.803 | 0.0744 | 2 | 9 | L-fucose catabolic process |
GO:0060054 | 0.0023 | 34.803 | 0.0744 | 2 | 9 | positive regulation of epithelial cell proliferation involved in wound healing |
GO:0050907 | 0.0025 | 12.1634 | 0.2728 | 3 | 37 | detection of chemical stimulus involved in sensory perception |
GO:0042221 | 0.0028 | 1.7082 | 32.3186 | 47 | 3912 | response to chemical |
GO:0042756 | 0.0029 | 30.4508 | 0.0826 | 2 | 10 | drinking behavior |
GO:0071600 | 0.0029 | 30.4508 | 0.0826 | 2 | 10 | otic vesicle morphogenesis |
GO:0075733 | 0.0029 | 30.4508 | 0.0826 | 2 | 10 | intracellular transport of virus |
GO:1902622 | 0.0035 | 10.8119 | 0.3057 | 3 | 37 | regulation of neutrophil migration |
GO:1903238 | 0.0035 | 27.0657 | 0.0909 | 2 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0035195 | 0.0038 | 3.387 | 2.5115 | 8 | 304 | miRNA-mediated gene silencing |
GO:0060429 | 0.0042 | 2.1496 | 9.0958 | 18 | 1101 | epithelium development |
GO:0016441 | 0.0048 | 3.2525 | 2.6106 | 8 | 316 | post-transcriptional gene silencing |
GO:0050789 | 0.0048 | 1.693 | 87.637 | 102 | 10608 | regulation of biological process |
GO:0002864 | 0.005 | 22.1419 | 0.1074 | 2 | 13 | regulation of acute inflammatory response to antigenic stimulus |
GO:0044406 | 0.005 | 22.1419 | 0.1074 | 2 | 13 | adhesion of symbiont to host |
GO:0048484 | 0.005 | 22.1419 | 0.1074 | 2 | 13 | enteric nervous system development |
GO:0050930 | 0.005 | 22.1419 | 0.1074 | 2 | 13 | induction of positive chemotaxis |
GO:0048512 | 0.005 | 9.4228 | 0.347 | 3 | 42 | circadian behavior |
GO:0032309 | 0.0061 | 8.7481 | 0.3718 | 3 | 45 | icosanoid secretion |
GO:0097530 | 0.0061 | 4.5797 | 1.1566 | 5 | 140 | granulocyte migration |
GO:0035176 | 0.0065 | 8.5441 | 0.38 | 3 | 46 | social behavior |
GO:0019373 | 0.0066 | 18.7331 | 0.1239 | 2 | 15 | epoxygenase P450 pathway |
GO:0031047 | 0.0071 | 3.0315 | 2.7924 | 8 | 338 | gene silencing by RNA |
GO:0006004 | 0.0075 | 17.3939 | 0.1322 | 2 | 16 | fucose metabolic process |
GO:1903588 | 0.0075 | 17.3939 | 0.1322 | 2 | 16 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO:0015908 | 0.0077 | 5.4687 | 0.7766 | 4 | 94 | fatty acid transport |
GO:0002686 | 0.0077 | 7.9854 | 0.4048 | 3 | 49 | negative regulation of leukocyte migration |
GO:0003144 | 0.0083 | Inf | 0.0083 | 1 | 1 | embryonic heart tube formation |
GO:0006585 | 0.0083 | Inf | 0.0083 | 1 | 1 | dopamine biosynthetic process from tyrosine |
GO:0018963 | 0.0083 | Inf | 0.0083 | 1 | 1 | phthalate metabolic process |
GO:0042666 | 0.0083 | Inf | 0.0083 | 1 | 1 | negative regulation of ectodermal cell fate specification |
GO:0045818 | 0.0083 | Inf | 0.0083 | 1 | 1 | negative regulation of glycogen catabolic process |
GO:0050677 | 0.0083 | Inf | 0.0083 | 1 | 1 | positive regulation of urothelial cell proliferation |
GO:0050783 | 0.0083 | Inf | 0.0083 | 1 | 1 | cocaine metabolic process |
GO:0060101 | 0.0083 | Inf | 0.0083 | 1 | 1 | negative regulation of phagocytosis, engulfment |
GO:0060436 | 0.0083 | Inf | 0.0083 | 1 | 1 | bronchiole morphogenesis |
GO:0060496 | 0.0083 | Inf | 0.0083 | 1 | 1 | mesenchymal-epithelial cell signaling involved in lung development |
GO:0060879 | 0.0083 | Inf | 0.0083 | 1 | 1 | semicircular canal fusion |
GO:0061115 | 0.0083 | Inf | 0.0083 | 1 | 1 | lung proximal/distal axis specification |
GO:0071338 | 0.0083 | Inf | 0.0083 | 1 | 1 | positive regulation of hair follicle cell proliferation |
GO:0090321 | 0.0083 | Inf | 0.0083 | 1 | 1 | positive regulation of chylomicron remnant clearance |
GO:0110119 | 0.0083 | Inf | 0.0083 | 1 | 1 | positive regulation of very-low-density lipoprotein particle clearance |
GO:1901625 | 0.0083 | Inf | 0.0083 | 1 | 1 | cellular response to ergosterol |
GO:1902203 | 0.0083 | Inf | 0.0083 | 1 | 1 | negative regulation of hepatocyte growth factor receptor signaling pathway |
GO:1902569 | 0.0083 | Inf | 0.0083 | 1 | 1 | negative regulation of activation of Janus kinase activity |
GO:1905608 | 0.0083 | Inf | 0.0083 | 1 | 1 | positive regulation of presynapse assembly |
GO:1905716 | 0.0083 | Inf | 0.0083 | 1 | 1 | negative regulation of cornification |
GO:2001113 | 0.0083 | Inf | 0.0083 | 1 | 1 | negative regulation of cellular response to hepatocyte growth factor stimulus |
GO:0009404 | 0.0085 | 16.2333 | 0.1404 | 2 | 17 | toxin metabolic process |
GO:0036065 | 0.0085 | 16.2333 | 0.1404 | 2 | 17 | fucosylation |
GO:0043588 | 0.0085 | 3.2046 | 2.3049 | 7 | 279 | skin development |
GO:0050909 | 0.0091 | 7.4951 | 0.4296 | 3 | 52 | sensory perception of taste |
GO:0009913 | 0.0091 | 3.5438 | 1.7845 | 6 | 216 | epidermal cell differentiation |
GO:0042749 | 0.0095 | 15.2178 | 0.1487 | 2 | 18 | regulation of circadian sleep/wake cycle |
GO:0043651 | 0.0095 | 15.2178 | 0.1487 | 2 | 18 | linoleic acid metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031640 | 0.0022 | Inf | 0.0022 | 1 | 36 | killing of cells of another organism |
GO:0050832 | 0.0028 | Inf | 0.0028 | 1 | 45 | defense response to fungus |
GO:0031214 | 0.0097 | Inf | 0.0097 | 1 | 158 | biomineral tissue development |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 0 | 25.8411 | 0.1835 | 4 | 93 | embryonic skeletal system morphogenesis |
GO:0010536 | 1e-04 | 269.7333 | 0.0118 | 2 | 6 | positive regulation of activation of Janus kinase activity |
GO:0002761 | 1e-04 | 21.2698 | 0.221 | 4 | 112 | regulation of myeloid leukocyte differentiation |
GO:0071622 | 1e-04 | 38.8412 | 0.0908 | 3 | 46 | regulation of granulocyte chemotaxis |
GO:0048598 | 1e-04 | 7.4814 | 1.166 | 7 | 591 | embryonic morphogenesis |
GO:0048568 | 2e-04 | 8.3967 | 0.8661 | 6 | 439 | embryonic organ development |
GO:0010468 | 2e-04 | 3.7475 | 8.9983 | 19 | 4561 | regulation of gene expression |
GO:0006357 | 3e-04 | 4.0879 | 4.6047 | 13 | 2334 | regulation of transcription by RNA polymerase II |
GO:0051241 | 6e-04 | 5.0627 | 1.9887 | 8 | 1008 | negative regulation of multicellular organismal process |
GO:0045638 | 7e-04 | 19.3689 | 0.1756 | 3 | 89 | negative regulation of myeloid cell differentiation |
GO:1902106 | 8e-04 | 18.299 | 0.1855 | 3 | 94 | negative regulation of leukocyte differentiation |
GO:0043009 | 0.0012 | 5.8633 | 1.2212 | 6 | 619 | chordate embryonic development |
GO:0010556 | 0.0015 | 3.1548 | 7.0096 | 15 | 3553 | regulation of macromolecule biosynthetic process |
GO:0045671 | 0.0016 | 38.4762 | 0.0592 | 2 | 30 | negative regulation of osteoclast differentiation |
GO:0045165 | 0.0016 | 8.9261 | 0.511 | 4 | 259 | cell fate commitment |
GO:0021767 | 0.002 | Inf | 0.002 | 1 | 1 | mammillary body development |
GO:0035732 | 0.002 | Inf | 0.002 | 1 | 1 | nitric oxide storage |
GO:0042668 | 0.002 | Inf | 0.002 | 1 | 1 | auditory receptor cell fate determination |
GO:0045609 | 0.002 | Inf | 0.002 | 1 | 1 | positive regulation of inner ear auditory receptor cell differentiation |
GO:0045633 | 0.002 | Inf | 0.002 | 1 | 1 | positive regulation of mechanoreceptor differentiation |
GO:0061374 | 0.002 | Inf | 0.002 | 1 | 1 | mammillothalamic axonal tract development |
GO:0061381 | 0.002 | Inf | 0.002 | 1 | 1 | cell migration in diencephalon |
GO:1901625 | 0.002 | Inf | 0.002 | 1 | 1 | cellular response to ergosterol |
GO:0003002 | 0.002 | 13.4499 | 0.2517 | 3 | 139 | regionalization |
GO:1902622 | 0.0024 | 30.7676 | 0.073 | 2 | 37 | regulation of neutrophil migration |
GO:0007417 | 0.0024 | 4.4268 | 1.9137 | 7 | 970 | central nervous system development |
GO:0032147 | 0.0025 | 12.3011 | 0.2723 | 3 | 138 | activation of protein kinase activity |
GO:0097530 | 0.0026 | 12.1201 | 0.2762 | 3 | 140 | granulocyte migration |
GO:0046427 | 0.0028 | 28.3333 | 0.0789 | 2 | 40 | positive regulation of receptor signaling pathway via JAK-STAT |
GO:0014014 | 0.0029 | 27.6051 | 0.0809 | 2 | 41 | negative regulation of gliogenesis |
GO:0051171 | 0.0037 | 2.7557 | 10.1958 | 18 | 5168 | regulation of nitrogen compound metabolic process |
GO:1903506 | 0.0037 | 2.933 | 6.0666 | 13 | 3075 | regulation of nucleic acid-templated transcription |
GO:0021543 | 0.0039 | 10.4288 | 0.3196 | 3 | 162 | pallium development |
GO:0021893 | 0.0039 | 522.1613 | 0.0039 | 1 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:0032812 | 0.0039 | 522.1613 | 0.0039 | 1 | 2 | positive regulation of epinephrine secretion |
GO:0042667 | 0.0039 | 522.1613 | 0.0039 | 1 | 2 | auditory receptor cell fate specification |
GO:0061379 | 0.0039 | 522.1613 | 0.0039 | 1 | 2 | inferior colliculus development |
GO:1902871 | 0.0039 | 522.1613 | 0.0039 | 1 | 2 | positive regulation of amacrine cell differentiation |
GO:1905590 | 0.0039 | 522.1613 | 0.0039 | 1 | 2 | fibronectin fibril organization |
GO:0032680 | 0.004 | 10.3629 | 0.3216 | 3 | 163 | regulation of tumor necrosis factor production |
GO:0002686 | 0.0042 | 22.895 | 0.0967 | 2 | 49 | negative regulation of leukocyte migration |
GO:0071396 | 0.0042 | 5.3053 | 1.0871 | 5 | 551 | cellular response to lipid |
GO:0071706 | 0.0043 | 10.0458 | 0.3314 | 3 | 168 | tumor necrosis factor superfamily cytokine production |
GO:0050789 | 0.0046 | 3.7104 | 20.9282 | 28 | 10608 | regulation of biological process |
GO:1903706 | 0.0047 | 6.5602 | 0.6885 | 4 | 349 | regulation of hemopoiesis |
GO:0080090 | 0.0051 | 2.6472 | 10.476 | 18 | 5310 | regulation of primary metabolic process |
GO:0006351 | 0.0051 | 2.8054 | 6.2875 | 13 | 3187 | transcription, DNA-templated |
GO:0042330 | 0.0052 | 5.0283 | 1.1443 | 5 | 580 | taxis |
GO:0050727 | 0.0053 | 6.3531 | 0.7102 | 4 | 360 | regulation of inflammatory response |
GO:0030900 | 0.0053 | 6.3349 | 0.7122 | 4 | 361 | forebrain development |
GO:0032774 | 0.0054 | 2.7857 | 6.3231 | 13 | 3205 | RNA biosynthetic process |
GO:0045604 | 0.0056 | 19.5552 | 0.1125 | 2 | 57 | regulation of epidermal cell differentiation |
GO:0007412 | 0.0059 | 261.0645 | 0.0059 | 1 | 3 | axon target recognition |
GO:0046952 | 0.0059 | 261.0645 | 0.0059 | 1 | 3 | ketone body catabolic process |
GO:0070253 | 0.0059 | 261.0645 | 0.0059 | 1 | 3 | somatostatin secretion |
GO:1901687 | 0.0059 | 261.0645 | 0.0059 | 1 | 3 | glutathione derivative biosynthetic process |
GO:2000503 | 0.0059 | 261.0645 | 0.0059 | 1 | 3 | positive regulation of natural killer cell chemotaxis |
GO:0042531 | 0.0062 | 18.5402 | 0.1184 | 2 | 60 | positive regulation of tyrosine phosphorylation of STAT protein |
GO:0045595 | 0.0063 | 3.3829 | 2.8804 | 8 | 1460 | regulation of cell differentiation |
GO:0007275 | 0.0063 | 2.6029 | 8.8957 | 16 | 4509 | multicellular organism development |
GO:0031663 | 0.0064 | 18.2249 | 0.1203 | 2 | 61 | lipopolysaccharide-mediated signaling pathway |
GO:0032502 | 0.0066 | 2.5697 | 11.6163 | 19 | 5888 | developmental process |
GO:0045859 | 0.0068 | 4.7052 | 1.2192 | 5 | 618 | regulation of protein kinase activity |
GO:0009888 | 0.0068 | 3.1239 | 3.5729 | 9 | 1811 | tissue development |
GO:0031326 | 0.0069 | 2.6371 | 7.3016 | 14 | 3701 | regulation of cellular biosynthetic process |
GO:0009952 | 0.0072 | 8.3117 | 0.3985 | 3 | 202 | anterior/posterior pattern specification |
GO:0001550 | 0.0079 | 174.0323 | 0.0079 | 1 | 4 | ovarian cumulus expansion |
GO:0032497 | 0.0079 | 174.0323 | 0.0079 | 1 | 4 | detection of lipopolysaccharide |
GO:0051771 | 0.0079 | 174.0323 | 0.0079 | 1 | 4 | negative regulation of nitric-oxide synthase biosynthetic process |
GO:0061030 | 0.0079 | 174.0323 | 0.0079 | 1 | 4 | epithelial cell differentiation involved in mammary gland alveolus development |
GO:0061737 | 0.0079 | 174.0323 | 0.0079 | 1 | 4 | leukotriene signaling pathway |
GO:0070093 | 0.0079 | 174.0323 | 0.0079 | 1 | 4 | negative regulation of glucagon secretion |
GO:0090024 | 0.0079 | 174.0323 | 0.0079 | 1 | 4 | negative regulation of neutrophil chemotaxis |
GO:2000330 | 0.0079 | 174.0323 | 0.0079 | 1 | 4 | positive regulation of T-helper 17 cell lineage commitment |
GO:0051252 | 0.008 | 2.6339 | 6.6111 | 13 | 3351 | regulation of RNA metabolic process |
GO:0050920 | 0.008 | 7.9865 | 0.4143 | 3 | 210 | regulation of chemotaxis |
GO:0071219 | 0.0086 | 7.7957 | 0.4242 | 3 | 215 | cellular response to molecule of bacterial origin |
GO:0030595 | 0.0094 | 7.5432 | 0.438 | 3 | 222 | leukocyte chemotaxis |
GO:0030101 | 0.0096 | 14.7169 | 0.148 | 2 | 75 | natural killer cell activation |
GO:0021855 | 0.0098 | 130.5161 | 0.0099 | 1 | 5 | hypothalamus cell migration |
GO:0060120 | 0.0098 | 130.5161 | 0.0099 | 1 | 5 | inner ear receptor cell fate commitment |
GO:0097211 | 0.0098 | 130.5161 | 0.0099 | 1 | 5 | cellular response to gonadotropin-releasing hormone |
GO:0009636 | 0.0099 | 7.3725 | 0.4478 | 3 | 227 | response to toxic substance |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 8.6194 | 2.6113 | 19 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 6.6679 | 3.4858 | 20 | 287 | detection of chemical stimulus |
GO:0007606 | 0 | 6.4231 | 3.6072 | 20 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 6.0662 | 3.8015 | 20 | 313 | detection of stimulus involved in sensory perception |
GO:0050877 | 0 | 3.3743 | 9.5202 | 28 | 828 | nervous system process |
GO:0007186 | 0 | 2.9101 | 10.4212 | 27 | 875 | G protein-coupled receptor signaling pathway |
GO:1903238 | 0 | 47.4197 | 0.1336 | 4 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0032501 | 0 | 1.9253 | 56.2086 | 81 | 5299 | multicellular organismal process |
GO:0035195 | 1e-04 | 3.8196 | 3.6922 | 13 | 304 | miRNA-mediated gene silencing |
GO:0007389 | 1e-04 | 3.2132 | 5.4047 | 16 | 445 | pattern specification process |
GO:0016441 | 1e-04 | 3.6655 | 3.838 | 13 | 316 | post-transcriptional gene silencing |
GO:0042756 | 2e-04 | 35.3814 | 0.1215 | 3 | 10 | drinking behavior |
GO:0035176 | 2e-04 | 10.1512 | 0.5587 | 5 | 46 | social behavior |
GO:0031047 | 3e-04 | 3.4126 | 4.1052 | 13 | 338 | gene silencing by RNA |
GO:0050789 | 4e-04 | 1.7619 | 125.9423 | 148 | 10540 | regulation of biological process |
GO:0001705 | 4e-04 | 164.3282 | 0.0364 | 2 | 3 | ectoderm formation |
GO:0007412 | 4e-04 | 164.3282 | 0.0364 | 2 | 3 | axon target recognition |
GO:0046968 | 4e-04 | 164.3282 | 0.0364 | 2 | 3 | peptide antigen transport |
GO:0048252 | 4e-04 | 164.3282 | 0.0364 | 2 | 3 | lauric acid metabolic process |
GO:0097377 | 4e-04 | 164.3282 | 0.0364 | 2 | 3 | spinal cord interneuron axon guidance |
GO:0048665 | 5e-04 | 12.7517 | 0.3644 | 4 | 30 | neuron fate specification |
GO:0048704 | 5e-04 | 6.6575 | 0.9865 | 6 | 82 | embryonic skeletal system morphogenesis |
GO:0048484 | 5e-04 | 24.7624 | 0.1579 | 3 | 13 | enteric nervous system development |
GO:0009888 | 5e-04 | 1.9208 | 21.9955 | 38 | 1811 | tissue development |
GO:0060795 | 6e-04 | 11.8394 | 0.3887 | 4 | 32 | cell fate commitment involved in formation of primary germ layer |
GO:1904994 | 7e-04 | 11.4304 | 0.4008 | 4 | 33 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0014031 | 7e-04 | 6.1827 | 1.0567 | 6 | 87 | mesenchymal cell development |
GO:0048864 | 7e-04 | 6.1827 | 1.0567 | 6 | 87 | stem cell development |
GO:0045596 | 7e-04 | 2.5365 | 7.6395 | 18 | 629 | negative regulation of cell differentiation |
GO:0001755 | 7e-04 | 7.8469 | 0.7044 | 5 | 58 | neural crest cell migration |
GO:0019373 | 7e-04 | 20.6327 | 0.1822 | 3 | 15 | epoxygenase P450 pathway |
GO:0050890 | 8e-04 | 3.3618 | 3.4979 | 11 | 288 | cognition |
GO:0002691 | 8e-04 | 10.6916 | 0.4251 | 4 | 35 | regulation of cellular extravasation |
GO:0009952 | 8e-04 | 3.9265 | 2.4534 | 9 | 202 | anterior/posterior pattern specification |
GO:0097022 | 9e-04 | 82.159 | 0.0486 | 2 | 4 | lymphocyte migration into lymph node |
GO:0032095 | 9e-04 | 19.0444 | 0.1943 | 3 | 16 | regulation of response to food |
GO:0045780 | 9e-04 | 19.0444 | 0.1943 | 3 | 16 | positive regulation of bone resorption |
GO:1903588 | 9e-04 | 19.0444 | 0.1943 | 3 | 16 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO:0014033 | 9e-04 | 5.7541 | 1.1295 | 6 | 93 | neural crest cell differentiation |
GO:0048568 | 0.001 | 2.8077 | 5.3319 | 14 | 439 | embryonic organ development |
GO:0042755 | 0.0011 | 9.7464 | 0.4615 | 4 | 38 | eating behavior |
GO:0006959 | 0.0012 | 3.7122 | 2.587 | 9 | 213 | humoral immune response |
GO:0014016 | 0.0014 | 54.7692 | 0.0607 | 2 | 5 | neuroblast differentiation |
GO:0060406 | 0.0014 | 54.7692 | 0.0607 | 2 | 5 | positive regulation of penile erection |
GO:0002523 | 0.0015 | 15.4707 | 0.2308 | 3 | 19 | leukocyte migration involved in inflammatory response |
GO:0048332 | 0.0016 | 6.3934 | 0.8502 | 5 | 70 | mesoderm morphogenesis |
GO:0072009 | 0.0018 | 5.0528 | 1.2753 | 6 | 105 | nephron epithelium development |
GO:0048869 | 0.0019 | 1.5908 | 47.6104 | 66 | 3920 | cellular developmental process |
GO:0002673 | 0.0021 | 8.0789 | 0.5465 | 4 | 45 | regulation of acute inflammatory response |
GO:0032309 | 0.0021 | 8.0789 | 0.5465 | 4 | 45 | icosanoid secretion |
GO:0002361 | 0.0021 | 41.0744 | 0.0729 | 2 | 6 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0010668 | 0.0021 | 41.0744 | 0.0729 | 2 | 6 | ectodermal cell differentiation |
GO:0060455 | 0.0021 | 41.0744 | 0.0729 | 2 | 6 | negative regulation of gastric acid secretion |
GO:0072143 | 0.0021 | 41.0744 | 0.0729 | 2 | 6 | mesangial cell development |
GO:2000252 | 0.0021 | 41.0744 | 0.0729 | 2 | 6 | negative regulation of feeding behavior |
GO:2000543 | 0.0021 | 41.0744 | 0.0729 | 2 | 6 | positive regulation of gastrulation |
GO:0022008 | 0.0023 | 1.8358 | 18.9834 | 32 | 1563 | neurogenesis |
GO:0002438 | 0.0023 | 13.0255 | 0.2672 | 3 | 22 | acute inflammatory response to antigenic stimulus |
GO:0042745 | 0.0023 | 13.0255 | 0.2672 | 3 | 22 | circadian sleep/wake cycle |
GO:0035850 | 0.0023 | 7.886 | 0.5587 | 4 | 46 | epithelial cell differentiation involved in kidney development |
GO:0008306 | 0.0024 | 5.7693 | 0.9352 | 5 | 77 | associative learning |
GO:0021537 | 0.0026 | 3.3017 | 2.8906 | 9 | 238 | telencephalon development |
GO:0051241 | 0.0027 | 2.0181 | 12.2427 | 23 | 1008 | negative regulation of multicellular organismal process |
GO:0023052 | 0.0029 | 1.5084 | 69.8366 | 89 | 5750 | signaling |
GO:0046850 | 0.0029 | 7.3589 | 0.5951 | 4 | 49 | regulation of bone remodeling |
GO:0002052 | 0.003 | 11.7835 | 0.2915 | 3 | 24 | positive regulation of neuroblast proliferation |
GO:0051971 | 0.003 | 32.8574 | 0.085 | 2 | 7 | positive regulation of transmission of nerve impulse |
GO:0120252 | 0.003 | 32.8574 | 0.085 | 2 | 7 | hydrocarbon metabolic process |
GO:0019731 | 0.0031 | 7.1985 | 0.6073 | 4 | 50 | antibacterial humoral response |
GO:0032104 | 0.0033 | 11.2472 | 0.3036 | 3 | 25 | regulation of response to extracellular stimulus |
GO:1903671 | 0.0033 | 11.2472 | 0.3036 | 3 | 25 | negative regulation of sprouting angiogenesis |
GO:2000177 | 0.0034 | 5.3235 | 1.0081 | 5 | 83 | regulation of neural precursor cell proliferation |
GO:0048731 | 0.0036 | 1.5803 | 40.9729 | 57 | 3554 | system development |
GO:0009820 | 0.0039 | 27.3795 | 0.0972 | 2 | 8 | alkaloid metabolic process |
GO:0019062 | 0.0039 | 27.3795 | 0.0972 | 2 | 8 | virion attachment to host cell |
GO:0048793 | 0.0039 | 27.3795 | 0.0972 | 2 | 8 | pronephros development |
GO:0072177 | 0.0039 | 27.3795 | 0.0972 | 2 | 8 | mesonephric duct development |
GO:0001656 | 0.004 | 5.1254 | 1.0445 | 5 | 86 | metanephros development |
GO:0048878 | 0.004 | 1.9195 | 13.4086 | 24 | 1104 | chemical homeostasis |
GO:0007154 | 0.0041 | 1.4857 | 69.7056 | 88 | 5797 | cell communication |
GO:0048771 | 0.0042 | 3.6759 | 2.0162 | 7 | 166 | tissue remodeling |
GO:0009653 | 0.0043 | 1.6133 | 31.469 | 46 | 2591 | anatomical structure morphogenesis |
GO:0050673 | 0.0043 | 2.5531 | 4.9675 | 12 | 409 | epithelial cell proliferation |
GO:0009605 | 0.0047 | 1.6181 | 29.9022 | 44 | 2462 | response to external stimulus |
GO:0001657 | 0.0048 | 4.883 | 1.0931 | 5 | 90 | ureteric bud development |
GO:0007369 | 0.005 | 3.5559 | 2.0806 | 7 | 173 | gastrulation |
GO:0042355 | 0.005 | 23.4667 | 0.1093 | 2 | 9 | L-fucose catabolic process |
GO:1904238 | 0.005 | 23.4667 | 0.1093 | 2 | 9 | pericyte cell differentiation |
GO:0072163 | 0.005 | 4.8259 | 1.1052 | 5 | 91 | mesonephric epithelium development |
GO:0048265 | 0.0051 | 9.5145 | 0.3522 | 3 | 29 | response to pain |
GO:1901700 | 0.0054 | 1.7529 | 18.4655 | 30 | 1535 | response to oxygen-containing compound |
GO:0031644 | 0.0055 | 3.9634 | 1.6032 | 6 | 132 | regulation of nervous system process |
GO:0015908 | 0.0058 | 4.6623 | 1.1417 | 5 | 94 | fatty acid transport |
GO:0007612 | 0.006 | 5.9328 | 0.7255 | 4 | 61 | learning |
GO:0043279 | 0.006 | 4.6102 | 1.1538 | 5 | 95 | response to alkaloid |
GO:0072171 | 0.0061 | 5.9093 | 0.7287 | 4 | 60 | mesonephric tubule morphogenesis |
GO:0035115 | 0.0062 | 8.8338 | 0.3765 | 3 | 31 | embryonic forelimb morphogenesis |
GO:0010986 | 0.0062 | 20.5321 | 0.1215 | 2 | 10 | positive regulation of lipoprotein particle clearance |
GO:0045472 | 0.0062 | 20.5321 | 0.1215 | 2 | 10 | response to ether |
GO:0048703 | 0.0062 | 20.5321 | 0.1215 | 2 | 10 | embryonic viscerocranium morphogenesis |
GO:0075733 | 0.0062 | 20.5321 | 0.1215 | 2 | 10 | intracellular transport of virus |
GO:0048333 | 0.0068 | 8.5286 | 0.3887 | 3 | 32 | mesodermal cell differentiation |
GO:0007218 | 0.0072 | 4.413 | 1.2024 | 5 | 99 | neuropeptide signaling pathway |
GO:0032835 | 0.0072 | 5.6078 | 0.7652 | 4 | 63 | glomerulus development |
GO:0002009 | 0.0072 | 2.2927 | 5.9756 | 13 | 492 | morphogenesis of an epithelium |
GO:0021794 | 0.0075 | 18.2496 | 0.1336 | 2 | 11 | thalamus development |
GO:0032099 | 0.0075 | 18.2496 | 0.1336 | 2 | 11 | negative regulation of appetite |
GO:0032108 | 0.0075 | 18.2496 | 0.1336 | 2 | 11 | negative regulation of response to nutrient levels |
GO:0060272 | 0.0075 | 18.2496 | 0.1336 | 2 | 11 | embryonic skeletal joint morphogenesis |
GO:0072178 | 0.0075 | 18.2496 | 0.1336 | 2 | 11 | nephric duct morphogenesis |
GO:0072182 | 0.0075 | 18.2496 | 0.1336 | 2 | 11 | regulation of nephron tubule epithelial cell differentiation |
GO:0030182 | 0.0076 | 1.7693 | 15.7163 | 26 | 1294 | neuron differentiation |
GO:2000026 | 0.0077 | 1.7678 | 15.7284 | 26 | 1295 | regulation of multicellular organismal development |
GO:0120254 | 0.0078 | 3.6696 | 1.7247 | 6 | 142 | olefinic compound metabolic process |
GO:0009954 | 0.008 | 7.9774 | 0.4129 | 3 | 34 | proximal/distal pattern formation |
GO:0010466 | 0.0085 | 2.9193 | 2.8785 | 8 | 237 | negative regulation of peptidase activity |
GO:0043009 | 0.0087 | 2.104 | 7.5181 | 15 | 619 | chordate embryonic development |
GO:0007501 | 0.0089 | 16.4236 | 0.1457 | 2 | 12 | mesodermal cell fate specification |
GO:0010273 | 0.0089 | 16.4236 | 0.1457 | 2 | 12 | detoxification of copper ion |
GO:0061564 | 0.009 | 2.308 | 5.4655 | 12 | 450 | axon development |
GO:0001501 | 0.0093 | 2.2163 | 6.1699 | 13 | 508 | skeletal system development |
GO:0050795 | 0.0094 | 5.1681 | 0.8259 | 4 | 68 | regulation of behavior |
GO:0021987 | 0.0098 | 4.0648 | 1.2996 | 5 | 107 | cerebral cortex development |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051919 | 2e-04 | Inf | 2e-04 | 1 | 4 | positive regulation of fibrinolysis |
GO:0031639 | 0.0015 | Inf | 0.0015 | 1 | 24 | plasminogen activation |
GO:1900047 | 0.003 | Inf | 0.003 | 1 | 49 | negative regulation of hemostasis |
GO:0050819 | 0.0032 | Inf | 0.0032 | 1 | 52 | negative regulation of coagulation |
GO:0030193 | 0.0041 | Inf | 0.0041 | 1 | 66 | regulation of blood coagulation |
GO:0061045 | 0.0044 | Inf | 0.0044 | 1 | 71 | negative regulation of wound healing |
GO:1903034 | 0.0097 | Inf | 0.0097 | 1 | 157 | regulation of response to wounding |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 61.8164 | 0.2386 | 8 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 45.6573 | 0.3185 | 8 | 287 | detection of chemical stimulus |
GO:0007606 | 0 | 44.0498 | 0.3296 | 8 | 297 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 41.697 | 0.3473 | 8 | 313 | detection of stimulus involved in sensory perception |
GO:0048252 | 0 | 2025.125 | 0.0033 | 2 | 3 | lauric acid metabolic process |
GO:0007186 | 0 | 12.6178 | 1.0809 | 8 | 974 | G protein-coupled receptor signaling pathway |
GO:0050877 | 0 | 9.9032 | 1.3528 | 8 | 1219 | nervous system process |
GO:0043651 | 2e-04 | 126.4531 | 0.02 | 2 | 18 | linoleic acid metabolic process |
GO:0032501 | 3e-04 | 7.0856 | 7.4552 | 15 | 6718 | multicellular organismal process |
GO:1901625 | 0.0011 | Inf | 0.0011 | 1 | 1 | cellular response to ergosterol |
GO:1905608 | 0.0011 | Inf | 0.0011 | 1 | 1 | positive regulation of presynapse assembly |
GO:0046456 | 0.0016 | 39.5858 | 0.0588 | 2 | 53 | icosanoid biosynthetic process |
GO:0003095 | 0.0022 | 953 | 0.0022 | 1 | 2 | pressure natriuresis |
GO:0031408 | 0.0022 | 953 | 0.0022 | 1 | 2 | oxylipin biosynthetic process |
GO:1905652 | 0.0022 | 953 | 0.0022 | 1 | 2 | negative regulation of artery morphogenesis |
GO:0036101 | 0.0044 | 317.6275 | 0.0044 | 1 | 4 | leukotriene B4 catabolic process |
GO:0051919 | 0.0044 | 317.6275 | 0.0044 | 1 | 4 | positive regulation of fibrinolysis |
GO:0015908 | 0.0048 | 21.8886 | 0.1043 | 2 | 94 | fatty acid transport |
GO:1905700 | 0.0055 | 238.2059 | 0.0055 | 1 | 5 | negative regulation of xenobiotic detoxification by transmembrane export across the plasma membrane |
GO:2001023 | 0.0066 | 190.5529 | 0.0067 | 1 | 6 | regulation of response to drug |
GO:0002933 | 0.0077 | 158.7843 | 0.0078 | 1 | 7 | lipid hydroxylation |
GO:0048680 | 0.0099 | 119.0735 | 0.01 | 1 | 9 | positive regulation of axon regeneration |
GO:0097267 | 0.0099 | 119.0735 | 0.01 | 1 | 9 | omega-hydroxylase P450 pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 25.4535 | 2.9294 | 47 | 215 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051606 | 0 | 11.986 | 5.8724 | 50 | 431 | detection of stimulus |
GO:0007186 | 0 | 6.9169 | 13.2709 | 65 | 974 | G protein-coupled receptor signaling pathway |
GO:0007600 | 0 | 7.5569 | 9.9055 | 55 | 727 | sensory perception |
GO:0003008 | 0 | 3.4669 | 26.6644 | 70 | 1957 | system process |
GO:0042221 | 0 | 2.4983 | 53.3016 | 97 | 3912 | response to chemical |
GO:0035195 | 0 | 5.1861 | 4.142 | 19 | 304 | miRNA-mediated gene silencing |
GO:0016441 | 0 | 4.9728 | 4.3055 | 19 | 316 | post-transcriptional gene silencing |
GO:0031047 | 0 | 4.6234 | 4.6053 | 19 | 338 | gene silencing by RNA |
GO:0023052 | 0 | 1.8883 | 78.3446 | 112 | 5750 | signaling |
GO:0048252 | 0 | Inf | 0.0409 | 3 | 3 | lauric acid metabolic process |
GO:0007154 | 0 | 1.8627 | 79.0259 | 112 | 5800 | cell communication |
GO:0051716 | 0 | 1.7614 | 90.4165 | 121 | 6636 | cellular response to stimulus |
GO:0019373 | 0 | 26.7918 | 0.2044 | 4 | 15 | epoxygenase P450 pathway |
GO:0042742 | 0 | 4.1389 | 3.4199 | 13 | 251 | defense response to bacterium |
GO:0045087 | 0 | 2.6908 | 9.7692 | 24 | 717 | innate immune response |
GO:0070328 | 2e-04 | 10.8694 | 0.5314 | 5 | 39 | triglyceride homeostasis |
GO:1905949 | 2e-04 | Inf | 0.0273 | 2 | 2 | negative regulation of calcium ion import across plasma membrane |
GO:0006952 | 3e-04 | 1.9995 | 20.4241 | 37 | 1499 | defense response |
GO:0009607 | 3e-04 | 2.0604 | 17.5628 | 33 | 1289 | response to biotic stimulus |
GO:0046968 | 5e-04 | 146.1005 | 0.0409 | 2 | 3 | peptide antigen transport |
GO:0019730 | 7e-04 | 5.2006 | 1.4579 | 7 | 107 | antimicrobial humoral response |
GO:0120254 | 7e-04 | 4.4468 | 1.9348 | 8 | 142 | olefinic compound metabolic process |
GO:1901386 | 0.0012 | 16.9224 | 0.218 | 3 | 16 | negative regulation of voltage-gated calcium channel activity |
GO:0014016 | 0.0018 | 48.6941 | 0.0681 | 2 | 5 | neuroblast differentiation |
GO:0001676 | 0.0025 | 4.7219 | 1.3625 | 6 | 100 | long-chain fatty acid metabolic process |
GO:2000252 | 0.0027 | 36.5183 | 0.0818 | 2 | 6 | negative regulation of feeding behavior |
GO:0033559 | 0.0027 | 4.623 | 1.3898 | 6 | 102 | unsaturated fatty acid metabolic process |
GO:0003071 | 0.0032 | 11.5741 | 0.2998 | 3 | 22 | renal system process involved in regulation of systemic arterial blood pressure |
GO:0036315 | 0.0032 | 11.5741 | 0.2998 | 3 | 22 | cellular response to sterol |
GO:0006690 | 0.0036 | 4.3494 | 1.4715 | 6 | 108 | icosanoid metabolic process |
GO:0002933 | 0.0037 | 29.2128 | 0.0954 | 2 | 7 | lipid hydroxylation |
GO:0120252 | 0.0037 | 29.2128 | 0.0954 | 2 | 7 | hydrocarbon metabolic process |
GO:0050789 | 0.0037 | 1.5427 | 119.9599 | 138 | 9345 | regulation of biological process |
GO:0002682 | 0.0039 | 1.8072 | 17.2086 | 29 | 1263 | regulation of immune system process |
GO:1903671 | 0.0046 | 9.994 | 0.3406 | 3 | 25 | negative regulation of sprouting angiogenesis |
GO:0050896 | 0.0048 | 3.0626 | 3.2411 | 9 | 367 | response to stimulus |
GO:0009820 | 0.0049 | 24.3425 | 0.109 | 2 | 8 | alkaloid metabolic process |
GO:0019062 | 0.0049 | 24.3425 | 0.109 | 2 | 8 | virion attachment to host cell |
GO:0070268 | 0.0049 | 24.3425 | 0.109 | 2 | 8 | cornification |
GO:0042110 | 0.0049 | 2.321 | 6.3629 | 14 | 467 | T cell activation |
GO:0051707 | 0.0051 | 1.8284 | 15.1937 | 26 | 1144 | response to other organism |
GO:0050909 | 0.0054 | 6.1256 | 0.7085 | 4 | 52 | sensory perception of taste |
GO:0022407 | 0.0055 | 2.3704 | 5.7771 | 13 | 424 | regulation of cell-cell adhesion |
GO:0055088 | 0.0056 | 3.4796 | 2.1255 | 7 | 156 | lipid homeostasis |
GO:0051481 | 0.0057 | 9.16 | 0.3679 | 3 | 27 | negative regulation of cytosolic calcium ion concentration |
GO:0097267 | 0.0062 | 20.8637 | 0.1226 | 2 | 9 | omega-hydroxylase P450 pathway |
GO:1903244 | 0.0062 | 20.8637 | 0.1226 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0001580 | 0.007 | 8.4543 | 0.3951 | 3 | 29 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0032410 | 0.007 | 4.4389 | 1.199 | 5 | 88 | negative regulation of transporter activity |
GO:0050907 | 0.0075 | 8.1512 | 0.4022 | 3 | 37 | detection of chemical stimulus involved in sensory perception |
GO:0032148 | 0.0077 | 8.1407 | 0.4088 | 3 | 30 | activation of protein kinase B activity |
GO:0010986 | 0.0077 | 18.2546 | 0.1363 | 2 | 10 | positive regulation of lipoprotein particle clearance |
GO:0075733 | 0.0077 | 18.2546 | 0.1363 | 2 | 10 | intracellular transport of virus |
GO:0001755 | 0.008 | 5.4429 | 0.7903 | 4 | 58 | neural crest cell migration |
GO:0007159 | 0.0084 | 2.4344 | 4.7416 | 11 | 348 | leukocyte cell-cell adhesion |
GO:0050869 | 0.0085 | 7.8494 | 0.4224 | 3 | 31 | negative regulation of B cell activation |
GO:0009605 | 0.0092 | 1.5194 | 33.5451 | 47 | 2462 | response to external stimulus |
GO:0060795 | 0.0093 | 7.5783 | 0.436 | 3 | 32 | cell fate commitment involved in formation of primary germ layer |
GO:0090051 | 0.0093 | 7.5783 | 0.436 | 3 | 32 | negative regulation of cell migration involved in sprouting angiogenesis |
GO:0051133 | 0.0094 | 16.2253 | 0.1499 | 2 | 11 | regulation of NK T cell activation |
GO:1903238 | 0.0094 | 16.2253 | 0.1499 | 2 | 11 | positive regulation of leukocyte tethering or rolling |
GO:0051384 | 0.0098 | 3.4877 | 1.8121 | 6 | 133 | response to glucocorticoid |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 10.6138 | 1.8042 | 16 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 5.6866 | 5.0823 | 24 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.7082 | 10.1645 | 31 | 1200 | signaling receptor activity |
GO:0008392 | 2e-04 | 35.8699 | 0.1101 | 3 | 13 | arachidonic acid epoxygenase activity |
GO:0018685 | 2e-04 | 237.5182 | 0.0254 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0070330 | 7e-04 | 19.9179 | 0.1779 | 3 | 21 | aromatase activity |
GO:0017083 | 0.001 | 59.3686 | 0.0508 | 2 | 6 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO:0102033 | 0.001 | 59.3686 | 0.0508 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0046790 | 0.0037 | 26.3779 | 0.0932 | 2 | 11 | virion binding |
GO:0020037 | 0.0042 | 5.0221 | 1.0588 | 5 | 125 | heme binding |
GO:0008417 | 0.0052 | 21.5793 | 0.1101 | 2 | 13 | fucosyltransferase activity |
GO:0004175 | 0.0058 | 2.9029 | 3.2865 | 9 | 388 | endopeptidase activity |
GO:0033038 | 0.0061 | 19.7798 | 0.1186 | 2 | 14 | bitter taste receptor activity |
GO:0005506 | 0.0062 | 4.5621 | 1.1605 | 5 | 137 | iron ion binding |
GO:0052689 | 0.0074 | 4.3622 | 1.2113 | 5 | 143 | carboxylic ester hydrolase activity |
GO:0004890 | 0.0079 | 16.952 | 0.1355 | 2 | 16 | GABA-A receptor activity |
GO:0004511 | 0.0085 | Inf | 0.0085 | 1 | 1 | tyrosine 3-monooxygenase activity |
GO:0008389 | 0.0085 | Inf | 0.0085 | 1 | 1 | coumarin 7-hydroxylase activity |
GO:0035478 | 0.0085 | Inf | 0.0085 | 1 | 1 | chylomicron binding |
GO:0043185 | 0.0085 | Inf | 0.0085 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0052722 | 0.0085 | Inf | 0.0085 | 1 | 1 | fatty acid in-chain hydroxylase activity |
GO:0102116 | 0.0085 | Inf | 0.0085 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0085 | Inf | 0.0085 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0042605 | 0.0089 | 15.8209 | 0.144 | 2 | 17 | peptide antigen binding |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003690 | 0 | 5.9723 | 3.2135 | 13 | 1551 | double-stranded DNA binding |
GO:0000978 | 0 | 6.6224 | 2.3081 | 11 | 1114 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0000976 | 0 | 5.8623 | 2.9131 | 12 | 1406 | transcription cis-regulatory region binding |
GO:0043565 | 0 | 5.2398 | 3.2239 | 12 | 1556 | sequence-specific DNA binding |
GO:0140110 | 1e-04 | 4.5182 | 3.6797 | 12 | 1776 | transcription regulator activity |
GO:0000981 | 6e-04 | 5.8158 | 1.5143 | 7 | 834 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0031490 | 0.001 | 16.7625 | 0.201 | 3 | 97 | chromatin DNA binding |
GO:0001228 | 0.0019 | 6.3483 | 0.9075 | 5 | 438 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0035730 | 0.0021 | Inf | 0.0021 | 1 | 1 | S-nitrosoglutathione binding |
GO:0035731 | 0.0021 | Inf | 0.0021 | 1 | 1 | dinitrosyl-iron complex binding |
GO:0046817 | 0.0021 | Inf | 0.0021 | 1 | 1 | chemokine receptor antagonist activity |
GO:0005504 | 0.0039 | 23.7398 | 0.0932 | 2 | 45 | fatty acid binding |
GO:0001632 | 0.0041 | 496.2121 | 0.0041 | 1 | 2 | leukotriene B4 receptor activity |
GO:0008260 | 0.0041 | 496.2121 | 0.0041 | 1 | 2 | 3-oxoacid CoA-transferase activity |
GO:0031729 | 0.0041 | 496.2121 | 0.0041 | 1 | 2 | CCR4 chemokine receptor binding |
GO:0045519 | 0.0041 | 496.2121 | 0.0041 | 1 | 2 | interleukin-23 receptor binding |
GO:0030298 | 0.0062 | 248.0909 | 0.0062 | 1 | 3 | receptor signaling protein tyrosine kinase activator activity |
GO:0070026 | 0.0062 | 248.0909 | 0.0062 | 1 | 3 | nitric oxide binding |
GO:0031726 | 0.0083 | 165.3838 | 0.0083 | 1 | 4 | CCR1 chemokine receptor binding |
GO:0035662 | 0.0083 | 165.3838 | 0.0083 | 1 | 4 | Toll-like receptor 4 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050591 | 7e-04 | Inf | 7e-04 | 1 | 1 | quinine 3-monooxygenase activity |
GO:0102320 | 7e-04 | Inf | 7e-04 | 1 | 1 | 1,8-cineole 2-exo-monooxygenase activity |
GO:0062181 | 0.0013 | 1639.8 | 0.0013 | 1 | 2 | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity |
GO:0106386 | 0.0013 | 1639.8 | 0.0013 | 1 | 2 | (3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity |
GO:0030343 | 0.002 | 819.85 | 0.002 | 1 | 3 | vitamin D3 25-hydroxylase activity |
GO:0062187 | 0.002 | 819.85 | 0.002 | 1 | 3 | anandamide 8,9 epoxidase activity |
GO:0062188 | 0.002 | 819.85 | 0.002 | 1 | 3 | anandamide 11,12 epoxidase activity |
GO:0070404 | 0.002 | 819.85 | 0.002 | 1 | 3 | NADH binding |
GO:0070576 | 0.002 | 819.85 | 0.002 | 1 | 3 | vitamin D 24-hydroxylase activity |
GO:0034875 | 0.0027 | 546.5333 | 0.0027 | 1 | 4 | caffeine oxidase activity |
GO:0050649 | 0.0027 | 546.5333 | 0.0027 | 1 | 4 | testosterone 6-beta-hydroxylase activity |
GO:0062189 | 0.0027 | 546.5333 | 0.0027 | 1 | 4 | anandamide 14,15 epoxidase activity |
GO:0101021 | 0.0033 | 409.875 | 0.0034 | 1 | 5 | estrogen 2-hydroxylase activity |
GO:0047035 | 0.0047 | 273.2167 | 0.0047 | 1 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:0035197 | 0.0054 | 234.1714 | 0.0054 | 1 | 8 | siRNA binding |
GO:0101020 | 0.0054 | 234.1714 | 0.0054 | 1 | 8 | estrogen 16-alpha-hydroxylase activity |
GO:0016725 | 0.006 | 204.8875 | 0.006 | 1 | 9 | oxidoreductase activity, acting on CH or CH2 groups |
GO:0008401 | 0.0067 | 182.1111 | 0.0067 | 1 | 10 | retinoic acid 4-hydroxylase activity |
GO:0044594 | 0.0087 | 136.5583 | 0.0087 | 1 | 13 | 17-beta-hydroxysteroid dehydrogenase (NAD+) activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 8.2145 | 4.479 | 30 | 300 | protein heterodimerization activity |
GO:0005509 | 0 | 3.6503 | 10.018 | 32 | 671 | calcium ion binding |
GO:0019904 | 7e-04 | 2.331 | 9.6447 | 21 | 646 | protein domain specific binding |
GO:0003677 | 8e-04 | 1.7036 | 34.4433 | 53 | 2307 | DNA binding |
GO:0045296 | 0.0013 | 2.8287 | 4.8821 | 13 | 327 | cadherin binding |
GO:0003730 | 0.0021 | 3.7294 | 2.2843 | 8 | 153 | mRNA 3'-UTR binding |
GO:0004867 | 0.0022 | 4.8642 | 1.3288 | 6 | 89 | serine-type endopeptidase inhibitor activity |
GO:0015125 | 0.0031 | 11.7754 | 0.2986 | 3 | 20 | bile acid transmembrane transporter activity |
GO:0019955 | 0.0035 | 3.8048 | 1.9558 | 7 | 131 | cytokine binding |
GO:0030414 | 0.0036 | 3.398 | 2.4933 | 8 | 167 | peptidase inhibitor activity |
GO:1903231 | 0.0037 | 3.7741 | 1.9707 | 7 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0016493 | 0.0041 | 10.5346 | 0.3285 | 3 | 22 | C-C chemokine receptor activity |
GO:0019957 | 0.0047 | 10.0072 | 0.3434 | 3 | 23 | C-C chemokine binding |
GO:0061135 | 0.005 | 3.2142 | 2.6277 | 8 | 176 | endopeptidase regulator activity |
GO:0042608 | 0.0059 | 22.166 | 0.1194 | 2 | 8 | T cell receptor binding |
GO:0046703 | 0.0059 | 22.166 | 0.1194 | 2 | 8 | natural killer cell lectin-like receptor binding |
GO:0001637 | 0.0059 | 9.0964 | 0.3732 | 3 | 25 | G protein-coupled chemoattractant receptor activity |
GO:0070567 | 0.0075 | 18.9982 | 0.1344 | 2 | 9 | cytidylyltransferase activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 8.8139 | 2.557 | 19 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 4.5304 | 7.2029 | 28 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.2001 | 14.4059 | 39 | 1200 | signaling receptor activity |
GO:0018685 | 4e-04 | 166.2769 | 0.036 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0008392 | 4e-04 | 25.0562 | 0.1561 | 3 | 13 | arachidonic acid epoxygenase activity |
GO:0000981 | 6e-04 | 2.0789 | 15.2702 | 29 | 1272 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0020037 | 8e-04 | 5.0252 | 1.5006 | 7 | 125 | heme binding |
GO:0019825 | 8e-04 | 10.8187 | 0.4202 | 4 | 35 | oxygen binding |
GO:0004890 | 9e-04 | 19.2704 | 0.1921 | 3 | 16 | GABA-A receptor activity |
GO:0045182 | 0.001 | 3.5144 | 3.0372 | 10 | 253 | translation regulator activity |
GO:0004497 | 0.001 | 5.6912 | 1.1405 | 6 | 95 | monooxygenase activity |
GO:1903231 | 0.0011 | 4.7417 | 1.5846 | 7 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:1904315 | 0.0016 | 8.8219 | 0.5042 | 4 | 42 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential |
GO:0017171 | 0.0018 | 3.8349 | 2.2209 | 8 | 185 | serine hydrolase activity |
GO:0070330 | 0.0019 | 13.9132 | 0.2521 | 3 | 21 | aromatase activity |
GO:0017083 | 0.0021 | 41.5615 | 0.072 | 2 | 6 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO:0102033 | 0.0021 | 41.5615 | 0.072 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:1990837 | 0.0025 | 1.8585 | 17.5151 | 30 | 1459 | sequence-specific double-stranded DNA binding |
GO:0001067 | 0.0029 | 1.8569 | 16.9029 | 29 | 1408 | transcription regulatory region nucleic acid binding |
GO:0004321 | 0.0029 | 33.2472 | 0.084 | 2 | 7 | fatty-acyl-CoA synthase activity |
GO:0004252 | 0.0037 | 3.7678 | 1.9688 | 7 | 164 | serine-type endopeptidase activity |
GO:0030414 | 0.0041 | 3.6964 | 2.0048 | 7 | 167 | peptidase inhibitor activity |
GO:0000977 | 0.0043 | 1.8389 | 15.7984 | 27 | 1316 | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO:0005184 | 0.0045 | 10.0132 | 0.3361 | 3 | 28 | neuropeptide hormone activity |
GO:0022835 | 0.0045 | 6.4412 | 0.6723 | 4 | 56 | transmitter-gated channel activity |
GO:0000987 | 0.0048 | 1.8876 | 13.6135 | 24 | 1134 | cis-regulatory region sequence-specific DNA binding |
GO:0008199 | 0.0049 | 23.7451 | 0.108 | 2 | 9 | ferric iron binding |
GO:0008503 | 0.0049 | 23.7451 | 0.108 | 2 | 9 | benzodiazepine receptor activity |
GO:0031956 | 0.0049 | 23.7451 | 0.108 | 2 | 9 | medium-chain fatty acid-CoA ligase activity |
GO:0047760 | 0.0049 | 23.7451 | 0.108 | 2 | 9 | butyrate-CoA ligase activity |
GO:0098960 | 0.0058 | 5.9796 | 0.7203 | 4 | 60 | postsynaptic neurotransmitter receptor activity |
GO:0022851 | 0.0073 | 18.4661 | 0.1321 | 2 | 11 | GABA-gated chloride ion channel activity |
GO:0046790 | 0.0073 | 18.4661 | 0.1321 | 2 | 11 | virion binding |
GO:0005237 | 0.0087 | 16.6185 | 0.1441 | 2 | 12 | inhibitory extracellular ligand-gated ion channel activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 13.1541 | 2.9068 | 29 | 300 | protein heterodimerization activity |
GO:0045296 | 0 | 4.9164 | 3.1684 | 14 | 327 | cadherin binding |
GO:0003677 | 0 | 2.365 | 22.353 | 44 | 2307 | DNA binding |
GO:0019904 | 0 | 3.3818 | 6.2592 | 19 | 646 | protein domain specific binding |
GO:0030414 | 2e-04 | 5.362 | 1.6181 | 8 | 167 | peptidase inhibitor activity |
GO:0003723 | 3e-04 | 2.1636 | 16.1519 | 31 | 1667 | RNA binding |
GO:0061135 | 3e-04 | 5.0719 | 1.7053 | 8 | 176 | endopeptidase regulator activity |
GO:0032552 | 6e-04 | 103.4968 | 0.0388 | 2 | 4 | deoxyribonucleotide binding |
GO:0051373 | 9e-04 | 68.9936 | 0.0484 | 2 | 5 | FATZ binding |
GO:0004867 | 0.0017 | 6.2488 | 0.8623 | 5 | 89 | serine-type endopeptidase inhibitor activity |
GO:0004930 | 0.0021 | 2.581 | 5.8135 | 14 | 600 | G protein-coupled receptor activity |
GO:0004984 | 0.0048 | 3.587 | 2.0638 | 7 | 213 | olfactory receptor activity |
GO:0097677 | 0.0048 | 22.9894 | 0.1066 | 2 | 11 | STAT family protein binding |
GO:0033038 | 0.0079 | 17.2389 | 0.1356 | 2 | 14 | bitter taste receptor activity |
GO:0008308 | 0.009 | 15.9118 | 0.1453 | 2 | 15 | voltage-gated anion channel activity |
GO:0032558 | 0.0096 | Inf | 0.0096 | 1 | 1 | adenyl deoxyribonucleotide binding |
GO:0001631 | 0.0097 | Inf | 0.0097 | 1 | 1 | cysteinyl leukotriene receptor activity |
GO:0002135 | 0.0097 | Inf | 0.0097 | 1 | 1 | CTP binding |
GO:0004113 | 0.0097 | Inf | 0.0097 | 1 | 1 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity |
GO:0031707 | 0.0097 | Inf | 0.0097 | 1 | 1 | endothelin A receptor binding |
GO:0032564 | 0.0097 | Inf | 0.0097 | 1 | 1 | dATP binding |
GO:0042586 | 0.0097 | Inf | 0.0097 | 1 | 1 | peptide deformylase activity |
GO:0046316 | 0.0097 | Inf | 0.0097 | 1 | 1 | gluconokinase activity |
GO:0047444 | 0.0097 | Inf | 0.0097 | 1 | 1 | N-acylneuraminate-9-phosphate synthase activity |
GO:0050462 | 0.0097 | Inf | 0.0097 | 1 | 1 | N-acetylneuraminate synthase activity |
GO:1990276 | 0.0097 | Inf | 0.0097 | 1 | 1 | RNA 5'-methyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070009 | 1e-04 | Inf | 1e-04 | 1 | 1 | serine-type aminopeptidase activity |
GO:0008238 | 0.006 | Inf | 0.006 | 1 | 99 | exopeptidase activity |
GO:0008201 | 0.0099 | Inf | 0.0099 | 1 | 163 | heparin binding |
GO:0004252 | 0.01 | Inf | 0.01 | 1 | 164 | serine-type endopeptidase activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 24.3104 | 0.2726 | 5 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 13.3187 | 0.7678 | 7 | 600 | G protein-coupled receptor activity |
GO:0038023 | 5e-04 | 6.3688 | 1.5356 | 7 | 1200 | signaling receptor activity |
GO:0031707 | 0.0013 | Inf | 0.0013 | 1 | 1 | endothelin A receptor binding |
GO:0031708 | 0.0038 | 409.675 | 0.0038 | 1 | 3 | endothelin B receptor binding |
GO:0003696 | 0.0051 | 273.1 | 0.0051 | 1 | 4 | satellite DNA binding |
GO:0019237 | 0.0077 | 163.84 | 0.0077 | 1 | 6 | centromeric DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 70.1919 | 0.2207 | 8 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 23.7252 | 0.6216 | 8 | 600 | G protein-coupled receptor activity |
GO:0018685 | 0 | 2185.6 | 0.0031 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0038023 | 0 | 11.3356 | 1.2431 | 8 | 1200 | signaling receptor activity |
GO:0102033 | 0 | 546.3 | 0.0062 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0008391 | 1e-04 | 145.5822 | 0.0176 | 2 | 17 | arachidonic acid monooxygenase activity |
GO:0070009 | 0.001 | Inf | 0.001 | 1 | 1 | serine-type aminopeptidase activity |
GO:0102116 | 0.001 | Inf | 0.001 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.001 | Inf | 0.001 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0050051 | 0.0041 | 341.4583 | 0.0041 | 1 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0020037 | 0.0073 | 17.6369 | 0.1295 | 2 | 125 | heme binding |
GO:0005506 | 0.0087 | 16.0573 | 0.1419 | 2 | 137 | iron ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 25.4803 | 2.9205 | 47 | 213 | olfactory receptor activity |
GO:0004930 | 0 | 10.0238 | 8.2267 | 58 | 600 | G protein-coupled receptor activity |
GO:0038023 | 0 | 5.7595 | 16.4534 | 68 | 1200 | signaling receptor activity |
GO:0005549 | 0 | 12.9271 | 0.8364 | 9 | 61 | odorant binding |
GO:0008392 | 0 | 45.9574 | 0.1782 | 5 | 13 | arachidonic acid epoxygenase activity |
GO:0070330 | 0 | 22.9673 | 0.2879 | 5 | 21 | aromatase activity |
GO:1903231 | 0 | 6.1239 | 1.8099 | 10 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0005506 | 0 | 5.881 | 1.8784 | 10 | 137 | iron ion binding |
GO:0020037 | 1e-04 | 5.7719 | 1.7139 | 9 | 125 | heme binding |
GO:0018685 | 6e-04 | 145.148 | 0.0411 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0051431 | 6e-04 | 145.148 | 0.0411 | 2 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0045182 | 8e-04 | 3.3864 | 3.4689 | 11 | 253 | translation regulator activity |
GO:0008395 | 0.0012 | 9.7466 | 0.4662 | 4 | 34 | steroid hydroxylase activity |
GO:0003730 | 0.0012 | 4.0782 | 2.0978 | 8 | 153 | mRNA 3'-UTR binding |
GO:0019825 | 0.0013 | 9.4316 | 0.4799 | 4 | 35 | oxygen binding |
GO:0004252 | 0.0019 | 3.788 | 2.2486 | 8 | 164 | serine-type endopeptidase activity |
GO:0030545 | 0.0024 | 2.4418 | 6.5128 | 15 | 475 | signaling receptor regulator activity |
GO:0102033 | 0.0027 | 36.2803 | 0.0823 | 2 | 6 | long-chain fatty acid omega-hydroxylase activity |
GO:0048018 | 0.0028 | 2.4784 | 5.9781 | 14 | 436 | receptor ligand activity |
GO:0004321 | 0.0038 | 29.0224 | 0.096 | 2 | 7 | fatty-acyl-CoA synthase activity |
GO:0016714 | 0.0038 | 29.0224 | 0.096 | 2 | 7 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen |
GO:0017171 | 0.0041 | 3.3342 | 2.5366 | 8 | 185 | serine hydrolase activity |
GO:0034235 | 0.005 | 24.1839 | 0.1097 | 2 | 8 | GPI anchor binding |
GO:0016705 | 0.0051 | 3.5346 | 2.0936 | 7 | 154 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0051427 | 0.0058 | 9.0997 | 0.3702 | 3 | 27 | hormone receptor binding |
GO:0019864 | 0.0063 | 20.7277 | 0.1234 | 2 | 9 | IgG binding |
GO:0031956 | 0.0063 | 20.7277 | 0.1234 | 2 | 9 | medium-chain fatty acid-CoA ligase activity |
GO:0047760 | 0.0063 | 20.7277 | 0.1234 | 2 | 9 | butyrate-CoA ligase activity |
GO:0004867 | 0.0076 | 4.3563 | 1.2203 | 5 | 89 | serine-type endopeptidase inhibitor activity |
GO:0030414 | 0.0083 | 3.216 | 2.2898 | 7 | 167 | peptidase inhibitor activity |
GO:0046790 | 0.0095 | 16.1196 | 0.1508 | 2 | 11 | virion binding |
GO:0008233 | 0.0099 | 2.0655 | 7.6234 | 15 | 556 | peptidase activity |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 0.008 | Inf | 0.008 | 1 | 132 | mRNA base-pairing post-transcriptional repressor activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 10.1546 | 3.6015 | 29 | 300 | protein heterodimerization activity |
GO:0030414 | 0 | 6.0872 | 2.0048 | 11 | 167 | peptidase inhibitor activity |
GO:0004867 | 0 | 8.4301 | 1.0684 | 8 | 89 | serine-type endopeptidase inhibitor activity |
GO:0045296 | 0 | 3.8862 | 3.9256 | 14 | 327 | cadherin binding |
GO:0061135 | 1e-04 | 5.1694 | 2.1129 | 10 | 176 | endopeptidase regulator activity |
GO:0015125 | 1e-04 | 20.9806 | 0.2401 | 4 | 20 | bile acid transmembrane transporter activity |
GO:0019904 | 1e-04 | 2.8135 | 7.7551 | 20 | 646 | protein domain specific binding |
GO:0032558 | 1e-04 | Inf | 0.024 | 2 | 2 | adenyl deoxyribonucleotide binding |
GO:0004984 | 3e-04 | 4.2175 | 2.557 | 10 | 213 | olfactory receptor activity |
GO:0033038 | 6e-04 | 22.7769 | 0.1681 | 3 | 14 | bitter taste receptor activity |
GO:0003677 | 6e-04 | 1.8259 | 27.6952 | 45 | 2307 | DNA binding |
GO:0032552 | 8e-04 | 83.1333 | 0.048 | 2 | 4 | deoxyribonucleotide binding |
GO:0051373 | 0.0014 | 55.4188 | 0.06 | 2 | 5 | FATZ binding |
GO:0015349 | 0.0021 | 41.5615 | 0.072 | 2 | 6 | thyroid hormone transmembrane transporter activity |
GO:0004930 | 0.0024 | 2.3657 | 7.2029 | 16 | 600 | G protein-coupled receptor activity |
GO:0047035 | 0.0029 | 33.2472 | 0.084 | 2 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:1903231 | 0.0052 | 4.0107 | 1.5846 | 6 | 132 | mRNA base-pairing post-transcriptional repressor activity |
GO:0003723 | 0.0091 | 1.6639 | 20.0121 | 31 | 1667 | RNA binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048252 | 0 | Inf | 0.0018 | 2 | 2 | lauric acid metabolic process |
GO:0019373 | 1e-04 | 157.5577 | 0.0164 | 2 | 18 | epoxygenase P450 pathway |
GO:0043651 | 1e-04 | 157.5577 | 0.0164 | 2 | 18 | linoleic acid metabolic process |
GO:0046456 | 0.001 | 50.3138 | 0.0475 | 2 | 52 | icosanoid biosynthetic process |
GO:0032787 | 0.0013 | 10.5004 | 0.5053 | 4 | 553 | monocarboxylic acid metabolic process |
GO:0031408 | 0.0018 | 1171.5 | 0.0018 | 1 | 2 | oxylipin biosynthetic process |
GO:0033559 | 0.002 | 35.2857 | 0.0682 | 2 | 86 | unsaturated fatty acid metabolic process |
GO:0050911 | 0.0021 | 14.1884 | 0.2622 | 3 | 287 | detection of chemical stimulus involved in sensory perception of smell |
GO:0016053 | 0.0021 | 14.0375 | 0.265 | 3 | 290 | organic acid biosynthetic process |
GO:0003095 | 0.0027 | 585.7143 | 0.0027 | 1 | 3 | pressure natriuresis |
GO:0031914 | 0.0027 | 585.7143 | 0.0027 | 1 | 3 | negative regulation of synaptic plasticity |
GO:0061789 | 0.0027 | 585.7143 | 0.0027 | 1 | 3 | dense core granule priming |
GO:0009593 | 0.0039 | 11.236 | 0.3289 | 3 | 360 | detection of chemical stimulus |
GO:0007606 | 0.0043 | 10.8625 | 0.3399 | 3 | 372 | sensory perception of chemical stimulus |
GO:0036101 | 0.0046 | 292.8214 | 0.0046 | 1 | 5 | leukotriene B4 catabolic process |
GO:0099525 | 0.0046 | 292.8214 | 0.0046 | 1 | 5 | presynaptic dense core vesicle exocytosis |
GO:0050906 | 0.0047 | 10.5125 | 0.3509 | 3 | 384 | detection of stimulus involved in sensory perception |
GO:0002249 | 0.0055 | 234.2429 | 0.0055 | 1 | 6 | lymphocyte anergy |
GO:0002667 | 0.0055 | 234.2429 | 0.0055 | 1 | 6 | regulation of T cell anergy |
GO:0002933 | 0.0064 | 195.1905 | 0.0064 | 1 | 7 | lipid hydroxylation |
GO:0009804 | 0.0064 | 195.1905 | 0.0064 | 1 | 7 | coumarin metabolic process |
GO:0046222 | 0.0064 | 195.1905 | 0.0064 | 1 | 7 | aflatoxin metabolic process |
GO:0043436 | 0.0065 | 6.5797 | 0.7885 | 4 | 863 | oxoacid metabolic process |
GO:0044255 | 0.0088 | 6.0017 | 0.8598 | 4 | 941 | cellular lipid metabolic process |
GO:0016081 | 0.0091 | 130.1032 | 0.0091 | 1 | 10 | synaptic vesicle docking |
GO:0016188 | 0.0091 | 130.1032 | 0.0091 | 1 | 10 | synaptic vesicle maturation |
GO:0097267 | 0.0091 | 130.1032 | 0.0091 | 1 | 10 | omega-hydroxylase P450 pathway |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051674 | 0 | 2.3163 | 56.3897 | 112 | 1610 | localization of cell |
GO:0022008 | 0 | 2.3046 | 46.2148 | 93 | 1338 | neurogenesis |
GO:0001655 | 0 | 3.52 | 11.5932 | 36 | 331 | urogenital system development |
GO:0007389 | 0 | 3.0499 | 15.4459 | 42 | 441 | pattern specification process |
GO:0032501 | 0 | 1.8686 | 96.5622 | 146 | 3293 | multicellular organismal process |
GO:0001568 | 0 | 2.4026 | 25.3228 | 55 | 723 | blood vessel development |
GO:0001501 | 0 | 3.2416 | 10.6672 | 31 | 312 | skeletal system development |
GO:0060429 | 0 | 2.0799 | 36.5688 | 69 | 1051 | epithelium development |
GO:0048731 | 0 | 2.1645 | 30.5589 | 59 | 1077 | system development |
GO:0045597 | 0 | 2.1743 | 28.1949 | 56 | 805 | positive regulation of cell differentiation |
GO:0021543 | 0 | 4.0128 | 5.639 | 20 | 161 | pallium development |
GO:0048598 | 0 | 3.5679 | 6.8797 | 22 | 204 | embryonic morphogenesis |
GO:0042221 | 0 | 1.5492 | 138.2073 | 187 | 3946 | response to chemical |
GO:0042330 | 0 | 2.3535 | 19.929 | 43 | 569 | taxis |
GO:0048568 | 0 | 2.6084 | 13.8116 | 33 | 397 | embryonic organ development |
GO:0060548 | 0 | 1.9895 | 32.2227 | 59 | 920 | negative regulation of cell death |
GO:0035107 | 0 | 4.0597 | 4.7283 | 17 | 135 | appendage morphogenesis |
GO:0009952 | 0 | 4.0507 | 4.7331 | 17 | 137 | anterior/posterior pattern specification |
GO:0072359 | 0 | 2.3231 | 18.7274 | 40 | 556 | circulatory system development |
GO:0051216 | 0 | 3.445 | 6.4445 | 20 | 184 | cartilage development |
GO:0060173 | 0 | 3.5749 | 5.9192 | 19 | 169 | limb development |
GO:0048880 | 0 | 2.5904 | 13.0292 | 31 | 372 | sensory system development |
GO:0030198 | 0 | 2.8272 | 10.0521 | 26 | 287 | extracellular matrix organization |
GO:0030326 | 0 | 4.2595 | 3.9928 | 15 | 114 | embryonic limb morphogenesis |
GO:1901214 | 0 | 2.8162 | 10.0871 | 26 | 288 | regulation of neuron death |
GO:0009954 | 0 | 9.2992 | 1.1208 | 8 | 32 | proximal/distal pattern formation |
GO:0021761 | 0 | 4.5192 | 3.5375 | 14 | 101 | limbic system development |
GO:0048729 | 0 | 2.195 | 20.6996 | 42 | 591 | tissue morphogenesis |
GO:0010562 | 0 | 2.0011 | 28.6502 | 53 | 818 | positive regulation of phosphorus metabolic process |
GO:0006928 | 0 | 1.944 | 32.4577 | 58 | 981 | movement of cell or subcellular component |
GO:0045766 | 0 | 3.4585 | 6.0943 | 19 | 174 | positive regulation of angiogenesis |
GO:0061138 | 0 | 3.4585 | 6.0943 | 19 | 174 | morphogenesis of a branching epithelium |
GO:0001654 | 0 | 2.5716 | 12.6789 | 30 | 362 | eye development |
GO:0051240 | 0 | 1.7711 | 47.2483 | 77 | 1349 | positive regulation of multicellular organismal process |
GO:0045944 | 0 | 1.8374 | 39.5078 | 67 | 1128 | positive regulation of transcription by RNA polymerase II |
GO:0042327 | 0 | 2.0181 | 26.1985 | 49 | 748 | positive regulation of phosphorylation |
GO:0007420 | 0 | 2.1416 | 21.1677 | 42 | 613 | brain development |
GO:0071495 | 0 | 1.7786 | 43.8509 | 72 | 1252 | cellular response to endogenous stimulus |
GO:0065007 | 0 | 1.4979 | 397.9503 | 442 | 11362 | biological regulation |
GO:0002520 | 0 | 1.915 | 31.5572 | 56 | 901 | immune system development |
GO:0051093 | 0 | 1.9235 | 30.2613 | 54 | 864 | negative regulation of developmental process |
GO:0045665 | 0 | 5.2174 | 2.4517 | 11 | 70 | negative regulation of neuron differentiation |
GO:0007167 | 0 | 1.8797 | 32.0826 | 56 | 916 | enzyme linked receptor protein signaling pathway |
GO:0048704 | 0 | 6.5086 | 1.6652 | 9 | 48 | embryonic skeletal system morphogenesis |
GO:0048869 | 0 | 1.6925 | 54.7767 | 84 | 1793 | cellular developmental process |
GO:0001656 | 0 | 5.6232 | 2.0898 | 10 | 60 | metanephros development |
GO:0051241 | 0 | 1.8216 | 36.0754 | 61 | 1030 | negative regulation of multicellular organismal process |
GO:0071310 | 0 | 1.5666 | 78.14 | 112 | 2231 | cellular response to organic substance |
GO:2000179 | 1e-04 | 6.1281 | 1.7512 | 9 | 50 | positive regulation of neural precursor cell proliferation |
GO:0097529 | 1e-04 | 2.9529 | 7.3902 | 20 | 211 | myeloid leukocyte migration |
GO:0008217 | 1e-04 | 3.2981 | 5.674 | 17 | 162 | regulation of blood pressure |
GO:0007517 | 1e-04 | 2.522 | 11.1378 | 26 | 318 | muscle organ development |
GO:0035239 | 1e-04 | 2.1305 | 18.6588 | 37 | 551 | tube morphogenesis |
GO:0032944 | 1e-04 | 2.9219 | 7.4603 | 20 | 213 | regulation of mononuclear cell proliferation |
GO:0043583 | 1e-04 | 2.9067 | 7.4953 | 20 | 214 | ear development |
GO:0030182 | 1e-04 | 1.817 | 33.7375 | 57 | 1009 | neuron differentiation |
GO:0045165 | 1e-04 | 3.5364 | 4.6905 | 15 | 137 | cell fate commitment |
GO:0040011 | 1e-04 | 2.2174 | 16.0215 | 33 | 495 | locomotion |
GO:0045785 | 1e-04 | 2.2697 | 14.6753 | 31 | 419 | positive regulation of cell adhesion |
GO:0043524 | 1e-04 | 3.4802 | 4.7634 | 15 | 136 | negative regulation of neuron apoptotic process |
GO:0090596 | 1e-04 | 2.6768 | 8.8963 | 22 | 254 | sensory organ morphogenesis |
GO:0072239 | 1e-04 | 27.7373 | 0.2802 | 4 | 8 | metanephric glomerulus vasculature development |
GO:0060537 | 1e-04 | 2.3104 | 13.4845 | 29 | 385 | muscle tissue development |
GO:0001708 | 1e-04 | 4.1474 | 3.2573 | 12 | 93 | cell fate specification |
GO:0022414 | 1e-04 | 1.6685 | 47.0381 | 73 | 1343 | reproductive process |
GO:0045840 | 1e-04 | 6.3722 | 1.5061 | 8 | 43 | positive regulation of mitotic nuclear division |
GO:0048663 | 1e-04 | 5.4876 | 1.9172 | 9 | 55 | neuron fate commitment |
GO:0043067 | 1e-04 | 1.6614 | 47.2133 | 73 | 1348 | regulation of programmed cell death |
GO:0018108 | 1e-04 | 2.3524 | 12.3287 | 27 | 352 | peptidyl-tyrosine phosphorylation |
GO:0051272 | 1e-04 | 2.0386 | 19.4037 | 37 | 554 | positive regulation of cellular component movement |
GO:0007369 | 1e-04 | 3.0242 | 6.1293 | 17 | 175 | gastrulation |
GO:0060993 | 1e-04 | 4.2718 | 2.907 | 11 | 83 | kidney morphogenesis |
GO:0051283 | 1e-04 | 3.6784 | 3.9228 | 13 | 112 | negative regulation of sequestering of calcium ion |
GO:0061333 | 2e-04 | 4.6555 | 2.4517 | 10 | 70 | renal tubule morphogenesis |
GO:0070665 | 2e-04 | 3.2627 | 5.0436 | 15 | 144 | positive regulation of leukocyte proliferation |
GO:0030901 | 2e-04 | 4.213 | 2.9421 | 11 | 84 | midbrain development |
GO:0032095 | 2e-04 | 12.6244 | 0.5604 | 5 | 16 | regulation of response to food |
GO:0048146 | 2e-04 | 5.868 | 1.6111 | 8 | 46 | positive regulation of fibroblast proliferation |
GO:0032835 | 2e-04 | 5.0222 | 2.0665 | 9 | 59 | glomerulus development |
GO:0048771 | 2e-04 | 3.056 | 5.709 | 16 | 163 | tissue remodeling |
GO:0051281 | 2e-04 | 6.7199 | 1.2609 | 7 | 36 | positive regulation of release of sequestered calcium ion into cytosol |
GO:0021542 | 2e-04 | 11.5716 | 0.5954 | 5 | 17 | dentate gyrus development |
GO:1990266 | 3e-04 | 10.7932 | 0.6242 | 5 | 18 | neutrophil migration |
GO:0050673 | 3e-04 | 2.1496 | 14.3951 | 29 | 411 | epithelial cell proliferation |
GO:0045137 | 3e-04 | 2.735 | 7.11 | 18 | 203 | development of primary sexual characteristics |
GO:0001822 | 3e-04 | 3.0703 | 5.3196 | 15 | 155 | kidney development |
GO:0007498 | 3e-04 | 3.4017 | 4.203 | 13 | 120 | mesoderm development |
GO:0035850 | 3e-04 | 6.307 | 1.3266 | 7 | 38 | epithelial cell differentiation involved in kidney development |
GO:0040017 | 3e-04 | 1.968 | 19.4737 | 36 | 556 | positive regulation of locomotion |
GO:0050865 | 4e-04 | 1.9448 | 19.6839 | 36 | 562 | regulation of cell activation |
GO:0051928 | 4e-04 | 3.496 | 3.7827 | 12 | 108 | positive regulation of calcium ion transport |
GO:1901342 | 4e-04 | 2.2876 | 11.2079 | 24 | 320 | regulation of vasculature development |
GO:0070779 | 4e-04 | 41.5385 | 0.1751 | 3 | 5 | D-aspartate import across plasma membrane |
GO:0007267 | 4e-04 | 1.5631 | 52.6421 | 77 | 1503 | cell-cell signaling |
GO:0070848 | 4e-04 | 1.9443 | 19.1292 | 35 | 554 | response to growth factor |
GO:0032879 | 4e-04 | 1.5697 | 52.0117 | 76 | 1572 | regulation of localization |
GO:0002064 | 4e-04 | 2.8191 | 6.1363 | 16 | 176 | epithelial cell development |
GO:0097553 | 5e-04 | 3.0637 | 4.9735 | 14 | 142 | calcium ion transmembrane import into cytosol |
GO:0014013 | 5e-04 | 3.6588 | 3.3273 | 11 | 95 | regulation of gliogenesis |
GO:0009653 | 5e-04 | 1.774 | 27.7049 | 46 | 892 | anatomical structure morphogenesis |
GO:0030879 | 5e-04 | 3.1914 | 4.4481 | 13 | 127 | mammary gland development |
GO:0071774 | 6e-04 | 3.3553 | 3.9228 | 12 | 112 | response to fibroblast growth factor |
GO:0072080 | 6e-04 | 3.8766 | 2.872 | 10 | 82 | nephron tubule development |
GO:0035924 | 6e-04 | 4.2537 | 2.3817 | 9 | 68 | cellular response to vascular endothelial growth factor stimulus |
GO:0008284 | 6e-04 | 1.9042 | 19.5012 | 35 | 580 | positive regulation of cell population proliferation |
GO:0032303 | 7e-04 | 8.6765 | 0.7355 | 5 | 21 | regulation of icosanoid secretion |
GO:0007218 | 7e-04 | 3.4916 | 3.4674 | 11 | 99 | neuropeptide signaling pathway |
GO:0042472 | 7e-04 | 3.4916 | 3.4674 | 11 | 99 | inner ear morphogenesis |
GO:0051173 | 7e-04 | 1.4066 | 99.1548 | 129 | 2831 | positive regulation of nitrogen compound metabolic process |
GO:0031175 | 7e-04 | 1.9737 | 16.6652 | 31 | 487 | neuron projection development |
GO:0090287 | 7e-04 | 2.2773 | 10.2973 | 22 | 294 | regulation of cellular response to growth factor stimulus |
GO:0048608 | 8e-04 | 2.0718 | 13.8347 | 27 | 395 | reproductive structure development |
GO:0030335 | 8e-04 | 1.9197 | 18.2128 | 33 | 520 | positive regulation of cell migration |
GO:0007417 | 8e-04 | 2.5796 | 7.0638 | 17 | 215 | central nervous system development |
GO:0010959 | 8e-04 | 2.1024 | 13.1343 | 26 | 375 | regulation of metal ion transport |
GO:0048701 | 8e-04 | 5.2643 | 1.5411 | 7 | 44 | embryonic cranial skeleton morphogenesis |
GO:0042940 | 8e-04 | 27.6906 | 0.2101 | 3 | 6 | D-amino acid transport |
GO:0007204 | 8e-04 | 2.252 | 10.4023 | 22 | 297 | positive regulation of cytosolic calcium ion concentration |
GO:0002696 | 8e-04 | 2.2035 | 11.1028 | 23 | 317 | positive regulation of leukocyte activation |
GO:0009967 | 9e-04 | 1.5403 | 49.7 | 72 | 1419 | positive regulation of signal transduction |
GO:0001569 | 9e-04 | 6.1765 | 1.1558 | 6 | 33 | branching involved in blood vessel morphogenesis |
GO:0003013 | 9e-04 | 1.8779 | 19.1585 | 34 | 547 | circulatory system process |
GO:0007155 | 9e-04 | 1.6563 | 33.2902 | 52 | 979 | cell adhesion |
GO:0048738 | 9e-04 | 2.4529 | 7.8455 | 18 | 224 | cardiac muscle tissue development |
GO:0055065 | 9e-04 | 1.8227 | 21.4701 | 37 | 613 | metal ion homeostasis |
GO:0048468 | 9e-04 | 1.6825 | 30.9364 | 49 | 955 | cell development |
GO:0006874 | 0.001 | 2.007 | 14.7804 | 28 | 422 | cellular calcium ion homeostasis |
GO:0001756 | 0.001 | 4.3836 | 2.0598 | 8 | 59 | somitogenesis |
GO:0072171 | 0.001 | 4.3686 | 2.0665 | 8 | 59 | mesonephric tubule morphogenesis |
GO:0001657 | 0.001 | 3.577 | 3.0822 | 10 | 88 | ureteric bud development |
GO:0030030 | 0.001 | 1.5304 | 49.9802 | 72 | 1427 | cell projection organization |
GO:0010975 | 0.001 | 2.0266 | 14.1149 | 27 | 403 | regulation of neuron projection development |
GO:0001759 | 0.001 | 7.7115 | 0.8056 | 5 | 23 | organ induction |
GO:0021871 | 0.001 | 7.7115 | 0.8056 | 5 | 23 | forebrain regionalization |
GO:0097150 | 0.001 | 7.7115 | 0.8056 | 5 | 23 | neuronal stem cell population maintenance |
GO:0051347 | 0.001 | 1.8799 | 18.5631 | 33 | 530 | positive regulation of transferase activity |
GO:0001764 | 0.001 | 2.7989 | 5.3938 | 14 | 154 | neuron migration |
GO:0002521 | 0.0011 | 1.8983 | 17.8276 | 32 | 509 | leukocyte differentiation |
GO:0010001 | 0.0011 | 3.5377 | 3.1097 | 10 | 90 | glial cell differentiation |
GO:0010721 | 0.0011 | 2.676 | 6.0242 | 15 | 172 | negative regulation of cell development |
GO:0098739 | 0.0011 | 2.676 | 6.0242 | 15 | 172 | import across plasma membrane |
GO:0000904 | 0.0011 | 1.7775 | 23.1863 | 39 | 662 | cell morphogenesis involved in differentiation |
GO:0030316 | 0.0011 | 3.5315 | 3.1172 | 10 | 89 | osteoclast differentiation |
GO:0072163 | 0.0011 | 3.5315 | 3.1172 | 10 | 89 | mesonephric epithelium development |
GO:0071805 | 0.0011 | 2.4833 | 7.3202 | 17 | 209 | potassium ion transmembrane transport |
GO:0048070 | 0.0011 | 11.0907 | 0.4903 | 4 | 14 | regulation of developmental pigmentation |
GO:0010628 | 0.0012 | 1.6128 | 36.0754 | 55 | 1030 | positive regulation of gene expression |
GO:1903508 | 0.0012 | 1.506 | 52.8873 | 75 | 1510 | positive regulation of nucleic acid-templated transcription |
GO:0032723 | 0.0012 | Inf | 0.07 | 2 | 2 | positive regulation of connective tissue growth factor production |
GO:0034125 | 0.0012 | Inf | 0.07 | 2 | 2 | negative regulation of MyD88-dependent toll-like receptor signaling pathway |
GO:0048252 | 0.0012 | Inf | 0.07 | 2 | 2 | lauric acid metabolic process |
GO:0060876 | 0.0012 | Inf | 0.07 | 2 | 2 | semicircular canal formation |
GO:2000768 | 0.0012 | Inf | 0.07 | 2 | 2 | positive regulation of nephron tubule epithelial cell differentiation |
GO:2000193 | 0.0013 | 7.3052 | 0.8406 | 5 | 24 | positive regulation of fatty acid transport |
GO:2000027 | 0.0013 | 3.0207 | 4.308 | 12 | 123 | regulation of animal organ morphogenesis |
GO:0034764 | 0.0013 | 2.5332 | 6.7598 | 16 | 193 | positive regulation of transmembrane transport |
GO:0060541 | 0.0013 | 2.5332 | 6.7598 | 16 | 193 | respiratory system development |
GO:0030323 | 0.0013 | 2.6253 | 6.1293 | 15 | 175 | respiratory tube development |
GO:1905710 | 0.0013 | 4.7495 | 1.6812 | 7 | 48 | positive regulation of membrane permeability |
GO:0021796 | 0.0013 | 20.7666 | 0.2452 | 3 | 7 | cerebral cortex regionalization |
GO:0072007 | 0.0013 | 20.7666 | 0.2452 | 3 | 7 | mesangial cell differentiation |
GO:0072197 | 0.0013 | 20.7666 | 0.2452 | 3 | 7 | ureter morphogenesis |
GO:0042531 | 0.0014 | 4.1252 | 2.1715 | 8 | 62 | positive regulation of tyrosine phosphorylation of STAT protein |
GO:0071542 | 0.0014 | 5.5578 | 1.2609 | 6 | 36 | dopaminergic neuron differentiation |
GO:0060401 | 0.0014 | 2.5926 | 6.1994 | 15 | 177 | cytosolic calcium ion transport |
GO:0051254 | 0.0015 | 1.4765 | 57.5455 | 80 | 1643 | positive regulation of RNA metabolic process |
GO:0032104 | 0.0015 | 6.9395 | 0.8756 | 5 | 25 | regulation of response to extracellular stimulus |
GO:0043931 | 0.0015 | 6.9395 | 0.8756 | 5 | 25 | ossification involved in bone maturation |
GO:0072507 | 0.0015 | 1.8915 | 16.7418 | 30 | 478 | divalent inorganic cation homeostasis |
GO:0032504 | 0.0015 | 1.6815 | 27.5994 | 44 | 788 | multicellular organism reproduction |
GO:0050905 | 0.0016 | 2.7957 | 5.0085 | 13 | 143 | neuromuscular process |
GO:0007507 | 0.0016 | 2.0881 | 11.6608 | 23 | 339 | heart development |
GO:0021675 | 0.0016 | 3.6349 | 2.7319 | 9 | 78 | nerve development |
GO:0023056 | 0.0016 | 2.5596 | 6.2716 | 15 | 187 | positive regulation of signaling |
GO:0090101 | 0.0018 | 2.8896 | 4.4832 | 12 | 128 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0031401 | 0.0018 | 1.6209 | 31.8724 | 49 | 910 | positive regulation of protein modification process |
GO:0030878 | 0.0018 | 6.6086 | 0.9106 | 5 | 26 | thyroid gland development |
GO:0120039 | 0.0019 | 1.7753 | 20.7696 | 35 | 593 | plasma membrane bounded cell projection morphogenesis |
GO:0043066 | 0.0019 | 1.7323 | 23.1141 | 38 | 672 | negative regulation of apoptotic process |
GO:0021879 | 0.0019 | 5.2098 | 1.3309 | 6 | 38 | forebrain neuron differentiation |
GO:0051270 | 0.0019 | 1.8833 | 16.2455 | 29 | 479 | regulation of cellular component movement |
GO:0055119 | 0.0019 | 9.2411 | 0.5604 | 4 | 16 | relaxation of cardiac muscle |
GO:0021516 | 0.0021 | 16.6903 | 0.2789 | 3 | 8 | dorsal spinal cord development |
GO:0030916 | 0.0021 | 16.6122 | 0.2802 | 3 | 8 | otic vesicle formation |
GO:0048664 | 0.0021 | 16.6122 | 0.2802 | 3 | 8 | neuron fate determination |
GO:0072050 | 0.0021 | 16.6122 | 0.2802 | 3 | 8 | S-shaped body morphogenesis |
GO:0030856 | 0.0021 | 2.6913 | 5.1837 | 13 | 148 | regulation of epithelial cell differentiation |
GO:0046661 | 0.0021 | 2.6913 | 5.1837 | 13 | 148 | male sex differentiation |
GO:0001658 | 0.0021 | 4.3263 | 1.8213 | 7 | 52 | branching involved in ureteric bud morphogenesis |
GO:0007160 | 0.0022 | 2.3239 | 7.7755 | 17 | 222 | cell-matrix adhesion |
GO:0001525 | 0.0022 | 2.2584 | 8.4546 | 18 | 249 | angiogenesis |
GO:0021983 | 0.0022 | 5.0516 | 1.366 | 6 | 39 | pituitary gland development |
GO:0061440 | 0.0022 | 6.3078 | 0.9457 | 5 | 27 | kidney vasculature development |
GO:0043269 | 0.0023 | 3.7689 | 2.345 | 8 | 69 | regulation of ion transport |
GO:1904064 | 0.0023 | 2.7925 | 4.6233 | 12 | 132 | positive regulation of cation transmembrane transport |
GO:0030003 | 0.0024 | 1.7461 | 21.0849 | 35 | 602 | cellular cation homeostasis |
GO:0043410 | 0.0024 | 2.013 | 12.0574 | 23 | 348 | positive regulation of MAPK cascade |
GO:0009887 | 0.0025 | 1.8285 | 17.2766 | 30 | 516 | animal organ morphogenesis |
GO:0045787 | 0.0025 | 2.084 | 10.6475 | 21 | 304 | positive regulation of cell cycle |
GO:0060441 | 0.0026 | 6.0332 | 0.9807 | 5 | 28 | epithelial tube branching involved in lung morphogenesis |
GO:0050920 | 0.0026 | 2.3454 | 7.2501 | 16 | 207 | regulation of chemotaxis |
GO:0051130 | 0.0026 | 1.5812 | 33.2734 | 50 | 950 | positive regulation of cellular component organization |
GO:1903530 | 0.0026 | 1.8005 | 18.1078 | 31 | 517 | regulation of secretion by cell |
GO:0031623 | 0.0026 | 3.0977 | 3.5025 | 10 | 100 | receptor internalization |
GO:0008285 | 0.0027 | 1.6696 | 25.1827 | 40 | 719 | negative regulation of cell population proliferation |
GO:0150076 | 0.0028 | 3.6502 | 2.4167 | 8 | 69 | neuroinflammatory response |
GO:0051960 | 0.0028 | 1.9014 | 14.3951 | 26 | 411 | regulation of nervous system development |
GO:0010557 | 0.0028 | 1.4336 | 59.7871 | 81 | 1707 | positive regulation of macromolecule biosynthetic process |
GO:0098727 | 0.0028 | 2.7239 | 4.7283 | 12 | 135 | maintenance of cell number |
GO:0043009 | 0.0028 | 1.7735 | 18.9669 | 32 | 549 | chordate embryonic development |
GO:0042475 | 0.0029 | 3.2986 | 2.9771 | 9 | 85 | odontogenesis of dentin-containing tooth |
GO:0048762 | 0.003 | 2.2461 | 8.0206 | 17 | 229 | mesenchymal cell differentiation |
GO:0032147 | 0.003 | 2.7018 | 4.7634 | 12 | 136 | activation of protein kinase activity |
GO:0050801 | 0.003 | 1.6685 | 24.5523 | 39 | 701 | ion homeostasis |
GO:0001707 | 0.003 | 3.5911 | 2.4517 | 8 | 70 | mesoderm formation |
GO:0008343 | 0.0031 | 13.8427 | 0.3152 | 3 | 9 | adult feeding behavior |
GO:0010533 | 0.0031 | 13.8427 | 0.3152 | 3 | 9 | regulation of activation of Janus kinase activity |
GO:0021520 | 0.0031 | 13.8427 | 0.3152 | 3 | 9 | spinal cord motor neuron cell fate specification |
GO:0071313 | 0.0031 | 13.8427 | 0.3152 | 3 | 9 | cellular response to caffeine |
GO:0015732 | 0.0031 | 7.9199 | 0.6304 | 4 | 18 | prostaglandin transport |
GO:0032693 | 0.0031 | 7.9199 | 0.6304 | 4 | 18 | negative regulation of interleukin-10 production |
GO:0060644 | 0.0031 | 7.9199 | 0.6304 | 4 | 18 | mammary gland epithelial cell differentiation |
GO:0061298 | 0.0031 | 7.9199 | 0.6304 | 4 | 18 | retina vasculature development in camera-type eye |
GO:0072077 | 0.0031 | 7.9199 | 0.6304 | 4 | 18 | renal vesicle morphogenesis |
GO:2001135 | 0.0031 | 7.9199 | 0.6304 | 4 | 18 | regulation of endocytic recycling |
GO:0061351 | 0.0031 | 3.2571 | 3.0086 | 9 | 87 | neural precursor cell proliferation |
GO:0002065 | 0.0031 | 3.2556 | 3.0121 | 9 | 86 | columnar/cuboidal epithelial cell differentiation |
GO:0001932 | 0.0031 | 1.5448 | 36.0754 | 53 | 1030 | regulation of protein phosphorylation |
GO:0034765 | 0.0032 | 1.8545 | 15.3058 | 27 | 437 | regulation of ion transmembrane transport |
GO:0046427 | 0.0032 | 4.6298 | 1.471 | 6 | 42 | positive regulation of receptor signaling pathway via JAK-STAT |
GO:0046579 | 0.0033 | 3.9721 | 1.9614 | 7 | 56 | positive regulation of Ras protein signal transduction |
GO:0032990 | 0.0033 | 1.7086 | 21.5051 | 35 | 614 | cell part morphogenesis |
GO:0021536 | 0.0034 | 5.5972 | 1.0423 | 5 | 30 | diencephalon development |
GO:0090132 | 0.0035 | 1.9802 | 11.6982 | 22 | 334 | epithelium migration |
GO:0060218 | 0.0036 | 5.5498 | 1.0507 | 5 | 30 | hematopoietic stem cell differentiation |
GO:0007412 | 0.0036 | 55.2914 | 0.1051 | 2 | 3 | axon target recognition |
GO:0038091 | 0.0036 | 55.2914 | 0.1051 | 2 | 3 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
GO:0060128 | 0.0036 | 55.2914 | 0.1051 | 2 | 3 | corticotropin hormone secreting cell differentiation |
GO:0060375 | 0.0036 | 55.2914 | 0.1051 | 2 | 3 | regulation of mast cell differentiation |
GO:0060480 | 0.0036 | 55.2914 | 0.1051 | 2 | 3 | lung goblet cell differentiation |
GO:0061056 | 0.0036 | 55.2914 | 0.1051 | 2 | 3 | sclerotome development |
GO:0072011 | 0.0036 | 55.2914 | 0.1051 | 2 | 3 | glomerular endothelium development |
GO:0072275 | 0.0036 | 55.2914 | 0.1051 | 2 | 3 | metanephric glomerulus morphogenesis |
GO:0072277 | 0.0036 | 55.2914 | 0.1051 | 2 | 3 | metanephric glomerular capillary formation |
GO:0097377 | 0.0036 | 55.2914 | 0.1051 | 2 | 3 | spinal cord interneuron axon guidance |
GO:0120253 | 0.0036 | 55.2914 | 0.1051 | 2 | 3 | hydrocarbon catabolic process |
GO:1902202 | 0.0036 | 55.2914 | 0.1051 | 2 | 3 | regulation of hepatocyte growth factor receptor signaling pathway |
GO:1902869 | 0.0036 | 55.2914 | 0.1051 | 2 | 3 | regulation of amacrine cell differentiation |
GO:0055082 | 0.0036 | 1.6268 | 26.4436 | 41 | 755 | cellular chemical homeostasis |
GO:0070482 | 0.0037 | 2.0475 | 10.2973 | 20 | 294 | response to oxygen levels |
GO:0055003 | 0.0038 | 7.3915 | 0.6655 | 4 | 19 | cardiac myofibril assembly |
GO:0072079 | 0.0038 | 7.3915 | 0.6655 | 4 | 19 | nephron tubule formation |
GO:0010647 | 0.0039 | 2.3982 | 6.2045 | 14 | 185 | positive regulation of cell communication |
GO:0040012 | 0.0039 | 1.9008 | 13.2757 | 24 | 393 | regulation of locomotion |
GO:0031328 | 0.0039 | 1.4037 | 63.2195 | 84 | 1805 | positive regulation of cellular biosynthetic process |
GO:0048661 | 0.0039 | 3.1329 | 3.1172 | 9 | 89 | positive regulation of smooth muscle cell proliferation |
GO:0021885 | 0.004 | 3.8158 | 2.0314 | 7 | 58 | forebrain cell migration |
GO:0007276 | 0.0041 | 1.6706 | 22.5909 | 36 | 645 | gamete generation |
GO:0021988 | 0.0041 | 5.336 | 1.0858 | 5 | 31 | olfactory lobe development |
GO:0048710 | 0.0041 | 5.336 | 1.0858 | 5 | 31 | regulation of astrocyte differentiation |
GO:0048799 | 0.0041 | 5.336 | 1.0858 | 5 | 31 | animal organ maturation |
GO:0060562 | 0.0042 | 2.1644 | 8.2951 | 17 | 240 | epithelial tube morphogenesis |
GO:0048589 | 0.0042 | 1.6931 | 21.0498 | 34 | 601 | developmental growth |
GO:1905954 | 0.0042 | 3.094 | 3.1522 | 9 | 90 | positive regulation of lipid localization |
GO:0021889 | 0.0043 | 11.8644 | 0.3502 | 3 | 10 | olfactory bulb interneuron differentiation |
GO:2001204 | 0.0043 | 11.8644 | 0.3502 | 3 | 10 | regulation of osteoclast development |
GO:0045995 | 0.0044 | 3.7422 | 2.0665 | 7 | 59 | regulation of embryonic development |
GO:0008584 | 0.0045 | 2.6908 | 4.3781 | 11 | 125 | male gonad development |
GO:0046620 | 0.0046 | 3.0561 | 3.1872 | 9 | 91 | regulation of organ growth |
GO:0021517 | 0.0046 | 4.2728 | 1.5761 | 6 | 45 | ventral spinal cord development |
GO:0001936 | 0.0046 | 2.4363 | 5.674 | 13 | 162 | regulation of endothelial cell proliferation |
GO:0033993 | 0.0047 | 1.6312 | 24.4069 | 38 | 704 | response to lipid |
GO:0060485 | 0.0047 | 4.2441 | 1.5829 | 6 | 46 | mesenchyme development |
GO:0098657 | 0.0047 | 2.1941 | 7.7054 | 16 | 220 | import into cell |
GO:0098751 | 0.0048 | 5.1381 | 1.1208 | 5 | 32 | bone cell development |
GO:0060041 | 0.0048 | 2.6606 | 4.422 | 11 | 127 | retina development in camera-type eye |
GO:0042102 | 0.0049 | 3.0191 | 3.2223 | 9 | 92 | positive regulation of T cell proliferation |
GO:0010927 | 0.0049 | 2.8145 | 3.8177 | 10 | 109 | cellular component assembly involved in morphogenesis |
GO:0007626 | 0.0049 | 2.3283 | 6.3745 | 14 | 182 | locomotory behavior |
GO:0001666 | 0.005 | 2.0745 | 9.1414 | 18 | 261 | response to hypoxia |
GO:0051235 | 0.005 | 1.9884 | 10.5775 | 20 | 302 | maintenance of location |
GO:0048513 | 0.005 | 1.5438 | 32.8416 | 48 | 1099 | animal organ development |
GO:0007283 | 0.0052 | 1.7448 | 17.4073 | 29 | 497 | spermatogenesis |
GO:0098660 | 0.0052 | 1.5894 | 27.004 | 41 | 771 | inorganic ion transmembrane transport |
GO:0043406 | 0.0052 | 2.7862 | 3.8527 | 10 | 110 | positive regulation of MAP kinase activity |
GO:2000736 | 0.0053 | 3.6032 | 2.1365 | 7 | 61 | regulation of stem cell differentiation |
GO:0030001 | 0.0053 | 1.8017 | 15.1264 | 26 | 442 | metal ion transport |
GO:0035148 | 0.0054 | 2.4887 | 5.1313 | 12 | 147 | tube formation |
GO:0032965 | 0.0055 | 4.9543 | 1.1558 | 5 | 33 | regulation of collagen biosynthetic process |
GO:0048566 | 0.0055 | 4.9543 | 1.1558 | 5 | 33 | embryonic digestive tract development |
GO:1905332 | 0.0055 | 4.9543 | 1.1558 | 5 | 33 | positive regulation of morphogenesis of an epithelium |
GO:0072273 | 0.0055 | 6.5432 | 0.7331 | 4 | 21 | metanephric nephron morphogenesis |
GO:0061042 | 0.0055 | 6.5211 | 0.7355 | 4 | 21 | vascular wound healing |
GO:0061448 | 0.0056 | 3.5634 | 2.1539 | 7 | 63 | connective tissue development |
GO:0050769 | 0.0056 | 2.2184 | 7.145 | 15 | 204 | positive regulation of neurogenesis |
GO:0016331 | 0.0056 | 2.4799 | 5.1486 | 12 | 147 | morphogenesis of embryonic epithelium |
GO:0042592 | 0.0056 | 1.3996 | 57.8958 | 77 | 1653 | homeostatic process |
GO:0001649 | 0.0056 | 2.1514 | 7.8455 | 16 | 224 | osteoblast differentiation |
GO:0097696 | 0.0057 | 2.372 | 5.8141 | 13 | 166 | receptor signaling pathway via STAT |
GO:0099072 | 0.0057 | 4.0639 | 1.6462 | 6 | 47 | regulation of postsynaptic membrane neurotransmitter receptor levels |
GO:0032099 | 0.0057 | 10.3807 | 0.3853 | 3 | 11 | negative regulation of appetite |
GO:0032108 | 0.0057 | 10.3807 | 0.3853 | 3 | 11 | negative regulation of response to nutrient levels |
GO:0048715 | 0.0057 | 10.3807 | 0.3853 | 3 | 11 | negative regulation of oligodendrocyte differentiation |
GO:0051133 | 0.0057 | 10.3807 | 0.3853 | 3 | 11 | regulation of NK T cell activation |
GO:0060009 | 0.0057 | 10.3807 | 0.3853 | 3 | 11 | Sertoli cell development |
GO:0021953 | 0.0058 | 2.7415 | 3.9073 | 10 | 113 | central nervous system neuron differentiation |
GO:0035904 | 0.0058 | 3.5374 | 2.1715 | 7 | 62 | aorta development |
GO:0050793 | 0.0058 | 1.7498 | 16.7916 | 28 | 523 | regulation of developmental process |
GO:1903039 | 0.0059 | 2.1409 | 7.8806 | 16 | 225 | positive regulation of leukocyte cell-cell adhesion |
GO:0014068 | 0.0059 | 3.179 | 2.7319 | 8 | 78 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0021782 | 0.0059 | 2.7312 | 3.9228 | 10 | 112 | glial cell development |
GO:0030593 | 0.006 | 2.9132 | 3.3273 | 9 | 95 | neutrophil chemotaxis |
GO:0035137 | 0.0062 | 4.7831 | 1.1908 | 5 | 34 | hindlimb morphogenesis |
GO:0007409 | 0.0062 | 1.8229 | 13.7891 | 24 | 395 | axonogenesis |
GO:0046850 | 0.0063 | 3.9669 | 1.6812 | 6 | 48 | regulation of bone remodeling |
GO:0006355 | 0.0063 | 1.3021 | 106.2298 | 130 | 3033 | regulation of transcription, DNA-templated |
GO:0008543 | 0.0063 | 3.1341 | 2.7669 | 8 | 79 | fibroblast growth factor receptor signaling pathway |
GO:0051716 | 0.0064 | 1.2417 | 232.5988 | 262 | 6641 | cellular response to stimulus |
GO:0060291 | 0.0065 | 2.8796 | 3.3624 | 9 | 96 | long-term synaptic potentiation |
GO:0032102 | 0.0065 | 1.8164 | 13.8347 | 24 | 395 | negative regulation of response to external stimulus |
GO:0051047 | 0.0066 | 1.9709 | 10.1221 | 19 | 289 | positive regulation of secretion |
GO:0032925 | 0.0066 | 6.1584 | 0.7705 | 4 | 22 | regulation of activin receptor signaling pathway |
GO:0050794 | 0.0066 | 1.2771 | 254.6805 | 281 | 8033 | regulation of cellular process |
GO:0030097 | 0.0067 | 1.9678 | 10.1377 | 19 | 297 | hemopoiesis |
GO:0051094 | 0.0067 | 1.8372 | 13.1169 | 23 | 395 | positive regulation of developmental process |
GO:0006820 | 0.0067 | 1.7451 | 16.1814 | 27 | 462 | anion transport |
GO:0016477 | 0.0069 | 2.1611 | 7.313 | 15 | 227 | cell migration |
GO:2001141 | 0.007 | 1.2972 | 106.545 | 130 | 3042 | regulation of RNA biosynthetic process |
GO:0001757 | 0.007 | 27.644 | 0.1401 | 2 | 4 | somite specification |
GO:0006565 | 0.007 | 27.644 | 0.1401 | 2 | 4 | L-serine catabolic process |
GO:0048069 | 0.007 | 27.644 | 0.1401 | 2 | 4 | eye pigmentation |
GO:0060018 | 0.007 | 27.644 | 0.1401 | 2 | 4 | astrocyte fate commitment |
GO:0060129 | 0.007 | 27.644 | 0.1401 | 2 | 4 | thyroid-stimulating hormone-secreting cell differentiation |
GO:0061754 | 0.007 | 27.644 | 0.1401 | 2 | 4 | negative regulation of circulating fibrinogen levels |
GO:0070093 | 0.007 | 27.644 | 0.1401 | 2 | 4 | negative regulation of glucagon secretion |
GO:0071657 | 0.007 | 27.644 | 0.1401 | 2 | 4 | positive regulation of granulocyte colony-stimulating factor production |
GO:0072278 | 0.007 | 27.644 | 0.1401 | 2 | 4 | metanephric comma-shaped body morphogenesis |
GO:0097476 | 0.007 | 27.644 | 0.1401 | 2 | 4 | spinal cord motor neuron migration |
GO:1900740 | 0.007 | 27.644 | 0.1401 | 2 | 4 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway |
GO:2000491 | 0.007 | 27.644 | 0.1401 | 2 | 4 | positive regulation of hepatic stellate cell activation |
GO:2000697 | 0.007 | 27.644 | 0.1401 | 2 | 4 | negative regulation of epithelial cell differentiation involved in kidney development |
GO:0060428 | 0.007 | 4.6234 | 1.2259 | 5 | 35 | lung epithelium development |
GO:0002040 | 0.0072 | 2.2962 | 5.9892 | 13 | 171 | sprouting angiogenesis |
GO:0060070 | 0.0073 | 1.9488 | 10.2272 | 19 | 292 | canonical Wnt signaling pathway |
GO:0042116 | 0.0074 | 2.8145 | 3.4324 | 9 | 98 | macrophage activation |
GO:0021527 | 0.0074 | 9.2267 | 0.4203 | 3 | 12 | spinal cord association neuron differentiation |
GO:0038180 | 0.0074 | 9.2267 | 0.4203 | 3 | 12 | nerve growth factor signaling pathway |
GO:0051549 | 0.0074 | 9.2267 | 0.4203 | 3 | 12 | positive regulation of keratinocyte migration |
GO:0060019 | 0.0074 | 9.2267 | 0.4203 | 3 | 12 | radial glial cell differentiation |
GO:0032890 | 0.0075 | 3.3538 | 2.2766 | 7 | 65 | regulation of organic acid transport |
GO:0001667 | 0.0075 | 1.7475 | 15.551 | 26 | 444 | ameboidal-type cell migration |
GO:0019220 | 0.0076 | 1.4282 | 45.462 | 62 | 1298 | regulation of phosphate metabolic process |
GO:0050671 | 0.0076 | 4.5219 | 1.2481 | 5 | 36 | positive regulation of lymphocyte proliferation |
GO:0072202 | 0.0078 | 5.8339 | 0.8056 | 4 | 23 | cell differentiation involved in metanephros development |
GO:0002682 | 0.0078 | 1.4345 | 43.7808 | 60 | 1250 | regulation of immune system process |
GO:0030334 | 0.0078 | 1.8098 | 13.2968 | 23 | 390 | regulation of cell migration |
GO:0007589 | 0.0079 | 3.0064 | 2.872 | 8 | 82 | body fluid secretion |
GO:0051781 | 0.0079 | 3.0064 | 2.872 | 8 | 82 | positive regulation of cell division |
GO:0070306 | 0.008 | 4.474 | 1.2609 | 5 | 36 | lens fiber cell differentiation |
GO:0060326 | 0.0082 | 3.2869 | 2.316 | 7 | 67 | cell chemotaxis |
GO:0001676 | 0.0084 | 2.7523 | 3.5025 | 9 | 100 | long-chain fatty acid metabolic process |
GO:0045637 | 0.0085 | 2.1714 | 6.7948 | 14 | 194 | regulation of myeloid cell differentiation |
GO:0051239 | 0.0085 | 1.6623 | 18.8924 | 30 | 583 | regulation of multicellular organismal process |
GO:0014070 | 0.0086 | 1.5729 | 24.5456 | 37 | 708 | response to organic cyclic compound |
GO:0030534 | 0.0087 | 2.5673 | 4.1485 | 10 | 119 | adult behavior |
GO:0021700 | 0.009 | 1.9443 | 9.7018 | 18 | 277 | developmental maturation |
GO:0022030 | 0.0091 | 5.5419 | 0.8406 | 4 | 24 | telencephalon glial cell migration |
GO:2000679 | 0.0091 | 5.5419 | 0.8406 | 4 | 24 | positive regulation of transcription regulatory region DNA binding |
GO:0045860 | 0.0091 | 2.0324 | 8.2647 | 16 | 239 | positive regulation of protein kinase activity |
GO:0042100 | 0.0091 | 2.9269 | 2.9421 | 8 | 84 | B cell proliferation |
GO:0051262 | 0.0091 | 2.9269 | 2.9421 | 8 | 84 | protein tetramerization |
GO:0055006 | 0.0091 | 2.9269 | 2.9421 | 8 | 84 | cardiac cell development |
GO:0043271 | 0.0093 | 2.4134 | 4.8334 | 11 | 138 | negative regulation of ion transport |
GO:0002763 | 0.0093 | 3.621 | 1.8213 | 6 | 52 | positive regulation of myeloid leukocyte differentiation |
GO:0046456 | 0.0093 | 3.621 | 1.8213 | 6 | 52 | icosanoid biosynthetic process |
GO:0021819 | 0.0094 | 8.3035 | 0.4553 | 3 | 13 | layer formation in cerebral cortex |
GO:0032308 | 0.0094 | 8.3035 | 0.4553 | 3 | 13 | positive regulation of prostaglandin secretion |
GO:0038092 | 0.0094 | 8.3035 | 0.4553 | 3 | 13 | nodal signaling pathway |
GO:0032355 | 0.0095 | 2.5313 | 4.203 | 10 | 120 | response to estradiol |
GO:0042476 | 0.0096 | 4.2492 | 1.3169 | 5 | 38 | odontogenesis |
GO:0043542 | 0.0096 | 1.9722 | 9.0364 | 17 | 258 | endothelial cell migration |
GO:0030595 | 0.0096 | 2.0739 | 7.6004 | 15 | 217 | leukocyte chemotaxis |
GO:0007565 | 0.0097 | 2.2914 | 5.5339 | 12 | 158 | female pregnancy |
GO:0021515 | 0.0098 | 4.2221 | 1.325 | 5 | 38 | cell differentiation in spinal cord |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0097275 | 1e-04 | Inf | 1e-04 | 1 | 1 | cellular ammonium homeostasis |
GO:0097276 | 1e-04 | Inf | 1e-04 | 1 | 1 | cellular creatinine homeostasis |
GO:0097277 | 1e-04 | Inf | 1e-04 | 1 | 1 | cellular urea homeostasis |
GO:0097070 | 6e-04 | 4102.75 | 6e-04 | 1 | 5 | ductus arteriosus closure |
GO:0055062 | 0.0013 | 1640.5 | 0.0013 | 1 | 11 | phosphate ion homeostasis |
GO:0072017 | 0.0013 | 1640.5 | 0.0013 | 1 | 11 | distal tubule development |
GO:0010960 | 0.0015 | 1491.2727 | 0.0015 | 1 | 12 | magnesium ion homeostasis |
GO:0035810 | 0.0015 | 1491.2727 | 0.0015 | 1 | 12 | positive regulation of urine volume |
GO:0072044 | 0.0018 | 1171.5 | 0.0018 | 1 | 15 | collecting duct development |
GO:0003091 | 0.0026 | 819.75 | 0.0026 | 1 | 21 | renal water homeostasis |
GO:0000122 | 0.0026 | Inf | 0.1014 | 2 | 832 | negative regulation of transcription by RNA polymerase II |
GO:0048485 | 0.0027 | 780.6667 | 0.0027 | 1 | 22 | sympathetic nervous system development |
GO:0010842 | 0.0029 | 712.6957 | 0.0029 | 1 | 24 | retina layer formation |
GO:0048745 | 0.0029 | 712.6957 | 0.0029 | 1 | 24 | smooth muscle tissue development |
GO:0055075 | 0.0038 | 546.1667 | 0.0038 | 1 | 31 | potassium ion homeostasis |
GO:0035137 | 0.0041 | 496.4242 | 0.0041 | 1 | 34 | hindlimb morphogenesis |
GO:0035136 | 0.0044 | 468 | 0.0044 | 1 | 36 | forelimb morphogenesis |
GO:0035909 | 0.0044 | 468 | 0.0044 | 1 | 36 | aorta morphogenesis |
GO:0055081 | 0.0044 | 468 | 0.0044 | 1 | 36 | anion homeostasis |
GO:0072210 | 0.0047 | 430.9737 | 0.0048 | 1 | 39 | metanephric nephron development |
GO:1903507 | 0.0048 | Inf | 0.1381 | 2 | 1134 | negative regulation of nucleic acid-templated transcription |
GO:0051253 | 0.0056 | Inf | 0.1503 | 2 | 1234 | negative regulation of RNA metabolic process |
GO:0043525 | 0.0057 | 355.8478 | 0.0057 | 1 | 47 | positive regulation of neuron apoptotic process |
GO:0055078 | 0.0063 | 320.8627 | 0.0063 | 1 | 52 | sodium ion homeostasis |
GO:0010558 | 0.0073 | Inf | 0.1714 | 2 | 1407 | negative regulation of macromolecule biosynthetic process |
GO:0030104 | 0.0079 | 255.4844 | 0.0079 | 1 | 65 | water homeostasis |
GO:0031327 | 0.008 | Inf | 0.1785 | 2 | 1465 | negative regulation of cellular biosynthetic process |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051674 | 0 | 2.678 | 17.1621 | 39 | 1610 | localization of cell |
GO:0040011 | 0 | 3.0549 | 7.7025 | 21 | 771 | locomotion |
GO:0016477 | 1e-04 | 3.3154 | 5.3052 | 16 | 524 | cell migration |
GO:1990266 | 2e-04 | 6.3428 | 1.2045 | 7 | 113 | neutrophil migration |
GO:0031589 | 3e-04 | 3.5608 | 3.635 | 12 | 341 | cell-substrate adhesion |
GO:0006811 | 4e-04 | 2.1701 | 14.8276 | 29 | 1391 | ion transport |
GO:0045785 | 6e-04 | 3.13 | 4.4664 | 13 | 419 | positive regulation of cell adhesion |
GO:0055119 | 6e-04 | 21.7742 | 0.1706 | 3 | 16 | relaxation of cardiac muscle |
GO:0051270 | 6e-04 | 2.282 | 11.0115 | 23 | 1033 | regulation of cellular component movement |
GO:0006950 | 8e-04 | 1.7324 | 36.8079 | 55 | 3453 | response to stress |
GO:0030198 | 0.001 | 3.4931 | 3.0593 | 10 | 287 | extracellular matrix organization |
GO:0019800 | 0.0011 | 62.578 | 0.0533 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0033591 | 0.0011 | 62.578 | 0.0533 | 2 | 5 | response to L-ascorbic acid |
GO:0060978 | 0.0011 | 62.578 | 0.0533 | 2 | 5 | angiogenesis involved in coronary vascular morphogenesis |
GO:0070779 | 0.0011 | 62.578 | 0.0533 | 2 | 5 | D-aspartate import across plasma membrane |
GO:0048514 | 0.0016 | 2.4733 | 6.9395 | 16 | 651 | blood vessel morphogenesis |
GO:0042940 | 0.0016 | 46.9306 | 0.064 | 2 | 6 | D-amino acid transport |
GO:0060017 | 0.0016 | 46.9306 | 0.064 | 2 | 6 | parathyroid gland development |
GO:0021543 | 0.0017 | 4.3528 | 1.7162 | 7 | 161 | pallium development |
GO:0021895 | 0.0018 | 14.1471 | 0.2452 | 3 | 23 | cerebral cortex neuron differentiation |
GO:0072359 | 0.0018 | 2.0911 | 11.9282 | 23 | 1119 | circulatory system development |
GO:0001817 | 0.0021 | 2.3434 | 7.7816 | 17 | 730 | regulation of cytokine production |
GO:0048699 | 0.0021 | 1.9808 | 14.2946 | 26 | 1341 | generation of neurons |
GO:0030154 | 0.0021 | 1.6281 | 41.0291 | 58 | 3849 | cell differentiation |
GO:2001257 | 0.0022 | 4.1617 | 1.7908 | 7 | 168 | regulation of cation channel activity |
GO:0015840 | 0.0023 | 37.5422 | 0.0746 | 2 | 7 | urea transport |
GO:0040012 | 0.0023 | 2.1214 | 10.681 | 21 | 1002 | regulation of locomotion |
GO:0045766 | 0.0027 | 4.0107 | 1.8548 | 7 | 174 | positive regulation of angiogenesis |
GO:0098655 | 0.0027 | 2.2247 | 8.677 | 18 | 814 | cation transmembrane transport |
GO:0042102 | 0.003 | 5.4615 | 0.9807 | 5 | 92 | positive regulation of T cell proliferation |
GO:0006026 | 0.0035 | 10.8784 | 0.3091 | 3 | 29 | aminoglycan catabolic process |
GO:0019730 | 0.0036 | 5.2201 | 1.0233 | 5 | 96 | antimicrobial humoral response |
GO:0060291 | 0.0036 | 5.2201 | 1.0233 | 5 | 96 | long-term synaptic potentiation |
GO:0023052 | 0.0037 | 1.5286 | 61.4317 | 79 | 5763 | signaling |
GO:0006928 | 0.0037 | 2.1191 | 9.6927 | 19 | 981 | movement of cell or subcellular component |
GO:0008343 | 0.0039 | 26.8126 | 0.0959 | 2 | 9 | adult feeding behavior |
GO:0050861 | 0.0039 | 26.8126 | 0.0959 | 2 | 9 | positive regulation of B cell receptor signaling pathway |
GO:0061037 | 0.0039 | 10.4748 | 0.3198 | 3 | 30 | negative regulation of cartilage development |
GO:0007399 | 0.0042 | 1.7032 | 23.9416 | 37 | 2246 | nervous system development |
GO:0035295 | 0.0042 | 2.0056 | 11.246 | 21 | 1055 | tube development |
GO:0048663 | 0.0046 | 6.4161 | 0.6716 | 4 | 63 | neuron fate commitment |
GO:0008015 | 0.0047 | 2.5315 | 5.0207 | 12 | 471 | blood circulation |
GO:0032743 | 0.0047 | 9.7512 | 0.3411 | 3 | 32 | positive regulation of interleukin-2 production |
GO:0050901 | 0.0047 | 9.7512 | 0.3411 | 3 | 32 | leukocyte tethering or rolling |
GO:0070092 | 0.0048 | 23.4595 | 0.1066 | 2 | 10 | regulation of glucagon secretion |
GO:0061448 | 0.0051 | 3.2076 | 2.6329 | 8 | 247 | connective tissue development |
GO:0061180 | 0.0051 | 6.205 | 0.6929 | 4 | 65 | mammary gland epithelium development |
GO:0002526 | 0.0053 | 4.7476 | 1.1193 | 5 | 105 | acute inflammatory response |
GO:0002430 | 0.0058 | 20.8516 | 0.1173 | 2 | 11 | complement receptor mediated signaling pathway |
GO:0048715 | 0.0058 | 20.8516 | 0.1173 | 2 | 11 | negative regulation of oligodendrocyte differentiation |
GO:0035924 | 0.006 | 5.913 | 0.7249 | 4 | 68 | cellular response to vascular endothelial growth factor stimulus |
GO:0002757 | 0.0063 | 3.3936 | 2.1746 | 7 | 204 | immune response-activating signal transduction |
GO:0098742 | 0.0064 | 3.0768 | 2.7395 | 8 | 257 | cell-cell adhesion via plasma-membrane adhesion molecules |
GO:0030001 | 0.0065 | 2.0769 | 8.709 | 17 | 817 | metal ion transport |
GO:0090049 | 0.0066 | 5.7331 | 0.7462 | 4 | 70 | regulation of cell migration involved in sprouting angiogenesis |
GO:0003008 | 0.0067 | 2.1856 | 7.3289 | 15 | 730 | system process |
GO:0032501 | 0.0068 | 1.5649 | 44.7793 | 59 | 4710 | multicellular organismal process |
GO:0034144 | 0.007 | 18.7653 | 0.1279 | 2 | 12 | negative regulation of toll-like receptor 4 signaling pathway |
GO:0007565 | 0.007 | 3.7582 | 1.6842 | 6 | 158 | female pregnancy |
GO:0032689 | 0.0071 | 8.3146 | 0.3944 | 3 | 37 | negative regulation of interferon-gamma production |
GO:0070887 | 0.0071 | 1.5919 | 29.8684 | 43 | 2802 | cellular response to chemical stimulus |
GO:0071805 | 0.0072 | 3.3086 | 2.2279 | 7 | 209 | potassium ion transmembrane transport |
GO:0043534 | 0.0072 | 3.7334 | 1.6949 | 6 | 159 | blood vessel endothelial cell migration |
GO:0009653 | 0.0073 | 1.6111 | 27.3208 | 40 | 2563 | anatomical structure morphogenesis |
GO:0071495 | 0.0073 | 1.8484 | 13.3459 | 23 | 1252 | cellular response to endogenous stimulus |
GO:0034765 | 0.0073 | 2.4902 | 4.6583 | 11 | 437 | regulation of ion transmembrane transport |
GO:0007154 | 0.0074 | 1.4736 | 61.9541 | 78 | 5812 | cell communication |
GO:1901342 | 0.0075 | 2.7773 | 3.4111 | 9 | 320 | regulation of vasculature development |
GO:0006954 | 0.0075 | 2.2133 | 6.7012 | 14 | 643 | inflammatory response |
GO:0051897 | 0.0075 | 4.3532 | 1.2152 | 5 | 114 | positive regulation of protein kinase B signaling |
GO:0097529 | 0.0075 | 3.2757 | 2.2492 | 7 | 211 | myeloid leukocyte migration |
GO:0051049 | 0.0076 | 1.7419 | 17.3646 | 28 | 1629 | regulation of transport |
GO:0009991 | 0.0079 | 2.4605 | 4.7116 | 11 | 442 | response to extracellular stimulus |
GO:0021954 | 0.008 | 5.4042 | 0.7888 | 4 | 74 | central nervous system neuron development |
GO:0010623 | 0.0082 | 17.0583 | 0.1386 | 2 | 13 | programmed cell death involved in cell development |
GO:0042755 | 0.0082 | 7.8517 | 0.4157 | 3 | 39 | eating behavior |
GO:0007186 | 0.0084 | 1.9057 | 11.1927 | 20 | 1050 | G protein-coupled receptor signaling pathway |
GO:0006029 | 0.0084 | 5.3277 | 0.7995 | 4 | 75 | proteoglycan metabolic process |
GO:0032413 | 0.0084 | 5.3277 | 0.7995 | 4 | 75 | negative regulation of ion transmembrane transporter activity |
GO:0030334 | 0.0085 | 1.973 | 9.7003 | 18 | 910 | regulation of cell migration |
GO:0014014 | 0.0088 | 7.6391 | 0.4264 | 3 | 40 | negative regulation of gliogenesis |
GO:0050877 | 0.0091 | 1.8085 | 13.6124 | 23 | 1277 | nervous system process |
GO:0014819 | 0.0095 | 15.6358 | 0.1492 | 2 | 14 | regulation of skeletal muscle contraction |
GO:0042127 | 0.0099 | 1.7182 | 16.9063 | 27 | 1586 | regulation of cell population proliferation |
GO:0048706 | 0.0099 | 4.0535 | 1.3005 | 5 | 122 | embryonic skeletal system development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007275 | 0 | 2.3415 | 55.8808 | 101 | 3167 | multicellular organism development |
GO:0022008 | 0 | 2.6963 | 19.4081 | 46 | 1040 | neurogenesis |
GO:0051674 | 0 | 2.2948 | 30.9898 | 62 | 1610 | localization of cell |
GO:0030182 | 0 | 2.4909 | 19.8153 | 44 | 1067 | neuron differentiation |
GO:0001655 | 0 | 3.6261 | 6.3712 | 21 | 331 | urogenital system development |
GO:0048468 | 0 | 2.3213 | 21.2159 | 44 | 1171 | cell development |
GO:0032095 | 0 | 23.5165 | 0.308 | 5 | 16 | regulation of response to food |
GO:0035239 | 0 | 2.5287 | 13.8529 | 32 | 732 | tube morphogenesis |
GO:0045165 | 0 | 3.7734 | 4.9276 | 17 | 256 | cell fate commitment |
GO:0001822 | 0 | 3.5958 | 5.4665 | 18 | 284 | kidney development |
GO:0001568 | 0 | 2.6075 | 11.6886 | 28 | 617 | blood vessel development |
GO:0048706 | 0 | 5.1954 | 2.3483 | 11 | 122 | embryonic skeletal system development |
GO:0061448 | 0 | 3.6641 | 4.7543 | 16 | 247 | connective tissue development |
GO:0040011 | 0 | 2.1174 | 22.4049 | 43 | 1217 | locomotion |
GO:0048880 | 0 | 3.0231 | 7.1604 | 20 | 372 | sensory system development |
GO:0009653 | 0 | 2.1254 | 21.3803 | 41 | 1231 | anatomical structure morphogenesis |
GO:0030198 | 0 | 3.3337 | 5.5243 | 17 | 287 | extracellular matrix organization |
GO:2000026 | 1e-04 | 2.0827 | 21.5254 | 41 | 1137 | regulation of multicellular organismal development |
GO:0099560 | 1e-04 | 15.2109 | 0.4235 | 5 | 22 | synaptic membrane adhesion |
GO:0060429 | 1e-04 | 2.0859 | 20.9037 | 40 | 1086 | epithelium development |
GO:0060978 | 1e-04 | 77.1518 | 0.0962 | 3 | 5 | angiogenesis involved in coronary vascular morphogenesis |
GO:0051272 | 1e-04 | 2.5289 | 10.6636 | 25 | 554 | positive regulation of cellular component movement |
GO:0001654 | 1e-04 | 2.939 | 6.9679 | 19 | 362 | eye development |
GO:0045597 | 1e-04 | 2.2343 | 15.4949 | 32 | 805 | positive regulation of cell differentiation |
GO:0032104 | 1e-04 | 12.9268 | 0.4812 | 5 | 25 | regulation of response to extracellular stimulus |
GO:2000145 | 1e-04 | 2.1046 | 18.5362 | 36 | 963 | regulation of cell motility |
GO:0060017 | 1e-04 | 51.4313 | 0.1155 | 3 | 6 | parathyroid gland development |
GO:0001525 | 2e-04 | 3.4036 | 4.4351 | 14 | 238 | angiogenesis |
GO:0034103 | 2e-04 | 5.6255 | 1.5784 | 8 | 82 | regulation of tissue remodeling |
GO:0040017 | 2e-04 | 2.4053 | 10.7021 | 24 | 556 | positive regulation of locomotion |
GO:0007156 | 2e-04 | 3.9687 | 3.0027 | 11 | 156 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0009792 | 2e-04 | 2.3003 | 12.1265 | 26 | 630 | embryo development ending in birth or egg hatching |
GO:0048146 | 2e-04 | 7.7715 | 0.8854 | 6 | 46 | positive regulation of fibroblast proliferation |
GO:0001501 | 2e-04 | 3.2476 | 4.6321 | 14 | 248 | skeletal system development |
GO:0048665 | 2e-04 | 10.3383 | 0.5775 | 5 | 30 | neuron fate specification |
GO:0072359 | 3e-04 | 2.4018 | 10.2755 | 23 | 556 | circulatory system development |
GO:0046620 | 4e-04 | 5.0127 | 1.7516 | 8 | 91 | regulation of organ growth |
GO:0032723 | 4e-04 | Inf | 0.0385 | 2 | 2 | positive regulation of connective tissue growth factor production |
GO:0032827 | 4e-04 | Inf | 0.0385 | 2 | 2 | negative regulation of natural killer cell differentiation involved in immune response |
GO:0048252 | 4e-04 | Inf | 0.0385 | 2 | 2 | lauric acid metabolic process |
GO:0006928 | 4e-04 | 1.8302 | 26.7831 | 45 | 1460 | movement of cell or subcellular component |
GO:0055003 | 4e-04 | 13.7487 | 0.3657 | 4 | 19 | cardiac myofibril assembly |
GO:0032879 | 5e-04 | 1.6099 | 50.1419 | 73 | 2605 | regulation of localization |
GO:0030335 | 5e-04 | 2.3445 | 10.0091 | 22 | 520 | positive regulation of cell migration |
GO:0120039 | 5e-04 | 2.2436 | 11.4143 | 24 | 593 | plasma membrane bounded cell projection morphogenesis |
GO:0010613 | 5e-04 | 8.6125 | 0.6737 | 5 | 35 | positive regulation of cardiac muscle hypertrophy |
GO:0060322 | 5e-04 | 2.1013 | 14.2438 | 28 | 740 | head development |
GO:0008343 | 5e-04 | 25.7109 | 0.1732 | 3 | 9 | adult feeding behavior |
GO:0007507 | 6e-04 | 2.2621 | 10.8368 | 23 | 563 | heart development |
GO:1905205 | 8e-04 | 22.0365 | 0.1925 | 3 | 10 | positive regulation of connective tissue replacement |
GO:0003002 | 8e-04 | 2.7487 | 5.8078 | 15 | 305 | regionalization |
GO:0031175 | 8e-04 | 2.3491 | 9.0624 | 20 | 487 | neuron projection development |
GO:0032990 | 8e-04 | 2.1608 | 11.8185 | 24 | 614 | cell part morphogenesis |
GO:0010975 | 9e-04 | 2.4657 | 7.7571 | 18 | 403 | regulation of neuron projection development |
GO:0045860 | 0.001 | 2.5002 | 7.2181 | 17 | 375 | positive regulation of protein kinase activity |
GO:0032099 | 0.001 | 19.2808 | 0.2117 | 3 | 11 | negative regulation of appetite |
GO:0032108 | 0.001 | 19.2808 | 0.2117 | 3 | 11 | negative regulation of response to nutrient levels |
GO:2000679 | 0.0011 | 10.3083 | 0.462 | 4 | 24 | positive regulation of transcription regulatory region DNA binding |
GO:0000904 | 0.0011 | 2.0856 | 12.7424 | 25 | 662 | cell morphogenesis involved in differentiation |
GO:0003008 | 0.0011 | 1.7713 | 24.9441 | 41 | 1331 | system process |
GO:0098609 | 0.0011 | 1.9473 | 16.4188 | 30 | 853 | cell-cell adhesion |
GO:0007412 | 0.0011 | 102.5478 | 0.0577 | 2 | 3 | axon target recognition |
GO:0038091 | 0.0011 | 102.5478 | 0.0577 | 2 | 3 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
GO:0060480 | 0.0011 | 102.5478 | 0.0577 | 2 | 3 | lung goblet cell differentiation |
GO:0072275 | 0.0011 | 102.5478 | 0.0577 | 2 | 3 | metanephric glomerulus morphogenesis |
GO:0072277 | 0.0011 | 102.5478 | 0.0577 | 2 | 3 | metanephric glomerular capillary formation |
GO:0097377 | 0.0011 | 102.5478 | 0.0577 | 2 | 3 | spinal cord interneuron axon guidance |
GO:1902869 | 0.0011 | 102.5478 | 0.0577 | 2 | 3 | regulation of amacrine cell differentiation |
GO:0048729 | 0.0011 | 2.1467 | 11.3758 | 23 | 591 | tissue morphogenesis |
GO:0048869 | 0.0011 | 1.7306 | 29.2643 | 46 | 1793 | cellular developmental process |
GO:0016339 | 0.0012 | 6.9801 | 0.8084 | 5 | 42 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0048705 | 0.0013 | 2.987 | 4.2731 | 12 | 222 | skeletal system morphogenesis |
GO:0001756 | 0.0013 | 5.4479 | 1.2126 | 6 | 63 | somitogenesis |
GO:0021953 | 0.0013 | 3.661 | 2.6347 | 9 | 138 | central nervous system neuron differentiation |
GO:0034762 | 0.0015 | 2.1851 | 10.1824 | 21 | 529 | regulation of transmembrane transport |
GO:0048598 | 0.0015 | 2.6711 | 5.5589 | 14 | 296 | embryonic morphogenesis |
GO:0048701 | 0.0015 | 6.6213 | 0.8469 | 5 | 44 | embryonic cranial skeleton morphogenesis |
GO:0034330 | 0.0015 | 2.0974 | 11.6258 | 23 | 609 | cell junction organization |
GO:0001503 | 0.0015 | 2.3974 | 7.5069 | 17 | 390 | ossification |
GO:0006811 | 0.0016 | 1.794 | 21.4551 | 36 | 1141 | ion transport |
GO:0007276 | 0.0016 | 2.0488 | 12.4152 | 24 | 645 | gamete generation |
GO:0030316 | 0.0016 | 4.4255 | 1.7131 | 7 | 89 | osteoclast differentiation |
GO:0048661 | 0.0016 | 4.4255 | 1.7131 | 7 | 89 | positive regulation of smooth muscle cell proliferation |
GO:0046717 | 0.0017 | 6.4554 | 0.8662 | 5 | 45 | acid secretion |
GO:0048935 | 0.0018 | 15.4227 | 0.2502 | 3 | 13 | peripheral nervous system neuron development |
GO:0002269 | 0.0018 | 6.2975 | 0.8854 | 5 | 46 | leukocyte activation involved in inflammatory response |
GO:0035924 | 0.0019 | 5.007 | 1.3089 | 6 | 68 | cellular response to vascular endothelial growth factor stimulus |
GO:0045123 | 0.0019 | 5.007 | 1.3089 | 6 | 68 | cellular extravasation |
GO:0070374 | 0.002 | 2.9884 | 3.9074 | 11 | 203 | positive regulation of ERK1 and ERK2 cascade |
GO:0014743 | 0.0021 | 4.9272 | 1.3281 | 6 | 69 | regulation of muscle hypertrophy |
GO:0002521 | 0.0021 | 2.1572 | 9.7974 | 20 | 509 | leukocyte differentiation |
GO:0070093 | 0.0022 | 51.2707 | 0.077 | 2 | 4 | negative regulation of glucagon secretion |
GO:0072278 | 0.0022 | 51.2707 | 0.077 | 2 | 4 | metanephric comma-shaped body morphogenesis |
GO:0097476 | 0.0022 | 51.2707 | 0.077 | 2 | 4 | spinal cord motor neuron migration |
GO:2000491 | 0.0022 | 51.2707 | 0.077 | 2 | 4 | positive regulation of hepatic stellate cell activation |
GO:0006026 | 0.0022 | 8.2441 | 0.5582 | 4 | 29 | aminoglycan catabolic process |
GO:0014744 | 0.0022 | 14.0198 | 0.2695 | 3 | 14 | positive regulation of muscle adaptation |
GO:0034332 | 0.0022 | 6.0039 | 0.9239 | 5 | 48 | adherens junction organization |
GO:0014897 | 0.0022 | 4.1698 | 1.8093 | 7 | 94 | striated muscle hypertrophy |
GO:0045665 | 0.0023 | 4.8499 | 1.3474 | 6 | 70 | negative regulation of neuron differentiation |
GO:0030001 | 0.0023 | 1.8868 | 15.7259 | 28 | 817 | metal ion transport |
GO:0010562 | 0.0023 | 1.8843 | 15.7451 | 28 | 818 | positive regulation of phosphorus metabolic process |
GO:0050670 | 0.0026 | 2.882 | 4.0422 | 11 | 210 | regulation of lymphocyte proliferation |
GO:0061900 | 0.0027 | 5.7363 | 0.9624 | 5 | 50 | glial cell activation |
GO:0072348 | 0.0027 | 5.7363 | 0.9624 | 5 | 50 | sulfur compound transport |
GO:0042327 | 0.0027 | 1.9097 | 14.3978 | 26 | 748 | positive regulation of phosphorylation |
GO:0023052 | 0.0028 | 1.3879 | 110.9282 | 135 | 5763 | signaling |
GO:0001764 | 0.003 | 3.226 | 2.9642 | 9 | 154 | neuron migration |
GO:0060041 | 0.003 | 3.5194 | 2.424 | 8 | 127 | retina development in camera-type eye |
GO:0048589 | 0.0031 | 2.0061 | 11.5683 | 22 | 601 | developmental growth |
GO:0031346 | 0.0031 | 2.45 | 6.0247 | 14 | 313 | positive regulation of cell projection organization |
GO:0009954 | 0.0032 | 7.3594 | 0.6159 | 4 | 32 | proximal/distal pattern formation |
GO:2000352 | 0.0032 | 7.3594 | 0.6159 | 4 | 32 | negative regulation of endothelial cell apoptotic process |
GO:0030879 | 0.0032 | 3.4884 | 2.4445 | 8 | 127 | mammary gland development |
GO:0006029 | 0.0032 | 4.4971 | 1.4436 | 6 | 75 | proteoglycan metabolic process |
GO:0045765 | 0.0033 | 2.4334 | 6.0632 | 14 | 315 | regulation of angiogenesis |
GO:0060749 | 0.0033 | 11.8614 | 0.308 | 3 | 16 | mammary gland alveolus development |
GO:0021510 | 0.0033 | 4.4711 | 1.4508 | 6 | 76 | spinal cord development |
GO:0043270 | 0.0034 | 2.631 | 4.8121 | 12 | 250 | positive regulation of ion transport |
GO:0001763 | 0.0034 | 2.9401 | 3.5994 | 10 | 187 | morphogenesis of a branching structure |
GO:0002064 | 0.0034 | 2.9401 | 3.5994 | 10 | 187 | epithelial cell development |
GO:0048562 | 0.0034 | 2.5156 | 5.4473 | 13 | 283 | embryonic organ morphogenesis |
GO:0030030 | 0.0034 | 1.7294 | 20.891 | 34 | 1114 | cell projection organization |
GO:0019800 | 0.0036 | 34.1783 | 0.0962 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0021855 | 0.0036 | 34.1783 | 0.0962 | 2 | 5 | hypothalamus cell migration |
GO:0033591 | 0.0036 | 34.1783 | 0.0962 | 2 | 5 | response to L-ascorbic acid |
GO:0060059 | 0.0036 | 34.1783 | 0.0962 | 2 | 5 | embryonic retina morphogenesis in camera-type eye |
GO:0060298 | 0.0036 | 34.1783 | 0.0962 | 2 | 5 | positive regulation of sarcomere organization |
GO:0060482 | 0.0036 | 34.1783 | 0.0962 | 2 | 5 | lobar bronchus development |
GO:0070779 | 0.0036 | 34.1783 | 0.0962 | 2 | 5 | D-aspartate import across plasma membrane |
GO:0072103 | 0.0036 | 34.1783 | 0.0962 | 2 | 5 | glomerulus vasculature morphogenesis |
GO:0007517 | 0.0036 | 2.4089 | 6.121 | 14 | 318 | muscle organ development |
GO:0007283 | 0.0036 | 2.0909 | 9.5664 | 19 | 497 | spermatogenesis |
GO:0014068 | 0.0039 | 4.3089 | 1.5014 | 6 | 78 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0048708 | 0.0039 | 4.3089 | 1.5014 | 6 | 78 | astrocyte differentiation |
GO:0050727 | 0.0039 | 2.3032 | 6.8524 | 15 | 356 | regulation of inflammatory response |
GO:1903978 | 0.0039 | 11.0135 | 0.3272 | 3 | 17 | regulation of microglial cell activation |
GO:0021543 | 0.004 | 3.0761 | 3.099 | 9 | 161 | pallium development |
GO:0007409 | 0.004 | 2.2271 | 7.5564 | 16 | 395 | axonogenesis |
GO:0008217 | 0.0042 | 3.0558 | 3.1182 | 9 | 162 | regulation of blood pressure |
GO:0006875 | 0.0043 | 2.0165 | 10.4326 | 20 | 542 | cellular metal ion homeostasis |
GO:0060840 | 0.0044 | 3.6617 | 2.0403 | 7 | 106 | artery development |
GO:0044057 | 0.0045 | 2.0086 | 10.4711 | 20 | 544 | regulation of system process |
GO:0002523 | 0.0047 | 10.2786 | 0.3465 | 3 | 18 | leukocyte migration involved in inflammatory response |
GO:0019373 | 0.0047 | 10.2786 | 0.3465 | 3 | 18 | epoxygenase P450 pathway |
GO:0043651 | 0.0047 | 10.2786 | 0.3465 | 3 | 18 | linoleic acid metabolic process |
GO:0060644 | 0.0047 | 10.2786 | 0.3465 | 3 | 18 | mammary gland epithelial cell differentiation |
GO:0061298 | 0.0047 | 10.2786 | 0.3465 | 3 | 18 | retina vasculature development in camera-type eye |
GO:0015711 | 0.0047 | 2.3307 | 6.3135 | 14 | 328 | organic anion transport |
GO:0070482 | 0.0047 | 2.4155 | 5.659 | 13 | 294 | response to oxygen levels |
GO:0043524 | 0.0048 | 3.2413 | 2.6178 | 8 | 136 | negative regulation of neuron apoptotic process |
GO:0051281 | 0.0049 | 6.4379 | 0.6929 | 4 | 36 | positive regulation of release of sequestered calcium ion into cytosol |
GO:0070306 | 0.0049 | 6.4379 | 0.6929 | 4 | 36 | lens fiber cell differentiation |
GO:0002694 | 0.005 | 2.0253 | 9.8552 | 19 | 512 | regulation of leukocyte activation |
GO:0006952 | 0.005 | 1.5891 | 28.7763 | 43 | 1495 | defense response |
GO:0007043 | 0.0051 | 3.2159 | 2.637 | 8 | 137 | cell-cell junction assembly |
GO:0042127 | 0.0051 | 1.6252 | 25.4983 | 39 | 1353 | regulation of cell population proliferation |
GO:0030900 | 0.0051 | 2.3062 | 6.3768 | 14 | 334 | forebrain development |
GO:0003278 | 0.0053 | 25.6322 | 0.1155 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0009253 | 0.0053 | 25.6322 | 0.1155 | 2 | 6 | peptidoglycan catabolic process |
GO:0042940 | 0.0053 | 25.6322 | 0.1155 | 2 | 6 | D-amino acid transport |
GO:0055009 | 0.0053 | 25.6322 | 0.1155 | 2 | 6 | atrial cardiac muscle tissue morphogenesis |
GO:0072284 | 0.0053 | 25.6322 | 0.1155 | 2 | 6 | metanephric S-shaped body morphogenesis |
GO:0032504 | 0.0054 | 1.8048 | 15.1677 | 26 | 788 | multicellular organism reproduction |
GO:0060421 | 0.0054 | 6.2424 | 0.7122 | 4 | 37 | positive regulation of heart growth |
GO:0016082 | 0.0054 | 9.6356 | 0.3657 | 3 | 19 | synaptic vesicle priming |
GO:0032835 | 0.0055 | 4.7776 | 1.1357 | 5 | 59 | glomerulus development |
GO:0070663 | 0.0056 | 2.5797 | 4.4849 | 11 | 233 | regulation of leukocyte proliferation |
GO:0030901 | 0.0056 | 3.9759 | 1.6169 | 6 | 84 | midbrain development |
GO:0007600 | 0.0058 | 1.7924 | 15.2639 | 26 | 793 | sensory perception |
GO:0048534 | 0.0059 | 1.7908 | 15.2818 | 26 | 802 | hematopoietic or lymphoid organ development |
GO:0030324 | 0.0059 | 2.8844 | 3.2915 | 9 | 171 | lung development |
GO:0050767 | 0.0062 | 2.2503 | 6.5252 | 14 | 339 | regulation of neurogenesis |
GO:1990266 | 0.0062 | 3.4184 | 2.1751 | 7 | 113 | neutrophil migration |
GO:0048754 | 0.0063 | 3.095 | 2.7333 | 8 | 142 | branching morphogenesis of an epithelial tube |
GO:0045944 | 0.0063 | 1.6539 | 21.7121 | 34 | 1128 | positive regulation of transcription by RNA polymerase II |
GO:0060548 | 0.0063 | 1.7249 | 17.7085 | 29 | 920 | negative regulation of cell death |
GO:0002042 | 0.0063 | 3.876 | 1.6554 | 6 | 86 | cell migration involved in sprouting angiogenesis |
GO:1905330 | 0.0063 | 4.6064 | 1.1741 | 5 | 61 | regulation of morphogenesis of an epithelium |
GO:0021516 | 0.0063 | 9.0682 | 0.385 | 3 | 20 | dorsal spinal cord development |
GO:0007399 | 0.0063 | 1.9141 | 11.5896 | 21 | 686 | nervous system development |
GO:0022414 | 0.0064 | 1.5976 | 25.8505 | 39 | 1343 | reproductive process |
GO:0050905 | 0.0065 | 3.0719 | 2.7525 | 8 | 143 | neuromuscular process |
GO:0031589 | 0.0065 | 2.2362 | 6.5637 | 14 | 341 | cell-substrate adhesion |
GO:0072210 | 0.0065 | 5.885 | 0.7507 | 4 | 39 | metanephric nephron development |
GO:1902414 | 0.0066 | 3.828 | 1.6746 | 6 | 87 | protein localization to cell junction |
GO:0006935 | 0.0067 | 1.9286 | 10.8753 | 20 | 565 | chemotaxis |
GO:0051896 | 0.0069 | 2.8142 | 3.3685 | 9 | 175 | regulation of protein kinase B signaling |
GO:0032924 | 0.0071 | 5.7212 | 0.7699 | 4 | 40 | activin receptor signaling pathway |
GO:0051347 | 0.0072 | 1.9517 | 10.2016 | 19 | 530 | positive regulation of transferase activity |
GO:0061037 | 0.0072 | 20.6765 | 0.1336 | 2 | 7 | negative regulation of cartilage development |
GO:0048645 | 0.0072 | 4.447 | 1.2126 | 5 | 63 | animal organ formation |
GO:0150146 | 0.0073 | 8.5639 | 0.4042 | 3 | 21 | cell junction disassembly |
GO:0015840 | 0.0073 | 20.5045 | 0.1347 | 2 | 7 | urea transport |
GO:0060215 | 0.0073 | 20.5045 | 0.1347 | 2 | 7 | primitive hemopoiesis |
GO:0061438 | 0.0073 | 20.5045 | 0.1347 | 2 | 7 | renal system vasculature morphogenesis |
GO:0071805 | 0.0074 | 2.6114 | 4.0229 | 10 | 209 | potassium ion transmembrane transport |
GO:0098771 | 0.0074 | 1.8221 | 13.2429 | 23 | 688 | inorganic ion homeostasis |
GO:0048513 | 0.0078 | 1.5967 | 25.4597 | 38 | 1509 | animal organ development |
GO:0001504 | 0.0078 | 5.5662 | 0.7892 | 4 | 41 | neurotransmitter uptake |
GO:0030534 | 0.0078 | 3.2645 | 2.2701 | 7 | 119 | adult behavior |
GO:0030856 | 0.008 | 2.9612 | 2.8488 | 8 | 148 | regulation of epithelial cell differentiation |
GO:0003018 | 0.0081 | 2.4455 | 4.7158 | 11 | 245 | vascular process in circulatory system |
GO:0051962 | 0.0081 | 2.4455 | 4.7158 | 11 | 245 | positive regulation of nervous system development |
GO:0003012 | 0.0081 | 2.0565 | 8.142 | 16 | 423 | muscle system process |
GO:0086013 | 0.0083 | 8.1127 | 0.4235 | 3 | 22 | membrane repolarization during cardiac muscle cell action potential |
GO:2000179 | 0.0083 | 5.4523 | 0.8037 | 4 | 42 | positive regulation of neural precursor cell proliferation |
GO:0006873 | 0.0083 | 1.8552 | 11.857 | 21 | 616 | cellular ion homeostasis |
GO:0035850 | 0.0085 | 5.4194 | 0.8084 | 4 | 42 | epithelial cell differentiation involved in kidney development |
GO:0032355 | 0.0086 | 3.2052 | 2.3098 | 7 | 120 | response to estradiol |
GO:0043583 | 0.0087 | 2.5466 | 4.1191 | 10 | 214 | ear development |
GO:0042063 | 0.0087 | 2.3145 | 5.428 | 12 | 282 | gliogenesis |
GO:0033002 | 0.0089 | 2.534 | 4.1384 | 10 | 215 | muscle cell proliferation |
GO:0043410 | 0.0091 | 2.4021 | 4.7968 | 11 | 255 | positive regulation of MAPK cascade |
GO:0032309 | 0.0092 | 5.2801 | 0.8277 | 4 | 43 | icosanoid secretion |
GO:0045840 | 0.0092 | 5.2801 | 0.8277 | 4 | 43 | positive regulation of mitotic nuclear division |
GO:0048538 | 0.0092 | 5.2801 | 0.8277 | 4 | 43 | thymus development |
GO:0016477 | 0.0093 | 1.7627 | 14.3087 | 24 | 792 | cell migration |
GO:0001759 | 0.0094 | 7.7065 | 0.4427 | 3 | 23 | organ induction |
GO:0021895 | 0.0094 | 7.7065 | 0.4427 | 3 | 23 | cerebral cortex neuron differentiation |
GO:0032331 | 0.0094 | 7.7065 | 0.4427 | 3 | 23 | negative regulation of chondrocyte differentiation |
GO:0097150 | 0.0094 | 7.7065 | 0.4427 | 3 | 23 | neuronal stem cell population maintenance |
GO:0003223 | 0.0096 | 17.086 | 0.154 | 2 | 8 | ventricular compact myocardium morphogenesis |
GO:0021940 | 0.0096 | 17.086 | 0.154 | 2 | 8 | positive regulation of cerebellar granule cell precursor proliferation |
GO:0072239 | 0.0096 | 17.086 | 0.154 | 2 | 8 | metanephric glomerulus vasculature development |
GO:0003206 | 0.0097 | 3.1217 | 2.3675 | 7 | 123 | cardiac chamber morphogenesis |
GO:0042476 | 0.0097 | 3.1217 | 2.3675 | 7 | 123 | odontogenesis |
GO:0032102 | 0.0098 | 2.0617 | 7.6031 | 15 | 395 | negative regulation of response to external stimulus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0061737 | 2e-04 | Inf | 2e-04 | 1 | 4 | leukotriene signaling pathway |
GO:0007200 | 0.0056 | Inf | 0.0056 | 1 | 92 | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO:0007218 | 0.006 | Inf | 0.006 | 1 | 99 | neuropeptide signaling pathway |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048843 | 0.0016 | Inf | 0.0016 | 1 | 26 | negative regulation of axon extension involved in axon guidance |
GO:1902284 | 0.0022 | Inf | 0.0022 | 1 | 36 | neuron projection extension involved in neuron projection guidance |
GO:0071526 | 0.0024 | Inf | 0.0024 | 1 | 40 | semaphorin-plexin signaling pathway |
GO:0050919 | 0.0028 | Inf | 0.0028 | 1 | 46 | negative chemotaxis |
GO:0001755 | 0.0035 | Inf | 0.0035 | 1 | 58 | neural crest cell migration |
GO:0050771 | 0.0036 | Inf | 0.0036 | 1 | 59 | negative regulation of axonogenesis |
GO:0030516 | 0.0052 | Inf | 0.0052 | 1 | 85 | regulation of axon extension |
GO:0014031 | 0.0052 | Inf | 0.0052 | 1 | 86 | mesenchymal cell development |
GO:0048864 | 0.0052 | Inf | 0.0052 | 1 | 86 | stem cell development |
GO:0014033 | 0.0055 | Inf | 0.0055 | 1 | 91 | neural crest cell differentiation |
GO:0048640 | 0.0064 | Inf | 0.0064 | 1 | 105 | negative regulation of developmental growth |
GO:0051961 | 0.0083 | Inf | 0.0083 | 1 | 137 | negative regulation of nervous system development |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050877 | 0.006 | Inf | 0.1556 | 2 | 1277 | nervous system process |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0018685 | 0 | 1359.5833 | 0.0034 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0102033 | 0 | 543.7333 | 0.006 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0008392 | 1e-04 | 209.0256 | 0.0129 | 2 | 15 | arachidonic acid epoxygenase activity |
GO:0070330 | 1e-04 | 142.9649 | 0.018 | 2 | 21 | aromatase activity |
GO:0020037 | 1e-04 | 36.5049 | 0.1063 | 3 | 124 | heme binding |
GO:0005506 | 2e-04 | 33.1866 | 0.1166 | 3 | 136 | iron ion binding |
GO:0102116 | 9e-04 | Inf | 9e-04 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 9e-04 | Inf | 9e-04 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0004984 | 0.0017 | 15.5077 | 0.2443 | 3 | 285 | olfactory receptor activity |
GO:0008389 | 0.0017 | 1255.0769 | 0.0017 | 1 | 2 | coumarin 7-hydroxylase activity |
GO:0042284 | 0.0017 | 1255.0769 | 0.0017 | 1 | 2 | sphingolipid delta-4 desaturase activity |
GO:0050251 | 0.0017 | 1255.0769 | 0.0017 | 1 | 2 | retinol isomerase activity |
GO:0016491 | 0.0019 | 9.5646 | 0.5649 | 4 | 659 | oxidoreductase activity |
GO:0008391 | 0.0029 | 493.9697 | 0.0029 | 1 | 4 | arachidonic acid monooxygenase activity |
GO:0050051 | 0.0043 | 313.7115 | 0.0043 | 1 | 5 | leukotriene-B4 20-monooxygenase activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 8.1186 | 2.7831 | 19 | 303 | protein heterodimerization activity |
GO:0005509 | 0 | 4.6709 | 6.0437 | 24 | 658 | calcium ion binding |
GO:0019904 | 0 | 4.437 | 5.7483 | 22 | 630 | protein domain specific binding |
GO:0003730 | 4e-04 | 4.9525 | 1.7451 | 8 | 190 | mRNA 3'-UTR binding |
GO:1903231 | 0.001 | 4.2235 | 2.0299 | 8 | 221 | mRNA base-pairing post-transcriptional repressor activity |
GO:0047035 | 0.0017 | 43.7189 | 0.0643 | 2 | 7 | testosterone dehydrogenase (NAD+) activity |
GO:0003723 | 0.0024 | 1.9283 | 16.0645 | 28 | 1749 | RNA binding |
GO:0005132 | 0.0029 | 31.2239 | 0.0827 | 2 | 9 | type I interferon receptor binding |
GO:0019531 | 0.0029 | 31.2239 | 0.0827 | 2 | 9 | oxalate transmembrane transporter activity |
GO:0045182 | 0.0043 | 3.0471 | 3.1321 | 9 | 341 | translation regulator activity |
GO:0005095 | 0.0052 | 21.8527 | 0.1102 | 2 | 12 | GTPase inhibitor activity |
GO:0008271 | 0.0052 | 21.8527 | 0.1102 | 2 | 12 | secondary active sulfate transmembrane transporter activity |
GO:0044594 | 0.0061 | 19.8649 | 0.1194 | 2 | 13 | 17-beta-hydroxysteroid dehydrogenase (NAD+) activity |
GO:0004503 | 0.0092 | Inf | 0.0092 | 1 | 1 | tyrosinase activity |
GO:0008811 | 0.0092 | Inf | 0.0092 | 1 | 1 | chloramphenicol O-acetyltransferase activity |
GO:0031751 | 0.0092 | Inf | 0.0092 | 1 | 1 | D4 dopamine receptor binding |
GO:0032089 | 0.0092 | Inf | 0.0092 | 1 | 1 | NACHT domain binding |
GO:0047743 | 0.0092 | Inf | 0.0092 | 1 | 1 | chlordecone reductase activity |
GO:0047969 | 0.0092 | Inf | 0.0092 | 1 | 1 | glyoxylate oxidase activity |
GO:0052665 | 0.0092 | Inf | 0.0092 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 10.003 | 3.2469 | 26 | 303 | protein heterodimerization activity |
GO:0005509 | 0 | 5.3318 | 7.051 | 31 | 658 | calcium ion binding |
GO:0019904 | 0 | 3.2828 | 6.7617 | 20 | 631 | protein domain specific binding |
GO:0045296 | 2e-04 | 3.8133 | 3.4076 | 12 | 318 | cadherin binding |
GO:0003730 | 0.001 | 4.2045 | 2.036 | 8 | 190 | mRNA 3'-UTR binding |
GO:0003677 | 0.0018 | 1.7834 | 24.3999 | 39 | 2277 | DNA binding |
GO:0016803 | 0.0039 | 26.6705 | 0.0964 | 2 | 9 | ether hydrolase activity |
GO:0005095 | 0.007 | 18.6659 | 0.1286 | 2 | 12 | GTPase inhibitor activity |
GO:0048020 | 0.0072 | 8.2705 | 0.3965 | 3 | 37 | CCR chemokine receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008191 | 0.0046 | 291.2857 | 0.0046 | 1 | 15 | metalloendopeptidase inhibitor activity |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005242 | 2e-04 | 17.0108 | 0.2794 | 4 | 27 | inward rectifier potassium channel activity |
GO:0005518 | 7e-04 | 7.7908 | 0.7037 | 5 | 68 | collagen binding |
GO:0005267 | 0.0014 | 5.275 | 1.2211 | 6 | 118 | potassium channel activity |
GO:0001664 | 0.0017 | 3.5089 | 2.732 | 9 | 264 | G protein-coupled receptor binding |
GO:0015276 | 0.0025 | 4.6848 | 1.366 | 6 | 132 | ligand-gated ion channel activity |
GO:0022843 | 0.0033 | 4.4363 | 1.4384 | 6 | 139 | voltage-gated cation channel activity |
GO:0004875 | 0.0045 | 24.1826 | 0.1035 | 2 | 10 | complement receptor activity |
GO:0019825 | 0.0051 | 9.404 | 0.3518 | 3 | 34 | oxygen binding |
GO:0022836 | 0.0051 | 2.9541 | 3.2184 | 9 | 311 | gated channel activity |
GO:0038023 | 0.0054 | 1.9024 | 13.0287 | 23 | 1259 | signaling receptor activity |
GO:0099186 | 0.0066 | 19.3437 | 0.1242 | 2 | 12 | structural constituent of postsynapse |
GO:0005179 | 0.0066 | 4.4901 | 1.1797 | 5 | 114 | hormone activity |
GO:0005539 | 0.0071 | 3.3143 | 2.2249 | 7 | 215 | glycosaminoglycan binding |
GO:0008237 | 0.009 | 3.547 | 1.7799 | 6 | 172 | metallopeptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048407 | 0 | 30.8283 | 0.2027 | 4 | 11 | platelet-derived growth factor binding |
GO:0005267 | 1e-04 | 5.0662 | 2.1749 | 10 | 118 | potassium channel activity |
GO:0005201 | 2e-04 | 4.0428 | 2.949 | 11 | 160 | extracellular matrix structural constituent |
GO:0005518 | 2e-04 | 6.233 | 1.2533 | 7 | 68 | collagen binding |
GO:0001228 | 4e-04 | 2.5669 | 7.907 | 19 | 429 | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO:0005178 | 4e-04 | 3.9287 | 2.7462 | 10 | 149 | integrin binding |
GO:0005017 | 0.001 | 107.2174 | 0.0553 | 2 | 3 | platelet-derived growth factor-activated receptor activity |
GO:0022843 | 0.0011 | 3.7698 | 2.5619 | 9 | 139 | voltage-gated cation channel activity |
GO:0086008 | 0.0015 | 16.1275 | 0.2396 | 3 | 13 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization |
GO:0003700 | 0.0015 | 1.7555 | 23.8131 | 39 | 1292 | DNA-binding transcription factor activity |
GO:0030546 | 0.0017 | 2.3075 | 8.2572 | 18 | 448 | signaling receptor activator activity |
GO:0000978 | 0.002 | 1.7984 | 20.1637 | 34 | 1094 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0008745 | 0.002 | 53.6054 | 0.0737 | 2 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0018685 | 0.002 | 53.6054 | 0.0737 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0038085 | 0.002 | 53.6054 | 0.0737 | 2 | 4 | vascular endothelial growth factor binding |
GO:0008392 | 0.0024 | 13.4379 | 0.2765 | 3 | 15 | arachidonic acid epoxygenase activity |
GO:0022832 | 0.0026 | 3.0603 | 3.4651 | 10 | 188 | voltage-gated channel activity |
GO:0016019 | 0.0033 | 35.7347 | 0.0922 | 2 | 5 | peptidoglycan immune receptor activity |
GO:0098973 | 0.0033 | 35.7347 | 0.0922 | 2 | 5 | structural constituent of postsynaptic actin cytoskeleton |
GO:0098918 | 0.0041 | 10.7483 | 0.3318 | 3 | 18 | structural constituent of synapse |
GO:0005539 | 0.0042 | 5.0887 | 1.0687 | 5 | 59 | glycosaminoglycan binding |
GO:0015272 | 0.0048 | 26.7993 | 0.1106 | 2 | 6 | ATP-activated inward rectifier potassium channel activity |
GO:0070697 | 0.0048 | 26.7993 | 0.1106 | 2 | 6 | activin receptor binding |
GO:0005179 | 0.0052 | 3.5432 | 2.1012 | 7 | 114 | hormone activity |
GO:0005242 | 0.0063 | 9.0135 | 0.3846 | 3 | 21 | inward rectifier potassium channel activity |
GO:0070330 | 0.0064 | 8.9553 | 0.3871 | 3 | 21 | aromatase activity |
GO:0102033 | 0.0067 | 21.4381 | 0.129 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0004497 | 0.0078 | 3.6846 | 1.7325 | 6 | 94 | monooxygenase activity |
GO:0020037 | 0.0081 | 3.2383 | 2.2855 | 7 | 124 | heme binding |
GO:0008198 | 0.0084 | 8.0587 | 0.4239 | 3 | 23 | ferrous iron binding |
GO:0000976 | 0.0084 | 1.5788 | 25.4719 | 38 | 1382 | transcription cis-regulatory region binding |
GO:0008201 | 0.0084 | 2.93 | 2.8753 | 8 | 156 | heparin binding |
GO:0003690 | 0.009 | 1.5457 | 28.1076 | 41 | 1525 | double-stranded DNA binding |
GO:0033612 | 0.0094 | 7.6745 | 0.4423 | 3 | 24 | receptor serine/threonine kinase binding |
GO:0016705 | 0.0097 | 2.8522 | 2.949 | 8 | 160 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001632 | 1e-04 | Inf | 1e-04 | 1 | 2 | leukotriene B4 receptor activity |
GO:0004953 | 9e-04 | Inf | 9e-04 | 1 | 14 | icosanoid receptor activity |
GO:0008528 | 0.0081 | Inf | 0.0081 | 1 | 133 | G protein-coupled peptide receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000979 | 5e-04 | 70.9586 | 0.0337 | 2 | 19 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0046539 | 0.0018 | Inf | 0.0018 | 1 | 1 | histamine N-methyltransferase activity |
GO:0052665 | 0.0018 | Inf | 0.0018 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GO:0031492 | 0.002 | 34.4275 | 0.0657 | 2 | 37 | nucleosomal DNA binding |
GO:0001730 | 0.0053 | 291.0714 | 0.0053 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
GO:0005509 | 0.0056 | 4.9927 | 1.1685 | 5 | 658 | calcium ion binding |
GO:0019834 | 0.0088 | 145.5179 | 0.0089 | 1 | 5 | phospholipase A2 inhibitor activity |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030215 | 0.0014 | Inf | 0.0014 | 1 | 23 | semaphorin receptor binding |
GO:0045499 | 0.0017 | Inf | 0.0017 | 1 | 28 | chemorepellent activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 14.0989 | 2.4491 | 26 | 303 | protein heterodimerization activity |
GO:0019904 | 0 | 5.4109 | 5.1002 | 23 | 631 | protein domain specific binding |
GO:0045296 | 0 | 5.1938 | 2.5703 | 12 | 318 | cadherin binding |
GO:0005509 | 3e-04 | 3.1016 | 5.3185 | 15 | 658 | calcium ion binding |
GO:0003677 | 5e-04 | 2.0729 | 18.4045 | 33 | 2277 | DNA binding |
GO:0044325 | 0.0027 | 5.6045 | 0.9538 | 5 | 118 | transmembrane transporter binding |
GO:0005095 | 0.0041 | 24.9062 | 0.097 | 2 | 12 | GTPase inhibitor activity |
GO:0031432 | 0.0048 | 22.6406 | 0.1051 | 2 | 13 | titin binding |
GO:0004854 | 0.0081 | Inf | 0.0081 | 1 | 1 | xanthine dehydrogenase activity |
GO:0004855 | 0.0081 | Inf | 0.0081 | 1 | 1 | xanthine oxidase activity |
GO:0043185 | 0.0081 | Inf | 0.0081 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0052665 | 0.0081 | Inf | 0.0081 | 1 | 1 | tRNA (uracil-2'-O-)-methyltransferase activity |
GO:0070674 | 0.0081 | Inf | 0.0081 | 1 | 1 | hypoxanthine dehydrogenase activity |
GO:0070675 | 0.0081 | Inf | 0.0081 | 1 | 1 | hypoxanthine oxidase activity |
GO:0102483 | 0.0081 | Inf | 0.0081 | 1 | 1 | scopolin beta-glucosidase activity |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 3.4017 | 6.0906 | 19 | 285 | olfactory receptor activity |
GO:0030280 | 1e-04 | 9.6228 | 0.748 | 6 | 35 | structural constituent of skin epidermis |
GO:0071949 | 1e-04 | 9.3015 | 0.7693 | 6 | 36 | FAD binding |
GO:0004930 | 3e-04 | 2.1584 | 14.3823 | 29 | 673 | G protein-coupled receptor activity |
GO:0016015 | 3e-04 | 34.6344 | 0.1496 | 3 | 7 | morphogen activity |
GO:0004867 | 4e-04 | 5.0434 | 1.7524 | 8 | 82 | serine-type endopeptidase inhibitor activity |
GO:0036122 | 4e-04 | 14.2421 | 0.3633 | 4 | 17 | BMP binding |
GO:0005509 | 4e-04 | 2.1256 | 14.0617 | 28 | 658 | calcium ion binding |
GO:0030414 | 5e-04 | 3.5545 | 3.3338 | 11 | 156 | peptidase inhibitor activity |
GO:0061135 | 9e-04 | 3.3231 | 3.5475 | 11 | 166 | endopeptidase regulator activity |
GO:0005094 | 0.0013 | 92.1095 | 0.0641 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0038023 | 0.0026 | 1.6598 | 26.9053 | 42 | 1259 | signaling receptor activity |
GO:0035804 | 0.0027 | 46.0519 | 0.0855 | 2 | 4 | structural constituent of egg coat |
GO:0005102 | 0.0033 | 1.6198 | 28.8714 | 44 | 1351 | signaling receptor binding |
GO:0004869 | 0.0038 | 5.2649 | 1.0471 | 5 | 49 | cysteine-type endopeptidase inhibitor activity |
GO:0005134 | 0.0044 | 30.6993 | 0.1069 | 2 | 5 | interleukin-2 receptor binding |
GO:0032190 | 0.0044 | 30.6993 | 0.1069 | 2 | 5 | acrosin binding |
GO:0071855 | 0.0046 | 6.6062 | 0.6839 | 4 | 32 | neuropeptide receptor binding |
GO:0031849 | 0.0065 | 23.0231 | 0.1282 | 2 | 6 | olfactory receptor binding |
GO:0030546 | 0.008 | 1.9668 | 9.5739 | 18 | 448 | signaling receptor activator activity |
GO:0005549 | 0.0087 | 3.6133 | 1.7737 | 6 | 83 | odorant binding |
GO:0016714 | 0.0089 | 18.4173 | 0.1496 | 2 | 7 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 8.7994 | 2.4432 | 18 | 285 | olfactory receptor activity |
GO:0004930 | 0 | 4.8801 | 5.5816 | 23 | 660 | G protein-coupled receptor activity |
GO:0038023 | 0 | 3.3202 | 10.793 | 30 | 1259 | signaling receptor activity |
GO:0018685 | 0 | 354.5255 | 0.0343 | 3 | 4 | alkane 1-monooxygenase activity |
GO:0008392 | 0 | 43.262 | 0.1286 | 4 | 15 | arachidonic acid epoxygenase activity |
GO:0102033 | 0 | 88.615 | 0.06 | 3 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0070330 | 0 | 27.9827 | 0.18 | 4 | 21 | aromatase activity |
GO:0004497 | 2e-04 | 8.1935 | 0.8058 | 6 | 94 | monooxygenase activity |
GO:0020037 | 7e-04 | 6.099 | 1.063 | 6 | 124 | heme binding |
GO:0050051 | 7e-04 | 78.2029 | 0.0429 | 2 | 5 | leukotriene-B4 20-monooxygenase activity |
GO:0005506 | 0.0011 | 5.5319 | 1.1659 | 6 | 136 | iron ion binding |
GO:0016705 | 0.0024 | 4.7289 | 1.3534 | 6 | 159 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0030621 | 0.0025 | 33.5072 | 0.0772 | 2 | 9 | U4 snRNA binding |
GO:0005509 | 0.0043 | 2.4672 | 5.6408 | 13 | 658 | calcium ion binding |
GO:0045125 | 0.0053 | 21.3175 | 0.1114 | 2 | 13 | bioactive lipid receptor activity |
GO:0008403 | 0.0086 | Inf | 0.0086 | 1 | 1 | 25-hydroxycholecalciferol-24-hydroxylase activity |
GO:0030342 | 0.0086 | Inf | 0.0086 | 1 | 1 | 1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity |
GO:0045237 | 0.0086 | Inf | 0.0086 | 1 | 1 | CXCR1 chemokine receptor binding |
GO:0052871 | 0.0086 | Inf | 0.0086 | 1 | 1 | alpha-tocopherol omega-hydroxylase activity |
GO:0052872 | 0.0086 | Inf | 0.0086 | 1 | 1 | tocotrienol omega-hydroxylase activity |
GO:0062180 | 0.0086 | Inf | 0.0086 | 1 | 1 | 25-hydroxycholecalciferol-23-hydroxylase activity |
GO:0070089 | 0.0086 | Inf | 0.0086 | 1 | 1 | chloride-activated potassium channel activity |
GO:0102116 | 0.0086 | Inf | 0.0086 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0086 | Inf | 0.0086 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0004866 | 0.01 | 4.0423 | 1.303 | 5 | 152 | endopeptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 8.7273 | 2.4607 | 18 | 285 | olfactory receptor activity |
GO:0038023 | 0 | 3.5801 | 10.8701 | 32 | 1259 | signaling receptor activity |
GO:0004930 | 0 | 4.5803 | 5.622 | 22 | 660 | G protein-coupled receptor activity |
GO:0008392 | 3e-04 | 29.308 | 0.1295 | 3 | 15 | arachidonic acid epoxygenase activity |
GO:0008745 | 4e-04 | 116.4604 | 0.0345 | 2 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0018685 | 4e-04 | 116.4604 | 0.0345 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0016019 | 7e-04 | 77.6355 | 0.0432 | 2 | 5 | peptidoglycan immune receptor activity |
GO:0070330 | 7e-04 | 19.5314 | 0.1813 | 3 | 21 | aromatase activity |
GO:0030246 | 0.0013 | 4.0316 | 2.1239 | 8 | 246 | carbohydrate binding |
GO:0102033 | 0.0015 | 46.5755 | 0.0604 | 2 | 7 | long-chain fatty acid omega-hydroxylase activity |
GO:0045125 | 0.0054 | 21.1629 | 0.1122 | 2 | 13 | bioactive lipid receptor activity |
GO:0004867 | 0.0055 | 6.0311 | 0.708 | 4 | 82 | serine-type endopeptidase inhibitor activity |
GO:0042834 | 0.0063 | 19.3981 | 0.1209 | 2 | 14 | peptidoglycan binding |
GO:0097153 | 0.0063 | 19.3981 | 0.1209 | 2 | 14 | cysteine-type endopeptidase activity involved in apoptotic process |
GO:0000993 | 0.0082 | 7.7995 | 0.4144 | 3 | 48 | RNA polymerase II complex binding |
GO:0031798 | 0.0086 | Inf | 0.0086 | 1 | 1 | type 1 metabotropic glutamate receptor binding |
GO:0102116 | 0.0086 | Inf | 0.0086 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0086 | Inf | 0.0086 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0004497 | 0.0089 | 5.223 | 0.8116 | 4 | 94 | monooxygenase activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 7.7824 | 2.412 | 16 | 303 | protein heterodimerization activity |
GO:0019904 | 0 | 4.0868 | 5.023 | 18 | 631 | protein domain specific binding |
GO:0005509 | 1e-04 | 3.4014 | 5.2379 | 16 | 658 | calcium ion binding |
GO:0005095 | 0.0039 | 25.2984 | 0.0955 | 2 | 12 | GTPase inhibitor activity |
GO:0031751 | 0.008 | Inf | 0.008 | 1 | 1 | D4 dopamine receptor binding |
GO:0043185 | 0.008 | Inf | 0.008 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0071667 | 0.008 | Inf | 0.008 | 1 | 1 | DNA/RNA hybrid binding |
GO:0102483 | 0.008 | Inf | 0.008 | 1 | 1 | scopolin beta-glucosidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 7.9696 | 4.6013 | 30 | 303 | protein heterodimerization activity |
GO:0005509 | 0 | 3.658 | 9.9923 | 32 | 658 | calcium ion binding |
GO:0019904 | 1e-04 | 2.6018 | 9.5823 | 23 | 631 | protein domain specific binding |
GO:0045296 | 4e-04 | 3.1054 | 4.8291 | 14 | 318 | cadherin binding |
GO:0044325 | 0.0022 | 4.1794 | 1.7919 | 7 | 118 | transmembrane transporter binding |
GO:0140031 | 0.0033 | 32.6809 | 0.0911 | 2 | 6 | phosphorylation-dependent protein binding |
GO:0030215 | 0.0049 | 9.8345 | 0.3493 | 3 | 23 | semaphorin receptor binding |
GO:0019531 | 0.0077 | 18.6713 | 0.1367 | 2 | 9 | oxalate transmembrane transporter activity |
GO:0004867 | 0.0082 | 4.2772 | 1.2452 | 5 | 82 | serine-type endopeptidase inhibitor activity |
GO:0045499 | 0.0086 | 7.8651 | 0.4252 | 3 | 28 | chemorepellent activity |
GO:0030414 | 0.0099 | 3.1061 | 2.369 | 7 | 156 | peptidase inhibitor activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
No LOLA Enrichment Analysis was conducted